2016 ProgramBook PDF

2016
SCHEDULE & GENERAL INFO
NEXTGENERATION LEARNING
d PD-L1 answers
can trust?
s two new FDA-approved PD-L1 pharmDx kits.
ng is a promising new tool for pathologists, oncologists and

ts opening new treatment possibilities. Only Dako provides
th two FDA-approved PD-L1 tests for patients with NSCLC.
HC 22C3 pharmDx
HC 28-8 pharmDx
QR codes to the right for more information on either

r contact your local sales representative.
visit us at booth #630 during USCAP16 Annual Meeting.
e at www.dako.com.
PD-L1
IHC 28-8
pharmDx
PD-L1
IHC 22C3
pharmDx
Shield_White_2013
Sharing
multiplies
your
knowledge
Version 1.1 25 October 2013
IntelliSite is a new innovative platform to

advance your digital pathology initiatives.
High resolution images, collaboration features
and case management support tools can
help you make that next step in workflow
improvement and accelerate knowledge sharing
between care providers.
Leveraging decades of Philips experience in
clinical digital transformation, the IntelliSite
pathology solution can provide you the speed,
quality and scalability you need. Helping you to
build and share valued knowledge amongst your
clinical colleagues.
Visit us at USCAP 2016 at booth #1002 or

www.philips.com/digitalpathology
IntelliSite
Pathology Solutions
The sponsor of this ad verifies that they had no input into decision making regarding selection of
educational programs, content or faculty for this 2016 Annual Meeting.
Stand Out with Biocare

Visit Biocare at Booth #801 to see how your laboratory can partner with Biocares extensive product portfolio of IHC and ISH
reagents to stand above the rest. With innovative IHC antibodies, advanced FISH probes and automated instrumentation,
Biocare can meet all of your clinical and research laboratory needs.
Learn more about our top IHC antibodies like p40 [BC28],
CDH17, SOX10 (M) and ERG. Biocare has also released a
new IVD Multiplex of CK HMW + p63 + AMACR (RM) and
additional double-stains to aid in solving complex clinical cases.
TRIDENT FISH probes are generated using the most

advanced genomic data, minimizing false positives and false
negatives while providing clear and concise signals. del-TECT
4-color probes minimize false positives seen in FFPE tissues.
CK HMW + p63 + AMACR (RM)
CytoFISH
Order Online 24/7! www.biocare.net 800 949 9799 facebook.com/biocaremedical

The sponsor of this ad verifies that they had no input into decision making regarding selection of educational programs, content or faculty for this 2016 Annual Meeting.
W H E N YO U S U S P EC T
LARGE CELL
LYMPHOMA...
IHC TESTING FOR CD30 CAN
AID IN YOUR DIFFERENTIAL
DIAGNOSIS.1
Inspirata and Philips are delivering on

the promise and value aorded by
To learn more about the role

of CD30 IHC in lymphoma,
digital pathology. Together, our goal is

to transform the pathology workow
with automated tools, cloud-based
technologies and a unique delivery
model that will enable cancer institutions
to address the growing demand for
cancer diagnostic servicesboth locally
and globally.
Learn more about PathologyNEXTSM
at Booth #1102 during USCAP.
www.inspirata.com
VISIT BOOTH #1007
The sponsor of this ad verifies that they had no input into decision making regarding selection of educational
programs, content or faculty for this 2016 Annual Meeting.
The sponsor of this ad veries that they had no input

into decision making regarding selection of educational
Reference: 1. Higgins RA, Blankenship JE, Kinney MC. Application of immunohistochemistry in the diagnosis of non-Hodgkin
and Hodgkin lymphoma. Arch Pathol Lab Med. 2008;132(3):441-461.
Seattle Genetics and
are US registered trademarks of Seattle Genetics, Inc.
2015 Seattle Genetics, Inc., Bothell, WA 98021
All rights reserved. Printed in USA USP-DIS-2015-0108
Need PD-L1 answers

you can trust?
Dako has two new FDA-approved PD-L1 pharmDx kits.
PD-L1 testing is a promising new tool for pathologists, oncologists and
their patients opening new treatment possibilities. Only Dako provides
your lab with two FDA-approved PD-L1 tests for patients with NSCLC.
PD-L1 IHC 22C3 pharmDx
PD-L1 IHC 28-8 pharmDx
Scan the QR codes to the right for more information on either

product, or contact your local sales representative.
Be sure to visit us at booth #630 during USCAP16 Annual Meeting.
PD-L1
IHC 28-8
pharmDx
PD-L1
IHC 22C3
pharmDx
Learn more at www.dako.com.
The sponsor of this ad verifies that they had no input

50242 2015NOV06
50242 2015NOV06 USCAP16 Program Advert_halfpage_horizontal.indd 1
06-11-2015 14:11:45
Official Silver Sponsor of USCAP 16 Booth #1018
Comprehensive Diagnostic and Predictive

Molecular Pathology Services including:
l
PD-L1 by IHC for Non-Small Cell Lung Cancer
Expanded RAS and RAF Predictive Testing for Colorectal Cancer
IntelliGEN Next Generation Sequencing Therapeutic Panel
Prosigna Breast Cancer Prognostic Gene Signature Assay
Reveal SNP Array for Hematologic Malignancies
Because Knowledge is a Powerful Tool.

To learn more about our test offerings,
please visit www.integratedoncology.com.
Prosigna is a registered trademark of NanoString Technologies, Inc.

2015 Laboratory Corporation of America Holdings. All rights reserved.
onc-887-v1-1115
Bristol-Myers Squibb
At the Forefront of Immuno-Oncology
Pathologists
ADVANCING
IMMUNE BIOMARKER
RESEARCH
Subspecialties
Lab for all your

Anatomic & Molecular
Pathology Needs
Empower your practice with support
from the largest, most diverse private
laboratory in the Pacific North West.
CellNetix was built by pathologists with
the commitment to provide unbeatable
accuracy, service, and value to our
patients and providers.
Discover how our exploration of

immune biomarkers is continuing
to shape research advances in
Immuno-Oncology
Visit us at Booth #433 and

ImmunoOncologyHCP.com
into decision-making regarding selection of educational
programs, content, or faculty for this 2016 Annual Meeting.
Symbiodx TM , Powered by CellNetix and PAML
P
into decision-making regarding selection of educational
programs, content, or faculty for this 2016 Annual Meeting.
IOUS1600010-01-01 01/16
2016 Bristol-Myers Squibb Company.
GLOBAL. EMPATHY.
UNDERSERVED.
PHILANTHROPY.
TECHNOLOGY. NEED.
DIGITAL OUTREACH.
KNOWLEDGE TRANSFER.
RESPONSIBILITY.
Creating a Better Pathologist

for a Healthier World.
www.USCAPFoundation.org
WHAT IS THE SINGLE BIGGEST CAUSE OF DEATH FOR WOMEN,

FOR CHILDREN UNDER AGE 5, IN THE DEVELOPING WORLD?
HUT LUNG: A POIGNANT PORTRAIT

This lecture reinforces the humanitarian
power of art in the context of diseases
affecting women in low-resource countries.
SPECIAL EVENT!
Monday, March 14, 6:15-7:00 PM
Hall 4E
Washington State Convention Center
THOMAS V. COLBY, M.D.

Distinguished Pulmonary
Pathologist
ANNIE GRIFFITHS
International
Photojournalist
AMI VITALE | RIPPLE EFFECT IMAGES
NEXTGENERATION LEARNING 20
2016 TABLE OF CONTENTS
TAB 1 SCHEDULE & GENERAL INFORMATION
TAB 5 SPECIAL COURSES
Certificate of CME/SAM Credit or Participation ........................... p. 3

Coffee Breaks/Headshot Lounge Open ......................................... p. 4
Daily Program Outline/Meeting at a Glance ............................ p. 5-12
Sheraton Convention Hall Floor Plans ........................................ p. 13
Washington State Convention Center Floor Plans................ p. 14-17
Exhibit Hall Information and Floor Plan...................................... p. 18
Poster Pickup and Viewing Station ............................................. p. 19
USCAP Secretariat Information ................................................... p. 19
Past Presidents and Secretary-Treasurers .................................. p. 20
In Memoriam of Past Members ................................................... p. 21
USCAP Board and Committee Members............................... p. 22-30
2016 Business Meeting Agenda ................................................. p. 31
2015 Business Meeting Minutes............................................. p. 32-34
International Academy of Pathology Session ............................ p. 35
2016 Affiliate Events ................................................................ p. 36-38
Saturday Residents Workshop: Genomic Medicine for

Pathologists: What You Need to Know .................................. p. 81-82
Saturday Residents Workshop: Leadership,
Collaboration and Change in Health Care
Essential Skills. ........................................................................ p. 83-84
Monday Clinical Application of Next Generation
Sequencing for the Management of Patients with
Solid Tumors ................................................................................. p. 85
Monday Tumor Immunology: Implications for
TNM Staging and Therapeutics.............................................. p. 86-87
Tuesday Molecular Diagnostic and Genomic
Applications in Cancer: A Primer for the Pathologist. .......... p. 88-90
Monday Interactive Microscopy. ......................................... p. 91-92
Tuesday Interactive Microscopy .......................................... p. 92-93
Thursday Interactive Microscopy ........................................ p. 93-94
Monday Hot Topics In Pathology.............................................. p. 95
Tuesday Hot Topics In Pathology ............................................. p. 95
Wednesday Hot Topics In Pathology ........................................ p. 95
Thursday Hot Topics In Pathology............................................ p. 96
Monday Practice Changers ....................................................... p. 97
Tuesday Practice Changers ....................................................... p. 98
Timely Topics Lecture ................................................................... p. 98
Hut Lung: A Poignant Portrait...................................................... p. 98
Maude Abbott Lecture ................................................................. p. 98
TAB 2 PATHOLOGISTS-IN-TRAINING
Welcome Message from Resident Advisory Chair .................... p. 39
Fellowship Fair ......................................................................... p. 40-41
Resident Advisory Committee ..................................................... p. 42
TAB 3 COMPANION SOCIETY MEETINGS

Saturday Companion Meetings ........................................... p. 43-48
Sunday Companion Meetings ............................................. p. 49-70
TAB 4 SPECIALTY CONFERENCES

Sunday Gynecologic Pathology............................................... .p. 71
Sunday Pulmonary Pathology ................................................. .p. 71
Sunday Renal Pathology .......................................................... .p. 72
Sunday Pediatric Pathology. .................................................... .p. 72
Sunday Housestaff..................................................................... p. 73
Sunday Ophthalmic Pathology ................................................. p. 73
Monday Surgical Pathology..................................................... .p. 74
Monday Cardiovascular Pathology ......................................... .p. 74
Monday infectious Disease Pathology .................................... .p. 75
Tuesday Genitourinary Pathology ............................................ p. 75
Tuesday Liver Pathology .......................................................... .p. 76
Tuesday Bone and Soft Tissue Pathology................................ p. 76
Tuesday Head, Neck and Endocrine Pathology ...................... .p. 77
Wednesday Hematopathology ................................................ .p. 77
Wednesday Cytopathology ...................................................... .p. 78
Wednesday Neuropathology ................................................... .p. 78
Thursday Gastrointestinal ........................................................ .p. 79
Thursday Evening Specialty Conferences Thursday
Dermatopathology........................................................................ p. 79
Thursday Evening Specialty Conferences Thursday
Breast Pathology........................................................................... p. 80
TAB 6 LONG COURSE

Diagnosing Distinctive Lesions of the Head and Neck ....... p. 99-100
TAB 7 SHORT COURSES

Wednesday ........................................................................... p. 101-102
Thursday............................................................................... p. 103-106
Friday .................................................................................... p. 107-108
TAB 8 SPECIAL LECTURES

TAB 9 USCAP HONORS
TAB 10 ABSTRACT
Proffered Papers
Monday AM.......................................................................... p. 109-114
Monday PM .......................................................................... p. 135-140
Tuesday AM ......................................................................... p. 163-169
Tuesday PM .......................................................................... p. 190-194
Poster Sessions
I Monday AM ..................................................................... p. 115-135
II Monday PM .................................................................... p. 141-162
III Tuesday AM .................................................................. p.169 - 190
IV Tuesday PM ................................................................... p. 195-215
V Wednesday AM ............................................................. p. 215-235
VI Wednesday PM ............................................................. p. 235-254
Abstract Review Board ............................................................... p. 255
Abstract Disclosure Information......................................... p. 256-271
TAB 11 - INDEX
Index ............................................................................................ p. 273
NOTES
2016 NEXTGENERATION LEARNING
CERTIFICATE OF CME/SAM CREDIT OR PARTICIPATION

ACCREDITATION STATEMENT
The United States and Canadian Academy of Pathology (USCAP) is accredited by the Accreditation Council for Continuing
Medical Education (ACCME) to provide continuing medical education for physicians.
AMA CREDIT DESIGNATION STATEMENT
The USCAP designates this live activity for a maximum of 55.5 AMA PRA Category 1 Credit(s). Physicians should only claim
the credit commensurate with the extent of their participation in the activity.
INTERNATIONAL PHYSICIANS
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are
eligible for AMA PRA Category 1 Credit(s).
HEALTH PROFESSIONALS
Health Professional participants (including residents and fellows-in-training) may claim hours to receive a Certificate of
Participation for an activity designated for AMA PRA Category 1 Credit(s).
SELF-ASSESSMENT MODULE CREDITS
The USCAP is approved by the American Board of Pathology to offer Self-Assessment Module (SAM) credits for the purpose of
meeting the American Board of Pathology (ABP) requirements for Maintenance of Certification (MOC). Registrants must take and
pass the post-test in order to claim SAM credit(s).
The number of SAM credits has increased again this year. There will be more than 302 SAMs credits offered during this year's
meeting. Since many of these offerings are presented in overlapping time slots, an individual may earn a maximum of 50.25
SAMs credit hours during the Annual Meeting.
SESSION TYPES FOR WHICH AMA PRA CATEGORY 1 CREDITS ARE OFFERED:
SCIENTIFIC ABSTRACT PRESENTATIONS
SPECIALTY CONFERENCES
KAUFMAN TIMELY TOPICS LECTURE
MAUDE ABBOTT LECTURE
LONG COURSE
SHORT COURSES
MOLECULAR DIAGNOSTIC AND GENOMIC APPLICATIONS IN CANCER
TUMOR IMMUNOLOGY: IMPLICATIONS FOR TNM
NEXT GENERATION SEQUENCING SPECIAL COURSE
PRACTICE CHANGERS
INTERACTIVE MICROSCOPY
HOT TOPICS IN PATHOLOGY
8.75 TOTAL CREDITS

2.0 CREDITS EACH
1.0 CREDIT
1.0 CREDIT
6.0 CREDITS
3.0 CREDITS EACH
7.25 CREDITS
3.0 CREDITS
3.75 CREDITS
0.25 CREDITS EACH
1.5 CREDITS EACH
1.0 CREDIT EACH
JOINT ACCREDITATION STATEMENT

The Association for Molecular Pathology Special Course, Molecular Diagnostic and Genomic Applications in Cancer: A Primer
for the Pathologist has been planned and implemented in accordance with the accreditation requirements and policies of
the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the United States
and Canadian Academy of Pathology and Association for Molecular Pathology. The United States and Canadian
Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the
Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the United States
and Canadian Academy of Pathology and American Society for Clinical Pathology. The United States and Canadian
Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.
Practice Changers- Health Information Technology and Clinical Informatics
Practice Changers- Workforce Issues in Pathology and Laboratory Medicine
JOINT ACCREDITATION STATEMENT (CONTINUED)

The USCAP jointly provides the programs of the following Companion Societies whose activities have been planned and
implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical
Education (ACCME) through the joint providership of the societies and the USCAP. The USCAP is accredited by the ACCME to
provide continuing medical education for physicians.
COMPANION SOCIETY MEETINGS EXCEPT*

*HISTORY OF PATHOLOGY SOCIETY AND PALEOPATHOLOGY CLUB
American Association of Neuropthologists
American Association of Ocular Oncologists and Pathologists
American Society for Clinical Pathology in collaboration
with the APF
American Society for Cytopathology
American Society of Dermatopathology
American Society for Investigative Pathology
Arthur Purdy Stout Society of Surgical Pathologists
Association for Molecular Pathology
Association for Pathology Informatics
Binford-Dammin Society of Infectious Disease Pathologists
College of American Pathologists
Endocrine Pathology Society

Hans Popper Hepatopathology Society
3.0 CREDITS EACH

1.5 CREDITS EACH
History of Pathology Society*

International Society of Bone & Soft Tissue Pathology
International Society of Breast Pathology
International Society of Gynecological Pathologists
International Society of Urological Pathology
North American Society of Head & Neck Pathology
Paleopathology Club*
Papanicolaou Society of Cytopathology
Pulmonary Pathology Society
Renal Pathology Society
Rodger C. Haggitt Gastrointestinal Pathology Society
Society for Cardiovascular Pathology
Society for Hematopathology
Society for Ultrastructural Pathology
COFFEE BREAKS
DAY
DATE
SUNDAY
MARCH 13 ...................................................10:00 AM
START TIME
END TIME
10:30 AM
SUNDAY
MARCH 13 ..................................................... 3:00 PM
3:30 PM
MONDAY
MARCH 14 .....................................................9:30 AM
11:00 AM
MONDAY
MARCH 14 ..................................................... 3:00 PM
4:30 PM
TUESDAY
MARCH 15 .....................................................9:30 AM
11:00 AM
TUESDAY
MARCH 15 ..................................................... 2:45 PM
4:00 PM
WEDNESDAY
MARCH 16 .....................................................9:30 AM
11:00 AM
WEDNESDAY
MARCH 16 ..................................................... 2:30 PM
4:00 PM
THURSDAY
MARCH 17 .....................................................9:30 AM
10:00 AM
THURSDAY
MARCH 17 ...................................................... 2:30 PM
3:00PM
FRIDAY
MARCH 18 ......................................................9:30 AM
10:00 AM
FRIDAY
MARCH 18 ...................................................... 2:30 PM
3:00 PM
HEADSHOT LOUNGE
Stop by CC 303 any time during the coffee breaks March 13-16 to get your headshot taken
by our professional photographers. This service will be complimentary for members and only
$50 for non-members.
To schedule an appointment, please contact Ethan Kaminsky at ethan@kamprod.com
201
2016
MEETING AT A GLANCE
INFORMATION IN THIS SECTION WAS CURRENT AS OF MARCH 1. PLEASE CHECK THE LAST MINUTE UPDATES
DOCUMENT DISTRIBUTED AT THE REGISTRATION DESK FOR ANY CHANGES IN PRESENTATION TIMES OR DATES.
ADDITIONALLY YOU CAN GO ONLINE AT WWW.USCAP.ORG

OR VIEW IN THE USCAP MOBILE APP USCAP365 AVAILABLE AT THE APP STORE AND GOOGLE PLAY.
USCAP 2016 NEWS EMBARGO POLICY
USCAP 2016 DISCLAIMER STATEMENT
Unless otherwise noted, all abstracts presented

at the USCAP Annual Meeting are embargoed
until the date and time of presentation.
Abstracts presented at a news conference are
embargoed until the date and time of the news
conference. The USCAP reserves the right to
lift the embargo on specific abstracts that are
selected for promotion prior to or during the
USCAP Annual Meeting.
The information presented at the USCAP

news conferences and within the Research
Summaries Book represents the opinion of the
presenters and authors and is not necessarily
the view of the USCAP. The USCAP makes
no representation as to the truth or warranty,
accuracy, or originality of the information
presented.
MEETING AT A GLANCE
TIME
SESSION
PAGE #
LOCATION
SATURDAY, MARCH 12, 2016

9:00 AM - 5:00 PM
SPECIAL COURSE
Residents Workshop: Genomic Medicine for Pathologists ......................................... p. 81-82 .......................... CC 602-604
12:00 AM - 5:00 PM
SPECIAL COURSE
Residents Workshop: Leadership, Collaboration and Change in Health Care ......... p. 83-84 .......................... CC 611-612
7:00 PM - 10:00 PM
COMPANION SOCIETY MEETINGS
American Association of Neuropathologists ............................................................... p. 43
Association for Pathology Informatics ......................................................................... p. 44
Endocrine Pathology Society ........................................................................................ p. 45
International Society of Urological Pathology ............................................................. p. 48
Papanicolaou Society of Cytopathology ...................................................................... p. 46
Pulmonary Pathology Society ....................................................................................... p. 47
............................... CC 608-609
............................... CC 613-614
............................... CC 606-607
...................... CC Ballroom 6 B
............................... CC 602-604
...................... CC Ballroom 6 A
SUNDAY, MARCH 13, 2016

8:30 AM - 12:00 PM
Arthur Purdy Stout Society of Surgical Pathologists .................................................. p. 49 ................... CC Ballroom 6 B/C
Binford-Dammin Society of Infectious Disease Pathologists ..................................... p. 50 ....................... CC Ballroom 6A
College of American Pathologists ................................................................................. p. 51 ............................... CC 602-604
Hans Popper Hepatopathology Society........................................................................ p. 52 .......................CC Ballroom 6 E
Renal Pathology Society ................................................................................................ p. 53 ................................ CC 606-607
Society for Cardiovascular Pathology .......................................................................... p. 54 ................................ CC 608-609
Society for Ultrastructural Pathology ........................................................................... p. 55 ....................................... CC 605
1:30 PM - 3:30 PM
Paleopathology Club .................................................................................................... p. 62 ................................ CC 602-604
1:30 PM - 5:00 PM
American Association of Ocular Oncologists and Pathologists ................................. p. 56 ....................................... CC 605
American Society for Investigative Pathology ............................................................. p. 58 ................................ CC 606-607
ASCP in collaboration with the APF.............................................................................. p. 57 ................................ CC 618-620
International Society of Bone and Soft Tissue Pathology ........................................... p. 60 ................................ CC 608-609
International Society of Gynecological Pathologists................................................... p. 64 ........................CC Ballroom 6 E
North American Society of Head and Neck Pathology ............................................... p. 61 ................................ CC 615-617
Rodger C. Haggitt Gastrointestinal Pathology Society ............................................... p. 59 .................... CC Ballroom 6 B/C
Society for Hematopathology ....................................................................................... p. 63 ....................... CC Ballroom 6 A
3:30 PM - 5:00 PM
History of Pathology Society ......................................................................................... p. 65 ............................... CC 602-604
7:30 PM - 9:30 PM
EVENING SPECIALTY CONFERENCES
Evening Specialty Conference - Gynecologic Pathology ............................................ p. 71
Evening Specialty Conference - Housestaff ................................................................. p. 73
Evening Specialty Conference - Ophthalmic Pathology ............................................ p. 73
Evening Specialty Conference - Pediatric Pathology .................................................. p. 72
Evening Specialty Conference - Pulmonary Pathology............................................... p. 71
Evening Specialty Conference - Renal Pathology........................................................ p. 72
...................... CC Ballroom 6 B
............................... CC 613-614
...................................... CC 605
............................... CC 606-607
...................... CC Ballroom 6 A
............................... CC 615-617
7:30 PM - 10:30 PM
American Society for Cytopathology............................................................................ p. 67-68 ................. CC Ballroom 6 C
American Society of Dermatopathology ...................................................................... p. 69 ............................... CC 608-609
Association for Molecular Pathology............................................................................ p. 70 .......................CC Ballroom 6 E
International Society of Breast Pathology .................................................................... p. 66 ................................CC Hall 4 E
MEETING AT A GLANCE
TIME
SESSION
PAGE #
LOCATION
MONDAY, MARCH 14, 2016

8:00 AM - 9:30 AM
Interactive Microscopy: Pathology of Common Interstitial Lung Diseases The Essentials for Practicing Pathologists ................................................................... p. 91 ...................................... CC 305
Interactive Microscopy: Unusual and Problem Cases in
Head and Neck Cytopathology ...................................................................................... p. 91 ...................................... CC 304
Interactive Microscopy: Fatty Tumors of the Retroperitoneum .................................. p. 91 ...................................... CC 306
8:00 AM - 12:00 PM
PROFFERED PAPERS
Proffered Papers Section A - Genitourinary Pathology............................................... p. 109 ..............................CC Hall 4 E
Proffered Papers Section B - Breast Pathology............................................................ p. 109-110 ............. CC Ballroom 6 C
8:00 AM - 12:00 PM
PROFFERED PAPERS
Proffered Papers Section C - Cytopathology................................................................ p. 110-111 ............. CC Ballroom 6 B
Proffered Papers Section D - Gastrointestinal Pathology ........................................... p. 111-112 ............. CC Ballroom 6 A
Proffered Papers Section E - Gynecologic Pathology ................................................. p. 112 ............................. CC 602-604
Proffered Papers Section F - Techniques ...................................................................... p. 112-113 ...................... CC 606-607
Proffered Papers Section G - Pulmonary Pathology ................................................... p. 113-114 ...................... CC 608-609
Proffered Papers Section H - Potpourri ........................................................................ p. 114 ............................. CC 615-617
8:00 AM - 12:00 PM
SPECIAL COURSE
Clinical Application of Next Generation Sequencing .................................................. p. 85 .......................CC Ballroom 6 E
9:30 AM - 12:00 PM
POSTER SESSIONS
Poster Presentations - Monday AM .............................................................................. p. 115-117 ...CC Exhibit Hall 4 A/B/C
9:45 AM - 10:05 AM
PRACTICE CHANGERS
Practice Changers-Adverse Event Disclosure and Management for Pathologists:
Where do We Stand Now?............................................................................................. p. 97 ................... CC Sky Bridge 4 D
Practice Changers-Pathologists in Gross Anatomy ..................................................... p. 97 ................... CC Sky Bridge 4 D
10:00 AM - 11:30 AM
Interactive Microscopy: Diagnostic Challenges in Cutaneous Soft Tissue Tumors .. p. 91 ...................................... CC 304
Interactive Microscopy: Tumor and Tumor-like Proliferations of the Spleen ............ p. 91 ...................................... CC 305
Interactive Microscopy: Surgical Pathology of Pancreatobiliary Tract ...................... p. 91 ......................................CC 306
10:20 AM - 10:40 AM
PRACTICE CHANGERS
Practice Changers-Prostate Biopsy Billing ................................................................... p. 97 ................... CC Sky Bridge 4 D
Practice Changers-Replacing Karyotyping with SNPM ............................................... p. 97 ................... CC Sky Bridge 4 D
12:00 PM - 1:00 PM
HOT TOPICS
Hot Topics in Pathology 01-Hematopathology ............................................................ p. 95 ...................................... CC 605
1:00 PM - 3:00 PM
PROFFERED PAPERS
Proffered Papers Section A - Genitourinary Pathology............................................... p. 135-136 .......................CC Hall 4 E
Proffered Papers Section B - Pulmonary Pathology .................................................... p. 136-137 ............. CC Ballroom 6 C
Proffered Papers Section C - Hematopathology .......................................................... p. 137 .................... CC Ballroom 6 B
Proffered Papers Section D - Breast Pathology ........................................................... p. 137-138 ............. CC Ballroom 6 A
Proffered Papers Section E - Kidney/Renal Pathology ................................................ p. 138 ............................. CC 602-604
Proffered Papers Section F - Head and Neck Pathology ............................................. p. 139 ............................. CC 606-607
Proffered Papers Section G - Quality Assurance ......................................................... p. 139-140 ...................... CC 608-609
Proffered Papers Section H - Endocrine Pathology ..................................................... p. 140 ............................. CC 615-617
1:00 PM - 4:30 PM
POSTER SESSIONS
Poster Presentations - Monday PM............................................................................... p. 141-162 ...CC Exhibit Hall 4 A/B/C
1:00 PM - 5:00 PM
SPECIAL COURSE
Tumor Immunology: Implications for TNM Staging and Therapeutics .................... p. 86-87 ..................CC Ballroom 6 E
1:30 PM - 3:00 PM
Interactive Microscopy: Interesting Lesions in Patients with
Testicular Neoplasms .................................................................................................... p. 91 ...................................... CC 306
Interactive Microscopy: Look at that Bug! Interesting Infectious Disease Cases...... p. 91 ...................................... CC 305
Interactive Microscopy: Uncommon Types of Invasive Mammary Carcinoma ........ p. 91 ...................................... CC 304
MEETING AT A GLANCE
TIME
SESSION
PAGE #
LOCATION
MONDAY, MARCH 14, 2016 ...CONTINUED

3:15 PM - 3:35 PM
PRACTICE CHANGERS
Practice Changers-Facebook & Twitter: How Pathologists can Change Their
Practice with Social Media............................................................................................. p. 97 ................... CC Sky Bridge 4 D
Practice Changers-Wikis: A Gateway to Quick Pathology Information and
Online Collaboration .................................................................................................... p. 97 ................... CC Sky Bridge 4 D
3:50 PM - 4:10 PM
PRACTICE CHANGERS
Practice Changers- Health Information Technology and Clinical Informatics ........... p. 97 ................... CC Sky Bridge 4 D
Practice Changers- Workforce Issues in Pathology and Laboratory Medicine.......... p. 97 ................... CC Sky Bridge 4 D
4:30 PM - 5:30 PM
SPECIAL LECTURES
Nathan Kaufman Timely Topics Lecture - "Riffs on Future Path:
The Fall of Paper, the Rise of Smarties and the Quest for Selfies" ............................ p. 98 ................................CC Hall 4 E
4:30 PM - 6:00 PM
Interactive Microscopy: Correlation of Tumorous and Non-Tumorous
Conditions of Bones and Joints with Clinical Imaging: How does the Pathology
Create hte Imaging Features and What You Need to Know About Them ................. p. 92 ...................................... CC 305
Interactive Microscopy: Mesenchymal Tumors of the Breast:
A Conceptual Framework for the Practicing Pathologist ............................................ p. 92 ...................................... CC 306
Interactive Microscopy: When and How to Use Molecular Studies in the
Diagnosis of Melanocytic Lesions................................................................................. p. 92 ...................................... CC 304
6:15 PM - 7:00 PM
SPECIAL LECTURES
Special Lecture - Hut Lung: A Poignant Portrait ......................................................... p. 98 ................................CC Hall 4 E
7:30 PM - 9:30 PM
Evening Specialty Conference - Cardiovascular Pathology ........................................ p. 74 .......................CC Ballroom 6 E
Evening Specialty Conference - Infectious Disease Pathology .................................. p. 75 ............................... CC 608-609
Evening Specialty Conference - Surgical Pathology ................................................... p. 74 ............... CC Ballroom 6 A/B/C
TUESDAY, MARCH 15, 2016

8:00 AM - 9:30 AM
Interactive Microscopy: Diagnostic Pitfalls in Prostate Pathology ............................ p. 92 ...................................... CC 306
Interactive Microscopy: Glioma Diagnosis-2016: What Pathologists
Need to Know.................. ............................................................................................... p. 92 ...................................... CC 304
Interactive Microscopy: Sneaky Cancers and Their Mimics ....................................... p. 92 ...................................... CC 305
8:00 AM - 12:00 PM
PROFFERED PAPERS
Proffered Papers Section A - Genitourinary Pathology............................................... p. 163 ..............................CC Hall 4 E
Proffered Papers Section B - Breast Pathology............................................................ p. 164 .................... CC Ballroom 6 A
Proffered Papers Section C - Hematopathology .......................................................... p. 164-165 ............. CC Ballroom 6 C
Proffered Papers Section D - Gastrointestinal Pathology ........................................... p. 165-166 ...................... CC 602-604
Proffered Papers Section E - Gynecologic Pathology ................................................. p. 166-167 ...................... CC 606-607
Proffered Papers Section F - Cytopathology ................................................................ p. 167-168 ...................... CC 608-609
Proffered Papers Section G - Bone and Soft Tissue Pathology .................................. p. 168 ............................. CC 611-612
Proffered Papers Section H - Liver Pathology .............................................................. p. 169 ............................. CC 615-617
8:00 AM - 5:15 PM
SPECIAL COURSES
Molecular Diagnostic and Genomic Applications in Cancer:
A Primer for the Pathologist .......................................................................................... p. 88-90 ................. CC Ballroom 6 B
9:30 AM - 12:00 PM
POSTER SESSIONS
Poster Presentations - Tuesday AM .............................................................................. p. 169-190 ...CC Exhibit Hall 4 A/B/C
9:45 AM - 10:05 AM
PRACTICE CHANGERS
Practice Changers - 3D Printed Microscopy and Alternatives to
Glass Slide Pathology .................................................................................................... p. 98 ................... CC Sky Bridge 4 D
Practice Changers - Novel Simple Method of Formalin Fixed Paraffin
Embedded Cell Block Preparation of Cytology Specimens ........................................ p. 98 .................... CC Sky Bridge 4 D
MEETING AT A GLANCE
TIME
SESSION
PAGE #
LOCATION
TUESDAY, MARCH 15, 2016...CONTINUED

10:00 AM - 11:30 AM
Interactive Microscopy: An Approach to Problematic Vascular Tumors:
Benign, Borderline, Malignant and Pseudomalignant ................................................ p. 92 ....................................... CC 304
Interactive Microscopy: Crazy Gynecologic Acronyms (LMP, SBT, STIC,
TILT and STIL): A Review of Challenging Uterine Adnexal Neoplasms .................... p. 92 ...................................... CC 306
Interactive Microscopy: Practical Approach to Papillary Problems and
Other Dilemmas in Breast Core Needle Biopsy Interpretation ................................... p. 92 ...................................... CC 305
10:20 AM - 10:40 AM
PRACTICE CHANGERS
Practice Changers - Disclosing Harmful Pathology Errors to Colleagues ................. p. 98 ................... CC Sky Bridge 4 D
Practice Changers - Impact of Genomics and Personalized Medicine ....................... p. 98 ................... CC Sky Bridge 4 D
12:00 PM - 1:00 PM
HOT TOPICS
Hot Topics in Pathology 02-Molecular Pathology ........................................................ p. 95 ...................................... CC 605
1:00 PM - 2:45 PM
PROFFERED PAPERS
Proffered Papers Section A - Informatics ..................................................................... p. 190 .................... CC Ballroom 6 A
Proffered Papers Section B - Autopsy .......................................................................... p. 190-191 ............. CC Ballroom 6 C
Proffered Papers Section C - Neuropathology ............................................................. p. 191 ............................. CC 602-604
Proffered Papers Section D - Gastrointestinal Pathology ........................................... p. 191-192 ...................... CC 606-607
Proffered Papers Section E - Dermatopathology ......................................................... p. 192 ............................. CC 608-609
Proffered Papers Section F - Pancreas and Biliary Tree Pathology ............................ p. 192-193 ...................... CC 611-612
Proffered Papers Section G - Hematopathology.......................................................... p. 193-194 ...................... CC 615-617
Proffered Papers Section H - Pathobiology .................................................................. p. 194 ............................. CC 618-620
1:00 PM - 4:30 PM
POSTER SESSIONS
Poster Presentations - Tuesday PM............................................................................... p. 93 ............CC Exhibit Hall 4 A/B/C
1:30 PM - 3:00 PM
Interactive Microscopy: Endometrial Pathology - Selected Challenging and
Informative Cases
.................................................................................................... p. 93 ...................................... CC 305
Interactive Microscopy: Sneaky GI Biopsies with Hidden Diagnoses:
Lessons in Applying a Systematic Approach............................................................... p. 93 ...................................... CC 306
Interactive Microscopy: The Well Differentiated Squamous Cell Carcinoma
of Head and Neck: A Practical Approach to Biopsy Interpretation............................ p. 93 ...................................... CC 304
4:30 PM - 6:00 PM
Interactive Microscopy: #GIDeadliestCatch: Practical Approaches to
Trending Topics in GI Pathology ................................................................................... p. 93 ...................................... CC 304
Interactive Microscopy: Frozen Section in Ovarian and Peritoneal Lesions:
Challenges and Controversies....................................................................................... p. 93 ...................................... CC 305
Interactive Microscopy: High Risk Non-Melanoma Skin Cancers: Lessons from
UV-Drenched New Zealand ........................................................................................... p. 93 ...................................... CC 306
5:00 PM - 5:50 PM
SPECIAL LECTURES
Maude Abbott Lecture ................................................................................................... p. 95 .................................CC Hall 4 E
7:30 PM - 9:30 PM
Evening Specialty Conference - Bone and Soft Tissue Pathology ............................. p. 76
Evening Specialty Conference - Genitourinary Pathology.......................................... p. 75
Evening Specialty Conference - Head and Neck/Endocrine Pathology ..................... p. 77
Evening Specialty Conference - Liver Pathology ......................................................... p. 76
...................... CC Ballroom 6 A
.......................CC Ballroom 6 E
...................... CC Ballroom 6 B
...................... CC Ballroom 6 C
MEETING AT A GLANCE
TIME
SESSION
PAGE #
LOCATION
WEDNESDAY, MARCH 16, 2016

8:00 AM - 12:00 PM
SHORT COURES
SC05-The Nerve Of Some Nerve Sheath Tumors!
A Practical Approach To Common Problems In Surgical Pathology ......................... p. 101 ............................. CC 615-616
SC11-Contemporary Cardiovascular Pathology from Bench to Bedside:
How Emerging Ancillary Tools are Transforming the Field ........................................ p. 101 ..................................... CC 608
SC22 Practical Guide to Error Reduction, Effective Communication, and
Damage Control in Surgical Pathology ........................................................................ p. 101 ..................................... CC 604
SC25-Colorectal Dysplasia in IBD: Diagnosis, Implications and Pitfalls .................... p. 101 .............................. CC 602-603
SC30-Diagnosis of Renal Neoplasms Using Integrated Histologic,
Cytologic and Molecular Approaches in the Era of Precision Medicine .................... p. 101 ..................................... CC609
SC31-Doing More with Less: A Cytology-Histology Correlation of
Pulmonary Masses
.................................................................................................... p. 101 .............................. CC 613-614
SC36-Inherited Gynecologic Cancer Syndromes - Pathologically and Clinically
Based Risk Assessment and Genetic Counseling: What every practicing
pathologist should know ............................................................................................... p. 101 ..................................... CC 606
SC45-Problematic Ductal Proliferations of the Breast ................................................. p. 101 ............................. CC 611-612
SC55-A Practical Approach to Infectious Disease Pathology ..................................... p. 101 ..................................... CC 607
8:00 AM - 5:15 PM
LONG COURSE
Long Course: Diagnosing Distinctive Lesions of the Head and Neck ........................ p. 99-100 ........ CC Ballroom 6 A/B/C
9:30 AM - 12:00 PM
POSTER SESSIONS
Poster Presentations - Wednesday AM ........................................................................ p. 215-235 ...CC Exhibit Hall 4 A/B/C
12:00 PM - 1:00 PM
HOT TOPICS
Hot Topics in Pathology 03-Genitourinary ................................................................... p. 95 ...................................... CC 605
1:00 PM - 4:00 PM
POSTER SESSIONS
Poster Presentations - Wednesday PM ......................................................................... p. 235-254 ...CC Exhibit Hall 4 A/B/C
1:30 PM - 5:30 PM
SHORT COURSES
SC04-Autopsy in the 21st Century: An Update for Pathologists Performing
Hospital Autopsies Today .............................................................................................. p. 102 .................................... CC 607
SC18-Diagnostic Criteria of The Paris System for Reporting Urinary Cytology ....... p. 102 ............................. CC 613-614
SC33-Ovarian Carcinoma: An Update On Histotype Diagnosis, Primary Site
Assignment, And Staging .............................................................................................. p. 102 .............................CC 611-612
SC39-Bone Marrow Manifestations of Systemic Disease ........................................... p. 102 .................................... CC 608
SC43-Medical Liver Biopsies: Translating Morphologic Patterns Into
Meaningful Pathology Reports ...................................................................................... p. 102 ............................. CC 602-603
SC59-Occupationally Related Pleural and Pulmonary Disorders in the
21st Century: Challenges, Pitfalls and No-Nos ............................................................ p. 102 ..................................... CC 609
SC62-Algorithmic Approach to Diagnosis of Inflammatory Disorders
of the GI Tract
.................................................................................................... p. 102 ..................................... CC 606
7:30 PM - 9:30 PM
Evening Specialty Conference - Cytopathology .......................................................... p. 78 ...................... CC Ballroom 6 B
Evening Specialty Conference - Hematopathology ..................................................... p. 77 ...................... CC Ballroom 6 A
Evening Specialty Conference - Neuropathology........................................................ p. 78 ...................... CC Ballroom 6 C
10
MEETING AT A GLANCE
TIME
SESSION
PAGE #
LOCATION
THURSDAY, MARCH 17, 2016

8:00 AM - 9:30 AM
Interactive Microscopy: An Approach to Intraoperative
Consultation in Neuropathology ................................................................................... p. 93 ....................................... CC 304
Interactive Microscopy: Diagnostic Issues in DLBCL: A 2016 Perspective .............. p. 93 ....................................... CC 306
Interactive Microscopy: Medical Liver Biopsies - How to Stay Out of Trouble ........ p. 93 ....................................... CC 305
8:00 AM - 11:30 AM
SHORT COURSES
SC06-Diagnostic Dilemma in Neoplastic and Non-Neoplastic Bone Pathology ....... p. 103 .............................. CC 615-616
SC08-The Pathologists Role in Guiding Breast Cancer Treatment in the Era of
Neoadjuvant Therapy .................................................................................................... p. 103 .............................. CC 619-620
SC10-Diagnostic Challenges in Prostate Pathology .................................................... p. 103 .............................. CC 611-612
SC16-Pathology of the Previable Fetus and Stillborn Infant for the
General Pathologist .................................................................................................... p. 103 ..................................... CC 604
SC20-Challenging Cases in Thyroid Cytopathology:
How Can Ultrasound Findings and Molecular Tests Help? .................................................................................. CC 602-603
SC21-Important Aspects of Skin Adnexal Tumor Pathology ...................................... p. 103 ..................................... CC 606
SC28-Pulmonary Infections: Morphologic And Molecular Tips For
The Surgical Pathologist ................................................................................................................................................ CC 617
SC32-Predictive Biomarkers: Lessons from Clinical Trials ......................................... p. 103 ..................................... CC 607
SC37-Head and Neck Pathology in the Human Papillomavirus Era:
A Crash Course
.................................................................................................... p. 103 ..................................... CC 608
SC40-Hematolymphoid Lesions at the Borderline Between Benign and
Malignant - Finding Your Way Out of Uncertainty....................................................... p. 104 ..................... CC Ballroom 6 C
SC46-Open Confession is Good for the Soul: Memorable Mistakes and
What We've Learned .................................................................................................... p. 104 ..................................... CC 609
SC50-Clinical Realities of Next-Generation Sequencing ...................................................................................... CC 613-614
SC56-Nerve and Muscle Biopsies: A Patient-Centered Approach for the
General Pathologist .................................................................................................... p. 104 .................................... CC 618
10:00 AM - 11:30 AM
Interactive Microscopy: Diagnostic Dilemmas in Skin Adnexal
Tumour Pathology
.................................................................................................... p. 94 ....................................... CC 306
Interactive Microscopy: Mesenchymal Tumors of the Uterus: An Update in
Classification, Immunostains, and Differential Diagnosis .......................................... p. 94 ....................................... CC 305
Interactive Microscopy: Twists in Liver Pathology: Unsuspected Findings
that Changed "Everything" ............................................................................................ p. 94 ....................................... CC 304
12:00 PM - 1:00 PM
HOT TOPICS
Hot Topics in Pathology 04-Gastrointestinal ................................................................ p. 96 ...................................... CC 605
1:00 PM - 2:30 PM
Interactive Microscopy: Don't Be Duped!: Look-alikes in Genitourinary Pathology ... p. 94 ....................................... CC 306
Interactive Microscopy: GI Biopsy Interpretation in Modern Medicine:
Drugs, Dysplasia and Other Dilemmas......................................................................... p. 94 ....................................... CC 305
Interactive Microscopy: Pitfalls in Effusion Cytology: The Usual, the Unusual
and the Mimickers
.................................................................................................... p. 94 ....................................... CC 304
1:00 PM - 4:30 PM
SHORT COURSES
SC03-Uses and Limitations of Immunohistochemistry and other Adjunctive
Studies in Breast Pathology .......................................................................................... p. 105 ............................. CC 602-603
SC07-It's not as Bad as it Looks: Look-Alike Lesions in Surgical Neuropathology... p. 105 ..................................... CC 618
SC12-Medical Renal Pathology for the General Surgical Pathologist ....................... p. 105 ..................................... CC 617
SC14-Biopsies of Mediastinal Lesions: Challenges, Pitfalls and Practical Tips ......... p. 105 ..................................... CC 607
SC17-Trapdoors in Testicular Pathology ...................................................................... p. 105 ..................................... CC 604
SC19-Melanocytic Lesions: A Practical Approach to Diagnosis, Adjunctive
Molecular Studies and Appropriate Therapy/Management ...................................... p. 105 ..................... CC Ballroom 6 C
SC23-Surgical and Molecular Pathology of Thyroid Neoplasia ................................. p. 105 .............................. CC 619-620
SC26-Colonic Polyps - Daily Problems Only Pathologists Understand ..................... p. 105 .............................. CC 611-612
SC35-Going with the Flow of Bile: An Update on Tumors of the Liver,
Bile Ducts and Gallbladder ............................................................................................ p.105 ...................................... CC 609
SC41-Expanding the Differential Diagnosis in Urologic Pathology: Controversies
and New Entities
.................................................................................................... p. 106 ..................................... CC 608
SC42-Difficult Diagnoses in Pediatric Hematopathology ............................................ p. 106 .............................. CC 615-616
SC47-Late Intrauterine Demise: Placental and Fetal Postmortem Pathology .......... p. 106 .............................. CC 613-614
SC54-Practical Informatics Solutions for Anatomic Pathology
Quality Management .................................................................................................... p. 106 .................................... CC 606
11
MEETING AT A GLANCE
THURSDAY, MARCH 17, 2016...CONTINUED
3:00 PM - 4:30 PM
Interactive Microscopy: Application of "The Paris System for Reporting
Urinary Cytopathology" on Liquid-Based Preparations............................................... p. 94........................................ CC 304
Interactive Microscopy: Common Diagnostic Dilemmas in Urinary
Bladder Pathology ..................................................................................................... p. 94........................................ CC 305
Interactive Microscopy: Neoplastic Lung Disease........................................................ p. 94 ....................................... CC 306
7:30 PM - 9:30 PM
Evening Specialty Conference - Breast Pathology....................................................... p. 80 ....................... CC Ballroom 6 C
Evening Specialty Conference - Dermatopathology.................................................... p. 79 ................................ CC 611-612
Evening Specialty Conference - Gastrointestinal Pathology....................................... p. 79 ...........................CC Ballroom E
FRIDAY, MARCH 18, 2016

8:00 AM - 11:30 AM
SHORT COURSES
SC02-Striving for Excellence: Leveraging CLIA Accreditation, ISO 15189
and Lean for Anatomic and Molecular Pathology Laboratories.................................. p. 107............................... CC 619-620
SC09-Recent Developments in Heart and Lung Transplant Pathology:
Navigating the Shifting Sands....................................................................................... p. 107 ..................................... CC 604
SC15-Practical Ocular Pathology for Pathologists........................................................ p. 107 ..................................... CC 607
SC24 -Bacterial Infection and the Kidney: Diagnostic
Difficulties in Kidney Biopsies........................................................................................ p. 107 .............................. CC 613-614
SC27-A Pattern-Based Approach to the Diagnosis of Soft Tissue Tumors................. p. 107 .............................. CC 602-603
SC29-Pathology in the Era of Genomic Medicine: New Frontiers
and New Challenges ..................................................................................................... p. 107 ..................................... CC 606
SC34-Non-Invasive Nightmares in Breast Pathology................................................... p. 107...................................... CC 609
SC44-Endocrine Tumor Board: Clinicopathological Correlations in
Endocrine Pathology ..................................................................................................... p. 107...................................... CC 608
SC52-Difficult Endometrial Biopsies: Malignancy, Mimics,
Molecular and Mishaps................................................................................................... p. 107............................... CC 611-612
SC53- Problems, Pitfalls and an Integrated Approach to Lymphoproliferative
Disorders in the Skin ..................................................................................................... p. 107............................... CC 615-616
1:00 PM - 4:30 PM
SHORT COURSES
SC38-Common Diagnostic Dilemmas in Head and Neck Pathology: Pitfalls,
Pearls and Clinical Insights............................................................................................. p. 108............................... CC 611-612
SC48-Problematic Areas in the Pathology of the Uterine Cervix................................ p. 108...................................... CC 608
SC49-Interstitial Lung Disease: What Your Clinician Wants to Know........................ p. 108............................... CC 602-603
SC51-High Yield Urological Pathology: Common and Important Diagnoses
Not To Be Missed in Daily Practice................................................................................ p. 108...................................... CC 606
SC57-Diagnosis of Challenging Plasma Cell Neoplasms............................................. p. 108...................................... CC 607
SC58-Second Opinions and Discrepancies in Fine Needle Aspiration
(FNA) Cytology: An Interactive Approach to Diagnostic Work-up.............................. p. 108...................................... CC 604
SC60-Practical Statistics for Pathologists: Case-based Instruction with Methods.... p. 108...................................... CC 609
12
8th AVENUE
CONVENTION HALL
The Conference
Center
Wild Rye
Caf Bakery
Entrance
PIKE STREET
7th AVENUE
PIKE STREET
nce
Entra
nce
Entra
Entrance
Entrance
Pike Street
Lobby
Levels 1-4
and to
Skybridge
Lobby
12
11
14
Entrance
Business
Center
To
Convention
Center
Parking
Garage
Entrance
FE
FE
Retail
Office Tower
10
ACT Theatre
utt
Sh
nd ENT
Tra IO
nsp N P
ort LA
ati CE
on
an
d
ou
Public
Restroom
Levels 1-4
and to
Atrium Lobby
CO
NV
Retail
(Gr
le)
Retail
UNION STREET
Washington State Convention Center Level One: Entrances, Shops and Services
13
CONVENTION HALL
Washington State Convention Center Level Two:
Meeting Rooms
2AB Lobby
Open
WSCC
Admin.
Office
To/From
Level 3
12
To/From
Level 1
11
FE
208*
2A
209*
2B
FE
205
FE
210*
10
Open
204
Ramp
Ramp
211
FE
212
202
FE
214
7
201
Ramp
FE
203
213
FE
To Two Union Square
Intl.
Meeting
Place
3AB Lobby
To/From
Level 2
12
To 301-310
Open
To/From
Level 4
11
3A
M
3B
FE
Main Entrance to
Parking Garage
10
FE
To Skybridge Lobby
Level Three:
306
Meeting Rooms
307
305
FE
308
FE
310
FE
FE
304
303
8th AVENUE
Open
309
302
Open
301*
To Garages
and Freeway
Park Garage
14
CONVENTION HALL
Washington State Convention Center Level Four: Exhibition Halls
Deli
FE
N-2
FE
North
Loading Dock
4E
DOWN
To/From
The Conference
Center
UP
N-1
4F
FE
FE
4D
Truck Bridge
FE
PIKE STREET (Below)
Skybridge
South Service Corridor
FE
FE
be
4C
4B
ub
10
4A
FE
7 6
Tr
uc
W M
WSCC Use
To/From
6
UP
FE
DOWN
To
Skybridge
Lobby
FE
kR
401
Levels 1 to 4
FE
am
pt
oH
FE
4C-4
South
Loading
Dock
Grill
4C-2
4C-1
FE
4C-3
416
FE
400
W
Solera
lac
12 To/From
11 Level 3
FE
ll P
Open
To Atrium Lobby
Skybridge
Lobby
FE
454
W
1 2
To/From
Level 6
Open
FE
FE
439
FE
438
DOWN
UP
FE
Waterfall Suite
Atrium Lobby
FE
FE
FE
Grand Staircase
FE
FE
To/From Levels 5&6
Ellis Plaza
15
CONVENTION HALL
Washington State Convention Center Level Six: Ballrooms & Meeting Rooms
FE
FE
Service
Service
FE
Service
FE
Service
FE
FE
4
6E
6C
6B
6A
Kitchen
10
610
FE
FE
618
617
619
616
611
620
615
612
FE
Fireplace
To/From
Level 4
6E Lobby
FE
FE
FE
614
605
W
W
609
606
608
607
602
Suite A
6ABC Lobby
7 6
603
FE
Suite C
1 2
604
657
613
Fireplace
601*
Terrace
Fireplace
Stairs
Escalators
To/From Level 4
Atrium Lobby
(Below)
To/From
Levels 4 & 5
16
SHERATON CONVENTION HALL
17
EXHIBIT HALL
Now that you are chock-full of new knowledge, heres a

great opportunity to apply it to current technology.
Weve assembled over 140 vendors in our Exhibition Hall
this year. From software to services, to equipment, you have a
one-stop shop of experts awaiting the opportunity to
explain how their company can support your professional
development.
Exhibition Hall Schedule
Stop by and please remember to thank our exhibitors; their

support is an integral component to our annual meeting.
Exhibit Hall Location
(same hours as the posters sessions)

MONDAY, MARCH 14
TUESDAY, MARCH 15
WEDNESDAY, MARCH 16
9:30 AM 5:00 PM
9:30 AM 5:00 PM
9:00 AM 4:00 PM
Washington State Convention Center, Exhibit Halls 4A-4C
Schedule a Meeting with a Vendor

Thanks to our mobile app you can now find all vendors and their locations within the Exhibition Hall. If youre pressed for time
or want to be assured of quality time with one of our vendors utilize the app to schedule a time to speak with the vendor.
Go to: www.tripbuilder.com/uscap365, to download the app today.
18
POSTER PICKUP & POSTER VIEWING STATION

Poster Pick-up Location: Call4Posters and iPosters, on Level 4, 4C in the Washington State Convention Center. The hours
are Monday and Tuesday, 7:00 AM 5:00 PM, and Wednesday, 7:00 AM 3:00 PM. Posters that were created or submitted for
printing and shipping using Learners Digest International Call4Posters may be picked up at their section. All poster presenters
have the option of submitting their posters electronically (free of charge) and having them posted on the USCAP website in the
iPosters, where they will be available for viewing after the meeting. Please visit the iPosters booth for details.
SECRETARIAT INFORMATION
The United States and Canadian Academy of Pathology

USCAP West
500 South Palm Canyon Drive, Suite 321
Palm Springs, CA 92264
p. (760) 327-6777
f. (760) 327-6477
USCAP East
404 Town Park Blvd., Suite 201
Evans, GA 30809
p. (706) 7337550
f. (706) 733-8033
David B. Kaminsky, MD, FIAC

Executive Vice President
executivevp@uscap.org
Carolyn Lane
Director of Membership Services
carolyn@uscap.org
Darlynne L. Baki
Director of Operation USCAP West
darlynne@uscap.org
Paul Lewin
Director of International Development
paul@uscap.org
Tina Bowie
Membership Services Assistant
tina@uscap.org
Travis Newman
Managing Director
travis@uscap.org
Krista M. Cairns
Educational Program Coordinator Annual Meeting
krista@uscap.org
Teresa Powers
Membership Services Coordinator
teresa@uscap.org
Denice Chinn
Educational Program Coordinator
denice@uscap.org
Cindy Pugh
Director of Information Technology/
Education Digital Coordinator
cindy@uscap.org
LaToya Collier
Educational Program Assistant
latoya@uscap.org
John C. Garrard
Director of Innovative Communications
and Product Design
john2@uscap.org
Deborah Waterhouse
Interactive Coordinator
deborah@uscap.org
Nancy West
Director of Meeting Services
nancy@uscap.org
19
PAST PRESIDENTS
1907-08
1908-10
1910-13
1913-15
1915-16
1916-20
1920-21
1921-22
1922-24
1924-29
1929-32
1932-33
1933-34
1934-36
1936-38
1938-39
1939-40
1940-41
1941-42
1942-47
1947-48
1948-49
1949-50
1950-51
1951-52
1952-53
1953-54
1954-55
1955-56
1956-57
1957-58
1958-59
1959-60
1960-61
1961-62
1962-63
1963-64
1964-65
1965-66
1966-67
1967-68
1968-69
1969-70
1970-71
1971-72
1972-73
1973-74
1974-75
1975-76
1976-77
1977-78
1978-79
20
James Carroll
W. G. MacCallum
A. S. Warthin
R. M. Pearce
A. S. Warthin
O. Klotz
W. M. L. Coplin
James Ewing
F. B. Mallory
James F. Coupal
H. E. Robertson
George R. Callender
Victor Jacobsen
William Boyd
V. H. Cornell
Carl V. Weller
James E. Ash
Tracy B. Mallory
William H. Feldman
Samuel R. Haythom
Ralph D. Lillie
Everett L. Bishop
James E. Ash
G. Lyman Duff
Granville A. Bennett
James B. McNaught
Averill A. Liebow
Harold L. Stewart
Jesse E. Edwards
Edward B. Smith
William O. Russell
Chapman H. Binford
Robert E. Stowell
F. W. Wiglesworth
Benjamin Castleman
John B. Hazard
J. Lowell Orbison
David E. Smith
Henry D. Moon
A. James French
Robert H. More
Joshua L. Edwards
Edward A. Gall
T. C. Jones
William Christopherson
F. K. Mostofi
Nathan Kaufman
Richard E. Palmer
Murray R. Abell
Jack M. Layton
Benjamin F. Trump
Jack P. Strong
1979-80
1980-81
1981-82
1982-83
1983-84
1984-85
1985-86
1986-87
1987-88
1988-89
1989-90
1990-91
1991-92
1992-93
1993-94
1994-95
1995-96
1996-97
1997-98
1998-99
1999-00
2000-01
2001-02
2002-03
2003-04
2004-05
2005-06
2006-07
2007-08
2008-09
2009-10
2010-11
2011-12
2012-13
2013-14
2014-15
William Hartmann
Kenneth M. Earle
Leland D. Stoddard
Bernard M. Wagner
F. Stephen Vogel
David M. Robertson
Robert McCluskey
John Yardley
Robert Leader
Ronald S. Weinstein
Cecilia Fenoglio-Preiser
David F. Hardwick
Costan W. Berard
Peter A. Ward
Ramzi S. Cotran
Hector Battifora
William Gardner
Richard L. Kempson
Sharon W. Weiss
Elaine S. Jaffe
Harvey Goldman
Deborah Powell
Ronald DeLellis
Louis P. Dehner
Virginia A. LiVolsi
Ricardo V. Lloyd
Sylvia L. Asa
Henry D. Appelman
Christopher P. Crum
Victor R. Reuter
Richard J. Zarbo
Stuart J. Schnitt
Gregory N. Fuller
Linda D. Ferrell
Jeffrey L. Myers
Celeste N. Powers
Past Secretary-Treasurers
1907-40
1940-49
1949-51
1951-52
1952-70
1970-79
1979-91
1991-99
1999-2011
2011-2014
Maude Abbott
James E. Ash
Ruell Sloan
Harold Stewart
F. K. Mostofi
Leland D. Stoddard
Nathan Kaufman
F. Stephen Vogel
Fred G. Silva
Bruce R. Smoller
IN MEMORIAM
THESE MEMBERS OF THE USCAP FAMILY HAVE A LEFT
AN INDELIBLE IMPRINT IN OUR MEMORIES:
F. Stephen Vogel, MD
(Past-President)
Bernard M. Wagner, MD
(Past-President)
Carrie Besanceney, MD
Charles H. Bridges, DVM
William Henry Chase, MD
Robert D. Collins, MD
Robert Coon, MD
Salomon Grinspan, MD
Carlos Jaramillo, MD
John Stephen Jobe, MD
George F. Kipkie, MD
Risa B. Mann, MD
Florabel G. Mullick, MD
Richard Otis, MD
Samuel H. Paplanus, MD
Livia Ross, MD
George E. Yee, MD
Wei Zhao, MD, PhD
ALMOST EVERYONE IS OBSESSED WITH LEAVING A MARK

UPON THE WORLD. BEQUEATHING A LEGACY. OUTLASTING
DEATH. WE ALL WANT TO BE REMEMBERED.
JOHN GREEN (The Fault in Our Stars)
21
BOARD & COMMITTEE MEMBERS

EXECUTIVE COMMITTEE
TERM ENDING
John R. Goldblum, M.D., President

N. Volkan Adsay, M.D., President-Elect
Christopher Fletcher, M.D., FRCPath, Vice-President
Celeste N. Powers, M.D., Ph.D., Past-President
John Sinard, M.D., Ph.D., Secretary
Wendy L. Frankel, M.D., Treasurer
David B. Kaminsky, M.D., FIAC, Executive Vice-President
2016
2016
2016
2016
2017
2016
BOARD OF DIRECTORS
Marie Christine Aubry, M.D.

Marc Ladanyi, M.D.
David John Grignon, M.D.
Julia C. Iezzoni, M.D.
Audrey J. Lazenby, M.D.
Suzanne Z. Powell, M.D.
Sanja Dacic, M.D., Ph.D.
Daniel A. Arber, M.D.
2016
2016
2017
2017
2017
2018
2018
2018
JOURNAL EDITORS LABORATORY INVESTIGATION
TERM ENDING
Gene P. Siegal, M.D., Ph.D.

Robert W. Hardy, M.D., Ph.D.
Alexander Lazar, M.D., Ph.D.
Catherine Ketcham, Ph.D., Managing Editor
12/31/18
12/31/18
12/31/18
JOURNAL EDITORS MODERN PATHOLOGY
TERM ENDING
John N. Eble, M.D.

Harvey M. Cramer, M.D.
Catherine Ketcham, M.D., Ph.D., Managing Editor
6/30/20
6/30/20
22

EDUCATION COMMITTEE MEMBERS
TERM ENDING
Laura W. Lamps, M.D., Chair

Edi Brogi, M.D., Ph.D.
Laura C. Collins, MBBS
John A. Hart, M.D.
Megan S. Lim, M.D., Ph.D.
Adeboye O. Osunkoya, M.D.
Robert A. Soslow, M.D.
Kiril Trpkov, M.D.
Alyssa M. Krasinskas, M.D.
Melinda E. Sanders, M.D.
Paul E. Wakely, Jr., M.D.
Anthony (Tony) Yachnis, M.D.
Rhonda K. Yantiss, M.D.
Amy Chadburn, M.D.
Dan A. Milner, Jr., M.D.
John D. Reith, M.D.
Raja R. Seethala, M.D.
Aleodor (Doru) Andea, M.D., MBA
Michelle S. Hirsch, M.D., Ph.D.
Carol F. Farver, M.D.
Meera R. Hameed, M.D.
2017
2016
2016
2016
2016
2016
2016
2016
2017
2017
2017
2017
2017
2018
2018
2018
2018
2019
2019
2019
2019
SUBCOMMITTEE CHAIRS / HOUSE STAFF
Jeffrey Prichard, D.O., Chair, Education Informatics Subcommittee

Jason L. Hornick, M.D., Ph.D., Abstract Assignment Committee
Marisa R. Nucci, M.D., Subcommittee for Unique Live Course Offerings
Eva Vertes George, M.D., House Staff
Michael Gerald Drage, M.D., House Staff
Bradley (Brad) J. Quade, M.D., Ph.D.
Steven D. Billings, M.D., Short Course Coordinator
David B. Kaminsky, M.D., FIAC (Ex-Officio)
2016
2017
2017
2017
2017
2017
2019
23

ABSTRACT ASSIGNMENT COMMITTEE
TERM ENDING
Jason L. Hornick, M.D., Ph.D. Chair

Jonathan L. Hecht, M.D., Ph.D.
Xiaohua Qian, M.D., Ph.D.
Justine Barletta, M.D.
Sarah M. Dry, M.D.
Simion I. Chiosea, M.D.
Daniel J. Brat, M.D., Ph.D.
Paul VanderLaan, M.D., Ph.D.
Keith K. Lai, M.D.
Leona Doyle, M.D.
Kristin Jensen, M.D.
Dylan V. Miller, M.D.
Rajiv Patel, M.D.
Raga Ramachandran, M.D., Ph.D.
Sean R. Williamson, M.D.
Charles M. Quick, M.D.
Elizabeth Morgan, M.D.
Bobbi S. Pritt, M.D.
Shree Sharma, M.D.
Alton B. (Brad) Farris, III, M.D.
Maria Westerhoff, M.D.
2017
2016
2016
2016
2016
2016
2016
2016
2016
2018
2018
2018
2018
2018
2018
2018
2018
2018
2018
2018
2018
EDUCATION INFORMATICS SUBCOMMITTEE
TERM ENDING
Jeffrey Prichard, D.O., Chair

Shree G. Sharma, M.D.
Chiraag Patel, M.D.
Rish K. Pai, M.D., Ph.D.
Darren T. Wheeler, M.D.
Liron Pantanowitz, M.D.
Laura Lamps, M.D. (Ex-Officio)
John Garrard (Director of Communications/Innovative Products)
24
2017
2016
2016
2017
2017
2017
2019

CME SUBCOMMITTEE MEMBERS
Bradley J. Quade, M.D., Ph.D., Chair

Sara C. Shalin, M.D., Ph.D.
Amy Chadburn, M.D.
John D. Reith, M.D.
Melinda E. Sanders, M.D.
Yaolin Zhou, M.D. (Resident)
SUBCOMMITTEE FOR UNIQUE LIVE COURSE OFFERINGS
Marisa Nucci, M.D., Chair

John A. Hart, M.D.
Megan S. Lim, M.D., Ph.D.
Alyssa M. Krasinskas, M.D.
Raja Seethala, M.D.
Dan A. Milner, Jr., M.D.
Rhonda K. Yantiss, M.D.
SUBCOMMITTEE FOR INTERACTIVE MICROSCOPY
Steven D. Billings, M.D., Chair

Laura W. Lamps, M.D.
Laura C. Collins, M.D.
Paul E. Wakely, Jr., M.D.
FINANCE COMMITTEE MEMBERS
David J. Grignon, M.D., Chair

Wendy L. Frankel, M.D., Treasurer
Mahul B. Amin, M.D.
Henry Tazelaar, M.D.
Robert P. Hasserjian, M.D.
Mary S. Richardson, M.D.
Allen Gown, M.D.
John R. Goldblum, M.D. (Ex-Officio)
Travis Newman (Managing Director, Accountant)
TERM ENDING
2017
2017
2018
2018
2018
2017
TERM ENDING
2016
2016
2016
2017
2019
2019
2019
TERM ENDING
2018
2018
2018
2018
TERM ENDING
2016
2016
2016
2018
2018
2018
2018
25

MEMBERSHIP COMMITTEE MEMBERS
TERM ENDING
Tarik Tihan, M.D., Ph.D., Chair

Suntrea TG Hammer, M.D.
Josette Ragheb, M.D., Ph.D.
Esmeralda C. Marginean, M.D.
Robert M. Najarian, M.D.
Laura C. Collins, MBBS, (Representative for Resident Advisory Committee)
Kristie White, M.D.
Patricia E. Goldhoff, M.D., MA (Resident)
Christina Magi-Galluzzi, M.D., Ph.D.
Lydia P. Howell, M.D.
Carolyn Lane (Director of Membership)
NOMINATING COMMITTEE MEMBERS
TERM ENDING
Celeste N. Powers, M.D., Ph.D., Chair

Gregory N. Fuller, M.D., Ph.D.
Linda D. Ferrell, M.D.
Christina Isacson, M.D., Member at Large
Esther Oliva, M.D., Member at Large
2016
2016
2017
2016
2017
PUBLICATIONS COMMITTEE MEMBERS
TERM ENDING
Murray B. Resnick, M.D., Ph.D., Chair

Arie Perry, M.D.
Elaine Jaffe, M.D.
Rajiv M. Patel, M.D.
Brian Rubin, M.D. Ph.D.
Romil Saxena, MBBS, FRCPath
John Garrard (Director of Innovative Comm. / Product Design)
26
2017
2016
2016
2017
2017
2017
2018
2018
2018
2018
2019
2016
2018
2019
2019
2019

CASTLEMAN AWARDS COMMITTEE
William C. Faquin, M.D., Ph.D., Chair

Michael (Mike) Bayerl, M.D.
Rana S. Hoda, M.D.
Victor E. Reuter, M.D.
Gregory N. Fuller, M.D., Ph.D.
David N. Louis, M.D., (Ex-Officio)
GOLDMAN AWARDS COMMITTEE
Stuart Schnitt, M.D., Chair

Jeffrey E. Saffitz, M.D., Ph.D.
Laura W. Lamps, M.D.
John R. Goldblum, M.D.
Steven D. Billings, M.D.
STOWELL-ORBISON AWARDS COMMITTEE
Omar Hameed, MBChB, Chair

Deborah J. Chute, M.D.
Leona A. Doyle, M.D.
Wayne Tam, M.D., Ph.D.
Andrew M. Bellizzi, M.D.
VOGEL AWARDS COMMITTEE (2 YEAR TERMS)
Adeboye O. Osunkoya, M.D., Chair

Laura Collins, MBBS
John A. Hart, M.D.
Brian P. Rubin, M.D., Ph.D.
John N. Eble, M.D., (Ex-Officio)
Gene P. Siegal, M.D., Ph.D., (Ex-Officio)
TERM ENDING
2018
2016
2016
2017
2017
2017
TERM ENDING
N/A
N/A
N/A
N/A
N/A
TERM ENDING
2016
2017
2018
2018
2018
TERM ENDING
2016
2016
2016
2016
2016
27

YOUNG INVESTIGATOR AWARDS COMMITTEE
TERM ENDING
Marc Ladanyi, M.D., Chair

Audrey J. Lazenby, M.D.
Julia C. Iezzoni, M.D.
Cristina R. Antonescu, M.D.
Celina G. Kleer, M.D.
2016
2017
2017
2017
2017
FOUNDATION COMMITTEE MEMBERS
TERM ENDING
Gregory N. Fuller, M.D., Ph.D. Chair

Julia A. Bridge, M.D.
Steven C. Smith, M.D., Ph.D.
Martha Bishop Pitman, M.D.
Celeste N. Powers, M.D., Ph.D.
Linda D. Ferrell, M.D.
Marie E. Robert, M.D.
Ann Marie Nelson, M.D.
Wendy L. Frankel, M.D. (Ex-Officio as Treasurer)
David B. Kaminsky, M.D. (Ex-Officio)
Paul M. Lewin (Director of International Development)
USCAP CANADA FOUNDATION
TERM ENDING
David F. Hardwick, M.D., Chair

Michael F. Allard, M.D.
Sylvia L. Asa, M.D., Ph.D.
C. Blake Gilks, M.D.
John Veinot, M.D.
Ilan Weinreb, M.D.
Paul M. Lewin (Director of International Development)
28
2018
2018
2018
2018
2018
2017
2016
2016
2016
2016
2018
2016
2016
2016
2016
2016
2016
2016

COURSE DIRECTORS
Diagnostic Cytopathology Kristen A. Atkins, M.D.,

Diagnostic Cytopathology - Ritu Nayar, M.D.
Practical Pathology Seminars - Jesse K. McKenney, M.D.
Diagnostic Pathology Update Wendy L. Frankel, M.D.
Diagnostic Pathology Update Adam Bagg, M.D.
Interactive Microscopy Steven D. Billings, M.D.
AMERICAN MEDICAL ASSOCIATION
Nicole D. Riddle, M.D., Delegate

James Michael Mitchell, M.D. (Alternate)
Daniel C. Zedek, M.D.
David B. Kaminsky, M.D., FIAC Pathology Section Representative
David S. Wilkinson, M.D., Ph.D. (CPT Advisor)
TERM ENDING
2016
2019
2016
2016
2019
2017
TERM ENDING
2016
2016
2016
AMERICAN REGISTRY OF PATHOLOGY
Ronald A. DeLellis, M.D.
BIOLOGICAL STAIN COMMISSION
Paul E. Swanson, M.D.
INTERSOCIETY COMMITTEE ON PATHOLOGY INFORMATION
Margaret M. Grimes, M.D.
INTERSOCIETY PATHOLOGY COUNCIL
David B. Kaminsky, M.D., FIAC

PROGRAM DIRECTORS SECTION OF ASSOCIATION OF PATHOLOGY CHAIRS (PRODS)
Suzanne Z. Powell, M.D.
29

SOCIAL MEDIA SUBCOMMITTEE
TERM ENDING
Jerad M. Gardner, M.D., Chair

Samson W. Fine, M.D.
Roseann I. Wu, M.D, M.P.H.
Nicole D. Riddle, M.D.
Xiaoyin Sara Jiang, M.D.
Nathan Lee, M.D.
Matthew Wasco, M.D.
Rashna Meunier, M.D.
Raul Gonzalez, M.D.
Ethan Kaminsky
John Garrard (Ex-Officio)
(Director of Innovative Communications/Product Design)
30
2017
2017
2017
2017
2017
2017
2017
2017
2017
2017
2017
2016 BUSINESS MEETING AGENDA

1. CALL TO ORDER .......................................................................................................... Dr. John R. Goldblum
2. INTRODUCTION ........................................................................................................... Dr. John R. Goldblum
3. APPROVAL OF MINUTES, 2015 BUSINESS MEETING .............................................. Dr. John R. Goldbum
4. REPORT OF THE PRESIDENT
General Information
Recognition of Dignitaries
Announcements
5. REPORT OF THE EXECUTIVE VICE PRESIDENT ..................................................... Dr. David B. Kaminsky
6. REPORT OF THE EDUCATION COMMITTEE ....................................................................... Dr. Laura Lamps
7. REPORT OF THE FINANCE COMMITTEE ........................................................................ Dr. David Grignon
8. REPORT OF THE MEMBERSHIP/RAC COMMITTEES ............................................................Dr. Tarik Tihan
9. REPORT OF THE FOUNDATION.............................................................................................. Dr. Greg Fuller
10. REPORT OF THE PUBLICATIONS COMMITTEE............................................................Dr. Murray Resnick
11. REPORT OF THE NOMINATING COMMITTEE ......................................................... Dr. Celeste N. Powers
12. ELECTION OF OFFICERS ........................................................................................... Dr. Celeste N. Powers
13. INSTALLATION OF THE PRESIDENT ....................................................................... Dr. John R. Goldblum
14. PRESENTATION OF THE PRESIDENTS MEDAL TO THE PAST-PRESIDENT ..............Dr. John Goldblum
15. REPORT OF THE IAP .......................................................................................................Dr. David Hardwick
Future Congresses (Cologne, Germany, 2016; Amman, Jordan, 2018)
16. OTHER BUSINESS ................................................................................................... Dr. John R. Goldblum
17. ADJOURNMENT ........................................................................................................ Dr. John R. Goldblum
SPECIAL AWARDS PRESENTATIONS

STOWELL-ORBISON.................................................................................................................. Dr. Laura Lamps
AUTOPSY & SURGICAL PATHOLOGY .................................................................................... Dr. Teri Longacre
CASTLEMAN AWARD ................................................................................................................. Dr. David Louis
VOGEL AWARD................................................................................................................. Dr. John R. Goldblum
DISTINGUISHED PATHOLOGIST AWARD....................................................................... Dr. John R. Goldblum
MOSTOFI AWARD ............................................................................................................ Dr. John R. Goldblum
RAMZI COTRAN YOUNG INVESTIGATOR AWARD ............................................................... Dr. Mark Ladanyi
HARVEY GOLDMAN MASTER TEACHER AWARD.................................................................Dr. Stuart Schnitt
DR. L. CLARKE JR. & ELAINE F. STOUT ENDOWMENT AWARD.................................. Dr. John R. Goldblum
DR. FLORABEL G. MULLICK AWARD .............................................................................. Dr. John R. Goldblum
5:00 PM INTRODUCTION OF MAUDE ABBOTT LECTURER AND PRESENTATION
OF MAUDE ABBOTT MEDALLION .................................................................................. Dr. John R. Goldblum
5:05-5:50 PM .....................................................................................................................Maude Abbott Lecture
31
2015 BUSINESS MEETING MINUTES

Tuesday, March 24, 2015
Auditorium, Hynes Convention Center
Boston, MA
3:30 PM
INTRODUCTION
The President, Dr. Celeste Powers and the Executive Vice-President, Dr. David B. Kaminsky opened the Business Meeting
at 3:30 PM. Both delivered monologues regarding the new leadership and direction of USCAP. Dr. Kaminsky described
the progressive atmosphere at the Annual Meeting and how each physician leaves the meeting knowing that USCAP is
creating a better pathologist. Dr. Powers addressed her leadership vision the beginning of the reimagined USCAP.
I. CALL TO ORDER
The 2015 USCAP Business Meeting was called to order by Dr. Celeste Powers on Tuesday, March 24, 2015, at 3:37 PM at
the Hynes Convention Center in Boston, Massachusetts.
II. ADOPTION OF THE AGENDA
A motion CARRIED to adopt the agenda published in the Program Book (verbal vote, no oppositions).
III. APPROVAL OF MINUTES, 2014 BUSINESS MEETING
A motion CARRIED to approve the minutes of the 2014 Annual Business Meeting as posted on the USCAP website (verbal
vote, no oppositions).
IV. VOTE ON BYLAWS REVISIONS
Dr. Powers requested a motion to approve the Bylaws revisions that were posted to the USCAP website and circulated
through e-mail. These revisions addressed new member categories and revised the general language to be compliant
with modern 501(c)3 Non-profit organizational standards. The motion CARRIED (verbal vote, no oppositions) and the
Bylaws revisions were accepted.
V. RECOGNITION OF DIGNITARIES
Dr. Powers recognized several dignitaries in attendance at the meeting. Their names were listed in the Program Book.
VI. REPORT OF THE PRESIDENT/EXECUTIVE VICE-PRESIDENT
Dr. Kaminsky thanked the staff of USCAP for their dedication. Dr. Celeste Powers described the two-day strategic plan
meeting in Chicago facilitated by CFAR (consulting group) to reinforce member engagement with definition of value,
strengthening governance, supporting operations and the EVP, global outreach, leveraging relationships and alliances
and the delivery of digital products. Dr. Kaminsky described the presentation to the Board by Sheri Jacobs (author of The
Art of Membership) on membership value and introduced the Memorandum of Understanding with the American Society
for Clinical Pathology and highlighted the resident engagement program as an example of the intended collaboration.
Dr. Powers explained that the Board of Directors had adopted the management style reflected by a metaphorical firewall
separating governance and operations. She introduced the new initiative of providing concierge services to recognize
the extraordinary volunteer work by the faculty and committees. Dr. Kaminsky explained that to enhance functionality,
navigability and a new website design, the Academy prepared surveys, held focus groups and a three-day vendor summit
prior to selection of a new web vendor and designer. The website is under construction and will be launched soon. Dr.
Kaminsky also explained the Academys efforts to develop new educational products focusing on digital assets designed
for delivery on hand-held and mobile devices. Dr. Powers described Dr. Kaminskys visits to Vancouver to meet with
Dr. David Hardwick for strengthening the relationship between the USCAP and the IAP. Dr. Kaminsky announced the
opening of a West Coast office (USCAP West) and the capabilities of the staff. Dr. Powers introduced the 2014 Interactive
Microscopy documentary and then asked Dr. Steven Billings to describe the new Interactive Center in Palm Springs (via
a short video in which Dr. Billings explaining the floor plan/layout of the interactive laboratory spaces). Dr. Kaminsky
concluded the report by describing his time in Evans, Georgia during the summer to interact with staff, refine operations,
standardize procedures, and assure risk management/financial security.
VII.
32
REPORT OF THE EDUCATION COMMITTEE - DR. LAURA LAMPS

Dr. Laura Lamps announced that the registration for the 2015 Annual Meeting had already exceeded 5000 people
representing 87 countries. She presented the 2015 Annual Meeting Statistics. She indicated that 3,096 abstracts
were submitted with 2,126 accepted (69%). 1,846 abstracts were assigned to posters and 280 to platforms. Registered
attendance for the long course this year is 696, Special Courses = 1,093, Companion Societies = 5,975, Evening Specialty
Conferences = 7,103 and Short Courses = 4,025. Dr. Lamps explained the total number of possible CMEs per person was
58.5 of a total of 445.5 CMEs available for the meeting. Maximum SAMs credits per person were 55.25 of a total of 309.25.

Dr. Lamps explained the excitement surrounding the new digital products, interactive Microscopy, the Interactive Center,
the opportunity to enhance mentoring and a reinvigorated subcommittee on Informatics. She concluded with a slide on a
Formula for Success, which contained all the above-referenced totals.
VIII.
REPORT OF THE FINANCE COMMITTEE DR. WENDY FRANKEL (TREASURER)

Dr. Wendy Frankel presented the names of the Finance Committee members and explained the evolution of the
Academys Operating Budget. Dr. Frankel notified the attendees of the unqualified opinion on the most current audit (an
unqualified opinion for an audit means there was no evidence of wrong-doing and the financial statements were errorfree). Next, the allocation of operating revenue for the Academy was presented.
IX.
REPORT OF THE MEMBERSHIP COMMITTEE DR. TARIK TIHAN

Dr. Tihan reviewed the members, structure and terms of office of the Membership Committee. He acknowledged Dr.
Iezzoni for her service as the past Chair. Dr. Tihan then presented the mission of the Membership Committee Provide
true value and purpose for membership that will respond to the members professional needs in accordance with the
mission of the Academy. Dr. Tihan discussed the action plan for the next cycle - the membership committee will refine
its operating guidelines, implement the mission of the committee, and draft guidelines for adopting initiatives which
had been presented to the EVP. He presented charts on member demographics, by institution type, region, and then
sub-specialty. Moving forward, the Membership Committee proposed the following priorities for 2015: trend analysis
of member data, increasing membership from the private pathology community, developing a welcome package for
new members, supporting the re-imagined ambassador program, and supporting/empowering the Resident Advisory
Subcommittee. He ended by providing detail on the 10 travel scholarships given by the Foundation in collaboration with
the Resident Advisory Subcommittee.
X.
REPORT OF THE FOUNDATION COMMITTEE DR. LINDA FERRELL

Dr. Linda Ferrell explained that philanthropy has always been at the Academys cornerstone, but that now, more than
ever, USCAP needs to become more visible in supporting pathologists globally, particularly in low-resource settings.
She presented the financial data supporting the G20 campaign and the travel grants for 10 trainees to attend the Annual
Meeting. Dr. Ferrell thanked Dr. and Mrs. Stout for partnering with the USCAP Foundation by providing an endowment.
She detailed the grants for Haiti including supporting three Haitian pathologists to attend the Annual Meeting and
implementation of on-site education and laboratory development assistance in Haiti. Grant money has also been awarded
to Dr. Cooke for the development of an Atlas of Infectious Diseases. The USCAP Foundation commits to contributing
resources and tools to Africa. Dr. Ferrell described the annual Miles for Mentors event. She announced the formation
of the USCAP Canadian Foundation. Dr. Ferrell concluded with special thanks to CytoTest and Virginia Commonwealth
University for their Foundation support, the latter in honor of Dr. Celeste Powers presidency.
XI.
REPORT OF THE PUBLICATIONS COMMITTEE DR. MURRAY RESNICK

Dr. Resnick commenced his presentation by acknowledging this has been a very successful year for both journals
Modern Pathology and Laboratory Investigation. He thanked the partnership between USCAP and Nature Publishing
Group, explained the structure of the journals and thanked the editors for their dedication.
Laboratory Investigation is among the top three journals devoted to general experimental pathology. New developments
for this journal include the addition of a Senior Associate Editor, Dr. Akihiro Umezawa, as a consequence of the
increased interest in the journal in Asia and upcoming special issues of Pathobiology in Focus. Dr. Resnick expressed his
appreciation to Dr. Gene Siegal for his leadership.
Dr. Resnick remarked that Modern Pathology is one of the leading journals devoted to general diagnostic anatomic/
surgical pathology. He acknowledged the contribution of Dr. John Eble who will begin his unprecedented fourth term as
editor in chief.
The 2014 projected impact factors for Laboratory Investigation is 3.86, and for Modern Pathology is 7.11. This data was
presented in comparison to competitors. Next, slides for the most cited papers, noted for both journals, were presented.
The submission processes were described by Dr. Resnick who concluded by thanking Dr. Catherine Ketcham, Martha
Simmons and the Editorial Boards and reviewers of Laboratory Investigation and Modern Pathology.
33

XII.
REPORT OF THE NOMINATING COMMITTEE DR. LINDA FERRELL

Dr. Ferrell began by thanking the members of the committee: Drs. Greg Fuller, Christina Isacson, and Fred Silva. Dr. Fred
Silva is rotating off. She announced that Drs. Sanja Dacic, Suzanne Powell, and Daniel Arber were elected by the USCAP
membership (prior electronic election) as the new members of the Board of Directors, effective April 1, 2015.
XIII.
ELECTION OF OFFICERS DR. LINDA FERRELL

Dr. Ferrell introduced Dr. Christopher Fletcher as the new USCAP Vice-President (effective April 1, 2015). She concluded
her report by thanking the Executive Committee and the Board of Directors for their dedication and leadership.
IV.
INSTALLATION OF THE PRESIDENT DR. CELESTE POWERS

Dr. Powers described the highlights of Dr. John Goldblums career. As the incoming President of USCAP, Dr. Goldblum
officially takes office on April 1, 2015.
XV.
PRESENTATION OF THE PRESIDENTS MEDAL TO THE PAST-PRESIDENT DR. CELESTE POWERS

Dr. Jeffrey Myers was not in attendance for the presentation.
XVI. REPORT OF THE INTERNATIONAL ACADEMY OF PATHOLOGY (IAP) DR. DAVID HARDWICK
Dr. Hardwick announced that the 2016 IAP Congress will be held on September 24-30th in Cologne, Germany. The 2018
Congress will take place in Amman, Jordan with the 2020 IAP Congress following in Glasgow, Scotland. Dr. Hardwick was
presented with a plaque by Dr. Powers to acknowledge his contribution to creation of the USCAP Canadian Foundation.
XVII. IN MEMORIAM
Dr. Kaminsky requested a minute of silence in memory of USCAP members who died during the previous year. Their
names were displayed.
XVIII. OTHER BUSINESS DR. CELESTE POWERS
Dr. Powers asked if there were other business to conduct. There was no other business.
XIX. ADJOURNMENT DR. CELESTE POWERS
Dr. Powers adjourned the 2015 Annual Business Meeting at 4:12 PM.
SEPTEMBER 15, 2015

John Sinard, M.D., Ph.D.
Secretary
34
Date Approved
IAP SESSION
International Academy of Pathology
Pathology Education in Africa and Other Low Resource Countries
12:00PM 1:45PM
CC 613-614
MODERATOR: H.K. Ng, MBChB, Chinese University of Hong Kong, Hong Kong
12:00PM
AFRICA CALLS
David Kaminsky, M.D., FIAC, USCAP Executive Vice President
12:20PM
PATHOLOGY SAFARI
Dan Berney, MB, BChir, MA, FRCPath, Consultant GU Pathologist, Dept. Cellular Pathology, Royal London Hospital
12:40PM
A COOKES ROUND THE WORLD TOUR OF MEDICAL MUSEUMS

Robin Cooke MD, FRCPA, FRCPath, FACTM, Mayne Medical School, University of Queensland, and Pathology
Queensland, Australia
1:00PM
BREAKING BARRIERS IN PATHOLOGY EDUCATION: MONGOLIA AND KOREA

Shin K. Khang, MD, PhD, Department of Pathology, Asan Medical Center,
University of Ulsan College of Medicine, Seoul, Korea
1:20PM
TO GO OR NOT TO GO, IS THIS A QUESTION ANYMORE?

H.K. Ng, MBChB, Chinese University of Hong Kong, Hong Kong
35

2016 AFFILIATE EVENTS
PLEASE NOTE:
For Alumni Receptions: You are invited to attend if you are an alumnus, a guest of an alumnus, or a friend of the institution.
For Specialty/Companion Society Receptions: You are invited if you are a member of this society or are considering joining the
society and wish to learn more about it. All luncheons are by invitation only.
SH = SHERATON SEATTLE HOTEL
CC = WASHINGTON STATE CONVENTION CENTER
FRIDAY, MARCH 11TH

8:00 AM - 5:00 PM
6:00 PM - 10:00 PM
INT'L ASSOCIATION FOR THE STUDY OF LUNG CANCER

ADASP COUNCIL MTG & DINNER
SH Cedar
SH Greenwood
SATURDAY, MARCH 12TH

7:30 AM - 5:00 PM
8:00 AM - 3:00 PM
8:00 AM - 6:00 PM
9:00 AM - 2:00 PM
10:00 AM 5:00 PM
12:00 PM - 1:30 PM
12:00 PM - 6:00 PM
2:00 PM - 6:00 PM
1:30 PM - 4:00 PM
3:00 PM - 5:00 PM
3:45 PM - 5:45 PM
4:00 PM - 6:00 PM
5:00 PM - 7:30 PM
5:00 PM - 7:00 PM
5:00 PM - 7:00 PM
5:30 PM - 7:00 PM
5:30 PM 9:00 PM
5:30 PM 7:30 PM
6:00 PM 7:00 PM
6:15 PM - 6:45 PM
7:00 PM - 8:00 PM
8:00 PM - 10:00 PM
ADASP ANNUAL MEETING

INT'L ASSOCIATION FOR THE STUDY OF LUNG CANCER
VHA NATIONAL DX ELECTRON MICROSCOPY AD HOC CMTE MEETING
INTL SOCIETY OF GYN PATH WORKING MTG
PAPANICOLAOU SOCIETY MEETING
ADASP LUNCHEON AND BUSINESS MEETING
CHINESE AMERICAN PATH ASSOC.
INT'L SOCIETY OF GYN PATHOLOGY EXEC COMMITTEE MTG
INT'L SOCIETY OF UROLOGICAL PATH EXEC. MTG
PULMONARY PATH SOCIETY COUNCIL MEETING
RENAL PATHOLOGY SOCIETY BOARD MTG
INT'L SOCIETY OF UROLOGICAL PATH RECEPTION
ASSOCIATION OF INDIAN PATH EXEC COMMITTEE MTG
PAPANICOLAOU SOCIETY RECEPTION
SOCIETY FOR ULTRASTRUCTURAL PATHOLOGY COMMITTEE MTG
ENDOCRINE SOCIETY RECEPTION
SOCIETY FOR HEMATOPATH EXECUTIVE COMMITTEE MTG
AFRICAN IAP ASSEMBLY/ASAP GROUP BOARD OF DIRECTORS MTG
CANCER CYTOS 20TH ANNIVERSARY RECEPTION
INT'L SOCIETY OF UROLOGICAL PATH AGM MTG
RENAL PATHOLOGY SOCIETY ANNUAL RECEPTION
RENAL PATHOLOGY SOCIETY ANNUAL DINNER
SH Grand Ballroom A
SH Cedar
SH Boren
SH Willow B
SH Redwood
SH Grand Ballroom B
SH Metro Ballroom A
SH Diamond
SH Greenwood
SH Eagle Boardroom
SH Aspen
SH Issaquah
SH Madrona
SH Willow A
SH Seneca
SH University
SH Juniper
SH Spruce
SH Ballard
CC BR 6B
SH Cedar
SH Redwood
SUNDAY, MARCH 13TH

7:00 AM - 8:00 AM
7:00 AM - 10:00 AM
7:15 AM - 8:30 AM
7:30 AM - 9:00 AM
8:00 AM - 12:00 PM
36
ENDOCRINE PATHOLOGY EDITORIAL BOARD MTG

SOCIETY FOR HEMEPATH FELLOWSHIP DIRECTORS BREAKFAST
ARTHUR PURDY STOUT SOCIETY COUNCIL BREAKFAST
WILEY-DIAGNOSTIC CYTOPATH /ED BOARD MTG
DICOM PATHOLOGY WORKING GROUP
SH Diamond
SH Grand Ballroom A
SH Madrona
SH Issaquah
SH Ballard

8:00 AM 3:30 PM
8:00 AM - 3:30 PM
8:00 AM - 5:00 PM
12:00 PM - 1:00 PM
12:30 PM - 5:00 PM
1:30 PM - 3:30 PM
1:30 PM - 4:30 PM
3:00 PM - 5:00 PM
5:00 PM - 6:45 PM
5:00 PM - 7:30 PM
5:00 PM - 7:00 PM
5:00 PM - 7:00 PM
5:00 PM - 6:45 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 6:30 PM
5:30 PM - 8:00 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM 7:30 PM
5:30 PM - 7:00 PM
7:00 PM - 12:00 AM
5:30 PM 7:30 PM
7:00 PM - 8:00 PM
7:00 PM - 7:20 PM
DIGITAL PATHOLOGY ASSOCIATION MEETING

ASCP RESIDENT'S COUNCIL
MESOTHELIOMA PANEL
RENAL PATHOLOGY SOCIETY BUSINESS MTG
ISUP INTERACTIVE CONFERENCE
INTERNATIONAL BREAST PATH MEETING
SOCIETY FOR CARDIOVASCULAR PATH EXEC COMMITTEE MTG
INT'L SOCIETY OF BREAST PATH COMMITTEE MTG
ARTHUR PURDY STOUT SOCIETY RECEPTION
ASSOCIATION OF INDIAN PATH RECEPTION
CYTO JOURNAL EDITORIAL BOARD ACTIVITY
HEAD & NECK RECEPTION
INT'L SOCIETY OF BREAST PATHOLOGY RECEPTION
ALBANY MEDICAL COLLEGE RECEPTION
COLUMBIA UNIV. (PRES HOSPITAL) ALUMNI REC.
GI PATHOLOGY SOCIETY RECEPTION
IRANIAN PATHOLOGISTS ASSOCIATION OF NA RECEPTION
IRISH/NORTH AMERICAN PATHOLOGY MTG
SOCIETY FOR HEMATOPATH RECEPTION
STANFORD UNIVERSITY RECEPTION
UNIVERSITY OF MIAMI RECEPTION
DUKE PATHOLOGY RECEPTION
UPMC FACULTY AND ALUMNI RECEPTION
UCSF RECEPTION
FRIENDS OF AFRICA INITIATIVE MTG
HEAD AND NECK JOURNAL BOARD MTG
INT'L SOCIETY OF BREAST PATH AGM MTG
SH Metro Ballroom A
SH Greenwood
SH Redwood
CC 606-607
SH Willow
SH Kirkland
SH Seneca
SH Medina
SH Madrona
SH Cirrus
SH Grand Ballroom D
SH Virginia
SH Leschi
SH Boren
SH Juniper
SH Grand Ballroom A
SH Capitol Hill
CC 605
SH Ravenna
SH Ballard
SH University
SH Cedar
SH Columbia
SH Jefferson
SH Issaquah
SH Diamond
CC Hall 4E
MONDAY, MARCH 14TH

7:00 AM - 8:00 AM
7:00 AM - 9:00 AM
7:00 AM - 9:00 AM
7:00 AM - 9:30 AM
8:00 AM - 12:30 PM
8:30 AM 2:30 PM
10:00 AM - 12:00 PM
10:30 AM - 3:00 PM
11:30 AM - 2:00 PM
11:30 AM - 1:30 PM
12:00 PM - 1:30 PM
12:00 PM 6:00 PM
11:30 AM 2:30 PM
4:00 PM 5:30 PM
5:00 PM - 6:30 PM
5:00 PM - 7:00 PM
5:00 PM - 7:00 PM
5:00 PM - 7:00 PM
5:00 PM - 7:00 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
ASSOCIATION FOR MOLECULAR

PATHOLOGYS MEET N GREET CAF FOR TRAINEES
TAYLOR & FRANCIS EDITORIAL BOARD MEETING
(ELSEVIER) CV PATH EDITORIAL BOARD MEETING
HUMAN PATH ASSOCIATE EDITORS MEETING
TRIG COMMITTEE MEETING
APC CHAIRS MEETING
MD SURVEY TASK FORCE
PANCREATIC GROUP-EMORY
HUMAN PATH EDITORIAL BOARD MEETING
INT'L JOURNAL OF GYN PATHOLOGY ED BOARD
MCGILL UNIVERSITY LUNCHEON
AFRICAN IAP ASSEMBLY/ASAP GROUP MEETING
PRODS MEETING
ENUP BOARD MEETING
ARCHIVES OF PATH RECEPTION
MT. SINAI ALUMNI RECEPTION
HOUSTON METHODIST HOSPITAL RESIDENT RECEPTION
UNIVERSITY OF PENNSYLVANIA RECEPTION
UNIVERSITY OF TEXAS MEDICAL BRANCH REUNION
ALUMNI & FRIENDS OF YALE RECEPTION
ARAB DIVISION OF IAP RECEPTION
SH Ballard
SH Kirkland
SH Issaquah
SH Medina
SH Chelan
SH Metro Ballroom B
SH Aspen
SH Redwood
SH Ravenna
SH Madrona
SH Willow A
SH Capitol Hill
SH Grand Ballroom C
SH Medina
SH Issaquah
SH Ravenna A
SH Boren
SH Juniper
SH Jefferson B
SH Jefferson A
SH Ballard
37

MONDAY, MARCH 14TH...CONTINUED
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:00 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:00 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM 7:30 PM
6:00 PM 8:00 PM
6:00 PM - 8:00 PM
6:00 PM 8:00 PM
9:00 PM - 11:00 PM
UNIVERSITY OF ROCHESTER MEDICAL CENTER ALUMNI RECEPTION

BRIGHAM & WOMENS HOSPITAL RECEPTION
CLEVELAND CLINIC ALUMNI RECEPTION
DARTMOUTH-HITCHCOCK/FLETCHER ALLEN RECEPTION
EMORY UNIVERSITY RECEPTION
JOHNS HOPKINS RECEPTION
LABORATORY MEDICINE & PATHOLOGY
(UNIV. OF TORONTO) RECEPTION
LATIN AMERICAN PATH FOUNDATION RECEPTION
MAYO CLINIC ALUMNI ASSOCIATION RECEPTION
MD ANDERSON RECEPTION
NORTHWESTERN UNIVERSITY RECEPTION
VCU RECEPTION
UCLA ALUMNI RECEPTION
UMASS MEDICAL SCHOOL ALUMNI RECEPTION
UNIVERSITY OF CHICAGO RECEPTION
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS RECEPTION
VANDERBILT ALUMNI RECEPTION
UNIVERSITY OF MICHIGAN A. JAMES FRENCH ALUMNI SOCIETY
WASHINGTON UNIVERSITY IN ST. LOUIS RECEPTION
MASSACHUSETTS GENERAL RECEPTION
NYU SCHOOL OF MEDICINE ALUMNI RECEPTION
HOUSTON METHODIST HOSPITAL RESIDENT RECEPTION
MOFFITT CANCER CENTER RECEPTION
INT'L ASSN OF CHINESE PATH ANNUAL REC
SH Madrona
SH Virginia
SH Cirrus
SH Diamond
SH Redwood
SH Willow A
SH Ravenna B
SH Grand Ballroom D
SH Willow B
SH Grand Ballroom B
SH Columbia
SH Aspen
SH Seneca
SH Ravenna C
SH Metro Ballroom A
SH Leschi
SH Cedar
SH Greenwood
SH Kirkland
SH University
SH Grand Ballroom A
SH Boren
SH Metro Ballroom B
SH Capitol Hill
TUESDAY, MARCH 15TH

7:30 AM - 9:30 AM
7:30 AM - 9:30 AM
11:30 AM - 2:30 PM
12:00 PM - 3:00 PM
5:00 PM - 7:00 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
5:30 PM - 7:30 PM
6:00 PM - 7:30 PM
38
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR

MORPHOLOGY ED. BOARD MEETING
ANNALS OF DIAGNOSTIC PATH (ELSEVIER)
AMERICAN JOURNAL OF SURGICAL PATH ED BOARD
SCVP MEETING
LWW - ADVANCES IN ANATOMIC PATH MTG.
BETH ISRAEL DEACONESS HOSPITAL RECEPTION
HISTOPATHOLOGY EDITORIAL BOARD RECEPTION
JAPANESE DIVISION OF IAP RECEPTION
MSKCC ALUMNI RECEPTION
SEMINARS IN DIAGNOSTIC PATH (ELSEVIER)
UNC RECEPTION
UNIVERSITY OF MARYLAND RECEPTION
SH Madrona
SH Ravenna
SH Jefferson
SH Cedar
SH Capitol Hill
SH Issaquah
SH Redwood
SH Greenwood
SH Jefferson
SH Ravenna
SH Ballard
SH Kirkland
2016
PATHOLOGISTS-IN-TRAINING
MENTORS
TABLE
at the
Meet Your Mentors.
Here is your opportunity to rub elbows

with the rockstars of the Pathology
world! Gain valuable insight and
knowledge in a casual and engaging
setting.
Topics of Discussion Include...

Whats concrete about the abstract?
Grasping informatics
Life cycle of the pathology trainee
The patient-centered cytopathology practice
Next Generation Sequencing/Molecular Pathology
#IAMUSCAP and how to engage social media

Conflict management
Finding empathy
How to get published!
Quality starts during training
March 14, 2016 Breakfast
Lynette M. Sholl, M.D.

Catherine M. Ketcham, Ph.D.
Laura Collins, M.D.
Rhonda Yantiss, M.D.
March 14, 2016 - Lunch
Christopher Fletcher, M.D., FRCPath

Celeste Powers, M.D., Ph.D.
Miguel Sanchez, M.D.
E. Blair Holladay, Ph.D.
Jerad M. Gardner, M.D.
March 15, 2016 Breakfast

Catherine M. Ketcham, Ph.D.
Stuart J. Schnitt, M.D.
Murray Resnick, M.D., Ph.D.
March 15, 2016 Lunch
Laura Lamps, M.D.

Wendy Frankel, M.D.
Marisa Nucci, M.D.
Yael Kushner Hehr, M.D., MPH, FRCPC
Jerad M. Gardner, M.D.
Richard L. Haspel, M.D., Ph.D.
RESIDENTS ON THE VERGE
Washington State Convention Center - 3AB | 7:00 am - 3:00 pm
PATHOLOGISTS-IN-TRAINING
Id like to extend a warm welcome to you, our pathologists-in-training, and congratulate you on taking the opportunity to attend
one of the greatest events in pathology in Seattle, Washington: The USCAP Annual Meeting. We continue to provide many
offerings especially designed for you. Begin your experience at the special trainee registration and information booth in the
registration area.
Dont miss these two workshops specifically targeted to trainees: Genomic Medicine for Pathologists and Leadership
Collaboration, and Change in Health Care. Both address core competencies that are critical to succeeding in a health care
environment increasingly delivered by integrated health care teams. Both events are topped off by a special reception for residents
and fellows attending the workshop, which is a great way to meet the instructors, USCAP officials, and your peers.
Other courses, including the Long Course, entitled Diagnosing Distinctive Lesions of Head and Neck; Special Courses like
Clinical Application of Next Generation Sequencing, and Molecular Diagnostic and Genomic Applications in Cancer: A Primer
for the Pathologist and popular programs like Hot Topics in Pathology, are led by world-class instructors and are not to be
missed; nor are our plenary lectures, the Maude Abbott Lecture and the Nathan Kaufman Timely Topics Lecture, which will push
your pathology knowledge to new boundaries and grow your mind. A special lecture by Dr. Thomas Colby and National Geographic
Magazine photojournalist, Annie Griffiths, looks at Hut Lung: A Poignant Portrait. Three Practice Changers are targeted to
pathologists-in-training, co-branded with ASCP. Practice Changers have been relocated external to the Exhibit Hall. Stop by any
of the 12 sessions, held Monday and Tuesday during the coffee breaks, to pick up tips from the most contemporary pathology
practices. The Evening Specialty Conference on Sunday, March 13 is dedicated to Preparing for Life Beyond Residency.
Find your future fellowship at the Fellowship Fair on Sunday evening where you can meet faculty and fellowship directors from
over 40 institutions. Before going, check out the Fellowship Fair charts found under this tab. Theyre designed to help you quickly
target the institutions and fellowships you seek.
Our annual Abstract Competition with its many awards draws the foremost pathology research from around the world. Make sure
you attend the Poster and Proffered Papers sessions early in the week. Awards for the leading presentations by pathologistsin-training will follow on Tuesday, March 15. We hope youll join the crowd to celebrate your peers achievements. The Annual
Business Meeting will generate buzz and reference our re-imagined Ambassador Program and social media outreach.
The Exhibition Hall is filled again with the leading companies and services that comprise our industry; knowledgeable representatives
are available to explain how their company can support your future pathology practice.
Finally, theres no better place to meet the world of USCAP than at the numerous receptions scheduled throughout the week.
Several have been created especially for you (see information under this tab) and present an ideal situation to meet our worldrenowned attendees. And, should you need a place to recharge, the Mentors at the Table (formerly House Staff Hospitality) Room,
Convention Center 3AB, (March 14-15, 7:00 a.m.-3:00 p.m) is a wonderful place to meet friends and grab breakfast, lunch, and
snacks while chatting with USCAP leaders throughout the day.
This year, the USCAP Foundation supported Pathologist-in-Training Travel Awards (through ten $1,000 scholarships) for
pathologists in training So much to do! Enjoy your visit to the worlds largest pathology meeting.
Laura C. Collins, MBBS
Resident Advisory Committee Chair
Beth Israel Deaconess Medical Center
39
FELLOWSHIP FAIR
#
SUB SPECIALTIES
BLOOD BANKING
BONE & SOFT TISSUE
BREAST
CANCER BIOMARKER
CARDIOVASCULAR PATHOLOGY
CHEMICAL PATHOLOGY
CLINICAL BIOCHEMICAL GENETICS
CLINICAL BIOCHEMISTRY
CLINICAL CHEMISTRY
10
CLINICAL CYTOGENETICS
11
CLINICAL IMMUNOLOGY
12
CLINICAL MICROBIOLOGY
13
CLINICAL MOLECULAR GENETICS
14
CYTOGENETICS
15
CYTOPATHOLOGY
16
DERMATOPATHOLOGY
17
ENDOCRINE
18
FORENSIC
19
GENITOURINARY
20
GENOMIC PATHOLOGY
21
GI PATHOLOGY
22
GYNECOLOGIC PATHOLOGY
23
HEAD & NECK
24
HEMATOPATHOLOGY
25
INSTITUTION (TABLE #)
FELLOWSHIPS OFFERED
BAYLOR COLLEGE OF MEDICINE (#17)
1, 9, 15, 16, 24, 33, 36, 41, 48, 50
BROWN UNIVERSITY ALPERT

MEDICAL SCHOOL (#20)
3, 21, 22, 36, 41, 42, 48, 54
CLEVELAND CLINIC - PATHOLOGY AND

LABORATORY MEDICINE (#6)
1, 2, 5, 8, 12, 15, 16, 19, 21, 24, 33, 50
EMORY UNIVERSITY (36)
15, 16, 18, 21, 24, 31, 33, 36, 41, 48, 50
HARTFORD HOSPITAL (41)
15, 24, 46
HOSPITAL OF THE UNIVERSITY OF

PENNSYLVANIA (#27)
15, 21, 24, 33, 48
HOUSTON METHODIST HOSPITAL (#4)
1, 9, 15, 24, 25, 33, 36, 39, 48, 50
ICAHN SCHOOL OF MEDICINE AT

MOUNT SINAI (#32)
3, 15, 16, 17, 19, 20, 21, 22, 23, 24,

29, 33, 36, 44
INDIANA UNIVERSITY (#30)
1, 15, 16, 18, 19, 21, 24, 31, 36, 48, 50
JACKSON MEMORIAL HOSPITAL /

UNIVERSITY OF MIAMI MILLER
SCHOOL OF MEDICINE (#22)
1, 3, 15, 19, 21, 22, 23, 24, 33, 41, 50
MAYO CLINIC ROCHESTER (#9)
2, 3, 5, 7, 9, 10, 12, 13, 16, 21, 24, 33,

36, 43, 44, 47, 48, 50
MD ANDERSON CANCER
CENTER (#5)
1, 2, 3, 4, 6, 15, 16, 19, 21, 22, 23, 24,33,34,

48, 49, 50
MEMORIAL SLOAN KETTERING

CANCER CENTER (#26)
3, 15, 16, 19, 21, 22, 24, 33, 38, 49
HLA
26
IMMUNOPATHOLOGY
MOFFITT CANCER CENTER (#34)
15, 16, 21, 24, 33, 48
27
INFORMATICS
NEPHROPATH (#1)
44
28
LABORATORY MEDICINE
29
LIVER/HEPATIC PATHOLOGY
15, 24, 48
30
MEDICAL GENETICS
NORTH SHORE LIJ HEALTH

SYSTEM (#18)
31
MEDICAL MICROBIOLOGY
3, 15, 19, 21, 24, 36, 41, 48
32
MICROBIOLOGY
NORTHWESTERN UNIVERSITY
FEINBERG SCHOOL OF MEDICINE (#7)
33
MOLECULAR GENETICS
15, 21, 24, 36, 52, 54
34
MULTIDISCIPLINARY
SUBSPECIALTY PATHOLOGY
NYU LANGONE MEDICAL

CENTER (#11)
35
MUSCULOSKELETAL PATHOLOGY
15, 24, 33, 36, 48
36
NEUROPATHOLOGY
OREGON HEALTH & SCIENCE

UNIVERSITY (#8)
37
ONCOLOGIC MOLECULAR
FELLOWSHIP ADS
38
ONCOLOGIC SURGICAL PATHOLOGY
PATHOLOGYOUTLINES.COM, INC.
(#12)
39
OPTHALAMIC PATHOLOGY
15, 38
40
ORTHOPEDIC PATHOLOGY
ROSWELL PARK CANCER

INSTITUTE (#10)
41
PEDIATRIC PATHOLOGY
THE CHILDREN'S HOSPITAL OF PHILADELPHIA (#43)
41
42
PERINATAL & DEVELOPMENTAL
43
PULMONARY PATHOLOGY
9, 15, 19, 21, 22, 24, 29, 31, 33, 36, 44,
48, 50
44
RENAL PATHOLOGY
THE JOHNS HOPKINS UNIVERSITY

SCHOOL OF MEDICINE - DEPARTMENT
OF PATHOLOGY (#25)
45
RESEARCH
TUFTS MEDICAL CENTER (#42)
48
46
SELECTIVE PATHOLOGY
47
SPECIAL COAGULATION
15, 16, 24, 48
48
SURGICAL PATHOLOGY
THE UNIVERSITY OF VERMONT

MEDICAL CENTER (#37)
49
THORACIC PATHOLOGY
15, 18, 24, 33, 36, 48
50
TRANSFUSION
UNIVERSITY OF ALABAMA AT
BIRMINGHAM (#35)
51
TRANSPLANTATION IMMUNOLOGY
UROPATHOLOGY
UNIVERSITY OF ARKANSAS FOR

MEDICAL SCIENCES (#33)
1, 15, 16, 24, 48
52
53
VIROLOGY
54
WOMENS PATHOLOGY
40
FELLOWSHIP FAIR
#
SUB SPECIALTIES
INSTITUTION (TABLE #)
FELLOWSHIPS OFFERED
BLOOD BANKING
BONE & SOFT TISSUE
UNIVERSITY OF CALIFORNIA IRVINE (UCI) (#23)
15, 48
BREAST
CANCER BIOMARKER
1, 15, 16, 21, 22, 24, 33, 36, 44, 48, 50
UNIVERSITY OF CALIFORNIA
SAN FRANCISCO (#14)
CHEMICAL PATHOLOGY
UNIVERSITY OF CHICAGO (#38)
CLINICAL BIOCHEMICAL GENETICS
1, 9, 15, 16, 21, 24, 25, 31, 33, 44, 48,

49, 50, 51
CLINICAL BIOCHEMISTRY
UNIVERSITY OF MARYLAND (#29)
15, 24
CLINICAL CHEMISTRY
UNIVERSITY OF MICHIGAN (#31)
10
CLINICAL CYTOGENETICS
2, 3, 6, 15, 16, 18, 19, 21, 22, 24, 25, 27, 33,
36, 41, 43, 48, 50
11
CLINICAL IMMUNOLOGY
CLINICAL MICROBIOLOGY
UNIVERSITY OF ROCHESTER
MEDICAL CENTER (#2)
3, 15, 19, 21, 24, 48
12
13
CLINICAL MOLECULAR GENETICS
14
CYTOGENETICS
15, 24, 48, 50
15
CYTOPATHOLOGY
UNIVERSITY OF TEXAS HEALTH

SCIENCE CENTER AT SAN ANTONIO
(#3)
16
DERMATOPATHOLOGY
17
ENDOCRINE
UNIVERSITY OF UTAH (#19)
7, 9, 10, 11, 13, 15, 21, 24, 30, 31, 33,

36, 41, 48
18
FORENSIC
19
GENITOURINARY
9, 15, 16, 22, 24, 36, 50
20
GENOMIC PATHOLOGY
UNIVERSITY OF VIRGINIA
HEALTH SYSTEM (#16)
21
GI PATHOLOGY
UNIVERSITY OF WASHINGTON (#21)
22
2, 3, 15, 16, 18, 21, 22, 24, 33, 36, 41,

44, 48
23
HEAD & NECK

HEMATOPATHOLOGY
UNIVERSITY OF WISCONSINMADISON (#39)
15, 24, 48, 50
24
25
HLA
IMMUNOPATHOLOGY
VANDERBILT UNIVERSITY
MEDICAL CENTER (#24)
12, 15, 21, 24, 33, 36, 41, 44, 48, 50
26
27
INFORMATICS
LABORATORY MEDICINE
VIRGINIA COMMONWEALTH UNIVERSITY HEALTH

SYSTEMS (#13)
15, 18, 24, 33, 36, 48
28
29
LIVER/HEPATIC PATHOLOGY
MEDICAL GENETICS
WASHINGTON UNIVERSITY
IN ST. LOUIS (#40)
15, 16, 21, 23, 24, 29, 33, 36, 48, 50
30
31
MEDICAL MICROBIOLOGY
32
MICROBIOLOGY
YALE UNIVERSITY SCHOOL OF

MEDICINE (#15)
3, 15, 17, 19, 21, 23, 24, 29, 32, 33, 44,
50
33
MOLECULAR GENETICS
34
MULTIDISCIPLINARY
SUBSPECIALTY PATHOLOGY
35
MUSCULOSKELETAL PATHOLOGY
36
NEUROPATHOLOGY
37
ONCOLOGIC MOLECULAR
38
ONCOLOGIC SURGICAL PATHOLOGY
39
OPTHALAMIC PATHOLOGY
40
ORTHOPEDIC PATHOLOGY
41
PEDIATRIC PATHOLOGY
42
PERINATAL & DEVELOPMENTAL
43
PULMONARY PATHOLOGY
44
RENAL PATHOLOGY
45
RESEARCH
46
SELECTIVE PATHOLOGY
47
SPECIAL COAGULATION
48
SURGICAL PATHOLOGY
49
THORACIC PATHOLOGY
50
TRANSFUSION
51
TRANSPLANTATION IMMUNOLOGY
52
UROPATHOLOGY
53
VIROLOGY
54
WOMENS PATHOLOGY
41
RESIDENT ADVISORY COMMITTEE

Laura C. Collins, MBBS, Chair
Marwan Yared, M.D.
Jane Bernstein, M.D.
Sean M. Kirby, M.D.
Amber Nolan, M.D., Ph.D.
Drew G. Davis, M.D.
Kurt W. Fisher, M.D., Ph.D.
Lindsay Alpert, M.D.
Martin J. Magers, M.D.
Lauren Ritterhouse, M.D., Ph.D.
Christine E. Fuller, M.D.
Benjamin C. Calhoun, M.D., Ph.D.
Jessica Davis, M.D.
42
2016
COMPANION MEETINGS
THE
COMPANY
WE KEEP
Subspecialty companions to USCAP

impact learning and connectivity from a
collective, diverse knowledge base.
Twenty-seven Societies comprise a
unique sphere of influence dramatically
enhancing the USCAP experience.
Surround yourself with the dreamers and the doers, the believers and the thinkers
- Edmund Lee
#USCAP2016
American Association of Neuropathologists
American Association of Ophthalmic Oncologists
and Pathologists
American College of Veterinary Pathologists
American Society for Clinical Pathology
American Society for Investigative Pathology
American Society of Cytopathology
American Society of Dermatopathology
Arthur Purdy Stout Society of Surgical Pathologists
Association for Molecular Pathology
Association for Pathology Informatics
Binford-Dammin Society of Infectious
Disease Pathologists
College of American Pathologists
Endocrine Pathology Society
History of Pathology Society

International Society of Bone & Soft Tissue Pathology
International Society of Breast Pathology
International Society of Gynecological Pathologists
International Society of Urological Pathology
North American Society for Head and Neck Pathology
Paleopathology Club
Papanicolaou Society of Cytopathology
Pulmonary Pathology Society
Renal Pathology Society
Rodger C. Haggitt Gastrointestinal Pathology Society
Society for Cardiovascular Pathology
Society for Hematopathology
Society for Ultrastructural Pathology
Hans Popper Hepatopathology Society
Thanks to our Companion Societies and attendees for making the

USCAP Annual Meeting the worlds largest pathology event.
See you next year in Texas!
COMPANION SOCIETY MEETING

AMERICAN ASSOCIATION OF NEUROPATHOLOGISTS
Neuropathology Companion Society Meeting

A Tribute to Dr. F. Stephen Vogel
7:00 PM 10:00 PM
CC 608 609
MODERATORS:
Gregory Fuller, MD, PhD, MD, Anderson Cancer Center, Houston, TX

Tarik Tihan, MD, PhD, University of California, San Francisco, CA
COURSE DESCRIPTION: Understanding of the underlying molecular drivers of malignant human brain tumor genesis and
progression has increased dramatically and exponentially over the past 10 years. This expanded knowledge has led to the
implementation of clinically-critical molecular signature determination for the major group of pediatric brain tumors (primitive
neuroectodermal, or embryonal, tumors, including medulloblastoma) as well as the major group of adult brain tumors (the
diffuse gliomas, including glioblastoma). The degree of maturity that the field has reached led to an international colloquium
in Haarlem, The Netherlands, in April, 2014, in which the principles of a major revision of the World Health Organization
Classification of Tumours of the Central Nervous System were debated and the conclusions codified (1). Based on this
foundation, a new, fully revised, Brain Tumor Classification will be released in March, 2016, which will include, for the first time,
the incorporation of clinically-critical molecular signature elements into the definition and diagnosis of the major classes of
malignant brain tumors, including the most common childhood brain malignancy, medulloblastoma, and the most common
adult brain tumor, glioblastoma, among others. There is therefore an urgent need to educate pathologists at all levels of career,
from trainees to seasoned private practicioners and professors, on the new Brain Tumor Diagnosis and Classification system and
how to implement it in the real world of clinical practice. This program will directly address this pressing need.
Upon completion of this educational activity, participants should be able to:
Understand the major clinically-relevant molecular alterations that underlie human brain malignancy tumorigenesis
and that have strong predictive power with regard to response to therapy and prognosis
Implement the determination and incorporation of clinically-critical molecular signatures into the diagnosis of
individual patient tumors using immunostain surrogate markers and other techniques that are commonly available
in the diagnostic pathology laboratory
Learn how molecular signature determination can facilitate accurate diagnosis in the face of problematic tumors and
in tumor histologic mimicry situations, and will be able to incorporate the new changes in brain tumor diagnosis
into their daily clinical practice
7:00 PM
Opening Remarks: A Tribute to Dr. F. Stephen Vogel

Gregory Fuller, MD, PhD, MD Anderson Cancer Center, Houston, TX
7:10 PM
REFLECTIONS ON A CAREER IN SURGICAL NEUROPATHOLOGY

Peter Burger, MD, The Johns Hopkins Hospital, Baltimore, MD
8:00 PM
WHAT DO I DO WITH THIS LOW GRADE GLIOMA?

Craig Horbinski, MD, PhD, University of Kentucky, Lexington, KY
8:30 PM
IF THIS IS NOT GLIOBLASTOMA, THEN WHAT IS IT?

Murat Gokden, MD, University of Arkansas for Medical Sciences, Little Rock, AR
9:00 PM
HOW DO I REPORT THIS EMBRYONAL TUMOR?

Maria Martinez-Lage Alvarez, MD, Hospital of University of Pennsylvania, Philadelphia, PA
43

ASSOCIATION FOR PATHOLOGY INFORMATICS
A Showcase of Image-based Analytics and

Diagnostic Digital Pathology in Clinical Practice and Research
7:00 PM 10:00 PM
CC 613 614
MODERATOR: J. Mark Tuthill, MD, Henry Ford Health System, Detroit, MI
COURSE DESCRIPTION: Digital pathology and analytics is being increasingly appreciated as a critical area of pathology
practice. The goal of the symposium is to present several aspects of digital pathology and image based analytics, and to apply
these approaches to current and future pathology practice. As digital pathology becomes more mainstream pathologists and
pathologists in training need to not only understand the use of this technology in routine practice, but how this technology
will change the pathology practice and research through advanced techniques leveraging image analysis utilizing both content
based image retrieval as well as quantitative analysis. Very little exposure to these concepts is available in most pathology
practices. This symposium will look at both clinical and research oriented applications of image based analytics.
Upon completion of this educational activity, participants should better able to:
Have a greater familiarity with the most recent advancement in the growing field of Digital Pathology and
image analysis
Understand the requirements for image based analysis of pathology specimens and systems implementation
Understand the opportunities afforded by the availability of digital pathology for computational analysis and
creation of decision support analytical tools
Apply concepts of digital image analysis to clinical practice and research such as multiplex analysis of
pathology samples
Present practical examples of image analysis in support of clinical diagnosis and pathology research
7:00 PM
INTRODUCTION AND SYMPOSIUM OVERVIEW

J. Mark Tuthill, MD, Henry Ford Health System, Detroit, MI
7:05 PM
IMAGE ANALYSIS IN CURRENT CLINICAL PRACTICE

Liron Pantanowitz, MD, UPMC Shadyside, UMPC Cancer Pavilion, Pittsburgh, PA
7:40 PM
STROMAL/TUMOR INTERACTION AND DIGITAL ANALYSIS

Andrew Beck, MD, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA
8:15 PM
CDIR: AUTOMATED DIFFERENTIAL DIAGNOSIS

Ulysses Balis, MD, University of Michigan Health System, Ann Arbor, MI
8:50 PM
WHOLE SLIDE IMAGING IN IMAGING RESEARCH AND CLINICAL

Yukako Yagi, PhD, Harvard Medical School, Massachusetts General Hospital, Boston, MA
9:25 PM
MULTIPLEX IMMUNOHISTOCHEMISTRY
Michael Feldman, MD, University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia, PA
44

ENDOCRINE PATHOLOGY SOCIETY MEETING
Impact of Large-Scale Genomic Data on Practicing Endocrine Pathology

7:00 PM 10:00 PM
CC 606 607
MODERATORS:
Justine A. Barletta, MD, Harvard University Medical School, Boston, MA

Giovanni Tallini, MD, University of Bologna School of Medicine, Bologna, Italy
COURSE DESCRITION: The Endocrine Pathology Society members determined the title, contents and speakers of this
companion meeting. The target audience includes practicing pathologists, academic pathologists, pathology residents and
fellows who have interests in the pathology of endocrine neoplasms.
This topic was chosen in order to present to the pathologist an updated overview of the most significant advances in the
molecular analysis of thyroid, pancreatic neuroendocrine and adrenocortical tumors. Recently, many large-scale genomic
papers have been published on endocrine tumors. The impact of these genomic studies on diagnosis, prognosis and therapy
is considerable. The molecular data, its correlations with histopathology and the clinical features of these neoplasms will be
reviewed and their influence on the daily pathology practice emphasized.
Appreciate the relevance of molecular alterations in papillary thyroid carcinoma and their clinical and
pathologic implications
Have an overview of the main molecular events in poorly differentiated and anaplastic thyroid carcinomas and their
impact on classification, risk stratification and therapy
Update their knowledge on the novel genomic data in pancreatic neuroendocrine tumors and its implications for
diagnosis and therapy
Understand the importance of genomics in the pathologic assessment of adrenocortical carcinomas
7:00 PM
PAPILLARY THYROID CARCINOMA TCGA AND BEYOND: IMPACT ON THYROID CANCER PRE-OPERATIVE
DIAGNOSIS, PROGNOSTICATION, AND RECLASSIFICATION OF ENCAPSULATED FOLLICULAR VARIANT OF
PAPILLARY CARCINOMA
Yuri E. Nikiforv, MD, PhD, University of Pittsburgh, Pittsburgh, PA
7:40 PM
GENOMIC LANDSCAPES OF POORLY-DIFFERENTIATED AND ANAPLASTIC THYROID CARCINOMA: CLUES FOR

BETTER CLASSIFICATION, RISK STRATIFICATION AND THERAPY
Ronald Ghossein, MD, Memorial Sloan-Kettering Cancer Center, New York, NY
8:20 PM
NEW GENETICS DATA OF PANCREATIC NEUROENDOCRINE TUMORS: IMPLICATIONS FOR DIAGNOSIS,

TREATMENT,
AND TARGETED THERAPIES
Anja Schmitt Kurrer, MD, University of Bern, Zurich, Switzerland
9:00 PM
GENOMIC APPRAISAL OF ADRENOCORTICAL CARCINOMAS: WHAT PRACTICING PATHOLOGISTS NEED TO KNOW

Thomas Giordano, MD, PhD, University of Michigan, Ann Arbor, MI
45

PAPANICOLAOU SOCIETY OF CYTOPATHOLOGY
Small Specimens vs. Big Questions in the

Era of Precision Medicine and Cost Containment
7:00 PM 10:00 PM
CC 602 604
MODERATOR: Zubair W. Baloch, MD, PhD, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
COURSE DESCRIPTION: The PSC solicited topics of interest from their membership at the annual business meetings. Several
potential topics were discussed at the Executive Board meeting and the topic for the 2016 session was chosen in agreement with
the chairs of the scientific program committees. New approaches and challenges that pertain to the diagnosis of FNA and small
tissue biopsies and related ancillary studies are of high interest to the PSC membership and are currently cited as an important
topic in cytopathology.
Our needs assessment process was based on the evaluation of the current literature and the feedback by PSC members.
The following topic will be discussed:
Diagnosing mesothelioma in limited tissue samples
Dos and donts of Immunohistochemistry of limited tissue samples
Update on molecular testing of cytology samples
Regulatory and cost containment issues affecting molecular diagnostic laboratory
The first presenter will address various aspects of the diagnosis of malignant mesothelioma in small biopsy specimens; core and
fine needle aspiration biopsy including diagnostic pitfalls and the incorporation of ancillary studies as an aid to the diagnosis of
these challenging and controversial lesions. The second presentation will focus on employing immunohistochemistry studies in
small biopsy specimen, including the use and abuse of various markers, judiciously using marker-panels and diagnostic pitfalls.
The third presenter will provide an overview of what is new and exciting in the field of molecular testing on cytology specimens.
This speaker will present their own institutional experience and how it measures against what is published in the literature. The
final presentation will have a much broader appeal as the topic addresses the biggest challenge we face, that is to provide the
best patient care possible in era of cost containment.
7:00 PM
INTRODUCTION OF PROGRAM AND SPEAKERS

Zubair Baloch, MD, PhD, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
7:05 PM
PSC AWARDS PRESENTATION

Tarik Elsheikh, MD, Cleveland Clinic, Cleveland, OH
7:20 PM
DIAGNOSING MESOTHELIOMA IN LIMITED TISSUE SAMPLES

Sanja Dacic, MD, PhD, University of Pittsburgh, PA
7:50 PM
DOS AND DONTS OF IMMUNOHISTOCHEMISTRY OF LIMITED TISSUE SAMPLES

Andrew Bellizzi, MD, University of Iowa Hospitals and Clinics, Iowa City, IA
8:20 PM
UPDATE ON MOLECULAR TESTING OF CYTOLOGY SAMPLES

Dara Aisner, MD, PhD, University of Colorado, Denver, CO
8:50 PM
REGULATORY AND COST CONTAINMENT ISSUES AFFECTING MOLECULAR DIAGNOSTIC LABORATORY

Jennifer Hunt, MD, University of Arkansas for Medical Sciences, Little Rock, AR
9:20 PM
DISCUSSION AND OPEN MICROPHONE SESSION
46

PULMONARY PATHOLOGY SOCIETY
Emerging Topics in Pulmonary Pathology

7:00 PM 10:00 PM
CC BALLROOM 6 A
MODERATORS: Kirtee Raparia, MD, Northwestern University, Chicago, IL

Keith M. Kerr, MD, Aberdeen University School of Medicine, Aberdeen, Scotland
COURSE DESCRIPTION: Emerging areas in lung pathology include liquid biopsy (circulating tumor cells and cell free DNA)
in patient plasma for lung cancer diagnostics and biomarker testing, immuno-oncology biomarker testing for immune
checkpoint inhibitor therapy, cryobiopsy as a modality for diagnosing interstitial lung diseases without surgical biopsy and
new multidisciplinary approaches to diagnosing interstitial lung diseases and new targeted therapies for these diseases. The
technology and knowledge in these topics are embryonic but rapidly developing, creating a need for education and update in
these fields for practicing pathologists. This program addresses each of these emerging topics as described in the objectives.
Discuss recent developments in lung cancer targeted therapy and companion diagnostics including liquid biopsy
and immuno-oncology
Appreciate how cryobiopsy is done, what the complications are, and its usefulness in ILD
Understand the importance of combining of pathologic, radiologic, and clinical evidence in the diagnosis of
interstitial lung diseases and discuss the therapeutic and prognostic implications of these diagnoses
Comprehend the current evidence supporting use of new targeted therapies in idiopathic pulmonary fibrosis and
other fibrosing lung diseases, and the rationales for the agents currently being evaluated in clinical trials
7:00 PM
WELCOME
Donald Guinee, MD, Virginia Mason Medical Center, Seattle, WA
7:05 PM
INTRODUCTION
Aliya N. Husain, MD, University of Chicago, Chicago, IL
7:15 PM
NEW FRONTIERS IN LUNG CANCER DIAGNOSTICS

Ming S. Tsao, MD, University of Toronto, University Health Network, Toronto, Ontario, Canada
8:00 PM
INTERSTITIAL LUNG DISEASES: WHY THE DIAGNOSIS MATTERS

Linda P. Hariri, MD, PhD, Wellman Center for Photo-medicine, Massachusetts General Hospital
and Harvard Medical School, Boston, MA
Lynette Sholl, MD, Brigham and Womens Hospital, Boston, MA
Andrew M. Tager, MD, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA
9:00 PM
CRYOBIOPSY FOR INTERSTITIAL LUNG DISEASE

Thomas V. Colby, MD, Mayo Clinic, Scottsdale, AZ
Sara Tomassetti, MD, GB Morgagni Hospital, Forli, Italy
47

INTERNATIONAL SOCIETY OF UROLOGICAL PATHOLOGY
Update on the 2016 WHO Classification of Tumors of the

Urinary System and Male Genital Organs
7:00 PM 10:00 PM
CC BALLROOM 6 B
MODERATORS: Jesse McKenney, MD, Cleveland Clinic, Cleveland, OH

Steven Shen, MD, PhD, Houston Methodist Hospital, Bellaire, TX
COURSE DESCRIPTION: The WHO committee for the classification of Genitourinary Tumors met in Zurich, Switzerland in March
of 2015 to update the official classification categories and criteria that were last published in 2004. The book that outlines the
WHO classification is planned for release in January of 2016. Given that the changes will be very recently published at the time
of the 2016 USCAP Annual Meeting and not well-known to the audience, we decided that an update on these recent changes
would be quite timely and useful for practicing surgical pathologists. This update session will be presented by the four lead
authors of the 2016 edition of WHO classification of genitourinary tumors including prostate (Peter Humphrey), urinary bladder
(Victor Reuter), kidney (Holger Moch) and testis (Thomas Ulbright).
Upon completion of this educational activity, participants should be better able to:
Understand changes to the latest WHO classification of prostate cancer emphasizing histologic, genetic and
molecular changes
Understand changes to the latest WHO classification of bladder cancer emphasizing histologic, genetic and
molecular changes
Understand changes to the latest WHO classification of kidney cancer emphasizing histologic, genetic and
molecular changes
Understand changes to the latest WHO classification of testis cancer emphasizing histologic, genetic and
molecular changes
7:00 PM
INTRODUCTION AND WELCOME FROM THE ISUP

Lars Egevad, MD, PhD, Karolinska University Hospital, Stockholm, Sweden
7:15 PM
UPDATE ON THE 2016 WHO CLASSIFICATION OF PROSTATE NEOPLASIA

Peter Humphrey, MD, Yale School of Medicine, New Haven, CT
8:00 PM
UPDATE ON THE 2016 WHO CLASSIFICATION OF BLADDER NEOPLASIA

Victor Reuter, MD, Memorial Sloan-Kettering Cancer Center, New York, NY
8:45 PM
UPDATE ON THE 2016 WHO CLASSIFICATION OF KIDNEY NEOPLASIA

Holger Moch, MD, University Hospital Zurich, Zurich, Switzerland
9:30 PM
UPDATE ON THE 2016 WHO CLASSIFICATION OF TESTICULAR NEOPLASIA

Thomas Ulbright, MD, Indiana University School of Medicine, Indianapolis, IN
48

ARTHUR PURDY STOUT SOCIETY OF SURGICAL PATHOLOGISTS
How Has Molecular Pathology Recently Changed

My Diagnostic Surgical Pathology Practice?
8:30 AM 12:00 PM
CC BALLROOM 6 B/C
MODERATORS: Jason L. Hornick, MD, PhD, Brigham and Womens Hospital, Boston, MA
Vania Nos, MD, PhD, Massachusetts General Hospital, Boston, MA
COURSE DESCRIPTION: Surgical pathology continues to evolve as genetic alterations and increasingly specific
immunohistochemical markers are identified. These new tools improve the ability of surgical pathologists to arrive at specific
diagnoses for optimal patient care. This symposium will focus on the ways in which molecular pathology has recently changed
surgical pathology practice in a wide range of organ systems.
Approach the differential diagnosis of challenging areas in surgical pathology
Understand how to apply new diagnostic immunohistochemical markers and molecular genetic findings to select
differential diagnoses in surgical pathology
8:30 AM
INTRODUCTION
Peter A. Humphrey, MD, Yale University School of Medicine, New Haven, CT
Jason L. Hornick, MD, PhD, Brigham and Womens Hospital, Boston, MA
Vania Nos, MD, PhD, Massachusetts General Hospital, Boston, MA
8:35 AM
PRESIDENTS AWARD
Peter A. Humphrey, MD, Yale University School of Medicine, New Haven, CT
8:45 AM
HEAD AND NECK PATHOLOGY

Ilan Weinreb, MD, University Health Network, Toronto, Ontario, Canada
9:10 AM
PULMONARY PATHOLOGY
Lynette M. Sholl, MD, Brigham and Womens Hospital, Boston, MA
9:35 AM
THYROID PATHOLOGY
Yuri E. Nikiforov, MD, PhD, University of Pittsburgh, Pittsburgh, PA
10:00 AM
BREAK
10:30 AM
PRIZE
10:40 AM
NEUROPATHOLOGY
Daniel J. Brat, MD, PhD, Emory University School of Medicine, Atlanta, GA
11:05 AM
HEPATIC PATHOLOGY
Sanjay Kakar, MD, University of California, San Francisco, CA
11:30 AM
UROLOGIC PATHOLOGY
Pedram Argani, MD, The Johns Hopkins University, Baltimore, MD
49

BINFORD - DAMMIN SOCIETY OF INFECTIOUS DISEASE PATHOLOGISTS
Infectious Diseases of the Lung

8:30 AM 12:00 PM
CC BALLROOM 6A
MODERATORS: Corinne Fligner, MD, University of Washington, Seattle, WA
David Myerson, MD, PhD, University of Washington, Seattle, WA
COURSE DESCRIPTION: Pulmonary infections remain a diagnostic challenge for diagnostic anatomic and clinical pathologists.
Known and emerging pathogens continue to challenge our diagnostic techniques. This symposium is designed to provide
information on integrated histopathologic and molecular diagnostic techniques in this rapidly evolving area. Experts in
diagnosis of viral, fungal and parasitic pathology will provide an update on current and evolving histopathologic and molecular
diagnosis of pulmonary infections.
Describe the histopathologic features of viral infections of the lungs, including those of influenza and novel/
emerging respiratory infections
Describe available and emerging molecular diagnostic tests for pulmonary viral infections
Describe histopathologic features of common and uncommon pulmonary fungal infections, and the available
molecular diagnostic techniques for identification and confirmation
Describe histopathologic features of parasitic lung infections, as well as artifacts mimicking infectious organisms
8:30 AM
VIRAL INFECTIONS OF THE LUNG, INCLUDING INFLUENZA AND EMERGING INFECTIONS: HISTOPATHOLOGY AND
MOLECULAR DIAGNOSIS
Atis Muehlenbachs, MD, PhD, Centers for Disease Control, Atlanta, GA
9:40 AM
PARASITIC INFECTIONS OF THE LUNG AND INFECTIOUS MIMICS

Bobbi Pritt, MD, MSc, DTM&H, Mayo Clinic, Rochester, MN
10:15 AM
BREAK
10:30 AM
FUNGAL INFECTIONS OF THE LUNG: HISTOPATHOLOGY AND MOLECULAR DIAGNOSIS

Jeannette Guarner, MD, Emory University, Atlanta, Georgia
Andrew Bryan, MD, PhD, University of Washington, Seattle, WA
11:40 AM
QUESTIONS
50

COLLEGE OF AMERICAN PATHOLOGISTS
Molecular Testing in Everyday Pathology Practice:

Evolving Evidence-Based Guidelines in the Workup of Common Neoplasms
8:30 AM 12:00 PM
CC 602 604
MODERATORS:
Robert M. Najarian, MD, Beth Israel Deaconess Medical Center, Boston, MA

Jennifer Laudadio MD, University of Arkansas for Medical Sciences, Little Rock, AR
COURSE DESCRIPTION: The Curriculum Committee of the College of American Pathologists considers the list of past offerings,
the current and evolving state of anatomic pathology, priority learning needs of pathologists, and expert opinion in selecting the
topic for the 2016 CAP Companion Society education symposium.
Molecular oncology testing is rapidly evolving and changing the landscape of diagnostic medicine and the practice of pathology.
Given this rapid evolution, the practicing pathologist may find it challenging to navigate the landscape of what molecular tests
are essential from a patient prognostic and treatment perspective versus those that are more experimental or esoteric.
Experts at the CAP and partner organizations identified a need for evidence based practice guidelines related to molecular
testing. The CAP Pathology and Laboratory Quality Center (CAP Center), along with our professional partners, advance the
practice of pathology and laboratory medicine by bringing evidence-based guidelines, and consensus recommendations
to the forefront of clinical decision making, including many recently published or active evolving guidelines on molecular
testing of tumors. These guidelines help pathologists and clinicians make more informed decisions about diagnosis and
optimal treatment, and place emphasis on the pathologists role at the center of patient care. Adopting these guidelines helps
pathologists and laboratory professionals to provide more effective testing, consistent and high-quality results, and expert
interpretations. The CAP Center develops evidence-based guidelines by following the Institute of Medicine's Standards for
Developing Trustworthy Clinical Practice Guidelines to ensure a transparent and unbiased approach.
Describe the Institute of Medicine standards for developing evidence based guidelines
Identify and apply existing evidence-based guidelines in the work-up of common neoplastic entities
Discuss upcoming guidelines that can be applied in future practice
8:30 AM
INTRODUCTION
Robert M. Najarian, MD, Beth Israel Deaconess Medical Center, Boston, MA
Jennifer Laudadio, MD, University of Arkansas for Medical Sciences, Little Rock, AR
8:50 AM
HPV TESTING IN HEAD AND NECK CARCINOMAS

William Faquin, MD, PhD, Massachusetts General Hospital, Boston, MA
9:20 AM
HER2 TESTING GUIDELINES FOR ADENOCARCINOMAS OF THE STOMACH AND GASTROESOPHAGEAL JUNCTION
Angela N. Bartley, MD, St. Joseph Mercy Hospital, Ann Arbor, MI
9:50 AM
BREAK
10:10 AM
RECOMMENDATIONS FOR HUMAN EPIDERMAL GROWTH FACTOR 2 TESTING IN BREAST CANCER

M. Elizabeth Hammond, MD, LDS Hospital, Salt Lake City, UT
10:40 AM
REVISION OF THE CAP/IASLC/AMP MOLECULAR TESTING GUIDELINE FOR LUNG CANCER BIOMARKERS
Philip T. Cagle, MD, Houston Methodist Hospital, Houston, TX
11:10 AM
MOLECULAR MARKERS FOR THE EVALUATION OF COLORECTAL CANCER

Stanley R. Hamilton, MD, MD Anderson Cancer Center, Houston, TX
51

HANS POPPER HEPATOPATHOLOGY SOCIETY
Liver Pathology 2016: New Perspectives on Old Themes

8:30 AM 12:00 PM
CC BALLROOM 6E
MODERATOR: M. Isabel Fiel, MD, Icahn School of Medicine at Mount Sinai, New York, NY
COURSE DESCRIPTION: The topics were chosen in order to update the audience on issues pertinent to both the practicing
general pathologist and liver pathology subspecialists alike. The presentations will cover drug-induced liver injury and the
histological features that a pathologist needs to be aware of when confronted with a liver biopsy, the newly-described entity,
atypical hepatocellular lesions, and how these are managed, as well as an update on metabolic liver diseases with a focus on
how these diseases present in adults. Additional lectures will cover recent developments in primary biliary cholangitis and
primary sclerosing cholangitis, a presentation on the overlap syndromes of primary biliary cirrhosis and autoimmune hepatitis
and primary sclerosing cholangitis and autoimmune hepatitis, with the final presentation being on pre-neoplastic lesions of the
biliary tree and what is recently known.
Understand what the pathologist needs to know regarding drug-induced liver injury (DILI), and to summarize the
role of the pathologist in diagnosing and helping manage a patient with DILI
Discuss the histological features of atypical hepatocellular lesions and the approach to their diagnosis and
management
Review the different metabolic liver diseases that may present in adults with emphasis on the lesser known entities
Explain what is new on primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC)
Discuss what is known about overlap syndromes of PBC and autoimmune hepatitis as well as PSC and
autoimmune hepatitis
Discuss what is known about novel findings of pre-neoplastic lesions in the biliary tree
8:30 AM
MEETING CALL TO ORDER AND INTRODUCTORY REMARKS

M. Isabel Fiel, MD, Icahn School of Medicine at Mount Sinai, New York, NY
8:35 AM
DRUG-INDUCED LIVER INJURY: ROLE OF THE PATHOLOGIST

Romil Saxena, MBBS, FRCPath, Indiana University, Indianapolis, IN
9:00 AM
ATYPICAL WELL-DIFFERENTIATED HEPATOCELLULAR NEOPLASMS:

CRUISING THROUGH THE MAZE OF CRITERIA, TERMINOLOGY AND RISK ASSESSMENT
9:25 AM
ADULT PRESENTATION OF METABOLIC LIVER DISEASES

John Hart, MD, University of Chicago, Chicago, IL
9:50 AM
PANEL: QUESTIONS AND ANSWERS
10:00 AM
COFFEE BREAK
10:30 AM
PRIMARY BILIARY CHOLANGITIS AND PRIMARY SCLEROSING CHOLANGITIS REVISITED

Marcela Salomao, MD, Columbia University Medical Center, New York, NY
10:55 AM
THE OVERLAP SYNDROMES: DO THEY EXIST?

Kay Washington, MD, PhD, Vanderbilt University Medical Center, Nashville, TN
11:20 AM
PRE-INVASIVE NEOPLASIA OF THE BILIARY TRACT

N. Volkan Adsay, MD, Emory University Hospital, Atlanta, GA
11:45 AM
PANEL: QUESTIONS AND ANSWERS
52

RENAL PATHOLOGY SOCIETY
Recently Described Entities in Nephropathology

8:30 AM 12:00 PM
CC 606 607
MODERATORS: Samih Nasr, MD, Mayo Clinic, Rochester, MN
Jeffrey Hodgin, MD, PhD, University of Michigan, Ann Arbor, MI
COURSE DESCRIPTION: Over the past few years, several novel entities in renal ptvathology have been described. Warfarin
nephropathy is a recently recognized complication of warfarin anticoagulation that can result in acute kidney injury.
Membranous-like glomerulopathy with masked IgG kappa deposits is a newly described lesion in which antigen retrieval
on formalin-fixed paraffin-embedded tissue is required to detect the monoclonal immunoglobulin by immunofluorescence.
This lesion is clinically distinct from other glomerulopathies with non-organized monoclonal IgG deposits, and typically
occurs in young adults who have clinical evidence of autoimmune phenomenon. Mesoamerican nephropathy is a primary
tubulointerstitial disease occurring with increasing frequency in Central America. It mainly affects men working in hot conditions
in agricultural communities, particularly workers in sugar cane fields, and may represent a form of chronic dehydration renal
disease. Acute kidney injury in the context of liver disease is mainly described as a hemodynamic phenomenon hepatorenal
syndrome." However, recent studies have shed light into an obstructive role of bile in distal tubules. The term bile cast
nephropathy is recently introduced to describe the spectrum of pathologic findings in patients with bile nephrosis.
Describe the risk factors, clinicopathologic characteristics and pathophysiology of Warfarin nephropathy
Describe the clinicopathologic characteristics of membranous-like glomerulopathy with masked IgG kappa deposits
and the indications for paraffin immunofluorescence in the detection of masked monoclonal immunoglobulin
deposits
Recognize the emerging epidemic of mesoamerican nephropathy, and recognize the renal biopsy findings in this
condition
Describe the pathologic findings and pathomechanisms of bile cast nephropathy
8:30 AM
WARFARIN NEPHROPATHY
Sergey V. Brodsky, MD, PhD, The Ohio State University, Columbus, OH
9:15 AM
MEMBRANOUS-LIKE GLOMERULOPATHY WITH MASKED IGG KAPPA DEPOSITS

Chris Larsen, MD, NephroPath, Little Rock, AR
10:00 AM
BREAK
10:30 AM
MESOAMERICAN NEPHROPATHY
Annika Wernerson, MD, Department of Clinical Science, Intervention and Technology, Stockholm, Sweden
11:15 AM
BILE CAST NEPHROPATHY

Anthony Chang, MD, FASN, University of Chicago Medical Center, Chicago, IL
53

SOCIETY FOR CARDIOVASCULAR PATHOLOGY
Advances in the Autopsy Assessment of Sudden Cardiac Death

8:30 AM 12:00 PM
CC 608 609
MODERATORS: James R. Stone, MD, PhD, Massachusetts General Hospital, Boston, MA

Cristina Basso, MD, PhD, University of Padua, Padova, Italy
COURSE DESCRIPTION: Cardiovascular diseases remain a significant cause of morbidity and mortality in developed countries.
Sudden unexpected cardiac death is particularly devastating as it often involves people otherwise thought to be relatively
healthy. These cases are routinely encountered by autopsy and forensic pathologists. This session will update the audience
on the latest developments in the field including instructions for doing autopsies on these cases and updates on the utility of
molecular approaches to ascertain a genetic diagnosis. Information gained from such cases can have a significant impact on
living family members and on furthering our understanding of these diseases. The session will be capped by Dr. Jeffrey Saffitz,
the recipient of the SCVP Distinguished Achievement Award, speaking on the anatomic pathology of sudden cardiac death. In
addition, there will be a portion of the session devoted to short presentations by a selected subset of young investigators who
have submitted heart- and vessel-oriented posters to USCAP. This will provide an important opportunity to develop and build
fellowship amongst junior and senior members of USCAP with an interest in cardiovascular pathology. Moreover, the brief
presentations will allow for a fairer judging of posters being considered for award of the SCVP Young Investigator prize, with
excellent feedback from an increased number of cardiovascular pathologists at the meeting.
Upon completion of this activity, participants should be able to:
Describe the approach to investigate sudden unexpected death at autopsy
Describe the sudden death in the young registry and how to utilize this registry
Describe cardiac conditions that can result in sudden unexpected death
Describe cardiac conditions for which molecular analyses may be useful at autopsy
8:30 AM
THE SUDDEN DEATH IN THE YOUNG REGISTRY: A RESOURCE FOR MEDICAL EXAMINERS, CORONERS,
PATHOLOGISTS, RESEARCHERS
Sam P. Gulino, MD, City of Philadelphia Medical Examiners Office, Philadelphia, PA
9:00 AM
SUDDEN UNEXPLAINED DEATH, THE MOLECULAR AUTOPSY AND GENETIC PURGATORY

Michael J. Ackerman, MD, PhD, Mayo Clinic, Rochester, MN
9:30 AM
MOLECULAR INVESTIGATION OF SUDDEN CARDIAC DEATH: THE NEW YORK EXPERIENCE

Barbara Sampson, MD, PhD, Office of Chief Medical Examiner of the City of New York, New York, NY
10:00 AM
BREAK
10:30 AM
YOUNG INVESTIGATOR PRESENTATIONS
11:00 AM
THE ANATOMIC PATHOLOGY OF SUDDEN CARDIAC DEATH

Jeffrey E. Saffitz, MD, PhD, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
54

SOCIETY FOR ULTRASTRUCTURAL PATHOLOGY
Small Blue Cell Tumors

8:30 AM 12:00 PM
CC 605
MODERATOR: Guillermo A. Herrera, MD, LSU Health, Shreveport, LA
COURSE DESCRIPTION: The topic of this years meeting was determined by the Society for Ultrastructural Pathology Board
of Directors. Open deliberation of its members concluded this was a timely topic to address at the USCAP. Topic was chosen
as this group of tumors often requires the use of various techniques for their speciation. The value of the use of ancillary
diagnostic techniques, including electron microscopy, in the diagnosis of this group of neoplasms is well recognized.
Ultrastructural pathology plays a key role in the diagnosis of small blue cell tumors. The target audience includes: general
surgical pathologists, trainees, academic pathologists, and ultrastructural pathologists and technicians/scientists who engage in
diagnostic transmission electron microscopy.
Define role of ancillary diagnostic techniques in the diagnosis of small blue cell tumors in different sites
Address the specific role of electron microscopy in todays healthcare environment in the evaluation/classification of
these neoplasms
Emphasize the important complementary role of ancillary diagnostic techniques in the evaluation/diagnosis of small
blue cell tumors in children and adults, and in cytopathology specimens
Evaluate cost-efficient use of ancillary diagnostic techniques when confronted with small blue cell tumors
8:30 AM
SMALL BLUE CELL TUMORS IN THE LUNG

Victor Roggli, MD, Duke University Medical Center, Durham, NC
9:15 AM
SMALL BLUE CELL TUMORS IN CHILDREN

John Hicks, MD, PhD, Texas Childrens Hospital, Houston, TX
10:00 AM
BREAK
10:30 AM
CYTOLOGY OF SMALL BLUE CELL TUMORS

Elba A. Turbat-Herrera, MD, LSU Health, Shreveport, LA
11:15 AM
SMALL BLUE CELL TUMORS IN SOFT TISSUE AND BONE

Cyril Fisher, MD, DSc, FRCPath, Sarcoma Unit, Royal Marsden Hospital, London, England
55

AMERICAN ASSOCIATION OF OCULAR ONCOLOGISTS AND PATHOLOGISTS
Pathology of the Orbit Current Diagnostic Approach

1:30 PM 5:00 PM
CC 605
MODERATOR: Patricia Chevez-Barrios, MD, The Houston Methodist Hospital, Houston, TX

COURSE DESCRIPTION: The topics are determined by a USCAP companion committee in our society that is formed by three
members. The current topic of orbital and lacrimal gland pathology was selected because this is a frequent type of pathology
encountered that is challenging for those not used to see these lesions. This topic has not been selected before for the
companion meeting. The target audience is surgical pathologists, dermatopathologists and neuropathologists that usually sign
out cases from these areas. It is also targeted to residents and fellows.
Upon completion of this activity, participants should be better able to:
Describe the importance of recognizing the most frequent pathologic diseases by location in the orbit
Describe the most frequent differential diagnosis in orbital pathology
Describe the impact of appropriate diagnosis in management of orbital tumors
Describe the indications for frozen sections, flow cytometry and other molecular tests in orbital pathology
1:30 PM
INTRODUCTION TO ORBIT AND ORBITAL BIOPSY

Patricia Chevez-Barrios, MD, The Houston Methodist Hospital, Houston, TX
1:50 PM
INFLAMMATORY AND BENIGN ORBITAL LESIONS

Diva Salomao, MD, Mayo Clinic College of Medicine, Rochester, MN
2:35 PM
BREAK
3:05 PM
BONE AND ORBITAL WALL LESIONS

Tatyana Milman, MD, University of Pennsylvania, Philadelphia, PA
3:50 PM
PRIMARY ORBITAL TUMORS

Sander Dubovy, MD, University of Miami, Miami, FL
4:35 PM
QUESTIONS AND ANSWERS

Patricia Chevez-Barrios, MD, The Houston Methodist Hospital, Houston, TX
56

AMERICAN SOCIETY FOR CLINICAL PATHOLOGY (ASCP) IN COLLABORATION
WITH THE AMERICAN PATHOLOGY FOUNDATION (APF)
Improving Diagnosis in Pathology:

The IOM Report, Safety Culture, Teamwork, Effective Communication and More
1:30 PM 5:00 PM
CC 618 620
MODERATOR: Omar Hameed, MD, FASCP, Vanderbilt University Medical Center, Nashville, TN
COURSE DESCRIPTION: The recently released Improving Diagnosis in Health Care, a continuation of the landmark Institute
of Medicine reports To Err Is Human: Building a Safer Health System (2000), outlines goals to reduce diagnostic error and
improve diagnosis. Tom Gallagher, a member of the IOM committee which wrote this report, will discuss the report goals
and their potential impact for pathologists. High reliability organizations (HROs) have systems in place that make them
exceptionally consistent in accomplishing these goals and avoiding potentially catastrophic errors. Elements of HROs and
include preoccupation with failure, reluctance to simplify, robust communication, transparency and non-punitive response to
error reporting. This course will discuss the goals outlined in the recent IOM report and their potential impact for pathologists,
introduce the concepts of HRO and safety culture and describe how different components were independently implemented in
two large pathology labs almost 2,500 miles apart.
Discuss the recent IOM report: Diagnosis in Health Care
Define High Reliability Organizations and identify the basic concepts of high reliability
Recognize the importance of a positive safety culture, teamwork and robust communication practices in improving
outcomes in anatomic pathology
Evaluate the safety culture in participant workplace using standardized tools
Recognize barriers in discussing pathology errors
Utilize gained knowledge to develop and implement plans for expanding high reliability in anatomic pathology
1:30 PM
INTRODUCTION AND OVERVIEW

Omar Hameed, MD, FASCP, Vanderbilt University Medical Center, Nashville, TN
1:40 PM
IMPROVING DIAGNOSIS IN HEALTH CARE: IMPACT IN PATHOLOGY

Thomas Gallagher, MD University of Washington, Seattle, WA
2:40 PM
BREAK
2:50 PM
HIGH RELIABILITY PRACTICE AND SAFETY CULTURE

Omar Hameed, MD, FASCP, Vanderbilt University Medical Center, Nashville, TN
4:00 PM
COMMUNICATING WITH COLLEAGUES, TREATING CLINICIANS AND PATIENTS

Suzanne Dintzis, MD, PhD, University of Washington, Seattle, WA
4:45 PM
PROGRAM WRAP-UP/DISCUSSION
57

AMERICAN SOCIETY FOR INVESTIGATIVE PATHOLOGY
The Pathologist and the Development of Targeted Therapies

1:30 PM 5:00 PM
CC 606 607
MODERATORS: Maria J. Merino, MD, National Cancer Institute, Bethesda, MD

Danny A. Milner, MD, MSc, Brigham and Womens Hospital, Boston, MA
Mark E. Sobel, MD, PhD, American Society for Investigative Pathology, Bethesda, MD
COURSE DESCRIPTION:
The integration of anatomic, molecular, and genomic pathology into surgical pathology practice is conspicuous in oncology,
where definition of molecular pathways important for specific tumors has enabled development of drugs and innovative
immunological approaches to target these pathways, and companion tests to predict which tumors are likely to respond to these
targeted agents. The role of the surgical pathologist as part of the oncologic healthcare team is rapidly evolving. This session
will focus on targeted therapies for melanoma and cancers of the brain, breast, and lung.
Describe the new morphologic and molecular classification scheme of gliomas
Describe approaches to cancer immunotherapies
Describe immune targeting in breast cancer
Describe the evolving molecular classification of lung cancer
1:30 PM
INTRODUCTION TO THE ASIP COMPANION MEETING

Mark E. Sobel, MD, PhD, American Society for Investigative Pathology, Bethesda, MD
1:35 PM
INTEGRATED MORPHOLOGIC AND MOLECULAR GLIOMA DIAGNOSTICS BASED ON THE 2016 WHO
CLASSIFICATION SCHEME
Arie Perry, MD, University of California, San Francisco, CA
2:15 PM
CANCER IMMUNOTHERAPY: THE ROLE OF THE PATHOLOGIST IN THE ONCOLOGY TEAM

James C. Yang, MD, National Cancer Institute, Bethesda, MD
3:00 PM
BREAK
3:30 PM
IMMUNE TARGETING IN BREAST CANCER

Ashley Cimino-Mathews, MD, The Johns Hopkins Hospital, Baltimore, MD
4:15 PM
BENCHTOP TO BEDSIDE: EVOLUTION OF MOLECULAR CLASSIFICATION OF LUNG CANCER

Neal Lindeman, MD, Brigham and Womens Hospital, Boston, MA
58

RODGER C. HAGGITT
GASTROINTESTINAL PATHOLOGY SOCIETY
Genetic Mechanisms Underlying Gastrointestinal Diseases:

New Developments for the Surgical Pathologist
1:30 PM 5:00 PM
CC BALLROOM 6 B/C
MODERATOR: John Hart, MD, University of Chicago, Chicago, IL

COURSE DESCRIPTION: The mission of the Rodger C. Haggitt Gastrointestinal Pathology Society is to emphasize the importance
of gastrointestinal pathology as a sophisticated and complex area of pathology. The Education Committee, in consultation
with Society officers, determined the title, contents, and speakers of this companion meeting. The topics chosen address new
advances in our understanding of the genetic alterations that underlie a variety of gastrointestinal disorders. The program will
emphasize the role of the surgical pathologist in the proper workup and reporting of these disease states, with an emphasis on
the facets of most importance in proper patient management. In the era of personalized medicine, the utility of an understanding
of the genetic pathogenesis of gastrointestinal tumorigenesis is essential to improving patient prognosis.
Upon completion of this education activity, participants should be able to:
Use new histologic features and molecular testing to aid in the diagnosis of rare gastrointestinal polyposis
syndromes
Identify the recently recognized hereditary forms of gastric cancer
Understand the molecular alterations that are useful in the diagnosis and management of patients with
pancreatic cancer
Understand how molecular analysis contributes to the proper diagnosis and management of gastrointestinal
stromal tumors
Become familiar with the recently opened NCI MATCH Trial as it pertains to gastrointestinal tumors, and the role of
pathologists in the initiative
1:30 PM
INTRODUCTION
1:35 PM
THE ROLE OF THE SURGICAL PATHOLOGIST IN THE DIAGNOSIS OF RARE POLYPOSIS SYNDROMES
Christophe Rosty, MD, University of Queensland, Queensland, Australia
2:05 PM
HEREDITARY GASTRIC CANCER SYNDROMES

Maria Fatima Carneiro, MD, PhD, Institute of Molecular Pathology and Immunology,
University of Porto, Porto, Portugal
2:35 PM
NEW DEVELOPMENTS IN THE MOLECULAR MECHANISMS IMPORTANT IN PANCREATIC CANCER PATHOGENESIS

Ralph H. Hruban, MD, The Johns Hopkins Hospital, Baltimore, MD
3:00 PM
BREAK
3:30 PM
GENETIC ALTERATIONS IN GASTROINTESTINAL STROMAL TUMORS: IMPLICATIONS

FOR DIAGNOSIS AND MANAGEMENT
Christopher Corless, MD, PhD, Oregon Health & Science University, Portland, OR
4:00 PM
RODGER C. HAGGITT MEMORIAL LECTURE: THE NCI MATCH INITIATIVE AND THE ROLE OF THE
GI PATHOLOGIST IN ONCOLOGIC MANAGEMENT
Stanley R. Hamilton, MD, The University of Texas MD Anderson Cancer Center, Houston, TX
59

INTERNATIONAL SOCIETY OF BONE AND SOFT TISSUE PATHOLOGY
The Evolving Concepts of Mesenchymal Tumor

1:30 PM 5:00 PM
CC 608 609
MODERATORS:
Jean-Michel Coindre, MD, Institut Bergoni, Bordeaux, France

Cristina R. Antonescu, MD, Memorial Sloan-Kettering Center, New York, NY
COURSE DESCRIPTION: The symposium theme and content is selected by the President with input from the Societys executive
officers of the International Society of Bone and Soft Tissue Pathology. The agenda has been designed to meet the educational
needs of general surgical pathologists as well as bone and soft tissue tumor subspecialists who are involved in the management
of patients with mesenchymal neoplasms. During the last 20 years, the classification of mesenchymal neoplasms has witnessed
striking transformation. In this companion meeting, the evolution of concepts regarding important mesenchymal tumor families
is emphasized concurrent with new developments and application, particularly in molecular biology.
Understand important concepts regarding mesenchymal tumor families
Recognize recent developments in genomic mechanisms in soft tissue and bone tumors
Describe the role of biomarkers in the diagnostic classification and management of soft tissue and bone tumors
Associate morphologic variants with specific genetic changes
1:30 PM
OPENING REMARKS
Jean-Michel Coindre, MD, Institut Bergoni, Bordeaux, France
1:35 PM
MDM2 AMPLIFIED SARCOMAS

Raf Sciot, MD, KU Leuven, Leuven, Belgium
2:05 PM
GIST: FROM LEIOMYOBLASTOMA TO WILD TYPE GIST

Markku M. Miettinen, MD, National Cancer Institute, Bethesda, MD
2:35 PM
EWING AND EWING-LIKE SARCOMAS

Cristina R. Antonescu, MD, Memorial Sloan-Kettering Cancer Center, New York, NY
3:05 PM
BREAK
3:30 PM
SWI/SNF DEPENDENT TUMORS

Francois Le Loarer, MD, Centre Leon Berard, Lyon, France
4:00 PM
ALK FUSION POSITIVE MESENCHYMAL TUMORS

Jason L. Hornick, MD, Brigham and Womens Hospital, Boston, MA
4:30 PM
CONCLUDING REMARKS
Cristina R. Antonescu, MD, Memorial Sloan-Kettering Cancer Center, New York, NY
60

NORTH AMERICAN SOCIETY OF HEAD & NECK PATHOLOGY
Genodermatoses Affecting the Skin & Mucosa of the Head & Neck:
Clinicopathologic, Genetic, & Molecular Aspects
1:30 PM 5:00 PM
CC 615 617
MODERATOR: Mark R. Wick, MD, University of Virginia Health System, Charlottesville, VA

COURSE DESCRIPTION: Head and neck pathology is complex, with numerous different tissue types and lesions occurring in
a myriad of different forms, arising from mucosal surfaces, salivary glands, soft tissue and bone, thyroid, parathyroid glands,
lymph nodes, and skin. Further, with the advances in molecular medicine, which is delineating the molecular basis of many
tumor types and genetic syndromes, practicing pathologists must stay up to date on pathology of many different types and the
manifestations and diagnostic features of common and uncommon genetic syndromes. This program will provide in depth
information on several important genodermatoses affecting the head and neck.
Enumerate the clinicopathologic components of Gorlin syndrome
Discuss the similarities and differences of pathologic entities encompassed by the Brooke-Spiegler syndrome
Identify tissues besides the skin that are affected by the PTEN syndrome
Outline the current diagnostic approach to diagnosis of the MEN2b syndrome
Describe the component lesions and evolution of the xeroderma pigmentosum syndrome
1:30 PM
INTRODUCTION
Mark R. Wick, MD, University of Virginia Health System, Charlottesville, VA
1:40 PM
BASAL CELL-NEVUS (GORLIN) SYNDROME

Scott Granter, MD, Brigham and Womens Hospital, Boston, MA
2:10 PM
BROOKE-SPIEGLER SYNDROME
Dmitry Kazakov, MD, Charles University, Czech Republic
2:40 PM
COWDEN-PTEN SYNDROME
Vania Nose, MD, PhD, Massachusetts General Hospital, Boston, MA
3:10 PM
BREAK
3:30 PM
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB

Peter M. Sadow, MD, PhD, Massachusetts General Hospital, Boston, MA
4:00 PM
XERODERMA PIGMENTOSUM SYNDROME

Jennifer Black, MD, Childrens Hospital of Colorado, Aurora, CO
61

PALEOPATHOLOGY CLUB
Paleopathology Around the Globe

1:30 PM 3:00 PM
CC 602 604
MODERATORS: Enrique Gerszten, MD, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, VA
Pedro L. Fernndez, MD, PhD, Hospital Clinic and University of Barcelona, Barcelona, Spain
COURSE DESCRIPTION: Paleopathology has a close relation with the history of medicine. This symposium focuses on
the use of modern techniques available to determine the diseases of the past. The topics were suggested by members of
the Paleopathology Club, and they were selected by the Chairmen of the Program. This symposium has been designed for
Pathologists to learn about the diseases that were present in the antiquity in different areas of the globe.
Identify the diseases presented in the symposium
Explain why some diseases in the antiquity have disappeared
1:30 PM
BLACK DEATH AND WHITE PLAGUE IN AN ENGLISH MEDIEVAL CEMETERY

Darlene A. Weston, University of British Columbia, Vancouver, Canada
2:00 PM
PALEOPATHOLOGY OF BONE-FORMING CONDITIONS: INDICATORS OF CULTURE AND THE ENVIRONMENT

Cynthia A. Wilczak, San Francisco State University, San Francisco, CA
2:30 PM
KUKU AND PIGBEL: DISEASES THAT HAVE DISAPPEARED FROM PAPUA NEW GUINEA
Robin A. Cooke, MD, University of Queensland, Brisbane, Australia
62

SOCIETY FOR HEMATOPATHOLOGY
Current Concepts in Aggressive B-Cell Leukemia/Lymphoma

1:30 PM 5:00 PM
CC BALLROOM 6A
MODERATORS: Eric Hsi, MD, Cleveland Clinic, Cleveland, OH
John Choi, MD, PhD, St. Jude Childrens Research Hospital, Memphis, TN
COURSE DESCRIPTION: The Society for Hematopathology (SH) Officers and Executive Committee deliberated extensively on the
selection of the 2016 USCAP/SH Companion Meeting topic and assessed need through review of prior topics, input for surveys
and discussions with the SH membership, and consideration of current progress in the field to include projected updates in
the WHO Classification for Hematolymphoid Neoplasms. This session will bring experts in the diagnosis, classification, and
treatment of B lymphoid malignancies.
Aggressive B-cell Neoplasms are among the most common types of B-cell neoplasms in the adult (Diffuse Large B-cell
Lymphoma, not otherwise specified, DLBCL, Nos) and pediatric populations (B-cell Acute Lymphoblastic Leukemia, B-ALL). Our
understanding of the biology, molecular sub-classification, and clinical features of the diffuse aggressive B-cell lymphomas
has advanced since the 2008 WHO Classification such that pathologists must be able to accurately diagnosis and assess
molecular biomarkers, so that clinicians can appropriately risk stratify and manage patients. Likewise, diagnosis, molecular
characterization, and disease monitoring for B-ALL has evolved beyond routine morphologic, phenotypic, and cytogenetic
classifications. Six lectures by authorities in the field discuss the latest advances in EBV+ B-cell lymphomas (Dr. Natkunam),
diagnosis of DLBCL, Nos and their related diffuse aggressive B-cell lymphomas (Dr. Medeiros), biomarker assessment for
DLBCL, nos (Dr. Rimsza) and treatment of diffuse aggressive B-cell lymphomas (Dr. Leonard). These will be followed by a review
of the advances in the molecular genetic classification (Dr. Mullighan) and diagnosis/monitoring (Dr. Wood) of patients with
B-ALL. This balanced program addresses both lymph node and bone marrow topics that pathologists may face in daily practice.
This activity has been designed to meet the educational needs of pathologists, pathology trainees, and other health care
professionals who are involved in diagnosis and management of patients with aggressive B-cell leukemias and lymphomas as
well as researchers who investigate the mechanisms of these diseases.
Incorporate EBV+ B-cell lymphoproliferative disorders in the differential diagnostic considerations and workup of
B-cell lymphomas, and understand how to select appropriate immunophenotypic and molecular ancillary studies to
support this spectrum of diagnoses
Recognize morphologic variants and subtypes of diffuse large B-cell lymphoma recognized by the World Health
Organization classification
Describe the clinical significance, biology, and methodologies for measuring DLBCL cell-of-origin, oncogene, and
immune/microenvironment biomarkers in order to provide precision healthcare for patients
Describe how the diagnosis of DLBCL, Nos and differentiation from other diffuse aggressive B-cell lymphomas
informs prognosis, risk stratification, and treatment decisions. Participants will also become familiar with promising
novel therapeutic options in these lymphomas
Discuss the different types of next generation sequencing used to analyze cancer genomes, understand the nature
of genetic alterations contributing to the pathogenesis of high risk and relapsed B-ALL, and describe the potential
for clinical sequencing in the management of ALL
Understand the application of modern laboratory testing to diagnose and monitor patients with B-ALL
1:30 PM
THE SPECTRUM OF EBV+ B-CELL LYMPHOPROLIFERATIVE DISORDERS

Yaso Natkunam, MD, PhD, Stanford University School of Medicine, Stanford, CA
2:00 PM
DIAGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA

L. Jeffrey Medeiros, MD, MD Anderson Cancer Center, Houston, TX
2:30 PM
DIFFUSE LARGE B-CELL LYMPHOMA: BIOMARKERS FOR PRECISION HEALTHCARE

Lisa M. Rimsza, MD, Mayo Clinic, Phoenix, AZ
3:00 PM
BREAK
3:30 PM
DLBCL, NOS FROM THE CLINICIAN PERSPECTIVE

John P. Leonard, MD, Weill Cornell Medical College, New York, NY
4:00 PM
ADVANCES IN THE GENETICS OF B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Charles Mullighan, MBBS, MD, St. Jude Childrens Research Hospital, Memphis, TN
4:30 PM
DIAGNOSIS AND FOLLOW-UP OF B LYMPHOBLASTIC LEUKEMIA

Brent L. Wood, MD, PhD, Hematopathology Laboratory, Seattle, WA
63

INTERNATIONAL SOCIETY OF GYNECOLOGICAL PATHOLOGISTS
Genetic Susceptibility Syndromes and Gynecological Neoplasia

1:30 PM 5:00 PM
CC BALLROOM 6 E
MODERATOR: Glenn McCluggage, MD, FRCPath, The Royal Hospitals, Belfast, Ireland
COURSE DESCRIPTION: Advances in knowledge about genetic susceptibility disorders have expanded the spectrum of gynecologic
malignancies associated with such syndromes. This has led to the generation of altered protocols for the processing and handling
of gynecological specimens, and influences what additional studies need be performed to allow appropriate patient management.
Pathologists need to be aware of these genetic associations to guide the clinician with respect to the choices and circumstances
for genetic testing. Pathologists should have sufficient familiarity with these tests to avoid over-utilization and counsel clinicians
on the implications of test results. This symposium aims to update the pathologist on recent advances in inherited and genetic
susceptibility disorders affecting the female genital tract. Specifically, it will provide the pathologist with 1) an overview of the
genetic susceptibility syndromes that predispose to neoplasms in the female genital tract; 2) update pathologists on the associations
of the various genetic syndromes in the female genital tract; 3) advise on the use of immunohistochemistry and molecular (PCR
based) testing in the setting of Lynch syndrome; 4) update pathologists on the implications of BRCA mutations with respect to
processing and diagnosis of gynecologic neoplasms; and 5) introduce the pathologist to more recently described molecular
signatures of mesenchymal, and non-epithelial tumors of the female genital tract and advise on the importance of making these
diagnoses. Practical approaches to addressing these issues will be highlighted using a case based format.
Upon completion of this symposium, participants should be better able to:

Describe the associations of the major gynecologic susceptibility disorders in the female genital tract; in particular
Lynch and BRCA associated Syndromes
Describe tumor types and tumor characteristics which if present, should result in reflex implementation of additional
testing either by immunohistochemistry or molecular methods to aid recognition of gynecologic susceptibility
disorders
Describe how patients at increased risk for hereditary breast and ovarian cancer (HBOC) can be identified at the time
of diagnosis of their tub-ovarian carcinoma and managed appropriately
Describe the rationale for suspecting a familial cancer syndrome, when dealing with an apparently sporadic
gynecologic tumor
Identify the connections between pathology, molecular genetics and oncology that are becoming increasingly
relevant in oncological gynecological pathology practice
Identify specific clinical scenarios in which PCR-based MLH1 methylation analysis and MSI analysis provides useful
data beyond that which immunohistochemistry can provide
Describe the characteristics of uterine mesenchymal tumors that should raise the possibility of a hereditary
syndrome
Implement a comprehensive and integrated reflex biomarker driven approach to identify Lynch syndrome in
patients with gynecologic malignancies
1:30 PM
IDENTIFYING LYNCH SYNDROME IN PATIENTS WITH GYNECOLOGIC CANCERS: ARRIVING WHERE WE STARTED
Blaise Clark, MD, Toronto General Hospital, Toronto, Ontario, Canada
2:00 PM
HEREDITARY OVARIAN AND BREAST CANCER SYNDROME

C. Blake Gilks, MD, Vancouver General Hospital, Vancouver, BC, Canada
2:30 PM
PATHOLOGICAL AND MOLECULAR FEATURES OF COWDEN AND PEUTZ-JEGHERS SYNDROME

Xavier Matias-Guiu, MD, PhD, Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain
SESSION 2: RARE GENETIC SUSCEPTIBILITY SYNDROMES AND GYNECOLOGICAL NEOPLASIA

3:30 PM
ANNOUNCEMENTS/AWARDS
3:35 PM
IMPORTANCE OF PCR-BASED TUMOR TESTING IN THE EVALUATION OF LYNCH SYNDROME

Russell Broaddus, MD, PhD, MD Anderson Cancer, Houston, TX
3:55 PM
BRAVE NEW GENOMIC WORLD: DO WE STILL NEED CLINICAL CANCER GENETICISTS, AND IF SO, WHY?
Will Foulkes, MBBS, PhD, Jewish General Hospital, Montreal, Quebec, Canada
4:15 PM
UTERINE MESENCHYMAL TUMORS: HEREDITARY ASPECTS

Karuna Garg, MD, University of California, San Francisco, CA
4:35 PM
DICER1 AND SMARCA4 MUTATIONS IN OVARIAN NEOPLASIA: RECENT DEVELOPMENTS

Esther Oliva, MD, Harvard Medical School, Massachusetts General Hospital, Boston, MA
4:55 PM
ROUND TABLE Q&A
64

HISTORY OF PATHOLOGY SOCIETY
Beginnings
3:30 PM 5:00 PM
CC 602 604
MODERATOR: Stephen A. Geller, MD, Weill Cornell Medical College, New York, NY
3:30 PM
TIME-TRAVELLING TO THE ORIGINS OF LUNG CANCER

Anthony A. Gal, MD, Emory University School of Medicine, Atlanta, GA
4:00 PM
ALFREDS MORGAGNI KLEMPERER CROHN DISEASE

Stephen A. Geller, MD, Weill Cornell Medical College, New York, NY
4:30 PM
HOW NEUROPATHOLOGIC OBSERVATIONS HAVE DETERMINED THE TREATMENT OF NEUROLOGIC DISEASES:

AN HISTORICAL PERSPECTIVE
Harry Vinters, MD, David Geffen School of Medicine, University of California, Los Angeles, CA
65

INTERNATIONAL SOCIETY OF BREAST PATHOLOGY
Second Opinions and Diagnostic Concordance in Breast Pathology

7:30 PM 10:30 PM
CC HALL 4 E
MODERATORS: Aysegul Sahin, MD, MD Anderson Cancer Center, Houston, TX

Gelareh Farshid, MD, The University of Adelaide, Australia
COURSE DESCRIPTION: The topics for the symposium were determined by the Executive Committee members of International
Society of Breast Pathology after soliciting input from membership. Our needs assessment process was based on the evaluation
of the current literature and feedback provided by audience participating in our prior companion symposiums.
An accurate diagnosis/classification of breast lesions is essential to ensure that the patients receive the most effective treatment.
Many Breast Cancer Advocacy groups have recommended that every patient with diagnosis of breast cancer should obtain
second opinion on both diagnosis/pathology and on treatment choices. Obtaining second opinions is an established part of
pathology practice, and many healthcare institutions have implemented policies requiring them. Many hospitals in the United
States mandate a second review of pathology slides from outside laboratories before surgical interventions or for all cancer
diagnoses before treatment planning. Second opinions may also be important for high-risk non-malignant borderline breast
lesions, which have greater diagnostic disagreement than malignant lesions, to assure that cancer is not misdiagnosed and
assess patient risk for development of breast cancer to guide surveillance and risk reduction strategies. Although second
opinions may improve diagnostic accuracy and the quality of patient care, as well as provide opportunities to educate
physicians, policies and practices for obtaining second opinions are not well established. In this session a multidisciplinary
panel of breast cancer experts will discuss importance and impact of pathology second opinions in breast cancer management.
The purpose of the companion meeting is to inform the audience regarding the most recent changes in the practice of breast
pathology. The current program will cover assessment of diagnostic accuracy of breast pathology and significance of second
opinions in breast pathology.
Discuss the clinical importance of prognostic and predictive factors in the classification of breast cancer and
understand the technical issues that may cause diagnostic difficulty
Evaluate and articulate the responsibility of the pathologists to provide second opinions
Identify common entities that may have borderline histopathologic findings and subjective evaluations that may
cause diagnostic discrepancies among different pathologists
Summarize the clinical uses and limitations of second opinion in breast pathology
7:00 PM
BUSINESS MEETING
7:20 PM
INTRODUCTION AND PRESIDENTS REMARKS

Ira Bleiweiss, MD, Mount Sinai Hospital, New York, NY
7:20 PM
PRESENTATION OF TRAINEE AWARDS

Puay Tan Hoon, MD, Singapore General Hospital, Singapore
7:30 PM
HOW GOOD ARE YOU AT BREAST PATHOLOGY? LESSONS FROM THE UK EQA PROGRAM
Ian O. Ellis, MD, University of Nottingham, Nottingham, England
8:00 PM
BREAST CANCER DIAGNOSIS AND SURGICAL PATHOLOGY A CRITICAL GLOBAL ONCOLOGY ISSUE
Benjamin O. Anderson, MD, University of Washington, Seattle, WA
8:30 PM
DISCREPANT DIAGNOSES WHERES THE HARM?

Jean F. Simpson, MD, Breast Pathology Consultants, Nashville, TN
9:00 PM
HOW ANCILLARY TECHNIQUES MAY BE UTILIZED TO IMPROVE DIAGNOSTIC ACCURACY IN BREAST PATHOLOGY
Allen M. Gown, MD, PhenoPath Laboratories, Seattle, WA
9:30 PM
QUESTIONS & ANSWERS
66

AMERICAN SOCIETY FOR CYTOPATHOLOGY
Everything That Shines Ain't Always Gonna Be Gold - Insights into

Cytology/Histology Correlations
7:30 PM 10:30 PM
CC BALLROOM 6 C
MODERATOR: Eva M. Wojcik, MD, Loyola University Medical Center, Maywood, IL

COURSE DESCRIPTION: The ASCs diverse membership shares a vision of education, research, and continuous improvement
in the standards and quality of patient care. From the diverse membership, the educational committees of the ASC determine a
set of educational standards that guide the committees as to the educational needs of the cytopathology community. Evaluation
of data from prior meetings and advances in medicine related to pathology/cytopathology are important sources of information
used by the education committees to plan ASC educational activities. The programs are reviewed and approved by the ASC
Executive Board.
Correlation of cytology findings with histologic biopsies is essential for successful quality assurance/improvement programs.
Traditionally, the diagnosis rendered on histologic specimens has been considered the gold standard, against which cytologic
interpretations are measured. In reality, both types of material are often complementary and, in many cases, different features
necessary to make a correct diagnosis are present only on one type of preparation. It is imperative to convey this information
to clinicians who usually consider the results of histologic examination as final. Currently, with an explosion of personalized
approach to diagnostic medicine, less and less material is available for diagnostic purposes. It is important for pathologists to
be comfortable with an evaluation of both cytology and histology specimens. It is essential to understand specific limitations
for each type of specimens, particularly in regards of how precise diagnosis can be made on cytology and small histological
material. In addition, it is important to realize that interpretation of adjuvant, particularly immunohistochemical, studies on
cytology and histology material may be different.
New classification systems and revision of the existing classification systems for surgical pathology diagnoses necessitate that
the cytopathologist adapt accordingly their diagnostic terminology. It can be challenging when the revised surgical pathology
terminology reclassifies neoplasms previously diagnosed as malignant to now benign neoplasms--or the other way around. The
question arises how to avoid over diagnosis of malignancy in thyroid FNA specimens if most cases of encapsulated follicular
variant of papillary carcinoma of the thyroid are diagnosed as Non-invasive follicular thyroid neoplasm with papillary-like
nuclear features (NIFT).
In few areas is fine needle aspiration as controversial as in the diagnosis and management of salivary gland lesions; while some
head and neck surgeons use it routinely, others deny its usefulness. This may, in part, be due to a lack of a practical terminology
and classification system for salivary gland aspirates that is useful for clinical decision-making. A new, clinically-oriented
classification system and reporting terminology specifically geared to fine needle aspiration cytology are being proposed.
Soft tissue tumors are the bane of both the surgical pathologist and the cytopathologist. An aspirate showing predominantly
spindle cells inspires well-founded fear in most pathologists; however, once the initial angst is overcome, careful review of
the morphology, coupled with judicious use of immunohistochemistry and molecular tests is frequently helpful to establish a
diagnosis, or at least give enough information to orient further management of the patient.
Gynecologic cytopathology remains one of the most difficult areas of cytopathology. Cytology- histology correlation is a
requirement. Many factors influence this correlation. Some are intrinsic to colposcopy, others relate to inter-observer variability
and still others pertain to the approaches that can be taken at the time of biopsy/LEEP sign out, including ancillary testing.
Together, these approaches can serve to refine interpretations and possibly improve the correlation.
Incorporate the new developments in thyroid pathology in their reporting of thyroid fine needle aspirates
Understand the need and rationale of a new standardized cytology reporting of salivary gland fine needle aspirates
Determine which type(s) of specimens should be sent for molecular testing in lung and mediastinal
biopsies and FNAs
Use an algorithmic diagnostic approach to spindle cell aspirates and determine what ancillary tests should be used
Understand the limitations of GYN cyto-histology correlations and practical approaches for improvement
CONTINUED ON NEXT PAGE
67

AMERICAN SOCIETY FOR CYTOPATHOLOGY...CONTINUED
Everything That Shines Ain't Always Gonna Be Gold - Insights into

Cytology/Histology Correlations
7:30 PM
WELCOME AND INTRODUCTION

Eva M. Wojcik, MD, Loyola University Medical Center, Maywood, IL
7:45 PM
THE NEW DIAGNOSTIC PARADIGMS IN THYROID SURGICAL PATHOLOGY AND EFFECTS ON REPORTING OF
THYROID FINE-NEEDLE ASPIRATION SPECIMENS
Zubair W. Baloch, MD, PhD, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
8:10 PM
TIME TO STANDARDIZE THE CYTOLOGY REPORTING OF SALIVARY GLANDS

INTRODUCTION OF THE MILAN SYSTEM
William Faquin, MD, PhD, Massachusetts General Hospital, Boston, MA
8:35 PM
IN AN ERA OF PERSONALIZED APPROACH TO LUNG CANCER WHICH TYPE OF SPECIMEN RULES SUPREME?
Swati Mehrotra, MD, Loyola University Medical Center, Maywood, IL
9:00 PM
EVERYTHING IS SPINDLE HOW FAR CAN WE GO WITH LIMITED MATERIAL?

Paul Wakely, Jr., MD, The Ohio State University Wexner Medical Center, Columbus, OH
9:25 PM
CYTOLOGY/BIOPSY/LEEP CORRELATION PRACTICAL CONSIDERATIONS AND APPROACHES

Fadi W. Abdul-Karim, MD, Med, Cleveland Clinic, Cleveland, OH
9:50 PM
GLANDULAR LESIONS ON PAP STILL DIFFICULT AFTER ALL THESE YEARS

Dina Mody, MD, The Methodist Hospital, Houston, TX
10:15 PM
68

AMERICAN SOCIETY OF DERMATOPATHOLOGY
Dermatopathology Insights from Pathology Consults

Cases I Remember and Learned From
7:30 PM 10:30 PM
CC 608 609
MODERATOR: Meera Mahalingam, MBBS, PhD, FRCPath, VA Boston Healthcare System, West Roxbury, MA
COURSE DESCRIPTION: This activity has been designed to meet the educational needs of general pathologists both in private
practice as well as in an academic setting.
The purpose of this topic is to highlight entities that present a diagnostic conundrum for the general pathologist as well as
the consultant dermatopathologists. Each dermatopathologist will present a minimum of five cases received for consultation
from a pathologist that were instructive. Cases discussed will encompass a spectrum of lineage-unrelated tumors as well as
inflammatory dermatoses. Relevance of clinicopathologic correlation as well as teaching points/take home messages will be
emphasized.
Select entities commonly encountered in daily practice that can present a diagnostic challenge for the pathologist as
well as the dermatopathologist
Utility of clinicopathologic correlation in dermatopathology
Clues and confounding issues associated with a spectrum of lineage-unrelated tumors as well as inflammatory
dermatoses encountered by a general pathologist both in private practice as well as an academic setting
7:30 PM
INTRODUCTION
Meera Mahalingam, MBBS, PhD, FRCPath, Veteran Affairs Boston Healthcare System,
Veteran Affairs Medical Center, West Roxbury, MA
7:35 PM
Asok Biswas, MD, FRCPath, DipRCPath, Western General Hospital, Edinburgh, UK
8:10 PM
Mai Hoang, MD, Harvard Medical School, Massachusetts General Hospital, Boston, MA
8:45 PM
Rossitza Lazova, MD, Yale Dermatopathology Laboratory, New Haven, CT
9:20 PM
Meera Mahalingam, MBBS, PhD, FRCPath, Veteran Affairs Boston Healthcare System, Veteran Affairs Medical Center,
West Roxbury, MA
10:00 PM
Rajendra Singh, MD, Icahn School of Medicine at Mount Sinai, New York, NY
69

ASSOCIATION FOR MOLECULAR PATHOLOGY
Implementing Molecular Testing to Make Treatment Decisions

7:30 PM 10:30 PM
CC BALLROOM 6 E
MODERATORS: Eric Duncavage, MD, Washington University School of Medicine St. Louis, MO
James R. Cook, MD, PhD, Cleveland Clinic, Cleveland, OH
COURSE DESCRIPTION: In order to fully realize the goals of precision medicine in cancer, accurate methods are needed to
gauge treatment response and monitor for cancer recurrence and progression. In the last several years next generation
sequencing (NGS) approaches have provided us with an unprecedented view of cancer genomics and have identified several
key genes involved in cancer pathogenesis. Clinical sequencing-based cancer gene panels are now being adopted in the
routine evaluation of many cancer types. While such panels can be used to identify therapeutic targets and stratify risk when
performed on the initial primary tumor, sequencing across serial time points can provide additional prognostic information, and
may be used to monitor cancer patients over time to determine the efficacy of a particular treatment and the extent to which a
tumor is cleared. This companion meeting will focus on recent advances and future applications for the use of sequencing-based
technologies to monitor tumor burden in hematologic malignancies and solid tumors.
Identify key methodological approaches and challenges in sequencing-based tumor burden monitoring
Compare the major advantages of multi time point tumor burden monitoring over current single time point cancer
panels to predict patient outcome
Describe how tumor burden monitoring is now being applied in the research setting and the impact of incomplete
molecular disease clearance in leukemia
Recognize new concepts and challenges in solid tumor monitoring including cell free DNA and liquid biopsy
applications
7:30 PM
NEW INSIGHTS INTO MOLECULAR MONITORING IN CANCER

Eric J. Duncavage, MD, Washington University School of Medicine, St. Louis, MO
7:45 PM
MOLECULAR MONITORING IN AML CAN INFORM PROGNOSIS

Jeffery M. Klco, MD, PhD, St. Jude Childrens Research Hospital, St. Louis, MO
8:20 PM
CLINICAL APPLICATION OF NGS FOR MRD MONITORING IN LYMPHOID NEOPLASMS

David Wu, MD, PhD, University of Washington, Seattle, WA
8:55 PM
CELL-FREE TUMOR DNA FOR CANCER MONITORING

Christina Lockwood, PhD, DABCC, FACB, University of Washington, Seattle, WA
9:30 PM
SUMMARY OVERVIEW
James Cook, MD, PhD, Cleveland Clinic, Cleveland, OH
10:00 PM
70
2016
SPECIALTY CONFERENCES
USCAP is Building its Future and Yours
Linder Learning Center

OPENING SPRING 2016
Broadcast television studio and conference theater
Real-time broadcasting for global educational
outreach
Unites pathologists world-wide with live courses
at the Powers-Sanchez Interactive Center for
interactive discussions
Digital asset productions targeted to global
outreach, particularly in low-resource countries
Visit Us Online for More Information
www.USCAPInteractiveCenter.org

Problematic Topics in Gynecologic Pathology: Gestational Trophoblastic Disease,

Metastases Mimicking Primary Tumors and Other Challenges
7:30 PM-9:30 PM
CC BALLROOM 6 B
MODERATOR:
Robert Soslow, MD, Memorial Sloan Kettering Cancer Center, New York, NY
PANELISTS:
Bojana Djordjevic, MD, University of Ottawa, Ottawa, ON

Matthew Cesari, MD, Sunnybrook Health Sciences Centre, Toronto, ON
Elizabeth Euscher, MD, MD Anderson Cancer Center, Houston, TX
Anais Malpica, MD, MD Anderson Cancer Center, Houston, TX

Recognize some uncommonly encountered pelvic tumors that feature in the differential diagnosis with primary
gynecologic malignancies
Become familiar with situations in which one should consider an extra-gynecologic cancer in the differential
diagnosis
Become familiar with some unusual manifestations of gestational trophoblastic disease
PULMONARY PATHOLOGY
I Finally Learned Something New

SUNDAY MARCH 13, 2016
7:30 PM- 9:30 PM
CC BALLROOM 6 A
MODERATOR:
Sanja Dacic, MD, PhD, University of Pittsburgh Medical Center, Center, Pittsburgh, PA
PANELISTS:
E. Handan Zeren, MD, Acibadem University School of Medicine, Istanbul, Turkey

Lucian Chirieac, MD, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Luka Brcic, MD, PhD, Institute of Pathology, Medical University of Graz, Graz, Austria
Andrew Churg, MD, University of British Columbia, Vancouver, BC
Andras Khoor, MD, PhD, Mayo Clinic Florida, Jacksonville, FL

Recognize mimickers of idiopathic interstitial lung disease
Understand significance of diagnostic molecular testing
Be aware of diagnostic limitations of small specimens
71

RENAL PATHOLOGY
Talking Points in Renal Pathology

7:30 PM-9:30 PM
CC 615-617
MODERATOR:
Vanesa Bijol, MD, Brigham and Womens Hospital, Boston, MA

Tibor Nadasdy, MD, The Ohio State University, Columbus, OH
PANELISTS:
Erika Bracamonte, MD, University of Arizona Medical Center, Tucson, AZ

Anthony Chang, MD, University of Chicago Medicine, Chicago, IL
Lynn Cornell, MD, Mayo Clinic, Rochester, MN
Charles J. Jennette, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC
Ivy A. Rosales, MD, Massachusetts General Hospital, Boston, MA

Work up the renal biopsy cases to the highest standard of practice based on clinical presentation of
individual patients
Demonstrate the ability to identify and explain the etiology, pathogenesis, relevant investigations, and the
differential diagnosis of discussed entities
Correlate the important clinical features of the disease with the pathologic changes
PEDIATRIC PATHOLOGY
Enteropathies of Infancy and Childhood

7:30 PM- 9:30 PM
CC 606-607
MODERATOR:
Kyle Kurek, MD, Alberta Children's Hospital and University of Calgary, Calgary, AB, Canada
Megan K. Dishop, MD, Children's Hospitals and Clinics of Minnesota, Minneapolis-St. Paul, MN
PANELISTS:
Jeffrey Goldsmith, MD, Beth Israel Deaconess Medical Center and Childrens Hospital, Boston, MA
Marie-Anne Brundler, MD, CLS/Alberta Childrens Hospital, AB, Canada
Sarangarajan Ranganathan, MD, Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA
Pierre A. Russo, MD, Childrens Hospital of Philadelphia, Philadelphia, PA

Provide a differential diagnosis of inflammatory enteropathies in the pediatric population
Identify the histopathologic patterns associated with specific pediatric enteropathies
Select ancillary studies, which aid in the diagnosis of pediatric enteropathies
List the known genetic determinants and syndromes associated with pediatric enteropathies
72

HOUSESTAFF
Preparing for Life Beyond Residency

7:30 PM- 9:30 PM
CC 613-614
MODERATOR:
Barbara S. Ducatman, MD, West Virginia University School of Medicine, Morgantown, WV
PANELISTS:
Kym Gyure, MD, West Virginia University Hospital, Morgantown, WV

Melissa Upton, MD, University of Washington, Seattle, WA
Ann Thor, MD, University of Colorado HSC, Aurora, CO

Identify and define activities for immediate adoption during residency and fellowship to enhance their ability to
obtain the fellowship and/or jobs of their choice
Define those competencies, skills, and abilities that fellowship directors and department chairs seek in hiring
decisions
Design and implement a five to ten year career development plan
OPHTHALMIC PATHOLOGY
Ophthalmic Pathology Unexpected and Challenging Cases

7:30 PM-9:30 PM
CC 605
MODERATOR:
Patricia Chevez-Barrios, MD, Weill Cornell Medicine, Houston Methodist Hospital, Houston, TX
PANELISTS:
Sander Dubovy, MD, University of Miami, Bascom Palmer Eye Institute, Miami, FL
Diva Salomao, MD, Mayo Clinic, Rochester, MN
Abelardo Rodriguez, MD, Hospital Luis Snchez Bulnes, Mxico City, Mxico
Tatyana Milman, MD, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Enumerate differential diagnosis of most common ocular and adnexal tumors
List different histopathologic and molecular techniques to approach ocular specimens
Correlate imaging findings with histopathologic diagnosis
73

SURGICAL PATHOLOGY
Beyond the H&E: Where Morphology Meets Molecular Maladies

MONDAY MARCH 14, 2016
7:30 PM-9:30 PM
CC BALLROOM 6 A/B/C
MODERATOR:
Kumarasen Cooper, MBChB, DPhil, University of Pennsylvania Hospital, Philadelphia, PA
PANELISTS:
Zubair Baloch, MD, Hospital of University of PA, Philadelphia, PA

Abbas Agaimy, MD, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
Runjan Chetty, MBBCh, University Health Network, Toronto, ON, Canada
Ondej Hes, MD, PhD, Biopticka Laboratory, Plzen, Czech Republic
Cristina Antonescu, MD, Memorial Sloan Kettering Cancer Center, New York, NY

Interpret and be aware of distinctive morphologies associated with unique molecular aberrations
Understand complex diagnostic processes and differential diagnoses of certain hereditary syndromic tumors
Appreciate the evolving molecular concepts as pertains to recently recognized entities
A Tale of Two Tickers: Pre- and Post-Transplant Pathology

7:30 PM-9:30 PM
CC BALLROOM 6E
MODERATOR:
Robert F. Padera, MD, PhD, Brigham and Women's Hospital, Boston, MA
PANELISTS:
Elizabeth Pavlisko, MD, Duke University Medical Center, Durham, NC

Frederick Schoen, MD, Brigham and Womens Hospital, Boston, MA
Carmela Tan, MD, Cleveland Clinic, Cleveland, OH
Karen Kelly, MD, East Carolina University, Greenville, NC
Jon Kobashigawa, MD, Cedars-Sinai Medical Center, Beverly Hills, CA

Identify clinically important pathologies in native heart biopsies and explants
Identify complications of mechanical circulatory support devices
Identify clinically important pathologies in post-transplant biopsies
Identify cardiovascular causes of death in heart transplant patients
74

INFECTIOUS DISEASE PATHOLOGY
Pathogen Detection: From Morphology to Molecular Testing

7:30 PM-9:30 PM
CC 608-609
MODERATOR:
Atis Muehlenbachs, MD, PhD, Centers for Disease Control and Prevention, Atlanta, GA
PANELISTS:
Gary Procop, MD, Cleveland Clinic, Cleveland, OH

Bobbi Pritt, MD, Mayo Clinic, Rochester, MN
Steve Salipante, MD, PhD, University of Washington Medical Center, Seattle, WA
Sherif Zaki, MD, PhD, Centers for Disease Control and Prevention, Atlanta, GA

Recognize the morphologic differential of selected infectious diseases, the contribution of special stains and
immunohistochemistry, and when molecular tests are indicated to further characterize the organism
Interpret molecular test results and their pitfalls for infectious disease diagnosis from pathology specimens
Describe cutting edge molecular techniques for the diagnosis of infectious diseases in formalin-fixed
paraffin-embedded tissues
GENITOURINARY PATHOLOGY
Uncommon Lesions with Papillary and/or Cribriform Architecture

7:30 PM-9:30 PM
CC BALLROOM 6E
MODERATOR:
Cristina Magi-Galluzzi MD, PhD, Cleveland Clinic and Lerner Research Institute, Cleveland, OH
PANELISTS:
Elsa F. Velazquez, MD, Tufts University and Miraca Life Sciences, Boston, MA
Christopher G. Przybycin, MD, Cleveland Clinic, Cleveland, OH
L. Priya Kunju, MD, University of Michigan, Ann Arbor, MI
Ming Zhou, MD, PhD, New York University Medical Center, New York, NY

Familiarize with uncommon and recently described entities in genitourinary pathology
Sharpen existing expertise and enhance the participants spectrum of professional competence
Review pitfalls and pearls to pathologic diagnosis as well as an approach to ancillary diagnostic techniques
75

LIVER PATHOLOGY
Secrets From the Consult Files: Great Liver Cases with Key Teaching Points
7:30 PM- 9:30 PM
CC BALLROOM 6C
MODERATOR:
Micheal Torbenson, MD, Mayo Clinic, Rochester, MN

Rish Pai, MD, Mayo Clinic, Scottsdale, AZ
PANELISTS:
Taofic Mounajjed, MD, Mayo Clinic, Rochester, MN

Matthew M. Yeh, MD, PhD, University of Washington Medical Center, Seattle, WA
Cynthia D. Guy, MD, Duke University Medical Center, Durham, NC
Maha Guindi, MD, Cedars-Sinai Medical Center, Beverly Hills, CA
Andrew Clouston, MD, Envoi Pathology, Kelvin Grove, Australia

Integrate clinical information and laboratory testing into the interpretation of liver biopsy injury patterns
Understand the appropriate approach for biopsies with fatty liver disease and elevated autoimmune markers
Effectively use immunohistochemical stains when evaluating biopsies
BONE AND SOFT TISSUE PATHOLOGY
Recent Changes in my Bone and Soft Tissue Pathology Practice

7:30 PM-9:30 PM
CC BALLROOM 6A
MODERATOR:
Jason L. Hornick, MD, PhD, Brigham and Women's Hospital, Boston, MA
PANELISTS:
Wei-Lien (Billy) Wang, MD, MD Anderson Cancer Center, Houston, TX

Karen J. Fritchie, MD, Mayo Clinic, Rochester, MN
Narasinham P. Agaram, MBBS, Memorial Sloan Kettering Cancer Center, New York, NY
Abbas Agaimy, MD, University of Erlangen, Erlangen, Germany
Sarah M. Dry, MD, University of California, Los Angeles, CA

Discuss recent updates in the diagnosis and classification of bone and soft tissue tumors
Apply new immunohistochemical markers for differential diagnosis
Interpret the results of molecular genetic findings in the context of histology
76

HEAD, NECK AND ENDOCRINE PATHOLOGY
Emerging Molecular Findings and Interesting Cases in Head, Neck

and Endocrine Pathology
7:30 PM-9:30 PM
CC BALLROOM 6B
MODERATOR:
Ilan Weinreb, MD, University Health Network, Toronto, ON
PANELISTS:
Vickie Y. Jo, MD, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Lori A. Erickson, MD, Mayo Clinic, Rochester, MN
Simon Chiosea, MD, University of Pittsburgh Medical Center, Pittsburgh, PA
Alena Skalova, MD, PhD, Charles University, Faculty of Medicine, Plzen, Czech Republic

Appreciate new diagnostic entities in head and neck and endocrine pathology
Help navigate the overlapping features of traditional head and neck and endocrine malignancies and their mimics
Appreciate the role of diagnostic nuances on sub classification and reporting in head and neck and endocrine cancer
HEMATOPATHOLOGY
Current Controversies in Hematopathology

7:30 PM- 9:30 PM
CC BALLROOM 6A
MODERATOR:
James R. Cook, MD, PhD, Cleveland Clinic, Cleveland, OH

Tracy George, MD, University of New Mexico, Albuquerque, NM
PANELISTS:
Scott J. Rodig, MD, PhD, Brigham and Women's Hospital, Boston, MA

Andrew L. Feldman, MD, Mayo Clinic, Rochester, MN
Yi-Hua Chen, MD, Northwestern University, Chicago, IL
Sherrie Perkins, MD, PhD, University of Utah, Salt Lake City, UT

Provide a differential diagnosis of hematopathology disorders based on select clinical and pathologic findings
Identify the key histopathologic features associated with specific hematopathology disorders
Select ancillary studies that aid in determining the diagnosis for specific hematopathology disorders
77

CYTOPATHOLOGY
New and Recent Developments in Cytopathology: A Case Based Approach

7:30 PM-9:30 PM
CC BALLROOM 6B
MODERATOR:
Dina Mody, MD, The Methodist Hospital, Houston, TX
PANELISTS:
Charles Sturgis, MD, Cleveland Clinic, Cleveland, OH

Sara Monaco, MD, UPMC Shadyside Hospital, Pittsburgh, PA
Mary Schwartz, MD, Houston Methodist, Houston, TX
Ron Balassanian, MD, University of California, San Francisco, CA

Understand challenges associated with diagnosing common and uncommon entities on cytology specimens
Be familiar with new developments in classification schemes, molecular testing and Immunohistochemical stains as
they apply to cytology specimens
Understand the benefits and challenges associated with newer methods of obtaining cytology specimens and how
to optimize the specimen for definitive diagnosis
NEUROPATHOLOGY
The Newly Updated WHO 2016 Blue Book

7:30 PM- 9:30 PM
CC BALLROOM 6C
MODERATOR:
PANELISTS:
Cristina Antonescu, MD, Memorial Sloan Kettering Cancer Center, New York, NY
Jason Huse, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY
Tarik Tihan, MD, PhD, University of California San Francisco, San Francisco, CA
David Ellison, MD, PhD, St. Jude Childrens Research Hospital, Memphis, TN
Beatriz Lopes, MD, PhD, University of Virginia Health System, Charlottesville, VA

Recognize new nervous system tumor entities in the WHO 2016 that incorporate not only morphologic, but also
molecular findings into their definition
Identify useful immunohistochemical surrogates that can be utilized to identify molecular subtypes in the
WHO 2016 classification scheme
Appreciate some of the molecular differences between common adult type and pediatric type brain tumor
counterparts
78

GASTROINTESTINAL
Coffee Talk: A Blend of Cases in GI Pathology

7:30 PM-9:30 PM
CC BALLROOM E
MODERATOR:
PANELISTS:
Alyssa Krasinskas, MD, Emory University, Atlanta, GA

Wendy Frankel, MD, The Ohio State University Wexner Medical Center, Columbus, OH
Olca Basturk, MD, Memorial Sloan Kettering Cancer Center, New York, NY
Bastiaan de Boer, MBBS, BMedSci, FRCPA, PathWest, QE II Medical Centre, Nedlands Perth, Western Australia
Laura Lamps, MD, University of Arkansas for Medical Sciences, Little Rock, AR
John Hart, MD, The University of Chicago, Chicago, IL

Include uncommon entities in the differential diagnosis of more common diseases of the GI tract
Describe a new polyposis syndrome
Recognize an uncommon intraepithelial neoplasm of the pancreas
DERMATOPATHOLOGY
I Cant Believe It, Surprises In Dermatopathology

7:30 PM-9:30 PM
CC 611-612
MODERATOR:
Victor G. Prieto, MD, PhD, University of Texas, MD Anderson Cancer Center, Houston, TX
PANELISTS:
Richard Danialan, DO, Tufts Medical Center, Boston, MA

Thuy Phung, MD, PhD, Baylor College of Medicine, Houston, TX
Chandra Smart, MD, University of California, Los Angeles, CA
Michael Tetzlaff, MD, University of Texas, MD Anderson Cancer Center, Houston, TX

Utilize immunohistochemistry to help in the differential diagnosis of primary and metastatic lesions to the skin
Distinguish histologically among the several cutaneous superficial neoplasms that display fibrohistiocytic lesions
Determine the clinical and histologic features of internal neoplasms metastatic to the skin
79

BREAST PATHOLOGY
Interesting Case Presentation

7:30 PM-9:30 PM
CC BALLROOM 6C
MODERATOR:
Jean Simpson, MD, Breast Pathology Consultants, Nashville, TN
PANELISTS:
Anna Marie Mulligan, MB, BCH, MRCPath, University of Toronto, ON

Xiaoxian Li, MD, Emory University, Atlanta, GA
Benjamin Calhoun, MD, PhD, Cleveland Clinic, Cleveland, OH
Ian Ellis, MD, The University of Nottingham, Nottingham, England
Deborah A. Dillon, MD, Brigham and Womens Hospital, Boston, MA

Recognize the salient diagnostic features of selected breast lesions
Integrate the imaging and pathology findings in the appropriate clinical context
Recognize the clinical management implications
80
2016
SPECIAL COURSES
Follow New Paths Yet Untraveled

#USCAP2016
#USCAP2016
#IAMUSCAP
#IAMUSCAP
#IAMUSCAP
#IAMUSCAP
#USCAP2016
#IAMUSCAP
#USCAP2016
#IAMUSCAP
#IAMUSCAP
#USCAP2016
#IAMUSCAP
#IAMUSCAP
#USCAP2016
#IAMUSCAP
24/7 around-the-globe contact with the USCAP

family on Twitter puts you in the NOW with flash
ideas and info you need to be a better pathologist.
Plus, join us on Facebook, Instagram and YouTube
for even more interaction.
www.USCAP.org
SPECIAL COURSES
Residents Workshop: Genomic Medicine for Pathologists:

What You Need to Know
9:00 AM 5:00 PM
CC 602 604
COURSE DIRECTOR: Richard Haspel, MD, PhD, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA
FACULTY: Debra G.B. Leonard, MD, PhD, University of Vermont College of Medicine, Burlington, VT
Tamara Williams, PhD, University of Vermont College of Medicine, Burlington, VT
COURSE DESCRIPTION: Next-generation sequencing methods and multi-gene panels have entered clinical practice.
Pathologists, as directors of molecular pathology laboratories, are already playing a leading role in applying genomic
technology to patient care. Regardless of your planned specialty, genomic pathology will become an important part of your
career as a pathologist. Using a case-based, interactive small-group approach, workshop participants will learn principles
related to the development of genomic assays and interpretation of results. The workshop will also include practical hands-on
instruction with the use of online genomic pathology tools.
The workshop was developed and will be led by members of the Training Resident in Genomics (TRIG) Working Group.
Established in 2010, this group made up of experts in molecular pathology, medical education, and genetic counseling was
formed to provide genomic pathology educational resources. The workshop will utilize a team-based learning approach. While
there will be short lectures at the beginning and end of each session, the majority of learning will take place in small resident
teams with faculty support.
Determine the clinical significance of genetic variants, using online tools
Describe the benefits and limitations of integrative genomic analyses
Describe the reporting issues related to genomic analyses
9:00 AM
SESSION 1: SINGLE GENE TESTING

List the factors that go into the determination of who is an appropriate candidate for cancer susceptibility genetic
testing
Determine the clinical significance of variant related to cancer susceptibility genetic testing, with the use of
online tools
10:30 AM
BREAK
10:45 AM SESSION 2: PROGNOSTIC GENE-PANEL TESTING

Describe the role of pathologists in facilitating prognostic gene-panel testing
Compare utility of prognostic gene-panel testing to histologic methods
Interpret a prognostic gene panel report and consider important components to ensure appropriate interpretation by
the ordering clinician
Describe the process of selecting genes for expression profiles for clinical use
12:15 PM
LUNCH
1:00 PM
SESSION 3: DESIGN OF A MULTIGENE ASSAY (CANCER GENE PANEL)

Describe different methods for detecting DNA variants (PCR vs. Sanger-based vs. NGS-based)
Determine the appropriate methodology for a selected gene panel
Describe the factors that determine the utility of inclusion of a specific gene in a multigene assay (in this case, a
cancer gene panel)
81
SPECIAL COURSES
2:30 PM
2:45 PM
BREAK
SESSION 4: WHOLE EXOME SEQUENCING
Describe key aspects of informed consent for genomic analyses
Describe the benefits and limitations of integrative genomic analyses for advanced cancer patients
Describe the reporting issues related to unintended findings
Use online tools to interpret the clinical significance of genomic data
4:15 PM
82
WRAP-UP/QUESTION AND ANSWER SESSION
SPECIAL COURSES
Residents Workshop: Leadership, Collaboration and Change in

Health Care Essential Skills
12:00 PM 6:00 PM
CC 611 612
COURSE DIRECTORS: Carol Farver, MD, MS, Cleveland Clinic, Cleveland, OH
Dani Zander, MD, Penn State Milton S. Hershey Medical Center, Hershey, PA
James K. Stoller, MD, MS, Cleveland Clinic, Cleveland, OH
COURSE DESCRIPTION: The delivery of health care in todays world is increasingly complex. Historically, medical training has
centered exclusively on developing clinical and research competence in the medical sciences. However, as healthcare is being
delivered more and more by integrated teams and organizations, medical education must teach physicians core competencies
of working in and leading healthcare organizations. This workshop is designed to educate residents in leadership, collaboration
and communication in healthcare organizations. The course syllabus and bibliography are developed from studies specific to
the health care industry that focus on the role of leadership and the functioning of teams within healthcare organizations. The
workshop will serve as an introduction to these concepts and an extensive bibliography for further reading will be provided.
The curriculum will provide an opportunity for residents to undertake a guided exploration of the
following areas of study:
The characteristics of effective leaders in health care
Emotional intelligence
Importance of mindful self-examination and mentoring in career success
Defining strategies for advancing your professional goals
The characteristics of effective teams and their importance in health care
Models of organizational change
Basic tools to manage conflict
12:00 PM
SESSION 1: LEADERSHIP AND CHANGE IN HEALTH CARE: THE TOOLS PHYSICIANS NEED TO LEAD
Carol Farver, MD, MS, Cleveland Clinic, Cleveland, OH
James K. Stoller, MD, MS, Clevelad Clinic, Cleveland, OH
Define emotional intelligence and the evidence for its importance in leadership
Discuss the important physician competencies needed to lead healthcare organizations
Define the models of organizational change
Review examples of change management in health care organizations
1:15 PM
SESSION 2: THE NEW PHYSICIAN LEADER: GOING BEYOND SURVIVAL TO SUCCESS

Dani Zander, MD, Penn State Milton S. Hershey Medical Center, Hershey, PA
Understand how mindful self-examination and mentorship contribute to professional development
Describe strategies for advancing your professional goals in an organization
2:15 PM
SESSION 3: BUILDING AN EFFECTIVE HEALTH CARE TEAM

James K. Stoller, MD, MS, Cleveland Clinic, Cleveland, OH
Review the importance of teams in health care
Define characteristics of effective health care teams
Summarize and reflect on ones own role in a team
83
SPECIAL COURSES
4:30 PM
SESSION 4: IDENTIFYING AND RESOLVING CONFLICT: EFFECTIVE TOOLS FOR TOMORROWS LEADERS
Carol Farver, MD, MS, Cleveland Clinic, Cleveland, OH
Review the types of conflict
Complete a standard inventory on how one handles conflict
List tools for conflict resolution
Discuss case scenarios of conflict that residents experience
5:30 PM
84
WRAP-UP AND EVALUATIONS
SPECIAL COURSES
Clinical Application of Next Generation Sequencing

for the Management of Patients with Solid Tumors
8:00 AM 12:00 PM
CC BALLROOM 6E
COURSE DIRECTOR: Jeffrey S. Ross, MD, Albany Medical Center, Albany, NY and Foundation Medicine, Inc., Cambridge, MA
CO-COURSE DIRECTORS: Neal I. Lindeman, MD, Brigham and Womens Hospital and Dana Farber Cancer Institute, Boston, MA
Stephen Yip, MD, PhD, University of British Columbia and Vancouver General Hospital, Vancouver, BC
COURSE DESCRIPTION: This half-day course is designed to familiarize the registrant with both the technical aspects and clinical
applications of NGS for the solid tumor cancer patient. The first section of the course is organized into a didactic series of short
lectures given by the course instructors to highlight the history of clinical DNA sequencing on cancer specimens focused on
the search for potential therapy targets for patients with relapsed and refractory disease. The technical section will emphasize
practical issues for pathologists including the types of samples that can be used, the quantity and proportion of tumor cells
needed and the pre-analytic factors that can influence NGS test results. Both formalin fixed paraffin embedded tissues and
blood-based liquid biopsies will be considered. The remaining sections of the course will consist of a case by case analysis
that includes lung cancer, breast cancer, colorectal cancer, melanoma, brain tumors and cancer of unknown primary origin.
Contrast the differences, advantages and disadvantages between next generation sequencing (NGS) technologies
and traditional Sanger Sequencing methods
Understand the current limitations of one off single gene hotspot sequencing tests versus comprehensive
genomic profiling by NGS
Contrast the advantages and disadvantages of the targeted NGS panel approach versus whole exome and whole
genome sequencing
Understand how next generation sequencing technologies can be applied to detect all classes of genomic
alterations including base substitutions , short insertions/deletions, fusions and translocations, and copy number
alterations including amplifications and homozygous deletions in a clinical grade, regulatory agency approved
(CLIA/CAP) format using routine clinical FFPE samples
Know how to preserve and prepare surgical pathology and cytologic samples including fluids and fine needle
aspirations for NGS testing
Contrast the uses and limitations of using a blood sample for analysis of circulating tumor cell and cell free DNA for
NGS
Be familiar with the potential of NGS to alter a cancer patients clinical outcome by identifying a genomic alteration
that can lead to a specific targeted therapy that would not have been considered if the NGS results had not been
available
Have a basic understanding of assessing quality assurance, proficiency testing and general validation of NGS
procedures used in clinical testing of patient samples
8:00 AM
INTRODUCTORY LECTURES: HISTORY OF DNA SEQUENCING, TRADITIONAL AND NGS SEQUENCING

TECHNOLOGIES AND THE ROLES OF PATHOLOGISTS IN THE PROVIDING OF NGS RESULTS DESIGNED TO DIRECT
PERSONALIZED CANCER TREATMENT
9:20 AM
CASE 1: NON-SMALL CELL LUNG CANCER
9:40 AM
CASE 2: BREAST CANCER
10:00 AM
BREAK
10:20 AM
CASE 3: MELANOMA
10:40 AM
CASE 4: COLORECTAL CANCER
11:00 AM
CASE 5: CANCER OF UNKNOWN PRIMARY ORIGIN
11:20 AM
CASE 6: BRAIN TUMORS
11:40 AM
QUESTIONS AND DISCUSSION
85
SPECIAL COURSES
Tumor Immunology: Implications for TNM Staging and Therapeutics

1:00 PM 5:00 PM
CC BALLROOM 6E
COURSE DIRECTORS: Janis M. Taube, MD, The Johns Hopkins University School of Medicine, Baltimore, MD
Robert A. Anders, MD, PhD, The Johns Hopkins University School of Medicine, Baltimore, MD
COURSE DESCRIPTION: The focus of the course is TNM-Immune staging and the emerging use of surgical pathology specimens
for immune-based assays, including immunologic biomarkers for therapeutic selection and monitoring. To date, the majority of
the findings emphasizing the role of the immune tumor microenvironment have been presented in the New England Journal of
Medicine, Science, and Nature Medicine etc., and oncology journals, such as Journal of Clinical Oncology, Cancer Research, and
Clinical Cancer Research, amongst others. In fact, this body of work was awarded Science Magazines Breakthrough of the Year
for 2013. There is a general lack of cutting-edge peer-reviewed publications on this topic in the pathology literature; however,
based on the interest level at the 2014 USCAP Annual Meeting (evidenced by posters on the topic) and the number of new
immunohistochemical assays and associated reports, the pathology community is now rapidly embracing and participating in
this new aspect of surgical pathology.
Summarize how the activity of checkpoint agents differs from that of more traditional therapeutics
Summarize the latest concepts regarding the immune contexture of malignant neoplasms
Discuss the histologic features associated with adaptive immune resistance
Understand the limitations of PD-L1 evaluation
Identify additional markers and associated detection techniques that will likely be employed in future
Immunopathology assays
1:00 PM
IMMUNE CHECKPOINTS, CHECKPOINT BLOCKADE THERAPY, AND RATIONAL PATIENT SELECTION: AN OVERVIEW
Janis M. Taube, MD, The Johns Hopkins University School of Medicine, Baltimore, MD
Familiarize participants with the immune synapse
Introduce checkpoint blocking agents and how their activity and side effects differ from other therapeutic agents
Summarize recent FDA approvals for this class of therapeutics and the specific indications
1:15 PM
THE IMMUNE CONTEXTURE IN HUMAN TUMORS: IMPACT ON CLINICAL OUTCOME

Jerome Galon, MD, PhD, Cordeliers Research Center, Paris, France
Identify the key inflammatory components in a malignant neoplasm
Summarize how the Immunoscore compares to current TNM staging
Understand how an Immunoscore is calculated and the status of the Immunoscore Task force in validating this
approach
1:50 PM
ADAPTIVE IMMUNE RESISTANCE: BIOMARKER IMPLICATIONS

Robert M. Anders, MD, The Johns Hopkins University School of Medicine, Baltimore, MD
Discuss the histologic features of adaptive immune resistance by tumor
Discuss the limitations of PD-L1 IHC evaluation in predicting response to anti-PD-1/PD-L1 therapies
Explain the pre- and post-analytic variables that influence determining if a malignancy expresses PD-L1
86
SPECIAL COURSES
2:25 PM
COMPARISON OF DIFFERENT ASSAY TECHNIQUES FOR IMMUNE MARKERS

David Rimm, MD, PhD, Yale University School of Medicine, New Haven, CT
Compare current chromogenic IHC testing methods for PD-L1
Highlight advantages for methods beyond chromogenic IHC for measuring PD-L1 and other checkpoint expression
in the tumor microenvironment
Explain the advantage of quantitative assessment of immune markers
3:00 PM
COFFEE BREAK
4:00 PM
IMMUNOARCITECTURAL FEATURES OF THE TUMOR MICROENVIRONMENT: BEYOND PD-L1

Scott Rodig, MD, PhD, Brigham and Womens Hospital, Boston, MA
Identify additional checkpoints and other markers in the tumor microenvironment thought to have clinical impact
Compare and contrast the tumor microenvironment of hematologic malignancies as compared to solid tumors
Summarize state-of-the-art methods used to evaluate the immunoarchitecture of FFPE specimens, including
multiplex IHC/IF
4:40 PM
CLOSING/Q&A
87
SPECIAL COURSES
Molecular Diagnostic and Genomic Applications in Cancer:

A Primer for the Pathologist
8:00 AM 5:15 PM
CC BALLROOM 6B
COURSE DIRECTORS: George J. Netto, MD, The Johns Hopkins University, Baltimore, MD
Karen Kaul, MD, PhD, North Shore University Health System, Evanston, IL
COURSE DESCRIPTION: The pathologist is increasingly expected to play a central role in the management of cancer patients in
the era of personalized oncology. Molecular diagnostic and genomic applications are rapidly penetrating the daily practice of
the pathologist as the list of actionable genetic alteration in solid and hematologic tumors continues to expand. As highlighted
in the USCAP 2012 combined companion meeting of the Association for Molecular Pathology Joint Meeting with American
Society for Clinical Pathology In Coordination With American Society for Investigative Pathology, efforts to develop residency
curricula that will address the educational needs in molecular and genomic pathology for pathologists in training are underway
by some academic institutions and others. These initiatives include the efforts sponsored by the Training Residents in Genomics
(TRIG) working group of the Pathology Residency Directors Section of the Association of Pathology Chairs. Similar educational
needs are evident among practicing pathologists in the community and academic centers, pathology residents and fellows in
institutions that are yet to develop a formal curriculum. A survey of the positive responses from attendees of the sold out
special course titled Basic Principles and Practice of Molecular Pathology in Cancer, which was in its final iteration at USCAP
2012, is very indicative of an urgent and important educational need. The current course proposal intends to build upon and
extend the role that the latter course, that is no longer offered, fulfilled. In fact, the proposal stems from the shared recognition
of the AMP, ASIP and ASCP organizations that sponsored the 2012 combined companion meeting and from the director and
faculty of the previous special course that there is the continuous need to offer educational opportunities to augment medical
knowledge and to address competency deficiencies among the intended target audience, which is, primarily, the group of
anatomic pathologists.
Select the appropriate and most cost-effective molecular and cytogenetic testing for workup of lymphomas and
tissue-based leukemic infiltrates of various types
Assess the technology, limitations and benefits of next generation mutation, array and transcriptional profiling in
lymphomas
Describe the emerging role of exome/whole genome sequencing in the management of patients with lymphoma
8:00 AM
INTRODUCTION
George J. Netto, MD, The Johns Hopkins University, Baltimore, MD
8:10 AM
CURRENT NEXT GENERATION SEQUENCING TECHNOLOGY: A PRIMER TO THE ANATOMIC PATHOLOGIST

Wayne W. Grody, MD, PhD, University of California Los Angeles School of Medicine, Los Angeles, CA
Upon completion of the educational activity, participants should be able to:
Discuss the overall principles of massively parallel sequencing (next generation sequencing) technologies
Illustrate practical examples of NGS based clinical diagnostics and how it will be impacting daily practice of
pathology
8:50 AM
NEXT-GEN SURGICAL PATHOLOGY: NEW OPPORTUNITIES AND CHALLENGES

Karen Kaul, MD, PhD, North Shore University Health System, Evanston, IL
Discuss how the evolving understanding of molecular events underlying cancer development is making molecular
characterization of tumors a necessity for diagnosis and prognostication in the practice of the pathologist
Present an overview of the evolution of molecular testing from single gene or mutation analysis to multiplex
capabilities including next generation sequencing
Discuss the challenges and opportunities associated with the incorporation of these tools into the daily practice of
the pathologist
88
SPECIAL COURSES
9:20 AM
MOLECULAR MARKERS FOR TARGETED LUNG CANCER THERAPY

John Iafrate, MD, PhD, Massachusetts General Hospital, Boston, MA
State the current genetic landscape of lung tumors
Identify the role of genetic testing in guiding targeted therapies in lung cancer
Appreciate the importance of advanced technologies in the future of pathologic assessment of tumors
10:00 AM
BREAK/POSTER SESSION
10:30 AM
MOLECULAR TESTING IN THE MANAGEMENT OF PATIENTS WITH BREAST CANCER:

CURRENT STATUS AND FUTURE DIRECTIONS
Stuart J. Schnitt, MD, Beth Israel Deaconess Medical Center, Boston, MA
Explain the molecular classification of breast cancer and its clinical implications
Review the uses and limitations of currently available molecular prognostic tests for patients with breast cancer
Describe the emerging role of exome /whole genome sequencing in the management of patients with breast cancer
11:00 AM
CLINICAL CYTOGENETIC AND MOLECULAR GENETIC TESTING IN BONE AND SOFT TISSUE TUMORS
Julia A. Bridge, MD, University of Nebraska Medical Center, Omaha, NE
Review sample requirements and handling for RT-PCF, FISH, and cytogenetic analysis as they pertain to evaluating
mesenchymal neoplasms
Describe the advantages and limitations of genetic approaches commonly used in the classification of mesenchymal
neoplasms to include conventional karyotyping, FISH and RT-PCR
Recognize the diagnostic, prognostic, and therapeutic value of molecular markers in mesenchymal neoplasia
11:40 PM
GIST AND MELANOMA: THE KIT CONNECTION AND SO MUCH MORE

Alexander Lazar, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX
Illustrate the techniques and results of molecular testing for gastrointestinal stromal tumor (GIST) and melanoma
Recognize the association between histologic and molecular features in GIST and melanoma
Interpret the emerging role of molecular diagnostics in patient management for GIST and melanoma
12:10 PM
LUNCH BREAK
1:10 PM
MOLECULAR DIAGNOSTICS OF LYMPHOMA: ASSAYS FOR CLASSIFICATION, OUTCOME PREDICTION AND

THERAPY RESPONSE
Dan Jones, MD, PhD, Quest Diagnostics Nichols Institute, Chantilly, VA
Select the appropriate and most cost-effective molecular and cytogenetic testing for workup of lymphomas and
tissue-based leukemic infiltrates of various types
Assess the technology, limitations and benefits of next generation mutation, array and transcriptional profiling in
lymphomas
Describe the emerging role of exome/whole genome sequencing in the management of patients with lymphoma
89
SPECIAL COURSES
1:50 PM
COLORECTAL CANCER: MOLECULAR TESTING FOR THE SURGICAL PATHOLOGIST

Kevin C. Halling, MD, PhD, Mayo Clinic, Rochester, MN
Discuss how MSI and DNA mismatch repair IHC testing and germline DNA mismatch repair gene sequencing are
used to identify, diagnose, and manage patients with HNPCC
Explain how microsatellite instability testing can be used to assess stage II and III CRC patients prognosis and
response to 5FU treatment. Describe how KRAS and BRAF testing can be used to predict response to anti-EGFR
therapies for patients with metastatic colorectal cancer (CRC)
Describe the emerging role of exome/whole genome sequencing in the management of patients with
colorectal cancer
2:30 PM
EMERGING IMMUNOLOGIC BIOMARKERS: PD-L1 AND BEYOND

Janis Taube, MD, PhD, The Johns Hopkins University, Baltimore, MD
Introduce the CTLA-4/CD80 or CD86 and PD-1/PD-L1 checkpoints, including physiologic and pathologic expression
Discuss the association of immunoarchitectural features of the tumor microenvironment and relationship to
response with anti-PD-1/PD-L1 checkpoint blockade
Compare available assays for PD-L1 detection in surgical pathology specimens
3:00 PM
BREAK/POSTER SESSION
3:30 PM
MOLECULAR DIAGNOSTICS OF CNS TUMORS

Arie Perry, MD, University of California San Francisco School of Medicine, San Francisco, CA
Review the most common molecular alterations in CNS tumors
Recognize the association between histologic and molecular features in CNS tumors
Interpret the emerging role of molecular diagnostics in patient management for CNS tumors
4:00 PM
MOLECULAR DIAGNOSTICS OF LEUKEMIA: CLASSIFICATION, OUTCOME PREDICTION AND THERAPY RESPONSE

Daniel Arber, MD, Stanford University, Stanford, CA
Select the appropriate and most cost-effective molecular and cytogenetic testing for workup of leukemia
Assess the technology, limitations and benefits of next generation mutation, array and transcriptional
profiling in leukemia
Describe the emerging role of exome/whole genome sequencing in the management of patients with leukemia
4:30 PM
MOLECULAR DIAGNOSTICS OF THYROID CANCER

Yuri E. Nikiforov, MD, PhD, University of Pittsburgh, UPMC Presbyterian, Pittsburgh, PA
Review the most common molecular alterations in thyroid tumors and their histopathologic correlates
Discuss specimen requirements and techniques for molecular testing of thyroid surgical resections and fine needle
aspiration (FNA) samples
Describe the diagnostic and prognostic application of specific molecular markers in thyroid cancer
5:00 PM
QUESTION PERIOD AND CONCLUDING REMARKS

George J. Netto, MD, The Johns Hopkins University, Baltimore, MD
90
8:00 AM 9:30 AM
CC 304
UNUSUAL AND PROBLEM CASES IN HEAD/NECK CYTOPATHOLOGY

Paul Wakely, Jr., MD, The Ohio State University Wexner Medical Center, Columbus OH
CC 305
PATHOLOGY OF COMMON INTERSTITIAL LUNG DISEASES- THE ESSENTIALS FOR PRACTICING PATHOLOGISTS
Carol Farver, MD, Cleveland Clinic, Cleveland, OH
CC 306
FATTY TUMORS OF THE RETROPERITONEUM

Karen Fritchie, MD, Mayo Clinic, Rochester, NY

10:00 AM 11:30 AM
CC 304
DIAGNOSTIC CHALLENGES IN CUTANEOUS SOFT TISSUE TUMORS

Steven Billings, MD, Cleveland Clinic, Cleveland, OH
CC 305
TUMOR AND TUMOR-LIKE PROLIFERATIONS OF THE SPLEEN

Daniel Arber, MD, Stanford University Medical Center, Stanford, CA
CC 306
SURGICAL PATHOLOGY OF PANCREATOBILIARY TRACT

N. Volkan Adsay, MD, Emory University Hospital, Atlanta, GA

1:30 PM 3:00 PM
CC 304
UNCOMMON TYPES OF INVASIVE MAMMARY CARCINOMA

Timothy DAlfonso, MD, Weill Cornell Medicine, New York, NY
CC 305
LOOK AT THAT BUG! INTERESTING INFECTIOUS DISEASE CASES

Kathleen Montone, MD, University of Pennsylvania, Philadelphia, PA
CC 306
INTERESTING LESIONS IN PATIENTS WITH TESTICULAR NEOPLASMS

Thomas Ulbright, MD, Indiana University School of Medicine, Indianapolis, IN
91
4:30 PM 6:00 PM
CC 304
WHEN AND HOW TO USE MOLECULAR STUDIES IN THE DIAGNOSIS OF MELANOCYTIC LESIONS
Aleodor (Doru) Andea, MD, University of Michigan, Ann Arbor, MI
CC 305
CORRELATION OF TUMOROUS AND NON-TUMOROUS CONDITIONS OF BONES AND JOINTS WITH CLINICAL
IMAGING: HOW DOES THE PATHOLOGY CREATE THE IMAGING FEATURES AND WHAT YOU NEED TO KNOW
ABOUT THEM
Michael Klein, MD, The Hospital for Special Surgery, New York, NY
CC 306
MESENCHYMAL TUMORS OF THE BREAST: A CONCEPTUAL FRAMEWORK FOR THE PRACTICING PATHOLOGIST
Jordi Rowe, MD, Cleveland Clinic, Cleveland, OH

8:00 AM 9:30 AM
CC 304
GLIOMA DIAGNOSIS- 2016: WHAT PATHOLOGISTS NEED TO KNOW

Anthony Yachnis, MD, University of Florida, Gainesville, FL
CC 306
DIAGNOSTIC PITFALLS IN PROSTATE PATHOLOGY

Adeboye O. Osunkoya, MD, Emory University School of Medicine, Atlanta, GA
CC 305
SNEAKY CANCERS AND THEIR MIMICS

Rhonda K. Yantiss, MD, Weill Cornell Medical College, New York, NY

10:00 AM 11:30 AM
CC 304
AN APPROACH TO PROBLEMATIC VASCULAR TUMORS: BENIGN, BORDERLINE, MALIGNANT AND

PSEUDOMALIGNANT
Andrew L. Folpe, MD, Mayo Clinic, Rochester, MN
CC 305
PRACTICAL APPROACH TO PAPILLARY PROBLEMS AND OTHER DILEMMAS IN BREAST CORE NEEDLE BIOPSY
INTERPRETATION
Andrea Dawson, MD, Cleveland Clinic Foundation, Cleveland, OH
CC 306
CRAZY GYNECOLOGIC ACRONYMS (LMP, SBT, STIC, TILT & STIL) A REVIEW OF CHALLENGING UTERINE ADNEXAL
NEOPLASMS
Rob Soslow, MD, Memorial Sloan Kettering Cancer Center, New York, NY
92
1:30 PM 3:00 PM
CC 304
THE WELL DIFFERENTIATED SQUAMOUS CELL CARCINOMA OF HEAD AND NECK: A PRACTICAL APPROACH TO
BIOPSY INTERPRETATION
Olga Gologan, MD, Research Center of the University of Montreal Hospital Center (CRCHUM),
Montreal, QC
CC 305
ENDOMETRIAL PATHOLOGY- SELECTED CHALLENGING AND INFORMATIVE CASES

Charles Quick, MD, University of Arkansas for Medical Sciences, Little Rock, AR
CC 306
SNEAKY GI BIOPSIES WITH HIDDEN DIAGNOSIS: LESSONS IN APPLYING A SYSTEMATIC APPROACH

Dora Lam-Himlin, MD, Mayo Clinic, Scottsdale, AZ

4:30 PM 6:00 PM
CC 304
#GIDEADLIESTCATCH: PRACTICAL APPROACHES TO TRENDING TOPICS IN GI PATHOLOGY

Christina Arnold, MD, The Ohio State University Wexner Medical Center, Columbus, OH
CC 305
FROZEN SECTION IN OVARIAN AND PERITONEAL LESIONS: CHALLENGES AND CONTROVERSIES

Andres Roma, MD, Cleveland Clinic Foundation, Cleveland, OH
CC 306
HIGH RISK NON-MELANOMA SKIN CANCERS: LESSONS FROM UV-DRENCHED NEW ZEALAND
Patrick Emanuel, MD, DML, St. Heliers, Auckland, New Zealand

8:00 AM 9:30 AM
CC 304
AN APPROACH TO INTRAOPERATIVE CONSULTATION IN NEUROPATHOLOGY

Richard Prayson, MD, Cleveland Clinic, Cleveland, OH
CC 305
MEDICAL LIVER BIOPSIES HOW TO STAY OUT OF TROUBLE

John Hart, MD, University of Chicago, Chicago, IL
CC 306
DIAGNOSTIC ISSUES IN DLBCL: A 2016 PERSPECTIVE

Megan Lim, MD, University of Pennsylvania, Philadelphia, PA
93
10:00 AM 11:30 AM
CC 304
TWISTS IN LIVER PATHOLOGY: UNSUSPECTED FINDINGS THAT CHANGED EVERYTHING

Oyedele Adeyi, MD, Toronto General Hospital, Toronto, ON
CC 306
DIAGNOSTIC DILEMMAS IN SKIN ADNEXAL TUMOUR PATHOLOGY

Thomas Brenn, MD, Western General Hospital, Scotland
CC 305
MESENCHYMAL TUMORS OF THE UTERUS: AN UPDATE IN CLASSIFICATION, IMMUNOSTAINS, AND

DIFFERENTIAL DIAGNOSIS
Joseph Rabban, MD, University of California, San Francisco, CA

1:00 PM 2:30 PM
CC 304
PITFALLS IN EFFUSION CYTOLOGY: THE USUAL, THE UNUSUAL AND THE MIMICKERS
Claire Michael, MD, Case Western Reserve University, Cleveland, OH
CC 305
GI BIOPSY INTERPRETATION IN MODERN MEDICINE: DRUGS, DYSPLASIA AND OTHER DILEMMAS

Marie Robert, MD, Yale University School of Medicine, New Haven, CT
CC 306
DONT BE DUPED! LOOK-ALIKES IN GENITOURINARY PATHOLOGY

Brian Robinson, MD, Weill Cornell Medical College, New York, NY

3:00 PM 4:30 PM
CC 304
APPLICATION OF THE PARIS SYSTEM FOR REPORTING URINARY CYTOPATHOLOGY ON LIQUID-BASED

PREPARATIONS
Rana Hoda, MD, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY
CC 305
COMMON DIAGNOSTIC DILEMMAS IN URINARY BLADDER PATHOLOGY

Qihui (Jim) Zhai, MD, Mayo Clinic, Jacksonville, FL
CC 306
NEOPLASTIC LUNG DISEASE

Lucian Chirieac, MD, Brigham and Womens Hospital, Boston, MA
94
Hot Topics in Pathology Hematopathology

12:00 PM 1:00 PM
CC 605
MODERATOR:
Adam Bagg, MD, University of Pennsylvania, Philadelphia, PA
PANELISTS:
Ahmet Dogan, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY
Lisa Rimsza, MD, Mayo Clinic, Scottsdale, AZ
Steven Swerdlow, MD, University of Pittsburgh, Pittsburgh, PA
Hot Topics in Pathology Molecular

12:00 PM 1:00 PM
CC 605
MODERATOR:
Dan Jones, MD, PhD, The Ohio State University, Columbus, OH
PANELISTS:
Dara L. Aisner, MD, PhD, University of Colorado Anshutz Medical Campus, Aurora, CO
Nikoletta Sidiropoulas, MD, The University of Vermont, Burlington, VT
Carl Morrison, MD, Roswell Park Cancer Institute, Buffalo, NY
Colin Pritchard, MD, PhD, University of Washington, Seattle, WA
Hot Topics in Pathology Genitourinary

12:00 PM 1:00 PM
CC 605
MODERATOR:
Peter Humphrey, MD, PhD, Yale University School of Medicine, New Haven, CT
PANELISTS:
Donna Hansel, MD, PhD, University of California San Diego, La Jolla, CA

Adebowale Adeniran, MD, Yale University School of Medicine, New Haven, CT
Cristina Magi-Galluzzi, MD, PhD, Cleveland Clinic, Cleveland, OH
95
Hot Topics in Pathology Gastrointestinal

12:00 PM 1:00 PM
CC 605
MODERATOR:
Liz Montgomery, MD, The Johns Hopkins Medical Institutions, Baltimore, MD
PANELISTS:
Rhonda Yantiss, MD, Weill Cornell Medical College, New York, NY

Dora Lam-Himlin, MD, Mayo Clinic, Scottsdale, AZ
Michael Vieth, MD, Institut fuer Pathologie, Bayreuth, Germany
96
PRACTICE CHANGERS
9:45 AM- 10:40 AM
CC SKY BRIDGE 4D
9:45 AM
PATHOLOGISTS IN GROSS ANATOMY

POD # 1
Charles M. Quick, MD, University of Arkansas for Medical Sciences, Little Rock, AR
9:45 AM
ADVERSE EVENTS DISCLOSURE & MANAGEMENT FOR PATHOLOGISTS: WHERE DO WE STAND NOW?
POD # 2
Yael Kushner Heher, MD, MPH, FRCPC, Beth Israel Deaconess Medical Center, Boston, MA
10:20 AM
REPLACING KARYOTYPING WITH SNPM

POD # 1
Ravindra Kolhe, MD, PhD, Georgia Regents University, Augusta, GA
10:20 AM
PROSTATE BIOPSY BILLING

POD # 2
Debra Zynger, MD, The Ohio State University Wexner Medical Center, Columbus ,OH

3:15 PM-4:10 PM
CC SKY BRIDGE 4D
3:15 PM
FACEBOOK & TWITTER: HOW PATHOLOGISTS CAN CHANGE THEIR PRACTICE WITH SOCIAL MEDIA
POD # 1
Jerad M. Gardner, MD, University of Arkansas for Medical Sciences, Little Rock, AR
3:15 PM
WIKIS: A GATEWAY TO QUICK PATHOLOGY INFORMATION & ONLINE COLLABORATION

POD # 2
Michael Bonert, MD, University of Calgary, Calgary, AB
3:50 PM
HEALTH INFORMATION TECHNOLOGY & CLINICAL INFORMATICS

POD # 1
Jeffrey W. Prichard, DO, Geisinger Medical Laboratories, Danville, PA
3:50 PM
WORKFORCE ISSUES IN PATHOLOGY & LABORATORY MEDICINE

POD # 2
Jennifer Hunt, MD, University of Arkansas for Medical Sciences, Little Rock, AR
97
PRACTICE CHANGERS
TUESDAY MARCH 15, 2016
9:45 AM-10:40 AM
CC SKY BRIDGE 4D
9:45 AM
3D PRINTED MICROSCOPY & ALTERNATIVES TO GLASS SLIDE PATHOLOGY

POD # 1
Hany Osman, MD, Indiana University School of Medicine, Indianapolis, IN
9:45 AM
NOVEL SIMPLE METHOD OF FORMALIN FIXED PARAFFIN EMBEDDED CELL BLOCK PREPARATION OF
CYTOLOGY SPECIMENS
POD # 2
Kathryn Lindsey, MD, Medical University of South Carolina, Charleston, SC
10:20 AM
IMPACT OF GENOMICS & PERSONALIZED MEDICINE

POD # 1
John Pfeifer, MD, Washington University, Saint Louis, MO
10:20 AM
DISCLOSING HARMFUL PATHOLOGY ERRORS TO COLLEAGUES

POD # 2
Suzanne M. Dintzis, MD, PhD, University of Washington Medical Center, Seattle, WA
SPECIAL LECTURES
MONDAY, MARCH 14
4:30 PM - 5:30 PM
CC HALL 4 E
NATHAN KAUFMAN TIMELY TOPICS LECTURE "RIFFS ON FUTURE PATH: THE FALL OF PAPER, THE RISE OF SMARTIES AND THE QUEST FOR SELFIES"
Eric F. Glassy, MD, Affiliated Pathologists Medical Group, Torrance, CA
MONDAY, MARCH 14
6:15 PM - 7:00 PM
CC HALL 4 E
HUT LUNG: A POIGNANT PORTRAIT

Thomas V. Colby, MD, Mayo Clinic, Scottsdale, AZ
Annie Griffiths, National Geographic Magazine International Photojournalist
TUESDAY, MARCH 15
5:00 PM - 5:50 PM
CC HALL 4 E
MAUDE ABBOTT LECTURE - THE ESSENTIAL ROLE OF THE PATHOLOGIST IN GUIDING MANAGEMENT OF
PATIENTS WITH BREAST DISEASE: FROM MORPHOLOGY TO MOLECULES
Stuart J. Schnitt, MD, Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA
98
2016
LONG COURSE
USCAP AMBASSADORS:
TAKING OUTREACH TO NEXT GENERATION CONNECTIVITY
Dr. Gerardo Vides Almonacid (left) is the first international Ambassador and Dr. Jerad Gardner is the first domestic Ambassador.
The re-imagined Ambassador Program is designed to achieve connectivity with future

generations of pathologists. Engagement of pathologists-in-training as members for life in
USCAP is critical to their career development and to becoming better pathologists.
Ambassadors function to communicate to pathologists-in-training the value of membership in
USCAP, engaging their interest, participation and loyalty.
USCAP West
For more information or to apply

for Ambassadorship, please contact us
500 South Palm Canyon Drive, Suite 321

Palm Springs, CA 92264
Phone | 760.327.6777
Fax | 760.327.6477
deborah@uscap.org
www.USCAP.org
LONG COURSE
Diagnosing Distinctive Lesions of the Head and Neck

8:00 AM- 5:30 PM
CC BALLROOM 6 A/B/C
COURSE DIRECTOR: Lester D.R. Thompson, MD, Woodland Hills Medical Center, Woodland Hills, CA
COURSE DESCRIPTION: There has been a remarkable increase in the knowledge about tumors, tumor development and tumor
genetics in the past 15 years since the last long course devoted to head and neck pathology. Many new entities have been
described, with their diagnostic criteria and ancillary supporting findings elucidated. The differential diagnostic considerations
of the head and neck are broad, due in part to the wide diversity of organs, many tissue types, and the often very limited size
of biopsy samples. The differences between benign, reactive lesions and lethal malignancies may be quite subtle. The primary
goal of this course is to present practical, common, every-day cases across a broad spectrum of anatomic sites, discussing the
development of differential diagnoses based on clinical and imaging findings, histologic features and additional techniques
that allow for an appropriate diagnosis to be reached. These diagnoses will be put in the context of management and outcome
differences, highlighting entities that provoke a broad differential diagnosis. The major topics will include sinonasal tract
tumors, newly described and basaloid salivary gland tumors, oropharyngeal carcinomas, lichenoid lesions of the oral cavity,
the viral-associated tumors of the nasopharynx, odontogenic cysts and tumors, squamous lesions of the larynx, with a focused
discussion on how and when to use molecular and genetic techniques. Information to be included in the 2016-17 WHO
classification will be discussed. The lectures are intended for general surgical pathologists, oral pathologists and pathology
residents and fellows.
8:00 AM
AN APPROACH TO DIAGNOSING SMALL SAMPLES OF ROUND BLUE CELL TUMORS OF THE SINONASAL TRACT
Lester D.R. Thompson, MD, Woodland Hills Medical Center, Woodland Hills, CA
Develop a clinical, imaging, and histolopathology differential diagnosis for small round blue cell lesions of the
sinonasal tract
Understand the fundamental treatment differences between the various diagnoses and how to reach a diagnostic
category based on selecting special studies to aid in separation
8:45 AM
NEWLY DESCRIBED SALIVARY GLAND TUMORS

Alena Skalova, MD, PhD, Charles University in Prague, Czech Republic
Recognize the characteristic histologic, immunohistochemical and genetic features of diagnostically challenging and
newly described tumor entities in salivary gland pathology; in particular mammary analogue secretory carcinoma
(MASC), cribiform cystadenocarcinoma of tongue and other minor salivary glands (CATS), and sclerosing polycystic
adenoma (SPA)
Describe the differential diagnosis for those entities, emphasizing the benign and low grade malignant possibilities.
Discussion of each entity will include histopathological features, differential diagnosis, utility of ancillary studies,
impact on surveillance and management, and insight into molecular pathogenesis
9:30 AM
BREAK
10:30 AM HPV-RELATED OROPHARYNGEAL CARCINOMAS- CATCH ME IF YOU CAN!

James Lewis, Jr., MD, Vanderbilt University Medical Center, Nashville, TN
Learn the numerous morphologic patterns that HPV-related oropharyngeal carcinomas can display, in the primary
and in the neck, and how to recognize them
Understand the clinical significance for diagnosing these tumors, including the significance of
morphologic subtypes
11:15 AM ORAL LICHENOID LESIONS: DISTINGUISHING THE BENIGN FROM THE DEADLY
Susan Muller, DMD, Emory University Medical Center, Atlanta, GA
Distinguish the pathologic findings of oral lichenoid lesions from oral lichen planus
Recognize the diagnostic criteria of premalignant oral lichen planus
99
LONG COURSE
12:00 PM LUNCH
1:00 PM
VIRUS-ASSOCIATED NEOPLASMS OF THE NASOPHARYNX AND SINONASAL TRACT: DIAGNOSTIC ISSUES

John K-C. Chan, MD, Queen Elizabeth Hospital, Hong Kong
Be familiar with the problems in rendering a histologic diagnosis of nasopharyngeal carcinoma, and in particular the
mimickers
Be familiar with the problems in diagnosing extra nodal NK/T-cell lymphoma, and the differential diagnosis
1:30 PM
BASALOID/ BLUE SALIVARY GLAND TUMORS

Raja R. Seethala, MD, UPMC Presbyterian, Pittsburgh, PA
Apply an algorithmic approach incorporating tumor border, stromal characteristics and cell types to distinguish
between various basaloid salivary gland tumors
Use morphologic and immunohistochemical findings to easily delineate polymorphous low grade adenocarcinoma
from adenoid cystic carcinoma
2:00 PM
HOW TO DIAGNOSE THE MOST COMMON ODONTOGENIC AND OSSEOUS LESIONS OF THE JAW
Robert Robinson, MD, PhD, University of Iowa Hospitals and Clinics, Iowa City, IA
Discriminate between periapical cyst, dentigerous cyst and keratocystic odontogenic tumor utilizing histologic and
radiographic criteria
Describe the clinical, radiographic and histologic differences between fibro-osseous lesions of the jaw
2:30 PM
USING MOLECULAR ASSAYS TO RESOLVE CHALLENGING DIFFERENTIALS AND TREATMENT

DECISIONS IN HEAD AND NECK CANCERS
Jennifer L. Hunt, MD, University of Arkansas for Medical Sciences, Little Rock, AR
Understand the benefits and limitations for molecular testing in head and neck cancers
Be able to utilize molecular assays to resolve challenging differential diagnosis in head and neck cancers
3:00 PM
BREAK
4:15 PM
SQUAMOUS CELL CARCINOMA OF THE UPPER AERODIGESTIVE TRACT: PREMALIGNANT LESIONS, INVASIVE
CARCINOMA AND SELECT VARIANTS
Bruce M. Wenig, MD, The Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel Medical Center,
New York, NY
Identify the diagnostic criteria and clinical relevance for keratinizing intraepithelial dysplasia of the upper
aerodigestive tract
Recognize the features of invasive squamous cell carcinoma and distinguish it from look-alike benign
Identify the clinical and pathologic features for select variants of squamous cell carcinoma
5:00 PM
WRAP- UP
Lester D.R. Thompson, MD, Woodland Hills Medical Center, Woodland Hills, CA
COMPILATION OF THE COURSE FOR THE DAY
100
2016
SHORT COURSES
2016
Diagnostic
Pathology Update
Pragmatic Approaches to Daily Practice
July 10-15
Snow King Lodge | Jackson Hole, WY
REGISTRATION
NOW OPEN
Practical Pathology
Seminars
#USCAP2016
2016
April 28 - May 1
New Orleans, Louisiana
Sheraton New Orleans Hotel
REGISTRATION
NOW OPEN
REGISTRATION
NOW OPEN
www.USCAP.org
SHORT COURSES
8:00 AM 12:00 PM
Room locations are printed on the Short Course Ticket
A COFFEE BREAK IS SCHEDULED FOR 9:30 AM - 10:30 AM
* Indicates this is a new course
++ Indicates this is an ending course
05
THE NERVE OF SOME NERVE SHEATH TUMORS! A PRACTICAL APPROACH TO COMMON PROBLEMS IN
SURGICAL PATHOLOGY*
Caterina Giannini, MD, PhD, Mayo Clinic College of Medicine, Rochester, MN
Fausto J. Rodriguez, MD, The Johns Hopkins University, Baltimore, MD
Andrew Folpe, MD, Mayo Clinic, Rochester, MN
11
CONTEMPORARY CARDIOVASCULAR PATHOLOGY FROM BENCH TO BEDSIDE: HOW EMERGING ANCILLARY TOOLS
ARE TRANSFORMING THE FIELD*
Joseph J. Maleszewski, MD, Mayo Clinic, Rochester, MN
Peter T. Lin, MD, Mayo Clinic, Rochester, MN
22
PRACTICAL GUIDE TO ERROR REDUCTION, EFFECTIVE COMMUNICATION, AND DAMAGE CONTROL IN

SURGICAL PATHOLOGY++
Carolyn Mies, MD, University of Pennsylvania, Philadelphia, PA
Raouf E. Nakhleh, MD, Mayo Clinic, Jacksonville, FL
25
COLORECTAL DYSPLASIA IN IBD: DIAGNOSIS, IMPLICATIONS, AND PITFALLS*

Alexandros D. Polydorides, MD, PhD, Icahn School of Medicine at Mount Sinai, New York, NY
Steven Itzkowitz, MD, Icahn School of Medicine at Mount Sinai, New York, NY
Noam Harpaz, MD, PhD, Icahn School of Medicine at Mount Sinai, New York, NY
30
DIAGNOSIS OF RENAL NEOPLASMS USING INTEGRATED HISTOLOGIC, CYTOLOGIC AND MOLECULAR

APPROACHES IN THE ERA OF PRECISION MEDICINE*
Christopher Przybycin, MD, Cleveland Clinic, Cleveland, OH
Jordan Reynolds, MD, Cleveland Clinic, Cleveland, OH
Ming Zhou, MD, PhD, New York University, New York, NY
31
DOING MORE WITH LESS: A CYTOLOGY-HISTOLOGY CORRELATION OF PULMONARY MASSES

Michele Hirsch, MD, PhD, Brigham and Women's Hospital, Boston, MA
Donna E. Hansel, MD, PhD, University of California at San Diego, La Jolla, CA
Mahul B. Amin, MD, Cedar-Sinai Medical Center, Los Angeles, CA
36
INHERITED GYNECOLOGIC CANCER SYNDROMES PATHOLOGICALLY AND CLINICALLY BASED RISK ASSESSMENT
AND GENETIC COUNSELING: WHAT EVERY PRACTICING PATHOLOGIST SHOULD KNOW++
Teri Longacre, MD, Stanford University Medical Center, Stanford, CA
Robert Soslow, MD, Memorial Sloan Kettering Cancer Center, New York, NY
(Course Material Contributed by Angela Arnold, MS, CGC, Memorial Sloan Kettering Cancer Center, New York, NY)
45
PROBLEMATIC DUCTAL PROLIFERATIONS OF THE BREAST

Melinda F. Lerwill, MD, Massachusetts General Hospital, Boston, MA
Kimberly H. Allison, MD, Stanford University, Stanford, CA
Kristin C. Jensen, MD, Stanford University, Stanford, CA
55
A PRACTICAL APPROACH TO INFECTIOUS DISEASE PATHOLOGY

Bobbi S. Pritt, MD, MSc, Mayo Clinic, Rochester, MN
101
SHORT COURSES
1:30 PM 5:30 PM
A COFFEE BREAK IS SCHEDULED FOR 3:00 PM - 4 :00 PM
04
AUTOPSY IN THE 21ST CENTURY: AN UPDATE FOR PATHOLOGISTS PERFORMING HOSPITAL AUTOPSIES TODAY*
Jody E. Hooper, MD, The Johns Hopkins University, Baltimore, MD
Alex K. Williamson, MD, North Shore-LIJ Health System, Hofstra North Shore-LIJ School of Medicine,
Long Island, NY
18
DIAGNOSTIC CRITERIA OF THE PARIS SYSTEM FOR REPORTING URINARY CYTOLOGY*

Dorothy L. Rosenthal, MD, FIAC, The Johns Hopkins University, Baltimore, MD
Christopher J. VandenBussche, MD, The Johns Hopkins University, Baltimore, MD
Matthew T. Olson, MD, The Johns Hopkins University, Baltimore, MD
Gliz A. Barkan, MD, FIAC, Loyola University Medical Center, Maywood, IL
Eva M. Wojcik, MD, Loyola University Medical Center, Maywood, IL
33
OVARIAN CARCINOMA: AN UPDATE ON HISTOTYPE DIAGNOSIS, PRIMARY SITE ASSIGNMENT, AND STAGING*
C. Blake Gilks, MD, University of British Columbia, Vancouver, BC
M. Kbel, MD, University of Calgary, Calgary, AB
Naveena Singh, MD, FRCPath, Barts Health NHS Trust, London, UK
39
BONE MARROW MANIFESTATIONS OF SYSTEMIC DISEASE*

Dita Gratzinger, MD, PhD, Stanford Medicine, Stanford, CA
David Czuchlewski, MD, University of New Mexico, Albuquerque, NM
C. Tracy George, MD, University of New Mexico, Albuquerque, NM
43
MEDICAL LIVER BIOPSIES: TRANSLATING MORPHOLOGIC PATTERNS INTO MEANINGFUL PATHOLOGY REPORTS*
Michael Torbenson, MD, Mayo Clinic, Rochester, MN
59
OCCUPATIONALLY RELATED PLEURAL AND PULMONARY DISORDERS IN THE 21ST CENTURY: CHALLENGES,
PITFALLS AND NO-NOS*
Victor L. Roggli, MD, Duke University Medical Center, Durham NC
Thomas A. Sporn, MD, Duke University Medical Center, Durham NC
Henry D. Tazelaar, MD, Mayo Clinic, Scottsdale, AZ
62
ALGORITHMIC APPROACH TO DIAGNOSIS OF INFLAMMATORY DISORDERS OF THE GI TRACT++

Amitabh Srivastava, MD, Brigham and Womens Hospital, Boston, MA
Robert D. Odze, MD, Brigham and Womens Hospital, Boston, MA
Gregory Y. Lauwers, MD, Massachusetts General Hospital, Boston, MA
102
SHORT COURSES
8:00 AM 11:30 AM
06
DIAGNOSTIC DILEMMA IN NEOPLASTIC AND NON-NEOPLASTIC BONE PATHOLOGY*

John D. Reith, MD, University of Florida College of Medicine, Gainesville, FL
Gunnlaugur Petur Nielsen, MD, Massachusetts General Hospital, Harvard Medical School. Boston, MA
Scott E. Kilpatrick, MD, Forsyth Regional Medical Center, Winston-Salem, NC
08
THE PATHOLOGISTS ROLE IN GUIDING BREAST CANCER TREATMENT IN THE ERA OF NEOADJUVANT THERAPY*
Veeryle Bossuyt, MD, Yale University, New Haven, CT
Elena Provenzano, MD, Addenbrookes Hospital, Cambridge, UK
W. Fraser Symmans, MD, The University of Texas MD Anderson Cancer Center, Houston, TX
10
DIAGNOSTIC CHALLENGES IN PROSTATE PATHOLOGY

Adeboye O. Osunkoya, MD, Emory University School of Medicine, Atlanta, GA
Cristina Magi-Galluzzi, MD, PhD, Lerner College of Medicine, Cleveland Clinic, Cleveland, OH
16
PATHOLOGY OF THE PREVIABLE FETUS AND STILLBORN INFANT FOR THE GENERAL PATHOLOGIST++
Debra S. Heller, MD, Rutgers New Jersey Medical School, Newark, NJ
Ona M. Faye-Petersen, MD, University of Alabama at Birmingham, Birmingham, AL
20
CHALLENGING CASES IN THYROID CYTOPATHOLOGY: HOW CAN ULTRASOUND FINDINGS AND MOLECULAR
TESTS HELP?
Helen H. Wang, MD, DrPH, Beth Israel Deaconess Medical Center, Boston, MA
Pamela Hartzband, MD, Beth Israel Deaconess Medical Center, Boston, MA
Michiya Nishino, MD, PhD, Beth Israel Deaconess Medical Center, Boston, MA
21
IMPORTANT ASPECTS OF SKIN ADNEXAL TUMOR PATHOLOGY++

Thomas Brenn, MD, PhD, FRCPath, Western General Hospital and The University of Edinburgh, Edinburgh, UK
Alexander Lazar, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX
Melissa Pulitzer, MD, Memorial Sloan Kettering Cancer Center, New York, NY
Jaime Eduardo Calonje, MD, DipRCPath, St. Johns Institute of Dermatology, St. Thomas Hospital, London, UK
28
PULMONARY INFECTIONS: MORPHOLOGIC AND MOLECULAR TIPS FOR THE SURGICAL PATHOLOGIST
Sanjay Mukhopadhyay, MD, Cleveland Clinic, Cleveland, OH
Gary Procop, MD, Cleveland Clinic, Cleveland, OH
Carol Farver, MD, Cleveland Clinic, Cleveland, OH
32
PREDICTIVE BIOMARKERS: LESSONS FROM CLINICAL TRIALS

Sunil S. Badve, MD, Indiana University, Indianapolis, IN
Josef Ruschoff, MD, Targos Molecular Pathology GmbH, Kassel, Germany
Reinhard Buttner, MD, University of Cologne and Center for Integrated Oncology, Cologne, Germany
37
HEAD AND NECK PATHOLOGY IN THE HUMAN PAPILLOMAVIRUS ERA: A CRASH COURSE*
James S. Lewis, Jr., MD, Vanderbilt University, Nashville, TN
Justin A. Bishop, MD, The Johns Hopkins University, Baltimore, MD
Rebecca D. Chernock, MD, Washington University, St. Louis, MO
103
SHORT COURSES
40
HEMATOLYMPHOID LESIONS AT THE BORDERLINE BETWEEN BENIGN AND MALIGNANT FINDING YOUR WAY OUT
OF UNCERTAINTY*
Eric D. Hsi, MD, Cleveland Clinic, Cleveland, OH
Carlos E. Bueso-Ramos, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX
Megan O. Nakashima, MD, Cleveland Clinic, Cleveland, OH
46
OPEN CONFESSION IS GOOD FOR THE SOUL: MEMORABLE MISTAKES AND WHAT WEVE LEARNED
Rhonda K. Yantiss, MD, Weill Cornell Medical College, New York, NY
50
CLINICAL REALITIES OF NEXT-GENERATION SEQUENCING*

John D. Pfeifer, MD, PhD, Washington University School of Medicine, St. Louis, MO
Nikoletta Sidiropoulos, MD, University of Vermont College of Medicine, Burlington, VT
Jennifer Sehn, MD, Washington University School of Medicine, St. Louis, MO
Eric Duncavage, MD, Washington University School of Medicine, St. Louis, MO
56
NERVE AND MUSCLE BIOPSIES: A PATIENT-CENTERED APPROACH FOR THE GENERAL PATHOLOGIST*
Peter Pytel, MD, University of Chicago, Chicago, IL
Douglas Anthony, MD, PhD, Brown University, Providence, RI
104
SHORT COURSES
1:00 PM 4:30 PM
A COFFEE BREAK IS SCHEDULED FOR 2:30 PM - 3:00 PM
03
USES AND LIMITATIONS OF IMMUNOHISTOCHEMISTRY AND OTHER ADJUNCTIVE STUDIES

IN BREAST PATHOLOGY
Stuart J. Schnitt, MD, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA
Laura C. Collins, MD, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA
07
ITS NOT AS BAD AS IT LOOKS: PAIRS OF LOOK-ALIKE LESIONS IN SURGICAL NEUROPATHOLOGY

Bette K. Kleinschmidt-DeMasters, MD, University of Colorado, Denver, CO
Richard A. Prayson, MD, Cleveland Clinic, Cleveland, OH
12
MEDICAL RENAL PATHOLOGY FOR THE GENERAL SURGICAL PATHOLOGIST

Anthony Chang, MD, University of Chicago Medical Center, Chicago, IL
Vanesa Bijol, MD, Brigham and Womens Hospital, Boston, MA
14
BIOPSIES OF MEDIASTINAL LESIONS: CHALLENGES, PITFALLS AND PRACTICAL TIPS

Anja C. Roden, MD, Mayo Clinic, Rochester, MN
Marie Christine Aubry, MD, Mayo Clinic, Rochester, MN
17
TRAPDOORS IN TESTICULAR PATHOLOGY++

Daniel M. Berney, MBBChir, MA, FRCPath, Barts and The London School of Medicine and Dentistry Queen Mary
University, London, UK
Muhammed T. Idrees, MD, Indiana University Medical Center, Indianapolis, IN
19
MELANOCYTIC LESIONS: A PRACTICAL APPROACH TO DIAGNOSIS, ADJUNCTIVE MOLECULAR STUDIES AND

APPROPRIATE THERAPY/MANAGEMENT*
Daniela Massi, MD, University of Florence, Florence, IT
Martin C. Mihm, Jr., MD, Brigham and Womens Hospital, Boston, MA
Richard A Scolyer, MD, Royal Prince Alfred Hospital, Sydney, AU
23
SURGICAL AND MOLECULAR PATHOLOGY OF THYROID NEOPLASIA*

Thomas J. Giordano, MD, PhD, University of Michigan Health System, Ann Arbor, MI
Bruce M. Wenig, MD, Mount Sinai Health System, New York, NY
26
COLONIC POLYPS-DAILY PROBLEMS ONLY PATHOLOGISTS UNDERSTAND*

David F. Schaeffer, MD, University of British Columbia, Vancouver, BC
Hector Li-Chang, MD, University of British Columbia, Vancouver, BC
Rish K. Pai, MD, Mayo Clinic, Scottsdale, AZ
35
GOING WITH THE FLOW OF BILE: AN UPDATE ON TUMORS OF THE LIVER, BILE DUCTS AND GALLBLADDER
N. Volkan Adsay, MD, Emory University, Atlanta, GA
Alyssa M. Krasinskas, MD, Emory University, Atlanta, GA
Matthew M. Yeh, MD, PhD, University of Washington, Seattle, WA
40
HEMATOLYMPHOID LESIONS AT THE BORDERLINE BETWEEN BENIGN AND MALIGNANT FINDING YOUR WAY OUT
OF UNCERTAINTY*
Eric D. Hsi, Cleveland Clinic, Cleveland, OH
Carlos E. Bueso-Ramos, The University of Texas MD Anderson Cancer Center, Houston, TX
Megan O. Nakashima, Cleveland Clinic, Cleveland, OH
105
SHORT COURSES
1:00 PM 4:30 PM
...continued
41
EXPANDING THE DIFFERENTIAL DIAGNOSIS IN UROLOGIC PATHOLOGY: CONTROVERSIES AND NEW ENTITIES
Michele Hirsch, MD, PhD, Brigham and Women's Hospital, Boston, MA
Donna E. Hansel, MD, PhD, University of California at San Diego, La Jolla, CA
Mahul B. Amin, MD, Cedar-Sinai Medical Center, Los Angeles, CA
42
DIFFICULT DIAGNOSES IN PEDIATRIC HEMATOPATHOLOGY*

Richard L. McMasters, MD, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH
Dehua Wang, MD, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH
Robert B. Lorsbach, MD, PhD, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH
47
LATE INTRAUTERINE DEMISE: PLACENTAL AND FETAL POSTMORTEM PATHOLOGY

Theonia K. Boyd, MD, Boston Childrens Hospital, Brigham and Womens Hospital and Harvard Medical School,
Boston, MA
Drucilla J. Roberts, MD, Massachusetts General Hospital and Harvard Medical School, Boston, MA
54
PRACTICAL INFORMATICS SOLUTIONS FOR ANATOMIC PATHOLOGY QUALITY MANAGEMENT

Jeffrey Prichard, DO, Geisinger Health System, Danville, PA
Steven Meschter, MD, Geisinger Health System, Danville, PA
106
SHORT COURSES
FRIDAY, MARCH 18, 2016 8:00 AM 11:30 AM

02
STRIVING FOR EXCELLENCE: LEVERAGING CLIA ACCREDITATION, ISO 15189 AND LEAN FOR ANATOMIC AND
MOLECULAR PATHOLOGY LABORATORIES++
Richard J. Zarbo, MD, Henry Ford Health System, Detroit, MI
Gaurav Sharma, MD, Henry Ford Health System, Detroit, MI
09
RECENT DEVELOPMENTS IN HEART AND LUNG TRANSPLANT PATHOLOGY: NAVIGATING THE SHIFTING SANDS
Dylan V. Miller, MD, Intermountain Medical Center and University of Utah, Salt Lake City, UT
Gerald J. Berry, MD, Stanford University, Stanford, CA
Henry D. Tazelaar, MD, Mayo Clinic- Arizona, Scottsdale, AZ
John P. Veinot, MD, The Ottawa Hospital, Ottawa, ON
15
PRACTICAL OCULAR PATHOLOGY FOR PATHOLOGISTS

Nora V. Laver, MD, New England Eye Center, Tufts University and Tufts Medical Center, Boston, MA
Anat Stemmer-Rachamimov, MD, Massachusetts General Hospital, Boston, MA
Charles S. Specht, MD, Penn State Hershey Medical Center, Hershey, PA
24
BACTERIAL INFECTION AND THE KIDNEY: DIAGNOSTIC DIFFICULTIES IN KIDNEY BIOPSIES

Anjali A. Satoskar, MD, The Ohio State University Wexner Medical Center, Columbus, OH
Tibor Nadasdy, MD, PhD, The Ohio State University Wexner Medical Center, Columbus, OH
27
A PATTERN-BASED APPROACH TO THE DIAGNOSIS OF SOFT TISSUE TUMORS

Leona A. Doyle, MD, Brigham and Womens Hospital, Harvard Medical School, Boston, MA
Jason L. Hornick, MD, PhD, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
29
PATHOLOGY IN THE ERA OF GENOMIC MEDICINE: NEW FRONTIERS AND NEW CHALLENGES++
George M. Yousef, MD, PhD, FRCPC, University of Toronto, ON
George Netto, MD, The Johns Hopkins University School of Medicine, Baltimore, MD
34
NON-INVASIVE NIGHTMARES IN BREAST PATHOLOGY

Timothy W. Jacobs, MD, Virginia Mason Medical Center, Seattle, WA
Yunn-Yi Chen, MD, PhD, University of California, San Francisco, CA
44
ENDOCRINE TUMOR BOARD: CLINICOPATHOLOGICAL CORRELATIONS IN ENDOCRINE PATHOLOGY++

Ozgur Mete, MD, University Health Network, Toronto, ON
Sylvia L. Asa, MD, PhD, University Health Network, Toronto, ON
Shereen Ezzat, MD, University Health Network, Toronto, ON
52
DIFFICULT ENDOMETRIAL BIOPSIES: MALIGNANCY, MIMICS, MOLECULAR AND MISHAPS

Bojana Djordjevic, MD, University of Ottawa, Ottawa, ON
Anais Malpica, MD, The University of Texas MD Anderson Cancer Center, Houston, TX
Russell Broaddus, MD, PhD, MD Anderson Cancer Center, Houston, TX
53
PROBLEMS, PITFALLS AND AN INTEGRATED APPROACH TO LYMPHOPROLIFERATIVE DISORDERS IN THE SKIN++

Melissa Pulitzer, MD, Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell
University, New York, NY
John Goodlad, MD, Western General Hospital, The University of Edinburgh, Edinburgh, UK
107
SHORT COURSES
FRIDAY, MARCH 18, 2016 1:00 PM 4:30 PM
A COFFEE BREAK IS SCHEDULED FOR 2:30 PM - 3:00 PM

38
COMMON DIAGNOSTIC DILEMMAS IN HEAD AND NECK PATHOLOGY: PITFALLS, PEARLS AND CLINICAL INSIGHTS*
Qihui Jim Zhai, MD, Mayo Clinic, Jacksonville, FL
John Casler, MD, Mayo Clinic, Jacksonville, FL
48
PROBLEMATIC AREAS IN THE PATHOLOGY OF THE UTERINE CERVIX

Esther Oliva, MD, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Carmen Tornos, MD, Stony Brook University Hospital, Stony Brook University, NY
49
INTERSTITIAL LUNG DISEASE: WHAT YOUR CLINICIAN WANTS TO KNOW++

Kristen L. Veraldi, MD, PhD, University of Pittsburgh, PA
Frank Schneider, MD, University of Pittsburgh, Pittsburgh, PA
51
HIGH YIELD UROLOGICAL PATHOLOGY: COMMON AND IMPORTANT DIAGNOSES NOT TO BE

MISSED IN DAILY PRACTICE++
Ming Zhou, MD, PhD, New York University Medical Center, New York, NY
Kiril Trpkov, MD, University of Calgary, Calgary, AB
Rajal B. Shah, MD, Miraca Life Sciences, Irving, TX
57
DIAGNOSIS OF CHALLENGING PLASMA CELL NEOPLASMS++

Robert B. Lorsbach, MD, PhD, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH
Marwan A. Yared, MD, Baylor College of Medicine, Houston, TX
58
SECOND OPINIONS AND DISCREPANCIES IN FINE NEEDLE ASPIRATION (FNA) CYTOLOGY: AN INTERACTIVE
APPROACH TO DIAGNOSTIC WORK-UP++
Tarik M. Elsheikh, MD, Cleveland Clinic, Cleveland, OH
Syed A. Hoda, MD, New York Hospital Cornell Medical Center, New York, NY
Rana S. Hoda, MD, New York Presbyterian Hospital, New York, NY
60
PRACTICAL STATISTICS FOR PATHOLOGISTS: CASE-BASED INSTRUCTION WITH METHODS++

Dan A. Milner, Jr., MD, Brigham and Womens Hospital, Boston, MA
Thing Rinda Soong, MD, Brigham and Womens Hospital, Boston, MA
108
2016
SPECIAL LECTURES
Pathology at the Speed of Thought

USCAP opened its
Interactive Center in
Palm Springs, CA on
October 30, 2015, to
provide a
state-of-the-art facility
for teaching interactive
microscopy, ultraultra
sound-guided fine needle aspiration biopsy procedures,
and related molecular/genomic sciences.
The Center is yet another expression of USCAPs
commitment to global health through education and
creating better pathologists. It is a place, like no other,
for mentoring and for learning.
Interactive Center features:

Two laboratory spaces, each with an 18-head teaching
microscope
High definition digital cameras with telepathy software
17 personal-use microscopes
Ultrasound equipment for hands-on instruction in
performing ultrasound-guided fine needle aspiration
biopsies with interpretations
Weekend courses offered year around in all
subspecialties of anatomic pathology taught by the
most accomplished pathologists in the field
An intimate learning experience that simulates
daily sign out
Snow King Lodge | Jackson Hole, WY
COURSE SCHEDULE AVAILABLE ONLINE
www.USCAPInteractiveCenter.org
2 0 1 6
USCAP HONORS
HIGH PERFORMANCE ACHIEVEMENT
THE UNITED STATES AND CANADIAN ACADEMY OF PATHOLOGY

RESONATES WITH EXCELLENCE.
WE ARE PROUD TO INTRODUCE THESE AWARD RECIPIENTS WHO HAVE MADE
OUTSTANDING CONTRIBUTIONS IN THE FIELD OF PATHOLOGY.
USCAP Is Gradually Going Green
2016 Executive Committee announces that USCAP

is going green for the 2017 Annual Meeting. To
preserve USCAPs portal to a new world of learning,
we are respecting the lives of trees in the spirit of
eco-balance by limiting the printing of traditional
educational materials, including the Program Book.
Please use your digital devices at the Annual Meeting
for downloading handouts from our website.
Download now at
www.uscap.org/programbook
2016
ABSTRACTS
YOUR FORMULA FOR SUCCESS
5021
+
+
+
1382
726
27
+
87 +3096
+
Companion Meeting
5,975 attendees total
2015 Annual Meeting

Attendance
Long Course attendees
Attendees were from

87 countries other than the
U.S. or Canada.
Scientific abstracts were

submitted for evaluation
Countries represented
60 +58.5 + 445.5
+19
+ 55.25 + 309.25
+
Short Courses offered this year,

4025 attendees
Possible CME Per Person=
HOURS
Possible SAMS Per Person
Total Possible CME=
HOURS
Total Possible SAMS=
Evening Specialty Courses

with 7,103 total attendees
HOURS
HOURS
= your Academy
With an exceptional education track for trainees, networking receptions, a huge fellowship fair and trainee conference rates,
the worlds largest pathology meeting is the perfect place to advance your career.
www.USCAP.org
PROFFERED PAPERS
Monday, March 14,

23, 2016
2015
CC HALL 4E
SECTION A - GENITOURINARY
CHAIRED BY: OMAR HAMEED AND TAMARA LOTAN
8:00
8:15
Validation of Reporting Percentage High Grade

Prostate Cancer in 988 Conservatively Treated Patients
with Long Term Outcome (863)
Daniel Berney, Gabrielle Fisher, Bernard North, Henrik
Moller, Peter Scardino, Jack Cuzick, Luis Beltran
Queen Mary University of London, London, United
Kingdom; Memorial Sloan-Kettering Cancer Center,
New York, NY; Kings College London, London, United
Kingdom
Do Specific Gleason Pattern 4 Morphologies Detected
on Transrectal Ultrasound (TRUS)-Guided Biopsies
Predict Upgrading or Upstaging in Gleason Score
3+4=7 Prostate Cancer? (950)
Kevin Hogan, Susan J Robertson, Nicola Schieda,
Kien T Mai, Daniel T Keefe, Eric C Belanger, Rodney H
Breau, Chris Morash, Trevor A Flood
The Ottawa Hospital, Ottawa, ON, Canada; The
University of Ottawa, Ottawa, ON, Canada
8:30
Metastatic Potential of Gleason Score 7 Tumor at

Radical Prostatectomy (RP) Using the 2014 Modified
Gleason Score: Effect of High Grade Tertiary Patterns
(899)
Mairo L Diolombi, Jonathan I Epstein
Johns Hopkins Hospital, Baltimore, MD
8:45
Significance of Percentage of Gleason Pattern 4 at

Needle Biopsy in Predicting Final Gleason Score and
Correlation with Pathologic Outcomes at Radical
Prostatectomy (956)
Mohsin Jamal, Sean R Williamson, Mireya Diaz-Insua,
Mani Menon, Hans Stricker, James Peabody, Craig G
Rogers, Nilesh S Gupta
Henry Ford Hospital, Detroit, MI
9:00
9:15
Radical Prostatectomy Findings in the Post-PSA

Screening Era (904)
Liz Edmund, Andres Matoso
Rhode Island Hospital and Brown University,
Providence, RI
Validation of Reactive Stroma as an Adverse
Prognostic Factor for Gleason Grade 3+3=6 and 3+4=7
Prostatic Adenocarcinomas (PCA) In the Canary
Retrospective Radical Prostatectomy (RP) Cohort (993)
Jesse K McKenney, Wei Wei, Sarah J Hawley, Heidi
Auman, Lisa Newcomb, Hilary Boyer, Ladan Fazli,
Jeff Simko, Antonio Hurtado-Coll, Dean Troyer, Maria
S Tretiakova, Funda Vakar-Lopez, Peter R Carroll,
Matthew R Cooperberg, Martin E Gleave, Raymond
Lance, Daniel Lin, Peter S Nelson, Ian Thompson,
Lawrence True, Ziding Feng, James D Brooks
Cleveland Clinic, Cleveland, OH; UT MD Anderson,
Houston, TX; Canary Foundation, Palo Alto, CA;
Fred Hutchinson CRC, Seattle, WA; University British
Columbia, Vancouver, BC, Canada; UCSF, San
Francisco, CA; Eastern Virginia MS, Norfolk, VA; UW
Medical Center, Seattle, WA; UT San Antonio, San
Antonio, TX; Stanford University, Stanford, CA
8:30 AM - 12:00 PM
8:00
11:00
Predictive Value of Intraductal Carcinoma and

Cribriform Architecture in Prostate Biopsies of Patients
Treated by Radiotherapy (1067)
Theodorus H Van der Kwast, Jure Murgic, Melania
Pintilie, Michelle Downes, Michael Fraser, Rob G
Bristow
University Health Network, Toronto, ON, Canada;
Princess Margaret Cancer Centre, Toronto, ON, Canada
11:15
Overexpression of the Long Non-Coding RNA SChLAP1

Independently Predicts Lethal Prostate Cancer (1065)
Aaron Udager, Arul M Chinnaiyan, Joshua Petimar,
Xuhong Cao, Felix Y Feng, Massimo Loda, Thomas
Ahearn, Philip W Kantoff, Lorelei A Mucci, Rohit Mehra
University of Michigan Health System, Ann Arbor,
MI; Michigan Center for Translational Pathology, Ann
Arbor, MI; Dana-Farber Cancer Institute, Boston, MA;
Harvard T. H. Chan School of Public Health, Boston,
MA
11:30
Concurrent TMPRSS2-ERG and SLC45A3-ERG

Rearrangements Plus PTEN Loss Are Associated with
an Aggressive Tumor Subset of Prostate Cancer (947)
Silvia Hernandez, Alba Font-Tello, Nuria Juanpere,
Silvia de Muga, Marta Lorenzo, Lluis Fumado, Sergio
Serrano, Josep Lloreta
Universitat Pompeu Fabra, Barcelona, Spain; Hospital
del Mar-Parc de Salut Mar-IMIM, Barcelona, Spain;
Autonomous University of Barcelona, Barcelona, Spain
11:45
Multi-Tumor Sampling Tissue Microarray Approach

from Radical Prostatectomies to Screen Biomarkers
Relevant to Active Surveillance (970)
Ibrahim Kulac, Gunes Guner, Helen Fedor, Stephanie
Glavaris, Tamara Lotan, H Ballentine Carter, Jonathan I
Epstein, Angelo M De Marzo
Johns Hopkins University, Baltimore, MD
12:00
BREAK
CC BR 6C
SECTION B - BREAST
CHAIRED BY: FOUAD BOULOS AND KRISTIN C JENSEN
8:00
Microglandular Adenosis and Risk of Breast Cancer: A

Mayo Benign Breast Disease Cohort Study (119)
Melanie C Bois, Zahraa Al-Hilli, Daniel W Visscher,
Tanya L Hoskin, Marlene H Frost, Derek C Radisky, Ruth
Kraft, Amy Degnim, Jodi M Carter
Mayo Clinic, Rochester, MN
8:15
Are Microglandular Adenosis and Breast Acinic Cell

Carcinomas Related Lesions? (160)
Felipe C Geyer, Salvatore Piscuoglio, Charlotte KY Ng,
Elena Guerini-Rocco, Caterina Marchio, Zsolt Hodi,
Emad Rakha, Ian O Ellis, Stuart Schnitt, Britta Weigelt,
Jorge S Reis-Filho
Memorial Sloan Kettering Cancer Center, New
York, NY; European Institute of Oncology, Milan,
Italy; University of Turin, Turin, Italy; University of
Nottingham, Nottingham, United Kingdom; Beth
Israel Deaconess Medical Center and Harvard Medical
School, Boston, MA
109
PROFFERED PAPERS
Monday, March 14,

23, 2016
2015
8:30
A Longitudinal Study of LCIS on CNB (224)

Lavinia Middleton
MD Anderson, Houston, TX
8:45
Atypical Ductal Hyperplasia (ADH) Versus Ductal

Carcinoma In-Situ (DCIS) in a Papilloma: Comparison
of Linear Dimension and Proportion Criteria (184)
Elizabeth Kalife, Kamaljeet Singh, C James Sung, M
Ruhul Quddus
Women and Infants Hospital, Providence, RI
9:00
9:15
11:00
11:15
11:30
110
8:30 AM - 12:00 PM
8:00
11:45
Histologic Features of Lymph Node Metastases and

Their Prognostic Significance in Node Positive Breast
Cancer (110)
Sura M Aziz, Elisabeth Wik, Goril Knutsvik, Tor Audun
Klingen, Ying Chen, Benedicte Davidson, Hans Aas,
Turid Aas, Ingunn Stefansson, Lars A Akslen
University of Bergen, Bergen, Norway; Haukeland
University Hospital, Bergen, Norway; Vestfold Hospital
Trust, Tnsberg, Norway; Akerhus University Hospital,
Lrenskog, Norway
Intraductal Papillomas without Atypia Need Not Be

Excised: A Hispanic Cohort Study (245)
Lurmag Orta, Eugenio Marcano, Mayra MaldonadoDuran
San Pablo Pathology Group, Bayamn, Puerto Rico;
University of Puerto Rico, Rio Piedras, Puerto Rico;
HIMA San Pablo Hospital, Bayamn, Puerto Rico
12:00
BREAK
Intraductal Papillomas of the Breast on Core Biopsy,

Re-Visiting 10 Years Experience with More Than 500
Cases (179)
Shabnam Jaffer, Bailey A Reindl, Ira J Bleiweiss,
Anupma Nayak
Mount Sinai Medical Center, New York, NY
8:00
Is There a Value for Age-Based Anal Cancer Screening

in HIV-Infected Males? (433)
Rana Naous, Lucinda Steele, Kamal K Khurana
SUNY Upstate Medical University, Syracuse, NY
8:15
Anal Cytology: Institutional Review of Statistics and

Histologic Correlation (430)
Elizabeth Morency, Nazneen Fatima, Tracey Harbert,
Dawn Heagley, Kruti Maniar, Ritu Nayar
Northwestern University, Chicago, IL
8:30
Human Papillomavirus (HPV) Genotypes and Anal

Squamous Intraepithelial Neoplasia (AIN) in HIV
Positive Women (454)
Qiusheng Si, Arnold H Szporn, Fadi Salem, Zesong
Zhang, David Zhang, Tamara L Kalir, David C Chhieng
Icahn School of Medicine at Mount Sinai, New York, NY
8:45
Trends in Rates of Failure of Care in Women with

Invasive Cervical Cancer: A Meta-Analysis (367)
Rohini Chennuri, Frida Rosenblum, Isam Eltoum
University of Alabama at Birmingham, Birmingham, AL
9:00
PCR Human Papillomavirus Detection in Invasive

Cervical Cancers with Prior Negative HC2 Test Results
(482)
Chengquan Zhao, Xiang Tao, BaoWen Zheng, Fufen
Yin, Christopher C Griffith, Zaibo Li, Bing Luo,
Xiangdong Ding, Xianrong Zhou
Uiversity Pittsburgh Medical Center, Pittsbrugh,
PA; Obstetrics and Gynecology Hospital of Fudan
University, Shanghai, China; Kingmed Diagnostics,
Guangzhou, China; Qingdao University Shool of
Medicine, Qingdao, China; Emory University Hospital,
Atlanta, GA; Ohio State University Wexner Medical
Center, Columbus, OH
The Mutational Landscape of Breast

Adenomyoepitheliomas (250)
Anastasios D Papanastasiou, Huei Chi Wen, Anne
M Schultheis, Charlotte KY Ng, Marcia Edelweiss,
Salvatore Piscuoglio, Luciano G Martelotto, Felipe
C Geyer, Kathleen Burke, Maria Rosaria De Filippo,
Gabriel S Macedo, Zsuzsanna Varga, Emad Rakha, Ian
O Ellis, Brian P Rubin, Britta Weigelt, Jorge S Reis-Filho
Memorial Sloan Kettering Cancer Center, New
York, NY; Nottingham University, Nottingham,
United Kingdom; University Hospital Zurich, Zurich,
Switzerland; Cleveland Clinic, Cleveland, OH
Evaluation of EZH2 Protein Expression in Normal
Epithelium as a Marker of Risk of Breast Cancer
Development Results from the Nurses Health Study
(117)
Francisco Beca, Kevin Kensler, Benjamin Glass, Rulla M
Tamimi, Andrew H Beck
Beth Israel Deaconess Medical Center, Boston, MA;
Harvard Medical School, Boston, MA; Harvard T.H.
Chan School of Public Health, Boston; Brigham and
Womens Hospital, Boston, MA
TP53 Alteration in Morphologically Normal/Benign
Cells in Breast Terminal Ductal Lobular Units (TDLU)
in Patients with or without BRCA Germline Mutation:
A Marker for Early Detection of High Risk Patients? [/
underline] (303)
Xi Wang, Amber A El-Halaby, Todd S Laughlin, Paul G
Rothberg, Kristin Skinner, David G Hicks
University of Rochester, Rochester, NY
CC BR 6B
SECTION C - CYTOPATHOLOGY
CHAIRED BY: JENNIFER HIPP AND CHARLES D STURGIS
PROFFERED PAPERS
9:15
11:00
Monday, March 14,

23, 2016
2015
Improved Detection of CIN 2+ Lesions by the Becton

Dickinson Focal Point GS Slide Profiler No Further
Review Technology (437)
David Nuttall, John OLeary, Cara Martin, Nick
Dallimore, Sharon Hillier, Sonia Sloan, Amanda
Savage, Helen Clayton, Rosemary Fox
Public Health Wales, Cardiff, United Kingdom;
Royal Gwent Hospital, Newport, United Kingdom;
Trinity College, Dublin, Ireland; Glan Clwyd Hospital,
Bodelwyddan, United Kingdom
Atypical Squamous Cells, Cannot Exclude High Grade
(ASC-H), High Risk Human Papillomavirus (hrHPV)Negative Risk Group: Should There Be an Alternative
Management? (369)
Jennifer A Collins, Vanessa DeVilla, Christopher J
VandenBussche
Johns Hopkins University School of Medicine,
Baltimore, MD; University of Santo Tomas Hospital,
Manila City, Manila, Philippines
11:15
Bethesda System Reporting of Benign-Appearing

Endometrial Cells in Women 40 and Older: Analysis
of Predictive Value from a Large Academic Womens
Hospital Database (479)
Jing Yu, Agnieszka Onisko, R Marshall Austin
Magee-Womens Hospital of UPMC, Pittsburgh, PA
11:30
Comparison of Molecular Platforms for Detection of

HPV in FNA Biopsies of the Head and Neck (431)
Zoltan Nagymanyoki, William Karlon, William C
Faquin, Jeffrey F Krane, Neal Lindeman, Dimity
Hall, Brenda J Sweeney, Britt-Marie Ljung, Ronald
Balassanian, Annemieke van Zante
University of California, San Francisco, San Francisco,
CA; Massachusetts General Hospital, Boston, MA;
Brigham and Womens Hospital, Boston, MA; West
Pacific Medical Laboratory, Santa Fe Springs, CA
11:45
Trichomonas vaginalis Is an Under-Described Infection

in Urine Cytologies from Men (378)
Erika E Doxtader, Tarik M Elsheikh
Cleveland Clinic Foundation, Cleveland, OH
12:00
BREAK
Mutation Profile of Colorectal Neuroendocrine

Neoplasm (721)
Sun Mi Lee, Russell Broaddus, Rajesh Singh,
Rajyalakshmi Luthra, Hui Chen
The University of Texas MD Anderson Cancer Center,
Houston, TX
8:15
Clinical Utility of Tumor Hotspot Sequencing in

Colorectal Cancer (701)
Ryan Jones, Siraj M Ali, Julia A Elvin, Ritu Nayar, Nike
Beaubier
Northwestern University, Chicago, IL; Foundation
Medicine, Cambridge, MA
8:30 AM - 12:00 PM
8:00
8:30
KRAS Mutations Are Frequently Identified in Colorectal

Carcinoma with BRAF Wild-Type Sporadic MLH1
Deficiency from MLH1 Promoter Hypermethylation
(673)
Lama Farchoukh, Reetesh K Pai, Shih-Fan Kuan
University of Pittsburgh Medical Center, Pittsburgh, PA
8:45
Discrete Punctate Nuclear Staining Pattern For MLH1

Protein Does Not Represent Intact Nuclear Expression
(830)
Zhaohai Yang
Penn State Milton S. Hershey Medical Center, Hershey,
PA
9:00
Colorectal Carcinomas with Isolated Loss of PMS2 by

IHC: An Unusual Subset of MSI-H Tumors (632)
Lindsay Alpert, Xiuli Liu, Rish Pai, Namrata Setia, ShuYuan Xiao, John Hart, Reetesh K Pai
University of Chicago, Chicago, IL; Cleveland Clinic,
Cleveland, OH; Mayo Clinic, Phoenix, AZ; University of
Pittsburgh, Pittsburgh, PA
9:15
Microsatellite Instability Is Associated with Reduced

Disease Specific Survival in Stage III Colon Cancer in a
Series of 1250 Colorectal Cancers Prospectively Tested
for MSI (680)
Robert Geraghty, Helen Mohan, Rory Kennelly,
Ishwaria Balasubramanian, Francesco G Sclafani,
Y-Ling Khaw, Elizabeth J Ryan, David Fennelly, Ray
McDermott, Diarmuid ODonoghue, John Hyland,
Sean T Martin, Ronan OConnell, Des Winter, Kieran
Sheahan
St. Vincents University Hospital, Dublin, Ireland;
University College Dublin, Dublin, Ireland
11:00
Novel Mutations in African American Colon Cancers

Define a Distinct Clinicopathological Entity Linked to
Poor Outcome (822)
Joseph Willis, Li Li, Martina Veigl, Alexander Miron,
Susan Lewis, James Lutterbaugh, Sanford Markowitz,
Zhenghe Wang, Kishore Guda
Case Medical Center / Case Comprehensive Cancer
Center, Cleveland, OH; Case Comprehensive Cancer
Center, Cleveland, OH
11:15
Overall Tumor Budding and Hotspot Scores in

Colorectal Cancer: A Simplification of the 10 HPF
Method (662)
Heather Dawson, Gregor Rieger, Viktor Koelzer, Lena
Sokol, Daniel Inderbitzin, Inti Zlobec, Alessandro Lugli
Institute of Pathology, University of Bern, Bern,
Switzerland; Inselspital Bern, Bern, Switzerland
11:30
Tumor Deposits and Venous Invasion in Colorectal

Cancer: Clarification of Morphologic Criteria and Role
of These Parameters in Staging (727)
Su-Yang Liu, Sanjay Kakar
CA
CC BR 6A
SECTION D - GASTROINTESTINAL
CHAIRED BY: WADE SAMOWITZ AND EFSEVIA VAKIANI
8:00
111
PROFFERED PAPERS
Monday, March 14,

23, 2016
2015
11:45
Comprehensive Morphological Assessment of

Colorectal Cancers Characterized by The Cancer
Genome Atlas (TCGA) Identifies Specific MorphologyMolecular Alteration Associations (795)
Jinru Shia, Deborah Kuk, Nikolaus Schultz, Michael
Berger, Sumit Middha, Efsevia Vakiani, Jaclyn
Hechtman, Zsofia Stadler, Martin Weiser, Mithat
Gonen, David Klimstra
Memorial Sloan Kettering Cancer Center, New York, NY
12:00
BREAK
CC 602-604
SECTION E - GYNECOLOGIC
CHAIRED BY: BROOKE E HOWITT AND RUSSELL BROADDUS
8:00
Fumarate Hydratase Alteration and Other Molecular

Changes in Two Histologic Variants of Atypical
Leiomyomas (1205)
Kate Poropatich, Qing Zhang, Julianne Martinez de
Ubago, Norma Frizzell, Beihuan Kong, Jian-Jun Wei
Northwestern University, Chicago, IL; Qilu Hospital,
Jinan, Shandong, China; University of South Carolina,
Columbia, SC
8:15
Current Practices in the Processing, Diagnosis and

Reporting of Endometrial Carcinoma. Results of a
Web Based Survey by the International Society of
Gynecological Pathologists (ISGyP) (1199)
Vinita Parkash, Anais Malpica, Xavier Matias-Guiu,
Esther Oliva, W Glenn McCluggage
Yale University School of Medicine, Bridgeport
Hospital, New Haven, CT; The University of Texas
MD Anderson Cancer Center, Houston, TX; Hospital
Universitari Arnau de Vilanova, University of Lleida,
IRBLleida, Lleida, Spain; Massachusetts General
Hospital, Boston, MA; Belfast Health and Social Care
Trust, Belfast, Ireland
8:30
Intraoperative Consultation in Low Grade Endometrial

Endometrioid Adenocarcinoma: Is Frozen Section
Superior to Gross Examination? (1167)
Barrett C Lawson, Esther Soundar, Shilpa Jain,
Matthew L Anderson, Ramya P Masand
Baylor College of Medicine, Houston, TX
8:45
Lymph Node Metastases in Low Grade Endometrial

Carcinoma (LGEC): What Matters? (1124)
Elizabeth D Euscher, Genevieve R Lyons, Roland L
Bassett, Elvio Silva, Anais Malpica
MD Anderson Cancer Center, Houston, TX
9:00
CTNNB1 (Beta Catenin) Mutation Identifies Patients

with Grades 1 or 2 Endometrioid-Type Endometrial
Carcinoma at Risk of Recurrence (1164)
Katherine Kurnit, Bryan Fellman, Diana Urbauer,
Gordon Mills, Russell Broaddus
MDACC, Houston, TX
112
8:30 AM - 12:00 PM
8:00
9:15
The Utility of a Next-Generation Sequencing (NGS)

Panel to Identify Germline Mutations Associated with
Endometrial Cancer (1214)
Kari Ring, Amanda Bruegl, Brian Allen, Eric Elkin,
Nanda Singh, Anne-Renee Hartman, Molly Daniels,
Russell Broaddus
M.D. Anderson Cancer Center, Houston, TX; Myriad
Genetics, Inc., Salt Lake City, UT
11:00
Hysterectomy Specimens of Patients with Lynch

Syndrome: Clinicopathologic Study of 70 Cases (1203)
Ana S Pires-Luis, Carla Bartosch, Catarina Meireles,
Carla Pinto, Jose M Lopes, Kristen M Shannon, Manuel
R Teixeira, Esther Oliva
IPO-Porto, Porto, Portugal; CHSJ, Porto, Portugal;
Massachusetts General Hospital, Boston, MA
11:15
Inter-Observer Agreement in Endometrial Carcinoma

(EC) Diagnosis Varies Depending on TCGA Subgroup
Assignment (1139)
Lien Hoang, Mary A Kinloch, Katherine Grondin,
Cheng-Han Lee, Carol Ewanowich, Martin Kobel, David
G Huntsman, Jessica N McAlpine, Robert Soslow,
Blake Gilks
Memorial Sloan Kettering Cancer Center, New York,
NY; Saskatoon City Hospital, Saskatoon, SK, Canada;
Laval University, Quebec City, QC, Canada; University
of Edmonton, Edmonton, AB, Canada; University of
Calgary, Calgary, AB, Canada; BC Cancer Agency,
Vancouver, BC, Canada; Vancouver General Hospital,
Vancouver, BC, Canada
11:30
Proactive Molecular Risk Classifier for Endometrial

Cancer (ProMisE) for Improved Endometrial Cancer
Management (1132)
Blake Gilks, Aline Talhouk, Melissa McConechy, David
G Huntsman, Cheng-Han Lee, Jessica N McAlpine
University of British Columbia, Vancouver, Canada;
University of Alberta, Edmonton, Canada
11:45
The Cancer Genome Atlas-Based Molecular Classifier

Identifies Prognostically Significant Subgroups of
Grade 3 Endometrioid Carcinoma of the Endometrium
(1235)
Robert Soslow, Blake Gilks, Douglas A Levine
NY; Vancouver General Hospital, Vancouver, Canada
12:00
BREAK
CC 606-607
SECTION F - TECHNIQUES
CHAIRED BY: MICHAEL CRUISE AND KUMARASEN COOPER
8:00
Mass Spectrometry of Formalin-Fixed ParaffinEmbedded Tissue: Proteome, Phosphoproteome and

Histone Post-Translational Modifications (2087)
John Wojcik, Simone Sidoli, Benjamin A Garcia,
Kumarasen Cooper
Hospital of the University of Pennsylvania,
Philadelphia, PA; University of Pennsylvania,
Philadelphia, PA
PROFFERED PAPERS
Monday, March 14,

23, 2016
2015
8:15
Feasibility of Ex-Vivo Confocal Fluorescence

Microscopy for Rapid Evaluation of Tissues in Surgical
Pathology Practice (2049)
Savitri Krishnamurthy, Andrea Cortes, Mirtha Lopez,
Michael Wallace, Sharjeel Sabir, Gordon Mills, Kenna
Shaw
8:30
Front End Genomics: Using an Alternative Approach

for the Recovery of High Quality DNA from Core
Needle Biopsies (2060)
Wilfrido Mojica, Paul Mojica, Rama Dey-Rao, Don
Sykes
University at Buffalo, Buffalo, NY; UCLA, Los Angeles,
CA
8:45
In Situ Evaluation of Telomerase Expression and

Function in Human Cells and Tissues (2040)
Nancy Greenland, Ajay Ravindranathan, Beth Cimini,
Morgan Diolaiti, Bradley Stohr
University of California, San Francisco, CA
9:00
Predicting DNA Yield by Calculation of Extracted Tissue

Area: Combining Digital and Molecular Pathology to
Empower Genetic Testing (2064)
Mariana Petaccia de Macedo, Lauren E Haydu, Tiffany
L Calderone, Khalida Wani, Sheila Duncan, Michael T
Tetzlaff, Victor G Prieto, Michael A Davies, Jeffrey E
Gershenwald, Alexander Lazar
9:15
Fluorescein: A Quick & Inexpensive Supplement to

Frozen Section for Diagnosing Myometrial Invasion in
Endometrial Cancer (2065)
Charles Quick, Kristin Zorn, Alexander Burnett
University of Arkansas for Medical Sciences, Little
Rock, AR
11:00
Ex Vivo Confocal Laser Endomicroscopy Is Useful in

the Evaluation of Pancreatic Cystic Lesions (2072)
Benjamin J Swanson, Wendy Frankel, Darwin L
Conwell, Peter Muscarella, Somashekar G Krishna
The Ohio State University Wexner Medical Center,
Columbus, OH; Montefiore Medical Center, Bronx, NY
11:15
New Laser Based Imaging Approaches for Infrared

Spectroscopy: Examples in Colon and Liver Tissue
(2063)
Ramayee Periakaruppan, Vishal Varma, Hari Sreedhar,
Francesca Gambacorta, Grace Guzman, Michael Walsh
University of Illinois Hospital and Health Sciences
System, Chicago, IL
11:30
Deep Convolutional Neural Network-Based Mitosis

Detection in Invasive Carcinoma of Breast by
Smartphone-Based Histologic Image Acquisition
(2048)
Seokhwi Kim, Jungin Lee, Soohyun Hwang, Sooyoun
Cho, Sangheum Hwang, Hyo-Eun Kim, Hyemin Shim,
Miso Yang, Sangyong Song
Samsung Medical Center, Sungkyunkwan University
School of Medicine, Seoul, Republic of Korea;
Lunit Inc., Seoul, Republic of Korea; Seoul National
University, Seoul, Republic of Korea
8:30 AM - 12:00 PM
8:00
11:45
Fusion Gene Detection in Sarcomas by the NanoString

nCounter Fusion Gene Analysis Assay (2030)
Kenneth Chang, Angela Goytain, Xiu Qing Wang, Tony
Ng
KK Womens and Childrens Hospital, Singapore,
Singapore; Duke-NUS Graduate Medical School,
Singapore, Singapore; University of British Columbia,
Vancouver, BC, Canada; Vancouver General Hospital,
Vancouver, BC, Canada
12:00
BREAK
CC 608-609
SECTION G - PULMONARY
CHAIRED BY: NATASHA REKHTMAN AND RODNEY A
SCHMIDT
8:00
Reproducibility in Classification of Small Lung

Adenocarcinomas: An International Interobserver
Study (1920)
Angela R Shih, Alona Muzikansky, Emine Bozkurtlar,
Jin-Haeng Chung, Yuko Minami, Lida P Hariri, Andre
Moreira, Hironori Uruga, He Wang, Akihiko Yoshizawa,
Mari Mino-Kenudson
Massachusetts General Hospital, Boston, MA; Marmara
University, Istanbul, Turkey; Seoul National University,
Bundang Hospital, Seongnam, Republic of Korea;
National Hospital Organization, Ibarakihigashi National
Hospital, Naka, Japan; Memorial Sloan Kettering
Cancer Center, New York City, NY; Temple University
School of Medicine, Philadelphia, PA; Kyoto University
Hospital, Kyoto, Japan
8:15
Bilateral Invasive Mucinous Adenocarcinomas (Former

Mucinous Bronchioloalveolar Carcinoma): Molecular
Analysis Confirms Intrapulmonary Spread Rather Than
Separate Primary Tumors (1880)
Charles Leduc, Kay See Tan, Shaozhou Tian, Snjezana
Dogan, Marc Ladanyi, William Travis, Natasha
Rekhtman
MSKCC, NY, NY
8:30
Dissecting Intra-Tumor Heterogeneity of Lung

Adenocarcinoma Reveals Dominant, Branching and
Private Gene Mutations within Individual Tumor
Nodules (1903)
Giuseppe Pelosi, Alessio Pellegrinelli, Alessandra
Fabbri, Adele Busico, Giulio Settanni, Barbara Valeri,
Angelica Sonzogni, Federica Perrone, Elena Tamborini,
Ugo Pastorino
Fondazione IRCCS Istituto Nazionale Tumori and
Universit degli Studi, Milan, Italy; Fondazione IRCCS
Istituto Nazionale Tumori, Milan, Italy
8:45
Next Generation Sequencing Reveals Genomic

Heterogenity of ALK Fusion Breakpoints in Non -Small
Cell Lung Cancer (1914)
Jason N Rosenbaum, Julie Branson, Catherine E
Cottrell, John D Pfeifer, Shashikant Kulkarni, Eric J
Duncavage
Washington University School of Medicine,
Department of Pathology and Immunology, St. Louis,
MO
113
PROFFERED PAPERS
Monday, March 14,

23, 2016
2015
9:00
Identification of a Novel Partner Gene, KIAA1217,

Fused to RET: Functional Characterization and Inhibitor
Sensitivity of Two Isoforms in Lung Adenocarcinoma
(1858)
Yoon-La Choi, Mi-Sook Lee, Jhingook Kim
Samsung Medical Center, Seoul, Korea
9:15
ROS1 Immunohistochemistry as a Screen for ROS1

Rearrangements in Lung Adenocarcinoma: Application
in Clinical Practice (1900)
Prodipto Pal, Peter Hammerman, David J Kwiatkowski,
Bruce E Johnson, Lynette M Sholl
Brigham and Womens Hospital, Boston, MA; Dana
Farber Cancer Institute, Boston, MA
11:00
Two Plasma MicroRNA Panels for Diagnosis and

Subtype Discrimination of Lung Cancer (1885)
Shaohua Lu, Hui Kong, Yingyong Hou, Hongguang
Zhu, Chunxue Bai
Zhongshan Hospital, Fudan University, Shanghai,
China; Fudan University, Shanghai, China
11:15
Histologic Findings of Video-Assisted Thoracoscopic

Surgery Lung Biopsies Performed in Patients with
Treatment-Resistant Severe Asthma (1930)
Humberto Trejo Bittar, Daniel Doberer, Mitra Mehrad,
Sally Wenzel, Samuel A Yousem
11:30
Venous Infarcts and Pathologic Changes Mimicking

Pulmonary Venoocclusive Disease Caused by
Pulmonary Vein Obstruction outside the Lungs (1895)
Sanjay Mukhopadhyay, Andrea V Arrossi, Carol Farver
Cleveland Clinic, Cleveland, OH
11:45
Identification of Steroid Receptor Expression in

Patients with Usual Interstitial Pneumonia (1890)
Mitra Mehrad, Humberto Trejo Bittar, Samuel A
Yousem
12:00
BREAK
8:15
114
Evaluation For Heritable Cardiovascular Disorders

Using Targeted Next-Generation Sequencing on
Formalin-Fixed Paraffin Embedded Tissue (324)
Charles Leduc, Laura J Train, Rajeswari Avula, Katrina
E Kotzer, Michelle L Kluge, Michael J Ackerman, Linnea
M Baudhuin, Joseph J Maleszewski
Long Term Durability of Edwards SAPIEN Transcatheter
Aortic Valves: A Pathology Study (322)
Elena Ladich, Kazuyuki Yahagi, Robert Kutys, Michelle
Olson, Renu Virmani
CVPath Institute, Gaithersburg, MD
8:30 AM - 12:00 PM
8:00
8:30
C4d-Negative, DSA Positive Antibody-Mediated

Rejection in Heart Allografts[/underline] (334)
Kelly Smith, Karen Nelson
University of Washington, Seattle, WA; BloodWorks
Northwest, Seattle, WA
8:45
TdT-Positive Cells in Inflamed Pediatric Kidney: A

Potential Diagnostic Pitfall (1833)
Jennifer Dunlap, Xavier Stacey, Sarah Click, Michael J
Cascio, Megan Troxell
OHSU, Portland, OR
9:00
Frequent HRAS Mutations in Ectomesenchymoma

(ECM): Overlapping Genetic Abnormalities with
Embryonal Rhabdomyosarcoma (ERMS) (1836)
Shih-Chiang Huang, Rita Alaggio, Yun-Shao Sung,
Narasimhan P Agaram, Cristina Antonescu
NY; Chang Gung Memorial Hospital, Taoyuan, Taiwan;
Padova University Hospital, Padova, Italy
9:15
NDER: A Novel Web Application for Teaching Histology

to Medical Students (560)
Elizabeth U Parker, Nicholas P Reder, Daniel Glasser,
Jonathan C Henriksen, Mara H Rendi
University of Washington, Seattle, WA
11:00
Correlation between USMLE Scores and Resident InService Examination (RISE) Scores: Should USMLE
Scores Be Used as a Benchmark When Selecting
Residents? (542)
Yasemin Akdas, Kamran M Mirza, Guliz A Barkan
University of Florida, Gainesville, FL; Loyola University
Medical Center, Maywood, IL
11:15
Impact of Pathologist Involvement in Sarcoma and

Rare Tumor Patient Support Groups on Facebook: A
Survey of 541 Patients (552)
Jasmine Haller, Marjorie David, Nathan Lee, Pamela
Holtzclaw Williams, Sara C Shalin, Jerad Gardner
Rock, AR
11:30
Validity of Minimally Invasive Autopsy (MIA) in

Assessing Cause of Death in Adults from Developing
Countries (1535)
Paola Castillo, Miguel J Martinez, Esperanca Ussene,
Dercio Jordao, Lucilia Lovane, Carla Carrilho, Mamudo
R Ismail, Cesaltina Lorenzoni, Jordi Vila, Clara
Menndez, Quique Bassat, Jaume Ordi
ISGlobal, Barcelona Center International Health
Research (CRESIB), Hospital Clnic, Barcelona, Spain;
Maputo Central Hospital, Maputo, Mozambique,
Maputo, Mozambique
11:45
Immunohistochemistry Is Rarely Justified for the

Diagnosis of Viral Infections (1544)
Isaac H Solomon, Jason L Hornick, Alvaro C Laga
Brigham and Womens Hospital, Boston, MA
12:00
BREAK
CC 615-617
SECTION H - POTPOURRI
CHAIRED BY: MARA H RENDI AND BOBBI PRITT
8:00
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
Board
Number
STOWELL-ORBISON AWARD POSTERS: AUTOPSY
Total Artificial Heart: An Autopsy Case Series (8)

Craig Dunseth, Dennis J Firchau
University of Iowa, Iowa City, IA
Malignant Transformation in Neurocutaneous

Melanosis (11)
Andrew Guajardo, Christopher J VandenBussche, D
Ashley Hill, Miguel Reyes-Mugica, Cheng-Ying Ho
The Johns Hopkins University, Baltimore, MD;
Chrildrens National Medical Center, Washington, DC;
Childrens Hospital of Pittsburgh, Pittsburgh, PA
Beckwith-Wiedemann Syndrome with Placental

Mesenchymal Dysplasia in a Male (46,XY) Infant:
Unique Findings at Autopsy (16)
Annie Laib, Jerzy Stanek
University of Cincinnati Medical Center, Cincinnati, OH;
Cincinnati Childrens Hospital, Cincinnati, OH
Comparison of Clinical Diagnoses and Autopsy

Findings: 6 Year Retrospective Study (17)
Hyejong S Marshall, Clara Milikowski
Jackson Memorial Hospital/ University of Miami,
Miami, FL
Different Strokes for Different Folks: A Case Series of

Abdominal Apoplexy (24)
Varsha Podduturi, Joseph M Guileyardo
Southwestern Institute of Forensic Sciences, Dallas,
TX; Baylor University Medical Center, Dallas, TX
Pulmonary Emboli and the Risk of Mortality in a

Diverse Disease Environment (25)
Maryam Shabihkhani, Jody E Hooper
Johns Hopkins Hospital, Baltimore, MD; Johns Hopkins
University School of Medicine, Baltimore, MD
STOWELL-ORBISON AWARD POSTERS: BONE AND SOFT
TISSUE PATHOLOGY
Ewing Sarcoma (ES) with ERG Gene Rearrangements:

A Molecular Study Focusing on the Prevalence of FUSERG and Common Pitfalls in Detecting EWSR1-ERG
Fusions by FISH (47)
Sonja Chen, Kemal Deniz, Yun-Shao Sung, Lei Zhang,
Sarah M Dry, Cristina Antonescu
NY; Erciyes University, Kayseri, Turkey; UCLA, Los
Angeles, CA
MDM2 and CDK4 Immunohistochemistry Is Inadequate
in the Diagnosis of Problematic Low-Grade Lipomatous
Tumors: A Follow-Up Study (48)
Michael Clay, Anthony Martinez, Mark A Edgar
Emory University Hospital, Atlanta, GA
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
9
Identification of Recurrent Copy Number Alterations

Specific to the De-Differentiated Component of
Liposarcoma, Using Capture-Based Next Generation
Sequencing (NGS) (51)
Brianne H Daniels, Daniel E Roberts, Nancy Joseph,
Andrew E Horvai
University of California San Francisco, San Francisco,
CA
10
Expression of TLE-1 and CD99 in Carcinoma: Pitfalls in

Diagnosis of Synovial Sarcoma (99)
Daniel Zaccarini, Xiaobing Deng, Jamie Tull, Charlene
Maciak, Alfredo Valente, Shengle Zhang
STOWELL-ORBISON AWARD POSTERS: BREAST PATHOLOGY
11
Histologic Characteristics of Breast Carcinomas with

Genetic Variants of Uncertain Significance: (103)
Ahmed Abdulrahman, Rebecca Heintzelman, Melanie
Corbman, Fernando Garcia
Drexel University College of Medicine, Philadelphia,
PA; Cancer Treatment Centers of America at Eastern
Regional Medical Center, Philadelphia, PA
12
Outcomes of Benign Intraductal Papillomas (IDP)

Diagnosed on Core Biopsy: Do All Need to Be Excised?
(108)
Jaya R Asirvatham, Angela Wu, Julie Jorns
University of Michigan, Ann Arbor, MI
13
Axillary Lymph Node FNA vs CNB in Breast Cancer

Patients: A Blinded Prospective Study (115)
Gonzalo Barraza, Robert L Schmidt, Elke Jarboe, Jason
M Wells, Nicole Winkler, Rachel E Factor
University of Utah Health Sciences Center, Salt Lake
City, UT
14
Do Breast Papillomas without Atypia on Core Biopsy

Require Excision? A 10-Year Single Institution Study
and Review of the Literature (120)
Christine Bookhout, Sheryl Jordan, Thomas Lawton
UNC Health Care, Chapel Hill, NC
15
Repeat HER-2/neu Testing on Grade 3 Invasive Breast

Carcinoma Resections (131)
Cody Carter, Julie Jorns
16
Micropapillary Mucinous Breast Carcinoma: An

Underrecognized Variant (140)
Katrina Collins, Andrew Ricci
Hartford Hospital, Hartford, CT
17
Optimizing Intraoperative Sentinel Lymph Node

Evaluation (142)
Margaret Compton, Emily S Reisenbichler
Vanderbilt University Medical Center, Nashville, TN
115
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
18
miR-139 in Breast Cancer Tumors and Serum a

Surrogate Marker for Tumor Aggression (143)
Hongyan Dai, Sarah Schmitt, Ziyan Pessetto, Fang Fan,
Andrew K Godwin, Ossama Tawfik
Kansas University Medical Center, Kansas City, KS
26
19
Sentinel Node Metastasis in Breast Cancer: Size

Matters (144)
Joanna Dalland, Patrick C McGrath, Reed Spaulding,
Robert McDonald, Shannon Crook, Luis Samayoa
University of Kentucky, Lexington, KY
Androgen Receptor Expression in HER2-Positive Breast

Carcinomas (203)
Alexandra Larson, Irene B Helenowski, Jennifer Pincus,
Julianne M Ubago, Adriana Rosca, Luis Z Blanco,
Kalliopi P Siziopikou
Northwestern University Feinberg School of Medicine,
Chicago, IL
27
Intratumoral Heterogeneity of Common Protein

Biomarkers Assessed by Immunohistochemistry in
Breast Cancer Tissues (206)
Jie Li, Theresa Dawidek, Veronika Liegsalz, Vasilis
Tzalis, Anette Feuchtinger, Stefanie Avril
Case Western Reserve University and University
Hospitals Case Medical Center, Cleveland, OH;
Technische Universitt Mnchen, Munich, Germany;
Helmholtz Zentrum Mnchen, Neuherberg, Germany
28
Analysis of Malignant Phyllodes Tumor (MPT) Genomic

Landscape Using Capture-Based Next Generation
Sequencing (Cb-NGS) (213)
Su-Yang Liu, Nancy Joseph, Yunn-Yi Chen, Poonam
Vohra, Gregor Krings
UCSF, San Francisco, CA
29
Breast Core Biopsy of Vascular Neoplasms -Pathologic

Features, Imaging and Clinical Findings (216)
Jose Mantilla Arango, Esperanza Villanueva-Siles,
Susan A Fineberg
Montefiore Medical Center, Bronx, NY
30
Is It Worth Performing ER, PR and HER2 Assays on All

Concurrently Sampled Ipsilateral Breast Cancers; Study
of 174 Biopsies from 85 Patients (218)
Shivali Marketkar, Kamaljeet Singh, Katrine Hansen,
Margaret Steinhoff
Women and Infants Hospital, Providence, RI; Rhode
Island Hospital, Providence, RI
31
Intraoperative Consultation of Sentinel Lymph Nodes

for Metastatic Breast Carcinoma in the Context of the
ASCOSOG Z0011 Trial (219)
Robert McDonald, Patrick C McGrath, Reed Spaulding,
Joanna Dalland, Shannon Crook, Luis Samayoa
32
Expression of Traditional Melanocytic Markers in

Invasive Mammary Carcinoma (220)
Stephanie McGregor, Gabrielle M Baker
University of Chicago Hospitals, Chicago, IL
33
Validation of Modified Magee Equation to Predict the

Oncotype DX Recurrence Score (238)
Cameron Neely, Jing Yang, Shristi Bhattarai, Limin
Peng, Uma Krishnamurti, Ritu Aneja, Xiaoxian Li
Emory University School of Medicine, Atlanta, GA;
Rollins School of Public Health, Emory University,
Atlanta, GA; Georgia State University, Atlanta, GA
34
Reactive Squamous Metaplasia in the Breast: A 20-Year

Review (239)
Emily R Nelson, Pedram Argani, Ashley CiminoMathews
Johns Hopkins, Baltimore, MD
20
21
22
23
24
25
116
The Detection of IHC-/FISH- ERBB2 Non-Amplification

Mutations in 5,606 Cases of Refractory and Metastatic
Breast Cancer: An Emerging Opportunity for Anti-HER2
Targeted Therapies (146)
Siddhartha Dalvi, Katherine Pinheiro, Ann B
Boguniewicz, Kai Wang, Siraj M Ali, Julia A Elvin, JoAnne Vergilio, James Suh, Vincent A Miller, Philip J
Stephens, Jeffrey S Ross
Albany Medical College, Albany, NY; Foundation
Medicine Inc., Cambridge, MA
Decreased Expression of miR-26b in Advanced Breast
Cancer (149)
Qingqing Ding, Yan Wang, Zhuang Zuo, Naoto T Ueno,
Wei Wei, Lei Huo
University of Texas MD Anderson Cancer Center,
Houston, TX
Impact of Chromosome 17 and HER2 Copy Number
Variability on HER2 FISH in Breast Cancer Cases with
CEP17 Copy Number Alterations[/underline] (152)
Alana R Donaldson, Shashirekha Shetty, Christine
Rivera, Bryce P Portier, James R Cook, G T Budd, Erinn
Downs-Kelly, Roger D Klein, Christopher P Lanigan,
Raymond Tubbs, Benjamin C Calhoun
Cleveland Clinic, Cleveland, OH; Houston Methodist
Hospital, Houston, TX; University of Utah, Salt Lake
City, UT
Apocrine Carcinomas Represent a Distinct, Androgen
Receptor-Positive Clinicopathologic Subset of TripleNegative Breast Cancers (162)
Chelsea E Gottlieb, Emaculate V Tebit, Scott M
Wendroth, Kristen A Atkins, Tiffany Pierson, Christiana
M Brenin, Anne M Mills
UVA, Charlottesville, VA
Correlation of p16 Expression on Cancer and
Stromal Cells with Clinicopathological and
Immunohistochemical Features of Lobular Breast
Carcinoma (169)
Aparna Harbhajanka, Ihab Lamzabi, Richa Jain, Ritu
Ghai, Vijaya B Reddy, Paolo Gattuso
Rush University Medical College, Chicago, IL
Distant Metastases in Breast Cancer Patients with
Oncotype Dx Recurrence Score Lower Than 18 (201)
Melissa Krystel-Whittemore, Edi Brogi, Zenica L
Bowser, Maura Dickler, Clifford Hudis, Hannah Y Wen
The University of Kansas Medical Center, Kansas City,
KS; Memorial Sloan Kettering Cancer Center, New
York, NY
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
35
Adrogen Receptor (AR) Expression in Resected Ductal

Carcinoma In Situ (DCIS) of Breast (240)
Laila Nomani, Olaronke O Oshilaja, Benjamin C
Calhoun, Christine N Booth, Charles D Sturgis
Clevleland Clinic, Cleveland, OH
43
36
Clinically Advanced and Metastatic Mucinous

Carcinoma of the Breast: A Comprehensive Genomic
Profiling Study (241)
Sahar Nozad, Kai Wang, Siraj M Ali, Ann B
Boguniewicz, Depinder Khaira, Julia A Elvin, JoAnne Vergilio, James Suh, Vincent A Miller, Philip J
Benign Vascular Lesions of the Breast Do Not Require

Excision (277)
Christopher Sebastiano, Lucas Gennaro, Edi Brogi,
Elizabeth Morris, Muzaffar Akram, Zenica L Bowser,
Adriana D Corben, Sandra Brennan, Melissa Murray
Memorial Sloan Kettering Cancer Center, NY, NY
44
Immunohistochemical Profile of Male Breast

Carcinoma (279)
Kate M Serdy, David Dabbs, Rohit Bhargava
Magee-Womens Hospital of University of Pittsburgh
Medical Center, Pittsburgh, PA
45
Basal Biomarkers Nestin and INPP4b Accurately

Identify Intrinsic Subtype in ER Weakly-Positive Breast
Cancer (281)
Brandon S Sheffield, Karama Asleh-Aburaya, Xiuqing
Wang, Dongxia Gao, Jennifer Won, Christine Chow,
Robert Wolber, Blake Gilks, Nickolas Myles, Malcolm M
Hayes, Philip Bernard, Torsten O Nielsen, Stephen KL
Chia, Zuzana Kos
University of British Columbia, Vancouver, BC, Canada;
University of Utah, Salt Lake City, UT; University of
Ottawa, Ottawa, ON, Canada
46
Incidence of Axillary Metastasis in Breast Carcinomas

Measuring 1cm or Less (286)
Reed Spaulding, Patrick C McGrath, Joanna Dalland,
Robert McDonald, Shannon Crook, Luis Samayoa
47
High Subcapsular CD4/CD8 Lymphocyte Ratio in the

Positive Sentinel/Axillary Lymph Node in Breast Cancer
(289)
Hongxia Sun, Min Li, Yan Gao, Robert L Hunter,
Songlin Zhang
The University of Texas Health Science Center at
Houston, Houston, TX
48
Suggested Management of Breast Sclerosing

Intraductal Papilloma without Atypia (SIP w/o A)
Diagnosed on Core Biopsy (CBX): A Semiquantitative
Approach (290)
Brittany Symbol, Andrew Ricci
49
PD-L1 Expression and the Immune Microenvironment

in Primary Invasive Lobular Carcinomas of the Breast
(293)
Elizabeth Thompson, Janis Taube, Rebecca J AschKendrick, Aleksandra Ogurtsova, Haiying Xu, Rajni
Sharma, Alan Meeker, Pedram Argani, Leisha Emens,
Ashley Cimino-Mathews
50
Mucocele-Like Lesions Diagnosed on Breast Core

Biopsy and the Risk of Upgrade to Carcinoma on
Excision (310)
Gloria Zhang, Dana Ataya, Paulette Lebda, Benjamin C
Calhoun
37
Stromal ColX1 and Tumor-Infiltrating Lymphocytes

Predict Response to Neoadjuvant Therapy in HER2Positive Breast Cancer Depending on Estrogen
Receptor Status (246)
Madhu Ouseph, Alexander Brodsky, Jinjun Xiong,
Dongfang Yang, Murray B Resnick, Yihong Wang
Rhode Island Hospital/ Brown University, Providence,
RI; Women and Infants Hospital/ Brown University,
Providence, RI
38
Papillomas without Atypia: Can Excision Be Spared?

(252)
Fresia Pareja, Sandra Brennan, Melissa Murray, Zenica
L Bowser, Elizabeth Morris, Edi Brogi, Adriana D
Corben
MSKCC, NYC, NY
39
40
41
42
Tumor Infiltrating Lymphocytes (TILs) in Triple

Negative Breast Cancer (TNBC): A Three-Tier System
Predicts Survival (253)
Fresia Pareja, Edi Brogi, Li Fu, Zenica L Bowser,
Muzaffar Akram, Larry Norton, Hannah Y Wen
MSKCC, NYC, NY; Tianjin Medical University, Tianjin,
China
p16 Is Highly Expressed in TNT and Is Associated with
Worse Overall Survival (OS) in All Breast Cancers (BC)
(260)
Kimberly S Point du Jour, Rachel Geller, Zachary J
Dureau, Yuan Liu, Cynthia Cohen, Gabriela M OpreaIlies
Emory University, Atlanta, GA; Winship Cancer
Institute
Integrated Radiopathologic Approach to Improve
Diagnostic Accuracy of Nodal Metastasis in Breast
Cancer (265)
Deepthi Rao, Irfanullah Haider, Fang Fan, Onalisa
Winblad, Ossama Tawfik
Impact of Cavity Shave Margins in Lumpectomies for
Breast Carcinoma on Final Margin Status and Rate of
Re-excision (273)
Nagla Salem, Sudeshna Bandyopadhyay, Vishakha
Pardeshi, MHD Fayez Daaboul, Lydia Choi-Kim, Rouba
Ali-Fehmi, Shashi Madan
WSU/DMC, Detroit, MI
117
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
Board
Number
STOWELL-ORBISON AWARD POSTERS: CARDIOVASCULAR
PATHOLOGY
51
52
Regional Differences in Ascending Aortic Histology:

A Comparative Histomorphologic Assessment with
Implication for Pathologic Classification (314)
Md Shahrier Amin, Cecilia Wu, Charles Leduc, Peter
T Lin, Sarah M Jenkins, William D Edwards, Joseph J
Maleszewski
Repair of the Injured Adult Heart Involves Regionally
Specific c-Kit+ Cardiac Stem Cells and New Myocyte
Formation (315)
David Angert, Remus Berretta, Hajime Kubo, Tim
Starosta, Daniel Luthringer, Steven R Houser
Cedars-Sinai Medical Center, Los Angeles, CA; Temple
University School of Medicine, Philadelphia, PA
58
Beta Amyloid Precursor Protein in Carotid Artery

Plaque Macrophages: Correlation with Features of
Plaque Stability (339)
Michael B Ward, Tyler A Jensen, Krishna Narra, Scott
McNally, Dylan Miller
Intermountain Medical Center/ University of Utah
School of Medicine, Salt Lake City, UT; University of
Utah School of Medicine, Salt Lake City, UT
59
Implementation of the New AECVP/SCVP Aorta

Consensus Grading Scheme (340)
Kevin Waters, Andrew Guajardo, Marc K Halushka
Johns Hopkins University SOM, Baltimore, MD
STOWELL-ORBISON AWARD POSTERS: CYTOPATHOLOGY
61
ATRX and DAXX Immunohistochemistry (IHC) in

Pancreatic Neuroendocrine Tumor (PNET) Fine Needle
Aspirations (FNA)- Can They Be Clinically Useful? (349)
Vaidehi Avadhani, Abigail Goodman, Cynthia Cohen,
Momin T Siddiqui
62
PLAG1: An Immunohistochemical (IHC) Marker with

Limited Utility in Separating Pleomorphic Adenoma
(PA) from Other Basaloid Salivary Gland Tumors (350)
Vaidehi Avadhani, Cynthia Cohen, Momin T Siddiqui
63
Sudden Cardiac Death with Structurally Normal Heart:

ECG Tracing and Molecular Autopsy as a Guide for
Conduction System Investigation (330)
Kalliopi Pilichou, Federico Migliore, Marco Cason,
Stefania Rizzo, Rudy Celeghin, Emanuele Bertaglia,
Elisabetta Lazzarini, Elisa Carturan, Marialuisa Valente,
Gaetano Thiene, Cristina Basso
University of Padua, Padua, Italy
ALK Rearrangement Fluorescent In-Situ Hybridization

Testing for Pulmonary Adenocarcinoma Utilizing Fine
Needle Aspiration Smears (357)
Scott Bibbey, Julie Branson, Anjum Hassan, Tu Dung T
Nguyen, Brian T Collins
Washington University in St. Louis, St. Louis, MO
64
Formalin Perfusion-Fixation of Autopsy Hearts for a

More Accurate Evaluation of Coronary Artery Stenosis
(336)
Jonathan Vaucher, Justine Turmel-Roy, Olga Sazonova,
Sylvain Page, Sylvain Trahan, Christian Couture,
Philippe Joubert
Institut Universitaire de Cardiologie et de Pneumologie
de Qubec, Quebec, QC, Canada
Bile Duct Brushings: Accuracy and Interobserver

Agreement (361)
Mary Anne Brett, Jennifer Ramsay, Leyo Ruo, Jessica
Bogach, Shangguo Tang, Tariq Aziz, Joseph Beyene,
Binod Neupane, Anne Ecobichon-Morris, Arlene
Murray, Lidia E Siek, Daniel Kowalsky-Moskaliuk, Alice
Lytwyn
McMaster University, Hamilton, ON, Canada
65
Candida and Trichomonas and High-Risk HPV Infection

(368)
Adam Cloe, Tatjana Antic
University of Chicago, Chicago, IL
54
Sudden Cardiac Death in Young Athletes: Are There

Gender Differences in the Cause of Death? (328)
Kalliopi Pilichou, Stefania Rizzo, Elisa Carturan,
Marialuisa Valente, Gaetano Thiene, Cristina Basso
55
Morphologic and Genetic Features of Arrhythmogenic

Cardiomyopathy: Are There Differences between
Sudden Death and Cardiac Transplantation Cases?
(329)
Kalliopi Pilichou, Stefania Rizzo, Elisabetta Lazzarini,
Elisa Carturan, Marco Cason, Rudy Celeghin, Annalisa
Angelini, Marialuisa Valente, Gaetano Thiene, Cristina
Basso
118
Board
Number
The Development of a Telomerase

Immunocytochemical Assay for the Detection of
Urothelial Neoplasms in Urinary Tract Cytopathology
Specimens (345)
Derek B Allison, Minesh Lalla, Sterling E Ford, Jennifer
A Collins, Christopher J VandenBussche
The Johns Hopkins University School of Medicine,
Baltimore, MD; Sienna Cancer Diagnostics Ltd.,
Melbourne, Australia
Endothelial Cell Chimerism in Human Cardiac

Allografts (320)
Gregory A Fishbein, Maristela L Onozato, Adriana Luk,
Michael M Givertz, Robert F Padera, Jr., Anthony J
Iafrate, Richard N Mitchell
Brigham and Womens Hospital, Boston, MA;
57
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
60
53
56
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
66
75
Pancreatic Endoscopic Ultrasound-Guided Fine Needle

Aspiration: The Impact of Rapid On-Site Evaluation
(427)
Ross A Miller, Mary R Schwartz, Kumar Krishnan, Dina
R Mody
Houston Methodist, Houston, TX
76
Utility of Immunohistochemistry and ETV6 (12p13)

Gene Rearrangement in Identifying Mammary Analog
Secretory Carcinoma of Salivary Gland among
Previously Diagnosed Cases of Acinic Cell Carcinoma
(432)
Rana Naous, Shengle Zhang, Alfredo Valente, Melissa
Stemmer, Kamal K Khurana
77
Next Generation Sequencing Adds Value to the PreOperative Diagnosis of Pancreatic Cysts (442)
Matthew W Rosenbaum, Martin Jones, Jonathan
Dudley, Long Le, A John Iafrate, Martha Pitman
Massachusetts General Hospital, Boston, MA; Stanford
University, Palo Alto, CA
78
Evaluation of Flow Cytometry Results from Serial

Lymph Node Specimens Shows Equally Robust
Results for FNA and Core Needle Biopsy Specimens in
Comparison to Open Biopsy Specimens (443)
Julie A Rosser, Kaleigh E Lindholm, Kathleen C Torkko,
Jeffrey T Schowinsky
University of Colorado School of Medicine, Aurora, CO
79
Accuracy of Grading Pancreatic Neuroendocrine

Tumors on Fine Needle Aspiration Samples (449)
Kurt Schaberg, Hubert D Lau, Allison J Zemek, Teri A
Longacre, Christina S Kong
Stanford University, Stanford, CA
80
RAS Mutations Are the Most Common Genetic

Alteration in Indeterminate Thyroid Cytology -2 Years
Institutional Experience (452)
Maryam Shahi, Rupendra Shrestha, Andrew Nelson,
Lynn Burmeister, Maria Evasovich Swenson, Khalid
Amin
University of Minnesota, Minneapolis, MN
False Negative HPV Tests in Women with High Grade

Squamous Intraepithelial Lesion or Carcinoma Pap
Tests: Clinical-Pathological Correlation (371)
Suzanne M Crumley, Haijun Zhou, Genevieve R Lyons,
Roland L Bassett, Abha Khanna, Gregg Staerkel, Ming
Guo
Houston, TX
67
Morphologic Criteria for Atypia in Upper Urinary

Tract Cytology: Should It Be Different from the Lower
Urinary Tract Criteria of the Paris System of Reporting
Urinary Tract Cytology (TPS)? (384)
Ozlem Fidan-Ozbilgin, Burak Bahar, Stefan E
Pambuccian, Eva M Wojcik, Guliz A Barkan
Loyola University Medical Center, Maywood, IL
68
Cytopathologist-Performed Ultrasound-Guided Fine

Needle Aspiration of PET-Detected Lesions (389)
Adam J Gomez, David Levy, Christina S Kong, Steven
R Long
Stanford Health Care, Stanford, CA
69
Benign Endometrial Cells Reporting on Pap Smears

(The 2014 Bethesda System): Is 45-Year Cutoff
Appropriate? A Study Based on 672,000 Pap Smears
with Follow-Up (390)
Zakaria Grada, Cherie Paquette, Claire M Eklund, C
James Sung, Margaret Steinhoff, M Ruhul Quddus
Women & Infants Hospital/Alpert Medical School of
Brown University, Providence, RI
70
PSMA Is a Sensitive Marker for the Diagnosis of

Metastatic Prostatic Carcinoma in Cytology Specimens
(406)
Yuying Jiang, Claire W Michael
University Hospitals Case Medical Center, Cleveland,
OH
71
Relative Value of a Cytopathologist (409)

Shivani Kandukuri, Steven Meschter, Jeffrey Prichard
Geisinger Medical Center, Danville, PA
72
Fluorescent In-Situ Hybridization with Bile Duct

Brushing Specimens: Correlation and Outcomes with
Reflex Testing Algorithm (411)
Stanley Kwong, Brian T Collins
81
The Impact of Application of the Proposed Paris

System on Concordance Rates and Frequency of
Diagnosis of Low-Grade Urothelial Carcinoma on
Voided Urine Cytology (422)
Martin J Magers, Judy C Pang, Xin Jing, Michael H
Roh, Brian Smola, Madelyn Lew
Utility of Folate Receptor Alpha (FRA)

Immunohistochemistry (IHC) in Cell Blocks (CB) of
Breast Ductal Carcinoma, Mllerian Serous Carcinoma
and Lung Adenocarcinoma (453)
Umer Sheikh, Cynthia Cohen, Momin T Siddiqui
82
On-Site Adequacy Evaluation Does Not Affect the Rate

of Nondiagnostic Thyroid Fine Needle Aspiration (466)
Janice Tyler, Helen Wang, Pamela Hartzband, James V
Hennessey, Michiya Nishino
Harvard Medical School, Boston, MA
73
74
Utility of BRCA1-Associated Protein 1 (BAP1)

Immunoperoxidase Stain in Cytology Smear/Cell Block
Preparations to Differentiate Benign Versus Malignant
Mesothelial Proliferations (426)
Zulfia McCroskey, Gregg Staerkel, Sinchita Roy
Chowdhuri
119
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
Board
Number
83
Next Generation Sequencing of NSCLC in EBUS-FNA

vs. Corresponding FFPE Samples (486)
Yaolin Zhou, Jordan P Reynolds, Maureen A
Jakubowski, Zhen Wang, Patrick C Feasel, Roger D
Klein, Yu-Wei Cheng
Laser Microdissection and Mass SpectrometricBased Proteomic Analysis of Sclerotic Bodies

(Elastocollagenous Balls) in Nephrogenic Systemic
Fibrosis (489)
Naziheh Assarzadegan, Michael J Imber, Patrick
Vanderboom, Cristine Charlesworth, Wonwoo Shon
University of Florida, Gainesville, FL; Mayo Clinic,
Rochester, MN
85
Melanoma Micronuclei Identification Using Integrative

Nuclear Grade Analysis (511)
Ying-Chun Lo, Alexander Baras, Robert W Veltri,
Nemanja Rodic
Yale-New Haven Hospital, New Haven, CT; Johns
Hopkins University School of Medicine, Baltimore, MD;
Yale University School of Medicine, New Haven, CT
86
Blood Staging in Mycosis Fungoides (521)

William Munday, Chris Tormey, Alexa Siddon
Yale School of Medicine, New Haven, CT
87
Comprehensive Genomic Profiling of Cutaneous

Merkel Cell Carcinoma (528)
Aseeb Rehman, Mark Bailey, Siraj M Ali, Julia A Elvin,
Jo-Anne Vergilio, James Suh, Ling Gao, Sara Shalin,
David M Jones, J Andrew Carslon, Martin C Mihm,
Vincent A Miller, Philip J Stephens, Jeffrey S Ross
Medicine Inc., Cambridge, MA; University of Arkansas
Medical Systems, Little Rock, AR; Brigham and
Womens Hospital and Harvard Medical School,
Boston, MA
88
89
120
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
STOWELL-ORBISON AWARD POSTERS: EDUCATION
90
STOWELL-ORBISON AWARD POSTERS:

DERMATOPATHOLOGY
84
Immunodetection of Mitotic Figures and G2+ Tumor

Nuclei with Histone Markers in Stage III Melanoma
Samples (540)
Daniel Wimmer, Michael T Tetzlaff, Carlos A TorresCabala, Denai R Milton, Priyadharsini Nagarajan, Phyu
P Aung, Victor G Prieto, Jonathan L Curry
Houston, TX
BRAF Mutation V600E Induces Expression Change
of Signaling Transduction Molecules in Metastatic
Melanoma Cell Lines (541)
Chunhui Yi, Fei Ye, Qiong Gan, David Zhang
St. Lukes-Roosevelt Hospital, Mount Sinai Medical
Center, New York City, NY; Mount Sinai Medical Center,
New York City, NY
Broadening Our Scope: A Conceptual Framework for

a Curriculum in Bioethics and Professionalism for
Pathology Trainees (559)
Ifeoma Nwadei, Cheryl Maier, Stewart Neill, Charles E
Hill, Kathy Kinlaw, Benjamin K Stoff
Emory University, Atlanta, GA; Emory University
Center for Ethics, Atlanta, GA
STOWELL-ORBISON AWARD POSTERS: ENDOCRINE
PATHOLOGY
91
Incidental Metastatic Papillary Thyroid Carcinoma: A

Clinicopathologic Study (574)
Kathleen Byrnes, Rebecca Chernock
92
Molecular and Histopathologic Characteristics of

Radioiodine-Refractory Papillary Thyroid Cancer (576)
Sung-eun Choi, Ju Yeon Pyo, Ji-seop Kim, Eunah Shin,
Soon Won Hong
Gangnam Severance Hospital, Seoul, Republic of
Korea; Hanyang University Guri Hospital, Guri-Si,
Kyeonggi-Do, Republic of Korea; CHA Gangnam
Hospital, Seoul, Republic of Korea
93
DAXX Gene: A Higher Rate of Mutation than ATRX

Gene in Neuroendocrine Tumors (580)
Abigail L Goodman, Vaidehi Avadhani, Cynthia Cohen,
Momin T Siddiqui
94
Anaplastic Thyroid Carcinoma Arising Outside the

Thyroid Gland: A Comparison of Clinical Outcomes
(588)
Jonathon Mahlow, Deborah J Chute
95
Low PASS Is an Effective Tool for Predicting NonMetastatic Pheochromocytomas (589)

Julia R Maisel, Lauren Fishbein, Katherine L
Nathanson, Virginia A LiVolsi, Debbie L Cohen,
Kathleen Montone
Perelman School of Medicine, University of
Pennsylvania, Philadelphia, PA
96
BRAF and RAS Mutation Analysis to Distinguish

Benign Ectopic Thyroid Tissue and Metatastatic
Thyroid Carcinoma (594)
Diana Murro, Sara Javidiparsijani, Alexandra
Vardouniotis, Lela Buckingham, Paolo Gattuso
Rush University Medical Center, Chicago, IL
97
Paradoxical Decrease of TSPO Expression in

Adrenocortical Carcinomas Confers a Worse Prognosis
(602)
Roberto Ruiz-Cordero, Mouhammed A Habra, Alia
Gupta, Merce Jorda, Kanishka Sircar
MD Anderson Cancer Center, Houston, TX; University
of Miami Jackson Memorial Hospital, Miami, FL
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
98
104
Increased Mucosal IgG4 Infiltration Is Associated with

Poor Clinical Outcomes in Ulcerative Colitis (641)
Brian T Brinkerhoff, Kian Keyashian, Laura Bradley,
Benjamin Larson, Jeong Lim, Nir Modiano, Judy
Collins, Terry K Morgan, Jody E Hooper
Oregon Health & Science University, Portland,
OR; Johns Hopkins University School of Medicine,
Baltimore, MD
105
Characterization of Colorectal Cancer MetastasisAssociated Genes Using Next-Generation Sequencing

(647)
Michael D Chang, Jesse L Kresak, Amy Collinsworth,
Kimberly J Newsom, Ryan A Hlady, Keith D Robertson,
Petr Starostik, Chen Liu
The University of Florida, Gainesville, FL; The Mayo
Clinic, Rochester, MN
106
Loss of Hes1 Expression Is Associated with

Microsatellite Instability in Human Colorectal
Carcinoma (661)
Min Cui, Amad Awadallah, Lan Zhou, Wei Xin
OH; Case Western Reserve University, Cleveland, OH
107
Combined GATA3 and BRST2 Immunohistochemistry

Is Both Sensitive and Specific in the Identification of
Metastatic Signet Ring Cell Carcinoma of Breast Origin
in the Upper GI Tract (669)
Elena D Diaconescu, Catherine J Streutker, Kiran Jakate
University of Toronto, Toronto, ON, Canada; Saint
Michaels Hospital, Toronto, ON, Canada
108
Are Mesenteric Tumor Deposits in Small Intestinal

Neuroendocrine Tumors a Stronger Indicator for Liver
Metastasis and Poor Prognosis Than Nodal Metastasis?
(674)
Cynthia Fata, Raul S Gonzalez, Justin M Cates,
Chanjuan Shi
Vanderbilt University, Nashville, TN; University of
Rochester Medical Center, Rochester, NY
109
Spectrum of Non-Synonymous Variants in Appendiceal

Epithelial Neoplasms Identified by Targeted Clinical
Next-Generation Sequencing (684)
Bella Goyal, Eric J Duncavage
Washington University in St. Louis, Saint Louis, MO
110
EBV Status and Molecular Alterations in Gastric

Carcinomas with Lymphoid Stroma (693)
Erika Hissong, Helen Fernandes, Pan Zhang, David
Klimstra, Jinru Shia, Rhonda K Yantiss
Weill Cornell Medical College, New York, NY; Memorial
Sloan Kettering Cancer Center, New York, NY
111
Human Papillomavirus Genotyping of Unexpected

Malignant and Pre-Malignant Lesions on
Hemorrhoidectomy Specimens (696)
Yiang Hui, M Ruhul Quddus, Jayasimha N Murthy,
Dongfang Yang, C James Sung, Shaolei Lu, Murray B
Resnick, Li Juan Wang
Warren Alpert Medical School of Brown University,
Providence, RI
Sclerosing Mucoepidermoid Carcinoma with

Eosinophilia: Clinicopathologic & Molecular Analysis of
a Distinct Entity (605)
Akeesha Shah, Kristin La Fortune, Stacey E Mills,
Zubair Baloch, Virginia LiVolsi, Sanja Dacic, Alyssa M
Luvison, Marina Nikiforova, Yuri E Nikiforov, Raja R
Seethala
University of Pittsburgh, Pittsburgh, PA; Indiana
University, Indianapolis, IN; University of Virginia,
Charlottesville, VA; University of Pennsylvania,
Philadelphia, PA
99
Mathematical Modeling of Epithelial-to-Mesenchymal

Transition in Thyroid Carcinoma Progression (607)
Kaitlin Sundling, Darya Buehler, Zhenying Guo,
Heather A Hardin, Rakesh Mandal, Celina MontemayorGarcia, Ricardo V Lloyd
University of Wisconsin, Madison, WI
100
Recurrent and Aggressive Pituitary Adenomas and

Carcinomas: A Comprehensive Genomic Profiling
Study (611)
Olga Voronel, Kyle Fedorchak, Siraj M Ali, Julia A Elvin,
Jo-Anne Vergilio, James Suh, Shakti H Ramkissoon,
Medicine Inc., Cambridge, MA; Brigham and Womens
Hospital, Boston, MA
101
Long Non-Coding RNA MALAT1 Expression in Thyroid

Tissues and Tumors (618)
Ranran Zhang, Heather A Hardin, Wei Huang, Darya
Buehler, Sofia Asioli, Alberto Righi, Francesca Maletta,
Anna Sapino, Ricardo V Lloyd
University of Wisconsin School of Medicine and Public
Health, Madison, WI; University of Bologna, Bologna,
Italy; Rizzoli Institute, Bologna, Italy; University of
Turin, Turin, Italy
STOWELL-ORBISON AWARD POSTERS: GASTROINTESTINAL

PATHOLOGY
102
103
Mcl-1 (Myeloid Cell Leukemia-1) as a Biomarker and

Prognosticator in Colorectal Adenocarcinomas (CRCs):
Protein Expression and Molecular Profiling (629)
Sanaz Ainechi, Sahar Nozad, Bryan Firestone, David M
Jones, Hwa Jeong Lee, Christine E Sheehan, Jeffrey S
Ross
Albany Medical College, Albany, NY
An Optimized Strategy for Candida Detection: Insights
from a Morphologic and Cost Comparison Study (634)
Mohammed Alsomali, Michael Arnold, Wendy L
Frankel, Rondell Graham, Phil A Hart, Dora Lam-Himlin,
Bita V Naini, Christina A Arnold
OSU, Columbus, OH; Nationwide Childrens Hospital,
Columbus, OH; Mayo Clinic, Rochester, MN; Mayo
Clinic, Scottsdale, AZ; UCLA David Geffen School of
Medicine, Los Angeles, CA
121
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
112
Yttrium-90 Microspheres as a Cause of Non-Healing

Gastric Ulcer: Histologic Features Often Mimic
Chemical Gastropathy (699)
Taylor M Jenkins, Stuti G Shroff, T Danielle Samulski,
Rashmi Tondon, Emma E Furth, Kristen Stashek
University of Pennsylvania, Philadelphia, PA
120
113
Molecular Analysis of Neurofibromatosis Type 1

Associated Gastrointestinal Stromal Tumors (710)
Heewon Kwak, Lei Zhao, Sabah Kadri, Jeremy Segal,
Bradley Long, Larissa V Furtado, Peter Pytel
University of Chicago, Chicago, IL; University of
Alabama at Birmingham, Birmingham, AL
Pediatric Focal Active Colitis. A Retrospective Review

(757)
Allison Osmond, Dhandapani Ashok, Courtney A
Francoeur, Michael Miller, Joanna C Walsh
Western University & London Health Sciences Centre,
London, ON, Canada; Childrens Hospital of Western
Ontario, London, ON, Canada
121
114
An Intimate Dance: Patterns and Clinical Relevance of

PD-L1 and PD-1 Expression in Colorectal Carcinoma
(718)
Lik Hang Lee, Marcela Santos Cavalcanti, Neil Segal,
Jaclyn Hechtman, Efsevia Vakiani, David Klimstra,
Jinru Shia
Comparison of Morphology and Proliferation

Markers of the Primary vs. Metastatic Lesions of
Gastroenteropancreatic Neuroendocrine Tumors (759)
Lincoln Pac, Claire E Murphy, Veena Shankaran,
Suntrea Hammer, Jingmei Lin, Maria Westerhoff
University of Washington, Seattle, WA; Indiana
University, Indianapolis, IN; UT Southwestern, Dallas,
TX
122
Clinicopathologic Features of Tumor Infiltrating

Neutrophils in MSI-H Colorectal Carcinoma (761)
Natalie Patel, Monika Vyas, Margaret Cho, Romulo
Celli, Buqu Hu, Xiting Yan, Dhanpat Jain, Xuchen
Zhang
123
Vasodilator-Stimulated Phosphoprotein (VASP)

Immunoreactivity Is Associated with Lymphovascular
Invasion of Colorectal Adenocarcinoma (CRC) Leading
to Liver and Lymph Node Metastases (767)
Jinhua Piao, Joanne KL Rutgers, Grant Kolar, Barbara
Nagel, Yongxin Chen, Nancy J Phillips, Susan E
Crawford, Ningling Kang, Jinping Lai
Saint Louis University School of Medicine, Saint Louis,
MO; Cedars-Sinai Medical Center, Los Angeles, CA; The
Hormel Institute, University of Minnesota and Mayo
Clinic, Austin, MN
124
Histopathologic Features of Colorectal Carcinoma in

Patients with HIV Infection (783)
Marcela Santos Cavalcanti, Keith Sigel, Jinru Shia,
Tanisha Daniel, Efsevia Vakiani, Carlie Sigel
NY; Mount Sinai School of Medicine, New York, NY
125
Pathologic Features and Pouch Outcome in Patients

with Ulcerative Colitis and Extended Backwash Ileitis
(786)
Erica Savage, John R Goldblum, Ana E Bennett, Luca
Stocchi, Deepa Patil
126
MicroRNA 150-5p Has a Role in Progression and

Possibly Therapy in Colorectal Cancer (789)
Aisha Sethi, Stefan Costinean, Prasanthi Kumchala,
Veronica Balatti, Luciano Cascione, Carlo Croce, Wendy
L Frankel
The Ohio State University, Columbus, OH; Institute
of Oncology, Bellinzona, Switzerland; University of
Nebraska Medical Center, Omaha, NE
115
A Prospective Evaluation of Incidental Fundic Gland

Polyps with Epithelial Dysplasia: Implications for
Clinical Management (728)
Isaac Lloyd, Wendy K Kohlmann, Erinn Downs-Kelly,
Wade S Samowitz, Mary P Bronner
University of Utah and ARUP Laboratories, Salt Lake
City, UT; University of Utah, Salt Lake City, UT
116
Histologic Features of Gastrointestinal Tract Biopsy in

Henoch-Schnlein Purpura (729)
Christine Y Louie, Teri A Longacre
Stanford Hospital & Clinics, Stanford, CA
117
The Notch Pathway Is Activated in Neoplastic

Progression in Esophageal Squamous Cell Carcinoma
(731)
Daniel Lubin, Stuti G Shroff, Kristen Stashek, Emma E
Furth
Philadelphia, PA
118
Goblet Cell Carcinoid of the Appendix An

Interobserver Variability Study Using Two Proposed
Classification Systems (732)
Chelsea Maedler, Thomas Arnason, Alastair P Dorreen,
Heidi Sapp, Mathieu Castonguay, Joanne Murphy,
Sorin Selegean, Weei-Yuarn Huang
Dalhousie University, Halifax, NS, Canada
119
Intestinal Helminths in a Vey Large US Patient CohortA Retrospective Review of over 81,000 Coloscopy
Samples (743)
Catherine S Morris, Nadeem Zafar, Richard S Kinsey
UTHSC, Memphis, TN; Gastrointestinal Pathology,
Memphis, TN
122
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
127
Comprehensive Multiplex Molecular Genomic

Signature in Barretts Carcinogenesis: Potential
Predictive, Prognostic, Early Diagnostic & Therapeutic
Role (791)
Seema Sethi, Shashirekha Shetty, Prashanthi N Thota,
Christine Rivera, Erica Savage, Kaveh Hajifathalian,
Mary Torrez, John R Goldblum, Deepa Patil
134
Bile Reflux May Play an Important Role in the

Development of Gastroesophageal/Gastric Cardia
Intestinal Metaplasia and Carcinoma (813)
Monika Vyas, Romulo Celli, Manpreet Singh, Natalie
Patel, Harry Aslanian, James J Farell, Daniel Boffa,
Dhanpat Jain
128
Immunostaining of Tyrosine Kinase PTK6 Decreases

in the Colonic Epithelium Ranging from Normal,
Hyperplasia, Dysplasia and Carcinoma, While
Stromal Immunostaining Increases as Tumorigenesis
Progresses (793)
Asma Sharif, Yanmin Zhang, Priya Mathur, Kyle
Meinke, Anish Shah, Roshan S Patel, Marlene
Gallegos, Ming Jin, Michael Walsh, Frederick Behm,
Virgilia Macias, Andre Kajdacsy-Balla, Angela Tyner,
Grace Guzman
University of Illinois at Chicago, Chicago, IL; Jesse
Brown Veterans Affairs, Chicago, IL
135
Epithelial to Mesenchymal Transition Predicts Distant

Metastasis in MMR-Intact Colonic Adenocarcinoma
(821)
Erik Williams, Lawrence Zukerberg, Kshitij Arora, David
T Ting, Vikram Deshpande
136
Gluten Free Diet Alleviates Irritable Bowel Syndrome

through Intestinal Epithelial Tight Junction Regulation
(824)
Richard L Wu, Artur Rangel, David Andrews, Michael
Camilleri, Jerrold R Turner
Jackson Memorial Hospital, University of Miami,
Miami, FL; Mayo Clinic, Rochester, MN; University of
Chicago, Chicago, IL
137
WNT Signaling Markers, LGR5 and AXIN2, Show

Unique Patterns of Expression in Colonic Polyps (831)
Osman Yilmaz, Tanupriya Agrawal, Kanchan Kantekure,
Yvelisse Suarez, Omer Yilmaz, Vikram Deshpande
Massachusetts General Hospital, Boston, MA; Tufts
Medical Center, Boston, MA; Massachusetts Institute of
Technology, Cambridge, MA
138
Post-Appendectomy Colorectal Adenocarcinomas

Associate with Low Rates of Lymph Node Metastasis
and High Rates of Mismatch Repair Deficiency (840)
Menglei Zhu, Wei Xin
University Hospitals Case Medical Center, Case
Western Reserve University, Cleveland, OH
129
Programmed Cell Death Ligand 1 (PD-L1) Expression in

Pancreatic Ductal Adenocarcinoma (794)
Brandon S Sheffield, Steve E Kalloger, Katy Milne, Brad
H Nelson, Daniel Renouf, David F Schaeffer
Vancouver General Hospital, Vancouver, BC, Canada;
British Columbia Cancer Agency, Victoria, BC, Canada;
British Columbia Cancer Agency, Vancouver, BC,
Canada
130
Helicobacter Heilmannii-Gastritis: Why Its Not Okay

to Wash Your Cats Bowl in the Kitchen Sink and Boys
Shouldnt Kiss Their Pigs (798)
Devin L Shrock, Andrew M Bellizzi
131
Comparative Study of Genome-Wide Copy Number

Aberrations in Colonic Mixed AdenoNeuroEndocrine
Carcinoma, Adenocarcinoma and Neuroendocrine
Carcinoma (800)
Namita Sinha, Weei-Yuan Huang
Dalhousie University, QEII Health Sciences Center,
Halifax, NS, Canada
132
Ipilimumab Induced Perforating Colitis: Severe Cases

Mimic Crohn Disease and Ulcerative Colitis (807)
Rashmi Tondon, Stuti G Shroff, Emma E Furth, Kristen
Stashek
133
Is Sloughing Esophagitis (SE) All That Its Cracked Up

to Be? Clinicopathologic Comparison of SE in Adults
and Children (809)
Yun-An Tseng, Evgeny Yakirevich, Shaolei Lu, Andres
Matoso, Murray B Resnick, Shamlal Mangray
Brown University/Rhode Island Hospital, Providence, RI
STOWELL-ORBISON AWARD POSTERS: GENITOURINARY

PATHOLOGY (INCLUDING RENAL TUMORS)
139
Prognostic Significance of Depth of Invasion in

Transurethral Resection of Bladder Specimens (843)
Mahmut Akgul, Matthew Bream, Nafiseh Janaki,
Hammad Tashkandi, Gregory MacLennan
OH
140
Does Multifocality Matter? An Evidence Based Study of

Multifocal Renal Carcinomas of Clear Cell Type (855)
Burak Bahar, Lu Wang, Nicole Andeen, Funda VakarLopez, Maria S Tretiakova, Neriman Gokden, Tatjana
Antic, Ming Zhou, Ximing Yang, Roberto Gamez,
Stefan Pambuccian, Maria M Picken, Eva M Wojcik,
Guliz A Barkan
Loyola University Medical Center, Maywood, IL;
Norhwestern University Feinberg School of Medicine,
Chicago, IL; University of Washington, Seattle, WA;
University of Arkansas, Little Rock, AR; University
of Chicago, Chicago, IL; NYU Medical Center Tisch
Hospital, New York, NY
123
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
141
149
Pathologic Correlation of Targeted Sampling in Patients

with 3D Magnetic Resonance Imaging/Transrectal
Ultrasound Fusion Biopsies (902)
Zachary J Dureau, M Andrew Toussaint, Adeboye O
Osunkoya
Emory University School of Medicine, Atlanta, GA
150
Clinicopathologic Features and Outcomes of AnteriorDominant Prostate Cancer (APCa): Implications for
Diagnosis and Treatment (905)
Sara Falzarano, Ming Zhou, Jesse K McKenney,
Christopher G Przybycin, Eric A Klein, Cristina MagiGalluzzi
Cleveland Clinic, Cleveland, OH; NYU, New York, NY
151
Pathologic Findings in Patients with Targeted

Magnetic Resonance Imaging-Guided Prostate Needle
Core Biopsies Following Prior Negative Transrectal
Ultrasound-Guided Prostate Needle Core Biopsies
(918)
Rachel Geller, Zachary J Dureau, M Andrew Toussaint,
Sherif G Nour, Adeboye O Osunkoya
152
MAGI-2 Is a Sensitive and Specific Marker of Prostatic

Adenocarcinoma: Comparison with AMACR (925)
Jeffery Goldstein, Rajen Goyal, Joseph T Roland, Lan
L Gellert, Peter E Clark, Giovanna A Giannico, Omar
Hameed
153
Breaking down the Contemporary Gleason Pattern

(GP) 4 in Prostate Cancers: Should We Report the
Percentage of Pattern 4 in Radical Prostatectomies
(RPs)? (882)
Bonnie Choy, Blake Anderson, Gladell P Paner
The University of Chicago, Chicago, IL
Human Epidermal Growth Factor Receptor 2

Expression in Micropapillary Urothelial Carcinoma of
the Bladder: An Analysis of 27 Cases (926)
Abigail L Goodman, Adeboye O Osunkoya
154
Human Hemochromatosis Protein (HFE)

Immunoperoxidase Stain Highlights Choriocarcinoma
within Mixed Germ Cell Tumors (888)
Jesse L Cox, Geoffrey A Talmon, Scott A Koepsell
University of Nebraska Medical Center, Omaha, NE
Molecular Evidence of Preneoplastic Potential of

Intestinal Metaplasia in the Urinary Bladder (928)
Zakaria Grada, Andres Matoso, Virginia Breese,
Cynthia Jackson, Ali Amin
Rhode Island Hospital/Brown University, Providence, RI
155
Oncocytic Adrenal Cortical Neoplasm, a Clinical and

Pathological Study of 39 Cases (951)
He Huang, Priya Rao, Kanishka Sirca, Mouhammed A
Habra, Miao Zhang
Houston, TX
156
Interobserver Agreement of Clear Cell Renal Cell

Carcinoma (CCRCC) Grading Systems among
Genitourinary Pathologists (957)
Matt Jeffreys, Jesse K McKenney, Neriman Gokden,
Shree G Sharma, Stephen M Bonsib, Christopher G
Przybycin, Cristina Magi-Galluzzi, Jordan P Reynolds,
Christina Stallworth, Jonathan Myles, Katherine Watts,
Emily Holthoff, Andres A Roma, Roni M Cox
UAMS, Little Rock, AR; Nephropath, Little Rock, AR;
142
143
144
145
146
147
148
124
Comparison of PTEN Expression in Mucinous Prostatic

Adenocarcinoma, Prostatic Adenocarcinoma with
Mucinous Features and Adjacent Conventional
Prostatic Adenocarcinoma: Potential Evidence of
Clonality (865)
Elizabeth Bertsch, Cristina Magi-Galluzzi, Liang Cheng,
Adeboye O Osunkoya
Emory University School of Medicine, Atlanta, GA; The
Cleveland Clinic, Cleveland, OH; Indiana University
School of Medicine, Indianapolis, IN
Divergent Molecular Pathogenesis of EBV-Negative
Lymphoepithelial Carcinomas Arising in the
Nasopharynx and Urinary Bladder Revealed by NextGeneration Sequencing (869)
Benjamin Buelow, Samia Naccache, Guixia Yu, Nancy
Joseph, Charles Chiu
CA
Mixed Epithelial and Stromal Tumor of Kidney (874)
Anna Calio, John N Eble, David J Grignon, Brett
Delahunt
University of Verona, Verona, Italy; Indiana University,
Indianapolis, IN; Wellington Medical School,
Wellington, New Zealand
Expression of Heterochromatin Protein 1 in Renal
Cortical Tumors and Identification of Its Target Genes
(880)
Lin Cheng, Tracy K Hale, Maria S Tretiakova
University of Washington, Seattle, WA; Massey
University, Palmerston North 4410, New Zealand
Molecular Subtypes of Bladder Cancer and Their

Signature Markers in Multi-Institutional Cohorts (891)
Vipulkumar Dadhania, Charles C Guo, Miao Zhang,
Tadeusz Majewski, Li Zhang, Jolanta Bondaruk,
Shizhen Zhang, Woonyoung Choi, David McConkey,
Colin Dinney, Keith Baggerly, Bogdan Czerniak
Houston, TX
Potential Pitfalls in the Utility of Programmed Death-1
Expression in the Prediction of Prognosis in Patients
with Metastatic and Non-Metastatic Clear Cell Renal
Cell Carcinoma: An Analysis of 72 Cases (898)
Michelle DiMarco, Rishi R Sekar, Dattatraya Patil, Viraj
A Master, Adeboye O Osunkoya
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
157
Whole-Mounting of Prostates from Radical

Cystoprostatectomies Enhances the Staging of Both
Bladder and Prostate Cancers within the Specimens
(958)
Liwei Jia, Robin M Elliott, Gregory MacLennan
Case Western Reserve University, Cleveland, OH
164
158
Genomic Analysis of Pure Adult Yolk Sac Tumor of the

Testis[/underline] (962)
Jennifer Katzenberg, John A Thorson, Thomas M
Ulbright, Donna Hansel
University of California at San Diego, San Diego, CA;
Indiana University, Indianapolis, IN
Next Generation Sequencing (NGS)-based Molecular

Characterization of High Grade Urothelial Carcinoma
(1017)
Dinesh Pradhan, Leonard J Appleman, Rahul Parikh,
Sheldon I Bastacky, Rajiv Dhir, Yuri E Nikiforov, Marina
Nikiforova, Somak Roy
UPMC, Pittsburgh, PA
165
159
Gleason Grade 4 Prostate Cancer Growth Patterns:

An Interobserver Study among Expert Genitourinary
Pathologists (971)
Charlotte Kweldam, Daan Nieboer, Theodorus H Van
der Kwast, Geert van Leenders, Gleason Grade 4
Subtype Collaborative Group
Erasmus Medical Center, Rotterdam, Netherlands;
University Health Network, Toronto, Canada
Papillary Renal Cell Carcinoma Is More Than One

Entity. Molecular Subtyping and Pathway Analysis
(1033)
Rola Saleeb, Pamela Plant, Eriny Tawedrous, Adriana
Krizova, Sahar Al-Haddad, Andrew Evans, Fadi Brimo,
Samantha J Wala, George M Yousef
University of Toronto, Toronto, ON, Canada; St.
Michaels Hospital, Li Ka Shing Knowledge Institute,
Toronto, ON, Canada; Toronto General Hospital,
Toronto, ON, Canada; Montreal General Hospital,
McGill University, Montreal, QC, Canada
166
The MiR-200 Family Has Prognostic Significance in

Clear Cell Renal Cell Carcinoma, through Regulation of
BAP1, and Related Molecular Pathways (1034)
Rola Saleeb, Heba WZ Khella, Qiang Ding, George M
Yousef
University of Toronto, Toronto, ON, Canada; Li Ka
Shing Knowledge Institute, St. Michaels Hospital,
Toronto, ON, Canada
167
Extensive Retraction Clefts in Invasive Urothelial

Carcinoma Are Associated with Aggressive Tumor
Behavior (1043)
Tanmay Shah, Matthew G Kaag, Jay D Raman, Wilson
Chen, Truc Tran, Sudhir Kunchala, David J DeGraff,
Guoli Chen, Joshua I Warrick
Penn State Hershey Medical Center, Hershey, PA
168
Prostate Cancer (PCa) with Overlapping Features of

Small Cell Carcinoma and Acinar Adenocarcinoma: A
Critical Appraisal of Morphology and Correlation with
Immunohistochemical (IHC) Markers (1045)
Deepika Sirohi, Steven Smith, Chisato Ohe, Mariza de
Peralta-Venturina, Daniel Luthringer, Scott A Tomlins,
Moushumi Suryavanshi, Arkadiusz Gertych, Beatrice
Knudsen, Mahul B Amin
Cedars-Sinai Medical Center, Los Angeles, CA; Virginia
Commonwealth University Health System, Richmond,
VA; University of Michigan Medical School, Ann Arbor,
MI; Rajiv Gandhi Cancer Institute and Research Center,
New Delhi, India
169
Tumors Involving the Ureteral Orifice: A

Clinicopathologic Analysis of 93 Cases (1050)
Keith Stevens, Adeboye O Osunkoya
Emory University, Atlanta, GA
170
Comparison of GRP52, mTOR, HoxB13, NKX3.1 and

Prostein in Metastatic Prostatic Adenocarcinoma
(1069)
Hai Wang, Yiang Hui, Dongfang Yang, Kara A
Lombardo, Evgeny Yakirevich, Murray Resnick, Lijuan
Wang, Shaolei Lu
160
161
Disease-Specific Survival of Patients with Invasive

Cribriform and Intraductal Prostate Cancer at
Diagnostic Biopsy (972)
Charlotte Kweldam, Intan Kummerlin, Daan Nieboer,
Esther Verhoef, Ewout Steyerberg, Theodorus H Van
der Kwast, Monique Roobol, Geert van Leenders
Erasmus Medical Center, Rotterdam, Netherlands;
University Health Network, Toronto, Canada
Pediatric Cystic Nephromas Are Morphologically,
Immunohistochemically, and Genetically Distinct from
Most Adult Cystic Nephroma/Mixed Epithelial Stromal
Tumor (MEST) Family Lesions (980)
Yunjie LI, Bruce R Pawel, Dana A Hill, George J Netto,
Jonathan I Epstein, Pedram Argani
Baltimore, MD; Childrens Hospital of Pennsylvania,
Philadelphia, PA; Childrens National Medical Center,
Washington, DC
162
FOXA1: A Transcription Factor Specific for

Neuroendocrine Differentiation in Prostate
Adenocarcinoma (1014)
Vamsi Parimi, Jung Kim, Jindan Yu, Ximing Yang,
Maria M Picken
163
Clinical Utility of FISH for the Detection of

Chromosome 3p Deletion in FFPE Tissue (1016)
Carmen M Perrino, Jason Orien, Weiqiang Zhao, Debra
L Zynger
The Ohio State University Medical Center, Columbus,
OH
125
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
171
177
The Role of Pathologic Evaluation of Endometrial

Ablation Resections in Predicting Ablation Failure and
Adenomyosis in Hysterectomy (1105)
Aurelia Busca, Carlos Parra-Herran
178
Cell Polarity Reversal in Ovarian Low-Grade

Serous Carcinomas and Micropapillary Serous
Borderline Tumors - Are They Bilogically Similar? An
Immunohistochemical Study (1145)
Yiang Hui, Joyce J Ou, Shahrzad Slater, C James Sung,
W Dwayne Lawrence, M Ruhul Quddus
Women & Infants Hospital/Alpert Medical School,
Providence, RI
179
The Microcystic, Elongated, and Fragmented (MELF)

Pattern of Invasion Is Associated with Non-Vaginal
Recurrences and Increased Lymph Node Metastases,
Even When Compared to Myoinvasive Infiltrative Cases
without MELF (1148)
Amy S Joehlin-Price, Kelsey McHugh, Julie A
Stephens, David E Cohn, David Cohen, Adrian A Suarez
The Ohio State University, Columbus, OH
180
Vulvar Elastosis: An Under-Recognized Entity Often

Confused with Lichen Sclerosus. Report of a Series
(1150)
Elizabeth Kalife, M Ruhul Quddus, Katrine Hansen,
Kamaljeet Singh, W Dwayne Lawrence
Women and Infants Hospital, Providence, RI
181
Loss of SWI/SNF Complex Protein Expression Is

Associated with Dedifferentiation in Endometrial
Carcinomas (1153)
Anthony Karnezis, Lien Hoang, Noorah Almadani,
Basile Tessier-Cloutier, Julie A Irving, Bojana
Djordjevic, Robert Soslow, David G Huntsman, C Blake
Gilks, Martin Kobel, Cheng-Han Lee
Royal Jubilee Hospital, Victoria, BC, Canada; The
Ottawa Hospital, Ottawa, ON, Canada; Memorial
Sloan Kettering Cancer Center, New York, NY; Calgary
Laboratory Services and University of Calgary, Calgary,
AB, Canada; Royal Alexandra Hospital and University
of Alberta, Edmonton, AB, Canada
182
Utility of Uroplakin-II Immunohistochemical Studies

in Differentiating Primary Cutaneous Vulvar Paget
Disease from Pagetoid Urothelial Intraepithelial
Neoplasia (1187)
Kent J Newsom, Layla Alizadeh, Samer Z Al-Quran,
Edward J Wilkinson
University of Florida, Gainesville, FL
172
The Correlation of TP53 and RB1 Genetic Alterations

and Immunohistochemical (IHC) Expression in Invasive
and Non-Invasive Urothelial Carcinoma[/underline]
(1080)
Xiaoyong Zheng, Qinghu Ren, Judy Sarungbam,
Emmet J Jordan, Satish K Tickoo, Samson Fine, YingBei Chen, Michael F Berger, Anuradha Gopalan, S
Joseph Sirintrapun, Gopa Iyer, Byron H Lee, Eugene K
Cha, Michael F Berger, David B Solit, Victor E Reuter,
Hikmat Al-Ahmadie
PD-L1 Protein Expression and PD-L1 Gene
Amplification in Urothelial Carcinoma of the Urinary
Bladder (1082)
Chunlai Zuo, Bhaskar VS Kallakury, Bryan Firestone,
Olga Voronel, Christine E Sheehan, Tipu Nazeer, Jeffrey
S Ross
Albany Medical College, Albany, NY; Georgetown
University Hospital, Washington, DC
STOWELL-ORBISON AWARD POSTERS: GYNECOLOGIC AND

OBSTETRIC PATHOLOGY
173
Discoidin Domain Receptor 1 in Advanced Stage

Ovarian Carcinoma: Prognostic Implications and
Epithelial-to-Mesenchymal Transition Associations
(1084)
Eman Abdulfatah, Marta Marco, Rafael Fridman,
Vishakha Pardeshi, Sharif Sakr, Robert T Morris,
Sudeshna Bandyopadhyay, Rouba Ali-Fehmi
WSU, Detroit, MI
174
Rare Subtype(s) and Frequency of Multi-Viral Subtype

High-Risk HPV infection in High-Grade SIL and
Squamous Cell Carcinoma in a Cervical Carcinoma
Prevalent Developing Country - A Multiplex Real-Time
PCR-Based Study (1088)
Shabnam Akhter, Pradip Manna, Mohammed Kamal, C
James Sung, W Dwayne Lawrence, M Ruhul Quddus
Women & Infants Hospital/Alpert Medical School
of Brown University, Providence, RI; BSM Medical
University, Dhaka, Bangladesh; Physicians Reference
Laboratory, Overland Park, KS
175
Prognostic Indicators of Uterine Carcinosarcoma in

Comparison to Uterine Serous Carcinoma (1090)
Baraa Alosh, Nagla Salem, MHD Fayez Daaboul, Rafic
Beydoun, Dongping Shi, Paul Tranchida, Sudeshna
Bandyopadhyay, Rouba Ali-Fehmi
WSU, Detroit, MI
176
Intervillous Thrombi Are Increased in Placentas from

Pregnancies Complicated by Diabetes (1096)
Kristen M Basnet, Rhonda Bentley-Lewis, Deborah
Wexler, Fusun Kilic, Drucilla Roberts
Massachusetts General Hospital, Boston, MA;
Rock, AR
126
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
183
Intravenous Leiomyomatosis (IVL), from Molecular

Genetics to Clinical Biomarkers: A Study of 26 Cases
(1195)
Zehra Ordulu, Anna G McDonald, Michele De Nictolis,
Eugenia Garcia-Fernandez, David Hardisson, Jaime
Prat, Esther Oliva
Massachusetts General Hospital, Boston, MA; San
Salvatore Hospital, Pesaro, Italy; Hospital Universitario
La Paz, Madrid, Spain; Wake Forest Baptist Medical
Center, Winston-Salem, NC; Hospital de la Sta Creu i
Sant Pau, Barcelona, Spain
190
184
Frequency of High-Risk Human Papillomavirus Types in

a Rural Appalachian Population (1215)
Ibrahim A Robadi, Majed Pharaon, Barbara Ducatman
West Virginia University, Morgantown, WV
Diagnostic and Prognostic Utility of MastermindLike 2 (MAML2) Gene Rearrangement Detected

by Fluorescent In-Situ Hybridization (FISH) in
Mucoepidermoid Carcinoma (1292)
Peter P Luk, James Wykes, Christina I Selinger, Rafael
Ekmejian, Jessica Tay, Kan Gao, Timothy J Eviston,
Trina Lum, Sandra A OToole, Jonathan R Clark, Ruta
Gupta
Royal Prince Alfred Hospital, Sydney, NSW, Australia;
Chris OBrien Lifehouse, Sydney, NSW, Australia;
University of New South Wales, Sydney, NSW,
Australia; The University of Sydney, Sydney, NSW,
Australia
191
Investigation of High Risk HPV E6/E7 mRNA

Transcriptional Activity by In Situ Hybridization in SinoNasal Inverted Papilloma with Associated Dysplasia
and Malignant Transformation (1298)
Shobha Parajuli, Rashmi Tondon, Amy Ziober, Kathleen
Montone, Kumarasen Cooper
Philadelphia, PA
192
Nuclear B-catenin Expression Provides a Consistent

Immunohistochemical Correlate for PAX3
Rearrangements in Biphenotypic Sinonasal Sarcoma
(1304)
Lisa M Rooper, Shih-Chiang Huang, Cristina
Antonescu, William H Westra, Justin A Bishop
Johns Hopkins Hospital, Baltimore, MD; Memorial
193
Expression of an Androgen Receptor Splice Variant in

Salivary Duct Carcinoma: An Instrument of Resistance?
(1306)
Dipti Sajed, Chin-Lee Wu, Vania Nose, Vikram
Deshpande
194
Programmed Cell Death-Ligand 1 (PD-L1) Expression in

Oral Cavity Squamous Cell Carcinoma (OSCC) (1308)
Laveniya Satgunaseelan, Jason Madore, Noel Chia,
Trina Lum, Carsten E Palme, Michael Boyer, Richard A
Scolyer, Jonathan R Clark, Ruta Gupta
University of Sydney, Sydney, NSW, Australia;
Melanoma Institute of Australia, Sydney, NSW,
Australia; University of New South Wales, Sydney,
NSW, Australia; Chris OBrien Lifehouse, Sydney, NSW,
Australia; Sydney Head and Neck Cancer Institute,
Sydney, NSW, Australia
195
Head and Neck Phosphaturic Mesenchymal Tumor:

A Report of 5 Cases with FGFR1 Fluorescence In Situ
Hybridization Analysis (1314)
Jason K Wasserman, Bibianna Purgina, Chi K Lai,
Alyssa Mahaffey, Denis Gravel, Diana Bell, Simion I
Chiosea
The Ottawa Hospital/University of Ottawa, Ottawa,
Canada; University of Pittsburgh Medical Center,
Pittsburgh, PA; MD Anderson Cancer Center, Houston,
TX
185
Mucinous Differentiation with Tumor Infiltrating

Lymphocytes Is a Feature of Sporadically Methylated
Endometrial Carcinomas (1231)
Emily A Sloan, Christopher A Moskaluk, Anne M Mills
University of Virginia, Charlottesville, VA
186
False Negative Endometrial Sampling in Patients with

Endometrial Carcinoma (1242)
Catalin Taraboanta, Heidi Britton, Blake Gilks
University of British Columbia, Vancouver, BC, Canada
187
Most High Grade Serous Carcinomas Arising in Low

Grade Serous Carcinomas Do Not Show Evidence of
TP53 or BRAF Mutations (1254)
Shabnam Zarei, Sarah E Kerr, Yan Wang, Sarah M
Jenkins, Debra A Bell
STOWELL-ORBISON AWARD POSTERS: HEAD AND NECK

PATHOLOGY
188
LEF-1 Expression in Basaloid Tumors of the Salivary

Gland (1283)
Reuben P Jacob, Shannon OBrien, Cynthia Cohen,
Momin T Siddiqui
189
Comprehensive Genomic Profiling of

Esthesioneuroblastoma Reveals a Relatively Low
Overall Genomic Alteration Frequency, but Identifies
Numerous Potential Opportunities for Targeted
Therapies (1287)
Sungeun Kim, Kyle Fedorchak, Siraj M Ali, Julia A
Elvin, Jo-Anne Vergilio, James Suh, Vincent A Miller,
Philip J Stephens, Jeffrey S Ross
127
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
196
Prognostic Histological Features in the

Phenotypic Spectrum of Polymorphous Low
Grade Adenocarcinoma (PLGA) and Cribriform
Adenocarcinoma of Minor Salivary Gland (CAMSG): A
Unicenter Retrospective Study of 69 Patients (1319)
Bin Xu, Ronald Ghossein, Nora Katabi
Memorial Sloan-Kettering Cancer Center, New York, NY
203
Absence of LEF1 Expression in Atypical CLL/SLL

Unmasks Other B-cell Lymphomas (1340)
Daniel Bustamante, Brittany Coffman, James Gale,
Mohammad Vasef, Tracy I George
University of New Mexico, Albuquerque, NM; Tricore
Laboratories, Albuquerque, NM
197
Prognostic Significance of Perineural Invasion (PNI)

in Oral Tongue Squamous Cell Carcinoma (OTSCC): A
Clinicopathologic Study of 381 Patients (1320)
Bin Xu, Jennifer Cracchiolo, Jocelyn C Migliacci,
Snehal Patel, Nora Katabi, Richard Wong, Ronald
Ghossein
204
Circulating D-2-Hydroxyglutarate and the D-2HG/L-2HG

Ratio Predict IDH Mutation in Acute Myeloid Leukemia
(1348)
Andrew Chu, Dinesh Rakheja, Richard Boriack, Mihail
Firan, Robert Collins, Arthur E Frankel, Dwight Oliver,
Weina Chen
UT Southwestern Medical Center, Dallas, TX
205
Programmed Death Ligand (PD-L1) Expression Is

Increased in Spleens of Myelofibrosis Patients (1353)
Ryan Craig, Sheryl R Tripp, Michael Deininger,
Mohamed E Salama
University of Utah, Salt Lake City, UT; ARUP Labs, Salt
Lake City, UT
206
Adult Mixed Phenotype Acute Leukemia: A Single

Institution Experience and Recommendations on
Further Refinement of Classification Criteria (1355)
Jake Dennis, Hamid Zia, Pu Chen, Andrew Chu, Prasad
Koduru, Hung S Luu, Franklin Fuda, Weina Chen
UT Southwestern, Dallas, TX
207
Decreased CCNA1 and Increased NOTCH1 Gene Levels

Correlate with Poor Treatment Response in Acute
Myeloid Leukemia (1378)
Zakaria Grada, Anna Chorzalska, Patrycja M
Dubielecka, Madhu Ouseph, Kara A Lombardo, Diana
O Treaba
Rhode Island Hospital, Warren Alpert Medical
School of Brown University, Providence, RI; Warren
Alpert Medical School of Brown University, Signal
Transduction Laboratory, Providence, RI
208
Expression of a Long Non-Coding RNA GATA3 AS-1 in

Peripheral T-Cell Lymphoma (PTCL) (1380)
Hua Guo, Peihong Hsu, Fatima-Zahra Jelloul, Peng Lee,
Judith Brody, Silvat Sheikh-Fayyaz, Xinmin Zhang
Hofstra North Shore-LIJ School of Medicine, Lake
Success, NY; New York University School of Medicine,
New York, NY
209
Genetic Heterogeneity, CD7 and CD34 Expression

Identifies a Subpopulation of Nucleophosmin
1-Mutated Acute Myeloid Leukemia (NPM1+ AML) with
Early Relapse (1393)
Carlo Hojilla, Mariam Thomas, Mahadeo Sukhai,
Suzanne Kamel-Reid, Amr Rajab, Mark Minden, Andre
Schuh, Anna Porwit
University Health Network (UHN), Toronto, ON,
Canada; The Princess Margaret Cancer Center, Toronto,
ON, Canada; UHN, Toronto, ON, Canada
STOWELL-ORBISON AWARD POSTERS: HEMATOPATHOLOGY
198
Transducer-like Enhancer of Split 1 (TLE1) and Estrogen

Receptor (ER) Are Expressed in Follicular Dendritic
Cells and Follicular Dendritic Cell Tumors: A Novel
Finding (1328)
Mir Alikhan, Hiapeng Shao, Marilyn Bui, Elizabeth
Hyjek, M Kamran Mirza, Thomas Krausz, Girish
Venkataraman
University of Chicago Medicine, Chicago, IL; Moffitt
Cancer Center, Tampa, FL; Loyola University Medical
Center, Maywood, IL
199
Ex Vivo Metabolic Analysis Using Isotopic Labeling:

A Novel Platform to Assess Cancer Metabolism in
Hematopoietic Malignancies (1332)
Sankha S Basu, Mark A Keibler, Gregory
Stephanopoulos, Scott B Lovitch
Massachusetts Institute of Technology, Cambridge, MA
200
Correlation of CD79a Expression with Additional B-Cell

Markers and Brutons Tyrosine Kinase Expression in
T-Cell Lymphoblastic Leukemia/Lymphoma (1333)
Bjorn Batdorf, Gabriela Gheorghe, Steven Kroft,
Alexandra Harrington, Horatiu Olteanu, Paul Hosking
Medical College of Wisconsin, Milwaukee, WI;
Childrens Hospital of Wisconsin, Milwaukee, WI
201
202
128
The Role of EBV in Advanced Cases of Cutaneous

T-Cell Lymphoma in Prognosis and the Immunologic
(PD-1/PD-L1) Milieu (1335)
Rahat Bhatti, Pierluigi Porcu, Bradley Haverkos, Aharon
Freud, Robert Baiocchi, Alejandro Gru
University of Virginia, Charlottesville, VA; Ohio State
University, Columbus, OH; University of Colorado,
Denver, CO
Lymphoma in IgG4-Related Disease (1336)
Jacob Bledsoe, Zachary S Wallace, John H Stone,
Vikram Deshpande, Judith A Ferry
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
210
216
Further Exploration of the Complexities of Large B-cell

Lymphomas (LBL) with MYC Abnormalities and the
Importance of a Blastoid Morphology (1436)
Erika M Moore, Nidhi Aggarwal, Urvashi Surti, Steven
H Swerdlow
University of Pittsburgh School of Medicine,
Pittsburgh, PA
217
Analysis of P53 and EZH2 Protein Expression Levels by

Immunohistochemical Staining with Mutation Burden
and Clinical Outcomes in Myelodysplastic Syndromes
(1444)
Johnny Nguyen, Kathy McGraw, Pardis Vafaii, Rami S
Komrokji, Lynn C Moscinski, Ling Zhang
Moffitt Cancer Center & Research Institute, Tampa, FL
218
Clinicopathologic Features of Erdheim-Chester Disease

(ECD): A Histiocytic Neoplasm Characterized by
Deregulation of RAS/RAF/MEK/ERK Pathway (1448)
Neval Ozkaya, Benjamin H Durham, Christopher Park,
Marc Rosenblum, Eli Diamond, Ahmet Dogan
219
Persistent Gene Mutations Detected by Next

Generation Sequencing in Acute Myeloid Leukemia
Following Induction Therapy (1449)
Aleksandra Paliga, Juan Ma, Elie Traer, Rita Braziel,
Richard Press, Guang Fan, Jennifer Dunlap
Oregon Health & Science University, Portland, OR
220
MUM1 is a Potential Marker of Bortezomib Resistance

in Mantle Cell Lymphoma (1451)
Sanjay Patel, Jens Eickhoff, Mohamed E Salama, Gene
Shaw, Brad Kahl, David T Yang
University of Wisconsin, Madison, WI; Marshfield
Clinic, Marshfield, WI; Washington University, St.
Louis, MO; University of Utah, Salt Lake City, UT
221
Genomic Abnormalities Correlated with FrenchAmerican-British (FAB) Subtypes of Acute Myeloid

Leukemia (AML) (1458)
Zheng Ping, Dejun Shen, Vishnu Reddy
222
LILRB1: A Novel Marker for Distinguishing Immature

and Mature B-cells from B Lymphoblastic Leukemia
Blasts by Flow Cytometry (1459)
Elaina Pirruccello, Hywyn Churchill, Weina Chen,
Franklin Fuda
223
Distinct Immunophenotypic Signature of MYCSingle Hit Lymphoma from MYC-Double or Triple Hit
Lymphomas (1460)
Elaina Pirruccello, Prasad Koduru, JoEllen Krueger,
Franklin Fuda, Weina Chen
224
Classification of Acute Myeloid Leukemia by the

Proposed 2016 World Health Organization Criteria at a
Single Academic Center (1472)
Meghan P Riley, Michael G Bayerl, David Claxton, Rina
Kansal
PennState Hershey Medical Center, Hershey, PA
211
212
213
214
215
A Custom Targeted Next-Generation Sequencing

Mutation Panel for Pediatric Myelodysplastic
Syndrome and Acute Myeloid Leukemia (1399)
Albert Huho, Hadi Sayeed, Erica Fang, Nimesh R Patel,
Alison A Bertuch, Angshumoy Roy, Jyotinder N Punia,
Dolores Lopez-Terrada, Maria M Gramatges, Kevin E
Fisher
Baylor College of Medicine/Texas Childrens Hospital,
Houston, TX
Proliferation Centers in Chronic Lymphocytic Leukemia/
Small Lymphocytic Lymphoma (CLL/SLL) Show
Enhanced Expression of the Therapeutic Target PI3K
and Other Targets of B-cell Receptor (BCR) Signaling
(1402)
Sarika Jain, Grant C Bullock, Steven H Swerdlow,
Sarah E Gibson
Pittsburgh, PA
ImmunoFISH Shows That the Proliferation Centers of
Chronic Lymphocytic Leukemia/Small Lymphocytic
Lymphoma (CLL/SLL) Are Not Enriched for CLLAssociated Chromosomal Abnormalities (1414)
Rebecca J Leeman-Neill, Wenhua Piao, Carol R Sherer,
Kathleen M Cieply, Steven H Swerdlow, Sarah E
Gibson
Pittsburgh, PA
Objective Quantification of BCL2 by
Immunofluorescence in Routine Biopsy Samples
Predicts Response to R-CHOP and Overall Survival in
Diffuse Large B-Cell Lymphoma (1417)
Yi Li, Kathrin Tyryshkin, Douglas Allan Stewart, Adnan
Mansoor, Tara Baetz, David P LeBrun, Ariz Akhter,
Danielle Oh
Queens University, Kingston, ON, Canada; University
of Calgary, Calgary, AB, Canada
Effects of the Use of a Hammer/Mallet during Bone
Marrow Biopsy Collection on Specimen Quality: A
Quality Improvement Project (1428)
Shakuntala Mauzo, Jesse M Jaso, Natalia Golardi,
Aaron J Baxter, Marylee M Kott, Robert L Hunter, Nghia
D Nguyen, Rongzhen Zhang, Lei Chen
University of Texas Health Science Center at Houston,
Houston, TX
Characterization of CD200 RNA and Protein Expression
in Large B-cell Lymphomas (1429)
Austin M McCuiston, Wan Rou Yang, Genevieve M
Crane, Christopher D Gocke, Michael J Borowitz,
Kathleen H Burns, Amy S Duffield
Baltimore, MD
129
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
225
Performance of Immunohistochemistry for Detection

of IDH1 R132H in Marrow Core Biopsy Specimens with
Acute Myeloid Leukemia (1477)
Julie A Rosser, Bradford Siegele, Jeffrey T Schowinsky
University of Colorado School of Medicine, Aurora, CO
232
226
Blocking a TNF Superfamily Ligand-Receptor Pair on

Acute Myeloid Leukemia Blasts Reduces Stemness,
Promotes Asymmetric Cell Division and Results in
Cellular Differentiation (1482)
Christian Schurch, Carsten Riether, Elias Buhrer,
Magdalena Hinterbrandner, Anne-Laure Huguenin,
Sabine Hoepner, Inti Zlobec, Ramin Radpour, Adrian
Ochsenbein
University of Bern, Bern, Switzerland; University
Hospital and University of Bern, Bern, Switzerland
Risk Stratification of Additional Chromosomal Changes

in Chronic Myelogenous Leukemia in Era of Tyrosine
Kinase Inhibitor Therapy (1509)
Wei Wang, Jorge Cortes, Guilin Tang, Joseph D
Khoury, Sa Wang, Carlos E Bueso-Ramos, Joseph
A DiGiuseppe, Zi Chen, Hagop Kantarjian, L Jeffrey
Medeiros, Shimin Hu
MD Anderson Cancer Center, Houston, TX; Hartford
Hospital, Hartford, CT
233
Biological and Clinical Significance of Cereblon

Expression in [/underline]De Novo[/underline] Diffuse
Large B-Cell Lymphoma (BLBCL)[/underline] (1522)
Yan Xie, Zijun Y Xu-Monett, Alexander Tzankov, Attilio
Orazi, Govind Bhagat, Eric D Hsi, Maurilio Ponzoni,
Michael B Moller, Miguel A Piris, L J Medeiros, Ken H
Young
Houston, TX; University of Texas Medical Branch,
Galveston, TX; University Hospital, Basel, Switzerland;
Weill Medical College of Cornell University, New York,
NY; Columbia University Medical Center, New York,
NY; Cleveland Clinic, Cleveland, OH; San Raffaele H.
Scientific Institute, Milan, Italy; Odense University
Hospital, Odense, Denmark; Hospital Universitario
Marques de Valdecilla, Santander, Spain
227
228
229
Myeloproliferative Neoplasms with Concurrent BCRABL1 Translocation and JAK2 V617F Mutation (1486)
Craig Soderquist, Mark D Ewalt, David Czuchlewski,
Julia Geyer, Heesun J Rogers, Daria Babushok,
Elizabeth Hexner, Attilio Orazi, Eric D Hsi, Sa Wang,
Carlos E Bueso-Ramos, Daniel A Arber, Adam Bagg
University of Pennsylvania, Philadelphia, PA; CedarsSinai Medical Center, Los Angeles, CA; University
of New Mexico, Albuquerque, NM; Cleveland Clinic,
Cleveland, OH; MD Anderson Cancer Center, Houston,
TX; Stanford University, Stanford, CA; Weill Cornell
Medical College, New York, NY
A Cytogenetic and Molecular Study of Myelodysplastic
/Myeloproliferative Neoplasm Unclassifiable (MDS/
MPN-U) (1501)
Pardis Vafaii, Jeffrey Lancet, Johnny Nguyen, Ling
Zhang
Moffitt Cancer Center, Tampa, FL
Analysis of ASXL1 Mutations in a Large Series of
Myeloid Malignancies (1503)
Michael Van Ness, Philippe Szankasi, Kimberly Frizzell,
Wei Shen, Todd W Kelley
University of Utah/ARUP Laboratories, Salt Lake City,
UT
230
Identification of Ph-Like Acute Lymphoblastic

Leukemia Based on Characteristic Morphologic,
Immunophenotypic, and Genetic Features (1504)
Charles van Slambrouck, Kai Lee Yap, Madina
Sukhanova, Emily Curran, Jason Cheng, John
Anastasi, Jennifer McNeer, Wendy Stock, Gordana
Raca, Sandeep Gurbuxani
231
Pathologist-Driven Test Utilization in Hematopathology

(1506)
Celina Villa, Tracy I George, Kathryn Foucar, Devon
Chabot-Richards
University of New Mexico, Albuquerque, NM
130
STOWELL-ORBISON AWARD POSTERS: INFECTIOUS DISEASE

PATHOLOGY
234
Human Parechovirus and Enterovirus Initiate Divergent

Innate Immune Responses in the CNS: Pathogenic and
Diagnostic Implications (1537)
Danielle Fortuna, Ana Maria Cardenas, Erin H Graf,
Larry Harshyne, Kevin Quann, DCraig Hooper, Mark T
Curtis
Thomas Jefferson University Hospital, Philadelphia,
PA; Childrens Hospital of Philadelphia, Philadelphia, PA
235
Whole-Genome Sequencing Analysis of blaKPCProducing Klebsiella pneumonia in Suburban New

York City, 2005-2014 (1539)
Pallavi Khattar, Henry Lin, Weihua Huang, Jian
Zhuge, Pramod Mayigowda, Taliya Farooq, Nevenka
Dimitrova, John T Fallon, Guiqing Wang
Westchester Medical Center at New York Medical
College, Valhalla, NY; New York Medical College,
Valhalla, NY; Philips Research North America, Briarcliff
Manor, NY
STOWELL-ORBISON AWARD POSTERS: INFORMATICS
236
A Web-Based Platform-Independent Whole Slide

Imaging Education Suite for Pathology Didactics
(1553)
Paul Christensen, Nathan Lee, Suzanne Z Powell,
Michael J Thrall, Patricia Chevez-Barrios
Houston Methodist Hospital, Houston, TX
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
237
245
Spectrum of Glomerular Lesions in Native Renal

Biopsies with TRIs (1602)
Rajib Gupta, Serena Bagnasco, Naima Carter-Monroe,
Lois Arend
246
Clinicopathologic Correlation of Acute Kidney Injury in

Human Patients (1604)
Satoru Kudose, Masato Hoshi, Sanjay Jain, Joseph
Gaut
247
Hypoxia in Human Renal Disease, Always Suspected,

but Not Usually Demonstrated: Analysis with Carbonic
Anhydrase 9 (1615)
Liza Quintana, Nika Aljinovic, Seymour Rosen
Boston Childrens Hospital, Boston, MA
248
Vinyl Carbamate Induces Membranoproliferative

Glomerulonephritis in an In-Bred Murine Bioassay
Model (1625)
Neha Varshney, Paula M Kramer, William T Gunning
University of Toledo, Toledo, OH
249
Molecular Diagnostics for Glomerulonephritis in

Routine Formalin-Fixed Paraffin-Embedded Native
Kidney Biopsies (1627)
Kristalee Watson, Benjamin Adam, Neesh Pannu,
Michael Mengel
University of Alberta, Edmonton, AB, Canada
250
Immunotherapy Mitigates Racial Disparities in Lupus

Nephritis Outcomes (1628)
Parker Wilson, Michael Kashgarian, Gilbert Moeckel
238
Validation of the Mobile Whole Slide Imaging as a

Low Resource Acquisition and Transport Technique for
Microscopic Pathological Specimens (1563)
Fatima-Zahra Jelloul, Louis J Auguste, Dhaval H
Palsana, Tawfiqul Bhuiya, Michael J Esposito
Hofstra North Shore-LIJ, Bellerose, NY; New York
Validation of Whole Frozen Section Slide Image
Diagnosis in Surgical Pathology (1576)
Vamsi Parimi, Adrianna Borys, Yi Zhou, Roberto
Gamez, Ewa Borys, Maria M Picken, Dariusz Borys
Loyola University Medical Center, Maywood, IL; NYU,
New York, NY
STOWELL-ORBISON AWARD POSTERS: KIDNEY/RENAL

PATHOLOGY (INCLUDING TRANSPLANTATION)
239
240
241
mRNA Diagnosis of Antibody-Mediated Rejection from

Routine Paraffin Sections of Renal Transplant Biopsies
in a Nonhuman Primate Model (1585)
Benjamin Adam, R Neal Smith, Tatsuo Kawai, A
Benedict Cosimi, Robert B Colvin, Michael Mengel
University of Alberta, Edmonton, AB, Canada; Harvard
Medical School and Massachusetts General Hospital,
Boston, MA
Acute Allograft Glomerulopathy: A Distinct Form of
Cellular Rejection (1586)
Osamah AL-Badri, Mariam P Alexander, Fernando G
Cosio, Lynn D Cornell
The Pathologic Spectrum of Acute Myoglobulinuric
Renal Failure (1587)
Firas Al-Delfi, Elba A Turbat-Herrera, Guillermo A
Herrera
Louisiana State University Health Sciences Center in
Shreveport, Shreveport, LA
242
Apolipoprotein A-IV Amyloidosis Has a Renal

Medullary Interstitial Pattern of Deposition Report of
10 Consecutive Cases (1590)
Md Shahrier Amin, Surendra Dasari, Paul J Kurtin,
Julie Vrana, Jason D Theis, Sanjeev Sethi
243
Dendritic Cells in Renal Biopsies of Patients with LightChain Mediated Tubular Interstitial Nephritis (1597)
Mingyu Cheng, Guillermo A Herrera
Louisiana State University Health Sciences Center,
Shreveport, LA
244
Capsulitis: A Novel Histologic Correlate in T-Cell

Mediated Rejection (1600)
Alexander J Gallan, Kammi J Henriksen, Anthony
Chang
STOWELL-ORBISON AWARD POSTERS: LIVER
251
Morphoproteomics Provides Tumorigenic Correlates in

Hepatitis C-Associated Hepatocellular Carcinoma with
and without TACE Treatment (1633)
Manju Ambelil, Suhair A AlSalihi, Sadhna Dhingra,
Robert Brown
Houston, TX
252
Is Von-Meyerberg Complex Preneoplastic for

Intrahepatic Cholangiocarcinoma? (1637)
Amarpreet Bhalla, Kurt Fisher, Jingmei Lin
253
Molecular and Cytogenomic Profiling of Hepatic

Adenocarcinoma Expressing Inhibin, a Mimicker
of Neuroendocrine Tumors: Proposal to Reclassify
as Cholangioblastic Variant of Intrahepatic
Cholangiocarcinoma (1639)
David R Braxton, Debra F Saxe, Kristen Stashek, Stuti
G Shroff, Naveena Damjanov, Jennifer JD Morrissette,
Rashmi Tondon, Emma E Furth
University of Pennsylvania, Philadelphia, PA; Emory
University, Atlanta, GA
131
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
254
Histologic Comparison of Donation after Cardiac Death

(DCD) Liver Transplant Recipients with Non-Hepatitis C
(HCV) Related Cirrhosis (1640)
Kathleen Byrnes, Neeta Vachharajani, Maria M Doyle,
Ilke Nalbantoglu
263
Is All Inflammation within Temporal Artery Biopsies

Temporal Arteritis? (1708)
Liwei Jia, Marta Couce, Mark L Cohen
Case Western Reserve University/University Hospitals
Case Medical Center, Cleveland, OH
255
Evaluation of the Clinical TNM Staging System,

Pathological TNM Staging System, and BCLC Staging
System of Hepatocellular Carcinoma: A Study of 1021
Cases of Curative Liver Resection (1655)
Tian Feng, Ji Yuan
Department of Pathology, Zhongshan Hospital, Fudan
University, Shanghai, Shanghai, China
264
256
Applying Criteria for Hepatocellular Neoplasm of

Uncertain Malignant Potential Reclassifies >50% of
Hepatocellular Adenomas (1668)
Brent Larson, Maha Guindi
Cedars-Sinai Medical Center, Los Angeles, CA
Filum Pathology of Occult Tethered Cord Syndrome in

Ehlers Danlos Patients (1728)
Michael Punsoni, Jeffrey Julian, Grant Jolly, Jerrold
L Boxerman, David B Choi, Pradeep Chopra, John E
Donahue, Krisztina Moldovan, Edward G Stopa, Petra
M Klinge
Brown University, Rhode Island Hospital, Providence,
RI; Warren Alpert Medical School of Brown University,
Providence, RI
265
MGMT Promoter Methylation Status and Overall

Survival in Glioblastoma Patients (1733)
Daniel Xia, Neal Lindeman
257
Mechanical Forces Directly Modulate Hepatocellular

Expression & Distribution of Nuclear Lamina Proteins
Lamin A & B: Congestive Hepatopathy as a Pure Force
Injury Model (1670)
Crystal Magno, Emma E Furth
Hospital of the University of Pennsylvania, Philadephia,
PA
258
Caught in Action! Hepatic Arteriolar Thrombi Are

a Likely Cause of Ischemic Cholangiopathy (IC) in
Donation after Cardiac Death (DCD) Allografts (1679)
Natalia Rush, Chandrashekhar Kubal, Romil Saxena
259
A Novel Histologic Diagnostic Algorithm for Hepatic

Graft Versus Host Disease (1683)
Ashley E Stueck, Thomas Schiano, M Isabel Fiel
260
Immature B-cells Can Be Detected in a Subset of Adult

and Pediatric Liver Biopsies: A Potential Pitfall in the
Diagnosis of B Lymphoblastic Leukemia/Lymphoma
(1688)
Kwun Wah Wen, Ryan M Gill
CA
261
Acute Antibody-Mediated Rejection after ABOCompatible Pediatric Liver Transplantation:

Histopathologic Study with Clinical Correlation (1694)
Wendi Zhou, Laura Wozniak, Jeffrey D Whitman, Bita
V Naini
UCLA, Los Angeles, CA
STOWELL-ORBISON AWARD POSTERS: NEUROPATHOLOGY

AND OPHTHALMIC PATHOLOGY
262
132
Malignant Peripheral Nerve Sheath Tumors

Are Negative for Estrogen Receptor by
Immunohistochemistry (1700)
Dylan Coss, Jennifer Ju, Anne M Mills
STOWELL-ORBISON AWARD POSTERS: PANCREAS AND

BILIARY TREE
266
Intra- and Interobserver Variability in the Assessment

of Ampullary Dysplasia (1739)
Felicia Allard, Jeffrey Goldsmith, Gamze Ayata, Larry
Brown, Tracy Challies, Robert Najarian, Imad Nasser,
Helen Wang, Eric Yee
267
Oncocytic-type of Intraductal Papillary Mucinous

Neoplasm (IPMN): An Analysis of 25 Cases (1740)
Gokce Askan, David Klimstra, Volkan Adsay, Peter
Allen, Bahar Memis, Carlie Sigel, Olca Basturk
MSKCC, NYC, NY; Emory University, Atlanta, GA
268
ATRX/DAXX Loss Is Highly Specific for Metastatic

Pancreatic Neuroendocrine Tumors (1749)
Michelle Heayn, Raja R Seethala, Aatur Singhi
269
Undifferentiated Pancreatic Carcinomas Display

Enrichment for Frequency and Extent of PD-L1
Expression by Tumor Cells (1756)
Heidi D Lehrke, Rondell Graham, Dora Lam-Himlin,
Robert R McWilliams, Thomas C Smyrk, Lizhi Zhang
Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale,
AZ
270
Concordance of Tumour Hypoxia in Resectable PDAC

in Patients on the Pimo-Panc Clinical Trial and Patient
Derived Xenografts Using Semi-Quantitative Image
Analysis (1774)
Iram Siddiqui, Neesha Dhani, Pinjiang Cao, Jade Bilkey,
Trevor McKee, Trevor Do, Jing Xu, Steven Gallinger,
David Hedley
University of Toronto, Toronto, ON, Canada; UHN,
Toronto, ON, Canada; Definiens Tissue Phenomics,
Boston, MA
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
271
GATA-3 Expression in Pancreas Cancer (1778)

Sagar J Vishal, Craig Dunseth, James J Mezhir,
Andrew M Bellizzi
278
272
The Diagnostic Utility of TCTE3 as a Novel

Immunohistochemical Marker for Pancreatobiliary
Tumors (1783)
Chaohui L Zhao, Lijuan Wang, Evgeny Yakirevich,
Murray B Resnick, Shaolei Lu
Next Generation Sequencing of Tumors: An

Institutional Experience of 200 Consecutive Cases
(1815)
Snehal Patel, Andy Pao, Jean Lopategui
279
273
Non-Mucinous Epithelium Is a Common Finding in

Mucinous Cystic Neoplasms of the Pancreas and
Liver and May Represent a Precursor to the Mucinous
Component (1784)
Kristen E Zhelnin, Yue Xue, Brian Quigley, Michelle
D Reid, Hyejeong Choi, Bahar Memis, Volkan Adsay,
Alyssa M Krasinskas
Emory University, Atlanta, GA; Ulsan University
Hospital, Ulsan, Republic of Korea
Utility of Genomic Analysis in Differentiating

Synchronous Independent Lung Adenocarcinomas
from Primary Adenocarcinomas with Intrapulmonary
Metastasis (1817)
Jad Saab, Hamid Zia, Susan Mathew, Michael J Kluk,
Navneet Narula, Helen Fernandes
NewYork Presbyterian Hospital-Weill Cornell Medical
College, New York, NY
STOWELL-ORBISON AWARD POSTERS: PEDIATRIC
PATHOLOGY
280
A Strategy for Helicobacter Immunohistochemistry

Utilization in the Pediatric Setting: Details from a
Morphologic and Cost: Benefit Analysis (1832)
Miriam Conces, Christina A Arnold, Michael Arnold
Nationwide Childrens Hospital, Columbus, OH;
Columbus, OH
281
High Level Expression of Divergent Endodermal

Lineage Markers in Gonadal and Extragonadal Yolk Sac
Tumors (1842)
Hadi Shojaei, Hong Hong, Raymond W Redline
OH
282
Targeted Sequencing Analysis of Aggressive Pediatric

Rhabdomyosarcomas (1843)
Olivia L Snir, Farzana D Pashankar, Zenta Walther, Karin
E Finberg, Jeffrey L Sklar, Raffaella Morotti
283
Tracheal Fibromas Represent -Catenin-Mediated

Fibroproliferative Disease (1847)
Henry Tran, David Parham
Childrens Hospital Los Angeles, Los Angeles, CA
STOWELL-ORBISON AWARD POSTERS: PATHOBIOLOGY

(INCLUDING PAN-GENOMIC/PAN-PROTEOMIC APPROACHES
TO CANCER)
274
275
276
277
Recurrent Chromosomal 8q24.21 Abnormalities

and Their Functional Relevance in Pediatric Acute
Leukemias (1791)
Jinjun Cheng, Joy Nakitandwe, Ina Radtke, Gang Wu,
Tanja Gruber, Jinghui Zhang, Charles G Mullighan,
James Downing
St Jude Childrens Research Hospital, Memphis, TN;
The University of Tennessee Health Science Center,
Memphis, TN
Clinical Utility of a Next-Generation Sequencing
Oncology Panel Designed for Low Input DNA (1796)
Midhat S Farooqi, David B Lieberman, Elizabeth M
Azzato, Daniel DeSloover, Robert Daber, Jennifer JD
Morrissette
Philadelphia, PA; St. Jude Childrens Research Hospital,
Memphis, TN; Color Genomics, Burlingame, CA; BioReference Laboratories, Elmwood Park, NJ
Proteomic Analysis of Formalin-Fixed ParaffinEmbedded Metastatic Well-Differentiated Pancreatic
Neuroendocrine Tumors Yields Valuable Insights into
Tumorigenesis, Biomarkers, and Therapeutic Targets
(1799)
Michael Greenwood, Stephen Luebker, Audrey J
Lazenby, Scott A Koepsell
Somatic Mutational Landscape of Inflammatory
Bowel Disease-Associated Signet Ring Cell Colorectal
Carcinoma (1807)
Amy A Lo, Helio A Costa, Jim Zehnder, Sam Rao,
Carlos D Bustamante, Guang-Yu Yang, Nike Beaubier
Stanford School of Medicine, Stanford, CA;
Northwestern School of Medicine, Chicago, IL
STOWELL-ORBISON AWARD POSTERS: PULMONARY

PATHOLOGY (INCLUDING MEDIASTINAL)
284
Squamous Metaplasia: Indicator of Acute Exacerbation

and Poor Prognostic Factor in Usual Interstitial
Pneumonia (1867)
Masatake Hara, Mikiko Hashisako, Yasuhiko Yamano,
Takeshi Johkoh, Yasuhiro Kondoh, Hiroyuki Taniguchi,
Junya Fukuoka
Nagasaki University School of Medicine, Nagasaki,
Japan; Nagasaki University Graduate School of
Biomedical Sciences, Nagasaki, Japan; Tosei General
Hospital, Seto, Aichi, Japan; Kinki Central Hospital
of Mutual Aid Association of Public School Teachers,
Itami, Hyogo, Japan
133
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
285
Next Generation Sequencing: A Novel Approach to

Distinguish Multifocal Primary Lung Adenocarcinomas
from Intrapulmonary Metastases (1872)
Wendy Kadi, Snehal Patel, Jean Lopategui, Ann
E Walts, Alberto M Marchevsky, Andy Pao, Tudor
Mudalige, Angela Aguiluz
Cedars Sinai Medical Center, Los Angeles, CA
293
286
Primary Mediastinal Germ Cell Tumors: A

Clinicopathologic Study of 32 Cases (1884)
Liping Liu, Rafael E Jimenez, John C Cheville, MarieChristine Aubry, Anja C Roden
Stromal Inflammation Score: A Prognostic H&E

Biomarker for Squamous Cell Carcinomas of the Lung
(1938)
Daniel Xia, Ruben Casanova, Alex Soltermann, Andrew
H Beck
University of Zurich, Zurich, Switzerland; Beth Israel
Deaconess Medical Center, Boston, MA
294
287
Pleuropulmonary Solitary Fibrous Tumors- A

Clinicopathologic Study of 84 Cases with Comparison
of Proposed Risk Stratification Systems (1893)
Wadad Mneimneh, Sarah M Jenkins, Marie Christine
Aubry, Jennifer M Boland
Malignant Melanoma Presenting as Thoracic Midline

Malignancy: Clinicopathological and Molecular
Features (1941)
Keluo Yao, Weiqiang Zhao, David Cohen, Alejandro
Gru, Greg Otterson, Konstantin Shilo
Columbus, OH
288
Detection of BRAF Mutation in Lung Adenocarcinoma

by Next-Generation Sequencing: Beyond V600E
Mutation (1916)
Kevan Salimian, Roghayeh Fazeli, Gang Zheng, Zahra
Maleki
The Johns Hopkins Hospital, Baltimore, MD
289
Programmed Cell Death 1 Biomarker Testing: RNA and

Protein Assessment (1919)
Brandon S Sheffield, Regan Fulton, Katy Milne, Celine
Jacquemont, Brad H Nelson, Cheryl Ho, Allen M Gown,
Diana N Ionescu
PhenoPath, Seattle, WA
290
Discrepancy in Detection of Anaplastic Lymphoma

Kinase (ALK) Gene Status in Lung Cancer by
Immunohistochemistry (IHC), and Fluorescent In Situ
Hybridization (FISH) (1921)
Hemlata Shirsat, Weei-Yuarn Huang, Wenda Greer,
Mathieu Castonguay, Zhaolin Xu
Dalhousie University, Halifax, NS, Canada
291
Airway Centered Neutrophils in Post-Transplant

Transbronchial Biopsies: A Poor Predictor of Infection
(1923)
Payal Sojitra, Akshay Muralidhar, Sana Quddus, Swati
Mehrotra, Vijayalakshmi Ananthanarayanan
292
134
Elevated Integrin 64 Expression Is Associated with

Venous Invasion and Decreased Survival in Squamous
Rachel Stewart, Dava West, Chi Wang, Heidi Weiss,
Tamas Gal, Eric Durbin, William OConnor, Min Chen,
Kathleen L OConnor
STOWELL-ORBISON AWARD POSTERS: QUALITY

ASSURANCE
295
Ambiguous p53 Immunohistochemical Patterns and

Role of Tissue Processing: Correlation with DNA
Sequencing (1946)
Anand Annan, Joe Z Zhao, Kelly Smith, Sanam Husain,
Elizabeth Gillies, Rosemary Zuna
University of Oklahoma Health Sciences Center,
Oklahoma City, OK; OU Medical Center, Oklahoma City,
OK
296
Quality of Reporting in Predictive Biomarker Studies in

Anatomic Pathology Journals (1955)
Justin Caron, Michael B Cohen, Robert L Schmidt
University of Utah School of Medicine, Salt Lake City,
UT
297
Fresh Cut Versus Stored Cut Paraffin-Embedded Tissue:

Effect on Immunohistochemical Staining for Common
Breast Cancer Markers (1967)
Catherine Forse, Dushanthi Pinnaduwage, Shelley Bull,
Anna Marie Mulligan, Irene Andrulis
University of Toronto, Toronto, ON, Canada; Mount
Sinai Hospital, Toronto, ON, Canada; University Health
Network, Toronto, ON, Canada
298
HPV Status and Other Contributing Factors to Negative

Pap Tests in Women with Biopsy Proven High Grade
Cervical Lesions (1970)
Steven Goodman, Roxanne R Mody, Donna Coffey,
Blythe Gorman, Eric Luna, Donna Armylagos, Mary R
Schwartz, Dina R Mody, Yimin Ge
Houston Methodist Hospital, Houston, TX; University
of Texas, Health Science Center, Houston, TX;
BioReference Laboratories, Elmwood Park, NJ
299
Impact of Changes in the Helicobacter Pylori (HP)

Detection Protocol on Reported HP Rates (1975)
Bogdan Isaila, Razvan Lapadat, Yi Zhou, Xianzhong
Ding, Stefan Pambuccian
POSTER
POSTERSESSION
SESSIONI
Monday,
Monday, March
March 14,
23, 2016
2015
9:30
9:30 AM
AM -- 12:00
12:00 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
300
Osteomyelitis and Lower Extremity Amputations at a

Single Institution: A Quality Assurance Study (1981)
Valerie Lockhart, Erin E Langford, Guillermo A Herrera
LSU Health Shreveport, Shreveport, LA
305
301
Validation of Computer-Assisted ER, PR, Her2, & Ki-67

IHC Quantitation (1989)
Charles Myers, Cynthia Cohen, Momin T Siddiqui, Bill
Li, Godfrey M Guerzon, Diane Lawson, Geoffrey Smith
Emory, Atlanta, GA
The Intraoperative Immunohistochemical Staining of

CD56 and CK19 Improves Surgical Decision for Thyroid
Follicular Lesions (2032)
Sung-eun Choi, Eunah Shin, Ju Yeon Pyo, Soon Won
Hong
Yonsei University Gangnam Severance Hospital, Seoul,
Republic of Korea; Hanyang University Guri Hospital,
Seoul, Republic of Korea; Gangnam CHA Hospital,
Seoul, Republic of Korea
302
Switching from Performing Helicobacter Pylori

Ancillary Studies Upfront to On Demand: Impact
on Reimbursements and Work Relative Value Units
(1991)
Reeba Omman, Razvan Lapadat, Yi Zhou, Mohammed
Atieh, Xianzhong Ding, Stefan E Pambuccian, Swati
Mehrotra
306
Pathologic Staging of Endometrial Cancers: Is There

Benefit to Submitting Adipose Tissue Remaining after
Gross Identification of Lymph Nodes? (2037)
Nicola Dundas, Jordan Roberts, Ekene Okoye, Donna
Coffey, Michael Deavers
Houston Methodist Hospital, Houston, TX
307
SOX11 Expression In 125 Neuroendocrine Tumors:

Increased Expression In Neuroendocrine Carcinomas
(2038)
Laura P Fajardo, Gustavo C Verardino, Anabela C
Caruso, Ana Lucia G Areas, Cesar S Bastos, Monique F
Silva, Fabiane C Macedo, Nathalie QPC Correa, Roberta
AP Albieri, Deborah P Siqueira, Andrea RC Pires
Fonte Medicina Diagnostica, Niteroi, RJ, Brazil;
Universidade Federal Fluminense, Niteroi, RJ, Brazil;
Hospital Naval Marcilio Dias, Rio de Janeiro, RJ, Brazil;
Hospital Sao Vicente de Paulo, Rio de Janeiro, RJ,
Brazil
308
Is Mammary Analogue Secretory Carcinoma of the

Salivary Glands a Distinct Entity from Acinic Cell
Carcinoma: An Ultrastructural Study (2041)
Julie Guilmette, William C Faquin, G Petur Nielsen,
Martin Selig, Vania Nose, Peter M Sadow
University of Montreal Medical Center, Montreal, QC,
Canada; Massachusetts General Hospital and Harvard
Medical School, Boston, MA
309
Calretinin-Positive Lung Adenocarcinoma: An

Ultrastructural Study (2077)
Ivonne Vazquez, Raquel Albero, Lorena Diaz, Nuria
Juanpere, Lara Pijuan, Teresa Baro, Sergio Serrano,
Josep Lloreta
Consorci Sanitari Parc de Salut Mar, Hospital del Mar,
Barcelona, Spain; University Pompeu-Fabra, Barcelona,
Spain; Autonomous University of Barcelona,
Barcelona, Spain
STOWELL-ORBISON AWARD POSTERS: TECHNIQUES

(INCLUDING ULTRASTRUCTURE)
303
304
Complementary Value of Electron Microscopy and

Immunohistochemistry in the Diagnosis of Non-Small
Raquel Albero, Lara Pijuan, Mercedes Simon, Nuria
Juanpere, Ivonne Vazquez, Adria Lloret, Jessica
Munne, Ignacio Sanchez, Sergio Serrano, Josep Lloreta
Hospital del Mar, Barcelona, Spain; Istituto Clinico
Humanitas, Milan, Italy; Autonomous University of
Barcelona, Barcelona, Spain; Pompeu Fabra University,
Barcelona, Spain
A Comparison of Manual Counting with Camera
Captured Images and Digital Image Analysis for
Ki-67 Proliferative Index Assessment in Pancreatic
Neuroendocrine Tumors (2029)
Elliott Burdette, Charles Myers, Geoffrey Smith,
Cameron Neely, Abigail L Goodman, Diane Lawson,
Cynthia Cohen
PROFFERED
PROFFERED PAPERS
PAPERS
Monday,
Monday,March
March23,
14,2015
2016
CC HALL 4E
CHAIRED BY: ONDREJ HES AND STEWART FLEMING
1:00
Clear Cell Renal Cell Tumors with Intact VHL and

Chromosome 3p: How Many Entities Exist? (1076)
Sean R Williamson, Dhananjay A Chitale, Laura
Favazza, Ravi Barod, Craig G Rogers, Nallasivam
Palanisamy, Nilesh S Gupta
Henry Ford Health System, Detroit, MI
1:15
1:00AM
PM- -12:00
3:00 PM
PM
|| 8:30
Sarcomatoid Clear Cell RCC Shows a Distinct

Molecular Pathogenesis and Driver Mutation Profile
(1044)
Kanishka Sircar, Zixing Wang, Tae-Beom Kim, Bo Peng,
Jose A Karam, Chad Creighton, Chi-Wan Chow, Jaime
Rodriguez Canales, Pheroze Tamboli, Gordon Mills,
Kenna Shaw, Ken Chen
MD Anderson, Houston, TX; Baylor College of
Medicine, Houston, TX
135
PROFFERED
PROFFERED PAPERS
PAPERS
Monday,
Monday,March
March23,
14,2015
2016
1:30
Detection Gene Fusion(s) in Melanotic Xp11

Translocation Renal Cancer by RNA-seq (854)
Sabina Babayeva, Weihua Huang, Humayun Islam,
John T Fallon, Minghao Zhong
New York Medical College, Valhalla, NY
1:45
Clinical and Immunohistochemical (IHC) Spectrum of

Renal Cell Carcinomas (RCCs) with Aberrant Fumarate
Hydratase (FH)-Related Studies: Report from the
High-Grade Distal Nephron Adenocarcinoma (HDNA)
International Consortium (1046)
Deepika Sirohi
2:00
Morphologic and Molecular Evaluation of Thyroid-Like

Follicular Carcinoma of the Kidney (933)
Previn Gulavita, Ming Zhou, Mahul B Amin, Deepika
Sirohi, Elizabeth Garcia, Paola Dal Cin, Sean R
Williamson, Michelle Hirsch
Brigham and Womens Hospital, Boston, MA; New York
University, New York, NY; Cedars Sinai Medical Center,
Irvine, CA; Henry Ford Hospital, Detroit, MI
2:15
Chromosomal Abnormalities of Tumors with Features

of Mucinous Tubular and Spindle Cell Carcinoma of the
Kidney yet with High Grade Cytology (1028)
Evita T Sadimin, Yingbei Chen, Pedram Argani,
Jonathan I Epstein
Rutgers Cancer Institute of New Jersey, New
Brunswick, NJ; Memorial Sloan Kettering Cancer
Center, New York, NY; Johns Hopkins Medical
Institutions, Baltimore, MD
2:30
136
Eosinophilic Solid and Cystic Renal Cell Carcinoma

(ESC RCC): A Novel Entity with Distinct Molecular
Karyotype (1062)
Kiril Trpkov, Hatem Abou-Ouf, Ondrej Hes, Jose I
Lopez, Gabriella Nesi, Eva Comperat, Mathilde Sibony,
Daniel Berney, Isabela W Cunha, Adeboye O Osunkoya,
Neriman Gokden, Ming Zhou, Tarek Bismar, Jesse K
McKenney
University of Calgary, Calgary, Canada; Charles
University, Pilsen, Czech Republic; Cruces University
Hospital, Bizkaia, Spain; Careggi Hopsital, Florence,
Italy; Piti-Salptrire Hospital, Paris, France; Hopital
Cochin, Paris, France; Barts Cancer Center, London,
United Kingdom; AC Camargo Cancer Center, Sao
Paulo, Brazil; Emory University School of Medicine,
Atlanta, GA; Univeristy of Arkansas, Little Rock, AR;
New York University, New York City, NY; Cleveland
Clinic, Cleveland, OH
1:00AM
PM- -12:00
3:00 PM
PM
|| 8:30
2:45
Diagnostic Criteria for Oncocytic Renal Neoplasms: A

Survey of Specialist Renal Tumor Pathologists (1074)
Sean R Williamson, Ramya Gadde, Kiril Trpkov,
Michelle Hirsch, John R Srigley, Victor E Reuter, Liang
Cheng, L Priya Kunju, Ravi Barod, Craig G Rogers, Brett
Delahunt, Ondrej Hes, John N Eble, Ming Zhou, Jesse
K McKenney, Guido Martignoni, Stewart Fleming,
David J Grignon, Holger Moch, Nilesh S Gupta
Henry Ford Health System, Detroit, MI; McMaster
University, Toronto, Canada; Memorial Sloan Kettering
Cancer Center, New York, NY; Indiana University,
Indianapolis, IN; University of Michigan, Ann Arbor,
MI; Wellington School of Medicine, Wellington, New
Zealand; Charles University, Plzen, Czech Republic;
New York University, New York, NY; Cleveland Clinic,
Cleveland, OH; University of Verona, Verona, Italy;
University of Calgary, Calgary, Canada; Brigham and
Womens Hospital, Boston, MA; University of Dundee,
Dundee, United Kingdom; University Hospital Zurich,
Zurich, Switzerland
3:00
BREAK
CC BR 6C
SECTION B - PULMONARY
CHAIRED BY: ANDRE MOREIRA AND ELIZABETH PAVLISKO
1:00
Spread through Air Spaces (STAS) Is an Independent

Predictor of Recurrence in Lung Squamous Cell
Carcinoma (1886)
Shaohua Lu, KS Tan, K Kadota, T Eguchi, S Bains, P
Adusumilli, W Travis
MSKCC, New York, NY; Fudan University, Shanghai,
China; Kagawa University, Kagawa, Miki-cho, Japan
1:15
Amplification of 3q26 and High Expression Levels of

SOX2 Are Associated with a Favorable Prognosis in
Patients with Lung Squamous Cell Carcinoma (1857)
Hoiwan H Cheung, Laura J Tafe
Geisel School of Medicine at Dartmouth, Hanover, NH;
Dartmouth-Hitchcock Medical Center, Lebanon, NH
1:30
Does Strong and Diffuse PAX-8 Positivity Exclude

Primary Lung Carcinoma? An Immunohistochemical
Study of Whole-Tissue Sections from 337 Resected
Primary Lung Carcinomas, and Review of 27 PAX-8Positive Carcinomas in Lung Specimens (1889)
Kelsey McHugh, Andrea V Arrossi, Carol Farver, Sanjay
Mukhopadhyay
1:45
Lung Adenocarcinomas with KRAS Mutations Are

Biologically Heterogeneous (1871)
Tiffany G Huynh, Justin F Gainor, Valentina Nardi, Mari
Mino-Kenudson
2:00
Non-Synonymous Mutation Burden in Lung Carcinoma

Is Associated with Durable Clinical Response to
Immune Checkpoint Blockade (1887)
Navin Mahadevan, Peter Hammerman, Mark Awad,
Lynette M Sholl
PROFFERED
PROFFERED PAPERS
PAPERS
Monday,
Monday,March
March23,
14,2015
2016
2:15
Next-Generation Sequencing of Pulmonary Large Cell

Neuroendocrine Carcinoma Reveals Clinically-Relevant
Subsets with Small Cell Carcinoma-Like and Non-Small
Cell Carcinoma-Like Molecular Profiles (1910)
Natasha Rekhtman, Jarushka Naidoo, Maria Pietanza,
Matthew D Hellmann, Arshi Arora, Ronglai Shen,
Darragh F Halpenny, Helen Won, Michael F Berger,
Shaozhou Tian, John T Poirier, Paul K Paik, Andre
Moreira, Charles M Rudin, William D Travis, Marc
Ladanyi
2:30
Myxoid Malignant Pleural Mesothelioma: A Rare

Histological Subtype with Good Prognosis (1878)
Sylvie Lantuejoul, Nolwenn Le Stang, Arnaud
Scherpereel, Jean-Claude Pairon, Francoise GalateauSalle
Centre Lon Brard, Lyon, France; Hpital Calmette,
CHRU de Lille, Lille, France; Universit Paris-Est Creteil,
Crteil, France
2:45
3:00
Pure Atypical Thymomas: A Clinicopathological

Analysis of 25 Cases (1936)
Annikka Weissferdt, Maheshwari Ramineni, Neda
Kalhor, Cesar A Moran
2:00
Most Myeloid Neoplasms with Deletion of

Chromosome 16q Are Distinct from Acute Myeloid
Leukemia with inv(16)(p13.1q22) (1473)
Heesun J Rogers, Eric D Hsi, Guilin Tang, Sa Wang,
Carlos E Bueso-Ramos, Daniel Lubin, Jennifer JD
Morrissette, Adam Bagg, Durga P Cherukuri, Tracy
I George, LoAnn Peterson, Yen-Chun Liu, Susan
Mathew, Attilio Orazi, Robert P Hasserjian
Cleveland Clinic, Cleveland, OH; MD Anderson Cancer
Center, Houston, TX; University of Pennsylvania,
Philadelphia, PA; University of New Mexico,
Albuquerque, NM; Northwestern University, Chicago,
IL; Weill Medical College of Cornell University, New
York, NY; Massachusetts General Hospital, Boston, MA
2:15
Mutational Status Correlates with Distinct Histologic

Features in Philadelphia Chromosome (Ph)-Negative
Myeloproliferative Neoplasms (MPN) (1516)
Waihay Wong, Robert P Hasserjian, Olga Pozdnyakova
2:30
Impact of Hematological and Morphological Features

on the Differential Diagnosis of Prefibrotic Primary
Myelofibrosis (prePMF) (1410)
Hans Michael Kvasnicka, Jurgen Thiele
University of Frankfurt, Frankfurt, Germany; University
of Cologne, Cologne, Germany
2:45
Targeted Next Generation Sequencing (NGS) of

Chronic Eosinophilic Leukemia, Not Otherwise
Specified (CEL, NOS) and of Idiopathic
Hypereosinophilic Syndrome (HES) (1508)
Sa Wang, Wayne Tam, Albert Tsai, Daniel A Arber,
Robert P Hasserjian, Julia Geyer, Tracy I George, David
Czuchlewski, Kathryn Foucar, Heesun J Rogers, Eric
D Hsi, Bryan Rea, Adam Bagg, Paola Dal Cin, Todd
W Kelley, Srdan Verstovsek, Carlos E Bueso-Ramos,
Attilio Orazi
MDACC, Houston, TX; Weill Cornell, New York, NY;
Stanford, Stanford, CA; MGH, Boston, MA; University
of New Mexico, Albuquerque, NM; Cleveland Clinic,
Cleveland, OH; University of Penn, Philadelphia, PA;
BWH, Boston, MA; ARUP, Salt Lake, UT
BREAK
BREAK
CC BR 6B
SECTION C - HEMATOPATHOLOGY
CHAIRED BY: RACHEL SARGENT AND OLGA POZDNYAKOVA
1:00
Significance of Gene Mutations in the Evaluation

of Patients with Pancytopenia: Impact of Clonal
Hematopoiesis of Indeterminate Potential (CHIP)
(1364)
Sebastian Fernandez-Pol, Lisa Ma, Daniel A Arber
1:15
Myelodysplastic Syndrome, Unclassifiable (MDS-U)

with 1% Blasts Is a Distinct Subgroup of MDS-U with a
Poor Prognosis (1427)
Elizabeth Margolskee, Jean Oak, Daniel A Arber, Robert
P Hasserjian, Attilio Orazi
Weill Cornell Medical College, New York, NY; Stanford
University, Stanford, CA; Massachusetts General
3:00
Next-Generation Sequencing Interrogation of

Molecular Profiles Distinguishes between MDS and
AML with MDS Related Changes (1400)
Mohammad O Hussaini, Hailing Zhang, Haipeng Shao,
Lynn C Moscinski, Jinming Song
1:00
1:30
1:45
Newly Emerged Isolated Del(7q) May Not Always Be

Associated with Therapy-Related Myeloid Neoplasms
in Patients with Prior Cytotoxic Therapies (1377)
Rashmi Goswami, Sa Wang, Yan Li, Shimin Hu, Jeffrey
Medeiros, Guilin Tang
UT MD Anderson Cancer Center, Houston, TX;
University Health Network, Toronto, ON, Canada
1:00AM
PM- -12:00
3:00 PM
PM
|| 8:30
CC BR 6A
SECTION D - BREAST
CHAIRED BY: EDI BROGI AND PUAY HOON TAN
TERT Hotspot Promoter Mutations and TERT Gene
Amplification in Phyllodes Tumors of the Breast (268)
Jorge S Reis-Filho, Salvatore Piscuoglio, Charlotte KY
Ng, Melissa Murray, Kathleen Burke, Marcia Edelweiss,
Gabriel S Macedo, Felipe C Geyer, Akiko Inagaki,
Anastasios D Papanastasiou, Luciano G Martelotto,
Caterina Marchio, Raymond Lim, Ino De Bruijn, Lilian
Smyth, Muzaffar Akram, Dara S Ross, Larry Norton,
David B Solit, Jose Baselga, Edi Brogi, Marc Ladanyi,
Britta Weigelt
137
PROFFERED
PROFFERED PAPERS
PAPERS
1:15
1:30
1:45
2:00
2:15
2:30
2:45
3:00
138
Monday,
Monday,March
March23,
14,2015
2016
Clonal Relationship among Synchronous Ipsilateral

Fibroepithelial Lesions: Progression from
Fibroadenomas to Phyllodes Tumors (259)
Salvatore Piscuoglio, Charlotte KY Ng, Melissa Murray,
Felipe C Geyer, Marcia Edelweiss, Britta Weigelt, Edi
Brogi, Jorge S Reis-Filho
Phenotype and Immunophenotype Analysis of Gene
Expression Defined Indolent Risk Breast Cancers
(122)
Alexander Borowsky, Carlie K Thompson, Ronald
Balassanian, Christina Yau, Yunn-Yi Chen, Gregor
Krings, Bo Nordenskjold, Olle Stal, Tommy Fornander,
Laura J Esserman, Laura J vant Veer, Linda S
Lindstrom
UC Davis, Sacramento, CA; UCSF, San Francisco, CA;
Karolinska, Stockholm, Sweden; Linkping University,
Linkping, Sweden
Predicting Metastatic Site of Triple Negative Breast
Cancers Using Immunohistochemical Biomarkers (196)
Sergey Klimov, Andrew Green, Mohammed A
Aleskandarany, Emad Rakha, Ian O Ellis, Michelle Reid,
Padmashree CG Rida, Ritu Aneja
Georgia State University, Atlanta, GA; University of
Nottingham, Nottingham, United Kingdom; Emory
University, Atlanta, GA, United Kingdom
Reproducible Evaluation of Tumor-Infiltrating
Lymphocytes (TILs) Using the Recommendations of
International TILs Working Group 2014 (197)
Yumi Kojima, Frances Compton, Hongxia Sun,
Xiaohong I Wang, Michael Covinsky, Songlin Zhang
Houston, TX
Evaluation of Histopathologic Features That Affect
Interobserver Agreement on Tumor Infiltrating
Lymphocyte (TIL) Quantities in Breast Cancer (307)
Fei Yang, Shannon Swisher, Elizabeth A Mittendorf,
Genevieve R Lyons, Coya Tapia, Xiuhong Wang,
Roland L Bassett, Kelly K Hunt, Aysegul A Sahin, Yun
Wu
Houston, TX
PD-L1 Protein Expression and PD-L1 Gene
Amplification in Breast Cancer (300)
Olga Voronel, Siddhartha Dalvi, Bhaskar VS Kallakury,
Christine E Sheehan, Ann B Boguniewicz, Jeffrey S
Ross
Albany Medical College, Albany, NY; Georgetown
University Hospital, Washington, DC
Programmed Cell Death Ligand 1 (PD-L1) Expression
in Estrogen Receptor Positive (ER+) Invasive Breast
Cancers (BC): A Pilot Study of 148 Cases (107)
Javier Arias-Stella, Brie Kezlarian, Laura Favazza,
Daniel Schultz, Dhananjay A Chitale
1:00AM
PM- -12:00
3:00 PM
PM
|| 8:30
CC 602-604
SECTION E - KIDNEY/RENAL
CHAIRED BY: CHARLES ALPERS AND MEGAN TROXELL
1:00
Apolipoprotein L1 (ApoL1) High-Risk Variants Correlate

with Parietal Epithelial Cell Activation among African
Americans with Arterionephrosclerosis (1596)
Justin H Chen, Huma Fatima, Haichun Yang, Agnes B
Fogo
Vanderbilt University Medical Center, Nashville, TN;
1:15
Membranous Glomerulonephritis with Monotypic IgG

Deposits: A Clinico-Pathological Analysis of 28 Cases
(1594)
Alejandro Best Rocha, Christopher Larsen
Nephropath, Little Rock, AR
1:30
C3 Glomerulopathy in Older Adults (1607)

Isaac Lloyd, Hunter Huston, Stephen Jenkins, Kalani
Raphael, Dylan Miller, Monica P Revelo, Mazdak
Khalighi
University of Utah, Salt Lake City, UT
1:45
Patterns of Immune Complex Deposits in 70 Kidney

Biopsies with Staphylococcus Infection Associated
Glomerulonephritis (1620)
Anjali Satoskar, Sarah Suleiman, Jessica Hemminger,
Sergey Brodsky, Gyongyi Nadasdy, Tibor Nadasdy
Ohio State University Wexner Medical Center,
Columbus, OH
2:00
Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2)

Is a Common Form of Renal Amyloidosis Among
Egyptians (1611)
Samih Nasr, Wesam Ismail, Paul J Kurtin, Julie Vrana,
Surendra Dasari, Christopher Larsen
Mayo Clinic, Rochester, MN; BeniSuef University,
BeniSuef, Egypt; Nephropath, Little Rock, AR
2:15
Accelerated Mesangial Repair by Mesenchymal Stem

Cells (MSCs) Incubated with Cocktail of Trophic /
Differentiation Factors (1623)
Jiamin Teng, Chun Zeng, Elba A Turbat-Herrera,
Guillermo A Herrera
LSUHSC-Shreveport, Shreveport, LA
2:30
Characterizing Glomerular Injury of Pediatric Kidneys

Transplanted to Adult Recipients (1619)
Steven Salvatore, Meredith J Aull, Muthukumar
Thangamani, Surya Seshan
Weill Cornell Medical College, New York, NY
2:45
Maximizing Information from the Renal Biopsy:

Computer-Generated Three-Dimensional Constructs
(1599)
Beverly E Faulkner-Jones, Devin Rosen, Seymour
Rosen, Kyle Harrington, Charles Law
BIDMC, Boston, MA; Kitware Inc, Clifton Park, NY
3:00
BREAK
BREAK
PROFFERED
PROFFERED PAPERS
PAPERS
Monday,
Monday,March
March23,
14,2015
2016
CC 606-607
SECTION F - HEAD & NECK
CHAIRED BY: DIANA BELL AND MANJU PRASAD
1:00
1:15
1:30
1:45
Molecular Analysis of Low-Grade Cribriform

Cystadenocarcinoma & Related In-Situ and Invasive
Carcinomas (1316)
Ilan Weinreb, Raja R Seethala, Simion I Chiosea,
Bayardo Perez-Ordonez, Martin Hyrcza, Lei Zhang,
Chun-Liang Chen, Yun-Shao Sung, Adel Assaad, Lester
DR Thompson, Cristina Antonescu
University of Pittsburgh Medical Center, Pittsburgh, PA;
Memorial Sloan-Kettering Cancer Center, New York,
NY; Virginia Mason Medical Center, Seattle, WA; Kaiser
Permanente Medical Center, Woodland Hills, CA
Clinicopathologic Characterization of Mammary
Analogue Secretory Carcinoma (1271)
Simion I Chiosea, Raja R Seethala, Lindsay Williams,
Adel M Assaad, Lester DR Thompson, Madalina Tuluc,
Bibianna Purgina, Chi K Lai, Nasir Ud Din, Alena
Skalova
University of Pittsburgh, Pittsburgh, PA; Virginia
Mason Medical Center, Seattle, WA; Southern
California Permanente Medical Group, Woodland
Hills, CA; Thomas Jefferson University, Philadelphia,
PA; University of Ottawa, Ottawa, Canada; Aga Khan
University Hospital, Karachi, Pakistan; Faculty of
Medicine, Plzen, Plzen, Czech Republic
A Subset of Ectomesenchymal Chondromyxoid Tumors
(ECTs) of the Tongue Shows EWSR1 Rearrangement
and Is Genetically Linked to Soft Tissue Myoepithelial
Neoplasms: A Study of 9 Cases (1261)
Prokopios Argyris, Elizabeth Bilodeau, Denise
Trochesset, Stefan E Pambuccian, Stephanie Wetzel,
Paul Freedman, Michelle M Dolan, Ioannis Koutlas
University of Minnesota, Minneapolis, MN; University
of Pittsburgh, School of Dental Medicine, Pittsburgh,
PA; Stony Brook Oral Pathology, Stony Brook, NY;
Loyola University Medical Center, Maywood, IL; New
York Hospital of Queens, Flushing, NY
Salivary Duct Carcinoma: Relationship between
Morphologic Evidence of Pleomorphic Adenoma,
PLAG1, HMGA2 Translocations and Mutations/Copy
Number Changes in 50 Cancer-Related Genes (1272)
Simion I Chiosea, Alyssa M Luvison, Caitlyn Miller,
Lester DR Thompson, Ilan Weinreb, William E Gooding
University of Pittsburgh, Pittsburgh, PA; Southern
California Permanente Medical Group, Woodland Hills,
CA; University Health Network, Toronto, Canada
1:00AM
PM- -12:00
3:00 PM
PM
|| 8:30
2:00
Identification of a Novel Junctional Site in the

Oropharynx, Permissive for Human Papillomavirus
Infection (1317)
Robbie Woods, Helen Keegan, Christine White, Prerna
Tewari, Danielle Costigan, Jacqueline Barry-OCrowley,
Mary Toner, Susan Kennedy, Esther M ORegan, Cara
M Martin, Conrad Timon, John OLeary
Royal Victoria Eye and Ear Hospital, Dublin, Ireland;
Dublin University, Trinity College, Dublin, Ireland; St.
Jamess Hospital, Dublin, Ireland; The Coombe Women
and Infants University Hospital, Dublin, Ireland; Cerviva
Research Consortium, Dublin, Ireland
2:15
Comparison of p16 Antibody Clones for the Evaluation

of Oropharyngeal Squamous Cell Carcinoma (1311)
Jeremy Shelton, Bibianna Purgina, Nicole A Cipriani,
James Lewis
University of Ottawa, Ottawa, ON, Canada; University
of Chicago, Chicago, IL
2:30
Activating KRAS Mutations Are Characteristic of

Oncocytic Sinonasal Papilloma and Associated
Sinonasal Squamous Cell Carcinoma (1313)
Aaron Udager, Raja R Seethala, Evgeny Yakirevich,
Jonathan McHugh, Bryan Betz, Megan S Lim, Kojo
Elenitoba-Johnson, Noah Brown
University of Michigan Health System, Ann Arbor, MI;
University of Pittsburgh Medical Center, Pittsburgh,
PA; Rhode Island Hospital and Brown University,
Providence, RI; Perelman School of Medicine at the
2:45
Head and Neck Presentation of Cutaneous Leishmania

in Syrian Refugees (1276)
Gabriel Dunya, Robert Habib, Roger Moukarbel,
Ibrahim Khalifeh
American Univeristy of Beirut, Beirut, Lebanon
3:00
BREAK
CC 608-609
SECTION G - QUALITY ASSURANCE
CHAIRED BY: YAEL K HEHER AND RAOUF E NAKHLEH
1:00
Results of College of American Pathologists

Proficiency Testing for Highly Sensitive ALK
Immunohistochemistry in Lung Adenocarcinoma
(1950)
Andrew M Bellizzi, Robert A Schwartz, Jason L Hornick,
CAP Immunohistochemistry Committee
University of Iowa, Iowa City, IA; Manchester
Memorial, Manchester, CT; Brigham and Womens,
Boston, MA
1:15
Prospective Quality Assurance of Breast Core Biopsies

Minimizes Errors and Improves Patient Safety (2005)
Sejal S Shah, Natalie S Campbell, Gary L Keeney,
Beiyun Chen, Daniel W Visscher
139
PROFFERED
PROFFERED PAPERS
PAPERS
Monday,
Monday,March
March23,
14,2015
2016
1:00AM
PM- -12:00
3:00 PM
PM
|| 8:30
1:30
Switching from FDA-Approved to LaboratoryDeveloped HER2 IHC Testing Decreases Costs by 85%:
A Micro-Costing Analysis (2000)
Carolyn Rysgaard, Ellen Abusada, Lisa Horning, Rose
Meyer, Kent Becker, Andrew M Bellizzi
University of Iowa Hospitals and Clinics, Iowa City, IA
1:30
TERT Promoter Mutation as a Prognostic Marker in

Follicular Carcinomas (612)
Michelle D Williams, Ying C Henderson, Gary L
Clayman, Gilbert Cote
Houston, TX
1:45
Identifying Targets for Reducing Immunohistochemical

Utilization: An Audit of 18,760 Cases[/underline] (1999)
Lisa M Rooper, Jonathan I Epstein, Ashley CiminoMathews
1:45
2:00
Pathology M&M Rounds: A Focus on Transparency and

Process Improvement (1958)
Yigu Chen, Jeffrey Goldsmith, Yael K Heher
Beth Israel Deaconess Medical Center, Boston, MA
The Presence of Combined BRAF, TP53 and PIK3CA

Mutations Have Prognostic Impact in the Hobnail
Variant of Papillary Thyroid Carcinoma (569)
Sofia Asioli, Luca Morandi, Francesca Maletta, Alberto
Righi, Marco Gallo, Anna Sapino, Ricardo V Lloyd
University of Bologna, Bologna, Italy; University of
Turin, Turin, Italy; Rizzoli Institute, Bologna, Italy;
Health, Madison, WI
2:15
A Quantitative Method to Measure Pathology

Assistants Productivity Using Standardized Relative
Value Units (2015)
Vladimir H Volel, Tarush Kothari, Raheela Querishi,
Diane Groppi, Mike Raugnath, Claudine Alexis, Tylis
Y Chang, Oksana Yaskiv, James M Crawford, Tawfiqul
Bhuiya
North Shore - LIJ Health System, Lake Success, NY
2:00
Clinical-Pathological Features of 55 Papillary Thyroid

Carcinomas Carrying BRAF Mutations Other Than
V600E (570)
Fulvio Basolo, Elisa Sensi, Mirella Giordano, Liborio
Torregrossa
DIPINT-University of Pisa, Pisa, Italy; AOUP, Pisa, Italy
2:15
Prospective Experience with Routine SSTR2A

Immunohistochemistry in Neuroendocrine Epithelial
Neoplasms (568)
Deema Alkapalan, Jessica E Maxwell, Thomas
ODorisio, James R Howe, Andrew M Bellizzi, Iowa
NET SPORE
2:30
Ampullary and Duodenal Somatostatin-Producing

Neuroendocrine Tumors: Two Histologically and
Clinico-Pathologically Distinct Entities (609)
Alessandro Vanoli, Stefano La Rosa, Luca Albarello,
Federica Grillo, Frediano Inzani, Rachele Manca,
Michele Martino, Ombretta Luinetti, Roberta
Maragliano, Catherine Klersy, Fausto Sessa, Roberto
Fiocca, Claudio Doglioni, Guido Rindi, Carlo R Capella,
Enrico Solcia
IRCCS San Matteo Hospital and University of Pavia,
Pavia, Italy; University of Insubria, Varese, Italy;
Ospedale di Circolo, Varese, Italy; San Raffaele
Hospital, Milan, Italy; University of Genoa, IRCCS San
Martino IST, Genoa, Italy; Catholic University, Rome,
Italy
2:45
Genomic Profiling of Neuroendocrine and

Neuroepithelial Neoplasms by Targeted Next
Generation Sequencing (601)
Jason N Rosenbaum, Chad Storer, Catherine E Cottrell,
Eric J Duncavage
Washington University Medical School, Department of
Pathology and Immunology, St. Louis, MO
3:00
BREAK
2:30
Elimination of Cutting and Saving Unstained Sections

of GI Biopsy Specimens Yields Significant Benefits with
No Untoward Effects on Quality (2002)
Safia N Salaria, Craig W Self, Mary F Abbuhl, Omar
Hameed, Lan L Gellert
Vanderbilt University School of Medicine, Nashville, TN
2:45
The Effect of Prolonged Duration of Formalin Fixation

on the Yield of Amplifiable DNA for Molecular Testing
(1990)
Niru Nahar, Caleb King, Celeste N Powers, Gorge A
Almenara, Catherine I Dumur, Michael O Idowu
Virginia Commonwealth University Health System,
Richmond, VA
3:00
BREAK
CC 615-617
SECTION H - ENDOCRINE
CHAIRED BY: BRUCE M WENIG AND ELHAM KHANAFSHAR
1:00
Clinico-Pathologic Features of Fatal Non-Anaplastic

Follicular Cell-Derived Thyroid Carcinomas (Non-ANA
FCDCs) (614)
Bin Xu, Tihana Ibrahimpasic, Laura Wang, R Michael
Tuttle, Ian Ganly, Ronald Ghossein
1:15
Metastatic Follicular Thyroid Carcinoma: Retrospective

Institutional Experience and Insight into Primary
Follicular Thyroid Neoplasia (579)
Krzysztof Glomski, Peter M Sadow
Massachusetts General Hospital and Harvard Medical
School, Boston, MA
140
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
BREAST PATHOLOGY
Breast Pathologic Diagnosis and BIRADS Classes

Correlation Study on 4118 Patients (174)
Shaomin Hu, James Szymanski, Yungtai Lo, Yanhua
Wang
Montefiore Medical Center/Albert Einstein College
of Medicine, Bronx, NY; Albert Einstein College of
Medicine, Bronx, NY
Diagnostic Terminology of Atypia on Breast Core

Needle Biopsy: Correlation with Excision and Upgrade
Rates (159)
Michael George, Debra L Zynger, Gary Tozbikian
Isolated FEA Is Not Associated with a Significant

Upgrade Rate: Correlation of Biopsy and Excision
Specimens (153)
Kathryn S Dyhdalo, Hannah Gilmore, Philip Bomeisl
OH
Expression of the Autophagy Protein p62 in FEA Does

Not Predict for Upgrading to Atypical Hyperplasia or
Carcinoma[/underline] (285)
Jordan Sim, Jason K Wasserman, Susan J Robertson
The Ottawa Hospital, Ottawa, ON, Canada
Impact of Atypia within Multiple Non-Synchronous
Biopsies on Breast Cancer Risk: A Mayo Benign Breast
Disease Cohort Study (133)
Jodi M Carter, Ryan D Frank, Robert A Vierkant, Stacey
Winham, Derek C Radisky, Marlene H Frost, Ruth Kraft,
Amy Degnim, Daniel Visscher
Mayo Clinic, Rochester, MN; Mayo Clinic, Jacksonville,
FL
Clinical-Pathological Analysis of Women with
Proliferative Breast Disease Undergoing Multiple
Benign Biopsies: A Mayo Benign Breast Disease Cohort
Study (132)
Jodi M Carter, Derek C Radisky, Ryan D Frank, Robert
A Vierkant, Stacey Winham, Marlene H Frost, Amy
Degnim, Daniel W Visscher
FL
Risk of Breast Cancer among African American Women
with Sclerosing Adenosis and Radial Scar (251)
Vishakha Pardeshi, Michele L Cote, Julie J Ruterbusch,
Eman Abdulfatah, Woodlyne Roquiz, Baraa Alosh,
Muhammad K Alsafadi, Daniel W Visscher, Sudeshna
Bandyopadhyay, Rouba Ali-Fehmi
WSU, Detroit, MI; Mayo Clinic, Rochester, MN
Subareolar Sclerosing Ductal Hyperplasia

(SSDH): Further Characterization of a Distinct
Clinicopathological Entity Based on Review of 35 Cases
(137)
Esther Cheng, Maria Arafah, Paula S Ginter, Timothy
DAlfonso, Syed Hoda
Weill Cornell Medical College, New York, NY; College of
Medicine, King Saud University, Riyadh, Saudi Arabia
Computational Image Analysis of Breast Biopsy

Specimens with Atypia - Through the Looking Glass of
Diagnostic Concordance among Pathologists (116)
Francisco Beca, Irshad Humayun, Donald L Weaver,
Joann Elmore, Andrew H Beck
Harvard Medical School, Boston, MA; University of
Vermont School of Medicine, Burlington, VT; University
of Washington School of Medicine, Seattle, WA
10
Increasing Concordance for Intraductal Proliferative

Lesions of the Breast Using NDER, a Novel Web
Application (266)
Nicholas P Reder, Daniel Glasser, Mara H Rendi,
Suzanne M Dintzis, Rochelle L Garcia, Jonathan C
Henriksen, Mark R Kilgore
University of Washington Medical Center, Seattle, WA
11
Concordance in the Cloud- A Multidisciplinary

Software Tool for Breast Core Biopsy Correlation (118)
Michael W Bennett, Tim Manning, Brian Kelly, Noel
Murphy, Paul Walsh, Tara Jane Browne, Fionnuala
OConnell
Cork University Hospital, Cork, Ireland; nSILICO, Cork,
Ireland; Health Innovation Hub, Cork, Ireland
12
When Pathological and Radiological Correlation Is

Achieved Excision of Fibroadenoma with Lobular
Neoplasia on Core Biopsy Is Not Warranted (127)
Tara Jane Browne, Cassie Fives, Michael W Bennett,
Linda Feeley, Rose Murphy, Mark Corrigan, Fionnuala
OConnell
Cork University Hospital, Cork, Ireland
13
Is Excision Biopsy of Fibroadenomas Based Soley on

Size Criteria Warranted? (128)
Tara Jane Browne, Michael W Bennett, Linda Feeley,
Mark Corrigan, Fionnuala OConnell
14
Indeterminate Fibroepithelial Lesions on Breast CoreNeedle Biopsy: Patient Characteristics, Management

and Outcomes (226)
Kelly Mooney, Kara-Lee Pool, David Y Lu, Peggy
Sullivan
David Geffen School of Medicine at UCLA, Los
Angeles, CA
141
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
15
23
Metaplastic Breast Carcinoma with an Admixed

Invasive Ductal Carcinoma Component: Does It Matter?
(255)
John M Pike, Katie Dennis, Ossama Tawfik, Fang Fan
University of Kansas Medical Center, Kansas City, KS
24
RNA-Seq of Pleomorphic & Classic Lobular Carcinoma

In Situ Identifies Significant Differences in Gene
Expression Indicating Pleomorphic LCIS Resembles
Luminal B-type Breast Cancer[/underline] (182)
Arthur Johnson, Christine Henzler, Molly Klein, Stuart
Cameron, James Richter, Sumaya Al Rawi, Jessica
Gruenberg, Aqsa Nasir, Maryam Shahi, Evan W Sell,
Kathryn L Schwertfeger, Richard Zera, Andrew C
Nelson
HCMC, Minneapolis, MN; University of MN,
Minneapolis, MN
25
Genomic Characterization of CDH1- Unaltered

Invasive Lobular Carcinoma of the Breast (257)
Zheng Ping, Gene P Siegal, Shuko Harada, Dejun Shen
26
Secretory Carcinoma of the Breast: Molecular

Characterization of 12 Cases by Standardized
Quantitative RT-PCR Analysis (113)
Helen Bailey, Debbie McCullough, Frederick L Baehner,
Carolyn Mies
Genomic Health, Inc., Redwood City, CA
27
An Appraisal of Epithelial and Myoepithelial Markers

in Adenoid Cystic Carcinoma of the Breast: A Unique
Reverse Staining Pattern of Cytokeratin 5/6 Excludes Its
Mimickers (236)
Tokiko Nakai, Shu Ichihara, Tomonori Kawasaki,
Suzuko Moritani, Akiko Kada, Noriko Ito, Tomoko
Uchiyama, Hiroe Itami, Kouhei Morita, Masato Takano,
Maiko Takeda, Kinta Hatakeyama, Chiho Ohbayashi
Nara Medical University, Kashihara, Nara, Japan;
Nagoya Medical Center, Nagoya, Aichi, Japan; Iwate
Medical University School of Medicine, Morioka, Iwate,
Japan; Shiga Medical University, Otsu, Shiga, Japan;
Clinical Research Center, Nagoya Medical Center,
Nagoya, Aichi, Japan
28
SOX10 Is a Novel Sensitive Diagnostic Marker

for Adenoid Cystic Carcinoma of the Breast:
Immunohistochemical Analysis of Adenoid Cystic
Carcinoma (306)
Chen Yang, Lingxin Zhang, Souzan Sanati
Washington University School of Medicine, St. Louis,
MO
29
Analysis of MYB IHC and FISH in Breast Adenoid

Cystic Carcinomas, Microglandular Adenosis and
Collagenous Spherulosis (261)
Justin Poling, Raluca Yonescu, Rajni Sharma, Yi Ning,
Ashley Cimino-Mathews
Johns Hopkins Medical Institutions, Baltimore, MD
Lipophyllodes of the Breast: A Multi-Institutional Study

of 22 Cases with Clinicopathological Correlations,
Molecular Insight and Follow Up (111)
Carlos E Bacchi, Sheila Wludarski, Janez Lamovec,
David Ben Dor, Giovanna De Maglio, Stefano Pizzolitto,
Elisa Ober, Fabrizio Zanconati, Giovanni Falconieri
Consultoria em Patologia, Botucatu, Sao Paulo, Brazil;
Institute of Oncology, Ljubljana, Slovenia; Barzilai
Medical Center, Askelon, Israel; University Hospital,
Udine, Italy; University Hospital, Trieste, Italy
16
Epithelial-Mesenchymal Transition and Cancer Stem

Cells Interactions in Phyllodes Tumours: Clinical
Relevance and Prognostic Significance (104)
Syed Salahuddin Ahmed, Jabed Iqbal, Aye Aye Thike,
Jeffry Chun Tatt Lim, Puay Hoon Tan
Singapore General Hospital, Singapore, Singapore
17
Analysis of MED12 and TERT Promoter Mutations in

Fibroepithelial Lesions (FEL), Metaplastic Carcinomas
(MC) and Spindle Cell Lesions (SCL) of the Breast (214)
Su-Yang Liu, Yunn-Yi Chen, Nancy Joseph, Poonam
Vohra, Gregor Krings
18
Management of Benign Papilloma of the Breast

Diagnosed on Core Biopsy, a Review of 4182 Cases
(208)
Xiaoxian (Bill) Li
19
Non-Atypical Intraductal Papillomas of the Breast

Diagnosed in Core Biopsies: Are Pathologic Factors
Predictive of Upgrade? (262)
Morad Qarmali, Oluwole Fadare
UC San Diego, San Diego, CA
20
Dysregulation of the PIK3CA/AKT Pathway in Spindle

Cell Metaplastic Carcinomas Arising from Papillary/
Adenomyoepithelial Tumors (136)
Esther Cheng, Timothy DAlfonso, Yifang Liu, Sandra J
Shin
21
Role of Epithelial-to Mesenchymal Transition Markers

in Metaplastic Breast Cancer with Coexistent Ductal
Carcinoma In-Situ (102)
Eman Abdulfatah, Rahman Chaudhry, Vishakha
Pardeshi, Muhammad K Alsafadi, Sherif Shazly, Rouba
Ali-Fehmi, Sudeshna Bandyopadhyay
WSU, Detroit, MI; Mayo, Rochester, MN
22
142
Expression Analysis of Epithelial-Mesenchymal

Transition Related Genes in Triple Negative Breast
Cancer (311)
Shuling Zhou, Anqi Li, Ming Li, Yan Xu, Yaoxing Xiao,
Wentao Yang
Fudan University Shanghai Cancer Center, Shanghai,
China
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
CYTOPATHOLOGY
30
Ultrasound Guided Fine Needle Aspiration of Salivary

Gland Nodules by Cytopathologists at The University
of Toledo Medical Center. A Fast, Safe, and Accurate
Approach (417)
Weihong Li, Stacy L Molnar, Richard Cantley, Lorene
Yoxtheimer, Luis De Las Casas
University of Toledo Medical Center, Toledo, OH
31
Risk-Stratified Triage of Salivary Gland Fine-Needle

Aspiration Specimens (428)
Jelena Mirkovic, Liena Zhao, William C Faquin, Vickie Y
Jo, Jeffrey F Krane
Massachusetts General Hospital, Boston, MA; Harvard
32
MYB Immunohistochemical (IHC) Stain: Potential Role

in Separating Adenoid Cystic Carcinoma (ACC) from
Pleomorphic Adenoma (PA) (429)
Andres Moon, Cynthia Cohen, Momin T Siddiqui
33
A Multiinstitutional Interobserver Variability (IOV)

Study Interpreting Thyroid FNA using the Bethesda
System for Classification of Thyroid Cytology
(TBSCTC) - A Focus on Atypical Cells of Undetermined
Significance (AUS)/ Follicular Lesion of Undetermined
Significance (FLUS) (438)
Vijayalakshmi Padmanabhan, Carrie B Marshall, Guliz
A Barkan, Mohiedean Ghofrani, Idris T Ocal, Charles D
Sturgis, Rhona J Souers, Daniel FI Kurtycz
DHMC, Lebanon, NH; University of Colorado, Aurora,
CO; Loyola University, Chicago, IL; PeaceHealth
Laboratories, Vancouver, WA; Mayo Clinic, Scottsdale,
AZ; Cleveland Clinic, Cleveland, OH; CAP, Chicago, IL;
University of Wisconsin, Madison, WI
34
Quality Management of Thyroid Fine Needle

Aspiration: Inter and Intra-Pathologist Diagnostic
Variation (360)
Tamar C Brandler, Melissa Klein, Gianna Ballon,
Mohamed S Aziz
Hofstra North Shore-LIJ School of Medicine, Lake
Success, NY
35
The Bethesda System Class III Thyroid Nodules: Follow

Up Data and Conclusions Based on 13,194 Thyroid Fine
Needle Aspirates (415)
Marcos Lepe, Mariana Canepa, Bassam Aswad, Latha
R Pisharodi
Rhode Island Hospital, Providence, RI; Brown
University, Providence, RI
36
The Value of Negative Diagnosis in Thyroid FineNeedle Aspiration: A Retrospective Study with
Histologic Follow-Up (342)
Rita Abi-Raad, Rebecca Baldassarri, Kevin Schofield,
Adebowale Adeniran
37
Differential Outcomes of Patients with FNA Diagnoses

of AUS Versus FLUS: The Potential Need for
Separation in the Bethesda System (374)
Georgios Deftereos, Tracy S Tylee, Emily E Waner,
Malak Itani, Manjiri K Dighe, Stephen C Schmechel
38
Indeterminate Thyroid Nodules: Does Asuragen Testing

Improve the Specificity of Afirma Test Results? (359)
Shikha Bose, Ann E Walts, Wendy Sacks
39
Refine Risk of Malignancy by Subclassifying Atypia

of Undetermined Significance (AUS) in Thyroid
Cytopathology (473)
Huaitao Yang, Wei Liu, David Steward, Abid Yaqub
Universiy of Cincinnati Medical Center (UCMC),
Cincinnati, OH; UCMC, Cincinnati, OH
40
Comparison of Malignancy Rates in Thyroid

Fine Needle Aspiration Using the Bethesda
Category System in a Tertiary Care Center and a
Comprenhensive Cancer Center: Institutional Statistics
(375)
Victor Delacruz, Claudia P Rojas, Elvia Goez-Gutierrez,
Carmen Gomez-Fernandez, Merce Jorda, Monica
Garcia-Buitrago
University of Miami Miller School of Medicine/ Jackson
Memorial Hospital, Miami, FL; Jackson Memorial
Hospital, Miami, FL
41
Fine-Needle Aspiration Cytology of Non-Invasive

Follicular Thyroid Neoplasm with Papillary-Like
Nuclear Features (NIFT), Single Institutional Study with
Comparison to Invasive Follicular Variant of Papillary
Thyroid Carcinoma (404)
Ashley Ibrahim, Kristin A La Fortune, Howard Wu
Indiana University School of Medicine, Indianapolis, IN
42
Applying Strict Cytomorphologic Criteria and

Minimizing Interobserver Variability in Diagnosing
Atypia of Uncertain Significance Increases the
Positive Predictive Value of the Afirma GEC Assay in
Thyroid Fine Needle Aspiration (447)
Rovin Saxena, Brant McCall, Nikhil Neelkantan,
Michael S Ballo
Northwest Hospital, Randallstown, MD; Howard
University Hospital, Washington, DC; International
American University College of Medicine, Vieux Fort,
Saint Lucia; Trinity School of Medicine, Kingstown,
Saint Vincent and the Grenadines
43
Impact of ThyroSeqv.2 Next-Generation Sequencing

Assay on Fine Needle Aspiration Cytology of Thyroid
Nodules (376)
Anita Deshpande, Huihong Xu, Sandra Cerda
Boston Medical Center, Boston, MA
44
Utility of Next Generation Sequencing (NGS) Cotesting

to Recategorize Bethesda-I Thyroid FNAs (386)
Reyhan Gedik, Anita Deshpande, Huihong Xu, Sandra
Cerda
Boston Medical Center, Boston, MA
143
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
45
53
Indefinite to Positive and Indefinite to Negative Ratios

Represent Potential Quality Measures for Biliary
Cytology (410)
Dina Kokh, Lynette Parker, Paul Staats
University of Maryland, Baltimore, MD
54
The Clinical Impact of Biliary Tract FISH Analysis (467)

Nilam Virani, Madelyn Lew, Bryan Betz, Michael H Roh,
Xin Jing, Amer Heider, Robertson Davenport, Judy C
Pang
55
Refined Diagnostic Criteria for the Cytopathologic

Diagnosis of Mucinous (Colloid) Adenocarcinoma of
the Pancreas (475)
Xiu Yang, Houda Alatassi, Mostafa M Fraig
University of Louisville, Louisville, KY
56
Can the Ki-67 Index Evaluated on Fine Needle

Aspiration Cellblock Material Reliably Grade Pancreatic
Neuroendocrine Tumors? (341)
Rita Abi Raad, Andrea L Barbieri, Xuchen Zhang,
Malini Harigopal, Rebecca Baldassarri, Angelique W
Levi, Susan V Fernandez, Diane Kowalski, Adebowale
Adeniran, Guoping Cai
Yale School of Medicine, Nerw Haven, CT
57
FNA-Based Grading of Pancreatic Neuroendocrine

Neoplasms Using Ki-67 (469)
Vivian L Weiss, Colleen M Kiernan, Jesse P Wright,
Nipun B Merchant, Alice Coogan, Chanjuan Shi
58
A Comparison of Automated Digital Image Analysis

(DIA) and Manual Count of Camera-Captured Images
in Calculating Ki-67 Proliferation Index (PI) in Cytologic
Samples from Pancreatic Neuroendocrine Neoplasms
(PanNENs) (435)
Cameron Neely, Elliott Burdette, Charles Myers,
Geoffrey Smith, Cynthia Cohen, Michelle Reid
59
Diagnostic Accuracy of Pancreatic Fine Needle

Aspiration and Evaluation of Discordant Cases (413)
Hubert D Lau, Michael A DiMaio, Teri A Longacre,
Christina S Kong
60
Indeterminate Cytologic Diagnoses in EUS-Guided

FNA of the Pancreas: Confusion or Comprehension?
(358)
Anna Biernacka, Xiaoying Liu, Jonathan Marotti,
Edward Gutmann, Thanapoom Boonipat, Timothy B
Gardner, Stuart R Gordon, Kerrington D Smith, J Marc
Pipas, Vijayalakshmi Padmanabhan
Dartmouth-Hitchcock Medical Center, Geisel School of
Medicine at Dartmouth, Lebanon and Hanover, NH
61
Pancreatic Metastases: Potential for Misdiagnosis on

Fine Needle Aspiration (423)
Brock A Martin, Teri A Longacre, Christina S Kong
46
The Diagnostic Accuracy of Thyroid Fine Needle

Aspirates for Atypia, Suspicion for Malignancy
and Malignancy in Hashimoto Thyroiditis, a Single
Jennifer A Collins, Christopher J VandenBussche, Syed
Z Ali
Baltimore, MD
Fine-Needle Aspiration of Thyroid Malignancies Arising
in Graves Disease: A Diagnostic Challenge? (441)
Marc Pusztaszeri, Peter M Sadow, Jeffrey F Krane,
Gilbert Daniels, William C Faquin
Geneva University Hospitals, Geneva, Switzerland;
Massachusetts General Hospital, Boston, MA; Brigham
and Womens Hospital, Boston, MA
47
Correlation of Fine-Needle Aspiration (FNA) and Frozen

Section (FS) Interpretations with the Final Pathological
Diagnosis in Thyroid Lesions: Possible Combined
Utility of FNA and FS in Managing Thyroid Lesions
(364)
Michael M Burt, Rashna Madan, Fang Fan
48
Multiple Squamous Cells in Thyroid Fine Needle

Aspiration: Friends or Foes? (385)
Heather M Gage, Laurentia Nodit
University of Tennessee Medical Center Knoxville,
Knoxville, TN
49
Stromal Tissue as an Adjunct Tool in the Diagnosis of

Follicular Thyroid Lesions by Fine Needle Aspiration
Biopsy (400)
Kevin Hogan, Jason K Wasserman, Kien T Mai
The Ottawa Hospital and University of Ottawa, Ottawa,
ON, Canada
50
Nuclear Size Does Not Predict Clinical Outcomes When

Evaluating Thyroid AFLUS by FNA (372)
Elizabeth Dacey, Terry K Morgan
OHSU, Portland, OR
51
Factors Impacting the Performance Characteristics of

Bile Duct Brushings (BDBs); an Analysis in 444 Patients
(392)
Ezgi Hacihasanoglu, Vaidehi Avadhani, Zerife Yusifli,
Bahar Memis, Alexa Freedman, Michael Goodman,
Volkan Adsay, Michelle Reid
52
144
When We Say Maybe, We Mean Yes; We Just

Dont Want to Say It (and Probably for a Good
Reason): Pathologists Own View on Their Uncertain
Diagnosis in Bile Duct Brushings (393)
Ezgi Hacihasanoglu, Krisztina Z Hanley, Rhonda
Everett, Vaidehi Avadhani, Alyssa M Krasinskas, Uma
Krishnamurti, Adeboye O Osunkoya, Alexa Freedman,
Bahar Memis, Michael Goodman, Volkan Adsay,
Michelle Reid
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
62
Efficacy of EUS-Guided Fine Needle Aspiration in the

Diagnosis of Upper Gastrointestinal Lesions (381)
Abdulwahab Ewaz, Reid Sakamoto, William Kawahara,
Renn Putorak, Pamela Tauchi-Nishi, Thomas Namiki
University of Hawaii, Honolulu, HI; Queens Medical
Center, Honolulu, HI
69
Development of a Web-Based Question Database (553)

Mark Lincoln, Jeff Lacombe, Melissa Austin
Walter Reed National Military Medical Center,
Bethesda, MD; Freelance Information Technologist,
Liverpool, NY
63
Cytotechnologist Assisted Adequacy Assessment of

Image Guided Fine Needle Aspiration Specimens (450)
Joshua Segal, Carol Anderson, Christina S Kong
70
An Interactive Online Unknown Conference with a

System for Ordering Immunostains and Molecular
Genetic Studies (555)
Leonel Maldonado, Brett Baskovich
University of South Alabama Medical Center, Mobile,
AL
71
Development of an Online Case Simulator as an

Educational Tool in Anatomic Pathology[/underline][/
underline] (546)
Michael Bonert, Jens Schittenhelm, Vinita Parkash,
Yuan Gao, Kiril Trpkov
McMaster University, Hamilton, Canada; University of
Tuebingen, Tuebingen, Germany; Yale University, New
Haven, CT; Memorial University of Newfoundland, St.
Johns, Canada; University of Calgary, Calgary, Canada
72
A Searchable Database of Anatomic Pathology

Diagnoses: A Tool Optimized for Trainee Eduction
(563)
Scott A Robertson, Alexander Baras
Johns Hopkins Hospital, Baltimore, MD; Cleveland
Clinic, Cleveland, OH
73
Implementation of Resident Sign Out Application with

Functions to Compare Resident and Attending Reports
(549)
Bryan J Dangott, Shuhua Ma, Renuka Malenie, Peter
Kragel
East Carolina University, Greenville, NC
74
Improving the Resident Selection Process (544)

Candice C Black
Dartmouth Hitchcock Medical Center, Lebanon, NH
75
Development of a Dynamic Leadership Curriculum

to Enhance Residency Education in Pathology and
Laboratory Medicine (548)
Carolyn Cambor, David B Roth, Craig Loundas, Monica
Heuer, Christopher D Watt, Kathleen Montone, Deborah
Sesok-Pizzini
University of Pennsylvania Health System and the
Perelman School of Medicine, Philadelphia, PA
76
A Histologic Checklist for Appropriate Diagnosis of

Melanocytic Lesions (547)
Ryanne Brown, Uma Sundram
Stanford Health Care, Stanford, CA; Currently at
Associated Pathology Medical Group, Los Gatos, CA
EDUCATION
64
A Patient Safety Curriculum for Pathology Trainees: A

Data Driven Institutional Endeavor (564)
T Danielle Samulski, Zubair Baloch
Philadelphia, PA
65
The Creation and Implementation of a Points-Based

System for Distributing Specimens to Residents at a
Tertiary Care Academic Residency Program (557)
Chelsea Mehr, Amrom Obstfeld, Amanda Barrett,
Kathleen Montone, Lauren Schwartz
Philadelphia, PA
66
Quantitative Assessment of Competency in Surgical

Pathology: Initial Promising Roll-Out Results at the
UNM Department of Pathology (562)
Benjamin Ramos, Fred Schultz, Teresa Quintana,
Joshua A Hanson, Sam Reynolds, Von G Samedi,
Therese Bocklage
University of New Mexico School of Medicine,
Albuquerque, NM
67
Introducing a Virtual Reality Experience in Anatomic

Pathology Education (554)
Emilio Madrigal, Shyam Prajapati, Jelena Krcedinac,
Juan C Hernandez-Prera
Mount Sinai Health System, New York, NY
68
Fine Needle Aspiration Cytology (FNAC) Simulation

Using Phantoms. University Teaching Experience (543)
Eduardo Alcaraz-Mateos, Alexandra Kundisova,
Aleksijs Stopinskijs, Joanna Lenik, Iga Leszczynska,
Iva Cerna, Martina Andrasova, Robert Roland, Agnes
Gilberte, Cristina Martin, Mauricio Borbolla, Gerardo
Valenzuela, Valeria Hernandez, Belen Roldan, Laura
Martinez, Fuensanta Caballero
Morales Meseguer University Hospital, Murcia, Spain;
University of Murcia, Murcia, Spain; Bratislava,
Bratislava, Slovakia (Slovak Republic); Riga, Riga,
Latvia; Krakow, Krakow, Poland; Prague, Prague, Czech
Republic; Montpellier, Montpellier, France; Salamanca,
Salamanca, Spain; Veracruz, Veracruz, Mexico;
Juarez, Durango, Mexico; Zaragoza, Zaragoza, Spain;
Castelln, Castelln, Spain
145
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
77
CyTEST- A Pan European Project for Training & Testing

in Cytopathology (556)
Caterina Marchio, Helena Barroca, Roberto Dina,
Emanuela Ovcin, Martin Toetsch, Ambrogio Fassina,
Gianni Bussolati
University of Turin, Turin, Italy; IPATIMUP, University
of Porto, Porto, Portugal; Imperial College, London,
United Kingdom; University of Graz, Graz, Austria;
University of Padua, Padua, Italy; COREP, Turin, Italy
85
78
Fellowship In-Service Hematopathology Examination

(FISHE) Predicts Success on the American Board
of Pathology Hematology Subspecialty Certifying
Examination (ABP-HE) (558)
Sara A Monaghan, Ray E Felgar, Melissa Kelly, Asma
Ali, John Anastasi, Aarti Bellara, Henry Rinder, Rachel
Sargent, Jay Wagner, Steven H Swerdlow, Rebecca L
Johnson
UT Southwestern, Dallas, TX; University of Pittsburgh,
Pittsburgh, PA; American Society Clinical Patholology,
Chicago, IL; University of Chicago, Chicago, IL;
American Board of Pathology, Tampa, FL; Yale, New
Haven, CT; University Penn, Philadelphia, PA
79
Resident In-Service Exam Review Series (551)

Jessica Forcucci, J M Hyer, David Lewin, Nicholas
Batalis
Medical University of South Carolina, Charleston, SC
80
Resident Incentive Program: Engaging Pathology

Residents in Quality Improvement Projects through
Financial Incentives (550)
Jessica Forcucci, Thomas Soike, Jim Madory, David
Lewin, Nicholas Batalis
81
Big Data: Bioinformatics Education during Residency

Demonstrates Immediate Value (566)
Amelia Sybenga, Riyam T Zreik, Amin Mohammad,
Arundhati Rao
Scott & White Memorial Hospital, Temple, TX
82
Pathology Knowledge Consumption Characteristics

Online Using an Open Access Pathology Wiki (545)
Michael Bonert, Vinita Parkash, Jens Schittenhelm
McMaster University, Hamilton, Canada; Yale
University, New Haven, CT; University of Tuebingen,
Tuebingen, Germany
83
Pathologists in Gross Anatomy? - Strategies for

Curriculum Integration (561)
Charles Quick, David L Davies
Rock, AR
84
Multidisciplinary Tumor Board: A Ready-Made Tool for

Competencies, Professionalism and Capturing Medical
Student Interest in Pathology (567)
Rebecca Wilcox
University of Vermont Medical Center, Burlington, VT
146
Four Years of Virtual Pathology Teaching Using

SlideAtlas, a Web-Based Open-Source Digital
Pathology Platform Supporting Multi-Touch Interaction
(565)
Kristen Smith, Kuda Maloney, Brian Helba, Charles
Law, Beverly E Faulkner-Jones
BIDMC, Bosotn, MA; MD Anderson Cancer Center,
Houston, TX; Kitware Inc, Clifton Park, NY
GENITOURINARY PATHOLOGY (INCLUDING RENAL TUMORS)
86
Clinical Validation of the 2005 ISUP Gleason Grading

System in a Cohort of Intermediate and High Risk Men
Undergoing Radical Prostatectomy (906)
Sheila Faraj, Stephania M Bezerra, Kasra Yousefi,
Helen Fedor, Stephanie Glavaris, Misop Han, Alan
Partin, Elizabeth Humphreys, Jeffrey Tosoian, Michael
H Johnson, Elai Davicioni, Bruce Trock, Edward M
Schaeffer, Ashley Ross, George J Netto
Johns Hopkins Medical Institution, Baltimore, MD;
GenomeDx Biosciences, Vancouver, BC, Canada
87
Can Contemporary Pure Gleason 3+3 (ISUP Grade

Group 1) Prostate Cancer Invade into the Extraprostatic
Tissue or Seminal Vesicle? (852)
Blake Anderson, Aria A Razmaria, Bonnie Choy, Scott
Eggener, Gladell P Paner
88
Small High Grade Cancer as the Largest Tumor at

Radical Prostatectomy (RP) (872)
Trevor Caldwell, Jonathan I Epstein
The Johns Hopkins Medical Institutions, Baltimore, MD
89
Does Zonal Distribution of the Index Tumor Influence

Prognostic Factors in Radical Prostatectomies? (867)
Athanase Billis, Leandro LL Freitas, Larissa BE Costa,
Camila M de Angelis, Kelson R Carvalho, Ruana M
Rocha, Lucas QA Bastos, Gabriel LP Oliveira, Marcel A
Asato, Karina S Araujo, Daniele M Losada, Amanda P
Herculiani
School of Medical Sciences, State University of
Campinas (Unicamp), Campinas, SP, Brazil
90
Is Zonal Distribution of Index Tumor Different in

Radical Prostatectomies Comparing Whites vs AfricanBrazilians? (866)
Athanase Billis, Leandro LL Freitas, Larissa BE Costa,
Camila M de Angelis, Kelson R Carvalho, Ruana M
Rocha, Lucas QA Bastos, Gabriel LP Oliveira, Marcel A
Asato, Karina S Araujo, Daniele M Losada, Amanda P
Herculiani
School of Medical Sciences, State University of
Campinas (Unicamp), Campinas, SP, Brazil
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
91
PTEN Expression in Mucinous Prostatic

Adenocarcinoma and Prostatic Adenocarcinoma with
Mucinous Features: A Multi-Institutional Study of 92
Cases (864)
Elizabeth Bertsch, Cristina Magi-Galluzzi, Liang Cheng,
Adeboye O Osunkoya
Emory University School of Medicine, Atlanta, GA; The
Cleveland Clinic, Cleveland, OH; Indiana University
School of Medicine, Indianapolis, IN
98
92
Mucinous Adenocarcinoma of Prostate and Prostatic

Adenocarcinoma with Mucinous Components; A
Clinicopathological Analysis of 81 Cases (946)
Samaratunga Hemamali, Brett Delahunt, Lars Egevad,
John Yaxley, Shulammite Johannsen, Geoff Coughlin,
Troy Gianduzzo
Aquesta Pathology, Brisbane, Queensland, Australia;
University of Queensland, Brisbane, Queensland,
Australia; Wellington School of Medicine and Health
Sciences, Wellington, Otago, New Zealand; Karolinska
Institute, Stockholm, Sweden; Wesley Hospital,
Brisbane, Queensland, Australia
Diagnostic Accuracy of Subpatterns of Gleason Pattern

4 Prostate Cancer Morphological Subpatterns (977)
Jianhong Li, Rajal Shah, Ali Amin, Ritu Bhalla, Kasturi
Das, Fang-Ming Deng, Peng Lee, Andres Matoso,
Jonathan Melamed, Savvas Mendrinos, Wei Tian,
Oksana Yaskiv, Ming Zhou
New York University, New York, NY; Miracal Life
Sciences, Irving, TX; Brown University, Providence,
RI; Louisiana State University, New Orleans, LA; North
Shore LIJ, Lake Success, NY
99
93
Prostate Cancer Gleason Grade 4 Pattern Heterogeneity

in Men on Active Surveillance Who Undergo Delayed
Prostatectomy (1061)
Patricia Troncoso, John W Davis, Elsa Li Ning Tapia, Ina
Prokhorova, John F Ward, Louis L Pisters, Mary Achim,
Christopher J Logothetis, Jeri Kim
Houston, TX
Quantifying Gleason Pattern 4 Prostate Cancer

in Prostate Needle Biopsy: An Interobserver
Reproducibility Study (979)
Jianhong Li, Jianbo Li, Ali Amin, Ritu Bhalla, Kasturi
Das, Fang-Ming Deng, Peng Lee, Andres Matoso,
Jonathan Melamed, Savvas Mendrinos, Wei Tian,
Oksana Yaskiv, Rajal Shah, Ming Zhou
New York University, New York, NY; Cleverland Clinic,
Cleveland, OH; Louisiana State University, New
Orleans, LA; Northshore LIJ Health System, Lake
Success, NY; Brown University, Providence, RI; Miracle
Life Sciences, Irving, TX
100
Interobserver Reproducibility of Percentage Gleason

Pattern 4 in Prostatic Adenocarcinoma (1029)
Evita T Sadimin, Francesca Khani, Mairo L Diolombi,
Abdelrazak Meliti, Jonathan I Epstein
101
Assessing % Gleason Pattern (GP) 4 in Needle

Biopsies: An Interobserver Reproducibility Study (910)
SW Fine, J Sarungbam, HA Al-Ahmadie, Y-B Chen, A
Gopalan, SJ Sirintrapun, VE Reuter, SK Tickoo
102
Quantitative Assessment of Perineural Invasion and

Percentage of Sites with 3+4=7 Carcinoma Predicts
Upstaging in Intermediate Risk Prostate Cancer (862)
Justin Bateman, Susan J Robertson, Nicola Schieda,
Daniel T Keefe, Eric C Belanger, Kien T Mai, Rodney H
Breau, Chris Morash, Trevor A Flood
The Ottawa Hospital, Ottawa, ON, Canada; The
103
Prostate Cancer Grade Group 4: Gleason 3+5=8 and

5+3=8 Outcomes Versus 4+4=8 (943)
Nicholas Harding-Jackson, Elizabeth Whittington,
Daniel C Eastwood, George A Tjionas, Oleksandr N
Kryvenko, Swikrity Upadhyay, Merce Jorda, Kenneth A
Iczkowski
University of Miami, Miami, FL
104
Mutational Analysis of Gleason Score 7 Prostate

Cancer Using Next Generation Sequencing and
Fluorescent In Situ Hybridization (1081)
Ming Zhou, Zach Liu, Roberto Zoino, Chrysostomos
Chrysostomou, Gaurav Rajoria, Szczepan Klimek,
Herber Lepor
New York University, New York, NY; Histopathology
Services, Ramsey, NJ
94
Proliferation Index of Gleason Grade 3 Prostate

Adenocarcinoma with and without Associated Grade 4
(952)
Michael Hwang, Liying Fu, Adebowale Adeniran, Peter
A Humphrey
95
Proliferation Index of Different Gleason Grade 4

Prostatic Adenocarcinoma Morphologies (915)
Liying Fu, Michael Hwang, Adebowale Adeniran, Peter
A Humphrey
96
Clinical Significance of Percentage of Gleason Pattern

4 in Gleason Score 7 Prostate Cancer at Radical
Prostatectomy (955)
Mohsin Jamal, Sean R Williamson, Mireya Diaz-Insua,
Mani Menon, Hans Stricker, James Peabody, Craig G
Rogers, Nilesh S Gupta
97
Correlation of Gleason Score 7 in Prostate

Adenocarcinoma on Needle Biopsy between General
and Urological Pathologists: Influence of Percent
Pattern 4 and Other Histological Factors (994)
Abdelrazak Meliti, Francesca Khani, Mairo L Diolombi,
Evita T Sadimin, Jonathan I Epstein
147
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
105
Mutational Analysis of Prostate Cancer Using Next

Generation Cancer Hotspot Panel (983)
Zach Liu, Ming Zhou, Herber Lepor, Roberto Zoino,
Gaurav Rajoria, Szczepan Klimek
Histopathology Services, Ramsey, NJ; New York
University Medical Center, New York City, NY
112
106
High-Grade Prostatic Intraepithelial Neoplasia with

Adjacent Small Atypical Glands (PINATYP): Reappraisal
of Diagnostic Criteria (978)
Jianhong Li, Fang Bu, Fang-Ming Deng, Peng Lee,
Jonathan Melamed, Rajal Shah, Ming Zhou
New York University, New York, NY; Miracal Life
Sciences, Irving, TX
Variant Histopathology in Young-Age Prostate Cancer

(1019)
Susan Prendeville, Andrew Evans, Rob G Bristow,
Theodorus H van der Kwast
Laboratory Medicine Programme, University Health
Network, Toronto, ON, Canada; Radiation Oncology,
113
Radical Prostatectomy (RP) Findings in Hispanic Men

Qualifying for Active Surveillance (AS) (969)
Oleksandr N Kryvenko, Kirill Lyapichev, Felix M Chinea,
Nachiketh S Prakash, Alan Pollack, Sanoj Punnen,
Merce Jorda
107
High Grade Prostatic Intraepithelial Neoplasia with

Adjacent Small Atypical Glands (PINATYP) on Core
Needle Biopsy: A Clinicopathological Analysis of 54
Cases with Emphasis on Predictors of Prostate Cancer
(1042)
Rajal Shah, Wei Tian, Ming Zhou, Jianbo Li
Miraca Life Sciences, Irving, TX; New York University
Langone Medical Center, New York, NY; Cleveland
Foundation Clinic, Cleveland, OH
114
Active Surveillance for Newly Diagnosed Low Risk

Prostate Cancer: Institutional Experience of Initial
Choice and Follow Up in a Racially Mixed Population
(944)
Oudai Hassan, MHD Fayez Daaboul, Dongping Shi,
Isaac Powell, Michael L Cher, Wael Sakr
WSU, Detroit, MI
115
Do African Americans with Low Risk Prostate Cancer

on Needle Biopsy (Eligible for Active Surveillance),
Have More Aggressive Pathology in Radical
Prostatectomy Specimens Compared to Their
European American Counterparts? (890)
MHD Fayez Daaboul, Oudai Hassan, Dongping Shi,
Muhammad K Alsafadi, Isaac Powell, Michael L Cher,
Wael A Sakr
WSU, Detroit, MI
116
Assessment of Differences in Prostate Cancer

Characteristics between Asian and Non-Asian Men
(967)
Pavel Kopach, Elizabeth Genega
Tufts Medical Center, Boston, MA
117
Prostate Intraductal Carcinoma, Multifocality and

Bilateral Significant Disease in Radical Prostatectomy
Specimens from United States and Japan (881)
Yu-Ching Peng, Toyonori Tsuzuki, Max Kong, Jianhong
Li, Fang-Ming Deng, Jonathan Melamed, Ming Zhou
New York University, New York, NY; Japanese Red
Cross Nagoya Daini Hospital, Nagoya, Japan
118
Identifying Additional Lymph Nodes In Radical

Prostatectomy Pelvic Lymph Node Specimens (1059)
Jessica Tracht, Win S Lai, Soroush Rais-Bahrami,
Jennifer B Gordetsky
119
Whole-Exome Sequencing of Prostatic Stromal

Sarcoma and Prostatic Stromal Tumor of Uncertain
Malignant Potential (1009)
Chin-Chen Pan, Jonathan I Epstein
Taipei Veterans General Hospital, Taipei, Taiwan; Johns
Hopkins Hospital, Baltimore, MD
108
Radical Prostatectomy Outcomes of Prostatic

Adenocarcinoma Diagnosed after Initial Diagnosis of
Atypical Glands on Prostate Needle Biopsy (1040)
Alpa Shah, Ramya Gadde, Javier Arias-Stella, Sean R
Williamson, Nilesh S Gupta
109
Diagnosis of Limited Prostate Adenocarcinoma on

Core Needle Biopsy: An Improvement of Interobserver
Reproducibility Using Comprehensive Morphological
and Molecular Criteria (1041)
Rajal Shah, Gioacchino Leandro, James Bentley,
Monica Chaterjee, Gloria Romerocases, Wei Tian,
Yousef Tadros, Jiyoon Yoon, Savvas Mendrinos
Miraca Life Sciences, Irving, TX; IRCCS De Bellis,
Castellana Grotte, Italy
110
111
148
Atypical Cribriform Lesion of the Prostate Shares

Similar ERG and PTEN Expression Patterns as
Intraductal Carcinoma of the Prostate and Is Associated
with a Higher Stage and Grade Than Invasive Cancer
Alone (949)
Richard Hickman, Hui Yu, Max Kong, Rajal Shah, Ming
Zhou, Jonathan Melamed, Fang-Ming Deng
NYU Langone Medical Center, New York, NY; Miraca
Life Sciences, Dallas, TX
Pathologic Outcomes and Biochemical Recurrence
(BCR) Free Survival in Men Younger Than 45 Years with
Prostate Cancer (PCa) Treated with Robotic Radical
Prostatectomy (RRP) (985)
Zhichun Lu, Sean R Williamson, Mireya Diaz-Insua,
Hans Stricker, Mani Menon, Nilesh S Gupta
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
120
Spectrum of Cystic Epithelial Tumors of the Prostate:

Most Cystadenocarcinomas (CACs) are Ductal Type
with Intracystic Papillary Pattern (1011)
Gladell P Paner, Antonio Lopez-Beltran, Toyonori
Tsuzuki, Jesse K McKenney
University of Chicago, Chicago, IL; Champalimaud
Clinical Center, Lisbon, Portugal; Nagoya Daini Red
Cross Hospital, Nagoya, Japan; Cleveland Clinic,
Cleveland, OH
127
Molecular Alterations in Verruciform Lesions and

Keratinizing Squamous Cell Carcinomas of the Vulva
(1248)
Jaclyn C Watkins, Brooke E Howitt, Neil Horowitz,
Lauren L Ritterhouse, Fei Dong, Marisa R Nucci,
Christopher P Crum
Brigham and Womens Hospital, Harvard Medical
School, Boston, MA
121
Novel and Rare Mesonephric-Type Tumors Arising

from the Urologic Tract (1012)
Gladell P Paner, Deepika Sirohi, Mukul Divatia, Mahul
B Amin
University of Chicago, Chicago, IL; Cedars-Sinai
Medical Center, Los Angeles, CA
128
Proteomic Profiles of Vulvar Squamous Cell Carcinoma

(1142)
Emily Holthoff, Stephanie Byrum, Thomas J Kelly, Alan
Tackett, Steven Post, Charles Quick
UAMS, Little Rock, AR
129
Recurrent Gains of CD274 and PDCD1LG2 in Squamous

Cell Carcinomas of Cervix and Vulva (1144)
Brooke E Howitt, Heather Sun, Margaretha GM
Roemer, Alyssa Kelly, Bjoern Chapuy, Emeline M Aviki,
Christine Pak, Evisa Gjini, Youling Yang, Larissa Lee,
Akila Viswanathan, Neil Horowitz, Donna Neuberg,
Christopher P Crum, Neal Lindeman, Frank Kuo, Azra H
Ligon, Gordon J Freeman, F Stephen Hodi, Margaret A
Shipp, Scott Rodig
130
PDL-1 Expression in Cervical Intraepithelial Neoplasia

(1213)
Carolina Reyes, Deepti Adhikari Guragain, Kumarasen
Cooper
Philadelphia, PA
131
Programmed Cell Death Ligand-1 Is Expressed in a

Significant Number of Uterine Cervical Carcinomas
(1212)
Opal L Reddy, Itsushi P Shintaku, Neda A Moatamed
Angeles, CA
GYNECOLOGIC AND OBSTETRIC PATHOLOGY
122
Vaginal Melanoma: A Molecular Analysis of 32 Cases

(1178)
Anais Malpica, Elizabeth D Euscher
123
Vulvovaginal Smooth Muscle Tumors (1230)

Shahrzad Slater, Jesse Hart, Maria Garcia-Moliner, Ali
Amin
Women and Infants Hospital, Providence, RI; Rhode
Island Hospital, Providence, RI; Warran Alpert Medical
School of Brown University, Providence, RI
124
HPV-Independent Vulvar Squamous Cell Carcinoma

Has a Significantly Worse Prognosis Than HPVAssociated Carcinoma (1152)
Anthony Karnezis, Angela Cheng, Samuel Leung,
Suzanne Jordan, Naveena Singh, Dianne M Miller,
Jessica N McAlpine, C Blake Gilks
Barts Health NHS Trust, London, United Kingdom
125
The Prevalence of Vulvar Lichen Sclerosus in Patients

with Vulvar Squamous Cell Carcinoma (1117)
Jonathan Davick, Colleen Stockdale, James T Krone,
Megan I Samuelson
University of Virginia, Charlottesville, VA; University of
Iowa, Iowa City, IA
132
Do Antibody Clones of PD-L1 and PD-1 Expressing

Tumor Infiltrating Lymphocytes in Cervical Tumors
Matter? (1107)
Luis F Carrillo, Peter N Bonneau, Alexander C
Mackinnon, Irene Aguilera-Barrantes
Medical College of Wisconsin, Milwaukee, WI
126
Classic Vulvar Intraepithelial Neoplasia with

Superimposed Lichen Simplex Chronicus: A Potential
Pitfall in the Diagnosis of Differentiated Vulvar
Intraepithelial Neoplasia (1247)
Jaclyn C Watkins, Eric Yang, Christopher P Crum,
Marisa R Nucci
School, Boston, MA; Stanford University Hospital, Palo
Alto, CA
133
Demise of the Pap Smear? Not So Fast! Report of HPV

DNA Negative Cervicovaginal Dysplasias (1146)
Yiang Hui, Katrine Hansen, Jayasimha N Murthy,
Danielle B Chau, C James Sung, M Ruhul Quddus
Women & Infants Hospital/Alpert Medical School of
Brown University, Providence, RI; Memorial Hospital/
Alpert Medical School of Brown University, Pawtucket,
RI
149
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
134
140
p16 Staining Has Limited Value in Predicting

Progression in Women with Histological Low-Grade
Squamous Intraepithelial Lesions of the Cervix (1220)
Amaia Sagasta, Natalia Rakislova, Paola Castillo, Adela
Saco, Aureli Torne, Roser Esteve, Lorena Marimon,
Marta del Pino, Jaume Ordi
Hospital Universitario Araba, Vitoria-Gasteiz, Spain;
Hospital Clinic, Barcelona University, Barcelona, Spain;
Center Int. Health Research (CRESIB), Barcelona, Spain
141
Overdiagnosis of HSIL (CIN 2): Four Nonspecific p16

Immunohistochemistry Patterns (1113)
Jennifer L Clark, Yuxin Liu
University of Massachusetts Medical School,
Worcester, MA
142
Systems Biology Approaches to Cervical Pre-Cancer

Diagnostics (1251)
Christine White, Lynne Kelly, Csaba Jeney, Prerna
Tewari, Sarah Mahan, Salih Bakhiet, Helen Keegan,
John J OLeary, Cara Martin
Trinity College Dublin, Dublin, Leinster, Ireland;
Coombe Women and Infants University Hospital,
Dublin, Leinster, Ireland; CellCall, Budapest, Hungary
143
The Assessment of Potential Biomarkers of Disease

Progression in High Grade Squamous Cervical Lesions
Promoter Methylation Analysis of Selected TumourSuppressor Genes and Viral/Microbial Co-Infection
(1154)
Jana Kaspirkova, Barbora Gomolcakova, Ondrej Ondic,
Michal Michal
Biopticka Laborator, Pilsen, Czech Republic
144
Transitional Cell Metaplasia of the Uterine Cervix: A

Histopathological and Immunohistochemical Analysis
Suggesting an Increased Androgenic Stimulation
during Cellular Differentiation (1162)
Kyu-Rae Kim, Ji Young Park, Su Hyun Yoo
Asan Medical Center, University of Ulsan College of
Medicine, Seoul, Korea; Daegu Catholic University
Medical Center, Daegu, Korea
145
Perineural Invasion Is a Valuable Prognostic Factor in

Advanced Stage and/or Lymph Node Positive Cervical
Cancer (1184)
Bahar Muezzinoglu, Cigdem Vural, Busra Yaprak
Bayrak, Izzet Yucesoy
Kocaeli University Medical School, Kocaeli, Turkey
146
Adenosquamous Carcinoma and Adenosquamous

Intraepithelial Lesion of the Cervix: Analysis of a
Rigorously Classified Case Series (1156)
Michael Keeney, Gary L Keeney, John Schoolmeester
147
Analysis of Pathologic Parameters in Adenocarcinoma

In Situ of the Cervix: Clinical Correlates and Outcomes
(1244)
Koah R Vierkoetter, Teresa C Porter, Keith Terada, David
Shimizu
John A Burns School of Medicine, Honolulu, HI
135
Application of Triage Markers for Management of HPV

Positive Women Presenting at Colposcopy with Minor
Cytological Abnormalities (1243)
Prerna Tewari, Christine White, Lynne Kelly, Padraig
Kearney, Loretto Pilkington, Tom DArcy, Cliona
Murphy, Nadine Farah, Eimear Lee, Dorinda Mullen,
Jacqui Barry-OCrowley, Sharon OToole, Linda Sharp,
John OLeary, Cara Martin
Trinity College, Dublin, Ireland; Coombe Women &
Infants University Hospital, Dublin, Ireland; Newcastle
University, Newcastle, United Kingdom
Clinical Outcomes of hrHPV-Positive/Cytology-Negative
Patients (1114)
Lani K Clinton, Jordan K Kondo, Pamela Tauchi-Nishi,
David Shimizu
University of Hawaii Pathology Residency Program,
Honolulu, HI; Queens Medical Center, Honolulu, HI
136
Validation of a Novel RNA ISH Assay for HR-HPV E6/7

mRNA (1182)
Anne M Mills, Mark H Stoler
UVA, Charlottesville, VA
137
Distribution of Cervical Lesions Associated with HPV

in the Democratic Republic of So Tom and Prncipe
(1193)
Rita SS Oliveira, Ana C Braga, Lucilia Goncalves,
Gabriela Gasparinho, Marco Ferreira, Luis V Pinto,
Ana Matos, Elizabete Carvalho, Manuel Cardoso,
Paula Guerra, Sara B Turpin, Ruben R Roque, Gilberto
Matias, Armandina Silveira, Raquel Almeida, Henrique
Nabais, Rui Nobre, Hugo Prazeres
Hospital Prof. Doutor Fernando Fonseca, E.P.E.,
Amadora, Portugal; Pathology Laboratory Roriz,
Lisboa, Portugal; Group for Cancer Intervention in
Low Resource Settings: STP Cervical Cancer Mission,
Lisboa, Portugal; Marques Valle Flor Institute ONG,
Lisboa, Portugal; Champalimaud Foundation, Lisboa,
Portugal; Armed Forces Hospital, Porto, Portugal;
Ministry of Health, So Tom, Sao Tome and Principe;
Coimbra University, Coimbra, Portugal; Portuguese
Oncology Institute, Coimbra, Portugal
138
HPV Vaccination Status in Patients with High Grade

Cervical Precancerous Lesions (1192)
Fredrick D Oakley, Manideepthi Pemmaraju, Marie R
Griffin, Mohamed M Desouki
Vanderbilt University, Nashville, TN
139
P16 Expression and Biologic Behavior of Flat Vulvar

Low-Grade Squamous Intraepithelial Lesions (LSIL)[/
underline] (1169)
Natasha Lewis, Kruti Maniar
Northwestern University-Feinberg School of Medicine,
Chicago, IL
150
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
148
Endocervical Adenocarcinoma (EEC): A Retrospective

Study of 75 Cases (1201)
Anna Pesci, Angela R Shih, Esther Oliva
Ospedale Sacro Cuore-Don Calabria, Negrar, Verona,
Italy; Massachusetts General Hospital, Boston, MA
154
149
Pattern C Invasive Endocervical Adenocarcinomas: Can

We Identify the More Aggressive Subset? (1257)
Ranran Zhang, Erin E Medlin, Paul S Weisman, Ahmed
Al-Niaimi, Aparna Mahajan
University of Wisconsin Hospital and Clinics, Madison,
WI
Expression of Claudin-18, a Novel Gastric Marker,

Is Associated with Poor Prognosis in Cervical
Daichi Maeda
Akita University, Graduate School of Medicine, Akita,
Japan
155
Genomic Characterization of Gastric-Type Endocervical

Adenocarcinomas (1185)
Rajmohan Murali, Maria De Filippo, Britta Weigelt, Kay
J Park
150
Validation of Pattern-Based Classification of

Endocervical Adenocarcinoma (EAC) (1219)
Joanne KL Rutgers, Andres A Roma, Kay J Park,
Richard Zaino, Dean Daya, Golnar Rasty, Abbey
Johnston, Teri A Longacre, Brigitte M Ronnett, Elvio G
Silva
Cedars Sinai, LA, CA; Memorial Sloan Kettering, NY,
NY; Cleveland Clinic, Cleveland, OH; MD Anderson,
Houston, TX; Penn State Hersey, Hershey, PA;
Juravinski, Hamilton, Canada; University Toronto,
Toronto, Canada; Ohio Health, Columbus, OH;
Stanford, Stanford, CA; Johns Hopkins, Baltimore, MD
151
152
153
Architectural Overlap between Benign Endocervix and

Pattern A Invasive Endocervical Adenocarcinoma: Are
All Pattern A Adenocarcinomas Really Invasive? (1120)
Greg Douglas, Brooke E Howitt, John Schoolmeester,
Lauren Schwartz, Zuzana Kos, Shahidul Islam, Bojana
Djordjevic, Carlos Parra-Herran
University of Ottawa, Ottawa, ON, Canada; Brigham
and Womens Hospital, Boston, MA; Mayo Clinic,
Rochester, MN; University of Pennsylvania,
Philadelphia, PA
Pattern Based Classification of Invasive Endocervical
Adenocarcinoma, Depth of Invasion Measurement and
Distinction from Adenocarcinoma In Situ: Interobserver
Variation among Academic Gynecologic Pathologists
(1200)
Carlos Parra-Herran, Monica Taljaard, Bojana
Djordjevic, Carolina Reyes, Lauren Schwartz, John
Schoolmeester, Ricardo R Lastra, Charles Quick, Anna
Laury, Golnar Rasty, Marisa R Nucci, Brooke E Howitt
of Pennsylvania, Philadelphia, PA; Mayo Clinic,
Rochester, MN; University of Chicago, Chicago, IL;
Rock, AR; Cedars-Sinai Medical Center, Los Angeles,
CA; Toronto East General Hospital, Toronto, ON,
Canada; Brigham and Womens Hospital, Boston, MA
Invasive Stratified Mucin-Producing Carcinoma and
Stratified Mucin-Producing Intraepithelial Lesion
(SMILE): 15 Cases Presenting a Spectrum of Cervical
Neoplasia with Description of a Distinctive Variant of
Invasive Adenocarcinoma (1166)
Ricardo R Lastra, Kay J Park, John Schoolmeester
University of Chicago, Chicago, IL; Memorial Sloan
Kettering Cancer Center, New York, NY; Mayo Clinic,
Rochester, MN
HEAD & NECK PATHOLOGY
156
Salivary Duct Carcinoma: Clinicopathologic Features,

Morphologic Spectrum and Somatic Mutations (1293)
Peter P Luk, Jared D Weston, Bing Yu, Christina I
Selinger, Rafael Ekmejian, Timothy J Eviston, Trina
Lum, Kan Gao, Michael Boyer, Sandra A OToole,
Jonathan R Clark, Ruta Gupta
Westmead Hospital, Sydney, NSW, Australia; The
University of Sydney, Sydney, NSW, Australia;
University of New South Wales, Sydney, NSW,
Australia; Chris OBrien Lifehouse, Sydney, NSW,
Australia
157
Comprehensive Genomic Profiling of Acinic Cell

Carcinoma of Salivary Glands (1260)
Siraj M Ali, Kyle Fedorchak, Kyle Gowan, Rodolfo
Bordoni, Timothy A Jennings, Julia A Elvin, JoAnne Vergilio, James Suh, Vincent A Miller, Philip J
Foundation Medicine, Inc., Cambridge, MA; Georgia
Cancer Specialists, Marietta, GA; Albany Medical
College, Albany, NY
158
Role of CRTC1/MAML2 Translocation in Determining

Prognosis and Clinical Outcomes in Mucoepidermoid
Carcinoma Patients: The MD Anderson Experience
(1266)
Diana Bell, Rami E Saade, Joaquin J Garcia, Dianna
Roberts, Randal S Weber
Houston, TX; Mayo Clinic, Rochester, MN
159
Sinonasal Tract Cribriform Adenocarcinoma of Minor

Salivary Glands (CAMSG): Description of a Recently
Recognized Neoplasm in a Previously Unrecognized
Anatomic Location (1294)
Abul Ala Syed Rifat Mannan, Juan C HernandezPrera, Cristina Antonescu, Carlos E Bacchi, Giovanni
Falconieri, Palmina Cataldi, Bruce M Wenig
Mount Sinai St.-Lukes Roosevelt Hospital Center, New
York, NY; Mount Sinai Beth Israel Medical Center, New
York, NY; Memorial Sloan Kettering Cancer Center,
New York, NY; Bacchi Lab/Consultoria em Patologia,
Botucatu, Brazil; University of Trieste, Trieste, Italy;
University of Udine, Udine, Italy
151
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
160
Use of p40, p63, and Ki-67 in the Differential Diagnosis

of Polymorphous Low-Grade Adenocarcinoma, Cellular
Pleomorphic Adenoma, and Adenoid Cystic Carcinoma
(1299)
Vatsal Patel, Tina Woods, Larry J Fowler, Donald Cohen
167
MYC and MYB Are Coexpressed in Adenoid Cystic

Carcinoma (1302)
Marc Pusztaszeri, Patrizia Bordignon, Thomas McKee,
William C Faquin
Geneva University Hospitals, Geneva, Switzerland;
161
Incidence of Recently Described Salivary Gland

Carcinoma Types Presenting in an Urban Population: A
Retrospective Analysis (1295)
Mena Mansour, Juan C Hernandez-Prera, G K Haines,
Elizabeth G Demicco
Mount Sinai Hospital, New York, NY
168
162
Population-Based 30-Year Retrospective Review

of Major Salivary Gland Carcinomas Identifies 22
Mammary-Analogue Secretory Carcinomas (MASC)
(1282)
Martin Hyrcza, Gareth Ayre, Alena Skalova, Amir
Rahemtulla, Eric Berthelet, Jonn Wu, Thomas Thomson
British Columbia Cancer Agency, Vancouver, BC,
Canada; Charles University, Faculty of Medicine, Plzen,
Czech Republic
Diagnostic Pitfalls of Infarcted Warthin Tumor in Frozen

Section Evaluation (1312)
Yaohong Tan, Oleksandr N Kryvenko, Christina
Kovacs, Jennifer Chapman, David J Arnald, Andrew E
Rosenberg, Carmen Gomez-Fernandez
Department of Pathology, Unversity of Miami Miller
School of Medicine, Jackson Memorial Hospital,
Miami, FL; Department of Surgery, Unversity of Miami
Miller School of Medicine, Jackson Memorial Hospital,
Miami, FL
169
The Utility of GATA3, GCDFP-15, Mammaglobin,

SOX10, and ER in Differential Diagnosis of Salivary
Tumors (1324)
Chaohui L Zhao, Evgeny Yakirevich, Kara A Lombardo,
Douglas R Gnepp, Yihong Wang
Brown University, Providence, RI; University
Pathologists, Fall River, MA
170
Myb and Androgen Receptor Expression in

Salivary Gland Basal Cell Adenoma and Basal Cell
Sydney Rooney, Brennan Tesdahl, Robert Robinson
171
PSMA Expression in Non-Neoplastic and Neoplastic

Salivary Gland (1270)
Esther Cheng, Neil H Bander, Brian D Robinson,
Theresa Scognamiglio
172
High Risk Human Papillomavirus in Primary Squamous

Cell Carcinoma of the Parotid Gland (1321)
Bin Xu, Lu Wang, Laetitia Borsu, Nora Katabi, Ian
Ganly, Snjezana Dogan
173
HPV Genotyping in Head and Neck Cancer: An

Aileen Grace P Arriola, Joshua Edwards, Vivianna M
Van Deerlin
Philadelphia, PA
174
Prognostic Significance of Histologic Features in HPVAssociated Tonsillar Squamous Cell Carcinoma (1284)
Jian Jing, Indu Varier, Joanna Dong, David Zhang,
Andrew G Sikora, Elizabeth G Demicco
Icahn School of Medicine at Mount Sinai, New York,
NY; Baylor College of Medicine, Houston, TX
163
Primary Cutaneous Mammary Analogue Secretory

Carcinoma: Series of 4 Cases Harboring ETV6 Gene
Rearrangements (1267)
Justin A Bishop, Janis Taube, Albert Su, Scott Binder,
William H Westra
Johns Hopkins, Baltimore, MD; University of California
Los Angeles, Los Angeles, CA
164
Macrocystic Mammary Analogue Secretory Carcinoma:

An Unusual Architectural Variant of a Recently
Described Salivary Gland Tumor (1279)
Juan C Hernandez-Prera, Alessandro Valentino, Carlos
E Bacchi, Fredrik Petersson, Vesna Najfeld, Bruce M
Wenig
Mount Sinai Beth Israel, New York, NY; Ospedale S.
Andrea, La Spezia, Italy; Bacchi Lab/Consultoria em
Patologia, Botucatu, Brazil; National University Health
System, Singapore, Singapore; Mount Sinai Hospital,
New York, NY
165
PS100 and Mamoglobin Coexpression Are Not

Sufficient to Affirm the Diagnosis of Mammary
Analogue Secretory Carcinoma (MASC) (1273)
Valerie Costes, Mathieu Gallo, Ariane Tempier, Vanessa
Szablewski, Valere Cacheux, Assia Hafidi Benammar
CHU Montpellier, Montpellier, France
166
Mammary Analog Secretory Carcinoma (MASC) with a

Predominant Cystic Intraductal Component: A Report
of 3 Cases (1274)
Jennifer L Dettloff, Justin A Bishop, Marino E Leon
Moffitt Cancer Center, Tampa, FL; Johns Hopkins
University, Baltimore, MD
152
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
175
Nonkeratinizing Carcinoma In Situ of the Upper

Aerodigestive Tract: An HPV-Related Entity (1323)
Lingxin Zhang, James Lewis, Samir K El-Mofty, Manoj
Gandhi, Rebecca Chernock
MO; Vanderbilt University Medical Center, Nashville,
TN; Affymetrix, Inc., Santa Clara, CA
176
A Second-Generation Probe for HPV DNA In-Situ

Hybridization Lacks Sensitivity for HPV Detection in
Oropharyngeal Squamous Cell Carcinoma[/underline]
(1305)
Lisa M Rooper, Justin A Bishop, William H Westra
177
Detection of HPV-DNA from May-Grnvald-Giemsa

Stained Fine-Needle Aspiration Specimens Using
Polymerase Chain Reaction (1269)
Hani I Channir, Christian G Larsen, Lise Ahlborn,
Thomas van Overeem Hansen, Thomas A Gerds,
Birgitte W Charabi, Ben Vainer, Christian von
Buchwald, Christel B Lajer, Katalin Kiss
Rigshospitalet, Copenhagen University Hospital,
Copenhagen, Denmark; University of Copenhagen,
Copenhagen, Denmark
178
The Utility of p16 Immunostaining in Fine Needle

Aspiration (FNA) Material in Human Papilloma
Virus (HPV)-Related Head and Neck Squamous Cell
Carcinoma (HNSCC) (1318)
Bin Xu, Ronald Ghossein, Jason Lane, Oscar Lin, Nora
Katabi
179
HPV Prevalence in HIV Patients with Head and Neck

Squamous Cell Carcinoma (1301)
Annabelle Picard, Cecile Badoual, Muriel Hourseau,
Caroline Halimi, Helene Pere, Beatrix Barry, Sebastien
Albert
Bichat Hospital, APHP, Paris, France; European G
Pompidou Hospital, APHP, Paris, France; Bichat
Hospital, Paris, France
180
HPV-Induced HNSCC, All Locations Combined:

Prevalence, Diagnostic Tests and Prognostic Impact of
HPV Status in a Heavy-Smoking French Population[/
underline] (1263)
Jeremy Augustin, Samah El Naderi, Helene Pere,
Helene Roussel, Cecile Badoual
Georges Pompidou Eureopean Hospital, Paris, France,
Metropolitan
Board
Number
HEMATOPATHOLOGY
181
Baseline Evaluation of Testing of Acute Leukemia

Samples: Results of a CAP/CDC Guideline Metric Expert
Panel Survey (1331)
Daniel A Arber, Thomas E Nicole, Rhona J Souers, Lisa
A Fatheree, Joseph A Tworek, Raouf E Nakhleh, Tracy
I George
Stanford University, Stanford, CA; College of American
Pathologists, Northfield, IL; St. Joseph Mercy Hospital,
Ann Arbor, MI; Mayo Clinic, Jacksonville, FL; University
of New Mexico, Albuquerque, NM
182
Determining Educational Needs in Myelodysplastic

Syndrome (1432)
Timothy G Miley, Mikkael A Sekeres, Marilyn L Slovak,
Rami S Komorkji, Asma Ali, Eric R Parks, Suzanne M
Ziemnik, Tracy I George
Park Nicollet Methodist Hospital, Minneapolis, MN;
Cleveland Clinic Taussig Cancer Institute, Cleveland,
OH; Sonora Quest, Phoenix, AZ; Moffit Cancer Center,
Tampa, FL; American Society for Clinical Pathology,
Chicago, IL; University of New Mexico, Albuquerque,
NM
183
Mutation Analysis in 117 Cases Newly Diagnosed

Myelodysplastic Syndrome: IPSS-R High and Very
High Risk by Next Generation Sequencing: A ClinicoPathologic Correlation (1374)
Kankana Ghosh, Parsa Hodjat, Priyanka Priyanka,
Beenu Thakral, Keyur P Patel, Mark Routbort, Rashmi
Kanagal-Shamana, C Cameron Yin, Zhuang Zuo,
Rajyalakshmi Luthra, Tariq Muzzafar
UT School of Public Health, Houston, TX; UT MD
Anderson Cancer Center, Houston, TX; UT Health
Science Center at Houston, Houston, TX
184
Mutation Analysis in 50 Cases of Newly Diagnosed

Acute Myeloid Leukemia Arising from Myelodysplastic
Syndrome by Next Generation Sequencing: A ClinicoPathologic Correlation (1388)
Parsa Hodjat, Priyanka Priyanka, Kankana Ghosh,
UT MD Anderson Cancer Center, Houston, TX; UT
Health Science Center at Houston, Houston, TX; UT
School of Public Health Houston, Houston, TX
185
Mutation Analysis in 8 Cases of Newly

Diagnosed Acute Myeloid Leukemia Arising from
Myeloproliferative Neoplasms by Next Generation
Sequencing: A Clinico-Pathologic Correlation (1389)
School of Public Health Houston, Houston, TX
153
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
186
192
De Novo Acute Myeloid Leukemia (AML) with RUNX1

Mutations Shows Characteristic Clinicopathologic
Features (1464)
Andres Quesada, Rajyalakshmi Luthra, Keyur P Patel,
Rajesh Singh, Mark Routbort, Sanam Loghavi, Joseph
D Khoury, Jeffrey Medeiros, Carlos E Bueso-Ramos,
Rashmi Kanagal-Shamanna
M.D. Anderson Cancer Center, Houston, TX
193
Immunophenotypic Abnormalities in Acute Myeloid

Leukemia Associated with NPM1 Mutation and Clinical
Significance of Minimal Residual Disease Detection
(1531)
Yi Zhou, David Wu, Xueyan Chen, Jonathan R Fromm,
Brent L Wood
194
Clinical Deep Sequencing of NPM1 for Minimal

Residual Disease Detection in Acute Myeloid Leukemia
(1394)
Eric Hoyle, Lena Murillo, Shannon Nesbitt, Yi Zhou,
Brent L Wood, Stephen J Salipante, David Wu
195
Multi-Locus DNA Methylation Measured by xMELP

Predicts Survival in Pediatric Patients with AML (1515)
Gerald Wertheim, Marlise Luskin, Catherine Smith,
Li Zhou, Jenna Harrison, Maria Figueroa, Daniel
Catchpoole, Richard Aplenc, Sarah Tasian, Martin
Carroll, Stephen R Master
Childrens Hospital of Philadelphia, Philadelphia, PA;
Weill Cornell Medical College, New York, NY; Perelman
School of Medicine at the University of Pennsylvania,
Philadelphia, PA; University of Michigan School of
Medicine, Ann Arbor, MI; The Childrens Hospital at
Westmead, Westmead, NSW, Australia
196
Integration of Multi-Locus DNA Methylation and

Genetic Alterations Outperforms Genetic Assessment
Alone for Outcome Prediction in Adult Patients with
Gerald Wertheim, Marlise Luskin, Phyllis A Gimotty,
Catherine Smith, Alison W Loren, Maria Figueroa,
Jenna Harrison, Zhuoxin Sun, Martin S Tallman,
Elisabeth M Paietta, Mark R Litzow, Ross Levine, Ari
M Melnick, Hugo F Fernandez, Selina M Luger, Martin
Carroll, Stephen R Master
Childrens Hospital of Philadelphia, Philadelphia, PA;
Perelman School of Medicine at the University of
Pennsylvania, Philadelphia, PA; University of Michigan
Medical School, Ann Arbor, MI; Dana-Farber Cancer
Institute, Boston, MA; Memorial Sloan Kettering Cancer
Center, New York, NY; Montefiore Medical Center,
Bronx, NY; Mayo Clinic, Rochester, MN; Moffit Cancer
Center, Tampa, FL; Weill Cornell Medical College, New
York, NY
187

Acute Myeloid Leukemia with Recurrent Cytogenetic
Abnormalities by Next Generation Sequencing: A
Clinico-Pathologic Correlation (1391)
School of Public Health, Houston, TX
Normal Karyotype Acute Myeloid Leukemia by
Next Generation Sequencing: A Clinico-Pathologic
Correlation (1390)
School of Public Health, Houston, TX
188
Utility of a Pan Genomic Fusion Panel (1300 Genes)

on a Next Generation Sequencing (NGS) Platform in
Evaluation of Hematologic Malignancies (HM) (1409)
Ravindra Kolhe, Alka Chaubey, Lisa C Watson, WonSok
Lee, Deepa Jagdale, Claire Attwooll, Ashis K Mondal
Georgia Regents University, Augusta, GA; Greenwood
Genetic Center, Greenwood, SC; Illumina, Inc, San
Diego, CA
189
High-Resolution, Genome-Wide Single Nucleotide

Polymorphism Microarray Analysis of Abnormal
Genomic Lesions in Patients with Myeloid Neoplasms
and Normal Karyotype (1438)
Pawel Mroz, Sue Miller, Lauren B Smith, Dale Bixby,
Lina Shao
University of MIchigan, Ann Arbor, MI
190
Acute Myeloid Leukemia (AML).Digital Quantification

of PRAME Transcript Provides Distinct Stratification
for Overall Survival (OS) in Various Cytogenetic Risk
Groups (1469)
Jabina Randev, Mohammad O Mansoor, Fahad Farooq,
Meer-Taher Shabani-Rad, Ariz Akhter
Foothills Medical Centre, Calgary, AB, Canada;
University of Calgary, Calgary, AB, Canada
191
Next Generation Sequencing Evaluation of ASXL1

Mutations in Large Cohort of Myeloid Malignancies
(1528)
Hailing Zhang, Mohammad O Hussaini, Xiaohui Zhang,
Haipeng Shao, Lynn C Moscinski, Jinming Song
154
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
197
205
Differential Impact of Additional Chromosomal

Abnormalities in Myeloid and Lymphoid Blast Phase of
Chronic Myelogenous Leukemia in the Era of Tyrosine
Kinase Inhibitors (1347)
Zi Chen, Wei Wang, Jeffrey Medeiros, Shimin Hu
Houston, TX
206
T-Lymphoblastic Blast Crisis of Chronic Myelogenous

Leukemia: A Study of 11 Cases (1521)
Wei Xie, Wei Wang, Yuan Ji, Yi Zhou, Jeffrey Medeiros,
Shimin Hu
Houston, TX; Baylor College of Medicine, Houston,
TX; University of Nebraska, Omaha, NE; University of
Washington, Seattle, WA
Bone Marrow Morphology Predicts Response to

Hypomethylating Agents (1387)
Lisa Hillen, Lawrence Zukerberg, Vikram Deshpande,
Arjen HG Cleven, Amir T Fathi, Axel zur Hausen, Robert
P Hasserjian
Maastricht University Medical Center MUMC+,
Maastricht, Netherlands; Massachusetts General
Hospital, Boston, MA; Leiden University Medical
Center, Leiden, Netherlands
198
The Significance of Morphologic Dysplasia in the

Absence of Increased Blasts Following Induction
Therapy for Acute Myeloid Leukemia (1350)
Daniel Cloetingh, Bruno C Medieros, Daniel Arber,
Robert S Ohgami
Stanford HealthCare, Stanford, CA
199
Hypoxia-Induced VEGF Overexpression Leads to

Treatment Resistance in Acute Promyelocytic Leukemia
(1487)
Payal Sojitra, Edith Cline-Kabba, Ameet Kini
207
Therapy-Related Chronic Myelogenous Leukemia: A

Retrospective Analysis of 19 Cases (1502)
Bethany Vallangeon, Yi Xie, Chad M McCall, Anand
Lagoo, Endi Wang
Duke University Medical Center, Durham, NC
200
MYC Protein Expression Does Not Correlate with MYC

Abnormalities but Predicts an Unfavorable Prognosis
in Acute Myeloid Leukemia (1346)
Pu Chen, Lucas Redd, Prasad Koduru, Jake Dennis,
Crystal Montgomery-Goecker, Kirthi Kumar, Yao
Schmidt, Weina Chen
UT Southwestern Medical Center at Dallas, Dallas, TX
208
Loss of 5-Hydroxymethylcytosine Staining Correlates

with Poorer Overall Survival in Patients with Chronic
Myelomonocytic Leukemia (1484)
William Selove, Karen Dresser, Benjamin J Chen
Worcester, MA
201
Near Bi-Phenotypic Antigen Expression Defines an

Acute Myeloid Leukemia (AML) Cohort with High-Risk
Molecular Genetic and Cytogenetic Features (1476)
Mikhail Roshal, April Chiu
209
202
Assessment of Myeloid And Monocytic Dysplasia by

Flow Cytometry in De Novo AML Helps Define an AML
with Myelodysplasia-Related Changes Category (1512)
Olga K Weinberg, Robert P Hasserjian, Betty Li, Olga
Pozdnyakova
Boston Childrens Hospital, Boston, MA;
Massachussets General Hospital, Boston, MA; Brigham
and Womens Hospital, Boston, MA
Bone Marrow Fibrosis in Chronic Myelomonocytic

Leukemia Is Associated with Increased Bone Marrow
Cellularity and Megakaryopoiesis, Spleen Size and with
a Shorter Median Time to Disease Progression (1455)
Kseniya Petrova-Drus, April Chiu, Elizabeth
Margolskee, Attilio Orazi
Weill Cornell Medical Center, New York, NY; Memorial
210
Primary Myelofibrosis Displays an InflammationAssociated Gene Profile Distinct from Polycythemia

Vera and Essential Thrombocythemia (1462)
Olga Pozdnyakova, Jon C Aster, Frank Kuo, Ronald
Brown, Michele Baltay, Robert P Hasserjian
Brigham & Womens Hospital, Boston, MA;
211
Immunophenotypic Aberrancy on Basophils, a

Biomarker for BCR-ABL1 Negative Myeloproliferative
Neoplasms (1349)
Andrew Chu, Kirthi Kumar, Sara A Monaghan, Franklin
Fuda, Weina Chen
212
Bone Marrow and Extramedullary Lesions in Patients

with Myeloproliferative Neoplasms Exhibit Similar
miRNA Profiles (1422)
Sanam Loghavi, Zhuang Zuo, Denaha J Doss, Erika J
Thompson, Chong Zhao, John Lee, Rashmi KanagalShamanna, L Jeffrey Medeiros, Carlos E Bueso-Ramos
The University of Texas, MD Anderson Cancer Center,
Houston, TX
203
Low CD177 (%) on Neutrophils Correlates with

Granulocytic Dysplasia and Adds Value for Identifying
Myelodysplasia by Flow Cytometry (1499)
Samir Turakhia, Howard J Meyerson
University Hospitals/Case Medical Center, Cleveland,
OH
204
Low-Level BCR-ABL1 Expression in Individuals without

Overt Hematologic Malignancy (1415)
Rebecca J Leeman-Neill, Steven H Swerdlow,
Catherine L Burnes, Marina Nikiforova, Nidhi Aggarwal
Pittsburgh, PA
155
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
213
Identification of Mutated CALR Protein Is Useful in

the Diagnosis and Prognostic Stratification of JAK-2
Negative, MPL-Negative Myeloproliferative Neoplasms
(1475)
Frances L Rosario Quinones, Achim Jungbluth, Raajit K
Rampal, Ross Levine, Filiz Sen, Ahmet Dogan
219
214
Performance of a Commercially Available

CALR Mutation-Specific Antibody for the
Immunohistochemical Assessment of Bone Marrow
Biopsies (1445)
Laila Nomani, Kelli Schneider, Juraj Bodo, Lisa M
Durkin, James R Cook, Eric D Hsi
Alternative Lengthening of Telomeres in Pancreatic

Carcinomas with Acinar Differentiation (1753)
Jiyoon Kim, Jacqueline Brosnan-Cashman, Soyeon An,
Do Youn Park, Haeryoung Kim, Young-Ha Oh, Ralph H
Hruban, Christopher M Heaphy, Seung-Mo Hong
Asan Medical Center, University of Ulsan College
of Medicine, Seoul, Korea; Johns Hopkins Medical
Institutions, Baltimore, MD; Pusan National University
Hospital, Pusan National University School of
Medicine, Busan, Korea; Seoul National University
Bundang Hospital, Seoul National University College
of Medicine, Seongnam, Kyung-ki do, Korea; Hanyang
University College of Medicine, Seoul, Korea
220
Type 1 Autoimmune Pancreatitis (AIP) Confined to

the Pancreatic Duct System with Massive Lobular
Effacement: A Type of AIP That Causes Pancreatic
Atrophy after Steroid Treatment? (1768)
Kenji Notohara, Takahiro Nakazawa, Tsuyoshi Uehara,
Shigeyuki Kawa
Kurashiki Central Hospital, Kurashiki, Japan; Japanese
Red Cross Nagoya Daini Hospital, Nagoya, Japan;
Shinshu University, Matsumoto, Japan
221
Pseudotumoral Pancreatitis: Clinicopathological

Analysis of 93 Cases Resected with Pre-Operative
Diagnosis of Pancreatic Ductal Adenocarcinoma but
Proved to Be Inflammatory Conditions (1766)
Takashi Muraki, Gabriela Bedolla, Michelle Reid, Grace
Kim, Alyssa M Krasinskas, Ipek E Seven, Bahar Memis,
Field Willingham, Juan Sarmiento, David Kooby,
Shishir Maithel, Pardeep Mittal, Volkan Adsay
Emory University, Atlanta, GA; UCSF, San Francisco,
CA
222
The Diagnostic Utility of Pancreatic Biopsy for

Inflammatory Bowel Disease-Associated Pancreatitis
(1769)
Kenji Notohara, Shigeyuki Kawa, Toshiharu
Ueki, Atsushi Kanno, Mamoru Watanabe, Tooru
Shimosegawa
Kurashiki Central Hospital, Kurashiki, Japan; Shinshu
University, Matsumoto, Japan; Fukuoka University
Chikushi Hospital, Fukuoka, Japan; Tohoku University,
Sendai, Japan; Tokyo Medical and Dental University,
Tokyo, Japan
223
Choledochal Cysts in the West: Clinicopathologic

Ezgi Hacihasanoglu, Michelle Reid, Takashi Muraki,
Bahar Memis, Pardeep Mittal, Humbert Polito, Nikou
Zarrabi, Burcu Saka, Alyssa Krasinskas, Brian Quigley,
Volkan Adsay
224
Gallbladder and Cystic Duct Invasion of Distal Bile Duct

Carcinomas (1750)
Sun-Young Jun, Soyeon An, Jae Hoon Lee, Kwang-Min
Park, Seung-Mo Hong
Incheon St. Marys Hospital, The Catholic University
of Korea, Incheon, Republic of Korea; Asan Medical
Center, University of Ulsan College of Medicine, Seoul,
Republic of Korea
215
Immunohistochemical Detection of Calreticulin

Mutations in Bone Marrow Biopsy Samples from
Patients with Myeloproliferative Neoplasms (1496)
Sheryl R Tripp, Anton V Rets, Tsewang Tashi,
Mohamed E Salama
ARUP Reference Laboratory, Salt Lake City, UT;
216
Hypereosinophilic Syndrome with Clonal T-cell

Receptor Gene Rearrangement: A Retrospective Study
of 51 Patients (1519)
Wenbin Xiao, Fei Li Kuang, Sachein Sharma, Jamie
Hahn, Maryalice Stetler-Stevenson, Mark Raffeld, Amy
Klion, Irina Maric
the Clinical Center, NIH, Bethesda, MD; NIAID, NIH,
Bethesda, MD; NCI, NIH, Bethesda, MD
217
Defining Prognostic Factors of Juvenile

Myelomonocytic Leukemia: A Clinicopathologic,
Immunophenotypic, and Genetic Approach (1513)
Kwun Wah Wen, Elliot Stieglitz, Ari Molofsky, Farid
Chehab, Kristie White, Sonam Prakash
PANCREAS & BILIARY TREE
218
156
Alternative Lengthening of Telomeres in Primary

Pancreatic Neuroendocrine Tumors Is Associated with
Aggressive Clinical Behavior and Poor Survival, but
Better Survival after Metastasis (1754)
Joo Young Kim, Jacqueline Brosnan-Cashman,
Soyeon An, Alan Meeker, Eunsil Yu, Ralph H Hruban,
Christopher M Heaphy, Seung-Mo Hong
Korea University Anam Hospital, Korea University
College of Medicine, Seoul, Republic of Korea;
Johns Hopkins Medical Institutions, Baltimore, MD;
Asan Medical Center, University of Ulsan College of
Medicine, Seoul, Republic of Korea
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
225
Mutational Profiling of Oncocytic Intraductal Papillary

Mucinous Neoplasms (IPMN-o) (1757)
Jochen K Lennerz, Charlotte I Wang, Leona Doyle,
Tiffany G Huynh, Neal Lindeman, Amitabh Srivastava,
Carlos Fernandez del-Castillo, Mari Mino-Kenudson
School, Boston, MA; Brigham and Womens Hospital,
Boston, MA
232
226
Comparative Clinicopathologic Study of Biliary

Intraductal Papillary Neoplasms and Papillary
Cholangiocarcinomas (1746)
Kohei Fujikura, Tomoo Itoh, Yoh Zen
Kobe University, Kobe, Hyogo, Japan
Prognosis of T2 Gallbladder Carcinomas: An Analysis

of 326 Cases Highlights a Prognosis Better Than the
Current Impression in the West, but Incomparably
Worse Than What Is Reported in Asia (1763)
Bahar Memis, Juan Carlos Roa, Takashi Muraki, KeeTaek Jang, Enrique R Bellolio, Juan Carlos Araya,
Miguel A Villaseca, Juan Sarmiento, Hector Losada,
Shishir Maithel, David Kooby, Nevra Dursun, Humbert
Polito, Sudeshna Bandyopadhyay, Pelin Bagci, Burcu
Saka, Michelle Reid, Volkan Adsay
Emory University, Atlanta, GA; Pontificia University,
Santiago, Chile; SMC, Seoul, Korea; University
Frontera, Temuco, Chile; WSU, Detroit, MI
227
Quasimesenchymal Phenotype Predicts Distant

Metastasis in Pancreatic Ductal Adenocarcinoma
(1747)
Rajib Gupta, Krishnan K Mahadevan, Cristina R
Ferrone, David T Ting, Vikram Deshpande
Baltimore, MD; Massachusetts General Hospital &
233
228
Genetic and Epigenetic Changes in Stromal Cells

Regulate Tumor Progression and Emphasize the
Genetic Complexity of the Tumor Microenvironment in
Pancreatic Cancer (1780)
Martin Wartenberg, Stefan Haemmig, Erik Vassella,
Aurel Perren, Eva Karamitopoulou
University of Bern, Bern, Switzerland
Not All T2 Gallbladder Carcinomas (GBC) Are Equal:

Proposal for Sub-Staging of T2 GBC with Significant
Prognostic Value (1764)
Bahar Memis, Juan Carlos Roa, Takashi Muraki, Ezgi
Hacihasanoglu, Nevra Dursun, Burcu Saka, Enrique R
Bellolio, Juan Carlos Araya, Juan Sarmiento, Hector
Losada, David Kooby, Shishir Maithel, Michelle Reid,
Brian Quigley, Alyssa Krasinskas, Volkan Adsay
Emory University, Atlanta, GA; Pontificia University,
Santiago, Chile; University Frontera, Temuco, Chile
229
230
231
Epigenetic Regulation through Differential MicroRNA

Expression by the Cellular Components of the Tumor
Microenvironment Influence the Phenotype of
Eva Karamitopoulou, Stefan Haemmig, Martin
Wartenberg, Erik Vassella, Aurel Perren
The Prognostic Role of Desmoplastic Stroma in
Lai Mun Wang, Mike Silva, Zenobia DCosta, Robin
Bockelmann, Zahir Soonawalla, Eric ONeill, Somnath
Mukherjee, W Gillies McKenna, Ruth Muschel,
Emmanouil Fokas
Oxford University Hospital NHS Trust, University of
Oxford, Oxford, United Kingdom; Oxford University
Hospital NHS Trust, Oxford, United Kingdom; CRUK/
MRC Institute for Radiation Oncology, University of
Oxford, Oxford, United Kingdom
Stromal Changes Related to Therapy in Pancreatic
Cancer (1773)
Daniel Rowan, Kiyoko Oshima
PULMONARY PATHOLOGY (INCLUDING MEDIASTINAL)
234
The Clinical Impact of Solid and/or Micropapillary

Subtypes in Resected Lung Adenocarcinoma (1940)
Naoki Yanagawa
Yamagata Prefectural Central Hospital, Yamagata,
Japan
235
High-Grade Components as the Second- or Third-Most

Predominant Pattern Predict Poor Prognosis in pT1
Lung Adenocarcinoma[/underline] (1866)
Makoto Hamasaki, Tomoyuki Hida, Masayo Yoshimura,
Sousei Abe, Akinori Iwasaki, Kazuki Nabeshima
Fukuoka University School of Medicine and Hospital,
Fukuoka, Japan
236
Pleomorphic Carcinomas of the Lung: A

Clinicopathological and Immunohistochemical Study
of 68 Cases (1937)
Annikka Weissferdt, Maheshwari Ramineni, Neda
Kalhor, Barbara Mino, Jaime Rodriguez Canales, Junya
Fujimoto, Ignacio I Wistuba, Cesar A Moran
237
Low Expression of SerpinB2 Is Associated with

Reduced Survival in Lung Adenocarcinomas (1908)
Maria Ramnefjell, Christina Aamelfot, Lars Helgeland,
Lars A Akslen
University of Bergen, Bergen, Norway; Haukeland
University Hospital, Bergen, Norway
157
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
238
Adipophilin Expression in Pulmonary Adenocarcinoma

Is Associated with Poor Clinical Prognosis:
Immunohistochemical Study of 328 Cases (1864)
Masakazu Fujimoto, Akihiko Yoshizawa, Shinji
Sumiyoshi
Kyoto University Hospital, Kyoto, Japan; Wakayama
Medical University, Wakayama, Japan; Kumamoto
University Hospital, Kumamoto, Japan
245
ALK Rearragnement Testing by Immunohistochemistry

and Fluorescent In Situ Hybridization in Lung Cancers:
A Canadian Reference Testing Centers Routine Clinical
Experience (1863)
Pierre Fiset, Jeffrey Tanguay, Scott Boerner, David M
Hwang, Ming-Sound Tsao
239
Lung Adenocarcinoma with Mucin-Related Antigen 4

Expression Is Associated with the Smoking Status and
Poor Prognosis (1913)
Mariyo Rokutan, Akihiko Yoshizawa, Hironori Haga
Kyoto University Hospital, Kyoto, Japan
246
Prevalence of ALK and ROS1 Rearrangements in

Mexican Patients with Lung Adenocarcinoma (1917)
Sergio Sanchez, Silvia Montilla, Pamela R Matias,
Julieta Garcia, Ivan R Gonzalez
Hospital Angeles Puebla, Puebla, Mexico
240
Differential Expression of SOX17 in Lung and

Endometrial Carcinomas (1924)
Tracy A Stein, Mohamed El Hag, Bo Ye, Prachi Raut,
Guang-Qian Xiao, Haodong Xu, Mahmoud Khalifa,
Faqian Li
University of Minnesota Medical Center, Minneapolis,
MN; University of Rochester Medical Center, Rochester,
NY; UCLA Medical Center, Los Angeles, CA
247
Programmed Death Ligand-1 (PD-L1) Expression in

Operable Non-Small Cell Lung Cancer (NSCLC) by
Immunohistochemical Analysis (1851)
Sabina Babayeva, Artem Dyatlov, Ranjita Pallavi,
Michael Fanucchi, Carmelo Puccio, Rocco Lafaro,
Fouzia Shakil, John T Fallon, Minghao Zhong
New York Medical College, Valhalla, NY
248
Prognostic Significance of lincRNA-p21 in Non-Small

Cell Lung Carcinoma (NSCLC) (1907)
Jose Ramirez, Joan J Castellano, Adela Saco, Jorge
Moises, Ana Cordeiro, Ramon Marrades, Nuria Vinolas,
Francisco Aya, Laureano Molins, Mariano Monzo,
Alfons Navarro
Hospital Clinic, University of Barcelona, Barcelona,
Spain; University of Barcelona, Barcelona, Spain;
Hospital Clinic, Barcelona, Spain
Programmed Death 1 (PD-1) and PD-L1 Expression

in Lung Adenocarcinoma, with Lower Expression in
In Situ and Minimally Invasive Tumors and Higher
Expression in Larger and Invasive Tumors (1888)
Osamu Matsubara, Yasuto Jin, Shuta Yamauchi,
Kazuteru Yamanaka, Yuichi Ishikawa, Eugene J Mark
The Cancer Insitute, Tokyo, Japan; Hiratsuka Kyosai
Hospital, Hiratsuka, Japan; Massachusetts General
Hospital and Harvard Medical School, Boston, MA
249
Cell Cycle Progression Score Is a Promising Predictor

of Recurrence in Primary Lung Carcinoid Tumors
(1874)
Neda Kalhor, Junya Fujimoto, Guoping Xu, Ryan Hoff,
Placede Tiemeny, Susanne Wagner, Reza J Mehran,
Cesar A Moran, Ignacio I Wistuba
MD Anderson Cancer Center, Houston, TX; Myriad
Genetics, Inc., Salt Lake City, UT; Dali University,
Yunnan, China
Relationship between PD-L1 Expression and Epithelial

Mesenchymal Transition in Adenocarcinoma of the
Lung (1876)
Sehui Kim, Moon-Young Kim, Jaemoon Koh,
Heounjeong Go, Yoon Kyung Jeon, Doo Hyun Chung
Seoul National University Hospital, Seoul, Republic of
Korea; Seoul National University College of Medicine,
Seoul, Republic of Korea; Asan Medical Center, Seoul,
Republic of Korea
250
Molecular Characterization of Invasive Mucinous

Adenocarcinomas of the Lung (1901)
Kyung Park, Shivakumar Subramaniyam, Jose
Jessurun, Helen Fernandes, Navneet Narula
NYPH-WCMC, NYC, NY
251
Pulmonary Mucinous Adenocarcinoma- A Molecular

Genetic Study of 52 Cases (1855)
Jennifer M Boland, Joseph J Maleszewski, Benjamin R
Kipp, Jason A Wampfler, Ping Yang, Eunhee S Yi
241
242
243
244
158
A Small Panel of microRNAs Effectively Separates

Typical Carcinoids from Neuroendocrine Carcinomas
and May Predict Outcome in Atypical Carcinoid Tumors
(1856)
Yao-Tseng Chen, Xiaojing Yang, Kathrin Tyryshkin,
Paula Ginter, Thomas Tuschl, Neil Renwick
Weill Cornell Medical College, New York, NY; Queens
University, Kingston, ON, Canada; Rockefeller
Borderline Neuroendocrine Carcinomas of the Lung
Are Clinically and Genomically Distinct from Large Cell
Neuroendocrine Carcinoma (1932)
Marina Vivero, Lynette M Sholl
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
252
Comprehensive Genomic Profiling of Lung Cancer is

Practical and Facilitates Implementation of the National
Comprehensive Cancer Network (NCCN) Guidelines
for Lung Cancer Biomarker Testing in Patients with
Advanced Stage Disease (1927)
James Suh, Adrienne Johnson, Kai Wang, Garrett
Frampton, Juliann Chmielecki, Julia A Elvin, Jo-Anne
Vergilio, Siraj M Ali, Vincent A Miller, Philip J Stephens,
Jeffrey S Ross
Foundation Medicine, Inc., Cambridge, MA; Albany
Medical College, Albany, NY
253
Lessons Learned from Next Generation Sequencing in

Use of Immunohistochemistry (IHC) for EGFR L858R
and ALK in Lung Cancer Predictive Testing (1894)
Joseph Montecalvo, C Leduc, N Rekhtman, A Moreira,
M Arcila, M Berger, C Rudin, V Rusch, D Jones, W
Travis
MSKCC, New York, NY; Mayo Clinic, Rochester, MN
254
BAP1 Immunostain and P16 FISH: Clinical Applicability

to Confirm Malignant Mesothelioma in Effusions
(1935)
Ann E Walts, Kenzo Hiroshima, Stephanie McGregor,
Aliya N Husain, Alberto M Marchevsky
Cedars-Sinai Medical Center, Los Angeles, CA; Tokyo
Womens Medical University Yachiyo Medical Center,
Yachiyo, Japan; University of Chicago Hospitals,
Chicago, IL
255
Utility of BAP1 FISH and immunohistochemistry in

Distinguishing between Mesothelioma and Reactive
Mesothelial Proliferation. Comparison with Analysis of
p16/CDKN2A (1869)
Kenzo Hiroshima, Di Wu, Mizue Hasegawa, Yasuo
Sekine, Daisuke Ozaki, Toshikazu Yusa, Zhibin Gao,
Ann E Walts, Alberto M Marchevsky, Yuji Tada, Hideaki
Shimada, Masatoshi Tagawa
Tokyo Womens Medical University, Yachiyo, Chiba,
Japan; Chiba Rosai Hospital, Ichihara, Chiba, Japan;
Yuyao Peoples Hospital, Yuyao, Ningbo, China;
CedarsSinai Medical Center, Los Angeles, CA; Chiba
University, Chiba, Japan; Toho University, Tokyo,
Japan; Chiba Cancer Center Research Institute, Chiba,
Japan
256
Correlation of Histologic and Radiologic Response to

Neoadjuvant Treatment of Thymic Epithelial Tumors
(1911)
Anja C Roden, Marie Christine Aubry, Eunhee S Yi,
Sarah M Jenkins, Yolanda I Garces, Randolph S Marks,
Stephen D Cassivi, Geoffrey B Johnson
Board
Number
QUALITY ASSURANCE
257
A Triaging Strategy Using Absolute White Blood Cell

Differential Counts and Smear Morphology Improves
Diagnostic Yield of Peripheral Blood Flow Cytometry[/
underline] (1974)
Amelia Huck, Christine Hong, Michelle E DeLelys,
Frederic I Preffer, Aliyah R Sohani
St. Barnabas Medical Center, Livingston, NJ; Harvard
College, Cambridge, MA; Massachusetts General
258
Ancillary Testing in Bone Marrow Staging for

Lymphoma: A Laboratory Utilization and Quality
Management Opportunity (1979)
K David Li, Jerry W Hussong, Sherrie L Perkins, Jay L
Patel
University of Utah/ARUP Laboratories, Salt Lake City,
UT
259
Diagnostic Value of Flow Cytometry as a Screening

Tool for Cerebrospinal Fluids in Patients with or
without Prior Hematologic Malignancy (1992)
Nupam Patel, Karthik A Ganapathi, Stefanie Forest,
Matthew B Thomsen, George Vlad, Govind Bhagat,
Bachir Alobeid, Daniela Hoehn
Columbia University Medical Center, New York, NY
260
Cerebrospinal Fluid Specimen Evaluation in Patients

with Hematopoietic Neoplasms: The Need for an
Integrated Approach (1954)
Darren Buonocore, Mikhail Roshal, Samuel I McCash,
Oscar Lin
261
Cost Comparison of First Line Multiplex PCR Versus

Screening with Influenza Single PCR for the Detection
of Upper Respiratory Tract Viral Infections (1953)
John Cannatella, Benjamin Buelow, Lynn Pulliam
CA
262
Bone Marrow Biopsy Practice and Quality Trends in

USA and Canada: A Multicenter Study (1985)
Mihai Merzianu
Roswell Park Cancer Institute, Buffalo, NY
263
Improving Utilization of Hemochromatosis Testing

(2023)
Yaolin Zhou, Gary Procop, Jacquelyn Riley
264
Pathologists Discussing Diagnoses with Patients: A

Pilot Study in Lymphoma Clinic (2008)
Lauren B Smith, Brian Tolle, William Sherman, Scott R
Owens, Mark Kaminski
159
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
265
274
Daily Surgical Pathology Huddles Positively Impact

Quality, Safety Culture and Team Engagement (1971)
Omar Hameed, Cheryl M Coffin, Anatomic Pathology
Team
275
Does Expert Review of Testis Biopsies for Infertility

Improve Clinicopathologic Correlation? (1998)
Brian D Robinson, Aaron Bernie, Peyman Tavassoli,
Theresa Scognamiglio, Francesca Khani, Peter N
Schlegel
276
Evaluating Pathologist Accuracy in Estimation of

Percentage of Malignant Cells (1957)
Hui Chen, Russell Broaddus, Bedia A Barkoh, Ronald
Abraham, Rajesh Singh, Raja Luthra, Sinchita Roy
Chowdhuri
277
Utilization of Pathologists Assistants in the Diagnostic

Arena: Working Differently in the Changing Health Care
Environment (1951)
Melissa M Blessing, David Schembri Wismayer, Diva
R Salomao, Adam J Wood, Sarah E Kerr, Monica L
Kendall, Kenneth M Smith, Carrie Y Inwards, Gary L
Keeney, Mariam P Alexander
278
Can Decalcification of Thyroid Tissue Cause

Overdiagnosis of Papillary Thyroid Carcinoma? (1947)
Dhanalakshmi Balakrishnan, Chengbao Liu, Laura
Birney, Syed Hoda, James Davis, Alan Heimann,
Jingxuan Liu
State University of New York, Stony Brook, Stony
Brook, NY
279
Impact of Intradepartmental Consultation on Amended

Report Rate; Findings from the Irish National Quality
Improvement Programme in Histopathology (2011)
Niall Swan, Philip Ryan, Kieran Sheahan, Ann Treacy,
Sine Phelan, Julie McCarthy, Mairead Guinan, John
Conor OKeane
Royal College of Physicians of Ireland, Dublin, Ireland
280
Quality Assurance Protocols for Breast and

Gynecologic Pathology Practice in a CLIA Laboratory
Minimize Serious Events and Maximize Patient Safety[/
underline] (2010)
Catherine Stoos, Rohit Bhargava, Gloria J Carter, Abbie
Mallon, David Dabbs
Magee Womens Hospital, Pittsburgh, PA
281
Cost Effectiveness Analysis of Core Needle Biopsy

Diagnosis of Papillomatous Breast Lesions (1984)
Clare McCormick-Baw, Mae Lopez, Ada WerlangPerurena, Riyam T Zreik, Amin Mohammad, Arundhati
Rao
Baylor Scott and White Memorial Hospital, Temple, TX
266
267
268
Communication from Referring Clinicians to

Pathologists in the Electronic Health Record Era (1948)
Andrea L Barbieri, Oluwole Fadare, Christopher
Sebastian, Hardeep Singh, Vinita Parkash
Yale University, New Haven, CT; University of California
San Diego, La Jolla, CA; VA Health Services Research
Center for Innovation & Baylor College of Medicine,
Houston, TX
Communication with Clinicians in Anatomical
Pathology (2012)
Ann Treacy, John Conor OKeane, Julie McCarthy, Sine
Phelan, Howard Johnson, Jennifer Martin, Mairead
Guinan, Philip Ryan, Niall Swan, Kieran Sheahan
Royal College of Physicians of Ireland, Dublin, Ireland;
HSE, Dublin, Ireland
Communication in a Pathology Report: Differences
between Pathology Attendings, Residents and
Clinicians (1969)
Blake Gibson, Robert R Klein, Ronald S Weinstein,
Erika Bracamonte
University of Arizona, Tucson, AZ
Image Documented Surgical Pathology (ID-SP) to
Enhance Patient Safety - Lean Redesign of the Value
Stream Steps from Gross Examination to Signout
(1961)
Dhananjay A Chitale, Jason Wozniak, Nelson Main,
Ruan Varney, Mark Tuthill, Richard J Zarbo
269
Quality Assurance of Anatomic Pathology Diagnoses:

Comparison of Alternate Approaches and Detection of
Diagnostic Error (1978)
Lester Layfield
University of Missouri, Columbia, MO
270
Turnaround Time In Surgical Pathology: The Patient

Perspective (1994)
Garrison Pease, Elisheva Shanes, Charnell Johnson,
William Watkin
University of Chicago (NorthShore), Evanston, IL
271
Adopting the Quality Dashboard in Pathology: RealTime Data Monitoring and Improvement (1959)
Yigu Chen, Gina McCormack, Yael K Heher
Beth Israel Deaconess Medical Center, Boston, MA
272
Laboratory Requisition Forms Often Lack Critical

Information: An Initiative to Improve Communication
and Enhance Patient Safety at The Ottawa Hospital
(2017)
Jason K Wasserman, Iris Teo, Darren Tse, John Veinot,
Bibianna Purgina
273
160
Use of Barcode Tracking in Routine Histology

Processing Significantly Decreases Pre-Analytical
Errors (1996)
Mahboubeh Rahmani, Kristi Bedrossian, Elizabeth
Genega
Tufts Medical Center, Tufts University School of
Medicine, Boston, MA
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
282
Pathology Review of Research Biopsies Highlights

Inter- and Intra-Tumor Variability: Towards Improving
Quality and Utility for Next-Generation Biospecimen
Research[/underline] (1956)
Dianne Chadwick, Michael H Roehrl
289
283
Duodenal Polyps Resembling Peptic Duodenitis in

Patients with Hereditary Cancer Syndromes (1963)
Kyle Devins, Lisa Wang, Maryam Zenali
SUNY Upstate Medical University, Syracuse, NY;
University of Vermont, Burlington, VT

Evaluation of Cancer (2031)
Alka Chaubey, Ravindra Kolhe, Lisa C Watson, Deepa
Jagdale, Claire Attwooll, WonSok Lee, Ashis K Mondal,
Sadanand Fulzele
Genetic Center, Greenwood, SC; Illumina, Inc, San
Diego, CA
290
Hepatitis C Virus Genotyping Using Next-Generation

SequencingAn Efficient and Cost-Effective
Alternative to Sanger Sequencing in the Hospital
Laboratory Setting[/underline] (2083)
Cameron Wales, George Corpus, Dimitri Gonzalez,
Chalom Sayada, Chung-Che Chang
UCF, Orlando, FL; ABL SA, Luxembourg, Luxembourg;
Florida Hospital, Orlando, FL
291
Whole-Exome Sequencing Identifies a Homozygous

POLG2 Missense Variant in an Infant with Fulminant
Hepatic Failure and Mitochondrial DNA Depletion
(2079)
Hemant Varma, Phyllis L Faust, Peter L Nagy, Alejandro
D Iglesias, Stephen M Lagana, Karen Wou, Michio
Hirano, Mahesh Mansukhani, Kirsten E Hoff, William C
Copeland, Ali B Naini
Columbia University Medical Center and New York
Presbyterian Hospital, New York, NY; National Institute
of Environmental Health Sciences, NIH, Research
Triangle Park, NC
284
A Comparative Study of Colon and Rectal Tumor

Specimens Gross Examination by Biomedical
Scientists, Residents and Pathologists: A Review of 688
Cases (1952)
Ana C Braga, Rita SS Oliveira, Marco Ferreira, Ana
Lopes, Katia Reis, Leontino Lampreia, Manuela Novo,
Rui Vaz, Rute Matos, Sara Marques
Hospital Prof. Doutor Fernando Fonseca, E.P.E.,
Amadora, Portugal
285
Utility of Routine Histopathological Analysis Following

Orthopaedic Procedures for Benign Indications (2018)
Anna-Sophie Weidner, Francesca Khani, Theresa
Scognamiglio
286
Single Versus Multiple Levels for Routine Endometrial

Biopsies: Single Institution Experience (1995)
Anna Plotkin, Linda R Kapusta, Keiyan Sy, Blake Gilks
University of Toronto, Toronto, ON, Canada; University
of British Columbia, Vancouver, BC, Canada
292
Comparing H&E Stained and Unstained Slides of

Frozen Tissue for Quality and Quantity of mRNA after
Laser Capture Microdissection in Human Tissue for the
Evaluation of the Microenvironment in Regressing and
Progressing Primary Cutaneous Melanoma (1987)
Kumaran Mudaliar, Solomiya Grushchak, Arielle Gray,
David Murray, Rebecca Tung, Stephanie Kliethermes,
Michael I Nishimura, Kelli A Hutchens
Loyola University Chicago Stritch School of Medicine,
Maywood, IL; Loyola University Medical Center,
Maywood, IL
RNAscope 2.5: A Robust and High Performance RNA

In Situ Hybridization Assay for Formalin-Fixed ParaffinEmbedded Tissue (2026)
Courtney Anderson, Li-chong Wang, Casey Kernag,
Bingqing Zhang, Emerald Butko, Melanie Miller,
Thomas Laver, Nan Su, Henry G Lamparski, Emily Park,
Yuling Luo, Xiao-Jun Ma
Advanced Cell Diagnostics, Hayward, CA
293
RNAscope 2.5 Duplex - A Robust High Performance

Chromogenic Duplex RNA In Situ Hybridization
Technology (2085)
Li-chong Wang, Bingqing Zhang, Casey Kernag, Daniel
Kim, Henry G Lamparski, Nan Su, Xiao-Jun Ma, Yuling
Luo
ACD, Inc, Hayward, CA
294
Development of RNAscope 2.5 for RNA In Situ

Hybridization on the Fully Automated Leica
Biosystems BOND Advanced Staining Platform (2051)
Henry G Lamparski, Bingqing Zhang, Melanie Miller,
Thomas Laver, Casey Kernag, Daniel Kim, Keith Young,
Kuang-Jung Chang, Nan Su, Xiao-Jun Ma, Yuling Luo
Advanced Cell Diagnostics, Hayward, CA
287
TECHNIQUES (INCLUDING ULTRASTRUCTURE)
288
Scalable Next Generation Sequencing Workflow for

Mutation Screening of Solid Tumors Using Ion S5XL
Sequencer (2058)
Meenakshi Mehrotra, Dzifa Y Duose, Rajesh Singh,
Bedia A Barkoh, Jawad Manekia, Jonathan Yau,
Michael A Harmon, Mark Routbort, L Jeffrey Medeiros,
Ignacio I Wistuba, Rajyalakshmi Luthra
The UT M.D. Anderson Cancer Center, Houston, TX
161
POSTER
POSTER SESSION
SESSION II
Monday,
Monday,March
March23,
14,2015
2016 | | 9:30
1:00AM
PM- -12:00
4:30 PM
PM CC
CC Exhibit
Exhibit Hall
Hall 4ABC
C/D
Board
Number
Board
Number
295
Optimizing Metastatic Bone Biopsies for Genomic

Testing in Precision Medicine (2035)
Joanna Cyrta, Marc Schiffman, Brian Sullivan, Chantal
Pauli, Olivier Elemento, Andrea Sboner, Brian D
Robinson, Himisha Beltran, Mark Rubin, Juan Miguel
Mosquera
NY
301
296
EDTABased Decalcification of Bone and Bone MarrowIdeal Tool for Protein and Nucleic Acid Preservation - A
Pilot Study (2062)
Peter Ntiamoah, George H Ayob, Richard R Clarke,
Doudja Nafa, Paulo A Salazar, Agnes Viale, Ahmet
Dogan, Meera Hameed
Digital Multi-Colour CTC Detection (2034)

Anthony Cooney, Brendan Ffrench, Cathy D Spillane,
Carmel Ruttle, Noreen Gleeson, Ciaran ORiain, Richard
Flavin, Michael F Gallagher, Cara Martin, Orla Sheils,
Sharon OToole, John OLeary
Trinity College Dublin, Dublin, Ireland; Coombe Women
& Infants University Hospital, Dublin, Ireland; Dublin
City University, Dublin, Ireland; St. Jamess Hospital,
Dublin, Ireland
302
297
Effects of Formalin Fixation Variables on DNA Integrity

for Genomic Applications in Cancer (2052)
Martina Lefterova, Michael J Clark, Ravi K Alla, Shujun
Luo, Massimo Morra, Elena Helman, Sean M Boyle,
Scott Kirk, Parin Sripakdeevong, Mirian Karbelashvili,
Deanna M Church, Michael P Snyder, John West,
Richard Chen
Stanford University, Stanford, Ca
Cytology Waste or Molecular Treasure? A Proposed

Algorithm for Molecular-Oriented Cytology Specimen
Utilization (2075)
Shaozhou Tian, Maria E Arcila, Andre Moreira, Justyna
Sadowska, Sumit Middha, Oscar Lin
Memorial Sloan Kettering Cancer Center, New York
City, NY
303
Utility of Dual-Color Silver In Situ Hybridization and

mRNA Chromogenic In Situ Hybridization in Adipocytic
Tumor MDM2 Assessment (2047)
Jong T Kim, John D Reith, Wonwoo Shon
304
Correlation between Immunohistochemical BRAF

V600E Expression and Mutational Status Detected
by Two Different PCR Based Molecular Techniques in
Papillary Thyroid Carcinomas (2073)
Jordi Temprana-Salvador, Javier Hernandez-Losa,
Carles Zafon, Jessica Camacho, Sherley Diaz, Irma
Ramos, Rosa Somoza, Ingrid Strohecker, Oscar
Gonzalez, Amparo Garcia-Burillo, Santiago Ramon y
Cajal, Carmela Iglesias
Vall dHebron University Hospital, Autonomous
University of Barcelona, Barcelona, Spain
305
Combined Molecular Testing (Mutational Analysis

and MicroRNA Panel) of Thyroid Nodules Can Be
Accomplished on Fine Needle Aspirate Slides (2076)
Maria L Torres, Angela M Sanguino Ramirez, Sydney D
Finkelstein, Jan Silverman
Allegheny Health Network, Pittsburgh, PA; Redpath /
Interpace Diagnostics, Pittsburgh, PA
298
Comparison of 5 Methods for Extraction of Cell-Free

DNA (2046)
Kevin Kelly, Vanessa Spotlow, Aleksandra Ras,
Samantha Helm, Joan Malcolm, Gregory J Tsongalis
The Jackson Laboratory for Genomic Medicine,
Farmington, CT; Dartmouth Hitchcock Medical Center
and The Audrey and Theodor Geisel School of
Medicine at Dartmouth, Lebanon, NH
299
Lesson Learned from the Evaluation of MYC NonIGH Translocation Partners in DLBCL- An Institutional
Experience (2027)
Renu Bajaj, Alexander Graham, Jerald Gong, Zi-Xuan
Wang, Stephen C Peiper, Guldeep Uppal
Thomas Jefferson University Hospital, Philadelphia, PA
300
Inexpensive Improvements in Processing Techniques

Can Significantly Improve Cell Block Cellular Yields
(2050)
Kristin La Fortune, Melissa L Randolph, Harvey M
Cramer
Indiana University Health, Indianapolis, IN
162
PROFFERED PAPERS
Tuesday,
Monday, March 23,
15, 2015
2016
CC HALL 4E
CHAIRED BY: FADI BRIMO AND DANIEL BERNEY
8:00
Comprehensive Molecular Characterization of 412

Muscle Invasive Urothelial Carcinomas of the Bladder
Final Analysis of The Cancer Genome Atlas (TCGA)
Project (846)
Hikmat A Al-Ahmadie, Seth Lerner, Jaegil Kim, Gad
Getz, David J Kwiatkowski, John Weinstein, Andrew
Cherniack, Guangwu Guo, Rehan Akbani, Katherine
A Hoadley, William Y Kim, Gordon Robertson, Andy
Mungall, Toshinori Hinoue, Peter Laird, Jonathan E
Rosenberg, Joaquim Bellmunt, Margaret B Morgan,
Chad Creighton, Dmitry A Gordenin, Joshua M Stuart,
Xiaoping Su, Raju Kucherlapati, Gordon Mills, Donna
Hansel, Brian D Robinson, Bogdan A Czerniak, Victor E
Reuter
The Cancer Genoma Atlas (TCGA) Bladder Cancer
Working Group, New York, NY
8:15
Comprehensive Genomic Profiling of Urothelial

Carcinoma of the Kidney and Ureter (1025)
Jeffrey S Ross, Julia A Elvin, Siraj M Ali, Jo-Anne
Vergilio, James Suh, Tipu Nazeer, Vincent A Miller,
Philip J Stephens
8:30
TERT Promoter Mutations in Aggressive Variants of

Urothelial Carcinoma (1004)
Doreen Nguyen, Simeon Springer, Morgan Cowan,
Diana Taheri, Gunes Guner, Maria Angelica Mendoza
Rodriguez, Stephania Bezerra, Isabela W Cunha,
Dilek Baydar, Maria DC Rodriguez, Yuxuan Wang,
Christopher J VandenBussche, Kenneth Kinzler,
Nickolas Papadopoulos, Bert Vogelstein, George J
Netto
Johns Hopkins Hospital, Baltimore, MD; Sidney
Kimmel Comprehensive Cancer Center, Baltimore, MD;
Isfahan University of Medical Sciences, Isfahan Kidney
Diseases Research Center, Isfahan, Islamic Republic
of Iran; AC Camargo Cancer Center, Sao Paulo, Brazil;
Hacettepe University, Ankara, Turkey
8:45
Comprehensive Molecular Analysis of Plasmacytoid

Variant Urothelial Carcinoma (847)
Hikmat A Al-Ahmadie, Gopa Iyer, Byron H Lee, Sasinya
N Scott, Rohit Mehra, Aditya Bagrodia, Emmet J
Jordan, Sizhi P Gao, Ricardo Ramirez, Eugene K Cha,
Neil Desai, Emily C Zabor, Irina Ostrovnaya, Anuradha
Gopalan, Ying-Bei Chen, Samson W Fine, Satish K
Tickoo, Agnes Viale, Maria E Arcila, Guido Dalbagni,
Jonathan E Rosenberg, Bernard H Bochner, Dean F
Bajorin, Michael F Berger, Victor E Reuter, Barry S
Taylor, David B Solit
8:30
8:00 AM - 12:00 PM
9:00
Molecular Characterization of Clinically Aggressive

Micropapillary Bladder Cancer (935)
Charles C Guo, Vipulkumar Dadhania, Li Zhang,
Jolanta Bondaruk, Tadeusz Majewski, Maciej Sykulski,
Weronika Wronowska, Anna Gambin, Ashish Kamat,
Colin Dinney, Woonyoung Choi, David McConkey, John
Weinstein, Bogdan Czerniak
Houston, TX; Institute of Statistics, University of
Warsaw, Warsaw, Poland
9:15
Invasion of Rete Testis, Hilar Fat, and Epididymis by

Testicular Malignant Germ Cell Tumors (MGCT) Does
Not Justify Upstaging to pT2 (1073)
Elizabeth Whittington, Nicholas Harding Jackson,
Nicola Pavan, Samarpit Rai, Kenneth A Iczkowski,
Oleksandr N Kryvenko, Merce Jorda
University of Miami/Jackson Memorial Hospital,
Miami, FL; Medical College of Wisconsin, Milwaukee,
WI
11:00
Lymphovascular Invasion of the Spermatic Cord in the

Absence of Soft Tissue Invasion is a High Risk Finding
in Testicular Nonseminomatous Germ Cell Tumors
(991)
Brandi C McCleskey, Julie Jorns, David Y Lu, Andres
Matoso, Lauren E Schwartz, Jonathan I Epstein,
Jennifer B Gordetsky
The University of Alabama at Birmingham,
Birmingham, AL; University of Michigan, Ann Arbor,
MI; David Geffen School of Medicine at UCLA, Los
Angeles, CA; Brown University, Providence, RI;
University of Pennsylvania, Philadelphia, PA; The
11:15
Morphologic Spectrum of Sertoliform Cystadenoma of

the Rete Testis (SCRT): 14 Cases with Clinical FollowUp (1008)
Swetha Paluru, Thomas M Ulbright, Mahul B Amin,
Rodolfo Montironi, Jonathan I Epstein
Johns Hopkins Medical Institute, Baltimore, MD;
Indiana University, Indianapolis, IN; Cedars-Sinai
Medical Center, Los Angeles, CA; Polytechnic
University of the Marche Region (Ancona), Ancona,
Italy
11:30
Prognostic and Pathologic Factors Determining

Outcomes in pT2/pT3 Penile Carcinoma: Time for a
Revised Staging System (1023)
Priya Rao, Jasreman Dhillon, Benjamin Naovarat,
Vipulkumar Dadhania, Xuemei Wang, Hsiang-Chun
Chen, Philippe E Spiess, Curtis A Pettaway, Pheroze
Tamboli
MD Anderson Cancer Center, Houston, TX; Moffitt
Cancer Center, Tampa, FL
11:45
Genitourinary Rhabdomyosarcoma A Comparative

Analysis of Adult vs. Pediatric Cases (945)
Jing He, Hernan Correa, Justin M Cates, Giovanna A
Giannico, Omar Hameed, Lan L Gellert
12:00
BREAK
163
PROFFERED PAPERS
Tuesday,
Monday, March 23,
15, 2015
2016
CC BR 6A
SECTION B - BREAST
CHAIRED BY: GELAREH FARSHID AND DHANANJAY A
CHITALE
8:00
8:15
Should Multiple Ipsilateral Invasive Breast Carcinomas

Routinely Undergo Biomarker Testing? (237)
Anupma Nayak, Ira J Bleiweiss, Bailey A Reindl,
Shabnam Jaffer
Evolution of Practices for HER2 Testing in Breast
Cancer (BC) in France: Results of PartenHER National
Survey of 109 Structures Practicing HER2 Test (254)
Frederique Penault-Llorca, Jerome Chetritt, Bruno
Poulet, Marie-Pierre Chenard, Magali Lacroix-Triki,
Gaetan MacGrogan, Laurent Arnould, Jean-Pierre
Bellocq
Centre Jean Perrin, Clermont-Ferrand, France;
Institut dHisto-Pathologie, Nantes, France; Institut
de Pathologie de Paris, Malakoff, France; Centre
Hospitalier Universitaire de Strasbourg, Strasbourg,
France; Institut Universitaire du Cancer de Toulouse
- Oncopole, Toulouse, France; Institut Bergoni,
Bordeaux, France; 7Centre Georges Franois Leclerc,
Dijon, France; AFAQAP, Strasbourg, France
8:30
Impact of 2013 ASCO/CAP Guidelines on HER2

Determination of Invasive Breast Cancer: A Single
Institution Experience Using Frontline FISH (264)
Moira Ragazzi, Alessandra Bisagni, Cristina Bassano,
Ione Tamagnini, Elisa Gasparini, Elisabetta Kuhn,
Giorgio Gardini
Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia,
Italy; Azienda USL - Scandiano, Reggio Emilia, Italy
8:45
Impact of an Alternative Chromosome 17 Probe

and the 2013 ASCO/CAP Guidelines on FISH for the
Determination of HER2 Gene Status in Breast Cancer
(151)
Alana R Donaldson, Shashirekha Shetty, Christine
Rivera, Bryce P Portier, James R Cook, G T Budd, Erinn
Downs-Kelly, Roger D Klein, Christopher P Lanigan,
Raymond Tubbs, Benjamin C Calhoun
Cleveland Clinic, Cleveland, OH; Houston Methodist
Hospital, Houston, TX; University of Utah, Salt Lake
City, UT
9:00
HER2 Gene Protein Assay Is Useful to Determine HER2

Status of Breast Carcinoma with HER2 IHC and FISH
Double Equivocal Results (210)
Zaibo Li, Yanjun Hou, Hiroaki Nitta
Ohio State University, Columbus, OH; Ventana Medical
Systems, Inc, Tucson, AZ
9:15
HER2 FISH Equivocal Category: Does Retesting Resolve

This Clinical Grey Zone? (114)
Morgan Ballard, Sucheta Srivastava, Robert B West,
Kristin C Jensen, Richard K Sibley, Kimberly Allison
Stanford Healthcare, Stanford, CA; VA Healthcare
System, Palo Alto, CA
164
8:30
8:00 AM - 12:00 PM
11:00
Analysis of Estrogen Receptor (ER)

Immunohistochemistry (IHC) in Breast Cancer with
ESR1 Mutations Detected by Hybrid Capture-Based
Next Generation Sequencing (NGS) (270)
Dara S Ross, Fumiko Konno, Edi Brogi, Ahmet Zehir,
Michael F Berger, Sarat Chandarlapaty, Pedram Razavi,
Jose Baselga, Hannah Y Wen
11:15
Cliniopathologic Features in Predicting Complete

Pathologic Response (pCR) after Neoadjuvant
Herceptin Chemotherapy in HER2+ Breast Cancers
(150)
Qingqing Ding, Elizabeth A Mittendorf, Genevieve
R Lyons, Roland L Bassett, Kelly K Hunt, Aysegul A
Sahin, Yun Wu
UT MD Anderson Cancer Center, Houston, TX
11:30
Cytologic Characteristics of Resistant Locally Advanced

Breast Carcinoma after Neoadjuvant Treatment (230)
Ann M Moyer, Daniel W Visscher, Vera J Suman, Travis
J Dockter, Krishna R Kalari, Donald W Northfelt, Sarah
A McLaughlin, Alvaro Moreno-Aspitia, Richard J Gray,
Judy C Boughey, Matthew Goetz
AZ; Mayo Clinic, Jacksonville, FL
11:45
Prognostic Significance of Stromal Versus Intratumoral

Infiltrating Lymphocytes in Different Molecular
Subtypes of Breast Cancer Treated with Neoadjuvant
Therapy[/underline][/underline] (192)
Thaer Khoury, Vidya Nagrale, Xuan Peng, Mateusz
Opyrchal, Dan Wang, Song Yao
Roswell Park, Buffalo, NY
12:00
BREAK
CC BR 6C
SECTION C - HEMATOPATHOLOGY
CHAIRED BY: DAVID CZUCHLEWSKI AND JOHN R GOODLAD
8:00
The Genetic Landscape in Follicular Lymphoma,

Pediatric Type (1483)
Janine Schmidt, Itziar Salaverria, Shunyou Gong,
Stefania Pittaluga, Blanca Gonzalez, Olga Balague,
Theresa Marafioti, Anna Mozos, Jose M Cabecadas,
Irina Bonzheim, Falko Fend, Elias Campo, Elaine S
Jaffe, Leticia Quintanilla-Fend
University Hospital, Tbingen, Germany; Hospital
Clinic, IDIBAPS, Barcelona, Spain; National Cancer
Insitute, Bethesda, MD; Barts and The London NHS
Trust, London, United Kingdom; Hospital de Sant Pau,
Barcelona, Spain; Instituto Portugues de Oncologa,
Lisboa, Portugal
PROFFERED PAPERS
Tuesday,
Monday, March 23,
15, 2015
2016
8:30
8:00 AM - 12:00 PM
8:15
EBV-Positive Follicular Lymphoma: Another AgeRelated Lymphoma with Aggressive Clinical Features?
(1425)
Nicholas Mackrides, Yvan Maque-Acosta, Adrienne
Moul, German Campuzano-Zuluaga, Yasodha
Natkunam, Francisco Vega, Jennifer Chapman
University of Miami and Sylvester Comprehensive
Cancer Center, Miami, FL; Stanford University School
of Medicine, Stanford, CA
11:30
Sin1 is Upregulated by NPM-ALK and Contributes to

Cell Cycle Progression and Survival in Anaplastic Large
Cell Lymphoma (1497)
Nikolaos Tsesmetzis, George Baltatzis, Dimitrios
Chioureas, Vasiliki Leventaki, Elias Drakos, Theocharis
Panaretakis, George Rassidakis
Karolinska Institutet, Stockholm, Sweden; St Jude
Childrens Research Hospital, Memphis, TN; University
of Crete Medical School, Heraklion Crete, Greece
8:30
Copy Number Gain of PD-L1 and PD-L2 in T-Cell/

Histiocyte Rich Large B-Cell Lymphoma (1379)
Gabriel K Griffin, Scott B Lovitch, Alyssa Kelley,
Margaretha GM Roemer, Bjoern Chapuy, Christine Pak,
Evisa Gjini, Gordon J Freeman, F Stephen Hodi, Azra H
Ligon, Margaret A Shipp, Scott Rodig
Brigham and Womens Hospital, Boston, MA; DanaFarber Cancer Institute, Boston, MA
11:45
8:45
The Activation of the JAK3/STAT3 Pathway Is

Associated with Inferior Outcome in Diffuse Large
B-cell Lymphoma and ALK-Positive Large B-cell
Lymphoma (1352)
Stefan Costinean, Mei Zheng, Xin Huang, Bin Meng,
Lynette M Smith, Adams K Appiah, Shimin Hu, Yi
Zhou, Zenggang Pan, Timothy C Greiner, Hina N
Qureishi, Catalina Amador, Kai Fu, Ji Yuan
UNMC, Omaha, NE; MD Anderson Cancer Center,
Houston, TX; University of Washington, Seattle, WA;
University of Colorado, Aurora, CO
Expression of Activated B-Cell Factor-1 in ALK-Negative

Anaplastic Large Cell and Other Lymphomas (1363)
Andrew L Feldman, Yu Zeng, Rebecca L Boddicker,
Michael Zimmermann, Karen L Grogg, James R
Cerhan, Susan L Slager, Matthew Maurer, Cristine
Allmer, Thomas Habermann, Brian Link, Surendra
Dasari
Mayo Clinic, Rochester, MN; University of Iowa, Iowa
City, IA
12:00
BREAK
9:00
Immunophenotypic and Molecular Profiling of HIVAssociated Diffuse Large B-cell Lymphomas from subSaharan Africa (1362)
Yuri Fedoriw, Nathan Montgomery, Joel Parker, Sadia
Salahuddin, Coxcilly Kampani, Steve Kamiza, Tamiwe
Tomoka, Robert Krysiak, N George Liomba, Kristy
Richards, Satish Gopal
University of North Carolina, Chapel Hill, NC; Cornell
University, Ithaca, NY; University of Malawi College
of Medicine, Blantyre, Malawi; University of North
Carolina Project Malawi, Lilongwe, Malawi
9:15
MYC Rearrangement in Chronic Lymphocytic

Leukemia, Is Not Often Associated with Poor Prognosis
(1416)
Yan Li, Shimin Hu, Sa Wang, Yang O Huh, Shaoying Li,
Jeffrey Medeiros, Guilin Tang
11:00
Chronic Lymphocytic Leukemia (CLL) with TP53 Gene

Abnormalities: A Detailed Clinicopathologic and
Molecular Analysis (1373)
Julia T Geyer, Richard R Furman, Susan Mathew, Attilio
Orazi, Yen-Chun Liu
11:15
Flow Cytometric Characterization of PD1 Expression in

Tumor Infiltrating T-cells in B-cell Lymphoproliferative
Disorders Identifies Distinct, Disease Specific Patterns
(1474)
Frances L Rosario Quinones, Ahmet Dogan, Mikhail
Roshal
CC 602-604
CHAIRED BY: GREG Y LAUWERS AND SUSAN C ABRAHAM
8:00
Conventional Risk Stratification Fails to Predict

Progression of Succinate Dehydrogenase-Deficient
Gastrointestinal Stromal Tumors (736)
Emily Mason, Jason L Hornick
School, Boston, MA
8:15
PD-L1 Expression and the Tumor Immune

Microenvironment of Esophageal Adenocarcinomas
(806)
Elizabeth Thompson, Janis Taube, Toby C Cornish,
Ronan Kelly, Robert Anders
8:30
Prognostic Value of a lncRNA Signature in Gastric

Cancer: A lncRNA Expression Analysis (751)
Shujuan Ni, Midie Xu, Cong Tan, Dan Huang, Weiwei
Weng, Qiongyan Zhang, Weiqi Sheng, Xiang Du
China
8:45
Stress-Induced Phosphoprotein 1 (STIP1) Promotes

Tumorigenesis and Predicts Poor Survival in Gastric
Carcinoma Through Induction of the Phospholipase C-
1 and ERK Signaling Pathway (691)
Xin He, Sui Peng, Ertao Zai, Shirong Cai, Yi Lin
Rhode Island Hospital, Providence, RI; the First
Affiliated Hospital of Sun Yat-sen University,
Guangzhou, Guangdong, China
165
PROFFERED PAPERS
9:00
9:15
11:00
11:15
Tuesday,
Monday, March 23,
15, 2015
2016
Hepatoid Carcinomas of the Gastrointestinal

Tract: A Reappraisal of Morphological and
Immunohistochemical Features (796)
Angela R Shih, Munita Bal, Lawrence Zukerberg, Ian
Brown, Gregory Y Lauwers, Xiuli Liu, Paul Kelly, Esther
Oliva, Soomin Ahn, Kyoung Kim, Vikram Deshpande
Massachusetts General Hospital, Boston, MA; Tata
Memorial Hospital, Mumbai, India; Royal Brisbane
and Womens Hospital, Brisbane, Australia; Cleveland
Clinic, Cleveland, OH; Royal Victoria Hospital, Queens
University Belfast, Belfast, United Kingdom; Samsung
Medical Center, Sungkyunkwan University, Seoul,
Republic of Korea
Evaluation of Ki-67 Index and Mitotic Count in
the Assessment of Prognosis of Small Intestinal
Neuroendocrine Tumor[/underline] (803)
Yu Sun, Christine M Lohse, Thomas C Smyrk, Timothy
J Hobday, Trynda N Kroneman, Lizhi Zhang
Peking University Cancer Hospital & Institute, Beijing,
China; Mayo Clinic, Rochester, MN
Significant Prognostic Factors in Invasive Ampullary
Adenocarcinoma (AC): Clinicopathologic Analysis of
367 Cases (772)
Michelle Reid, Serdar Balci, Yue Xue, Nobu Ohike,
Takuma Tajiri, Olca Basturk, Takashi Muraki, Grace
E Kim, Alyssa M Krasinskas, Brian Quigley, Burcu
Saka, Pelin Bagci, Bassel El-Rayes, David Kooby, Juan
Sarmiento, Shishir Maithel, Volkan Adsay
Emory University, Atlanta, GA; MSKCC, NY, NY; UCSF,
San Francisco, CA
Immunohistochemical Typing of Ampullary
Carcinomas May Not Be Ready for Prime Time:
Analysis of 136 Cases Fails to Confirm Strong
Prognostic Correlation with Recently Proposed Marker
Panels, but Finds Strong Prognostic Value in MUC5AC
(826)
Yue Xue, Michelle Reid, Serdar Balci, Brian Quigley,
Bahar Memis, Jun Xia, Takashi Muraki, Ezgi
Hacihasanoglu, Gabriela Bedolla, Grace E Kim, Takuma
Tajiri, Nobu Ohike, Ritu Aneja, Alyssa M Krasinskas,
Volkan Adsay
CA; GSU, Atlanta, GA
11:30
Regression Grading in Pancreatic Cancer: An

Interobserver Study (747)
Sangeetha N Kalimuthu, Stefano Serra, Alice Wei,
Neesha Dhani, Sara Hafezi-Bakhtiari, Eva Szentgyorgyi,
Rajkumar Vajpeyi, Runjan Chetty
Toronto General Hospital, Toronto, ON, Canada
11:45
Circulating Tumor Cells and Circulating Tumor DNA in

Patients with PseudoMyxoma Peritonei (665)
Marie Dazza, Emmanuel Toure, France Blanchard,
Marianne Paresy, Nasrin Sarafan-Vasseur, JeanChristophe Sabourin
Rouen University Hospital, Rouen, France
12:00
BREAK
166
8:30
8:00 AM - 12:00 PM
CC 606-607
SECTION E - GYNECOLOGIC
CHAIRED BY: MARTIN KOBEL AND ELIZABETH D EUSCHER
8:00
Detection of Serous Tubal Intraepithelial Carcinoma

(STIC) in Incidentally Removed Fallopian Tubes from
Low-Risk Women (1180)
Emily Meserve, Jelena Mirkovic, James Conner, Eric
Yang, Brooke E Howitt, Christopher P Crum
Brigham & Womens Hospital, Boston, MA
8:15
Cytological Recognition of Serous Tubal Intraepithelial

Carcinoma from Tubal Cytology and and Pelvic
Washing Samples (1110)
Hao Chen, Robert R Klein, Stacy J Arnold, Li Li,
Setsuko K Chambers, F Zahra Aly, Wenxin Zheng
8:30
HER4 Expression and Overall Survival in Ovarian

Serous Carcinoma (1240)
Carolina Strosberg, Robert M Wenham, Ardeshir
Hakam, Anthony M Magliocco, Ozlen Saglam
8:45
FOXL2 Mutation Status in Ovarian Granulosa-Theca

Cell Tumors (1189)
Amber Nolan, Charles Zaloudek, Joseph Rabban,
Nancy M Joseph, Ankur R Sangoi, Karuna Garg
CA; El Camino Hospital, Mountain View, CA
9:00
Distinct SMARCA4/ARID1A and Genomic Profiles in

Classic Versus Large Cell Variant of Ovarian Small Cell
Carcinoma, Hypercalcemic-type (1174)
Douglas Lin, Joel Greenbowe, Jeffrey S Ross, Siraj M
Ali, Julia A Elvin
Foundation Medicine, Cambridge, MA; Albany Medical
College, Albany, NY
9:15
Are the Genomics in the Cancer Genome Atlas

Representative of Patients with Recurrent Ovarian
High Grade Serous Carcinoma That Is Refractory to
Standard Therapy? (1104)
Emily Broaddus, Scott Kopetz, J Jack Lee, Jiexin
Zhang, Kenna Shaw, Russell Broaddus
University of Texas, Austin, TX; M.D. Anderson Cancer
Center, Houston, TX
11:00
Assessment of the Chemotherapy Response Score

(CRS) System in High Grade Serous Carcinoma (HGSC)
(1118)
Helena M Ditzel, Kyle Stickland, Emily Meserve,
Mamta Gupta, Jonathan H Hecht, Doug I Lin, Kirsten M
Jochumsen, William R Welch, Michelle Hirsch, Bradley
J Quade, Kenneth R Lee, George L Mutter, Christopher
P Crum, Marisa R Nucci, Brooke E Howitt
School, Boston, MA; Beth Israel Deaconess Medical
Center, Harvard Medical School, Boston, MA; Odense
University Hospital, University of Southern Denmark,
Odense, Denmark
PROFFERED PAPERS
Tuesday,
Monday, March 23,
15, 2015
2016
11:15
Distribution and Potential Significance of Placental

Intravillous Particulate Microcalcifications (1255)
Jennifer Zeng, Alan Marcus, Tatiana Buhtoiarova,
Khushbakhat Mittal
NYU Langone Medical Center, New York, NY
11:30
Morphological Diversity in Lichen Sclerosus with

Emphasis on Features of Differentiated Vulvar
Intraepithelial Neoplasia (1127)
William Frampton, Jordan M Newell, Rebecca Phaeton,
Joshua P Kesterson, Joshua I Warrick
11:45
12:00
Histological Characteristics of HPV-Associated and

Independent Squamous Cell Carcinomas of the Vulva:
A Study of 791 Cases (1194)
Jaume Ordi, Natalia Rakislova, Omar OC Clavero,
Maria Alejo, Belen Lloveras, Laia Alemany, Xavier
Bosch, Silvia de Sanjose
Hospital Clinic - Barcelona University, Barcelona,
Spain; ISGlobal, Barcelona, Spain; Catalan Institute
of Oncology, IDIBELL, LHospitalet deLlobregat,
Barcelona, Spain
8:00
8:15
8:30
Comparing Next-Generation Sequencing in

Concurrently Acquired Cytology Fine Needle
Aspirations and Surgical Core Needle Biopsies of Solid
Organ Malignancies (444)
Sinchita Roy Chowdhuri, Rajesh Singh, Jawad
Manekia, Bedia A Barkoh, Hui Yao, Savitri
Krishnamurthy, L Jeffrey Medeiros, Gregg Staerkel,
John M Stewart, Rajyalakshmi Luthra
Houston, TX
Alcohol-Fixed Direct Smears Yield High Quality NextGeneration Sequencing Data (365)
Sarah Calkins, Carlitos Chen, Kirk Jones, Britt-Marie
Ljung, Donald P Pizzo, Nancy M Joseph
Univeristy of California, San Francisco, San Francisco,
CA; University of California, San Diego, San Diego, CA
Suspicious AFIRMA Gene Expression Classifier Test
Result in Thyroid Fine Needle Aspiration Cytology:
Implications for Patient Management (353)
Rebecca Baldassarri, Susan Fernandez, Angelique W
Levi, Malini Harigopal, Diane Kowalski, Guoping Cai,
Kevin Schofield, Adebowale Adeniran
8:30
8:00 AM - 12:00 PM
8:45
Performance of the Afirma Gene Expression Classifier

in the Evaluation of Cytologically Indeterminate
Thyroid Nodules: An Institutional Experience (416)
Jenna Lewis, Claudia Rojas, Carmen GomezFernandez, Merce Jorda, Monica Garcia-Buitrago
University of Miami Miller School of Medicine /Jackson
Memorial Hospital, Miami, FL
9:00
The Cytologic Diagnosis of Non-Invasive Follicular

Variant of Papillary Thyroid Carcinoma: A Prospective
Analysis (458)
Kyle C Strickland, Marina Vivero, Vickie Y Jo, Alarice
Lowe, Monica Hollowell, Xiaohua Qian, Tad Wieczorek,
Christopher A French, Lisa A Teot, Markus Eszlinger,
Ralf Paschke, Peter M Sadow, Edmund Cibas, Justine A
Barletta, Jeffrey F Krane
Universitt Leipzig, Leipzig, Germany
9:15
Cytologic Predictors of Malignancy in Bile Duct

Brushings (BDBs): A Multi-Reviewer Analysis of 60
Cases (351)
Vaidehi Avadhani, Ezgi Hacihasanoglu, Krisztina Z
Hanley, Uma Krishnamurti, Alyssa M Krasinskas,
Adeboye O Osunkoya, Lauren Daniels, Alexa
Freedman, Michael Goodman, Volkan Adsay, Michelle
Reid
11:00
Grading of Pancreatic Neuroendocrine Neoplasms by

Ki-67 Staining on Cell Blocks: Manual Count and Digital
Image Analysis (407)
Ming Jin, Rachel Roth, Vera Gayetsky, Nicholas
Niederberge, Paul E Wakely
Columbus, OH; Bethesda North Hospital, Cincinnati,
OH
11:15
The Diagnostic Utility of CK7, MASPIN and MUC5AC

In Distinguishing Gastric-Foveolar Type Mucinous
Neoplasm of the Pancreas from Gastric Contaminants
on Fine Needle Aspiration Specimens (408)
Shivani Kandukuri, Haiyan Liu, Fan Lin
11:30
Genetic Alterations Detected in Urine Cytology

Specimens from Patients with High Risk Non-Muscle
Invasive Urothelial Carcinoma Treated with BCG (418)
Oscar Lin, Sasinya N Scott, Nancy Bouvier, Caroline M
Lin, Bernard H Bochner, Michael F Berger
BREAK
CC 608-609
SECTION F - CYTOPATHOLOGY
CHAIRED BY: SAVITRI KRISHNAMURTHY AND STEFAN E
PAMBUCCIAN
167
PROFFERED PAPERS
11:45
12:00
Tuesday,
Monday, March 23,
15, 2015
2016
Secondary Malignancies in Salivary Glands: A MultiInstitutional FNA Cohort from Trans-Atlantic Academic
Institutions (468)
He Wang, Raza S Hoda, William C Faquin, Esther Rossi,
Nihar Hotchandani, Tianlin Sun, Marc Pusztaszeri,
Tommaso Bizzarro, Massimo Bongiovanni, Viren Patel,
Nirag Jhala, Yun Gong
Temple University Hospital, Philadelphia, PA;
Massachusetts General Hospital, Boston, MA; Catholic
University of Rome, Rome, Italy; MD Anderson Cancer
Center, Houston, TX; Geneva University Hospital,
Geneva, Switzerland; University of Lausanne,
Lausanne, Switzerland
Loss of H3K27 Trimethylation Distinguishes Malignant

Peripheral Nerve Sheath Tumors from Histologic
Mimics (89)
Inga-Marie Schaefer, Christopher Fletcher, Jason L
Hornick
Brigham and Womens Hospital/Harvard Medical
School, Boston, MA
9:15
TERT Promoter Mutations and Prognosis in Solitary

Fibrous Tumor (39)
Armita Bahrami, Seungjae Lee, Inga-Marie Schaefer,
Jennifer M Boland, Kurt T Patton, Christopher Fletcher
St. Jude Childrens Research Hospital, Memphis,
TN; Brigham & Womens Hospital, Boston, MA;
Mayo Clinic, Rochester, MN; Trumbull Laboratories,
Germantown, TN
11:00
P16 Expression as a Prognostic and Predictive Marker

in Osteosarcoma of Bone (82)
Alberto Righi, Marco Gambarotti, Marta Sbaraglia,
Andrea Sisto, Stefano Ferrari, Piero Picci, Paolo Dei tos
Department of Pathology, Rizzoli Institute, Bologna,
Italy; Department of Pathology, Treviso Regional
Hospital, Treviso, Italy; Department of Oncology,
Rizzoli Institute, Bologna, Italy; University of Eastern
Piedmont, Polis-Public Policy and Choice, Alessandria,
Italy
11:15
ETV4 Is a Useful Marker for the Diagnosis of CIC-DUX4

Round Cell Sarcomas: A Study of 110 Cases Including
Mimicking Lesions (73)
Sophie Le Guellec, Valerie Velasco, Gaelle Perot, Sarah
Watson, Franck Tirode, Jean-Michel Coindre
Institut Claudius Regaud, Toulouse, France; Institut
Bergoni, Bordeaux, France; Institut Curie, Paris,
France
11:30
Recurrent BCOR Internal Tandem Duplication (ITD) and

YWHAE-NUTM2B Fusions in Undifferentiated Round
Cell Sarcoma (URCS) of Infancy Overlapping Genetic
Features with Clear Cell Sarcoma of Kidney (CCSK)
(65)
Yu-Chien Kao, Shih-Chiang Huang, Pedram Argani,
Catherine Chung, Nicole Graf, Rita Alaggio, Cristina
Antonescu
NY; Shuang Ho Hospital, Taipei Medical University,
Taipei, Taiwan; Chang Gung Memorial Hospital,
Taoyuan, Taiwan; Johns Hopkins University School
of Medicine, Baltimore, MD; The Hospital for Sick
Children, Toronto, ON, Canada; The Childrens Hospital
of Westmead, Westmead, Australia; University of
Padua, Padua, Italy
11:45
A New Simple Low-Cost Multiplexed Targeted

Sequencing Assay to Detect Recurrent Fusion Genes in
Sarcomas (38)
Emilie Angot, Philippe Ruminy, Vinciane Marchand,
France Blanchard, lodie Colasse, Marie Cornic,
Christian Bastard, Fabrice Jardin, Jean-Christophe
Sabourin
University Hospital, Rouen, France; Centre Henri
Becquerel, Rouen, France
12:00
BREAK
BREAK
8:15
Recurrent Novel CIC Gene Abnormalities in

Angiosarcoma: A Molecular Study of 120 Cases with
Concurrent Investigation of PLCG1, KDR, MYC, and
FLT4 Gene Alterations (58)
Shih-Chiang Huang, Lei Zhang, Yun-Shao Sung, YuChien Kao, Narasimhan P Agaram, Cristina Antonescu
NY; Chang Gung Memorial Hospital, Taoyuan City,
Taiwan; Shuang Ho Hospital, Taipei Medical University,
New Taipei City, Taiwan
Spindle Cell Lipoma Arising at Atypical Locations: A
Clinicopathologic Review of 56 Cases (100)
Pingchuan Zhang, Nasir Ud Din, Andrew L Folpe, Karen
Fritchie
Mayo Clinic, Rochester, MN; Aga Khan University
Hospital, Karachi, Pakistan
8:30
Diagnostic Value of Histone 3 Mutations in OsteoclastRich Bone Tumors (80)

Erik Nohr, Marco Perizzolo, Lik Hang Lee, Justin M
Cates, Doug Demetrick, Doha Itani
University of Calgary / Calgary Laboratory Services,
Calgary, AB, Canada; Vanderbilt University Medical
Center, Nashville, TN
8:45
Malignant Peripheral Nerve Sheath Tumor Is a

Challenging Diagnosis: A Systematic Pathology
Review, Immunohistochemistery and Molecular
Analysis in 160 Patients from the French Sarcoma
Group Database (74)
Sophie Le Guellec, Anne-Valerie Decouvelaere,
Thomas Filleron, Isabelle Valo, Celine Charon-Barra,
Yves-Marie Robin, Philippe Terrier, Christine Chevreau,
Jean-Michel Coindre
Institut Claudius Regaud, Toulouse, France; Centre
Lon Brard, Lyon, France; Centre Paul Papin, Angers,
France; Centre Georges-Franois Leclerc, Dijon, France;
Centre Oscar Lambret, Lille, France; Institut Gustave
Roussy, Paris, France; Institut Bergoni, Bordeaux,
France
168
8:30
8:00 AM - 12:00 PM
9:00
CC 611-612
SECTION G - BONE & SOFT TISSUE
CHAIRED BY: JUDITH BOVEE AND BENJAMIN HOCH
8:00
PROFFERED PAPERS
Tuesday,
Monday, March 23,
15, 2015
2016
CC 615-617
SECTION H - LIVER
CHAIRED BY: RYAN M GILL AND HANLIN L WANG
8:00
8:15
8:30
8:45
9:00
PRKACA Fluorescent In Situ Hybridization Reveals

Novel Findings in Fibrolamellar Carcinoma (1657)
Rondell Graham, Matthew Yeh, Dora Lam-Himlin,
Luigi M Terracciano, Michael Cruise, Patricia Greipp,
Stephanie Roessler, Thomas Longerich, Peter
Schirmacher, Michael Torbenson
Mayo Clinic, Rochester, MN; University of Washington,
Seattle, WA; Mayo Clinic, Scottsdale, AZ; University
Hospital, Basel, Switzerland; Cleveland Clinic,
Cleveland, OH; University of Heidelberg, Heidelberg,
Germany
Liver Transplantation in the Setting of Hepatocellular
Carcinoma: Role of Tumor Differentiation in Predicting
the Risk of Recurrence (1678)
Daniel E Roberts, Sanjay Kakar, Ryan M Gill
CA; University of California San Francisco, San
Francisco, CA
Alpha 1-Antitrypsin (A1AT) Globules Are Highly
Encountered in Liver Explants for Non-Alcoholic
Steatohepatitis (NASH) and in Patients with Body Mass
Index>30 kg/m2[/underline] (1646)
Gregory Cheeney, Purva Gopal, Lincoln Pac, Charles
Landis, Maria Westerhoff
University of Washington, Seattle, WA; University of
Texas South Western, Dallas, TX
Fatty Liver Binding Protein 4: A New Mediator in Liver
Carcinogenesis Related to Metabolic Syndrome (1672)
Emma Norkowski, Samira Laouirem, Aurelie Sannier,
Miguel Albuquerque, Julie Di Martino, Frederic Saltel,
Olivier Soubrane, Pierre Bedossa, Pierre-Emmanuel
Rautou, Valerie Paradis
INSERM UMR 1149, Inflammation Research Center,
Paris-Montmartre, France; Beaujon Hospital, Clichy,
France; INSERM UMR 970, Paris Cardiovascular
Research Center, Paris, France; INSERM UMR 1053,
GREF, Bordeaux, France
Clinical Significance of Liver Biopsy Findings
Suggestive of, Suspicious for or Consistent with
Biliary Obstruction[/underline] (1689)
Annie Wu, Hanlin L Wang
UCLA, Los Angeles, CA
POSTER
POSTERSESSION
SESSIONIII
Novel Chromogenic RNA In Situ Hybridization Assay Is

an Accurate Method for Tissue Diagnosis of Hepatitis E
Virus Infection (1658)
Rondell Graham, Jeffrey Germer, Joseph Yao, Michael
Leise, Rish K Pai, John Poterucha, Michael Torbenson
AZ
11:00
A Panel of Three Markers (H4K20me2, H4K16ac and

PIVKA-II) for Prediction of Microvascular Invasion in
Hepatocellular Carcinoma (1677)
Nicolas Pote, Francois Cauchy, Miguel Albuquerque,
Olivier Soubrane, Pierre Bedossa, Valerie Paradis
Department of Pathology, Beaujon Hospital, Clichy,
France; INSERM UMR 1149 (Centre de Recherche
sur lInflammation), Beaujon Hospital, Clichy, France;
Department of Hepatobiliary Surgery and Liver
Transplantation, Beaujon Hospital, Clichy, France
11:15
Distinct Patterns of Reticulin Framework Alterations

in Telangiectatic/Inflammatory Adenoma: Diagnostic
Clues and Pitfalls (1648)
Jason Chesser, Ashwini K Esnakula, Deepa Patil,
Thomas Plesec
Cleveland Clinic, Cleveland, OH; University of Florida,
Gainesville, FL
11:30
Different Types Of Glutamine Synthetase

Immunostaining in Hepatocellular Adenoma (1638)
Paulette Bioulac-Sage, Brigitte Le Bail, Claire Castain,
Christine Sempoux, Charles Balabaud
Universit Bordeaux, Bordeaux, France; CHU
Bordeaux, Bordeaux, France; Centre Hospitalier
Unversitaire Vaudois, Lausanne, Switzerland
11:45
Distinctive Morphologic Pattern and In Situ

Hybridization for Albumin Distinguishes Intrahepatic
Cholangiocarcinoma from Metastatic Adenocarcinoma
(1630)
Tanupriya Agrawal, Osman Yilmaz, Ricard Masia,
Lipika Goyal, Andrew Zhu, Vikram Deshpande
Tufts Medical Center, Boston, MA; Massachusetts
General Hospital, Boston, MA
12:00
BREAK
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
BREAST PATHOLOGY
8:30
8:00 AM - 12:00 PM
9:15
Monday,
Tuesday, March
March 23,
15, 2015
2016
Board
Number
Cytokeratin 7-Negative Mammary Pagets Disease - A

Diagnostic Pitfall (247)
Ugur Ozerdem, Jennifer M McNiff, Fattaneh A
Tavassoli
Correlation of Protein Expression with Chromosomal

Copy Number Alterations in the Progression of Early
Breast Neoplasia to DCIS[/underline] (156)
Erna Forgo, Sushama Varma, Robert B West
Stanford University School of Medicine, Stanford, CA
169
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
Genomic Profiling of Ductal Carcinoma In Situ: Can We

Predict Outcome? (211)
Chieh-Yu Lin, Sujay Vennam, Robert T Sweeney,
Shirley X Zhu, Sushama Varma, Robert B West
Stanford University Medical Center, Stanford, CA
11
Ductal Carcinoma In Situ (DCIS) Invasive Carcinoma

Risk Prediction Model (DRPM): A Novel Biomarker
Model to Predict Local Recurrence in Large Cohort of
Women Diagnosed with DCIS and >15yr Follow Up
(129)
Gautam Bulusu, Adam Brufsky, Jennifer Picarsic,
Gretchen Ahrendt, Gloria Carter, Mamatha Chivukula
Mills-Peninsula Health Services (a Sutter Health
Affiliate); Dorothy Schneider Breast Cancer Center,
Burlingame, CA; Univeristy of Pittsburgh, Magee
Womens Hospital, Pittsburgh, PA; University of
Pittsbrugh, Magee Womnens Hospital, Pittsburgh, PA
Correlation of OncotypeDx Recurrence Score with

IHC3/IHC4 and Grade in Ductal Carcinoma In Situ
(DCIS) (299)
Poonam Vohra, Gregor Krings, Manjiv Vohra, Yunn-Yi
Chen
12
Histologic Grade 1 in Breast Cancer Indicates a Lack of

Benefit in Ordering Oncotype DX (274)
Mary Ann Sanders, Elizabeth C Riley
13
Progesterone Receptor and Ki-67 Discordance in

African American Women with Hormone Receptor
Positive Breast Cancer Submitted for Oncotype DX
Testing (296)
Bradley Turner, Nyrie Soukiazian, Ping Tang, David G
Hicks
University of Rochester Medical Center, Rochester, NY;
14
Interobserver Agreement of Breast Cancer IHC4 after

Score the Core Training (121)
Alexander Borowsky, Ronald Balassanian, Christina
Yau, Jesse A Engelberg, Carlie K Thompson, Hanna
EG Retallack, John W Bishop, Robert Cardiff, Philip M
Carpenter, Yunn Yi Chen, Brian Datnow, Farnaz Hasteh,
Gregor Krings, Fritz Lin, Yanhong Zhang, Linda S
Lindstrom
UC Davis, Sacramento, CA; UCSF, San Francisco, CA;
UCSD, La Jolla, CA; USC, LA, CA; UCI, Irvine, CA;
Karolinska, Stockholm, Sweden
15
Validation of a Random Forests Based Model Using

Routine Pathologic Features to Predict OncoType Dx
Risk Scores (205)
Zach Lee, Hyunseok Kim, Tyler A Jensen, Chris B
Umbricht, Leslie Cope, Bradley Turner, David G Hicks,
Martin Rosman, W Charles Mylander, Antonio C Wolff,
Dylan Miller
University of Utah, Salt Lake City, UT; Hopkins
University School of Medicine, Baltimore, MD; Johns
Hopkins, Baltimore, MD; University of Rochester,
Rochester, NY; Anne Arundel Medical Center,
Annapolis, MD; Intermountain Medical Center /
University of Utah, Salt Lake City, UT; Intermountain
Biorepository, Salt Lake City, UT
16
Prediction of Oncotype DX Recurrence Score: Use of a

Pathology-Generated Equation (172)
Yanjun Hou, Gary Tozbikian, Debra L Zynger, Zaibo Li
Columbus, OH
17
Adjust Cut-Off Values of Immunohistochemistry

Models to Predict Risk of Distant Recurrence in
Invasive Breast Carcinoma Patients (134)
Yen-Ying Chen, Ling-Min Tseng, Ching-Fen Yang, ChihYi Hsu
Taipei Veterans General Hospital, Taipei City, Taiwan
Role of Biomarkers (CD44, E-cadherin and -catenin)

in Predicting Recurrence and Progression of Ductal
Carcinoma In Situ of the Breast (292)
Benjamin Yongcheng Tan, Clara Ong, Valerie Koh, Aye
Aye Thike, Puay-Hoon Tan
Negative Progesterone Receptor Status, Mitotic

Activity and Periductal Chronic Inflammation (PDCI)
Around DCIS Does Not Predict Recurrences in DCIS
Cases (267)
Bailey A Reindl, Shabnam Jaffer, Ira J Bleiweiss,
Anupma Nayak
Comparison of Estrogen Receptor Antibody Reagents

Using Proficiency Testing Data (294)
Megan Troxell, Jason L Hornick, Abiy B Ambaye,
Kristin C Jensen, CAP Immunohistochemistry
Committee
OHSU, Portland, OR; Brigham & Womens, Boston,
MA; UVM, Burlington, VT; VAPAHCS, Palo Alto, CA;
CAP, Chicago, IL
A Systematic Method of Assessing ER/PR/Her2 on Core

Biopsy and or Excision Specimens (180)
Shabnam Jaffer, Bailey A Reindl, Ira J Bleiweiss,
Anupma Nayak
The Mount Sinai Medical Center, New York, NY
Characterization of Estrogen Receptor Positive/

Progesterone Receptor Negative/(ER+/PR-) Breast
Cancer (BC) (283)
Tiansheng Shen, Tao Guo, Omar Hameed, Gene P
Siegal, Shi Wei
10
170
Gene Expression Analysis in Estrogen Receptor

Subsets Defined by Immunohistochemistry in Breast
Invasive Duct Carcinoma (105)
Di Ai, Bing Leng, Kimberly L Walker, Shelby
Hendrickson, Ada Werlang-Perurena, Arundhati Rao
Baylor Scott & White Memorial Hospital, Temple, TX;
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
18
Comparison of Magee and OncotypeDx Recurrence

Scores in Luminal-B Immunophenotype Breast Cancers
(302)
Ann E Walts, Shikha Bose
26
19
Comparison of Magee and OncotypeDx Recurrence

Scores in Luminal-A Immunophenotype Breast Cancers
(123)
Shikha Bose, Ann E Walts
20
Oncotype DX Test and Modified Magee Equations: Are

They Different? (138)
Sachica Cheris, Jianmin Wang, Bradley Turner, Kristin
Skinner, David G Hicks, Ping Tang
RTI Health Solution, Research Triangle Park, NC
Analysis of Clinical-Pathological Data with Impact on

Overall Survival (OS) in Male Breast Carcinoma: An
International Multi-Institutional Study of 220 Cases
(287)
Simona Stolnicu, Denisa Moncea, Alis Dema, Rares
Buiga, Cosmin Moldovan, Rares Georgescu, Cornelia
Toganel, Septimiu Voidazan, Erika Resetkova, Maria
Comanescu, Isabel Alvarado-Cabrero
University of Medicine and Pharmacy Tg Mures,
Targu Mures, Romania; University of Medicine Victor
Babes, Timisoara, Romania; Oncologic Institute I.
Chiricuta, Cluj Napoca, Romania; MD Anderson
Cancer Center, Houston, TX; Victor Babes Institute,
Bucuresti, Romania; Oncologic Institute, Mexico City,
Mexico
27
Comprehensive Evaluation of Ki67 in Luminal/HER2Negative Breast Cancer in the AMBER Consortium

(193)
Thaer Khoury, Gary Zirpoli, Stephanie M Cohen, Mihai
Merzianu, Melissa Troester, Joseph Geradts, Amber
Worral, Wiam Bshara, Christine Ambrosone
Roswell Park, Buffalo, NY; University North Carolina,
Chapel Hill, NC
Male Breast Cancers: Are They Different Than Female

Breast Cancers? (278)
Kate M Serdy, David Dabbs, Rohit Bhargava
28
Proportion of Estrogen Receptor Positive and HER2

Positive Breast Cancer in a Rural Rwandan Cancer
Center When Considering Duration of Ischemic and
Fixation Time (223)
Emily Meserve, Gaspard Muvugabigwi, Irenee
Nshimiyimana, Krishan Taneja, Lydia Pace, Danny
A Milner, Lawrence N Shulman, Deborah A Dillon,
Tharcisse Mpunga
Brigham & Womens Hospital, Boston, MA; Butaro
Cancer Center of Excellence, Butaro, Rwanda;
The Genetic Landscape of Neuroendocrine Breast

Carcinomas (217)
Caterina Marchio, Charlotte KY Ng, Salvatore
Piscuoglio, Anne M Schultheis, Elena Guerini-Rocco,
Marco Cupo, Felipe C Geyer, Anna Sapino, Britta
Weigelt, Jorge S Reis-Filho
University of Turin, Turin, Italy; Memorial Sloan
Kettering Cancer Center, New York, NY; University
Hospital, Cologne, Germany; European Institute of
Oncology, Milan, Italy
29
Clinicopathological Features of 40 Mammary

Carcinomas with Neuroendocrine Differentiation (248)
Ugur Ozerdem, Malini Harigopal, Fattaneh A Tavassoli
21
22
23
24
25
Pathologic Characteristics and Outcome of Low

Positive Hormone Receptor Invasive Breast Carcinoma
(233)
Jodi S Music, Theera Rojanapremsuk, Sunati Sahoo
University of Texas Southwestern Medical Center,
Dallas, TX
Nuclear Grading of Breast Cancer Based on Training by
Examination of Estrogen-Receptor Negative Tumors:
Performance with and without Incorporation into the
Edinburgh Simplification of Nottingham Grade (145)
Leslie Dalton
South Austin Medical Center, Austin, TX
Male Breast Carcinoma Has Worse Prognosis Than
Female Breast Carcinoma (209)
Xiaoxian (Bill) Li, Uma Krishnamurti, Lei Huo, Limin
Peng
Emory University, Atlanta, GA; University of Texas MD
Anderson Cancer Center, Houston, TX
30
Biochemical Signature of Antibody-Mediated Rejection

in Cardiac Allograft Biopsies (335)
Imran Uraizee, Michael Walsh, Peter Nguyen, Aliya N
Husain
University of Chicago, Chicago, IL; University of Illinois
at Chicago, Chicago, IL
31
Diagnostic Value of T helper Type 17 (Th17) Cells in

Moderate Acute Cellular Rejection of Cardiac Allograft
(338)
Yinong Wang, Leland B Baskin, Daniel G Fontaine,
Shuhong Liu, Christopher Naugler
Calgary Laboratory Services, University of Calgary,
Calgary, AB, Canada
32
Myocardial Capillary Density in Left and Right

Ventricles of Explanted Hearts from Patients after Short
and Long Term Heart Transplantation (331)
Jihui J Qiu, Theodore Vasiliadis, Xu Wang, Jieliang Li,
Xulei Liu, Nirag C Jhala, He Wang
171
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
33
Left Ventricular Assist Device Can Increase Capillary

Density of Human Heart (337)
Jindong Wang, Theodore Vasiliadis, Eman Hamad, Xu
Wang, Viren Patel, Jieliang Li, Xulei Liu, Nirag Jhala,
He Wang
41
34
Erosion Is More Common as a Cause of AMI in the

Elderly: A Pathologic Study of Coronary Arteries in 884
Human Autopsy Cases (333)
Atsuko Seki, Koji Chida, Akihiko Hamamatsu, Motoji
Sawabe, Yoko Matsuda, Keisuke Nonaka, Shinichiro
Ohkawa, Tomio Arai
Tokyo Metropolitan Geriatric Hospital, Itabashi, Tokyo,
Japan; Kasumigaseki Clinic, Chiyoda, Tokyo, Japan
Unique Insights into Cardiac Metastases and Tumor

Biology from a Cancer Centers Rapid Research
Autopsy Program (317)
Prashant Bavi, Hamidreza Sharifzad, Qian Yang, Leslie
Oldfield, Anthony Joshua, Jagdish Butany, Michael H
Roehrl
42
Characterization of LVAD Ventricular and Aortic

Interfaces: Potential Role in Device Thrombosis (327)
Daniel Pelletier, Stanley J Radio
43
Transcathether Ablation of the Atrio-Ventricular

Junction: Histopathology Findings and Interventional
Anatomy of the Tricuspid Valve (332)
Stefania Rizzo, Andrea Corrado, Franco Zoppo,
Marialuisa Valente, Gaetano Thiene, Cristina Basso
University of Padua, Padova, Italy; Mirano Hospital,
Mirano, Italy; Mestre Hospital, Mestre, Italy
44
How to Choose the Pathologic Marker of Evaluate the

Irreversibility of Congenital Heart Disease Associated
Pulmonary Hyptertension[/underline] (326)
Li Li, Changming Xiong, Shian Huang, Chao Liu,
Hongyue Wang, Xuejing Duan, Jianguo He
Fuwai Hospital, National Center for Cardiovascular
Diseases, Chinese Academy of Medical Sciences,
Peking Union Medical College, Beijing, China;
Guangdong Medical College Affiliated Zhanjiang
Hospital, Zhanjiang, China; Gaozhou Peoples Hospital,
Gaozhou, China
45
Human Plaque-Aortic Ring Co-Culture: A Novel Assay

for the Study of Atherosclerosis-Induced Angiogenesis
(316)
Alfred C Aplin, Ted Kohler, Roberto Nicosia
University of Washington, Seattle, WA; VA Puget
Sound HCS, Seattle, WA
35
Neoatherosclerosis as a Cause of Late Stent Failure

Following Bare Metal and 1st- and 2nd-Generation DrugEluting Stent Placement: An Autopsy Study (323)
Elena Ladich, Maria Romero, Fumiyumi Otsuka, Renu
Virmani
CVPath Institute, Gaithersburg, MD
36
Clinicopathologic Experience with Mitral Valve Repairs

Using CorMatrix ECM Technology (318)
Siddharth Bhattacharyya, Shiguang Liu, Nirag Jhala,
He Wang
Temple University Hospital, Philadelphia, PA
37
Apolipoprotein A-IV Associated Cardiac Amyloidosis

(319)
Melanie C Bois, Surendra Dasari, Jason D Theis, Julie
Vrana, Martha Grogan, Angela Dispenzieri, Paul J
Kurtin, Joseph J Maleszewski
38
NRG1-ERBB4-PSEN1 Dysfunction in Human

Myocarditis and Dilated Cardiomyopathy (321)
Paul J Hanson, Erika L Jang, Angela Y Chang, Harpreet
Rai, Angela Y Mo, Bruce M McManus, Michael A
Seidman
Providence Health Care, Vancouver, BC, Canada
39
Unusual Complications of Prosthetic Vascular

Reconstruction: A Clinicopathologic Case Series (313)
Ibrahim Aboshady, Naveed U Saqib, Deborah Vela, Ana
M Segura, Kamal Khalil, L Maximilian Buja
Texas Heart Institute, Houston, TX; The University of
Texas HSC, Houston, TX
40
Cardiac Angiosarcoma: Histopathologic,

Immunohistochemical, and Molecular Genetic Analysis
of 10 Cases (325)
Charles Leduc, William R Sukov, Jeannette G Rustin,
Joseph J Maleszewski
172
ENDOCRINE PATHOLOGY
46
Non-Invasive Follicular Variant of Papillary Thyroid

Carcinoma and the Afirma Gene-Expression Classifier
(613)
Kristine S Wong, Trevor Angell, Kyle C Strickland, Erik
K Alexander, Edmund Cibas, Jeffrey F Krane, Justine A
Barletta
47
Does Reclassification of Follicular Variant of Papillary

Thyroid Carcinoma Affect Rates of Malignancy by
Bethesda Category? (575)
Allison B Cavallo, Daniel N Johnson, Saaduddin
Saddiqui, Raymon Grogan, Peter Angelos, Edwin L
Kaplan, Tatjana Antic, Nicole A Cipriani
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
48
Encapsulated Follicular Variant of Papillary Thyroid

Carcinoma with Minimal Invasion Is Biologically
Indolent (616)
Jennifer Zeng, Michael Bannan, Cheng Z Liu, FangMing Deng
56
Oncocytic Adrenocortical Adenomas: An Important

Cause of False Positive Malignant Results in
Preoperative Urine Steroid Profiling (578)
Salvador Diaz-Cano, Cathy Zhang, Norman Taylor
Kings College Hospital/Kings College London, London,
United Kingdom
49
Cytology/Histology Correlation of Follicular Variant of

Papillary Thyroid Carcinoma: The UCSF Experience
(595)
Dianna Ng, Zheng Ma, Britt-Marie Ljung, Elham
Khanafshar
UCSF Medical Center, San Francisco, CA
57
Succinate Dehydrogenase Deficiency in

Pheochromocytoma and Paraganglioma (581)
Evan Holleran, Brandon Boldt, Devin McKissic, Jason L
Hornick, Andrew M Bellizzi
University of Iowa, Iowa City, IA; Brigham and
Womens, Boston, MA
50
Non-Invasive Follicular Variant of Papillary Thyroid

Carcinoma Accounts for over Half of Carcinomas
Harboring RAS Mutations (599)
Vera Paulson, Priyanka Shivdasani, Brooke E Howitt,
Matthew Ducar, Trevor Angell, Erik K Alexander,
Edmund Cibas, Jeffrey F Krane, Neal Lindeman,
Justine A Barletta
58
GATA3 Immunohistochemistry Differentiates Malignant

Pheochromocytoma from Adrenal Cortical Carcinoma
(600)
Carmen M Perrino, Alex Ho, Debra L Zynger
The Ohio State University Medical Center, Columbus,
OH
59
Immunohistochemical Expression of OCT3/4 in

Adrenal Gland Pheochromocytomas and Prevertebral
Paragangliomas (596)
Marlo Nicolas, Patricia Dahia
University of Texas Health Science Center at San
Antonio, San Antonio, TX
60
Thyroglossal Duct Cyst Carcinomas: A

Clinicopathologic Series of 21 Cases (608)
Lester DR Thompson, Hannah B Herrera, Sean K Lau
SCPMG, Woodland Hills, CA; SCPMG, Anaheim, CA
61
Can Medullary Carcinoma Arise in Thyroglossal Duct

Cysts? A Search for Parafollicular C-cells in 38 Resected
Cases (606)
Tracy A Stein, Paari Murugan, Faqian Li, Mohamed El
Hag
MN
62
TROP-2 and CD117 Expression in Oncocytic Lesions

of the Thyroid: Exceptional Sensitivity and Mediocre
Specificity for Oncocytic Papillary Thyroid Carcinoma
(396)
Christopher Hartley, Peter N Bonneau, Bryan Hunt
51
52
53
54
55
Node-Negative Versus Node-Positive Papillary Thyroid

Carcinoma: A Comparison of Clinicopathologic and
Molecular Findings (584)
Justin A Kotliar, Peter Kragel
The Brody School of Medicine at East Carolina
University, Greenville, NC
Clinical and Morphologic Features of ETV6-NTRK3
Translocated Papillary Thyroid Carcinoma (604)
Raja R Seethala, Simion I Chiosea, Cheng Z Liu, Marina
Nikiforova, Yuri E Nikiforov
University of Pittsburgh, Pittsburgh, PA; NYU Medical
Center, New York, NY
Frequency of TERT Promoter Mutations in Thyroid
Carcinoma Metastases (603)
Karan Saluja, Ying C Henderson, Maria Cabanillas,
Elizabeth G Grubbs, Stephen Y Lai, Michelle D Williams
Metabolic Reprograming in Adrenocortical Tumors in
Children: A Promising New Pathway in the Biology of
This Disease (617)
Maria Zerbini, Celine Pinheiro, Sara Granja, Adhemar
Longatto, Andre M Faria, Maria CV Fragoso, Silvana
M Lovisolo, Antonop M Lerario, Madson Q Almeida,
Fatima Baltazar
University of Sao Paulo School of Medicine, Sao Paulo,
SP, Brazil; University of Minho, Braga, Guimaraes,
Portugal; Barretos Cancer Hospital, Barretos, SP, Brazil
Adrenal Cortical Neoplasms: Are Immunostains Useful
to Distinguish Benign from Malignant? (573)
Shikha Bose, Shefali Chopra, Ann E Walts
Cedars-Sinai Medical Center, Los Angeles, CA;
University of Southern California, Los Angeles, CA
GASTROINTESTINAL PATHOLOGY
63
Role of Submucosal Glands in the Development and

Progression of Adenocarcinoma in Barretts Esophagus
(700)
Melanie Johncilla, Robert Odze, Agoston Agoston
173
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
64
73
Is Classification of T cell Subsets Useful in the

Evaluation of Gastrointestinal Graft Versus Host
Disease? (689)
Christopher Hartley, Luis F Carrillo, Daniel Rowan,
Catherine Hagen
74
Positive Fungal Testing Associated with Higher Grade

Graft Versus Host Disease and Increased Mortality in
Stem Cell Transplant Recipients[/underline] (722)
Long Li, Suntrea Hammer
75
Comparison of Dysplastic Fundic Gland Polyps in

Patients with and without Familial Adenomatous
Polyposis (802)
Shana Straub, Raul S Gonzalez
76
Predictive Factors for Curative Endoscopic Submucosal

Dissection in Superficial Esophageal Squamous Cell
Carcinoma (828)
Jung Wook Yang, Yoon-La Choi
School of Medicine, Seoul, Republic of Korea; SAIHST,
Sungkyunkwan University, Seoul, Republic of Korea
77
Low Frequency of Epithelial PD-L1 Staining

in Esophageal and Other Gastrointestinal
Bastian Dislich, Alexandra Stein, Christian A Seiler,
Axel Walch, Sabina Berezowska, Inti Zlobec, Jose A
Galvan, Rupert Langer
Switzerland; University of Bern, Bern, Switzerland;
Helmholtz Center, Neuherberg, Germany
78
PD-L1 Expression Correlated with Lymphocytes

Infiltrating in Gastric Cancer (713)
Yumei Lai, Li Sun, Jing Gao, Lin Shen, Zhongwu Li
Key Laboratory of Carcinogenesis and Translational
Research (Ministry of Education), Peking University
Cancer Hospital & Institute, Beijing, China
79
Ideal Number of Biopsy Tumor Fragments for

Predicting HER2 Status in Gastric Carcinoma Resection
Specimens (720)
Minju Lee, Sangjeong Ahn, Soomin Ahn, Michael Van
Vrancken, Sang Yun Ha, Kyoung-Mee Kim
School of Medicine, Seoul, Korea; Samsung Medical
Center, Seoul, Korea
80
CD66b-Positive Tumor-Associated Neutrophils in

Epstein-Barr Virus Associated Gastric Carcinoma:
A Comparative Study with CD8-Positive Cytotoxic
T-Lymphocytes (619)
Hiroyuki Abe, Teppei Morikawa, Ruri Saito, Hiroharu
Yamashita, Yasuyuki Seto, Masashi Fukayama
The University of Tokyo Hospital, Tokyo, Japan;
Graduate School of Medicine, the University of Tokyo,
Tokyo, Japan
65
66
Role of Mucosal Glands in the Progression of

Neoplasia in Barretts Esophagus (672)
Jonathan England, Anne-Fre Swager, Simon
Schlachter, Brian Sundell, Jacques JGHM Bergman,
Gregory Y Lauwers, Robert Odze
Massachusetts General Hospital, Boston, MA; Brigham
and Womens Hospital, Boston, MA; NinePoint
Medical, Boston, MA; Academisch Medisch Centrum,
Amsterdam, Netherlands
LGR5 Expression in Barretts Esophagus and
Associated Neoplasia: Support for Its Role as a Cancer
Stem Cell and Diagnostic Marker (667)
Vikram Deshpande, Krishnan K Mahadevan, Gregory Y
Lauwers, Antony Mattia, Lawrence Zukerberg, Robert
Odze
Massachusetts General Hospital/Brigham and Womens
Osmoprep-Associated Gastritis: A Histopathologic
Mimic of Iron Pill Gastritis and Mucosal Calcinosis
(687)
Dorina Gui, Kristin A Olson, Sooraj Tejaswi, Erica F
Clayton, Anne Thai, Karen Matsukuma
University of California Davis, Sacramento, CA; Marin
Medical Laboratories/PathGroup SF, Greenbrae, CA;
Mid Peninsula Endoscopy Center, San Mateo, CA
67
Gastric Intestinal Metaplasia: Is It a Worrisome Feature

Warranting Follow-Up? (638)
Pablo A Bejarano, Mariana Berho
Cleveland Clinic Florida, Weston, FL
68
See a Sleeve Today ...Save a Life Tomorrow? (708)

Pavel Kopach, Elizabeth Genega, Yvelisse Suarez
Tufts Medical Center, Boston, MA
69
Re-Appraisal of Clinical Features, Treatment, and

Outcome in Patients with a Histologic Diagnosis of
Collagenous Sprue (835)
Lisi Yuan, Nan Lan, Bo Shen, Xiuli Liu
70
Extra-Ileal Manifestations of Crohns Disease at Initial

Presentation (740)
Gregory Miller, Ian Brown
Envoi Specialist Pathologists, Brisbane, Queensland,
Australia
71
Clinicopathologic Study of the Ipilumimab-Induced

Colitis Compared to Emerging Inflammatory Bowel
Disease (703)
Maryam Kherad Pezhouh, Elizabeth M Jaffee, Elizabeth
A Montgomery, Robert A Anders
72
174
Gastrointestinal Graft Versus Host Disease in

Allogeneic and Autologous Stem Cell Transplant
Patients: Does Cytotoxic, Helper, or Regulatory T Cell
Infiltration Distinguish Alloimmunity from a Failure of
Self Tolerance? (644)
Luis F Carrillo, Christopher Hartley, Daniel Rowan,
Catherine Hagen
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
81
Solid-Type Gastric Carcinomas: Categorization and

Comparison with Solid-Type Colonic Carcinomas (682)
Raul S Gonzalez, Justin M Cates, Mary K Washington
89
82
Concurrent Biopsies Improve Diagnosis of Malignancy

over Bile Duct Brushings (BDBs) Alone (636)
Vaidehi Avadhani, Ezgi Hacihasanoglu, Zerife Yusifli,
Bahar Memis, Serdar Balci, Lauren Daniels, Michael
Goodman, Alyssa M Krasinskas, Volkan Adsay,
Michelle Reid
Prediction of Clinical Outcomes of Stage 3 Colorectal

Carcinomas with FOLFOX Adjuvant Chemotherapy
According to Molecular Subtypes (697)
Mi Jang, Hoguen Kim
Department of Pathology and the Brain Korea 21 PLUS
Project for Medical Science, Yonsei University College
of Medicine, Seoul, Korea
90
Development and Validation of a Prognostic Nine Gene

Expression Signature for Stage II/III Colorectal Cancer
Patients (651)
Liang Cheng, Lisha Wang, Xiaohan Shen, Fei Ren,
Weiqi Sheng, Xiaoyan Zhou, Xiang Du
Indiana University School of Medicine, Indianapolis, IN;
China
91

Representative of Colorectal Cancer Patients with
Recurrent Disease Refractory to Front-Line Therapy?
(642)
Emily Broaddus, Jiexin Zhang, J Jack Lee, Scott
Kopetz, Kenna Shaw, Russell Broaddus
University of Texas, Austin, TX; MDACC, Houston, TX
92
The Genetic Landscape of Interval Colon Cancers Is

Similar to Sporadic Non-Interval Colon Cancers (801)
Thing Rinda Soong, Matthew D Stachler, Jennifer
Nayor, Molly Perencevich, Jonathan Nowak, Kunal
Jajoo, John R Saltzman, Neal Lindeman, Amitabh
Srivastava
93
Concomitant Loss of MSH6 and PCNA Expression: A

Putative Mechanism of Reduced MSH6 Expression
in Microsatellite Stable Colorectal Cancer after
Neoadjuvant Therapy (774)
Bing Ren, Reetesh K Pai, Shih-Fan Kuan
94
Clinicopathologic Features of Interval Colorectal

Carcinomas in Inflammatory Bowel Disease (836)
Xiaofei Zhang, Alexandros D Polydorides
Icahn School of Medicine at Mount Sinai Hospital, New
York, NY
95
Colorectal Adenocarcinoma with ALK Rearrangement:

Clinicopathologic and Molecular Characteristics (827)
Evgeny Yakirevich, Siraj M Ali, Shamlal Mangray,
Michael Wheeler, Kara A Lombardo, Kyoung-Mee Kim,
Anthony J Gill, Kai Wang, Kyle Gowen, Jeffrey S Ross,
Howard Safran, Murray B Resnick
RIH and Brown University, Providence, RI; Foundation
Medicine Inc, Cambridge, MA; Samsung Medical
Center, Seoul, Republic of Korea; Royal North Shore
Hospital, St Leonards, Australia; Albany Medical
College, Albany, NY
96
Objective Measurement of HER2 in Colorectal

Adenocarcinomas Reveals Heterogeneity of the
Proteins Extracellular Domain (649)
Peter Chen, David L Rimm, Daniel Carvajal-Hausdorf
83
84
Distinct Protein Expressions of the Key Molecules

in the Activated Signaling Pathways of SolidPseudopapillary Neoplasm of the Pancreas (705)
Eun Kyung Kim, Minhee Park, Hoguen Kim
Department of Pathology and the Brain Korea 21 PLUS
Project for Medical Science, Yonsei University College
of Medicine, Seoul, Korea
Transcription Factor E3 as a Novel Diagnostic Marker
for Solid Pseudopapillary Neoplasm (688)
Grant Harrison, Amanda Hemmerich, Cynthia Guy,
Shannon J McCall, Diana M Cardona, Xuefeng Zhang
Duke University, Durham, NC
85
Sporadic Gastric Well-Differentiated Neuroendocrine

Tumors Have a Higher Ki-67 Proliferation Index (714)
Hee Eun Lee, Taofic Mounajjed, Lori A Erickson, TsungTeh Wu
86
Synaptophysin-Ki67 Double Stain: A Novel Technique

That Can Improve Inter-Observer Agreement in the
Grading of GI Neuroendocrine Tumors (755)
Kristin A Olson, Dorina Gui, Regina Gandour-Edwards,
Karen Matsukuma
University of California at Davis, Sacramento, CA
87
An Unusual Case of Colitis Cystica Profunda CoExisting with Adenocarcinoma: Literature Review and
Case Comparison[/underline] (723)
Yu-I Li, Yen-Chieh Chang, Chia-Tung Shun
National Taiwan University, Taipei, Taiwan; New Taipei
City Hospital, New Taipei City, Taiwan; National Taiwan
University Hospital, Taipei, Taiwan
88
High Expression of EphA4 Predicts Lesser

Degree of Tumor Regression after Neoadjuvant
Chemoradiotherapy in Rectal Cancer (690)
Hong-Lin He, Yow-Ling Shiue, Ying-En Lee, Chien-Feng
Li
Department of Pathology, E-DA Hospital, I-Shou
University, Kaohsiung, Taiwan; Institute of Biomedical
Science, National Sun Yat-sen University, Kaohsiung,
Taiwan; Department of Anesthesiology, Kaohsiung
Chang Gung Memorial Hospital and Chang Gung
University College of Medicine, Kaohsiung, Taiwan;
Department of Pathology, Chi Mei Medical Center,
Tainan, Taiwan
175
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
97
Comparison of Universal Screening for Lynch

Syndrome in Small Bowel and Colorectal
Adenocarcinoma: Small Bowel Adenocarcinoma
More Frequently Exhibits Lynch Syndrome-Associated
Mismatch Repair Deficiency but Does Not Harbor
Sporadic MLH1 Deficiency (825)
Michelle Xia, Aatur Singhi, Reetesh K Pai
105
The Spectrum of Oncocytic Renal Tumors from

Oncocytoma to Eosinophilic Variant Chromophobe
Renal Cell Carcinoma Is There a Need to Sub-Classify
and What Is the Malignant Potential?[/underline][/
underline] (917)
Ramya Gadde, Ravi Barod, Craig G Rogers, Nilesh S
Gupta, Sean R Williamson
Henry Ford Health System, Detroit, MI
98
PTEN- Key Molecule in Lynch Syndrome Related

MicroRNA Deregulation in Colorectal Cancer (790)
Aisha Sethi, Stefan Costinean, Prasanthi Kumchala,
Luciano Cascione, Heather Hampel, Carlo Croce,
Wendy L Frankel
The Ohio State University, Columbus, OH; Institute
of Oncology, Bellinzona, Switzerland; University of
Nebraska, Omaha, NE
106
Clinical Follow-Up of Renal Oncocytomas with Vascular

Invasion (1077)
Sara E Wobker, Jonathan I Epstein
The Johns Hopkins Medical Institutions, Baltimore, MD
107
Unclassified Renal Cell Carcinomas with Low-Grade

Oncocytic Features: A Histopathologic Study with
Outcome (987)
Martin J Magers, Angela Wu, Lakshmi P Kunju
108
Using Next Generation Sequencing and Fluorescence

In Situ Hybridization to Identify a Hemizygous
Deletion of the RB1 Gene in Chromophobe Renal
Cell Carcinoma: Its Potential Role in Distinguishing
Chromophobe Renal Cell Carcinoma from Renal
Oncocytoma (982)
Qingqing Liu, Kristine M Cornejo, Liang Cheng, Lloyd
Hutchinson, Keith Tomaszewicz, Ediz F Cosar, Bruce A
Woda, Zhong Jiang
University of Massachusetts Medical School and
UMass Memorial Medical Center, Worcester, MA;
109
Clinico-Pathologic Analysis of 12 Cases of Primary

Renal Glomus Family of Tumors (1047)
Deepika Sirohi, Jonathan I Epstein, Bonnie L Balzer,
Oleksandr N Kryvenko, Swetha Paluru, Mariza de
Peralta-Venturina, Mahul B Amin
Cedars-Sinai Medical Center, Los Angeles, CA; The
Johns Hopkins Hospital, Baltimore, MD; University of
Miami Miller School of Medicine, Miami, FL
110
A Reappraisal of Morphologic Differences between

Renal Medullary Carcinoma (RMC) and Collecting Duct
Carcinoma (CDC) after Exclusion of Newer Subtypes
of Renal Cell Carcinoma (RCC): Report from the
High-Grade Distal Nephron Adenocarcinoma (HDNA)
International Consortium (1005)
Chisato Ohe
111
A Novel Low Grade Morphologic Variant of Hereditary

Leiomyomatosis-Renal Cell Carcinoma SyndromeAssociated Renal Cell Carcinoma (HLRCC-RCC)? (1048)
Steven Smith, Deepika Sirohi, Chisato Ohe, Jonathan
McHugh, Jason Hornick, Jigna Kalariya, Sushil Karia,
Katie Snape, Shirley Hodgson, Scott Tomlins, Rohit
Mehra, Mahul B Amin
Richmond, VA; Cedars-Sinai Medical Center, Los
Angeles, CA; University of Michigan, Ann Arbor,
MI; Brigham and Womens Hospital, Boston, MA; B
T Savani Kidney Hospital, Rajkot, India; St Georges
Hospital, London, United Kingdom
99
100
Identification of Copy Number Variation in Chromatin

Regulators in Microsatellite-Stable Hereditary NonPolyposis Colorectal Cancer (819)
Chen Weixiang, Ding Jun
Gongli Hospital, Pudong New Area, Shanghai, China
The Immune Microenvironment of Medullary Colon
Cancer Differs from Other Microsatellite Unstable (MSI)
Tumors: A Gene Expression and Immunohistochemical
Kenneth Friedman, Stephanie M Wood, Alexander
S Brodksy, Shaolei Lu, Kara A Lombardo, Dongfang
Yang, Anthony J Gill, Murray B Resnick
Rhode Island Hospital - Alpert Medical School at Brown
University, Providence, RI; Royal North Shore Hospital,
St. Leonards, Australia
101
Multivisceral Transplant Is a Viable Treatment

for Patients with Unresectable Intra-Abdominal
Fibromatosis (652)
Zhikai Chi, Richard S Mangus, Shaoxiong Chen,
Jingmei Lin
102
Appendiceal Goblet Cell Carcinoid Tumors Findings

after Definitive Resection[/underline] (679)
Kenneth Friedman, Wai Chin Foo, Susan C Abraham,
Asif Rashid, Melissa W Taggart
University of Texas M.D. Anderson Cancer Center,
Houston, TX
103
Succinate Dehydrogenase (SDH)-Deficient Renal Cell

Carcinoma, a Report of 7 Cases with an Emphasis on
High Grade Morphologic Features (940)
Xueli Hao, Hikmat A Al-Ahmadie, Anuradha Gopalan,
Sahussapont J Sirintrapun, Samson Fine, Satish K
Tickoo, Victor E Reuter, Ying-Bei Chen
104
Paraganglioma Associated Renal Lesions (937)

Sounak Gupta, Jun Zhang, Lori A Erickson
176
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
112
Chromosome 6p Amplification Including the TFEB

Gene: A Novel Mechanism of Renal Cell Carcinoma
Pathogenesis? (1075)
Sean R Williamson, David J Grignon, Laura Favazza,
Nilesh S Gupta, Dhananjay A Chitale, Nallasivam
Palanisamy
Henry Ford Health System, Detroit, MI; Indiana
University, Indianapolis, IN
117
113
Recurrent Alterations of Hippo Signaling Pathway

Genes in Mucinous Tubular and Spindle Cell
Carcinoma (MTSCC) of Kidney (1066)
Aaron Udager, Jesse K McKenney, Pankaj Vats,
Fengyun Su, Xuhong Cao, Jincheng Pan, Rui Wang,
Javed Siddiqui, Alon Z Weizer, Khaled Hafez, J Stuart
Wolf, Ganesh Palapattu, Saravana M Dhanasekaran,
Arul M Chinnaiyan, Rohit Mehra
University of Michigan Health System, Ann Arbor,
MI; Michigan Center for Translational Pathology,
Ann Arbor, MI; Cleveland Clinic, Cleveland, OH; First
Affiliated Hospital, Sun Yat-Sen University, Guangzhou,
China
High Grade Renal Cell Carcinoma with Emperipolesis.

Clinicopathological, Immunohistochemical and
Molecular-Genetic Analysis of 14 Cases (1027)
Pavla Rotterova, Petr Martinek, Kristyna Kalusova, Ivan
Damjanov, Saul Suster, Isabel Alvarado-Cabrero, Maris
Sperga, Marian Svajdler, Kvetoslava Peckova, Kristyna
Pivovarcikova, Ondrej Daum, Milan Hora, Michal
Michal, Ondrej Hes
University Hospital Plzen, Charles University, Plzen,
Czech Republic; University of Kansas, Kansas, KS;
Medical College of Wisconsin, Milwaukee, WI; Centro
Medico, Mexico City, Mexico; East University, Riga,
Latvia
118
Multicystic Chromophobe Renal Cell Carcinoma:

A Challenging Unusual Architectural Variant.
Morphological, Immunohistochemical and arrayCGH
Maria Pane Foix, Ana Dunatov, Petr Martinek, Enric
Condom-Mundo, Saul Suster, Maris Sperga, Jose
I Lopez, Monika Ulamec, Stela Bulimbasic, Michal
Michal, Kvetoslava Peckova, Kristyna Pivovarcikova,
Ondrej Daum, Pavla Rotterova, Kristyna Kalusova,
Milan Hora, Ondrej Hes
Bellvitge University Hospital, Barcelona, Spain;
University Split, Split, Croatia; Medical Teaching
School, University Hospital, Charles University,
Plzen, Czech Republic; Medical College of Wisconsin,
Milwaukee, WI; East University, Riga, Latvia; Cruces
University Hospital, Barakaldo, Spain; University
Hospital Zagreb, Zagreb, Croatia; Medical Teaching
School, University Hospital, Charles University, Plzen,
Czech Republic
119
PTEN Expression in Chromophobe Renal Cell

Carcinoma Versus Clear Cell Renal Cell Carcinoma
(953)
Gena Ibrahim, Manal Gabril, Christopher Howlett
Western University/ London Health Sciences Centre,
London, ON, Canada
120
Characterization of Papillary Hyperplasia in

Nephrectomy Specimens from Patients with
Autosomal Dominant Polycystic Kidney Disease - A
Lu Wang, Rajen Goyal, Ondrej Hes, Ximing Yang
Northwestern University, Feinberg School of Medicine,
Chicago, IL; Charles University Hospital, Alej Svobody,
Plzen, Czech Republic
121
Renal Tumors with Papillary Morphology (966)

Max Kong, Jianhong Li, Fang-Ming Deng, Peng Lee,
Jonathan Melamed, Ming Zhou
New York University, New York, NY
122
Application of ISUP Grading in a Series of Papillary

Renal Cell Carcinoma Cases from a Tertiary Institution
(845)
Ashwin Akki, Rodrigo A Ledezma, Gladell P Paner
University of Chicago, Chicago, IL; Universidad de
Chile, Santiago, Chile
114
Clear Cell Papillary Renal Cell Carcinoma Shows

Marked Depletion of Mitochondrial Content: A
Comparative Differential Diagnostic Study (1036)
Judy Sarungbam, Ed Reznik, A Ari Hakimi, Ann Bialik,
S Joseph Sirintrapun, Hikmat Al Ahmadie, Anuradha
Gopalan, Samson W Fine, Ying-Bei Chen, Chris Sander,
Victor E Reuter, Satish K Tickoo
MSKCC, NY, NY
115
Distinct Clinicopathological Features in Metanephric

Adenoma Harboring BRAF Mutation (873)
Anna Calio, John N Eble, Ondrej Hes, Guido
Martignoni, Sean R Williamson, Matteo Brunelli,
Adeboye O Osunkoya, Lisha Wang, Eva Comperat,
Mingsheng Wang, Shaobo Zhang, Kendra Curless,
Kristin Post, Hsim-Yee Chang, Lee Ann Baldridge,
Gregory MacLennan, Rodolfo Montironi, David J
Grignon, Liang Cheng
University of Verona, Verona, Italy; Indiana Univesity,
Indianapolis, IN; Charles Univesity Hospital Plzen,
Pilsen, Czech Republic; Henry Ford Health System,
Detroit, MI; Emory University, Atlanta, GA; Fudan
University Shangai Cancer Center, Shangai, China;
Groupe Hospitalier Pitie-Salpetriere, Paris, France;
Case Western Reserve University, Cleveland, OH;
Polytechnic University of the Marche Region, Ancona,
Italy
116
Cystic Nephroma in Adults (875)

Anna Calio, John N Eble, David J Grignon, Brett
Delahunt
University of Verona, Verona, Italy; Indiana University,
Indianapolis, IN; Wellington Medical School,
Wellington, New Zealand
177
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
123
Racial Disparity in Papillary Renal Cell Carcinoma (841)

Adebowale Adeniran, Abiodun Mafolasire, Aaron
Hartman, Cayce Nawaf, Peter A Humphrey, Brian
Shuch
130
124
Growth Pattern Analysis in Low Grade Clear Cell

Renal Cell Carcinomas: Prognostic Value and Biologic
Significance (897)
Salvador Diaz-Cano, Russel Sutherland, Jane
Moorhead, Alfredo Blanes, Richard Dobson
United Kingdom; University of Malaga School of
Medicine, Malaga, Spain
Sunitinib Treatment Induces the Formation of

Stem Cell-Like Cancer Cells in Clear Cell Renal Cell
Carcinoma (981)
Zsuzsanna Lichner, Henriett Butz, Roy Nofech-Mozes,
Sara Riad, Andras Kapus, George M Yousef
Li Ka Shing Knowledge Institute, St Michaels Hospital,
Toronto, ON, Canada; University of Toronto, Toronto,
ON, Canada
131
Tumor Somatic Mutation Rate Predicts Response to

Anti-PD-1 Therapy in RCC: A Pilot Study (1053)
Diana Taheri, Maria Angelica Mendoza Rodriguez, Mark
W Ball, Stephania M Bezerra, Bert Vogelstein, Kenneth
Kinzler, Janis Taube, Charles Drake, Mohamad E Allaf,
George J Netto
Johns Hopkins Medical Institutions, Baltimore, MD;
Diseases Research Center, Isfahan, Islamic Republic of
Iran
132
Higher Expression of CDKN2A Gene Is Potential

Prognostic Marker for Clear Cell Renal Cell Carcinoma
(1057)
Eriny Tawedrous, Samantha J Wala, Rola Saleeb, Fabio
Rotondo, Qiang Ding, George M Yousef
St. Michaels Hospital, Li Ka Shing Knowledge Institute,
Toronto, ON, Canada; University of Toronto, Toronto,
ON, Canada
133
EZH2 as a Novel Target for Aggressive Clear Cell Renal

Cell Carcinoma (914)
Paul Friedman, Alana Christie, Xian-Jin Xie, Dinesh
Rakheja, James Brugarolas, Payal Kapur
Dallas, TX
134
Immunohistochemical Comparison of BAP1

Immunoexpression Status between Needle Biopsies
and Nephrectomies in Clear Cell Renal Cell Carcinoma
(913)
Paul Friedman, Farrah Homayoun, Vitaly Margulis,
Jeffrey Cadeddu, Dinesh Rakheja, James Brugarolas,
Payal Kapur
Dallas, TX
135
PNL2: An Adjunctive Biomarker for Renal

Angiomyolipomas and PEComas (932)
Previn Gulavita, Christopher Fletcher, Michelle Hirsch
136
Identification of Urinary MiRNAs for the Assessment of

Small Renal Masses (896)
Ashley Di Meo, Henriett Butz, Maria D Pasic, Michael
Jewett, Alexander Romaschin, Eleftherios P Diamandis,
George M Yousef
Li Ka Shing Knowledge Institute of St. Michaels
Hospital, Toronto, ON, Canada; The Advanced Centre
for Detection of Cancer at the Lunenfeld-Tanenbaum
Research Institute of Mount Sinai Hospital, Toronto,
ON, Canada; University of Toronto, Toronto, ON,
Canada; Princess Margaret Hospital, University Health
Network, University of Toronto, Toronto, ON, Canada
125
126
127
Comparison of Margin Status and Clinical FollowUp between Simple Tumor Enucleation and Partial
Nephrectomy of Small Renal Tumors (1071)
Lu Wang, Ian Hughes, Connor Snarskis, Gopal Gupta,
Maria M Picken
Loyola University Chicago, Maywood, IL; Loyola
University, Maywood, IL; Stritch School of Medicine,
Maywood, IL
Needle Biopsy of Renal Masses: Analysis of 121
Matched Biopsy and Resection Cases (942)
Saul E Harari, Daniel J Sassoon, John Eble, Liang
Cheng, Mohammed Idrees, Helen E Michael, David J
Grignon
Lymph Nodes Metastasis in Patients with Renal Cell
Carcinoma: Correlation with Histologic Subtype and
Other Pathologic Features (997)
Gabriel E Morey, Jae Y Ro, Luan D Truong, Alberto G
Ayala, Steven S Shen
Houston Methodist Hospital and Weill Medical College
of Cornell University, Houston, TX
128
Clinical Utility of Comparative Genomic Array Testing

for Unclassified and Advanced Stage Renal Cell
Carcinomas (851)
Nicole Andeen, Xiaoyu Qu, Tatjana Antic, Scott Tykodi,
Min Fang, Maria S Tretiakova
University of Washington, Seattle, WA; University of
Chicago, Chicago, IL
129
High Fidelity of Driver Chromosomal Alterations

among Primary and Metastatic Renal Cell Carcinomas:
Implications for Disease Evolution and Treatment (968)
Erik Kouba, Novae Simper, John N Eble, David J
Grignon, Mingsheng Wang, Shaobo Zhang, Lisha
Wang, Guido Martignoni, Sean R Williamson, Matteo
Brunelli, Claudio Luchini, Anna Calio, Liang Cheng
Indiana University School of Medicine, Indianapolis, IN;
China; Universit di Verona, Verona, Italy; Henry Ford
Health System, Detroit, MI
178
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
137
Morphologic and Immunohistochemical Correlates of

99m
Tc-sestamibi SPECT/CT Imaging Findings of Renal
Neoplasms (927)
Michael A Gorin, Steve P Rowe, Mehrbod S Javadi,
Mohamad E Allaf, Jonathan I Epstein, Alexander Baras
145
138
Spectrum of Phosphorylated STAT3 (pSTAT3)

Expression in a Large Cohort of Common Renal
Tumors (1039)
Benjamin Scheier, Aaron Udager, Tina Fields, Dafydd
Thomas, Thomas J Giordano, J Stuart Wolf, Bruce
Redman, Lakshmi P Kunju
University of Michigan Health System, Ann Arbor, MI
Novel Marker GREB1 Is Frequently Expressed in -Major

Ovarian Carcinoma Histotypes (1141)
Kendra Hodgkinson, Carlos Parra-Herran, Barbara
Vanderhyden, Bojana Djordjevic
Ottawa Health Research Institute, University of Ottawa,
Ottawa, ON, Canada; The Ottawa Hospital, University
of Ottawa, Ottawa, ON, Canada
146
Usefulness of Napsin A Immunohistochemistry in the

Diagnosis of Clear Cell Carcinoma of the Ovary (1100)
Sarah Bell, Darren Ennis, Aoisha Hoyle, Iain McNeish,
David Millan
Queen Elizabeth University Hospital, Glasgow,
Scotland, United Kingdom; Institute of Cancer
Sciences, University of Glasgow, Glasgow, Scotland,
United Kingdom
147
Clear Cell Carcinomas of the Ovary: A MonoInstitutional Study of 73 Cases in China with Analysis
of the Prognostic Significance of Clinicopathologic
Parameters and IMP3 Expression (1101)
Rui Bi, Xuxia Shen, Weiwei Zhang, Yufan Cheng,
Zheng Feng, Xu Cai, Wentao Yang
China; School of Public Health, Hong Kong, Hong Kong
148
Mismatch Repair (MMR) Protein Deficiency in Early

Stage Ovarian Carcinomas. [/underline][/underline]
A Study by Spanish Ovarian Cancer Research Group
(GEICO)[/underline][/underline][/underline] (1197)
Jose Palacios, Ana Gutierrez-Pecharroman, Eva
Cristobal, Jose Antonio Lopez-Guerrero, Ignacio
Romero, David Hardisson, Francisco Vera, Begona
Vieites, Angel Garcia, Javier Ibarra, Sofia Hakin, Rosa
Guarch, Encarna Andrada, Santiago Montes, Francisco
Pastor, Maria C Gomez, Maria C Gomez, Andres
Poveda
Hospital Universitario Ramon y Cajal, Madrid, Spain;
Instituto Valenciano de Oncologia, Valencia, Spain;
Spanish Ovarian Cancer Research Group, Barcelona,
Spain
139
Expression of PD-L1 and PD-1 Positive Tumor

Infiltrating Lymphocytes in Ovarian Tumors (1103)
Peter N Bonneau, Luis F Carrillo, Alexander C
Mackinnon
140
Expression of PD-L1 in Ovarian Tumors May Provide

Potential Immunotherapy Candidates (1211)
Opal L Reddy, Itsushi P Shintaku, Neda A Moatamed
Angeles, CA
141
B7-H4 Expression in Ovarian Serous Carcinoma: A

Study of 306 Tissue Samples (1171)
Li Liang, Yi Jiang, Jun-song Chen, Na Niu, Jinsong Liu
Houston, TX; The First Affiliated Hospital of Nanjing
Medical University, Nanjing, China
142
Objective, Domain-Specific HER2 Measurement in

Uterine and Ovarian Serous Carcinomas and Its Clinical
Significance (1109)
Daniel Carvajal-Hausdorf, Kurt Schalper, Yalai Bai,
Jonathan Black, Alessandro D Santin, David L Rimm
149
OTUB1 Exhibts a Subtype-Specific Expression

and Predicts Poor Prognosis by Promoting Tumor
Progression in Ovarian Epithelial Cancer (1245)
Yiqin Wang, Midie Xu, Weiwei Weng, Qiongyan Zhang,
Xianrong Zhou, Xiang Du
Obstetrics and Gynecology Hospital of Fudan
University, Shanghai, China; Shanghai Cancer Center,
Shanghai, China
MMR Protein Expression in Ovarian Carcinoma: A

Dina Bassiouny, Sharon Nofech-Mozes, Nadia Ismiil,
Matthew Cesari, Valerie Dube, Guangming Han,
Elzbieta Slodkowska, Hak Fai Chiu, Eugene Hsieh, Nim
Li, Magda Naeim, Mahmoud Khalifa, Fang-I Lu
Sunnybrook Health Sciences Centre, University of
Toronto, Toronto, ON, Canada
150
HNF1- Is Strongly Expressed in Ovarian Mucinous

Carcinoma (1097)
Dina Bassiouny, Nadia Ismiil, Matthew Cesari, Valerie
Dube, Guangming Han, Fang-I Lu, Elzbieta Slodkowska,
Hak Fai Chiu, Nim Li, Magda Naeim, Mahmoud Khalifa,
Sharon Nofech-Mozes
143
144
Expression of Alcohol Dehydrogenase 5 in Ovarian

Carcinoma: Effect on Prognosis and Therapeutic
Potential (1083)
Eman Abdulfatah, Giri Shailendra, Rattan Ramandeep,
Mohammed F Daaboul, Sharif Sakr, Baraa Alosh,
Muhammad K Alsafadi, Fatimah Alruwaii, Vishakha
Pardeshi, Sudeshna Bandyopadhyay, Adnan R
Munkarah, Rouba Ali-Fehmi
WSU, Detroit, MI
179
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
151
Mucinous Tumors Involving the Ovary: GREB1 and

Pax8 Immunopanel Identifies Ovarian Primaries with
High Sensitivity (1119)
Bojana Djordjevic, Sarah Strickland, Kendra
Hodgkinson, Barbara Vanderhyden, Carlos ParraHerran
The Ottawa Hospital, University of Ottawa, Ottawa, ON,
Canada; Ottawa Hospital Research Institute, University
158
Microcystic, Elongated, and Fragmented (MELF)

Pattern Invasion in Ovarian Endometrioid Carcinoma:
Immunohistochemical Profile and Prognostic
Implications (1134)
Allison Goldberg, Lauren Cooper, Daniel De Cotiis,
Norman Rosenblum, Joanna Chan
Thomas Jefferson University, Philadelphia, PA;
Hospital of University of Pennsylvania, Philadelphia, PA
152
Analysis of Ovarian Mucinous Neoplasms by Single

Nucleotide Polymorphism/Copy Number Variation
Assays (1221)
Ozlen Saglam, Jacob P Crowley, Sean Yoder, Robert M
Wenham, Anthony M Magliocco
Moffitt Cancer Center, Tampa, FL; Affymetrix, Santa
Clara, CA
159
Malignant Brenner Tumors Show an Absence of TERT

Promoter Mutations Which Are Commonly Present in
Urothelial Carcinoma (1159)
Francesca Khani, Mairo L Diolombi, Pallavi Khattar,
Weihua Huang, John T Fallon, Jonathan I Epstein,
Minghao Zhong
The Johns Hopkins Hospital, Baltimore, MD; New York
Medical College, Westchester, NY
153
A MicroRNA Whole Transcriptome Assay to Distinguish

between Histological Subtypes of Ovarian Carcinomas
(1092)
Le Aye, Jonas Pettersson, Craig Stephens, Miriana
Moran, Tiffany I Long, Stephanie H Astrow, Robert
Makowsky, Chris Roberts, Louis Dubeau, Pamela M
Ward
USC, Los Angeles, CA; Response Genetics, Los
Angeles, CA; HTG Molecular Diagnostics, Tucson, AZ
160
Whole Exon Sequencing of Malignant Brenner Tumor:

Differences from Conventional Urothelial Carcinoma
(1160)
Pallavi Khattar, Francesca Khani, Mairo L Diolombi,
Weihua Huang, John T Fallon, Jonathan I Epstein,
Minghao Zhong
College, Valhalla, NY; John Hopkins University,
Baltimore, MD
154
Genomic Analysis of Low-Grade Serous Ovarian

Tumors Associated with High-Grade Serous Carcinoma
or Undifferentiated Carcinoma (1186)
Rajmohan Murali, Raghu Chandramohan, Robert
Soslow, Donavan Cheng, W Glenn McCluggage
NY; Illumina, San Francisco, CA; Belfast Health and
Social Care Trust, Belfast, United Kingdom
161
Glucocorticoid Receptor Expression in Ovarian Tumors

(1089)
Ghassan Allo, Dhananjay A Chitale, Sharon H Alford,
Adnan R Munkarah, Ira Winer, Manohar Ratnam
Henry Ford Hospital, Detroit, MI; Karmanos Cancer
Institute, Detroit, MI
162
Biomarker Selection in Early Ovarian Cancer (1190)

John J OLeary, Sara OKane, Sharon OToole, John K
OBrien, Stephen R Pennington, Dolores J Cahill
Trinity College Dublin, Dublin, Ireland; University
College Dublin, Dublin, Ireland
163
Molecular Mechanism of Ovarian Tumor Induced

Immunosuppression and Its Prevention by Metformin
(1095)
Animesh Barua, SaRah McNeal McNeal, Lindsey
Franklin, Paolo Gattuso, Sameer Sharma, Pincas
Bitterman
RUsh University Medical Center, Chicago, IL
164
Morphologic Features of High Grade Serous

Carcinoma of Adnexal/Peritoneal Origin Treated with
Neo-Adjuvant Chemotherapy (1253)
Anna Yemelyanova, Anais Malpica, Elizabeth D
Euscher, Preetha Ramalingam
165
Patient Outcome Is Not Related to Chemotherapeutic

Response Score (CRS) (1125)
Elizabeth D Euscher, Roland L Bassett, Anna
Yemelyanova, Preetha Ramalingam, Anais Malpica
155
156
157
180
Combination of Ki-67, MCM2, p16, and p53 Expression

Can Distinguish High Grade Serous Carcinoma From
Low Grade Serous Tumors (1158)
Sarah M Kelting, Cherie Paquette, Mark E Smolkin,
Amir A Jazaeri, Megan R Barrett, Mark H Stoler
University of Virginia, Charlottesville, VA; Women
and Infants Hospital, Providence, RI; MD Anderson,
Houston, TX
Serous Psammocarcinoma Revisited: A Single
Institution Experience (1093)
Keegan Barry-Holson, Ann K Folkins, Teri A Longacre
Ovarian Endometrioid Adenocarcinomas: Morphology,
Associations and Outcomes in 79 Patients (1228)
Annacarolina Silva, Jennifer A Bennett, Rouba AliFehmi, Sudeshna Bandyopadhyay, Esther Oliva
Dana-Farber Cancer Institute, Boston, MA; Lahey
Hospital and Medical Center, Burlington, MA; Wayne
State University, Detroit, MI; Massachusetts General
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
166
172
Correlates of Physiologic and Neoplastic Human

Fallopian Tube Stem Cells (1252)
Wa Xian, Yusuke Yamamoto, Gang Ning, Brooke E
Howitt, Molly Brewer, Frank D McKeon, Christopher P
Crum
National Cancer Center Research Institute, Tokyo,
Japan; The Jackson Laboratory, Farmington, CT;
University of Connecticut Health Sciences Center,
Farmington, CT; University of Houston, Houston, TX
173
BRCA Status Can Be Determined Using FFPE Blocks, a

Feasibility Pilot Study (1087)
Mohammad R Akbari, Robert Royer, Dina Bassiouny,
Nadia Ismiil, Matthew Cesari, Valerie Dube, Guangming
Han, Fang-I Lu, Elzbieta Slodkowska, Magda Naeim,
Mahmoud Khalifa, Sharon Nofech-Mozes
Womens College Research Institute, Womens College
Hospital, University of Toronto, Toronto, ON, Canada;
Dalla Lana School of Public Health, University of
Toronto, Toronto, ON, Canada; Sunnybrook Health
Sciences Centre, University of Toronto, Toronto, ON,
Canada
Inter-Observer Agreement in Assessment of Response

to Neo-Adjuvant Chemotherapy in Tubo-Ovarian HighGrade Serous Carcinoma (1229)
Naveena Singh, Ian Said, Asma Z Faruqi, Sarah L Leen,
Giorgia Trevisan, Lynn Hirschowitz, Raji Ganesan, Jo
Vella, Glenn McCluggage, Blake Gilks, Steffen Boehm
Barts Health NHS Trust, London, United Kingdom;
University College Hospital, London, United Kingdom;
Birmingham Womens Hospital, Birmingham, United
Kingdom; Royal Victoria Hospital, Belfast, United
Kingdom; Vancouver General Hospital, Vancouver,
Canada
167
TLR4 and MAD2: Drivers of Chemoresistance in

Ovarian Cancer (1099)
Mark Bates, Luke Gubbins, Dorinda Mullen, Eimear
Lee, Jacqui Barry-OCrowley, Danielle Costigan, Ciaran
ORiain, Cathy D Spillane, Michael F Gallagher, Cara
Martin, Amanda McCann, Sharon OToole, John J
OLeary
Trinity College Dublin, Dublin 2, Ireland; University
College Dublin, Belfield, Dublin 4, Ireland; Coombe
Women & Infants University Hospital, Dublin 8, Ireland;
St Jamess Hospital, Dublin 8, Ireland
168
Epidemiologic Dissociation between Two Subtypes of

Molecularly Similar Tumors (1206)
Julio Poveda, Carmen Gomez-Fernandez, Paula
Espinal, Ernesto Martinez-Duarte, Elena Vrotsos, Pan
Yue, Andre Pinto
University of Miami / Jackson Health System, Miami,
FL; University of Miami Miller School of Medicine,
Miami, FL
169
170
171
Incidence of Occult Carcinomas in Fallopian Tubes in

High-risk Patients A Prospective Study from North
Shore LIJ Health System (1218)
Sudarshana Roychoudhury, Peter Farmer, Cathy Fan,
Sharon Liang
Hofstra North Shore -LIJ Health System, Lake Success,
NY
Would Fallopian Tube Tissue Be Left Behind?
Quantitation of Tubal-Type Epithelium within Ovary
at Time of Risk Reducing Salpingo-Oophorectomy
Implications for Ovary Conserving Strategies (1177)
Sarah Mahon, Julie McFadden, Noreen Gleeson,
Ciaran ORiain
St. Jamess Hospital, Dublin, Ireland
Serial Sectioning and TP53 Sequencing of Occult
Intraepithelial Lesions in Distal Fallopian Tubes:
Implications for the Origin of High-Grade Ovarian
Serous Carcinoma (1234)
Thing Rinda Soong, Brooke E Howitt, Helena M Ditzel,
Alexander Miron, Frank Campbell, Christopher P Crum
Brigham and Womens Hospital, Boston, MA; Case
Western Reserve University, Cleveland, OH; Covariance
Biosciences, Cleveland, OH
INFORMATICS
174
Stain Normalization in Digital Pathology Images Using

Deep Learning (1561)
Andrew Janowczyk, Ajay Basavanhally, Anant
Madabhushi
Inspirata, Tampa, FL
175
Development of New Fluorescence Virtual Slide

System Equipped with the Liquid Crystal Filter Unit[/
underline] (1573)
Hiroyuki Nozaka, Tomisato Miura, Zhongxi Zheng
Hirosaki University, Hirosaki, Aomori, Japan
176
Digital Image Analysis Reliably Estimates Bone Marrow

Trephine Biopsy Cellularity (1558)
Ashley S Hagiya, Ali Etman, Imran N Siddiqi, Russell K
Brynes, Mohamed E Salama
Keck School of Medicine, University of Southern
California, Los Angeles, CA; University of Utah, Salt
Lake City, UT
177
Fully Automated, Accurate, and Efficient Segmentation

of Cancer Nuclei in Breast Pathology Images (1562)
Andrew Janowczyk, Hannah Gilmore, Anant
Madabhushi
University Hospitals, Cleveland, OH
178
Computer Extracted Features of Nuclear Morphology

from Digital H&E Images Are Predictive of Recurrence
in Stage I and II Non-Small Cell Lung Cancer (1583)
Xiangxue Wang, Andrew Janowczyk, Yu Zhou, Sagar
Rakshit, Vamsidhar Velcheti, Anant Madabhushi
181
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
179
Pathology-Driven Cloud-Based Mutidisciplinary Team

Meeting Software (1574)
Fionnuala OConnell, Tim Manning, Brian Kelly, Noel
Murphy, Paul Walsh, Tara Jane Browne, Michael W
Bennett
Cork University Hospital, Cork, Ireland; nSILICO, Cork,
Ireland; Health Innovation Hub, Cork, Ireland
186
180
Live Remote Digital Microscopy in Peripheral Smear

Evaluation: Validation and Intraobserver Variability
(1559)
Diana M Haninger, Mehdi Nassiri, Elizabeth D
Settembre, Shanxiang Zhang, Jiehao Zhou
Digital Pathology and Anatomic Pathology Laboratory

Information System Integration Supports Digital
Surgical Pathology Sign-Out[/underline] (1557)
Huazhang Guo, Douglas J Hartman, Jonhan Ho,
Anthony L Piccoli, Matthew OLeary, Jeffrey McHugh,
Joe Birsa, Mark Nyman, Curtis Stratman, Jeffrey L
Fine, Samuel A Yousem, Liron Pantanowitz
187
181
Implementation of Whole-Slide Imaging in the Routine

Diagnosis in a Pathology Laboratory: Consequences
for File Storage (1577)
Jose Ramirez, Adela Saco, Monica Hernandez, Rosana
Millan, Margarita Mainar, Paola Castillo, Natalia
Rakislova, Jaume Ordi
Hospital Clinic - Barcelona University, Barcelona,
Spain; ISGlobal, Barcelona, Spain
The Influence of Prior Laboratory Values and Patient

Demographics on Physician Test Ordering: Capturing
Non-Linear Effects within a Population-Based
Retrospective Cohort Study (1570)
Eric Morgen, Christopher Naugler
Mount Sinai Hospital, Toronto, ON, Canada; University
of Toronto, Toronto, ON, Canada; Calgary Laboratory
Services, Calgary, AB, Canada; University of Calgary,
Calgary, AB, Canada
188
An Enterprise Approach for Pathology Reporting

Utilizing PDF Functionality for the Electronic Medical
Record (1579)
S Joseph Sirintrapun, Tianhao Zhao, Evangelos
Stamelos, George Tsividakis, Jonathan Gurman, Mary
J Mitchell, Victor E Reuter, David Klimstra
City, NY; Wake Forest Baptist Health, Winston Salem,
NC
189
Turn Around Time Monitoring in Anatomical

Pathology: Time to Event Analysis (1572)
Nickolas Myles, Douglas Filipenko, Marin J Trotter
Providence Healthcare, Vancouver, BC, Canada
190
Multi-Site Digital Pathology Validation Using

Standardized Coded Checklists and Predetermined
Discordance Tables (1582)
Katy Wack, Laura M Drogowski, Murray Treloar,
Andrew Evans, Jonhan Ho, Anil Parwani, Michael
Montalto
Omnyx, LLC, Pittsburgh, PA; Dr. Murray Treloar
Medicine Professional Corp, Port Hope, ON, Canada;
University Health System, Toronto, ON, Canada;
PA; Ohio State University Wexner Medical Center,
Columbus, OH
191
Machine Learning to Predict Successful Hematopoietic

Progenitor Cell Collection from the Sysmex XN3000
Blood Analysis Data (1550)
German Campuzano-Zuluaga, Cesar A Llanos, Joseph
Zeitouni, Artur Rangel-Filho
University of Miami Health System, Miami, FL
192
MRI Derived Histologically Trained Maps of Epithelium

Density Predict Prostate Cancer Presence (1565)
Peter S LaViolette, Amy Kaczmarowski, Kenneth A
Iczkowski, Kenneth Jacobsohn, Paul M Knechtges,
Mark Hohenwalter, William See
182
183
Can Polarizable Material Be Identified from

Automatically Acquired Digital Slides? (1560)
Douglas J Hartman, Morgan Jessup, Simon Watkins,
Liron Pantanowitz
PA; University of Pittsburgh School of Medicine,
Pittsburgh, PA
Successful Secure HD Streaming Telecytology for
Remote Cytologic Evaluation (1581)
S Joseph Sirintrapun, Dorota Rudomina, Rusmir
Feratovic, Oscar Lin
City, NY
184
The Importance of Quality Control in Report Translation

in an International Telepathology Practice (1564)
Christopher J Kim, Guofeng Wang, Li-Rong Chen,
Jianyu Rao
University of California, Los Angeles, Los Angeles, CA;
Zhejiang University School of Medicine, Hangzhou,
China
185
Central Histopathology Review of Essential

Thrombocythemia and Polycythemia Vera Bone
Marrow Biopsies via Digital Tools in a Clinical Trial on
Pegylated Interferon Alfa-2a (1584)
Delu Zhou, Olga Pozdnyakova, Rajan Dewar, Robert P
Hasserjian, Ali Etman, Ronald Hoffman, Mohamed E
Salama
University of Utah, Salt Lake City, UT; Brigham and
Womens Hospital, Boston, MA; University of Michigan,
Ann Arbor, MI; Massachusetts General Hospital,
Boston, MA; Mount Sinai School of Medicine, New
York, NY
182
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
Board
Number
193
Image Recognition: Orientation and Visual Field Bias in

Digital Pathology (1556)
Sharon E Fox, Richard S Vander Heide, Charles Law,
Beverly E Faulkner-Jones
LSU Health Sciences Center, New Orleans, LA; Boston
Childrens Hospital, Boston, MA; Kitware, Inc., Clifton
Park, NY; Beth Israel Deaconess Medical Center,
Boston, MA
194
The Use of Computer Vision in the Differential

Diagnosis of Ovarian Carcinomas (1567)
Xinyan Li, Vassilios Morellas, Nikolaos
Papanikolopoulos, Alexander M Truskinovsky
University of Minnesota, Minneapolis, MN; Roswell
Park Cancer Institute, Buffalo, NY
195
Functional Validation of MicroRNA Activity Inferred by

ActMiR in Bladder Cancer (1551)
Mireia Castillo-Martin, Ana Collazo Lorduy, EunJee
Lee, Jun Zhu, Carlos Cordon-Cardo
196
An Independent, Variant-Level Assessment Exposes

Gaps in Probe Design and Coverage in SequencingBased EGFR Testing (1549)
Michelle Call, Sushama Thakker, Charlie Kim, Glenda
Anderson
Farsight Genome Systems, Sunnyvale, CA
197
Hierarchical Clustering of Mutational Profile of Uterine

Carcinosarcomas and Comparison with Uterine
Endometrioid and Serous Adenocarcinomas (1569)
Amir Momeni Boroujeni, Elham Yousefi, Remegio
Maglantay, Raavi Gupta, Ning Neil Chen
SUNY Downstate Medical Center, Brooklyn, NY
198
199
200
Data Analysis of RNA-Seq of the Bone Marrow from

Patients with Myeloid Neoplasms Using Multiple
Bioinformatic Pipelines (1578)
Thomas Schneider, Geoffrey Smith, Scott Newman,
Linsheng Zhang
Emory University, Atlanta, GA; Winship Cancer
Institute of Emory University, Atlanta, GA
Analysis of Available Clinical Trials for Targeted
Therapies in Solid Tumors (1568)
Susan Mockus, Sara E Patterson, Rangjiao Liu, Cara
Statz
The Jackson Laboratory for Genomic Medicine,
Farmington, CT
A Bioinformatics Software Pipeline for Identifying
Causal Genetic Mechanisms of Antibiotic Resistance in
Bacterial Pathogens (1571)
Karthikeyan Murugesan, Xinran Li, Pramod
Mayigowda, Henry Lin, Guiqing Wang, Abhay Dhand,
Weihua Huang, John T Fallon, Nevenka Dimitrova
Philips Research North America, Cambridge, MA; New
York Medical College, Valhalla, NY
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
KIDNEY/RENAL PATHOLOGY (INCLUDING
TRANSPLANTATION)
201
Routine Clinical Use of Exome NGS for Diagnosis in

Patients with Renal Disease (1601)
Joseph Gaut, Sanjay Jain, John D Pfeifer, Catherine E
Cottrell
Washington University, St. Louis, MO
202
IgA Dominant Post-Infectious Glomerulonephritis in

the Pediatric Population (1613)
Paul Persad, Agnes Fogo
Vanderbilt, Nashville, TN
203
Clinical Significance of Glomerular IgG Deposits in IgA

Nephropathy (1591)
Nicole Andeen, Anthony S Alvarado, Sergey
Brodsky, Alice Hinton, Tibor Nadasdy, Charles Alpers,
Christopher Blosser, Behzad Najafian, Brad Rovin
University of Washington, Seattle, WA; Ohio State
University, Columbus, OH
204
Relationship Between Glomerular Macrophage

Numbers and the Oxford Classification of IgA
Nephropathy (1622)
Maria Fernanda Soares, Clare MacEwen, Aron Chakera,
Shuba S Bellur, Ian SD Roberts
Federal University of Parana, Curitiba, Parana, Brazil;
Oxford University Hospitals NHS Trust, Oxford, Oxon,
United Kingdom; University of Western Australia,
Perth, Western Australia, Australia
205
Quantitative Assessment of Density of Deposits in C3

Glomerulopathies (1608)
Mark Lusco, Agnes B Fogo
206
PLA2R+ Membranous Nephropathy Has Greater C3

Deposition Than Non-Lupus PLA2R- Membranous
Nephropathy (1624)
Mirna Toukatly, Behzad Najafian
207
Comparison of Renal Biopsy Pathology in Adults and

Children with Systemic Lupus (1606)
Li Lei, Craig Zuppan
Loma Linda University Medical Center, Loma Linda, CA
208
ANA-Negative Renal-Limited Lupus Nephritis Is

Associated with Poor Renal Outcomes (1614)
David Portnoy, Daphne Knicely, Warren K Bolton,
James Cain, Helen Cathro
University of Virginia, Charlottesville, VA; The Johns
Hopkins University, Baltimore, MD; Valley Nephrology
Associates, Roanoke, VA
209
Utility and Patterns of C5b-9 and C4d

Immunohistochemical (IHC) Staining in Thrombotic
Microangiopathies (TMA) (1589)
Mustafa Al-Kawaaz, Steven Salvatore, Surya Seshan
Weill Cornell Medical College, NY, NY
183
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
211
Loss of Glomerular Basement Membrane Staining for

COL4A5 in Alport Syndrome Correlates with Age at
Diagnosis and Severity of Ultrastructural Alterations
(1618)
Samar Said, Mary E Fidler, Brooke McCann, Lynn D
Cornell, Mariam Priya Alexander, Samih Nasr
218
Diagnostic Accuracy of the Liver Imaging Reporting

and Data System (LI-RADS) for Hepatic Nodules in
Cirrhotic Patients: A 2 year Retrospective Analysis
(1631)
Hana Albrecht, Richard Gilroy, Ryan Ash, Maura ONeil
212
Clinical Significance of the Pathological Evaluation

of Non-Neoplastic Renal Tissue in Post-Radical
Nephrectomy (1610)
Madeleine Moussa, Adiel Mamut, Gena Ibrahim,
Patrick Luke, Fulan Cui, Neal Rowe, Manal Gabril
Western University, London, ON, Canada
219
213
BK Virus: Unveiling a Pathogen in 46 Autopsies of

Allogeneic Stem Cell Transplant Recipients (912)
Kenneth Friedman, Rima Pai, William F Glass, Elizabeth
Shpall, Katy Rezvani, Ala Abudayyeh, Miao Zhang
Houston, TX; University of Texas Health Science Center
at Houston, Houston, TX
The Prognostic Value of Mitotic Rate in the

Fibrolamellar Variant of Hepatocellular Carcinoma
in a Well-Characterized Series of 13 Cases Showing
DNAJB1-PRKACA Transcript (1666)
Andrea Jones, Rondell Graham, Rish K Pai, Volkan
Adsay, Michael Torbenson, Roger Moreira
AZ; Emory University, Atlanta, GA
220
Early Hepatocellular Carcinoma with High-Grade

Atypia in Small Vaguely Nodular Lesions (1673)
Hidenori Ojima, Yohei Masugi, Hanako Tsuijikawa,
Osamu Itano, Yuko Kitagawa, Michiie Sakamoto
Keio University School of Medicine, Tokyo, Japan
221
Neuroglobin and Cytoglobin, Regulators of Oxidative

Stress Are Associated with Poor Prognosis in
Raghavendra Pillappa, Jignesh G Parikh, Wafi Bibars,
Cameila Johns
University of Tennessee Health Science Center,
Memphis, TN; University of Miami/Jackson Memorial
Hospital, Miami, FL
222
Aldoketoreductase Family 1B10 (AKR1B10) Is a

Sensitive Biomarker to Identify Well-Differentiated
Andrew Bandy, Xiaoming You, Haonan Li, Jie Liao,
Sambasiva Rao, Xiaoqi Lin, Guang-Yu Yang
223
Investigating Predictive Models Based on Circulating

Cell-Free INK4A DNA Methylation, Alpha-Fetoprotein,
Platelet Count, and Age for Diagnosis and Prognosis of
Rebecca Waters, Yan Xie, Jianli Dong, Roger Soloway
University of Texas Medical Branch, Galveston, TX
224
Associations of Tumor Response to Neoadjuvant TACE

Following Liver Transplantation (1693)
Yang Zhang, William S Twaddell
225
In-Situ Hybridization for Albumin RNA in Pediatric Liver

Cancers Compared to Common Immunohistochemical
Markers (1667)
Anne K Koehne de Gonzalez, Ladan Fazlollahi, Amy
Coffey, Helen Remotti, Stephen M Lagana
Columbia University, New York, NY
LIVER
214
215
216
217
184
Lymphocyte Infiltration Is a Promising New Prognostic

Factor for Hepatocellular Carcinoma (1661)
Akimasa Hayashi, Kento Misumi, Junji Shibahara,
Junichi Arita, Yoshihiro Sakamoto, Kiyoshi Hasegawa,
Norihiro Kokudo, Masashi Fukayama
Graduate School of Medicine, University of Tokyo,
Tokyo, Japan
Poorly Differentiated Hepatocellular Carcinomas and
Hepatocellular Carcinomas with a Brisk Lymphocytic
Infiltrate Are Enriched for PD-L1 Expression on Tumor
Cells (1684)
Michael Torbenson, Taofic Mounajjed, Robert R
McWilliams, Rondell Graham
BSEP and MDR3: Useful Immunohistochemical
Markers for the Discrimination of Hepatocellular
Carcinomas from Not Only Intrahepatic
Cholangiocarcinomas but Also Hepatoid Carcinomas
(1656)
Kohei Fujikura, Takashi Yamasaki, Kyoko Otani,
Takanori Hirose, Tomoo Itoh, Yoh Zen
Kobe University, Kobe, Hyogo, Japan; Hyogo Cancer
Center, Kobe, Hyogo, Japan
GATA4 Expression Is a Prognostic Factor of Recurrence
in Hepatocellular Carcinoma (1691)
Kijong Yi, Rehman Abdul, Yumin Chung, Dong Ho
Choi, Dae Won Jun, Seung Sam Paik, Kiseok Jang
Hanyang University College of Medicine, Seoul,
Republic of Korea
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
226
Pathologic Features of Synchronous Hepatocellular

and Renal Cell Carcinomas in Non-Cirrhotic Patients
(1632)
Lindsay Alpert, Wendi Zhou, Hanlin L Wang, Lisa
Yerian, Lei Zhao, Gladell P Paner, John Hart
University of Chicago, Chicago, IL; UCLA, Los Angeles,
CA; Cleveland Clinic, Cleveland, OH; University of
Alabama at Birmingham, Birmingham, AL
234
Primary and Secondary Hepatic Presentation of

Hodgkin Lymphoma: A Multi-Institutional Study (1680)
Rasha Salama, Purva Gopal, Maria Westerhoff,
Hwajeong Lee, Jiehao Zhou, Jingmei Lin
Indiana University, Indianapolis, IN; University of Texan
Southwestern Medical Center, Dallas, TX; University
of Washington, Seattle, WA; Albany Medical Center,
Albany, NY
227
Arginase Is Superior to Hepar for Distinguishing Clear

Cell Hepatocellular Carcinoma from Clear Cell Tumors
Metastatic to the Liver (1669)
Brent Larson, Deepti Dhall, Maha Guindi
235
228
10% of Well Differentiated Hepatocellular Carcinomas

Are Negative for Arginase-1 on Needle Biopsies: An
Important Diagnostic Pitfall (1643)
Vishal Chandan, Sejal S Shah, Roger Moreira, TsungTeh Wu, Michael Torbenson
Aberrant Keratin Expression Is Common in Primary

Hepatic Malignant Vascular Tumors: A Potential
Diagnostic Pitfall (1644)
Vishal Chandan, Hee Eun Lee, Michael Torbenson,
Tsung-Teh Wu
236
229
Combination of Astrocyte Elevated Gene 1 and

Glypican 3 Immunochemistry Improves Diagnostic
Accuracy of Hepatocellular Carcinoma (1642)
Wenqing Cao, Benedict Maliakkal, Mark Orloff, Meenal
Sharma
New York University Langone Medical Center, New
York, NY; University of Rochester Medical Center,
Rochester, NY
TFE3 Immunohistochemistry Is Useful to Distinguish

Epithelioid Hemangioendotheliomas from
Angiosarcomas and Hemangiomas of the Liver (1671)
Cheryl Mather, Hsuan-Ying Huang, Ting Ting Liu,
Benjamin Hoch, Robert W Ricciotti, Matthew Yeh
University of Washington, Seattle, WA; Kaohsiung
Chang Gung Memorial Hospital, Taiwan, Taiwan
230
231
232
233
Steatosis and Steatohepatitis in Hepatocellular

Carcinoma: What Is the Significance? (1692)
Funda Yilmaz, Umut Aykutlu, Alper Uguz, Deniz Nart,
Ahmet Coker
University of Ege Faculty of Medicine, Izmir, Turkey
Diagnostic Utility of Clusterin Immunostaining in
Differentiating Hepatocellular Carcinoma from Tumors
of Other Origins (1695)
Wendi Zhou, Jamie Koo, Hanlin L Wang, Haiyan Liu,
Zongming E Chen, Fan Lin
UCLA, Los Angeles, CA; Cedar Sinai Medical Center,
Los Angeles, CA; Geisinger Medical Center, Danville,
PA
Hepar-1 Loss in Telangiectatic/Inflammatory Hepatic
Adenomas A Novel Observation with Potential Tumor
Biology Implications (1665)
Andrea Jones, Rondell Graham, Taofic Mounajjed,
Michael Torbenson, Roger Moreira
Copper Deposition in Focal Nodular Hyperplasia and
Inflammatory Hepatic Adenoma (1645)
Vishal Chandan, Taofic Mounajjed, Sejal S Shah,
Michael Torbenson, Tsung-Teh Wu
NEUROPATHOLOGY & OPHTHALMIC PATHOLOGY
237
Targeted Next-Generation Sequencing in the Molecular

Profiling of Lower-Grade Gliomas (1697)
Jamal H Carter, Catherine E Cottrell, Eric J Duncavage
Washington University, St Louis, MO
238
Absence of CMV Components in High Grade Gliomas

by Real-Time PCR, Immunohistochemistry and
Chromogenic In-Situ Hybridization (1703)
Gunes Guner, Fausto Rodriguez, Jessica Hicks, Xiaobu
Ye, Stuart Grossman, Peter Burger, Charles G Eberhart,
Angelo M De Marzo, Ravit Boger, Matthias Holdhoff
239
Reclassification of Mixed Oligoastrocytic Tumors

Including Glioblastoma with Oligodendroglioma
Component by Genetics Integrated Diagnosis (1710)
Seong-Ik Kim, Yujin Kim, Sung-Hye Park
Korea
240
Utility of Whole Genome Single Nucleotide

Polymorphism Microarray (SNPM) and Targeted
Somatic Mutations Analysis in the Evaluation of Adult
Brain Tumors (1711)
Ravindra Kolhe, Alka Chaubey, Barbara R DuPont,
WonSok Lee, Ashis K Mondal, Amyn Rojiani
Genetic Center, Greenwood, SC
241
Genetic Alterations of EGFR in High Grade Gliomas

and Its Prognostic Significance (1714)
Minju Lee, So Young Kang, Yeon-Lim Suh
School of Medicine, Seoul, Korea
185
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
242
Gliomas of Children and Young Adults-BRAFV600E

Mutation (1701)
Anupurva Dutta, Hetakshi Kurani, Aliasgar Moiyadi,
Prakash Shetty, Jayant Sastri, Tejpal Gupta, Rakesh
Jalali, Sridhar Epari
TMC, Mumbai, India
249
243
Pangenomic Analysis of BRAF Genomic Alterations

Across All Types of Brain Tumors Reveals Expanded
Opportunities for Targeted Therapies (1699)
Zachary Chalmers, Juliann Chmielecki, Julia A Elvin,
Jo-Anne Vergilio, James Suh, Shakti H Ramkissoon,
Garrett Frampton, Vincent A Miller, Philip J Stephens,
Jeffrey S Ross
Foundation Medicine, Inc., Cambridge, MA; Brigham
and Womens Hospital, Boston, MA; Albany Medical
College, Albany, NY
MiR-16, but Not MiR-519, Suppresses Tumor Cell

Proliferation in Meningiomas via HuR Inhibition (1698)
Jean-Matthieu Casse, Abderrahim Oussalah, Charlene
Vigouroux, Lydia Brochin, Deborah Helle, Rose
Ghemrawi, Sandra Lomazzi, Helene Busby-Venner,
Nicolas Gambier, Julien Scala-Bertola, Jean-Louis
Gueant, Jean-Michel Vignaud, Shyue-Fang BattagliaHsu, Guillaume Gauchotte
Faculty of Medicine, University of Lorraine,
Vandoeuvre-les-Nancy, France; University Hospital of
Nancy, Nancy, France; University Hospital of Nancy,
Vandoeuvre-les-Nancy, France; University of Lorraine,
Vandoeuvre-les-Nancy, France
250
Atypical Teratoid/Rhabdoid Tumors (AT/RTs) of the

Sellar Region in Adults: Characterization of Five Cases
(1724)
Michael Paolini, Benjamin R Kipp, William R Sukov,
Aditya Raghunathan, Emily G Barr Fritcher, Derick
M Aranda, Karen SantaCruz, Sadeq Al-Dandan, Pete
Fisher, William McDonald, Charles P Bondurant, Grant
Van Dyke Darkow, Caterina Giannini, Joseph E Parisi,
Mark E Jentoft
Mayo Clinic, Rochester, MN; Northwestern University,
Chicago, IL; University of New Mexico, Albuquerque,
NM; King Fahad Medical City, Riyadh, Saudi
Arabia; North Valley Hospital, Kalispell, MT; Abbott
Northwestern Hospital, Minneapolis, MN; Boone
Hospital Center, Columbia, MO
244
Thyroid Transcription Factor-1 Is a Useful Maker in

Distinguishing Subependymal Giant Cell Astrocytoma
and Other Mimickers (1704)
Jen-Fan Hang, Chih-Yi Hsu, Donald M-T Ho
Taipei Veterans General Hospital, Taipei, Taiwan
245
Infratentorial Ependymomas: Clinicopathological and

Immunohistochemical Characterization (1709)
Gordana Juric-Sekhar, Tatsuya Ozawa, Jason K Barber,
Eric C Holland
University of Washington, Seattle, WA; Fred
Hutchinson Cancer Reseach Center, Seattle, WA;
Universitiy of Washington, Seattle, WA
251
246
Mutational Profiling of Ependymomas by NextGeneration Sequencing and the Potential Correlation

with Clinical Outcome (1730)
Yuan Rong, Hope T Richard, Catherine I Dumur
Department of Pathology, Virginia Commonwealth
University, Richmond, VA
Utility of PIT-1 Immunostaining in Distinguishing

Pituitary Adenomas of Primitive Differentiation from
Null Cell Adenomas (1713)
Julieann Lee, Melike Pekmezci, Arie Perry, Tarik Tihan
CA
252
247
Targeted Next Generation Sequencing Reveals Unique

Mutation Profile of Primary Melanocytic Tumors of the
Central Nervous System (1721)
Rajmohan Murali, Johannes van de Nes, Marco Gessi,
Antje Sucker, Inga Moeller, Mathias Stiller, Susanne
Horn, Simone Scholz, Carina Pischler, Nadine Stadler,
Bastian Schilling, Lisa Zimmer, Uwe Hillen, Richard
A Scolyer, Michael Buckland, Libero Lauriola, Torsten
Pietsch, Andreas Waha, Dirk Schadendorf, Klaus
Griewank
University Hospital Essen, Essen, Germany; University
of Bonn Medical Center, Bonn, Germany; Medical
University of Graz, Graz, Austria; Royal Prince Alfred
Hospital, Sydney, Australia; Catholic University, Rome,
Italy; Memorial Sloan Kettering Cancer Center, New
York, NY
SSTR2a Status and Response to Somatostatin

Analogues for Acromegaly (1715)
Giselle Lopez, Lewis S Blevins, Arie Perry
University of California- San Francisco, San Francisco,
CA
253
Tumor-like Mass Arising as a Side Effect of Intrathecal

Therapeutic Stem Cell Injections (1720)
Michael B Miller, Saad Mir, Indira Guleria, John H Chi,
Aaron L Berkowitz, Keith L Ligon
254
Chemotherapy Exposure Is Associated with Loss of

Heterochromatin, Increased Oxidative Stress, and
Microglial Activation in the Frontal Cortex (1732)
Matthew Torre, Mel Feany
Brigham and Womens Hospital, Boston, MA; Harvard
255
CA1-Predominant Hippocampal Sclerosis in Medically

Refractory Temporal Lobe Epilepsy (1702)
Jordan M Gales, Ruta Yardi, Lara Jehi, Richard Prayson
248
186
Intracranial Fibrosarcomas: Clinicopathologic

Characteristics in 9 Patients (1707)
Bryan Iorgulescu
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
256
Expression of Nuclear Receptor NR4A3 in Multiple

System Atrophy and Dementia With Lewy Bodies
(1726)
Itzel Pineda, Nancy Edwards, David Goldstein, Abhik
Ray-Chaudhury
NINDS, NIH, Bethesda, MD
265
257
Impact of Cerebral Amyloid Angiopathy on the

Integrity of the Blood Brain Barrier (1716)
Shino Magaki, Zhaoyi Tang, Darrick Lo, Spencer Tung,
Harry V Vinters
University of California, Los Angeles (UCLA) Medical
Center and David Geffen School of Medicine, Los
Angeles, CA
PD-L1 Expression in Intraocular Malignant Melanomas.

Correlation with Morphologic Patterns and Outcome
(1718)
Aoife McCarthy, Vanessa Moreno, Xu Naizhen, Susan
Kennedy, Maria J Merino
The Royal Victoria Eye and Ear Hospital, Dublin,
Ireland; National Cancer Institute, Bethesda, MD
266
258
Slide-Free Histology Via MUSE: Ultraviolet Surface

Excitation Microscopy for Imaging Unprocessed
Tissue: Applications in Neuropathology (1712)
Mirna Lechpammer, Kiarash Shahlaie, Farzad
Fereidouni, Zachary T Harmany, Alex R Krueger,
Richard Levenson
University of California Davis, Sacramento, CA
Intraocular Malignant Melanoma: Correlation of

Morphological and Molecular Findings with Outcome
in an Irish Cohort (1717)
Aoife McCarthy, Vanessa Moreno, Xu Naizhen, Susan
Kennedy, Maria J Merino
The Royal Victoria Eye and Ear Hospital, Dublin,
Ireland; National Cancer Institute, National Institutes of
Health, Bethesda, MD
267
Conjunctival Melanomas Harbor BRAF Mutations:

Confirmatory Exome Sequencing Analysis of 409
Cancer-Related Genes (1705)
Margaret P Holmes, Diana Bell, Rajesh Singh, Raja
Luthra, Russell Broaddus, Michael T Tetzlaff, Bita
Esmaeli
Houston, TX
259
260
261
Succinate Dehydrogenase B (SDHB)

Immunohistochemistry Is an Effective Alternative
to SDH Histochemistry in the Evaluation of Muscle
Biopsies (1729)
Michael Punsoni, Kara A Lombardo, Shamlal Mangray,
Edward G Stopa, Evgeny Yakirevich
Brown University and Rhode Island Hospital,
Providence, RI
Low Percentage of Subsarcolemmal Mitochondrial
Aggregates Is Associated with Cytochrome c Oxidase
Deficiency in Muscle of Children with Suspected
Mitochondrial Disorder (1719)
LiLi Miles, Paul Horn, Michael Miles
Nemours Childrens Hospital, Orlando, FL; Cincinnati
Childrens Hospital, Cincinnati, OH
Histopathologic Features of Peripheral Nerve Sheath
Tumors Involving the Eye and Ocular Adnexa (1734)
Mingjuan L Zhang, Maria J Suarez, Fausto Rodriguez
Baltimore, MD
262
Histopathological Study of 167 Cases of Blind Painful

Eyes: A Topographic Analysis (1736)
Pablo Zoroquiain, Mohammed Qutub, Natalia Vila,
Patrick Logan, Will Binotti, Miguel N Burnier
McGill University, Montreal, QC, Canada
263
Malignant Apocrine Tumors of the Eyelid in a Review

of 5,453 Specimens (1737)
Pablo Zoroquiain, Sultan Aldrees, Mohammed Qutub,
Patrick Logan, Leonardo Dias, Miguel N Burnier
Mcgill University, Montreal, QC, Canada
264
Combinatorial Targeted Next-Generation Sequencing

and Cytogenetic Microarray Profiling Identify Novel
Molecular Mutations in Uveal Melanoma (1731)
James Solomon, David Brown, Frances Wu, Marie
dellAquila, John A Thorson, Jonathan H Lin
University of California, San Diego, San Diego, CA
268
Salivary Gland-Type Primary Tumors of the Lung: A

Systematic Review (1905)
Emilian Racila, Erin Maxfield
269
Are There Biologic Relationships between Pulmonary

Adenofibromas and Breast Fibroadenomas? (1865)
Nicola Fusco, Elena Guerini-Rocco, Davide Tosi, Marco
Maggioni, Letterio Runza, Claudia Augello, Caterina
Fumagalli, Davide Vacirca, Giulia Ercoli, Silvano Bosari,
Massimo Barberis, Stefano Ferrero
Fondazione IRCSS Ca Granda - Ospedale Maggiore
Policlinico, Milan, Italy; European Institute of Oncology,
Milan, Italy; University of Milan, Milan, Italy
270
Aggressive B-cell Lymphomas of the Respiratory

System: Histologic, Immunohistochemical and Genetic
Evaluation of a Large Series (1896)
Yalda B Naeini, Annie Wu, Dennis OMalley
UCLA, Los Angeles, CA; Clarient Pathology Services,
Aliso Viejo, CA
271
Non-neoplastic Pulmonary Parenchymal Findings in

Patients Undergoing Lung Resection for Mass Lesions
(1870)
Yin Hung, Gary M Hunninghake, Rachel K Putman,
Lynette M Sholl, Marina Vivero
272
Histologic Patterns of Resected Lung Adenocarcinoma

Brain Metastases and Correlation with Molecular
Analysis (1929)
Laura N Toth, Laura J Tafe
187
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
273
Caveolin-1 Enhances Brain Metastasis in Lung Cancer,

Associated with SNAIL[/underline] (1882)
Jae-Hyuk Lee, Kyung-Hwa Lee, Kyung-Sub Moon, Ji
Shin Lee, Chan Choi
Chonnam National University Hwasun Hospital,
Jellanam-do, Republic of Korea
281
274
Mcl-1 Protein Expression and MCL1 Gene Amplification

in Non Small Cell Lung Cancer (NSCLC) (1860)
Siddhartha Dalvi, Sungeun Kim, Christine E Sheehan,
Jeffrey S Ross
The High Delta Ct Value of EGFR Exon 19 Deletion

by PNA-Mediated PCR Clamping Can Predict Longer
Progression-Free Survival in Non-Small Cell Lung
Cancer (1859)
Yu-Deok Choi
Chonnam National University Medical School,
Gwangju, Republic of Korea
282
275
KRAS Mutations Are Predictive of Outcome in Patients

with Pulmonary Sarcomatoid Carcinoma (1891)
Mitra Mehrad, Pimpin Incharoen, Marina Nikiforova,
Humberto Trejo Bittar, Sanja Dacic
Mahidol University, Bangkok, Thailand
Clinical Detection of Resistance to EGFR Inhibitors in

Lung Cancers by Next Generation Sequncing (1854)
Deborah Belchis, Li-Hui Tseng, Lisa Haley, Peter B Illei,
Christopher D Gocke, James R Eshleman, Ming-Tseh
Lin
Johns Hopkins School of Medicine, Baltimore, MD;
National Taiwan Univeristy, Taipei, Taiwan
283
Janus Kinase 3 (JAK3) Aberrations in Non-Small Cell

Lung Cancer (1928)
Laura N Toth, Christopher I Amos, Konstantin H
Dragnev, Gregory J Tsongalis, Laura J Tafe
Dartmouth-Hitchcock Medical Center, Lebanon, NH;
Norris Cotton Cancer Center, Lebanon, NH
284
Predictors of High Levels of Mutant cfDNA in Plasma

from Patients with Advanced Lung Adenocarcinoma
(1922)
Lynette M Sholl, Prodipto Pal, Ryan S Alden, Nora
Feeney, Cloud Paweletz, Adrian Sacher, Geoffrey R
Oxnard
Farber Cancer Institute, Boston, MA; Belfer Center for
Applied Cancer Science, Boston, MA
285
Evaluation of Genomic Complexity in Next-Generation

Sequencing of T1 vs Stage IV Non-Small Cell Lung
Cancer (1909)
Amanda J Redig, Christine Lydon, Pasi A Janne,
Lynette M Sholl
Dana-Farber Cancer Institute, Boston, MA; Harvard
Medical School, Boston, MA; Brigham and Womens
286
Next Generation Sequencing Approach to Non-Small

Cell Lung Carcinoma Testing Yields More Actionable
Results (1892)
Mitra Mehrad, Marina Nikiforova, Humberto Trejo
Bittar, Sanja Dacic
287
Inactivation of BRCA1 Associated Protein-1 (BAP1) in

Mesothelioma. Immunohistochemical and Molecular
Genetic Study of 94 Cases (1862)
Anna Felisiak-Golabek, Bartosz Wasag, Zengfeng
Wang, Piotr Czapiewski, Wojciech Biernat, Jerzy
Lasota, Markku Miettinen
National Cancer Institute, Bethesda, MD; Medical
University of Gdansk, Gdansk, Poland
288
Absence of Nuclear BAP1 Protein Expression Is

Highly Sensitive for Loss-of-Function BAP1 Genomic
Alterations in Malignant Mesothelioma (1898)
Prodipto Pal, Fei Dong, Marina Vivero
276
Diagnostic Utility of Orthopedia Homeobox (OTP) in

Pulmonary Carcinoid Tumor (1897)
Daisuke Nonaka, George Papaxoinis, Was Mansoor
The Christie Hospital, Manchester, United Kingdom;
The University of Manchester, Manchester, United
Kingdom
277
Neuroendocrine Markers Possible Predictive Factors

for Survival in Small Cell Lung Carcinoma (1883)
James Lee, Zahra Maleki
278
Expression of Programmed Death-Ligand 1 in Small

Cell Lung Cancer May Correlate with Better Patient
Outcome: Analysis of 29 Cases (1931)
Pamela Villalobos, Kathryn A Gold, Edwin Parra,
Barbara Mino, Jaime Rodriguez-Canales, Reza J
Mehran, Cesar A Moran, Ignacio I Wistuba, Bonnie
Glisson, Neda Kalhor
279
280
188

Squamous Cell Carcinoma from Different Anatomic
Sites (1852)
Sabina Babayeva, Hongfeng Zhang, Michael Fanucchi,
Rocco Lafaro, Yasmin Yusuf, John T Fallon, Minghao
Zhong
New York Medical College, Valhalla, NY; Central
Hospital of Wuhan, Wuhan, China
Comprehensive Analysis of EGFR Mutation
Status in Lung Adenocarcinoma Combined with
Nonadenocarcinoma Component (1912)
Mee Sook Roh, Hyoun Wook Lee
Dong-A University College of Medicine, Busan,
Korea; Samsung Changwon Hospital, Sungkyunkwan
University School of Medicine, Changwon, Korea
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
289
296
Direct IHC by Using PolyHRP Labeled Trastuzumab

(Herceptin) - A Potential New Companion Diagnostic
Test for Herceptin Treatment (2084)
Li Juan Wang, Yihong Wang, Song Q Zhao, Yonghua
Zhang, Zhiqing Zhang
Brown University Alpert School of Medicine,
Providence, RI; St Mary Hospital, Madison, WI;
Novodiax, Hayward, CA
297
Whole Slide Digital Imaging and Analysis of a PDL1 Immunohistochemical Assay Is Quantifiably
Reproducible (2033)
Jarish Cohen, Sarah Bowman, Daniel E Roberts,
Vighnesh Walavalkar, Laura Laszik, Zoltan Laszik
CA
298
Immunohistochemical Double and Triple Stain

Strategies with CD8, CD103, PD-1, FOXP3 and CK8/18
in Colon Adenocarcinoma[/underline] (2091)
Wei Yuan, Jillian Tyrrell, David Tacha
Biocare Medical, Concord, CA
299
Optimization of Rapid Immunohistochemical Stains on

Frozen Tissue Sections (2054)
Haiyan Liu, Song Q Zhao, Yonghua Zhang, Zhiqing
Zhang, Fan Lin
Geisinger Medical Center, Danville, PA; St. Marys
Hospital, Madison, WI; NovoDiax, Inc., Hayward, CA
300
Breast Biomarkers Can Be Reliably Tested on Tissue

Fixed and Processed by Same Day Automated
Microwave-Assisted Method (2071)
Elzbieta Slodkowska, Fang-I Lu, Wedad Hanna,
Houman Nafisi, Guangming Han, Patrice Boulianne,
Sharon Nofech-Mozes
301
Digital Image Analysis Requires the Supervision by the

Pathologist: A Study on Immunohistochemical Scoring
(2080)
Pamela Villalobos, Edwin Parra, Barbara Mino, Kathryn
ODonnell, Jaime Rodriguez-Canales
MD Anderson Cancer Center, Houston, TX; UT
Southwestern Medical Center, Dallas, TX
302
Successful IHC Staining of Pancreatic Tissue after

Optical Clearing for Advanced Imaging (2070)
Paul D Simonson, Ronnie Das, Eric J Seibel, Melissa P
Upton
303
Multiplex and Multispectral Analysis of Immune Cells

in Tumor Draining Lymph Nodes of the Axilla in Breast
Cancer (2039)
Syed Gilani, Chichung Wang, Clifford C Hoyt, Alejandro
Contreras
Houston, TX; PerkinElmer, Inc., Hopkinton, MA
Loss of p16INK4A Expression Predicts Worse Outcome in

Thymic Carcinoma (1849)
Scott W Aesif, Marie-Christine Aubry, Eunhee S Yi,
Sarah M Jenkins, Grant Spears, Anja C Roden
290
291
Clear Cell Renal Cell Carcinomas with Clear Cell

Tubulopapillary Renal Cell Carcinoma-Like Features: A
Comparative Ultrastructural Study (2045)
Nuria Juanpere, Mercedes Simon, Ivonne Vazquez,
Raquel Albero, Marta Salido, Anna Puiggros, Albert
Frances, Laia Serrano, Sergio Serrano, Josep Lloreta
Hospital del Mar-PSMar, Barcelona, Spain; Pompeu
Fabra University, Barcelona, Spain; Autonomous
Neuroendocrine and Non-Neuroendocrine
Synaptophysin Expression in Prostatic
Adenocarcinoma: An Immunohistochemical, qRT-PCR,
and Ultrastructural Study (2055)
Josep Lloreta, Nuria Juanpere, Silvia Hernandez, Alba
Font, Marta Lorenzo, Lluis Fumado, Jose A Lorente,
Ivonne Vazquez, Raquel Albero, Laia Serrano, Sergio
Serrano
University of Barcelona, Barcelona, Spain; Hospital
Quirn, Barcelona, Spain
292
Drug Induced Phospholipidosis in Kidney:

Ultrastructural Features (2088)
Guanjun Xia, Sirma Koutzaki, Shahad Abdulameer,
Shraddha Patel, Suganthi Soundararajan
Drexel University College of Medicine, Philadelphia, PA
293
Agonal-Stress Vesicles Detected on Ultrastructural

Examination in Pediatrics: Potential Mimicker of
Metabolic Disease (2043)
John Hicks, Eric P Wartchow, Debra Keaney, Gary
Mierau
Texas Childrens Hospital and Baylor College of
Medicine, Houston, TX; Childrens Hospital Colorado,
Aurora, CO
294
Comparison of Three TTF-1 Antibody Clones on NonSmall Cell Lung Carcinomas with Correlation of IHC
Expression, mRNA Levels and Patient Outcome (2081)
Pamela Villalobos, Carmen Behrens, Edwin Parra,
Barbara Mino, Jaime Rodriguez-Canales
295
TFE3 Immunohistochemistry: A Comparison of Two

Methods, with Discussion of the Implications for the
Diagnosis of TFE3-Rearranged Neoplasms (2069)
Rosalind Sandell, Allen M Gown, Andrew L Folpe
Mayo Clinic, Rochester, MN; PhenoPath Laboratories,
Seattle, WA
189
POSTER
POSTERSESSION
SESSIONIII
Monday,
Tuesday, March
March 23,
15, 2015
2016
9:30 AM
AM -- 12:00
12:00 PM
PM
|| 9:30
CC
CC Exhibit
Exhibit Hall
Hall C/D
4ABC
Board
Number
Board
Number
304
Validation of Multiplex Immunofluorescence Assays

for Use in Analysis of Tumour Infiltrating Lymphocytes
(2056)
James Mansfield, Henry Galletta, Richard Byers,
Kenneth Oguejiofor
University of Manchester, Manchester, United
Kingdom; PerkinElmer, Inc., Hopkinton, MA
306
305
Development of Multiplex Immunofluorescence Assays

to Characterize the Tumor Microenvironment (2067)
Sandra Rost, Chenery Lowe, Cecile M Chalouni,
Hartmut Koeppen
Genentech, South San Francisco, CA
Immunoprofiling in Solid Tumors: Development of

a 6-plex Imaging Assay To Characterize Infiltrating
Immune Status in Solid Tumor Sections (2057)
James Mansfield, Kristin Roman, Chichung Wang,
Junya Fujimoto, Ignacio I Wistuba, Jing Wang, Steven
Lin, Clifford C Hoyt
PerkinElmer, Hopkinton, MA; MD Anderson, Houston,
TX
307
Correlation of Flow Cytometry Analysis of Minimal

Residual Disease (MRD) in Myeloma to Serum Free
Light Chain (FLC) Nephelometry, Serum Protein
Electrophoresis (SPEP) and Bone Marrow Chromogenic
In Situ Hybridization (CISH) (2061)
Drew Nedved, Wei Cui, Mark T Cunningham, Da
Zhang, Janet Woodroof
PROFFERED
PROFFERED PAPERS
PAPERS
Monday,
Tuesday,March
March23,
15,2015
2016
CC BR 6A
SECTION A - INFORMATICS
CHAIRED BY: ULYSSES BALIS AND GAURAV SHARMA
1:00
Development of a Cloud-Based Histology Database for

Collaborative Cancer Research (1552)
Ke Cheng
HistoWiz Inc, Brooklyn, NY; SUNY Downstate Medical
Center, Brooklyn, NY
1:15
HCV Genie V 2.0: A Web 2.0 Interpretation and

Analytics Platform for the Versant Hepatitis C Virus
(HCV) Genotype Line Probe Assay (1554)
Alex Dussaq, Abha Soni, Christopher D Willey, Seung L
Park, Shuko Harada
UAB, Birmingham, AL; Community Health Systems,
Franklin, TN
1:30
Assessment of Workload Measures in Anatomic

Pathology (1548)
Gareth W Bryson
Queen Elizabeth University Hospital, Glasgow, United
Kingdom
1:45
Exploring Oculus Rift for Viewing Whole Slide Images

in a Virtual Reality Environment (1575)
Liron Pantanowitz, Navid Farahani, Brian J Kolowitz,
Robert Post, Teppituk Krinchai, Isthiaque Ahmed,
Sara E Monaco, Jeffrey L Fine, Jon Duboy, Douglas J
Hartman
2:00
190
Evaluating Reproducibility of Computer Extracted

Histologic Image Features for Predicting Biochemical
Recurrence in Prostate Cancer: A Multi-Site, MultiScanner Study (1566)
Patrick Leo, George Lee, Anant Madabhushi
Case Western Reserve University, Cleveland, OH
1:00AM
PM- -12:00
2:45 PM
PM
| | 8:30
2:15
Machine-Readable, Structured Pathology Report Data:

A Requirement for Pathologists Computer Assisted
Diagnosis (pCAD) in Breast Cancer Signout (1555)
Jeffrey L Fine, Michelle Heayn, Navid Farahani
Pittsburgh, PA
2:30
Robotic Telecytology for Successful Remote Cytologic

Evaluation without On-Site Cytopathology Staffing
(1580)
S Joseph Sirintrapun, Dorota Rudomina, Rusmir
Feratovic, William Alago, Robert Siegelbaum, Oscar Lin
City, NY
CC BR 6C
SECTION B - AUTOPSY
CHAIRED BY: CHRISTINE VANBEEK AND PAISIT
PAUEKSAKON
1:00
The Role of Communication between Physician,

Pathologist and Family in Autopsy Rate (15)
Justin Juskewitch, Michael Paolini, Joseph J
Maleszewski, R Ross Reichard, Marie-Christine Aubry
1:15
Coroner Autopsy Findings in Medical Center Quality

Assurance (6)
John B Carter, M John Spalding
Lexington Medical Center, West Columbia, SC
1:30
Our Rapid Research Autopsy Program: A Solid

Platform for Next Generation Clinical Trials (2)
Prashant Bavi, Hamidreza Sharifzad, Jagdish Butany,
Anthony Joshua, Michael H Roehrl
PROFFERED
PROFFERED PAPERS
PAPERS
1:45
Monday,
Tuesday,March
March23,
15,2015
2016
Immune-Related Adverse Events (irAEs) Following

CTLA-4 and PD-1/PD-L1 Blockade in Advanced
Melanoma: A Comprehensive Rapid Autopsy Study (3)
Prashant Bavi, Rasmus Kiehl, Oyedele Adeyi, Ozgur
Mete, Carmen Avila-Casado, Hamidreza Sharifzad,
Anthony Joshua, Jagdish Butany, Michael H Roehrl
2:00
Medical Renal Diseases Are Frequent but Often

Unrecognized in Adult Autopsies (22)
Marie Perrone, Anthony Chang, Kammi J Henriksen
2:15
Hematopoietic Cell Transplant: Kidney Findings at

Autopsy (5)
Brian T Brinkerhoff, Donald C Houghton, Megan Troxell
OHSU, Portland, OR
2:30
Quantitation of Oil Red O Staining Via Digital

Imaging Analysis in the Evaluation for Pulmonary Fat
Embolization at Autopsy (4)
Melissa M Blessing, Toby C Cornish, John R Lehman,
Sarah M Jenkins, Joseph J Maleszewski, Marie
Christine Aubry, Peter T Lin
Mayo Clinic, Rochester, MN; Johns Hopkins University,
Baltimore, MD
1:45
Molecular Characterization of 52 Glioblastomas in

Young Adult Patients (1727)
Helene Plouhinec, Blandine Boisselier, Quentin Breton,
Sophie Michalak, Philippe Menei, Philippe Guardiola,
Audrey Rousseau
Angers University Hospital, Angers, France
2:00
Pten Deletion Synergizes with Tp53 Mutation to Drive

Medulloblastoma and Highly Infiltrative Gliomas in
Mouse Brain (1735)
Guo Zhu, Suzanne J Baker
St. Jude Childrens Research Hospital, Memphis, TN;
The University of Tennessee Health Science Center,
Memphis, TN
2:15
Oncogenic Mutations in PI3Kinase in Skull-Based

Meningioma (1696)
Malak Abedalthagafi, Wenya L Bi, Ayal A Aizer, Parker
Merrill, Ryan Brewster, Marc Listewnik, Paul Van
Hummelen, Shakti H Ramkissoon, Rebecca D Folkerth,
Keith L Ligon, Azra H Ligon, Brian M Alexander, Ian F
Dunn, Rameen Beroukhim, Sandro Santagata
School, Boston, MA; King Fahad Medical City, Riyadh,
Saudi Arabia; King Abdulaziz City for Science and
Technology, Riyadh, Saudi Arabia
2:30
Chronic Traumatic Encephalopathy-Like Abnormalities

in a Routine Neuropathology Service (1723)
Shawna Noy, Sherry Krawitz, Marc Del Bigio
University of Manitoba, Winnipeg, MB, Canada
CC 602-604
SECTION C - NEUROPATHOLOGY
CHAIRED BY: ANAT STEMMER-RACHAMIMOV AND MARIA
MARTINEZ-LAGE ALVAREZ
1:00
Molecularly Defined Adult Gliomas with Known ATRX

Status: Does TERT Have an Additional Prognostic Role
(1725)
Melike Pekmezci, Kyle M Walsh, Annette Molinaro,
Paul A Decker, Helen M Hansen, Hugues Sicotto, Terri
Rice, Tom Kollmeyer, Lucie McCoy, Gobinda Sarkar,
Alissa A Caron, Arie Perry, Caterina Giannini, Tarik
Tihan, Mitchel S Berger, Joseph Wiemels, Jeanette
Eckel-Passow, Dan Lachance, John Wiencke, Robert B
Jenkins, Margaret Wrensch
CA
1:15
The High Expression of Programmed Death-1 Ligand-1

(PD-L1) and Its Receptor PD1 Correlates with a Poorer
Prognosis In Glioblastomas (1706)
Miguel A Idoate, Inigo Arana, Adriana Hogeboom, Jose
I Echeveste, Alvaro Lopez-Janeiro, Ricardo Diez-Valle,
Luis D Mejias Sosa, Francisco Guillen
University of Navarra, Pamplona, Navarra, Spain
1:30
Targeted Next Generation Sequencing Panel (GlioSeq)

Provides Comprehensive Genetic Profiling of CNS
Tumors (1722)
Marina Nikiforova, Abigail I Wald, Somak Roy, Ronald
Hamilton, Yuri E Nikiforov, Craig Horbinski
1:00AM
PM- -12:00
2:45 PM
PM
| | 8:30
CC 606-607
CHAIRED BY: HENRY D APPELMAN AND AUDREY J LAZENBY
1:00
Esophageal Squamous Papillomas: Incidentaloma or

Harbinger of Human Papilloma Virus Infection? (748)
Robert Najarian, Gyanprakash Ketwaroo, Deepa Patil,
Anthony Lembo
1:15
Substantial Interobserver Agreement in the

Assessment of Barretts Esophagus within an Expert
Panel of Gastrointestinal Pathologists (811)
Myrtle J van der Wel, Cornelis A Seldenrijk, G Johan A
Offerhaus, Mike Visser, Fiebo J ten Kate, Jan G Tijssen,
Roos E Pouw, Jacques JGHM Bergman, Sybren L
Meijer
Academic Medical Center, Amsterdam, Netherlands;
University Medical Center, Utrecht, Netherlands; St.
Antonius Ziekenhuis, Nieuwegein, Netherlands; Zaans
Medisch Centrum, Zaandam, Netherlands
1:30
Clinicopathologic Features and IgG4 Reactivity of

Eosinophilic and Collagenous Gastritis in Adult and
Pediatric Populations (837)
Xiaofei Zhang, Huaibin Mabel Ko, Margret S Magid,
Alexandros Polydorides, Stephen C Ward, Noam
Harpaz, Hongfa Zhu
191
PROFFERED
PROFFERED PAPERS
PAPERS
1:45
Monday,
Tuesday,March
March23,
15,2015
2016
Myointimal Hyperplasia of the Mesenteric Veins: A

Rare Disease with Distinct Histopathologic Features in
Colonic Biopsy Specimens (659)
Isabelle Cui, Rhonda K Yantiss, Anna-Sophie Weidner,
Otto Walter, Zhengming Chen, Nicole Panarelli, Jose
Jessurun
New York Presbyterian-Weill Cornell Medical College,
New York, NY; Montefiore Medical Center, New York,
NY; UMass Memorial Medical Center, Worcester, MA
2:00
Immune Complexes and Eosinophil Activation in

Eosinophilic Esophagitis[/underline] (655)
Frederic Clayton, Kathryn Peterson, Gerald Gleich,
Kristin Leiferman
2:15
The Duodenal Microbiome in Refractory Celiac Disease

(712)
Stephen M Lagana, Ian S Cohn, Mara R Rubinstein,
Benjamin Lebwohl, Peter HR Green, Yiping W Han,
Govind Bhagat
Columbia University/NY Presbyterian Hospital, New
York, NY; Columbia University, College of Physicians
and Surgeons, New York, NY; Columbia University/NY
Presbyterian Hospital, NY, NY
2:30
Histologpic Spectrum of Ipilimumab Associated Colitis

Is Narrow and Resembles Inflammatory Bowel Disease
(622)
Atin Agarwal, Dipen Maru
University of Texas, MD Anderson Cancer Center,
Houston, TX
CC 608-609
SECTION E - DERMATOPATHOLOGY
CHAIRED BY: MAY CHAN AND JENNIFER KO
1:00
1:15
192
Differential Neurofibromin Protein Expression in

Desmoplastic Melanoma Subtypes - Implicating NF1
Allelic Loss as a Distinct Genetic Driver? (502)
Alexander Kadokura, Noah Frydenlund, Dominick
Leone, Shi Yang, Mai P Hoang, April Deng, Marier
Hernandez, Asok Biswas, Rajendra Singh, Meera
Mahalingam
BUSM, Boston, MA; MGH, Boston, MA; UMASS
Medical School, Worcester, MA; Mt Sinai Hospital, New
York, NY; Miraca LS, Newton, MA; Western General
Hospital, Edinburgh, Scotland, United Kingdom; VA
Consolidated Laboratories, Boston, MA; Carver Coll of
Medicine, Iowa City, IA
The Expanded Eight-Probe Melanoma Fluorescence
In Situ Hybridization (FISH) Assay as an Ancillary Tool
in Diagnosing Ambiguous Melanocytic Lesions: An
Updated Clinical, Pathological and Cytogenetic Review
of 416 Cases (500)
Ruifeng Guo, Kabeer Shah, Lori A Erickson, Thomas
Flotte, William R Sukov
1:00AM
PM- -12:00
2:45 PM
PM
| | 8:30
1:30
Validation of a New SNP-Array Platform as an Ancillary

Tool for the Diagnosis of Difficult Melanocytic Lesions
(487)
Ahmed Alomari, Paul W Harms, Lori Lowe, Douglas R
Fullen, Rajiv Patel, Alexandra Hristov, May P Chan, Min
Wang, Aleodor A Andea
1:45
Melanomas of the Vulva: A Retrospective Analysis of

Clinical and Histopathologic Parameters in 40 Patients
(523)
Priyadharsini Nagarajan, Jonathan L Curry, Jing Ning,
Jin Piao, Phyu P Aung, Doina Ivan, Carlos A TorresCabala, Victor G Prieto, Anais Malpica, Michael T
Tetzlaff
Houston, TX
2:00
Whole Exome Sequencing of 409 Cancer Associated

Genes Demonstrates Frequent Clinically Actionable
Mutations in Sebaceous Carcinoma (534)
Michael T Tetzlaff, Rajesh Singh, Elena G Seviour,
Jonathan L Curry, Diana Bell, Russell Broaddus,
Prahlad Ram, Victor G Prieto, Rajyalakshmi Luthra, Bita
Esmaeli
Houston, TX
2:15
Nuclear TFE3 Immunoreactivity Is Present in

Angiomatoid Fibrous Histiocytomas but Not in Other
Cutaneous Histiocytomas (536)
Dianne Torrence, Karen Fritchie, John D Reith, William
R Sukov, Wonwoo Shon
University of Florida College of Medicine, Gainesville,
FL; Mayo Clinic, Rochester, MN
2:30
Efficiency of Direct Immunofluorescence Testing:

Examination of a Single Institution Experience with
Bullous Pemphigoid[/underline] (507)
Jennifer S Ko, Patrick C Feasel, Steven D Billings
CC 611-612
SECTION F - PANCREAS
CHAIRED BY: LAURA WOOD AND DAVID F SCHAEFFER
1:00
Clinicopathologic and Molecular Analysis of Pancreatic

Ductal Adenocarcinoma in Patients with Lynch
Syndrome (1775)
Aatur Singhi, Jinru Shia, Marina Nikiforova, Jason L
Hornick, David Klimstra, Sapna Syngal, Beth Dudley,
Randall E Brand, Herbert J Zeh, Ralph H Hruban
PA; Memorial Sloan Kettering Cancer Center, New
York, NY; Brigham and Womens Hospital, Boston, MA;
PROFFERED
PROFFERED PAPERS
PAPERS
Monday,
Tuesday,March
March23,
15,2015
2016
1:15
Undifferentiated Carcinoma with Osteoclast-like Giant

Cells of the Pancreas: Clinico-Pathological Analysis of
20 Cases Highlights a More Protracted Clinical Course
Than Currently Appreciated (1765)
Takashi Muraki, Gabriela Bedolla, Kee-Taek Jang,
Pelin Bagci, Pardeep Mittal, Michelle Reid, Bahar
Memis, Olca Basturk, Sudeshna Bandyopadhyay, Juan
Sarmiento, Alyssa Krasinskas, Volkan Adsay
Emory University, Atlanta, GA; SMC, Seoul, Korea;
MSKCC, NY, NY; DMC, Detroit, MI
1:30
A Clinicopathologic Study of ALK Rearrangements in

Pancreatic Ductal Adenocarcinoma (1776)
Aatur Singhi, Siraj M Ali, Joel Greenbowe, Jeffrey S
Ross, Khanh Nguyen, Marina Nikiforova, Herbert J Zeh,
Inderpal S Sarkaria, Nathan Bahary
Foundation Medicine Inc, Cambridge, MA
1:45
The Predictive Effect of Human Equilibrative

Transporter 1 Stratified by Mismatch Repair Deficiency
in Resected Pancreatic Ductal Adenocarcinoma
Patients Treated With Adjuvant Gemcitabine (1751)
Steve Kalloger, Maziar Riazy, Joanna Karasinska,
Renata Peixoto, Setareh Samimi, Christine Chow,
Brandon S Sheffield, Daniel Renouf, David F Schaeffer
Pancreas Centre British Columbia, Vancouver, BC,
Canada; British Columbia Cancer Agency, Vancouver,
BC, Canada
2:00
2:15
Clinicopathologic Associations of Paraduodenal

(Groove) Pancreatitis, an Under-Recognized Entity: An
Analysis of 47 Resected Examples with Emphasis on
Imaging-Pathology Correlation (1767)
Takashi Muraki, Grace E Kim, Pardeep Mittal, Gabriela
Bedolla, Michelle Reid, Bahar Memis, Alyssa M
Krasinskas, Ipek Erbarut Seven, Hyejeong Choi, David
Kooby, Shishir Maithel, Juan Sarmiento, Volkan Adsay
CA; Ulsan University, Seoul, Korea
Marked Geographic Differences in the Pathologic
Diagnosis of Non-Invasive (Tis) vs Minimally Invasive
(T1) Gallbladder Cancer: Santiago Consensus
Conference Highlights the Need for the Unifying
Category Early Gallbladder Cancer (EGBC) (1772)
Juan Carlos Roa, Olca Basturk, Javiera Torres,
Francisco Mucientes, Maeva Del Pozo, Miguel A
Villaseca, Gloria Aguayo, Enrique R Bellolio, Juan
Carlos Araya, Itaru Endo, Kee-Taek Jang, KyoungBun
Lee, Jin-Young Jang, Nobu Ohike, Michio Shimizu,
Kenichi Hirabayashi, Benoit Terris, Giuseppe Zamboni,
Michelle Reid, Yue Xue, Gabriela Bedolla, Brian
Quigley, Alyssa M Krasinskas, Gizem Akkas, Bahar
Memis, David Klimstra, Ralph H Hruban, Bin Zhu,
Alison L Van Dyke, Jill Koshiol, Volkan Adsay
Pontificia University, Santiago, Chile; MSKCC, NY,
NY; Yokohama City University, Yokohama, Japan;
SMC, Seoul, Korea; SNU, Seoul, Korea; Showa,
Tokyo, Japan; Hakujikai Hospital, Tokyo, Japan; Tokai
University, Tokyo, Japan; H Cochin, Paris, France;
University Verona, Verona, Italy; Emory University,
Atlanta, GA; JHU, Baltimore, MD; NIH, Bethesda, MD
2:30
1:00AM
PM- -12:00
2:45 PM
PM
| | 8:30
Epithelial Atypia in the Gallbladder: Diagnosis and

Classification in an International Consensus Study
(1738)
Volkan Adsay, Juan Carlos Roa, Olca Basturk, Javiera
Torres, Francisco Mucientes, Maeva Del Pozo, Miguel
A Villaseca, Gloria Aguayo, Enrique R Bellolio, Juan
Carlos Araya, Itaru Endo, KyoungBun Lee, Kee-Taek
Jang, Jin-Young Jang, Nobu Ohike, Michio Shimizu,
Kenichi Hirabayashi, Benoit Terris, Giuseppe Zamboni,
Michelle Reid, Yue Xue, Gabriela Bedolla, Brian
Quigley, Alyssa Krasinskas, Gizem Akkas, Bahar
Memis, David Klimstra, Ralph H Hruban, Bin Zhu,
Alison L Van Dyke, Jill Koshiol
Emory, Atlanta, GA; Pontificia University, Santiago,
Chile; MSKCC, NY, NY; Yokohama City University,
Yokohama, Japan; SNU, Seoul, Korea; SMC, Seoul,
Korea; Showa, Tokyo, Japan; Hakujikai H, Tokyo,
Japan; Tokai, Tokyo, Japan; H Cochin, Paris, France;
University Verona, Verona, Italy; JHU, Baltimore, MD;
NIH, Bethesda, MD
CC 615-617
SECTION G - HEMATOPATHOLOGY
CHAIRED BY: NATHANAEL G BAILEY AND ELIZABETH A
MORGAN
1:00
miRNA Expression Profiles of T Lymphoblastic

Leukemia/Lymphoma and Normal Thymocytes Defined
by Next Generation Sequencing (1354)
Magdalena Czader, Andrea Moffitt, Mehdi Nassiri,
Anupama Tewari, Cassandra Love, Sandeep Dave
Indiana University, Indianapolis, IN; Duke University,
Durham, NC
1:15
Leukemic Stem Cell Responses to Induction

Chemotherapy Identify Novel Prognostic Biomarkers in
Patricia Raciti, Wenhuo Hu, Alec Stranahan, Carolien
Woolthuis, Sean Devlin, Christopher Park
1:30
Bone Marrow Failure in Telomere Disease in

Comparison to Aplastic Anemia and GATA2 Deficiency
(1405)
Michael E Kallen, Danielle M Townsley, Bogdan
Dumitriu, Amy P Hsu, Karthik A Ganapathi, Weixin
Wang, Charles Bolan, Steven M Holland, Neal S Young,
Katherine R Calvo
NIH, Bethesda, MD; NCI, Bethesda, MD
1:45
Additional Chromosome Structural Aberrations Are

Associated with Poorer Clinical Outcomes in Multiple
Myeloma Patients with Hyperdiploidy (1341)
Adrian Carballo-Zarate, L Jeffrey Medeiros, Suyang
Hao, Robert Orlowski, Pei Lin, Lu Xinyan
UT MD Anderson Cancer Center, Houston, TX; Houston
Methodist Hospital, Houston, TX
193
PROFFERED
PROFFERED PAPERS
PAPERS
Monday,
Tuesday,March
March23,
15,2015
2016
2:00
Activating Mutations in MAPK Pathway Members in

Langerhans Cell Histiocytosis: A Stanford Experience[/
underline] (1430)
Lisa McGinnis, Grant Nybakken, Lisa Ma, Daniel A
Arber
Stanford University School of Medicine, Stanford, CA
2:15
Histologic, Immunophenotypic and Chromosomal

Evaluation of Reactive Lymph Node Hyperplasia with
Giant Follicles; a Clonal Peri-Parotid Lesion in Boys
with Features Overlapping Follicular Lymphoma (1434)
Kamran Mirza, Gordana Raca, Jennifer K Ramey, Carrie
A Fitzpatrick, Charles Rubin, James W Vardiman, John
Anastasi
Childrens Hospital Los Angeles, Los Angeles, CA;
2:30
Variability and Adequacy of Evaluable Marrow Space

Length (EMSL) in Bone Marrow Biopsies: A MultiInstitutional Study (1443)
Vishala Neppalli
Roswell Park Cancer Institute; On Behalf of Bone
Marrow Study Group, Buffalo, NY
CC 618-620
SECTION H - PATHOBIOLOGY
CHAIRED BY: JUAN MIGUEL MOSQUERA AND ADRIAN
MARINO-ENRIQUEZ
1:00
1:15
194
Interim Analysis of 708 Patients Enrolled in the

MOSCATO 01 (Molecular Screening for Cancer
Treatment Optimization) Trial (1822)
Philippe Vielh, Zsofia Balogh, Adeline Perez, Thierry
De Baere, Antoine Hollebecque, Christophe Massard,
Charles Ferte, Ludovic Lacroix, Nathalie Auger, MarieCecile Le Deley, Eric Angevin, Fabrice Andre, JeanCharles Soria
Gustave Roussy Cancer Center, Villejuif, France
Germline Variants and Secondary Findings in a Cancer
Precision Medicine Cohort (1828)
Tuo Zhang, Alessandro Romanel, Michael J Kluk, Ken
Eng, Ivan Iossifov, Andrea Sboner, Steven Lipkin, Colin
Pritchard, Himisha Beltran, Mark Rubin, Francesca
Demichelis, Olivier Elemento
Weill Cornell Medicine, New York, NY; Cold Spring
Harbor Laboratories, New York, NY; University of
Washington, Seattle, WA; University of Trento, Trento,
Italy
1:00AM
PM- -12:00
2:45 PM
PM
| | 8:30
1:30
Integrative Immuno-Mapping of a Precision Cancer

Medicine Cohort: Towards Establishing Predictive
Molecular, Neoepitopes and TCR Signatures (1786)
Bhavneet Bhinder, David Redmond, Bishoy Faltas, Ken
Eng, Rohan Bareja, Andrea Sboner, Himisha Beltran,
Mark Rubin, Olivier Elemento
Weill Cornell Medicine, New York, NY
1:45
Comprehensive Genomic Profiling of Lung

Adenocarcinoma Identifies Patients with Genomic
Alterations beyond Clinical Testing Guidelines Who
May Benefit from Enrollment in Mechanism Driven
Clinical Trials (1785)
Lee Albacker, Juliann Chmielecki, Julia A Elvin, JoAnne Vergilio, Vincent A Miller, Philip J Stephens,
Jeffrey S Ross, Siraj M Ali, James Suh
2:00
Targeted Sequencing of Somatic Mutations in Plasma

Circulating DNA of Patients with Primary Central
Nervous System Lymphoma (PLCNS) (1809)
Florent Marguet, Maxime Fontanilles, Elodie Bohers,
Jean-Michel Picquenot, Annie Laquerriere, Fabrice
Jardin, Jean-Christophe Sabourin
Rouen University Hospital, Rouen, France; Henri
Becquerel Cancer Research Center, Rouen, France
2:15
Uterine Adenosarcoma and Phyllodes Tumor of the

Breast Have Similar Repertoires of Somatic Genetic
Alterations (1823)
Britta Weigelt, Felipe C Geyer, Kathleen Burke,
Charlotte KY Ng, Melissa Murray, Dara S Ross, Robert
Soslow, Brian P Rubin, Marc Ladanyi, Edi Brogi, Jorge
S Reis-Filho
NY; Cleveland Clinic, Cleveland, OH
2:30
Metaplastic Breast Carcinomas and Gynecologic

Carcinosarcomas: Variations of the Same Theme or
Distinct Entities? (1798)
Felipe C Geyer, Charlotte KY Ng, Salvatore Piscuoglio,
Kathleen Burke, Yong Hannah Wen, Anne VincentSalomon, Jorge S Reis-Filho, Britta Weigelt
NY; Institut Curie, Paris, France
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
Board
Number
Board
Number
AUTOPSY
Retropleural Hypertension: A Probable Cause of

Descending Thoracic Aortic (DTA) Occlusion in a
Traumatic DTA Tear (29)
Melissa Van Dellen, Zulfiqar Cheema, Gregory Wolfe,
Clarke Stout
Involvement of the Liver By Primary and Secondary
Malignant Tumors at Autopsy in a Cohort of Male U.S.
Veterans, with Comparison to the General Population
(20)
Aqsa Nasir, Hira Yousaf, Richard Dykoski, Juan Carlos
Manivel, Hector Mesa
University of Minnesota Medical School, Minneapolis,
MN; Veterans Affairs Health Care System, Minneapolis,
MN
Intravascular Large B Cell Lymphoma as a Mimicker of
Susac Syndrome (7)
Margaret Compton, Hilary Highfield Nickols, Claudio A
Mosse, Stephen J Schultenover
Veterans Affairs Tennessee Valley Healthcare System,
Nashville, TN
CPR-Associated Right Ventricular Rupture in the

Setting of Pulmonary Embolism (12)
Tyler Hickey, Ginjeet GK Gill, Michael A Seidman,
Douglas Webber
St. Pauls Hospital, Vancouver, BC, Canada
Monosomy/Trisomy 21 Mosaicism: Correlations of

Karyotype to Phenotype in Multiple Tissues (9)
Rachel Fielden, Tracy Shipe, Raymond Lewandowski,
Colleen Jackson-Cook
Virginia Commonwealth University, Richmond, VA
Network Analysis of Placental Findings in Fetal

Autopsies (19)
Amir Momeni Boroujeni, Derek Laskar, Elham Yousefi,
Virginia Anderson
SUNY Downstate Medical Center, Brooklyn, NY
The Final Timepoint of Disease Progression: Rapid

Autopsy in the Precision Medicine Era (23)
David Pisapia, Steven Salvatore, Chantal Pauli, Joanna
Cyrta, Robert Kim, Bishoy Faltas, Jeffrey Greenfield,
Brian D Robinson, Andrea Sboner, Olivier Elemento,
Himisha Beltran, Mark Rubin, Juan Miguel Mosquera
Weill Cornell Medical College (WCMC), New York, NY;
WCMC, New York, NY
CC Exhibit Hall C/D

4ABC
Eosinophilic Myocarditis Is a Relatively Common Cause

of Sudden Cardiac Death Due to Myocarditis (31)
Yang Zhang, Allen P Burke
Architecture of Colonic Lamina Propria Stromal Cells Is

Altered in Portal Hypertension (21)
Joie Otto, Judith Aronson
10
Distribution of Lesions in Sudden Unexpected Deaths

by Sarcoidosis (32)
Yang Zhang, Allen P Burke
11
Fatal Arterial Dissections and Tears A Retrospective

Review of 42 Post-Mortem Cases (18)
Peter Molony, Catherine Keohane, Louise Burke,
Margot Bolster
12
Novel SIX3 Mutation Leading to Holoprosencephaly

(14)
Samuel Hwang, Lindsay Taute, Michael Knapp,
Christian Lanciault
Oregon Health Sciences University, Portland, OR
13
The Role of Rapid Autopsy as a Central Resource

Available to All Researchers (13)
Jody E Hooper, Jowaly Camacho
Baltimore, MD
14
Next Generation Sequencing (NGS) Solves Autopsy

Mystery of Metastatic Poorly Differentiated Malignancy
(30)
Laura Warmke, Austin Wiles, Catherine I Dumur,
Melissa J Contos, Steven Smith
Richmond, VA
15
Cardiac Conduction System Pathology in the Hospital

Setting: A Selection of Cases (28)
Michelle Stram, Jeffrey Nine
UPMC Presbyterian, Pittsburgh, PA
16
Digitalis Intoxication and Death from Accidental

Foxglove Ingestion (10)
Margaret Flanagan, Richard C Harruff
University of Washington, Seattle, WA; King County
Medical Esaminer, Seattle, WA
17
Malignant Tumors Associated with Breast Cancer:

Analysis of 164,211 Autopsy Cases in Japan (26)
Yukiko Shibahara, Yumi Sugawara, Yasuhiro Miki,
Yasuhiro Nakamura, Ichiro Tsuji, Hironobu Sasano
Tohoku University Graduate School of Medicine,
Sendai, Miyagi, Japan
18
The Autopsy Findings of 116 Fetuses with Prenatally

Diagnosed Central Nervous System Anomalies (1)
Hulya Akgun, Mustafa Basbug, Figen Ozturk, Turhan
Okten
Erciyes University, Kayseri, Turkey
19
Autopsy Review of Neonatal Deaths by Disseminated

Herpesvirus Infection [/underline] (27)
Emily A Sloan, M Beatriz Lopes, Robin LeGallo
195
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
Board
Number
Board
Number
BONE & SOFT TISSUE PATHOLOGY
20
21
Transcriptomic Reappraisal Identifies Overexpressed

PLCB4 as an Adverse Prognosticator in Primary
Localized Gastrointestinal Stromal Tumors (GISTs) (75)
Chien-Feng Li, I-Chieh Chuang, Hsuan-Ying Huang
Chi Mei Medical Center, Tainan, Taiwan; Kaohsiung
Chang Gung Memorial Hospital and Chang Gung
University College of Medicine, Kaohsiung, Taiwan
RNA-Sequencing Identifies ETV6-NTRAK3 as a Gene
Fusion Involved in Gastrointestinal Stromal Tumors
(84)
Sabrina Rossi, Monica Brenca, Maurizio Polano,
Daniela Gasparotto, Dominga Racanelli, Lucia Zanatta,
Laura Valori, Stefano Lamon, Roberta Maestro, Angelo
P Dei Tos
Treviso General Hospital, Treviso, Italy; CRO National
Cancer Institute, Aviano, Italy
22
ETV6 Gene Rearrangement in Inflammatory

Myofibroblastic Tumor (97)
Hidetaka Yamamoto, Akihiko Yoshida, Kenichi Kohashi,
Yoshinao Oda
Kyushu University, Fukuoka, Japan; National Cancer
Center Hospital, Tokyo, Japan
23
NTRK1 Associated Gene Fusions in Pediatric

Fibroblastic / Myofibroblastic Neoplasms: A Molecular
Narasimhan P Agaram, Lei Zhang, Yun-Shao Sung,
Chun-Liang Chen, Catherine Chung, Christopher
Fletcher, Cristina Antonescu
NY; The Hospital for Sick Children, Toronto, ON,
Canada; Brigham and Womens Hospital, Boston, MA
24
25
26
196
CC Exhibit Hall C/D

4ABC
Correlation of Histological Grade of Dedifferentiation

with Clinical Outcome in 51 Cases of Dedifferentiated
Liposarcomas (52)
Kossivi E Dantey, Oleksandr Yergiyev, Karen Schoedel,
Uma Rao
Man Versus FISH: How Accurately Can Soft Tissue
Experts Predict MDM2 Amplification of Deep Seated
Adipocytic Neoplasms Based on Histology? (68)
Vadim Khachaturov, John R Goldblum, Steven D
Billings, Brian P Rubin
Spindle Cell/Pleomorphic Lipomas of the Distal
Extremities: Not Just a Myth (67)
Vadim Khachaturov, Jennifer S Ko, Jason L Hornick,
John R Goldblum, Brian P Rubin, Steven D Billings
Cleveland Clinic, Cleveland, OH; Brigham and Womens
27
Fibrous Hamartoma of Infancy- A Clinicopathologic

Study of 122 Cases, Including 2 with Malignant
Progression (36)
Alyaa Al-Ibraheemi, Anthony Martinez, Sharon W
Weiss, Harry Kozakewich, Antonio Perez-Atayde, Karen
Fritchie, Andrew L Folpe
Mayo Clinic, Rochester, MN; Emory University, Atlanta,
GA; Boston Childrens Hospital, Boston, MA
28
Malignant Tenosynovial Giant Cell Tumor- A

Clinicopathological and Immunohistochemical Study
of 7 Cases (37)
Alyaa Al-Ibraheemi, Andre Oliveira, Andrew L Folpe
29
A Novel Subgroup of Deep Myxoma with Specific

Genetic and Histologic Findings and No Evidence of
GNAS Mutations: Analysis of Three Cases (41)
Ryan Berry, JIn Wu, Therese Bocklage
30
Analysis of GNAS Mutations in a Series of

Intramuscular Myxomas with Identification of a Novel
R201L Mutation (40)
Ryan Berry, JIn Wu, Therese Bocklage
31
Clinical and Pathological Correlation of ATRX Loss in

Large Series of Leiomyosarcomas (61)
Jolanta Jedrzkiewicz, Parnian Ahmadi, Davis Ingram,
Vinod Ravi, Keila Torres, Andrew Futreal, Elizabeth G
Demicco, Alexander Lazar, Wei-lien Wang
MD Anderson Cancer Center, Houston, TX; Mount Saini
32
Leiomyosarcomas and Rhabdomyosarcomas OverExpress Nicotinamide Phosphoribosyltransferase (92)

Rodney E Shackelford, Rabie Shanti, Junaid Ansari,
Moiz Vora
LSU Health Sciences, Shreveport, LA; Feist Weiller
Cancer Center, Shreveport, LA
33
Histology and Fusion Status in Metastatic

Rhabdomyosarcoma (85)
Erin R Rudzinski, James Anderson, Doug Hawkins
Seattle Childrens Hospital, Seattle, WA; Frontier
Science and Technology Research Foundation,
Madison, WI; University of Washington and Fred
Hutchinson Cancer Research Center, Seattle, WA
34
Follicular Dendritic Cell Sarcomas: Insights into Its

Molecular Landscape (64)
George Jour, Ahmet Zehir, Mrinal M Gounder, Omar
Abdel-Wahab, Jacklyn Casanova, Ahmet Dogan, Marc
Ladanyi, David Klimstra, Maria E Arcila
NY; Memorial Sloan-Kettering Cancer Center, New
York, NY
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
35
42
Primary Adult Skeletal Osteosarcoma: A

Clinicopathological and Molecular Study (34)
Deepu Alex, Lu Wang, George Jour, Sumit Middha,
Raghu Chandramohan, John Healey, Khedoudja Nafa,
Meera Hameed
43
Utility of SATB2 as a Quality Control Indicator in

Osteosarcoma Tissue Microarray (53)
Elizabeth G Demicco, Jen-Wei Tsai, Davis Ingram, Weilien Wang
Mount Sinai Hospital, New York, NY; The University of
Texas M. D. Anderson Cancer Center, Houston, TX
44
The Wnt Signaling Antagonist Sclerostin in

Osteosarcoma (79)
Carolyn A Meyers, Jia Shen, Swati Shrestha, Greg
Asatrian, Gregory LaChaud, Vi Nguyen, Arun Singh,
Noah Federman, Sarah M Dry, Kang Ting, Chia Soo,
Aaron James
University of California, Los Angeles, Los Angeles, CA
45
Identifying Unique Genome Abnormalities That

Distinguish Enchondroma from Chondrosarcoma (88)
John Scarborough, Robert Ricciotti, Yu Wu, Yuhua Liu,
Benjamin Hoch, Yajuan Liu, Eleanor Chen
46
Diagnostic Utility of IDH1/2 Mutation To

Distinguish Dedifferentiated Chondrosarcoma from
Undifferentiated Pleomorphic Sarcoma (46)
Shaoxiong Chen, Karen Fritchie, Shi Wei, Kendra
Curless, Kristin Post, Liang Cheng
Indiana University, Indianapolis, IN; Mayo Clinic,
Rochester, MN; The University of Alabama at
Birmingham, Birmingham, AL
36
37
38
39
Expression of Enhancer of Zeste Homolog 2 (EZH2)

Protein and Intracellular Signaling Molecules p-ERK,
MYC, and p-STAT3 in Histiocytic and Dendritic Cell
Neoplasms (94)
Xuejun Tian, Jason L Hornick, Christopher Fletcher, Jie
Xu, Ali Shahsafaei, David M Dorfman
School, Boston, MA; MD Anderson Cancer Center,
Houston, TX
A Subset of Epithelioid Sarcomas with Intact INI1
(SMARCB1) Is Deficient for SMARCA4 and SMARCA2
(55)
Leona A Doyle, Christopher Fletcher, Jason L Hornick
Department of Pathology, Brigham and Womens
Hospital, Harvard Medical School, Boston, MA
SWI/SNF Chromatin Remodeling Complex Status in
SMARCB1/INI1-Preserved Epithelioid Sarcoma Cases
(70)
Kenichi Kohashi, Hidetaka Yamamoto, Yuichi Yamada,
Yoshinao Oda
Department of Anatomic Pathology, Graduate School
of Medical Sciences, Kyushu University, Fukuoka,
Japan
Superficial Angiomyxoma Is Characterized by Loss of
PRKAR1A Expression (77)
Adrian Marino-Enriquez, Christopher Fletcher, Leona A
Doyle
Department of Pathology, Brigham and Womens
Hospital and Harvard Medical School, Boston, MA
Identification of Novel Gene Fusion FUS-CREM in Clear
Cell Sarcoma of Soft Tissue by Anchored Multiplex
Polymerase Chain Reaction (44)
Kenneth Chang, Angela Goytain, Xiu Qing Wang, Tracy
Tucker, Amy Lum, Stephen Yip, Torsten O Nielsen,
Tony Ng
KK Womens and Childrens Hospital, Singapore,
Singapore; Duke-NUS Graduate Medical School,
Singapore, Singapore; University of British Columbia,
Vancouver, BC, Canada; BC Cancer Agency, Vancouver,
BC, Canada; Vancouver General Hospital, Vancouver,
BC, Canada
40
RNA-seq Study of TFE3 Translocation-Associated

Perivascular Epithelioid Cell Neoplasm (PEComa) (69)
Pallavi Khattar, Weihua Huang, Ximing Yang, Patricia V
Adem, John T Fallon, Minghao Zhong
College, Valhalla, NY; NorthWestern University
Feinberg School of Medicine, Chicago, IL
41
SIRT5 Is Required for Viability of the Ewing Sarcoma

Cell Line A673 and the Osteosarcoma Cell Line U2OS
(91)
David Seward, Sarah Bergholtz, Elizabeth Pederson,
Mary Skinner, Jeongsoon Park, Elizabeth R Lawlor,
David Lombard
BREAST PATHOLOGY
47
HER2 FISH Testing with RAI1 Alternate Probe Will

Resolve HER2 Status in Majority of Equivocal Cases
(175)
Ling Hui, Katherine Geiersbach, Erinn Downs-Kelly,
Rachel E Factor, H Evin Gulbahce
University of Utah, SLC, UT; ARUP, SLC, UT
48
Droplet Digital Polymerase Chain Reaction Detection

of HER2 Amplification in Formalin Fixed Paraffin
Embedded Breast and Gastric Carcinoma Samples
(312)
Ya-Zhen Zhu, Dan Lu, Maruja E Lira, Qing Xu, Yunzhi
Du, Jianghong Xiong, Mao Mao, Hyun Cheol Chung,
Guangjuan Zheng
Guangdong Provincial Hospital of Traditional Chinese
Medicine (GPHTCM), Guangzhou, China; WuXi AppTec,
Shanghai, China; Pfizer Oncology, San Diego, CA;
Yonsei University College of Medicine, Seoul, Korea
197
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
49
HER2 Immunohistochemical and Fluorescence In Situ

Hybridization Discordances in Invasive Carcinoma with
Micropapillary Features (130)
Justin Caron, Erinn Downs-Kelly, H Evin Gulbahce,
Rachel E Factor
University of Utah/ARUP, Salt Lake City, UT
58
CA20 Is a Better Predictor of Breast Cancer-Specific

Survival Than CIN25 (244)
Angela Ogden, Padmashree CG Rida, Michelle D Reid,
Ritu Aneja
Georgia State University, Atlanta, GA; Emory
University Hospital, Atlanta, GA
50
Co-Amplification of Chromosome 17 Genes Impacts

HER2 Scoring (112)
Sunil Badve, Yesim Gokmen-Polar
59
51
Impact of Genetic Heterogeneity on HER2 Status with

Implementation of the 2013 ASCO/CAP HER2 Reporting
Guidelines (155)
Monica V Estrada, Maria G Kuba, Brent Rexer, Suzanne
Manning, Ferrin Wheeler, Ashwini Yenamandra,
Melinda E Sanders
Molecular Alterations and Clinical Test Utilization in

Advanced Breast Cancer - Parallel Characterization of
Two Next-Generation Sequencing Panels (166)
Grzegorz T Gurda, Kate M Serdy, David Dabbs, Rachel
Jankowitz, Shannon L Puhalla, Adam Brufsky, Rohit
Bhargava
60
Detection of Gene Amplifications in Invasive Breast

Cancers by SNP-based Chromosomal Microarray (148)
Jessica L Dillon, Jonathan Marotti, Joel Lefferts, Laura
J Tafe
61
Negative Association between GATA3 and Fascin

Could Predict Relapse-Free and Overall Survival in
Patients with Breast Cancer (194)
Dong-Hoon Kim, Kyueng-Whan Min, Sung-Im Do,
Seoung Wan Chae, Jin Hee Sohn
Kangbuk Samsung Hospital, Sungkyunkwan University
School of Medicine, Seoul, Republic of Korea; Hallym
University Sacred Heart Hospital, Hallym University
College of Medicine, Anyang, Gyeonggi-do, Republic
of Korea
62
The Expression of Metallopanstimulin-1 in Low

and High-Grade In Situ and Invasive Breast Ductal
Carcinoma[/underline] (272)
Daryoush Saeed-Vafa, Marilin Rosa
Moffitt Cancer Center and Research Institute, Tampa,
FL
52
Impact of the Change of the Criteria for HER2

Immunohistochemistry Interpretation on HER2 Status
in Breast Cancer (168)
Shuko Harada, Dejun Shen, Shi Wei
53
The Impact of 2013 ASCO/CAP Guidelines on the

Practice of HER2 Testing in a Reference Laboratory
(167)
Wedad Hanna, Elzbieta Slodkowska, Fang-I Lu,
Guangming Han, Houman Nafisi, Sharon NofechMozes
SHSC, U Toronto, Toronto, ON, Canada
54
Increased HER2 FISH-IHC Discordance and Decreased

FISH Equivocals Result from 2013 ASCO-CAP HER2
Scoring Guidelines: A Study of 11,813 Cases (157)
Regan Fulton, Allen M Gown
PhenoPath, Seattle, WA
55
HER-France A National Database Containing 105 000

Result Records of Predictive Breast Cancer Markers.
Focus on HER2 Positivity (135)
Marie-Pierre Chenard, Caroline Egele, Dominique
Fetique, Jean-Pierre Bellocq
Hpitaux Universitaires de Strasbourg, Strasbourg,
France; AFAQAP (Association Franaise dAssurance
Qualit en Anatomie et Cytologie Pathologiques),
Strasbourg, France
63
MCL1 Is a Predictive Biomarker of Triple Negative

Status and Therapy Response in Relapsed and
Metastatic Breast Cancer (271)
Jeffrey S Ross, Sungeun Kim, Aseeb Rehman, Ann B
Boguniewicz, Christine E Sheehan, Kai Wang, Adrienne
Johnson, Julia A Elvin, Jo-Anne Vergilio, James Suh,
Vincent A Miller, Philip J Stephens, Siraj M Ali
56
Improving the Accuracy of ERBB2 (HER2) FISH Testing

in Breast Cancer by Implementing a Robust Approach
Encompassing Real-Time Histopathologic, and
Immunohistochemistry Charactieristics: A Survey of
2000 Invasive Carcinomas (228)
Diana Morlote, Robert Poppiti, Ariana Lopez, Hadi Yaziji
Vitro Molecular Laboratories, Miami, FL; Mt. Sinai
Medical Center, Miami Beach, FL
64
57
Establishing Recommendations for Her2 Staining in

Cytology Cell Block Material (198)
Fumiko Konno, Nyasha Bullock, Elyn Riedel, Gitika
Aggarwal, Muzaffar Akram, Marcia Edelweiss
MSKCC, New York, NY
Clinical-Pathologic Analysis of Luminal B Breast

Carcinoma (305)
Xuemei Wu, Judy C Boughey, Ann M Moyer, Krishna R
Kalari, Vera J Suman, Jason P Sinnwell, Erin E Carlson,
Travis J Dockter, Alvaro Moreno-Aspitia, Richard J
Gray, Sarah A McLaughlin, Donald W Northfelt, Katie
N Jones, Amy L Conners, Eric D Wieben, Liewei Wang,
Richard M Weinshilboum, Matthew Goetz, Daniel W
Visscher
FL; Mayo Clinic, Scottsdale, AZ
198
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
65
RUNX3 Epigenetic Inactivation Is Associated with

Estrogen-Receptor Positive Breast Cancer (212)
Hui Liu, Zhantao Yan, Kai Cao, Jaime RodriguezCanales, Yongping Wu
Xuzhou Medical College, Xuzhou, Jiangsu, China; MD
73
66
Validation of the Rochester University Modified Magee

Algorithm (RUMMA) for Risk Stratification of Estrogen
Receptor Positive Breast Cancer Patients (295)
Bradley Turner, Nyrie Soukiazian, Ping Tang, David G
Hicks
Unversity of Rochester Medical Center, Rochester, NY;
Towards Automated Histopathology of Breast Cancer

Using Spatial Light Interference Microscopy (SLIM)
(215)
Hassaan Majeed, Tan Nguyen, Virgilia Macias,
Krishnarao Tangella, Andre Kajdacsy-Balla, Minh Do,
Gabriel Popescu
University of Illinois at Urbana Champaign, Urbana, IL;
University of Illinois at Chicago, Chicago, IL
74
Reduced BAP1 Expression in Invasive Carcinoma of the

Breast (221)
Stephanie McGregor, Gabrielle M Baker
University of Chicago Medicine, Chicago, IL
75
Breast Cancer Tumor Stroma Ratio and Stroma Type

Are Not Associated with Hormone Receptor Status,
Lymph Node Status or Tumor Grade (141)
Frances Compton, Yumi Kojima, Hongxia Sun,
Xiaohong I Wang, Michael Covinsky, Songlin Zhang
The University of Texas Health Science Center at
Houston, Houston, TX
67
GATA3 Expression Is Correlated with AR and ER

Expression and Negatively Correlated with Nuclear
Grade in Mammary Carcinomas (124)
Agedi Boto, Rita Abi Raad, Sara Rutter, Lori Charette,
Malini Harigopal
Yale New Haven Hospital, New Haven, CT
68
High EZH2 Expression Accompanied by Low

H3K27me3 Predicts Poorer Outcome in Metaplastic
Carcinoma of the Breast (291)
Benjamin Yongcheng Tan, Clara Ong, Valerie Koh, Aye
Aye Thike, Puay-Hoon Tan
69
Molecular Features of Breast Cancers with TripleNegative Phenotype among Older Women (164)
H Evin Gulbahce, Rachel E Factor, Philip Bernard, Bette
J Caan, Carol Sweeney
University of Utah, SLC, UT; ARUP, SLC, UT; Kaiser
Permanente Northern California, Oakland, CA
DERMATOPATHOLOGY
76
Clinicopathologic Characterization of Rare Newly

Described Follicular Helper T-Cell Variant of Primary
Cutaneous T-Cell Lymphoma (538)
James Wang, Giang H Nguyen, Shabnam Montahen,
Cynthia Magro
Weill Cornell MC, New York, NY; University of Colorado
Anschutz, Aurora, CO
77
Differential NFAT Expression in Primary Cutaneous

CD4+ Small Medium Sized Pleomorphic T Cell
Lymphoma and Other Forms of Cutaneous T Cell
Lymphoma and Pseudolymphoma (517)
Shabnam Momtahen, Aaron Muhlbauer, Cynthia
Magro
Weill Cornell Medical College, New York, NY; Ross
School of Medicine, Portsmouth, Dominica
70
Breast Cancer in Women over 75: An Evaluation of

Predictive Markers and Aggressive Subtypes in Non
Screen Detected Cancers (126)
Tara Jane Browne, Michael W Bennett, Linda Feeley,
Aoife McCarthy, Mark Corrigan, Fionnuala OConnell
71
Feasibility of Using Confocal Fluorescence Microscopy

for Imaging Breast Tissue in Surgical Pathology
Practice (199)
Savitri Krishnamurthy, Andrea Cortes, Mirtha Lopez,
Michael Wallace, Sharjeel Sabir, Gordon Mills, Kenna
Shaw
78
Cytogenetic Analysis as a Diagnostic Adjunct in

Distinguishing the Borderline Melanocytic Tumor from
Melanoma (518)
Shabnam Momtahen, Aaron Muhlbauer, James Wang,
Cynthia Magro
Weill Cornell Medical College, New York, NY; Ross
School of Medicine, Portsmouth, Dominica
72
Prediction of Breast Cancer Recurrence Risk Categories

Using Automatic Mitotic Detection Algorithms Based
on Deep Learning[/underline][/underline] (269)
David Romo-Bucheli, Andrew Janowczyk, Hannah
Gilmore, Eduardo Romero, Anant Madabhushi
Universidad Nacional de Colombia, Bogota, Colombia;
University Hospitals, Cleveland, OH; Case Western
Reserve University, Cleveland, OH
79
A New FISH Panel and Next Generation Sequencing

May Aid in Classifying Atypical Melanocytic
Neoplasms (509)
Luke Latario, Kristine M Cornejo, Xun Wu, Melissa
McEnery-Stonelake, Xiuling Meng, Keith Tomaszewicz,
Ediz F Cosar, April Deng, Lloyd Hutchinson
UMass Memorial Healthcare, Worcester, MA
199
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
80
86
Histopathologic Comparison of Epidermotropic/Dermal

Metastatic Melanoma and Primary Nodular Melanoma
(531)
Stephanie L Skala, Douglas R Fullen, David P Arps,
May P Chan
87
The Microenvironment in Primary Cutaneous

Melanomas: Immunophenotypic Characterization and
Evaluation for T Regulatory Cells (Tregs) in a Subset of
Tumor Infiltrating T Lymphocytes (TIL) Associated with
Primary Melanocytic Tumor Regression (520)
Kumaran Mudaliar, Arielle Gray, Solomiya Grushchak,
Michael I Nishimura, Stephanie Kliethermes, Kyle
Carey, Kelli A Hutchens
Loyola University Chicago, Maywood, IL
88
A Functional In Situ Approach to TILs in Melanoma: A

Critique on the Current Morphological Classification
(492)
Francesca Bosisio, Jasper Wouters, Nathalie Volders,
Marguerite Stas, Joost van den Oord
KUL, Leuven, Belgium; Universit degli studi di MilanoBicocca, Milan, Italy
89
Prognostic Significance of Regression in Patients with

Thin Primary Cutaneous Melanoma (490)
Phyu P Aung, Sanjita Ravishankar, Kenneth Friedman,
Denai R Milton, Jonathan L Curry, Carlos A TorresCabala, Doina Ivan, Michael T Tetzlaff, Jeffery E
Gershenwald, Victor G Prieto, Priyadharsini Nagarajan
90
BRAF Profiling and Testing in an Irish Population (524)

Odharnaith OBrien, Sandra Murphy, Linda Feeley,
Derek Power, Cynthia Heffron
91
BRAF and Epithelial-Mesenchymal Transition in

Primary Cutaneous Melanoma Insights Provided by
Snail and E-Cadherin Expression (516)
Brendon Mitchell, Dominick Leone, John K Feller, Noah
Frydenlund, Shi Yang, Meera Mahalingam
University of Florida, College of Medicine, Gainesville,
FL; BUSM, 72 E Concord Street, Boston, MA; University
of Iowa, Carver College of Medicine, Iowa City, IA; VA
Medical center, 1400 VFW PKWY, West Roxbury, MA
92
BRAF Mutation Analysis: A New Tool for Pathologists

in Metastatic Melanoma; Multicenter Retrospective
Evaluation on 239 Cases in French Private Pathologists
Laboratories (493)
Jerome Chetritt, Nicolas Josselin, Alain Gaillot, Claude
Deplechain, Emmanuel Watkin, Philippe Chalabreysse,
Delphine Raoux, Nicolas Weinbreck
Institut dHisto Pathologie - IHP, Nantes, France; Sipath,
Clermont-Ferrand, France; Cypath, Lyon, France;
Medipath, Frejus, France
Utility of Whole Genome Single Nucleotide

Polymorphism Microarray (SNPM) and Targeted
Somatic Mutations in Evaluation of Histologic Mimics
of Melanoma (508)
Ravindra Kolhe, Alka Chaubey, Deepa Jagdale,
WonSok Lee, Barbara R DuPont, Ashis K Mondal
Genetic Center, Greenwood, SC
81
A Diagnostic Algorithm for Atypical Spitzoid Tumor:

Guidelines for Immunohistochemical and Molecular
Assessment (494)
Jeong Hee Cho-Vega
University of Miami Miller School of Medicine, Miami,
FL
82
Comparison of Genomic Abnormalities and Gene

Expression Analysis in Atypical, Ambiguous and
Malignant Melanocytic Lesions (537)
Grace Wang, Min Wang, Ahmed Alomari, Aleodor
Andea
83
Comparison between myPath-Melanoma Gene

Expression Score and Fluorescence In-Situ
Hybridization on an Extended Series of Melanocytic
Lesions[/underline] (515)
Eugen C Minca, Rami N Al-Rohil, Min Wang, Jennifer
Ko, Victor G Prieto, Michael T Tetzlaff, Steven D
Billings, Aleodor Andea
Cleveland Clinic, Cleveland, OH; MD Anderson
Cancer Center, The University of Texas, Houston, TX;
University of Michigan Medical Center, Ann Arbor, MI
84
85
200
An Independent Validation of a Gene Expression

Signature to Differentiate Malignant Melanoma from
Benign Melanocytic Nevi (505)
Hillary Kimbrell, Loren E Clarke, Darl D Flake, Klaus
Busam, Clay J Cockerell, Klaus F Helm, Jennifer
M McNiff, Jon A Reed, Jaime Tschen, Jinah Kim,
Raymond Barnhill, Rosalie Elenitsas, Victor G Prieto,
Jonathan Nelson, Kathryn A Kolquist, Krystal Brown,
M Bryan Warf, Benjamin B Roa, Richard J Wenstrup
Myriad Genetic Laboratories, Inc., Salt Lake City, UT;
Myriad Genetics, Inc., Salt Lake City, UT; Memorial
Sloan Kettering Cancer Center, New York, NY;
University of Texas, Southwestern Medical Center,
Dallas, TX; Penn State Hershey Dermatology,
Hershey, PA; Yale Dermatopathology, New Haven, CT;
Baylor College of Medicine, Houston, TX; St. Joseph
Dermatopathology, Houston, TX; Stanford School of
Medicine, Stanford, CA; University of California, Los
Angeles, Los Angeles, CA; Curie Institute, Paris, France;
Subungual Atypical Lentiginous Junctional
Melanocytic Proliferation in Children and Adolescents:
A Clinicopathologic Study (503)
Sameer Khatri, Min Wang, Aleodor Andea, May P Chan
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
93
Clinical Significance of BRAF V600E Mutational Status

in Capsular Nevi of Sentinel Lymph Nodes in Patients
with Primary Cutaneous Melanoma (530)
Alan E Siroy, Carlos A Torres-Cabala, Michael T Tetzlaff,
Priyadharsini Nagarajan, Denai R Milton, Jonathan L
Curry, Victor G Prieto, Phyu P Aung
The University of Texas - MD Anderson Cancer Center,
Houston, TX
100
94
Expression of Melanocytic Immunohistochemical

Markers in Melanophages: A Comparison across
Platforms (533)
Char-Loo Tan, Priyanka Maheshwari, Yiong-Huak Chan,
Shoa-Nian Choo, Siok-Bian Ng
National University Health System, Singapore,
Singapore; National University of Singapore,
Singapore, Singapore
A Combined Deposition of Lanthanum and

Hemodialysis-Associated Amyloid in the
Gastroduodenal Mucosa: An Immunohistochemical,
Electron Microscopic and Dispersive X-Ray
Spectrometric Analysis (735)
Riruke Maruyama, Takayoshi Komatsu-Fujii, Hideyuki
Onuma, Tomohiko Yamamoto, Youichi Miyaoka,
Noriyoshi Ishikawa, Asuka Araki, Nahoko Ishikawa,
Yoshikazu Kinoshita, Pamela Tauchi-Nishi
Shimane University Faculty of Medicine, Izumo, Japan;
Shimane Prefectural Central Hospital, Izumo, Japan;
Queens Medical Center/University of Hawaii, Honolulu,
HI
101
Lanthanum Deposition Is Frequently Observed in the

Gastric Mucosa of Dialysis Patients with Lanthanum
Carbonate Therapy: A Clinicopathologic Study of
13 Cases Including One Colon Case and Two NonGranulomatous Gastric Cases (683)
Keisuke Goto, Kumiko Ogawa
Kainan Hospital, Yatomi, Japan; National Institute of
Health Sciences, Tokyo, Japan
102
Sleeve Gastrectomy: Unanticipated Findings in the

Pathology Review. More Than Anyone Expects! (778)
Claudia P Rojas, Nyasha Bullock, Jignesh G Parikh,
Nilesh D Kashikar, Clara Milikowski, Monica GarciaBuitrago
University of Miami Miller School of Medicine/Jackson
103
Doxycycline Induced Gastrointestinal Injury: Case

Series with New Sites of Involvement (621)
Kajsa Affolter, Kathleen Boynton, Wade S Samowitz,
Erinn Downs-Kelly
University of Utah Health Sciences Center and ARUP,
Salt Lake City, UT; University of Utah Health Sciences
Center, Salt Lake City, UT
104
Lymphocytic Esophagitis (LE) with CD8

T-Cell Predominance May Be Associated with
Gastroesophageal Reflux Disease (GERD) (756)
Nicholas Olson, Juan Putra, Xiaoying Liu, Arief A
Suriawinata, Mikhail Lisovsky
105
Patterns of Lymphocytic Gastritis May Reflect the

Underlying Etiology (660)
Isabelle Cui, Zhengming Chen, Nicole Panarelli,
Rhonda K Yantiss
New York Presbyterian-Weill Cornell Medical College,
New York, NY; Montefiore Medical Center, New York,
NY
106
Lymphocytic Colitis: Are There Pathologic Predictors of

Response to Therapy? (633)
Lindsay Alpert, Namrata Setia, Hamed Khalili, Gregory
Y Lauwers
University of Chicago, Chicago, IL; Massachusetts
95
ALK-1 Expression in Metastatic Melanoma: Potential

for a Therapeutic Target (529)
Kabeer Shah, Justin Moser, Aaron S Mansfield, Lori A
Erickson, Thomas Flotte
96
Use of a Novel Rabbit Monoclonal Phospho-Histone

H3 (Ser10) Versus H&E Mitotic Count in Invasive
Melanoma (499)
Regan Fulton, David Altree-Tacha
Phenopath, Seattle, WA; Biocare Medical, Concord, CA
97
98
99
Treponema pallidum Immunohistochemistry

Is a Sensitive Diagnostic Adjunct for Intestinal
Spirochetosis (686)
Rondell Graham, Bita V Naini, Sejal S Shah, Christina
A Arnold, Rajesh Kannangai, Michael Torbenson, Dora
Lam-Himlin
Mayo Clinic, Rochester, MN; UCLA, Los Angeles, CA;
The Ohio State University, Columbus, OH; Christian
Medical College, Vellore, India; Mayo Clinic, Scottsdale,
AZ
Rare Sarcina Ventriculi of Human Gastrointestinal
Tract: Six New Examples (695)
Thomas Huebner, Alina Iuga, Adnan Khan, Helen
Remotti, Saurabh Malhotra, JC Fanburg-Smith
Integrated Cellular and Molecular Diagnostics,
Greenbelt, MD; Columbia University, New York, NY
Brincidofovir (CMX001) Toxicity: Another Potential
Mimicker of Gastrointestinal Graft Versus Host Disease
(668)
Claire J Detweiler, Anthony D Sung, Jennifer L Saullo,
Vinod K Prasad, Diana M Cardona
201
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
107
Microscopic Crohns Disease Activity at Resection

Margins Is Not Significantly Associated with PostOperative Clinical Outcomes (725)
Li Liu, Amit Singal, Akbar Waljee, Purva Gopal
UT Southwestern Medical Center, Dallas, TX;
University of Michigan Medical Center, Ann Arbor, MI
114
108
Morphologic Heterogeneity of Dysplasia in

Inflammatory Bowel Disease: A Clinicopathologic
Study (764)
Deepa Patil, Erica Savage, John Goldblum, Robert
Odze
Concordance of HER2 Status between Local and

Central Review in Gastric (GC) and gastroesophageal
Junction Cancers (GEJC): A French Observational
Study of 394 Specimens: HERable Study (671)
Laurent Doucet, Benoit Terris, Marie-Pierre Chenard,
Frederic Bibeau, Frederique Penault-Llorca, Mouna
Bougrini, Emmanuele Conde Da Silva Fraga,
Genevieve Monges
Hpital Cavale Blanche, Brest, France; Hpital Cochin,
Paris, France; Hpital Hautepierre, Strasbourg, France;
Institut du Cancer de Montpellier, Montpellier, France;
Centre Jean Perrin, Clermont Ferrand, France; Roche,
Boulogne-Billancourt, France; Hpital Pasteur, Nice,
France
109
Clinicopathologic Predictors of Long Term and

Disease-Free Survival in Esophageal Squamous Cell
Carcinomas with Complete Pathologic Response to
Neoadjuvant Chemoradiation[/underline] (625)
Agoston Agoston, Yifan Zheng, Raphael Bueno, Robert
Odze
Brigham & Womens Hospital, Boston, MA
115
As an Independent Prognostic Factor, EZH2 Promotes

Gastric Cancer Progression via Akt Pathway (805)
Cong Tan, Mi-die Xu, Shujuan Ni, Weiwei Weng,
Xiangjie Sun, Qiongyan Zhang, Dan Huang, Weiqi
Sheng, Xiang Du
China
110
A Modified Tumor Regression Grade Incorporating

Lymph Node Involvement for Assessing Response to
Neoadjuvant Chemotherapy in Oesophageal Cancer
(733)
Amr Mahmoud, Derek Power, Tom Murphy, Michael W
Bennett
University College Cork, Cork, Ireland; Mercy
University Hospital, Cork, Ireland; National Cancer
Screening Service, Cork, Ireland
116
111
HMGA2 Expression Correlates with High Tumor Stage,

Nodal Metastasis, and Poor Outcomes in Patients with
Esophageal Adenocarcinoma (742)
Jeffrey Mito, Agoston Agoston, Paola Dal Cin, Amitabh
Srivastava
A New Immunohistochemistry Prognostic Score

(IPS) for Recurrence and Survival in Pancreatic
Neuroendocrine Tumors (PanNET) (812)
Antonio Viudez, Filipe LF Carvalho, Zahra Maleki,
Marianna Zahurak, Daniel Laheru, Alejandro Stark,
Nilofer S Azad, Christopher L Wolfgang, Stephen
Baylin, James G Herman, Ana De Jesus-Acosta
The Sidney Kimmel Comprehensive Cancer Center
at Johns Hopkins Medical Institutions, Baltimore,
MD; Johns Hopkins University School of Medicine,
Baltimore, MD
117
WHO Morphologic Classification of Gastric Cancer

Correlates with Protein Expression Based Classification
(792)
Namrata Setia, Lindsay Alpert, Gregory Y Lauwers
University of Chicago, Chicago, IL; Massachusetts
L861Q EGFR Mutation in a Metastatic SolidPseudopapillary Neoplasm of the Pancreas (749)

Kevin Neill, Xiaohui Zhang, Sameer Al Diffalha,
Mokenge P Malafa, Barbara A Centeno, Anthony M
Magliocco, Domenico Coppola
Moffitt Cancer Center, Tampa, FL; M2Gen, Tampa, FL
118
The Prognostic Significance of Infiltrating Lymphocytes

in Patients with Pancreatic Ductal Adenocarcinoma
Treated with Neoadjuvant Therapy (750)
Reza Nejati, Daniel M Halperin, Jennifer B Goldstein,
Hua Wang, Asif Rashid, Matthew H Katz, Jeffrey E Lee,
Jason B Fleming, Jaime Rodriguez Canales, Jorge
Blando, Ignacio I Wistuba, Anirban Maitra, Robert A
Wolff, Gauri R Varadhachary, Huamin Wang
The University of Texas M.D. Anderson Cancer Center,
Houston, TX
119
Pancreatic Mesenchymal Chondrosarcoma Harboring

HEY1-NCOA2 Gene Fusion (657)
Jarish Cohen, David Solomon, Andrew E Horvai,
Sanjay Kakar
CA
112
113
202
Molecular Classification in Gastric Cancer Using

Sangjeong Ahn, So Jeong Lee, Young Geum Kim,
Chung Su Hwang, Ahrong Kim, Nari Shin, Kyung
Un Choi, Chang Hun Lee, Gi Young Huh, Gregory Y
Lauwers, Do Youn Park
Pusan National University Hospital, Pusan
National University Medical School, Busan, Korea;
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
120
Intestinal Metaplasia of Appendiceal Endometriosis

Is Not Uncommon and May Mimic Appendiceal
Mucinous Neoplasm (814)
Monika Vyas, Serena Wong, Xuchen Zhang
128
121
Mucinous Neoplasms of the Appendix: Challenges in

Grading and Staging with Proposal for a New System
(810)
S Umetsu, N Shafizadeh, S Kakar
UCSF, San Francisco, CA; Kaiser, Woodland Hills, CA
Utilization of High Throughput Cancer Hotspot

Mutations Screening for the Molecular Profiling of
Colorectal Cancer (631)
Jaudah Al-Maghrabi, Ashraf Dallol, Abdelbaset
Buhmeida, Mahmoud Al-Ahwal, Adel Abuzenadah
Faculty of Medicine, King Abdulaziz University, Jeddah,
Saudi Arabia; King Abdulaziz University, Jeddah, Saudi
Arabia
129
High FAK in the Background of Low c-MET and Low

RON Levels Is Associated with Worse Survival in Stage
I-III Colorectal Adenocarcinoma Patients (834)
J-Y Yoon, Prashant Bavi, Sheng-Ben Liang, Michael H
Roehrl
130
Nuclear Maspin Expression Is an Independent

Prognostic Marker in Microsatellite Stable Stage II
Colorectal Carcinoma (637)
Prashant Bavi, Qian Yang, Michael H Roehrl
131
DNA Mutational Signature in Colorectal Cancer

Predicts Mismatch Repair Pathway Status (752)
Jonathan Nowak, Priyanka Shivdasani, Agoston
Agoston, Shuji Ogino, Frank Kuo, Amitabh Srivastava,
Fei Dong
132
Diagnosing Colorectal Medullary Carcinoma:

Interobserver Variability and Clinicopathological
Implication (719)
Lik Hang Lee, Bing Ren, Rhonda K Yantiss, Eran Sadot,
Efsevia Vakiani, Jaclyn Hechtman, Sinisa Ivelja, Zsofia
Stadler, Martin Weiser, David Klimstra, Jinru Shia
NY; Weill Cornell Medical College, New York, NY
133
Comprehensive Genomic Profiling of Advanced Stage

Colorectal Carcinoma Reveals Alterations in Epigenetic
Regulators (758)
Madhu Ouseph, Shaolei Lu, Shamlal Mangray,
Alexander Brodsky, James Sun, Siraj M Ali, Jeffrey S
Ross, Murray B Resnick, Evgeny Yakirevich
Rhode Island Hospital/Brown University, Providence,
RI; Foundation Medicine Inc, Cambridge, MA; Albany
Medical Center, Albany, NY
134
Mismatch Repair-Deficient Neuroendocrine

Carcinomas of the Lower GI Tract (785)
Marcela Santos Cavalcanti, Lik Hang Lee, Efsevia
Vakiani, Jaclyn F Hechtman, David Klimstra, Jinru Shia
135
Mutational Landscape of Anal Melanoma (694)

Susan J Hsiao, David F Schaeffer, David Horst, Chi K
Lai, Helen Remotti, Mahesh Mansukhani, Basil A Horst,
Hui-Min Yang
Columbia University, New York, NY; University of
British Columbia, Vancouver, BC, Canada; LudwigMaximilians-Universitt Mnchen, Munich, Germany;
122
123
miRNA Analysis Identified PTEN Loss in Goblet

Cell Carcinoid of Appendix in Comparison to Well
Differentiated Neuroendocrine Tumors (639)
Amarpreet Bhalla, Shadan Ali, Raagini Suresh, Manjula
Garapati, Anthony Shields, Philip Philip, Fazlul Sarkar,
Vinod B Shidham
Detroit Medical Center, WSU SOM & Karmanos Cancer
Center, Detroit, MI; Indiana University, Indianapolis, IN;
Karmanos Cancer Center, Detroit, MI
Immunohistochemical and Molecular Characterization
of Colonic Sessile Serrated Adenomas/Polyps with
Serrated Versus Intestinal Dysplasia (646)
Odise Cenaj, Robert Odze, Monika Vyas, Joanna A
Gibson
Brigham and Womens Hospital, Boston, MA; Yale-New
Haven Hospital, New Haven, CT
124
Clinicopathologic and Outcome Study of Sessile

Serrated Adenomas/Polyps with Serrated Versus
Intestinal Dysplasia (645)
Odise Cenaj, Robert Odze, Monika Vyas, Joanna A
Gibson
Brigham and Womens Hospital, Boston, MA; Yale-New
Haven Hospital, New Haven, CT
125
Extended RAS Mutations and Microsatellite Instability

in Patients with Colorectal Cancer (702)
Rossana Kazemimood, Ma Li, Mazur Lech, Mike
Mihalov
University of Illinois at Chicago, Chicago, IL; ACL
Laboratories, Rosemont, IL
126
127
Dual Stain with SATB2 and CK20 Is Useful to

Distinguish Colorectal Carcinoma from Other Tumors
(724)
Zaibo Li, Jonathan Rock, Rachel M Roth, William L
Marsh, Adrian A Suarez, Wendy L Frankel
Ohio State University, Columbus, OH
Immunohistochemistry for the Mismatch Repair
Proteins is Concordant between Colorectal Cancer and
Corresponding Metastasis (788)
Aisha Sethi, Sigurdis Haraldsdottir, Rachel Roth,
Heather Hampel, Rachel Pearlman, Christina A Arnold,
Wendy L Frankel
203
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
136
142
TERT Promoter Mutations in Squamous Cell Carcinoma

of the Bladder (887)
Morgan Cowan, Simeon Springer, Doreen Nguyen,
Rodriguez, Maria DC Rodriguez, Isabela W Cunha,
Dilek Baydar, Yuxuan Wang, Kenneth Kinzler, Nickolas
Papadopoulos, Bert Vogelstein, George J Netto
Johns Hopkins Hospital, Baltimore, MD; Sidney
Kimmel Comprehensive Cancer Center, Baltimore, MD;
of Iran; AC Camargo Cancer Center, Sao Paulo, Brazil;
143
TERT Promoter Mutations in Urinary Bladder

Morgan Cowan, Simeon Springer, Doreen Nguyen,
Rodriguez, Isabela W Cunha, Dilek Baydar, Stephania
Bezerra, Christopher J VandenBussche, Yuxuan
Wang, Kenneth Kinzler, Nickolas Papadopoulos, Bert
Vogelstein, George J Netto
Johns Hopkins Hospital, Baltimore, MD; Isfahan
University of Medical Sciences, Isfahan Kidney
of Iran; AC Camargo Cancer Centre, Sao Paulo, Brazil;
144
Mutational Profile Using Next Generation Sequencing

May Aid in Distinguishing Urachal Adenocarcinoma
from Bladder Adenocarcinoma (885)
Kristine M Cornejo, Gladell P Paner, Keith Tomaszewicz,
Xiuling Meng, Vikas Mehta, Sahussapont J Sirintrapun,
Guliz Barkan, Ediz F Cosar, Lloyd Hutchinson
UMass Memorial Healthcare, Worcester, MA;
University of Chicago, Chicago, IL; Loyola University
Medical Center, Maywood, IL; Memorial Sloan
Kettering Cancer Center, New York, NY
145
Unraveling the Molecular Characteristics of Urachal

Adenocarcinoma Starting from an Extreme-Responder
Patient (877)
Mireia Castillo-Martin, Ana Collazo Lorduy, John P
Sfakianos, Carlos Cordon-Cardo, Matthew Galsky
146
Analysis of Urothelial Carcinomas with Grade

Heterogeneity: Evidence for an Early Role of CDKN2A
Deletions in the FGFR3 Pathway (900)
Michelle Downes, Berber Weening, Bas WG van Rhijn,
Cherry L Have, Kilian M Treurniet, Theo Van Der Kwast
Sunnybrook Health Sciences Centre, Toronto,
ON, Canada; University Health Network, Toronto,
ON, Canada; Erasmus Medical Centre, Rotterdam,
Netherlands; Netherlands Cancer Institute, Amsterdam,
Netherlands; Academic Medical Centre, Amsterdam,
Netherlands
Intestinal Follicular Lymphoma: Outcomes of Low

Versus High Stage Disease (768)
Meredith E Pittman, Arunima Ghosh, Elizabeth A
Montgomery, Amy S Duffield
137
Clonality of Urothelial Carcinoma Developing in the

Bladder Following Radical Nephroureterectomy (1000)
Paari Murugan, Eugene K Cha, Ying-Bei Chen,
Sahussapont J Sirintrapun, Anuradha Gopalan,
Samson W Fine, Satish K Tickoo, Victor E Reuter,
John P Sfakianos, Sasinya N Scott, Gopa Iyer, Aditya
Bagrodia, Ronak Shah, Dean F Bajorin, Jonathan
E Rosenberg, Michael Berger, Bernard H Bochner,
Jonathan A Coleman, David B Solit, Hikmat A AlAhmadie
University of Minnesota, Minneapolis, MN; Memorial
138
Urothelial Carcinoma of the Upper Urinary Tract: A

Syed Gilani, Bogdan A Czerniak, Charles C Guo
139
Integrated Whole Exome and RNA Sequencing Reveals

Distinct Genomic and Transcriptomic Landscape of
Upper Tract Urothelial Carcinoma (1024)
Brian D Robinson, Bishoy Faltas, Rohan Bareja,
Himisha Beltran, Joanna Cyrta, Peyman Tavassoli,
Manoj Rai, Scott T Tagawa, David M Nanus, Francesca
Khani, Juan Miguel Mosquera, Andrea Sboner,
Douglas Scherr, Olivier Elemento, Mark Rubin
140
141
204
Comprehensive Molecular Analysis of Small Cell

Carcinoma of the Bladder (939)
Xueli Hao, Matthew T Chang, Alexander V Penson,
Neil Desai, Gopa Iyer, Victor E Reuter, Satish K Tickoo,
Anuradha Gopalan, Sahussapont J Sirintrapun,
Samson Fine, Ying-Bei Chen, Jonathan E Rosenberg,
Anne M Schultheis, Britta Weigelt, Sasinya N Scott,
Eugen K Cha, Dean F Bajorin, Michael F Berger,
Bernard H Bochner, Guido Dalbagni, David B Solit,
Barry S Taylor, Hikmat A Al-Ahmadie
NY; UT Southwestern, Dallas, TX
An Immunohistochemical Study of the Molecular
Subtypes of Combined Urinary Bladder Urothelial and
Small Cell Carcinoma (857)
Mary Barrett, Pamela Unger, Jerome Jean-Gilles, Nisha
Patel, Qi Yang, Loralee McMahon, Guang-Qian Xiao
Lenox Hill Hospital - LIJ Northshore Health System,
New York, NY
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
147
155
Amyloidosis of the Bladder and Association with

Urothelial Carcinoma: Report of 18 Cases (986)
Daniel J Luthringer, Deepika Sirohi, Mahul B Amin
156
Neoadjuvant Chemotherapy (NAC)-Related Histological

Changes in Radical Cystectomy (RC): Assessment
Accuracy and Prediction of Response (1070)
Hui Jun Wang, Wassim Kassouf, Fadi Brimo
McGill University Health Center, Montreal, QC, Canada
157
The Depth of Tumor Invasion Is Superior to the AJCC/

UICC Staging System to Predict Patient Outcomes after
Radical Cystectomy: A Proposal for a New Staging
System (1063)
Toyonori Tsuzuki, Toshinori Nishikimi, Yukiko Mori,
Naoto Sassa, Masashi Kato, Shin Yamada, Kuniaki
Tanaka, Satoru Takahashi, Yasushi Yoshino, Ryohei
Hattori, Momokazu Gotoh
Japanese Red Cross Nagoya Daini Hospital, Naogya,
Japan; Nagoya City University, Nagoya, Japan; Nagoya
University Hospital, Naogya, Japan; Japanese Red
Cross Nagoya Daiichi Hospital, Naogya, Japan; Okazaki
Municipal Hospital, Okazaki, Japan; Kariya General
Hospital, Kariya, Japan
158
Regional and Racial Disparities in Bladder Cancer

Pathology Undergoing Secondary Review at a Tertiary
Referral Center in Alabama (884)
Robin Collingwood, Win Shun Lai, Soroush RaisBahrami, Jennifer B Gordetsky
148
Metabolomics Analysis Reveals Distinct Profiles of

Non-Muscle Invasive and Muscle-Invasive Bladder
Cancer (1032)
Divya Sahu, Yair Lotan, Bryan Wittman, Bruce Neri,
Donna Hansel
University of California at San Diego, San Diego,
CA; Metabolon Inc, Durham, NC; University of Texas
Southwestern Medical Center, Dallas, TX
The Ratio of CD8 to Treg Tumor Infiltrating
Lymphocytes Is Associated with Neoadjuvant Cisplatin
Based Chemotherapy Response in Patients with
Muscle Invasive Urothelial Carcinomas of the Bladder
(856)
Alexander Baras, Charles Drake, Jen-Jane Liu, Nilay
Gandhi, Max Kates, Mohamed Hoque, Alan Meeker,
Noah M Hahn, Mark Schoenberg, Janis Taube, Trinity J
Bivalacqua, George J Netto
Johns Hopkins, Baltimore, MD; Montefiore Medical
Center, Bronx, NY
149
Human Papillomavirus in Urothelial Carcinoma In-Situ:

Does It Have a Role in Urothelial Carcinogenesis? (859)
Sheldon I Bastacky, Dinesh Pradhan, Somak Roy, Rajiv
Dhir
150
Muscularis Mucosae (MM) Thickness in Cystectomy

Specimens: A Practical Objective Approach to
Distinguishing from Muscularis Propria (MP) (1007)
Swetha Paluru, Jonathan I Epstein
Johns Hopkins Medical Institute, Baltimore, MD
151
Utility of Immunohistochemistry for Distinguishing

Luminal and Basal Subtypes of Urothelial Carcinoma
on Formalin Fixed Paraffin Embedded Tissues (1018)
Dinesh Pradhan, Anthony Green, Kimberly A Fuhrer,
Sheldon I Bastacky, Rajiv Dhir, Anil Parwani, Somak
Roy
UPMC, Pittsburgh, PA; Wexner Medical Center,
Columbus, OH
159
Prognostic Significance of Lymphatic, Vascular and

Perineural Invasion in Bladder Cancer Treated by
Radical Cystectomy (999)
Prasuna Muppa, Sounak Gupta, Igor Frank, Stephen
A Boorjian, R Jeffrey Karnes, R Houston Thompson,
Prabin Thapa, Robert F Tarrell, Loren P Herrera
Hernandez, Rafael E Jimenez, John C Cheville
152
CK20 and p53 Immunohistochemistry: Staining

Patterns and Follow Up in Urinary Bladder Specimens
with Urothelial Atypia (853)
Javier Arias-Stella, Alpa B Shah, Nilesh S Gupta, Sean
R Williamson
160
Submitting the Entire Packet Increases Lymph Node

Yield in Cystectomy Pelvic Lymphadenectomy
Specimens (992)
Rebekah McIntosh, Soroush Rais-Bahrami, Jennifer B
Gordetsky
UAB, Birmingham, AL
153
Clear Cell Urothelial Carcinoma: Immunohistochemical

and Topographic Studies Are Suggestive of
Mesonephric Differentiation (861)
Justin Bateman, Jason K Wasserman, Trevor A Flood,
Eric C Belanger, Bojana Djordjevic, Kien T Mai
ON, Canada
161
Occult Metastases in Pelvic Lymph Nodes Removed

during Radical Cystectomy for Urothelial Carcinoma[/
underline][/underline] (922)
Briana R Gibson, James L Ellenburg, Todd M Stevens,
William E Grizzle, Soroush Rais-Bahrami, Jennifer B
Gordetsky
154
Clear Cell Urothelial Carcinoma: A Clinicopathological

Study of Nine Cases and a Review of Literature (860)
Justin Bateman, Jason K Wasserman, Trevor A Flood,
Bojana Djordjevic, Eric C Belanger, Kien T Mai
ON, Canada
162
Reduced Survival in Estrogen Receptor Beta

Expressing Bladder Cancer: Association with Altered
PTEN/mTOR Status (1049)
James Solomon, Irene Thung, David Tacha, Ahmed
Shabaik, Donna Hansel
University of California at San Diego, San Diego, CA;
Biocare Medical, Concord, CA
205
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
Board
Number
Board
Number
163
FOXO1 and p53 Are Associated with Poor Prognosis in

Urothelial Cell Carcinoma (948)
Silvia Hernandez, Alba Font-Tello, Nuria Juanpere,
Marta Lorenzo, Lara Nonell, Albert Frances, Sergio
Serrano, Josep Lloreta
Parc de Salut Mar-IMIM, Barcelona, Spain; Hospital
172
164
HER2 Status in Metastazising Urothelial Bladder

Cancers (919)
Vera Genitsch, Philipp Niederberger, Aurel Perren,
Roland Seiler, George N Thalmann, Achim
Fleischmann
165
166
167
ELK1 Immunohistochemistry in Bladder Cancer

as a Predictor of Tumor Progression as Well as
Chemosensitivity (963)
Takashi Kawahara, Hiroki Ide, Hasanain Shareef,
Satoshi Inoue, Eiji Kashiwagi, George J Netto,
Alexander Baras, Hiroshi Miyamoto
Analysis of PD-L1 Expression Pattern in Advanced
Bladder Cancer and Lymph Node Metastasis (1052)
Yue Sun, Max Vaickus, Sandra Cerda, Huihui Ye
Boston University Medical Center, Boston, MA; Beth
Israel Deaconess Medical Center, Boston, MA
Study of KRAS and BRAF Mutations among Different
Tumor Types in the Lower Urinary Tract (938)
Jen-Fan Hang, Chin-Chen Pan
168
Stathmin1 is a Sensitive and Specific Biomarker for

High Grade Urothelial Carcinomas (990)
Douglas A Mata, Brooke E Howitt, Justine A Barletta,
Michelle Hirsch
169
Immunohistochemistry of Prostaglandin Receptors in

Bladder Cancer as Predictors of Tumor Progression as
Well as Chemosensitivity (961)
Eiji Kashiwagi, Hiroki Ide, Satoshi Inoue, Takashi
Kawahara, George J Netto, Alexander Baras, Hiroshi
Miyamoto
170
Copper Transporter CTR1 Expression Predicts Platinum

Response in Muscle-Invasive Bladder Cancer[/
underline] (965)
Deepak Kilari, Kenneth A Iczkowski, Chintan Pandya,
Adam Robin, Edward M Messing, Elizabeth Guancial,
Eric S Kim
171
Urinary Bladder Paragangliomas: Analysis of Succinate

Dehydrogenase and Outcome (936)
Sounak Gupta, Jun Zhang, Lori A Erickson
206
CC Exhibit Hall C/D

4ABC
Clinicopathologic Characteristics and Mutational Status

of Succinate Dehydrogenase in Paraganglioma of
Urinary Bladder with Emphasis on Malignancy: MultiInstitutional Study in Korea (1015)
Sanghui Park, Ghee Young Kwon, Ji Eun Kwon, Sang
Kyum Kim, Ji Yeon Kim, Chul Whan Kim, Hyun-Jung
Kim, Kyung Chul Moon, Yong Wook Park, Won Young
Park, Eun Su Park, Ji Youn Sung, Sun Hee Sung, Seung
Eun Lee, Wonae Lee, Jong Im Lee, Soo Jin Jung, MinSun Cho, Yong Mee Cho, Hyun Yee Cho, Eun Jung Cha,
Yang Seok Chae, Gheeyoung Choi, Yeong Jin Choi,
Jooryung Huh, Jae Y Ro
Ewha Womans University, Seoul, Korea; Other
Hospitals, Korea; The Methodist Hospital, Houston, TX
HEAD & NECK PATHOLOGY
173
Arrested Pneumatization of the Skull Base: A Sheep in

Wolfs Clothing (1290)
Jean Lewis, Carrie Y Inwards, Kirk M Welker
174
Ameloblastoma: Twenty Five Year Experience at a

Single Institution (1296)
Tatyana Milman, Wei Pan, Virginia LiVolsi
Perelman School of Medicine, Philadelphia, PA
175
BRAF, KIT, NRAS and TERT Mutation Analysis in Head

and Neck Mucosal Melanomas (1307)
Sule Sari, Ismail Yilmaz, Orhun C Taskin, Yasemin
Ozluk, Nesimi Buyukbabani
IU Istanbul Faculty of Medicine, Istanbul, Turkey; GATA
Military Hospital, Istanbul, Turkey
176
The Great Mimicker - Metastatic Breast Carcinoma to

the Head and Neck with Emphasis on Unusual Clinical
and Pathologic Features (1275)
Dikson Dibe Gondim, Rebecca Chernock, Samir K ElMofty, James Lewis
Washington University in St. Louis, Saint Louis, MO;
177
Characterization of Inflammatory Infiltrates and

Programmed Death Ligand 1 (PD-L1) Expression in
Squamous Carcinoma Precursor Lesions in Organ
Transplant Recipients (1286)
D Anand Rajan Kanagasabapathy, Samir K El-Mofty
Washington University School of Medicine, St Louis,
MO
178
Human Papillomavirus and Activating EGFR Mutations:

Alternative Oncogenic Mechanisms in Inverted
Sinonasal Papilloma (1268)
Noah Brown, Aaron Udager, Jonathan McHugh,
Thomas E Carey
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
179
Sinonasal Carcinoma Arising in Schneiderian

Papilloma: Clinicopathological Review of 27 Cases
(1300)
Asawari Patil, Tanvee Kulkarni, Ashwini Natu, Munita
Bal, Rajiv Kumar, Swapnil Rane, Shubhada Kane
Tata Memorial Centre, Mumbai, Maharashtra, India
187
The Effects of Chemoradiotherapy on Patient

Outcomes and Tumor Viability in Cervical Lymph
Node Metastases in Head and Neck Squamous Cell
Carcinoma (1309)
Kathryn Scherpelz, Mark Lingen, Nicole A Cipriani
180
JAK2 Overexpression Is a Prognostic Indicator for

Worse Outcome in Nasopharyngeal Carcinoma and
Is Independent of JAK2 Exon 12 and JAK2 V617F
Mutation (1291)
Peir-In Liang, Chien-Feng Li
Kaohsiung Medical University Hospital, Kaohsiung
Medical University, Kaohsiung City, Kaohsiung, Taiwan;
Chi Mei Foundation Medical Center, Tainan City,
Tainan, Taiwan; Southern Taiwan University of Science
and Technology, Tainan City, Tainan, Taiwan; National
Health Research Institutes, National Institute of Cancer
Research, Tainan City, Tainan, Taiwan
188
Prognostic Significance of Histological Tumor

Regression at Primary Site and Nodal Metastases in
Patients with Oral Squamous Cell Carcinoma, Treated
by Neo-Adjuvant Chemotherapy Followed by Surgery
(1297)
Ashwini N, Kumar Prabhash, Shubhada Kane, Anil
DCruz, Munita Bal, Rajiv Kaushal, Asawari Patil
Tata Memorial Centre, Mumbai, Maharashtra, India
189
Lymphovascular Invasion and Pattern of Invasion

in Floor of Mouth Squamous Cell Carcinoma: An
Interobserver Variability Study (1265)
Caitlin Beggan, Cassie Fives, Gerard OLeary, Patrick
Sheahan, Cynthia Heffron, Linda Feeley
Cork University Hospital, Cork, Ireland; South
Infirmary-Victoria University Hospital, Cork, Ireland
190
Three-Dimensional Histology: Spatial Envisioning of

Pattern of Invasion (1280)
Yan Hu, Elliot Yu, Claudia Velosa, Jessica Xu, Qiuying
Shi, John Tomaszewski, Scott Doyle, Margaret
Brandwein
University at Buffalo, Buffalo, NY; Allegheny Health
Network, Pittsburgh, PA; University of Kentucky,
Lexington, KY
191
Reliability of Tumor Depth and Thickness

Measurements in T1 Oral Cancer (1264)
Saad Baqai, Norbert Sule, Wei Tan, Gregory Wilding,
Mihai Merzianu
Roswell Park Cancer Institute, Buffalo, NY
192
Clinicopathological, Immunohistochemical and

Molecular Approach of a Series of Multiple Primary
Oral Carcinomas (1289)
Ana Larque, Jorge De la Oliva, Marta Bodalo, Lara
Nonell, Carles Marti, Alfons Nadal, Llucia Alos
Hospital Clinic, Barcelona, Spain; Institut Hospital del
Mar dInvestigacions Mediques, Barcelona, Spain
193
Cuniculatum, Papillary & Verrucous Carcinomas: A

Comparative Assessment (1310)
Akeesha Shah, Simion I Chiosea, Christopher C Griffith,
Seungwon Kim, Raja R Seethala
University of Pittsburgh, Pittsburgh, PA; Emory
194
MUC4 Protects Aniokios in Head and Neck Squamous

Xiu Yang, Sham S Kakar, Muzafar A Macha, Surinder K
Batra
University of Louisville, Louisville, KY; University of
Nebraska, Omaha, NE
181
Abstract Withdrawn
182
Next Generation Sequencing of Olfactory

Neuroblastoma Nominates Potential Oncogenic Drivers
Including Wnt/Beta-catenin Signaling, FGFR3, and
Cyclin D1 (1278)
Paul W Harms, Lorena Lazo de la Vega, Andi K Cani,
Jonathan McHugh, Daniel H Hovelson, Michaela J
Haller, Komal Kunder, Chia-Jen Liu, Scott A Tomlins
Department of Pathology, Ann Arbor, MI; Michigan
Center for Translational Pathology, Ann Arbor, MI
183
Sinonasal leiomyosarcoma: Analysis of 9 Cases

Exploring Their Clinicopathological and Morphological
Spectrum with Emphasis on Previous Irradiation and
Association with Other Malignancies (1258)
Abbas Agaimy, Sarina Muller, Lester DR Thompson
University Hospital of Erlangen, Erlangen, Germany;
Woodland Hills Medical Center, Woodland Hills, CA
184
Clinicopathological Features of Extranodal Follicular

Dendritic Cell Sarcoma of Head and Neck Region:
Report of 18 Cases of an Uncommon Entity (1288)
Rajiv Kumar, Anuja Pradhan, Munita Bal, Asawari Patil,
Prathamesh Pai, Sarbani Laskar, Jai P Agarwal, Anil
DCruz, Shubhada Kane
Tata Memorial Hospital, Mumbai, India
185
Parapharyngeal Nerve Sheath Tumors: A

Clinicopathological Study of 34 Cases Including Four
Malignant Peripheral Nerve Sheath Tumors[/underline]
(1315)
Jason K Wasserman, Akeesha Shah, Raja R Seethala,
Bibianna Purgina
of Pittsburgh Medical Centre, Pittsburgh, PA
186
-catenin Expression Is Frequent in Sinonasal

Hemangiopericytoma and Its Mimics (1285)
Vickie Y Jo, Christopher Fletcher
Brigham and Womens Hospital and Harvard Medical
School, Boston, MA
207
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
195
The Effect of MGMT and p16 on Prognosis in

Oropharyngeal Squamous Cell Carcinomas Is
Independent of Tumor Grade and Lymphovascular
Invasion (1277)
David Fink, Sameer Jhavar, Marcus Volz, Kimberly L
Walker, Arundhati Rao
Baylor Scott and White, Temple, TX
201
196
Cutaneous Leishmaniasis Presenting as Facial Midline

Lesions: A Series of 15 Cases (1259)
Elie Alam, Ossama Abbas, Roger Moukarbel, Ibrahim
Khalifeh
American University of Beirut Medical Center, Beirut,
Lebanon
MLL-Rearranged T-Lymphoblastic Leukemias Are

Associated with CD34+ and Non-dual CD4+CD8+
Phenotype but Not with Unfavorable Outcome in
Pediatric Patients (1485)
Bradford Siegele, Karen Swisshelm, Billie J Carstens,
Xiayuan Liang
University of Colorado School of Medicine, Aurora, CO;
Childrens Hospital Colorado, Aurora, CO; Colorado
Genetics Laboratory, Denver, CO
202
T Cell Acute Lymphoblastic Leukemias in E/VH miR155

Transgenic Mice (1351)
Stefan Costinean, Lauren R Kauffman, Stefano Volinia,
Cristian Taccioli, Kari Green-Church, Ji Yuan, Carlo
Croce, Kai Fu
University of Nebraska Medical Center, Omaha, NE;
Ohio State Wexner Medical Center, Columbus, OH
203
Comprehensive Genomic Profiling (CGP) of Blastic

Plasmacytoid Dendritic Cell Neoplasms (BPDCN)
(1505)
Jo-Anne Vergilio, Samantha Morley, Justin Allen, Julia
A Elvin, James Suh, Jie He, Rachel Erlich, Philip J
Stephens, Vincent A Miller, Jeffrey S Ross
Foundation Medicine, Inc, Cambridge, MA; Albany
204
Differential Expression of Enhancer of Zeste Homolog

2 (EZH2) Protein and Intracellular Signaling Molecules
p-ERK, MYC, and p-STAT3 in Low and High Grade
B-Cell Non-Hodgkin Lymphomas (1493)
Xuejun Tian, Ali Shahsafaei, David M Dorfman
School, Boston, MA
205
Expression of Enhancer of Zeste Homolog 2 (EZH2)

Protein Correlates with p-ERK, p-STAT, and MYC
Expression in Lymphocyte Predominant (LP) Cells of
Nodular Lymphocyte Predominant Hodgkin Lymphoma
(NLPHL) and Reed-Sternberg (HRS) Cells of Classical
Hodgkin Lymphoma (CHL) (1494)
Xuejun Tian, Ali Shahsafaei, David M Dorfman
School, Boston, MA
206
Histone Methyltransferase EZH2 Expression Marks

Proliferation Rate and Histologic Progression Not
Subtype in Chronic Lymphocytic Leukemia in Contrast
to Methylated DNA Levels (1529)
Weiqiang Zhao, Shweta Chaudhary, Kara Patterson,
Guojuan Zhang, David Kellough, Dan Jones
Columbus, OH
207
Chronic Lymphocytic Leukemia Transdifferentiates into

Neuroendocrine Carcinoma: Really? (1342)
Diana Castro, Subhadra Nandula, Weiyi Chen, Shahida
Ahmed, Jin Choe, Donghong Cai
Rutgers - New Jersey Medical School, Newark, NJ;
Cancer Genetics Inc., Rutherford, NJ; VA New Jersey
Medical Center, East Orange, NJ
HEMATOPATHOLOGY
197
Peripheral Blood Minimal Residual Disease Analysis

by Flow Cytometry Has High Concordance with
Bone Marrow Analysis for Adult Patients with Acute
Lymphoblastic Leukemia (1433)
Alissa Minkovsky, Elizabeth A Morgan, Karry
Charest, Ryan Schmidt, Debra Briggs, Betty Li, Olga
Pozdnyakova
198
Clinical Implementation of a FISH Panel and Testing

Algorithm for Diagnosis of Ph-like B-cell Acute
Lymphoblastic (1424)
Xinyan Lu, Alexandra Reynolds, Sergej Naumovich
Konopleva, Sa Wang, Guilin Tang, Zhenya Tang, Patrick
A Zweidler-McKay, Jeffrey L Jorgensen, Keyur P Patel,
L Jeffrey Medeiros, Pei Lin, Marina Konopleva, Nitin
Jain
The University of Texas, M.D. Anderson Cancer Center,
Houston, TX; TheUniversity of Texas, M.D. Anderson
Cancer Center, Houston, TX
199
200
208
CD25 Expression in B-Lymphoblastic Leukemia (B-LL)

Is a Biomarker for the Philadelphia Chromosome (BCRABL1) Translocation and an Adverse Risk Factor in Ph
Negative B-LL (1345)
Pu Chen, Andrew Chu, Hamid Zia, Prasad Koduru,
Franklin Fuda, Weina Chen
UT Southwestern Medical Center at Dallas, Dallas, TX
Mixed Phenotype Acute Leukemia with T-cell
Differentiation Demonstrate Immunophenotypic and
Genetic Similarities to Early T-cell Precursor Acute
Lymphoblastic Leukemia (1420)
Yen-Chun Liu, Julia T Geyer, Wayne Tam, Attilio Orazi
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
208
A Study of MUM-1 Expression Pattern in Follicular

Lymphoma (1479)
Ana Ruano, Eric D Hsi
217
209
CXCR4 Expression in Follicular Lymphoma (1329)

Maryam D Ameri, Jerry T Wong, Lawrence Low, Yuan
Yuan Chen, Dennis D Weisenburger, Raju Pillai, Young
S Kim, Joo Y Song
City Of Hope Natinal Medical Center, Duarte, CA
RNA In Situ Hybridization for [/underline]IRTA1[/

underline] as a Specific Marker for Marginal Zone
Lymphoma[/underline] (1510)
Zhen Wang, James R Cook
218
210
Correlation Between Isotype Switch and Somatic

Hypermutation in Follicular Lymphoma (1397)
Chad Hudson, Janice M Spence, Sapna S Patel,
Richard Burack
University of Rochester Medical Center, Rochester, NY
Chronic Memory B-cell Leukemia: Primary Peripheral

Blood Presentation of Low-Grade, Marginal ZoneDerived B-cell Lymphomas (1530)
Mei Zheng, Jennifer N Sanmann, Warren G Sanger,
Samuel J Pirruccello
219
EBV+ Marginal Zone Lymphoma in

Immunocompromised Patients: Report of Five Cases
(1376)
Shunyou Gong, Karthik A Ganapathi, Chad M McCall,
Genevieve M Crane, Liqiang Xi, Mark Raffeld, Stefania
Pittaluga, Amy S Duffield, Elaine S Jaffe
National Institutes of Health, Bethesda, MD; Johns
Hopkins University, Baltimore, MD
220
AID-Generated IGH Glycosylation Sites but Not

Somatic Hypermutation Rate Differentiate Marginal
Zone Lymphoma and Follicular Lymphoma (1398)
Chad Hudson, Hani Katerji, Janice M Spence, Diana
Adlowitz, Richard Burack
221
Classification of Non-Hodgkin Lymphoma (NHL) in the

Developing World: The International NHL Classification
Project (1454)
Anamarija Perry, Jacques Diebold, Kenneth
MacLennan, H Konrad Muller-Hermelink, Bharat N
Nathwani, Eugene Boilesen, Martin Bast, James
Armitage, Dennis D Weisenburger
City of Hope National Medical Center, Duarte, CA
222
Burkitt Lymphoma Presenting within the Thyroid

Gland: Clinicopathologic Features in Seven Patients
(1465)
Andres Quesada, Huifei Liu, Roberto Miranda, Jeffrey
Medeiros, Natalia Golardi, Shahreen Billah, Jesse M
Jaso
M.D. Anderson Cancer Center, Houston, TX; UTHealth
Medical School at Houston, Houston, TX
223
Post-Treatment Residual Disease Detection by Droplet

Digital PCR in Hairy Cell Leukemia: Comparison with
Allele Specific PCR and Immunohistochemistry (1500)
Silvia Uccella, Nora Sahnane, Roberta Cerutti,
Francesca Magnoli, Leonardo Campiotti, Michele Merli,
Stefano La Rosa, Fausto Sessa, Daniela Furlan
University of Insubria, Varese, VA, Italy; Ospedale di
Circolo di Varese, Varese, VA, Italy
224
Plasma Cells in Monoclonal Gammopathy of

Undetermined Significance Exhibit Significantly Fewer
Immunophenotypic Aberrancies Than Those of Plasma
Cell Myeloma[/underline] (1381)
Sarika Gupta, Andrew M Bellizzi, Nitin Karandikar,
Carol Holman
University of Iowa Hospitals and Clinics, Iowa City, IA
211
Role of Autophagy in Follicular Lymphoma (1480)

Ana Ruano, Juraj Bodo, Eric D Hsi
212
Coexpression of MYC and BCL2 Proteins Identifies

a Subset of Follicular Lymphoma That Undergoes
Transformation to Diffuse Large B-cell Lymphoma and
Correlates with Poor Overall Survival (1423)
Lawrence Low, Joo Y Song, Yuan Y Chen, Maria Valle,
Dennis D Weisenburger, Young S Kim
City of Hope National Medical Center, Duarte, CA
213
Gene Expression Signaling Signature Provides Insights

into Poor Survival Associated with High Expression of
BRIC5 (Survivin) in Mantle Cell Lymphoma (1361)
Ghaleb Elyamany, Ariz Akhter, Leslie Street, Etienne
Mahe, Ali Matar Al Zahrani, Meer-Taher Shabani-Rad,
Douglas Allan Stewart, Adnan Mansoor
University of Calgary, Calgary, Canada; Prince Sultan
Military Medical City, Riyadh, Saudi Arabia; University
of Calgary / Calgary Laboratory Services, Calgary,
Canada; Alberta Health Services, Calgary, Canada
214
Immunophenotypically Atypical Mantle Cell

Lymphoma (aMCL) Is Clinically Distinct from Typical
Mantle Cell Lymphoma (tMCL) (1330)
Barina Aqil, John L Frater, Anjum Hassan, Marianna B
Ruzinova, Eric J Duncavage, Friederike H Kreisel
Washington University School of Medicine, St Louis,
MO
215
A Unique Variant of Indolent Mantle Cell Lymphoma

Exclusively Involving Gastrointestinal Tract (1481)
Wichit Sae-Ow, Janine Pichardo, Zhitao Ying, Kumar
Anita, Andrew D Zelenetz, Anas Younes, Ahmet Dogan
MSKCC, New York, NY; Sloan Kettering Institution,
New York, NY
216
Mantle Cell Lymphoma with MYC Rearrangement:

Best Considered as a Form of Double Hit Lymphoma?
(1396)
Zhihong Hu, Wei Wang, Zi Chen, Guilin Tang, Xinyan
Lu, Shaoying Li, L Jeffrey Medeiros, Shimin Hu
Houston, TX
209
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
Board
Number
Board
Number
225
Cost Effectiveness of Cell Proliferation vs. Cytogenetics

for Risk Stratification in Multiple Myeloma (1360)
Scott Ely, David Tacha, Peter Forsberg, Ihsane
Ouansafi, Ruben Niesvizky, Tomer Mark
Weill Cornell, New York, NY; Biocare, Inc., Concord, CA
233
226
Cytogenetic Subgroups and Their Clinical Implications

in Multiple Myeloma Patients with TP53 Deletion[/
Suyang Hao, Sergej Konoplev, Robert Orlowski, L
Jeffrey Medeiros, Shimin Hu, Pei Lin, Xinyan Lu
Houston Methodist Hospital, Houston, TX; UTMD
Anderson Cancer Center, Houston, TX; UT MD
227
228
229
230
231
232
210
Immunophenotypic and Cytogenetic Evolution Pattern

of the Neoplastic Cells in Relapsed Multiple Myeloma
after Stem Cell Transplant (1471)
Anton V Rets, Reha M Toydemir, Jerry W Hussong,
Mohamed E Salama
University of Utah, Salt Lake City, UT; ARUP
Laboratories, Salt Lake City, UT
Next Generation Sequencing (NGS) of Somatic
Mutations for Residual Disease Detection of Plasma
Cell Neoplasms in Instances of a PCR Negative
Immunoglobulin Gene Rearrangement Assays (1523)
Wei Xing, Xiuling Meng, Yiqin Xiong, Keith
Tomaszewicz, Bruce A Woda, Ediz F Cosar, Lloyd
Hutchinson
Worcester, MA
A Quantitative and Qualitative Approach Using a Dual
Immunostain to Estimate the Percentage of Tumor
Associated Macrophages and Reed-Sternberg Cells in
Classical Hodgkin Lymphoma (1344)
Catherine Chaudoir, Diana Veillon, James Cotelingam,
Menchu Ong, John Glawe, Chris Pattillo, Chris Kevil
LSUHSC Shreveport, Shreveport, LA
Epstein Barr Virus-Positive Classical Hodgkin
Lymphoma: Characterization of Microenvironment
Using CD 163 and PD-1 Expression by
Ali Al-Habib, Janice Ahn, Ryan Okal, Jeffrey Vos, Flavia
G Rosado
West Virginia University, Morgantown, WV
PD-L1 Expression and T-Nk Cell Alterations in Staging
Bone Marrow Biopsies of Newly Diagnosed Classical
Hodgkin Lymphoma Patients[/underline] (1524)
Wei Xing, Karen Dresser, Rui Zhang, Benjamin J Chen
UMass Memorial Medical Center and University of
Massachusetts Medical School, Worcester, MA; School
of Public Health, Boston University, Boston, MA
PD-L1 Expression Correlates with EBV Status in PostTransplant Lymphoproliferative Disorders (1447)
Horatiu Olteanu, Paul Hosking, Alexandra Harrington,
Steven Kroft
MCW, Milwaukee, WI
CC Exhibit Hall C/D

4ABC
Tumor Suppressor IRF-1 Expression Is Decreased in

Post-Transplant Lymphoproliferative Disorder (1446)
Horatiu Olteanu, Wadzanai Mboko, Vera Tarakanova,
Paul Hosking, Alexandra Harrington, Steven Kroft
MCW, Milwaukee, WI
INFECTIOUS DISEASE PATHOLOGY
234
Histologic Features and Immunohistochemical

Characterization of Inflammatory Infiltrates in Eschar
Biopsy Specimens from Patients with Rickettsia parkeri
Rickettsiosis (1541)
Dianna Ng, Tara Jones, Christopher Paddock
Centers for Disease Control and Prevention, Atlanta,
GA
235
NKX3.1 Identifies Fungal Organisms from the

Esophagus (1543)
Martina Pejchal, Reetesh K Pai, Douglas J Hartman
236
Evolution of High-Risk Human Papillomavirus

Genotypes in Anal Biopsies from HIV-Positive Patients
after Long-Term Follow-Up (1547)
Hai Wang, Yiang Hui, M Ruhul Quddus, Jayasimha N
Murthy, Zakaria Grada, Dongfang Yang, C James Sung,
Shaolei Lu, Li Juan Wang
Warren Alpert Medical School of Brown University,
Providence, RI
237
Development of an RNA In Situ Hybridization Assay

for Hepatitis C Virus (HCV) Detection in Patient FFPE
Samples (1542)
Emily Park, Na Li, Hongzhe Sun, Jing-min Zhao, Shuhong Liu, Mindy Wang, Yuling Luo, Xiao-Jun Ma
Advanced Cell Diagnostics, Inc., Hayward, CA; 302
Military Hospital of China, Beijing, China
238
Histopathologic Features of T. Pallidum Infection Differ

between the Rectum and Anus (1546)
Julie Y Tse, Vikram Deshpande, Judith A Ferry,
Lawrence Zukerberg
239
Yersinia Pestis Osteomyelitis: An Underreported

Complication of Plague (1538)
Gillian L Hale, Sherif R Zaki, Sarah M Dry
Centers for Disease Control and Prevention, Atlanta,
GA; UCLA, Los Angeles, CA
240
Investigation of Potential Misdiagnosis of

Corynebacteria as Mycobacteria Based on Acid Fast
Stains in Surgical Pathology Specimens (1536)
Derrick J Chen, Scott A Cunningham, Elizabeth M
Druffel, Robin Patel, Bobbi Pritt
241
Staph Pseudintermedius: An Emerging Pathogen

(1533)
John Biemer, Paul Schreckenberger
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
242
Morphoproteomics to Define Targets for Host-Directed

Therapy in Tuberculosis (1534)
Robert Brown, Shen-An Hwang, Robert L Hunter
University of Texas Health Science Center at Houston
Medical School, Houston, TX
250
243
Interpretation of HSV Positive Respiratory Specimens

Using Quantitative PCR (1545)
Christopher Suciu, Michelle Stram, Jansen Seheult,
Charles R Rinaldo
Bile Duct Brush and EUS FNA Pancreas in PancreaticBiliary Disease Management: A 5-Year Audit (1777)
Lakshmi Venkatraman, Alexandra Doyle, Paul Kelly,
Neil H Anderson
Belfast Health and Social Care Trust, Belfast, United
Kingdom
251
244
Return of the Great Mimicker: Treponema Pallidum

in the Gastrointestinal Tract (1540)
Jennifer Muir, Richard Kirsch, Paul Medline, Robert H
Riddell
University of Toronto, Toronto, ON, Canada; Mount
Sinai Hospital, Toronto, ON, Canada; Gamma Dynacare
Medical Laboratories, Brampton, ON, Canada
Significance of E-cadherin Expression in Pancreatic

Intraepithelial Neoplasia and Ductal Adenocarcinoma
(1742)
Joon H Choi, Min J Kim, Hyeong C Shin, Mi J Gu,
Young K Bae
Yeungnam University College of Medicine, Daegu,
Republic of Korea
252
Molecular Profile of Pancreas Ductal Adenocarcinoma

with CancerSCANTM Panel Analysis (1743)
Misun Choi, Kee-Taek Jang, Donghyun Park,
Woongyang Park, Seoung Ho Choi
Samsung Medical Center, Seoul, Republic of Korea;
Sungkyunkwan University School of Medicine, Suwon,
Gyeonggi-do, Republic of Korea
253
Clinicopathological Significance of MUC13 Expression

in Pancreatic Ductal Adenocarcinoma (PDAC); the
Positive Prognostic Marker and Possible Candidate for
Molecular Targeted Therapy (1760)
Katsuji Marukawa, Tomoko Mitsuhashi, Yutaka
Hatanaka, Asami Morooka, Daisuke Sato, Takeo Nitta,
Toru Nakamura, Satoshi Hirano, Yoshihiro Matsuno
Hokkaido University Hospital, Sapporo, Japan
254
SMAD4 Inactivation as Assessed by Diligently

Evaluated Immunohistochemistry Is Highly Associated
with Adverse Prognosis in Pancreas Cancer (1745)
Craig Dunseth, Sarah L Mott, Jason Hornick, James J
Mezhir, Andrew M Bellizzi
University of Iowa, Iowa City, IA; Brigham and
Womens, Boston, MA
255
Long Noncoding RNA MALAT1 Sequesters miR-217

in Nucleus and Acts as a Oncogene in Pancreatic
Carcinogenesis (1741)
Jie Chen
Peking Union Medical College Hospital, Beijing, China
256
CD13hi Neutrophil-Like Myeloid-Derived Suppressor

Cells Exert Immune Suppression through Arginase
1 Expression in Pancreatic Ductal Adenocarcinoma
(1782)
Jing Zhang, Xiongfei Xu, Min Shi, Ying Chen, Danghui
Yu, Chenyan Zhao, Yan Gu, Biao Yang, Gang Jin,
Minghua Zhu
Changhai Hospital, Shanghai, China; Second Military
Medical University, Shanghai, China
245
Prevalence of Adenovirus Colitis in Stem Cell

Transplant Recipients (1532)
Andrew Bandy, Xiaoming You, Haonan Li, Jie Liao,
Sambasiva Rao, Guang-Yu Yang
PANCREAS & BILIARY TREE
246
247
248
249
Morphologic Characterization of Intrahepatic

Cholangiocarcinomas (ICCs) (1759)
David Martin, Hyejeong Choi, Bahar Memis, Volkan
Adsay, Alyssa M Krasinskas
Emory University, Atlanta, GA; Ulsan University
Hospital, Ulsan, Republic of Korea
Comparative Study of Isocitrate Dehydrogenase 1
Mutations in Intraheptatic Cholangiocarcinoma by
Immunohistochemistry and Pyrosequencing (1758)
Amy A Lo, Helio A Costa, Jim Zehnder, David Dittman,
Sam Rao, Guang-Yu Yang, Nike Beaubier
Stanford School of Medicine, Stanford, CA;
Northwestern School of Medicine, Chicago, IL
Impact of Training and Experience on Evaluation of
Biliary Brushings (BDB) (1771)
Michelle Reid, Ezgi Hacihasanoglu, Vaidehi Avadhani,
Adeboye O Osunkoya, Uma Krishnamurti, Krisztina
Z Hanley, Alyssa Krasinskas, Lauren Daniels, Alexa
Freedman, Michael Goodman, Volkan Adsay
Intraepithelial Neoplasia as a Pitfall in Fine Needle
Aspiration of Solid Pancreatic Masses (1744)
Jennifer L Dettloff, Pamela J Hodul, Jason Klapman,
Cynthia Harris, Mokenge P Malafa, Domenico Coppola,
Barbara A Centeno
211
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
257
264
20q Gain Is an Oncogenic Driver Event That Occurs

Preferentially in KRAS/ BRAF Wild Type Colorectal
Carcinoma (1814)
Carlos Pagan, Ryan Ptashkin, Ahmet Zehir, Michael
F Berger, Jinru Shia, Efsevia Vakiani, Marc Ladanyi,
Jaclyn Hechtman
265
Recurrent, Truncating SOX9 Mutations Are Associated

with KRAS and PI3K Pathway Mutations and May Be
Oncogenic in Colorectal Carcinoma (1801)
Jaclyn Hechtman, Breanna M Javier, Efsevia Vakiani,
Jinru Shia, Ahmet Zehir, Christine Iacobuzio-Donahue
266
Up-regulated S100A4 Is Associated with Tumor

Progression in Signet-Ring Cell Carcinoma (1808)
Yihong Ma, Gene P Siegal, Shi Wei
267
Correlation between the Expression of Mismatch

Repair Proteins (MLH1, MSH2, MSH6, and PMS2) and
Cell Proliferation Status in Mismatch Repair-Proficient
Tissues: Biological and Pathological Implications
(1790)
Haiyan Chen, Liang Huang, Neelima Valluru,
Xiuzhen Duan, Yi Zhou, Mohammed Atieh, Stefan E
Pambuccian, Xianzhong Ding
268
Immuno-Proteomics of Colon Cancer: PSMA1 Is

Implicated in Colorectal Carcinogenesis and Has
Prognostic Significance (1826)
Qian Yang, Prashant Bavi, Julia Y Wang, Michael H
Roehrl
269
Clinician Experience with an NGS Clinical Observation

Trial in Oncology (1810)
Susan Mockus, Cara Statz, Petra Helbig, Sara E
Patterson, Victoria Sanders, Marek Skacel, Gregory J
Tsongalis, Jens Rueter
Jackson Laboratory, Farmington, CT; EEMC, Brewer,
ME; Dahl-Chase Pathology, Bangor, ME; DHMC,
Lebanon, NH
270
Validation of a Clinical 1400-Gene Assay for Genomic

Profiling of Cancer from DNA and RNA (1792)
Michael J Clark, Martina Lefterova, Elena Helman, Ravi
K Alla, Deanna M Church, Sean M Boyle, Shujun Luo,
Massimo Morra, Jason Harris, Nan Leng, Christian
Haudenschild, Richard Chen, John West
Personalis, Menlo Park, CA
271
Utility of a Rapid Turnaround, Clinically-Relevant Gene

Panel for Next Generation Sequencing (NGS) Analysis
of FFPE Solid Tumors (1804)
Ravindra Kolhe, Alka Chaubey, Deepa Jagdale,
WonSok Lee, Ashis K Mondal, Andrew Hadd
Genetics Center, Greenwood, SC; Asuragen, Inc.,
Austin, TX
Neoadjuvant Therapy (NAT) for Borderline Resectable

Pancreatic Cancer (BRPC): Comparison of Histologic
Grading Systems of Residual Adenocarcinoma
Following Chemotherapy (CT) Alone (1755)
Sunhee S Kim, Andrew H Ko, Eric K Nakakura, Zhen J
Wang, Carlos U Corvera, Hobart W Harris, Kimberly S
Kirkwood, Ryutaro Hirose, Margaret A Tempero, Grace
E Kim
258
Lymph Node Yield and Excision Margin Status in

Pancreaticoduodenectomy (Whipples) Specimens: A
Three and a Half Year Audit Assessing the Impact of
Neoadjuvant Therapy (1762)
Brianan McGovern, Daniele M di Capua, Luigi Bonanni,
Rozana Abdul Rahman, Jean Murphy, Kieran Sheahan,
Niall Swan
St. Vincents University Hospital, Dublin, Ireland
259
MicroRNA Expression in Pancreatic Ductal

Adenocarcinoma: A Comparative Study to Predict
Metastasis after Neoadjuvant Chemoradiation (1770)
Juan Putra, Francine de Abreu, Eric B York, Scott M
Palisoul, Arief A Suriawinata, Xiaoying Liu, Gregory J
Tsongalis
260
Unique Mutational Signature of Pancreatic

Neuroendocrine Tumors with Mismatch Repair
Mutations (1761)
Cheryl A Mather, Jenny Qi, Emily K Bergsland, Grace E
Kim, Scott A Oakes
CA
261
Loss of MGMT Protein Expression in Pancreatic

Neuroendocrine Neoplasms Does Not Affect Overall
Survival (1781)
Allison J Zemek, John Allen, Hemamalini Vairamuthu,
Pamela L Kunz, Teri A Longacre
PATHOBIOLOGY (INCLUDING PAN-GENOMIC/PANPROTEOMIC APPROACHES TO CANCER)
262
263
212
Identification and Validation of Differentially

Expressed miRNAs in Appendiceal Mucinous
Cystadenocarcinoma from Mucinous Cystadenoma
(1825)
Richard L Wu, Shadan Ali, Artur Rangel-Filho, David
Andrews, Yao-Shan Fan, Fazlul Sarkar, Rafic Beydoun
Jackson Memorial Hospital, University of Miami,
Miami, FL; Detroit Medical Center, Wayne State
University, Detroit, MI
LINE-1 RNA and ORF1p Protein Are Broadly CoExpressed in Colon Cancer[/underline] (1821)
Martin Taylor, Dipti Sajed, Erik Williams, David T Ting,
Vikram Deshpande
School, Boston, MA
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
272

Representative of Patients with Recurrent Cancer That
Is Refractory to Standard Therapy? (1788)
Emily Broaddus, Scott Kopetz, J Jack Lee, Jiexin
Zhang, Kenna Shaw, Russell Broaddus
University of Texas, Austin, TX; M.D. Anderson Cancer
Center, Houston, TX
279
273
Development of Patient Derived Tumor Organoids to

Guide Precision Medicine (1816)
Chantal Pauli, Loredana Puca, Brooke Emerling,
Benjamin Hopkins, Michael Augello, Andrea Sboner,
Olivier Elemento, David Pisapia, Rema Rao, Brian D
Robinson, Juan Miguel Mosquera, David Rickman,
Himisha Beltran, Mark Rubin
Weill Cornell Medical College-New York Presbyterian
Copy Number Alterations in Primary and Recurrent

Breast Tumors (1802)
Rahul M Jawale, Kevin C Johnson, Kristin E Williams,
Brian T Pentecost, Brock C Christensen, Christopher N
Otis, Kathleen F Arcaro
Baystate Medical Center, Springfield, MA; Geisel
School of Medicine at Dartmouth, Hanover, NH;
University of Massachusetts, Amherst, MA; Wadsworth
Center, NYS DoH, Albany, NY
280
Shifts in Mutation Profiles between Primary and

Synchronous Lymph Node Metastases (mLN) in Triple
Negative Breast Cancer (1829)
Weiqiang Zhao, Kara Patterson, Susan Long, Kevin Y
Zhao, Nehad Mohamed, Joshua Coleman, Yan Tang,
Bhuvaneswari Ramaswamy, Daniel Jones
Columbus, OH; The Ohio State University James
Cancer Center, Columbus, OH
281
PITPNC1 in Breast Cancer (1824)

Phillip Williams, Ranju Nair, Grace Cheung, Naomi A
Miller, Bruce J Youngson, Susan J Done
University Health Network, Toronto, Canada; University
of Toronto, Toronto, Canada
282
Multiplex Gene Expression Analysis of Eosinophilic

Esophagitis Refractory to Therapy Using Nanostring
Technology (1793)
David Corney, Sonja Chen, Yiang Hui, Kara A
Lombardo, Shamlal Mangray, Murray B Resnick,
Andres Matoso
Thomas Jefferson, Philadelphia, PA; Rhode Island
Hospital and Brown University, Providence, RI
283
Utility of Oral Fluid (Saliva) for Molecular Profiling in

Hematologic Malignancy (1803)
Jonathan Killian, Maria E Arcila, Connie Batlevi, Marc
Ladanyi, Paul Meltzer, Ryan Ptashkin, Anas Younes
National Cancer Institute, Bethesda, MD; Memorial
284
Cigarette Smoke Associated Genetic Alterations Found

in Urine Specimens from Patients with Superficial
Non-Muscle Invasive High Grade Urothelial Carcinoma
(1827)
Ming Zhang, Sasinya N Scott, Nancy Bouvier, Michael
F Berger, Oscar Lin
285
Combined Molecular Testing (Mutational Analysis and

MicroRNA Classifier Status) Advances Understanding
of Molecular Pathobiology of Thyroid Follicular
Neoplasia (1818)
Angela M Sanguino Ramirez, Maria L Torres, Jan F
Silverman, Sydney D Finkelstein
Allegheny Health Network, Pittsburgh, PA; RedPath /
Interpace Diagnostics, Pittsburgh, PA
274
275
276
277
278
MET Molecular Epidemiology of Advanced Solid

Tumors Candidate to Targeted Therapies[/underline]
(1813)
Paolo Nuciforo, Analia Azaro, Ludmila Prudkin,
Roberta Fasani, Paola Martinez, Maria Diaz, Jose
Jimenez, Wei-Li Liao, Alejandra Iglesias, Marta Vilaro,
Debora Moreno, Fabiola Cecchi, Adele Blackler, Todd
Hembrough, Ana Vivancos, Jordi Rodon
Vall dHebron Institute of Oncology, Barcelona, Spain;
Oncoplex Diagnostics, Rockville, MD; NantOmics,
Culver City, CA
Distribution of IDH1 and IDH2 Genomic Alterations
across the Landscape of Relapsed and Refractory Solid
Tumors and Hematologic Malignancies (1795)
Julia A Elvin, Jo-Anne Vergilio, Garrett Frampton,
Zachary Chalmers, James Suh, Laurie Gay, Siraj M Ali,
Differential Expression of PDGFRB and EGFR in
Microvascular Proliferation in Glioblastoma (1806)
Jianyi Li, Guiyan Xu
North Shore University Hosiptal and Long Island
Jewish Medical Center, Lake Success, NY; Northwell
Health, Lake Success, NY
Retrospective Review of Targeted Molecular
Genotyping of Lung Adenocarcinomas at Baylor
University Medical Center (1812)
Stacey L Murthy, Cody Thomas, Stacia Clement-Kruzel,
George J Snipes
Baylor University Medical Center, Dallas, TX
Frequency of KRAS Subtypes in Non-Small Cell Lung
Cancer (1787)
Anna Biernacka, Peter D Tsongalis, Jason D Peterson,
Francine de Abreu, Candice C Black, Edward Gutmann,
Xiaoying Liu, Vijayalakshmi Padmanabhan, Laura J
Tafe, Christopher I Amos, Gregory J Tsongalis
Dartmouth Hitchcock Medical Center, Norris Cotton
Cancer Center, and Geisel School of Medicine at
Dartmouth, Lebanon and Hanover, NH
213
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
286
292
Role of NOTCH Signaling Molecules in the

Development of Barretts Associated Adenocarcinoma
(1789)
Weibiao Cao, Dan Li, Fadlallah Habr, Jack Wands
Rhode Island Hospital and Warren Alpert Medical
School of Brown University, Providence, RI
293
Platelet Cloaking Maintains Migratory and Invasive

Characteristics of CTCs (1820)
Cathy D Spillane, Sinead Skehan, Cara M Martin,
Sharon OToole, Orla Sheils, John OLeary
Trinity College Dublin, Dublin, Ireland; Coombe Women
& Infants University Hospital, Dublin, Ireland; Dublin
City University, Dublin, Ireland
287
288
289
290
291
214
mTOR Pathway Genes Drive Intratumor Heterogeneity

and Morphological Progression in Clear Cell Renal Cell
Carcinomas (1794)
Salvador Diaz-Cano, Russel Sutherland, Jane
Moorhead, Alfredo Blanes, Richard Dobson
United Kingdom; University of Malaga School of
Medicine, Malaga, Spain
TGF Is an Upstream Regulator of mTORC2-Dependent
Bladder Cancer Migration and Invasion (1800)
Sounak Gupta, Andrew M Hau, Hikmat A Al-Ahmadie,
Jyoti Harwalkar, Aaron C Shoskes, Paul Elson, Jordan
R Beach, George S Hussey, Thomas T Egelhoff, Philip
H Howe, Donna Hansel
Mayo Clinic, Rochester, MN; University of California
San Diego, La Jolla, CA; Memorial Sloan Kettering
Cancer Center, New York, NY; Cleveland Clinic,
Cleveland, OH; Medical University of South Carolina,
Charleston, SC
Molecular Profiling Reveals That Multiple Merkel Cell
Carcinoma Tumors May Represent Either Clonally
Related Metastases or Multiple Clonally Distinct
Primaries (1805)
Lorena Lazo de la Vega, Kelly L Harms, Daniel H
Hovelson, Samantha Rahrig, Andi K Cani, Chia-Jen
Liu, Douglas R Fullen, Timothy M Johnson, Scott A
Tomlins, Paul W Harms
Concordance of Anti-BRAF p.V600E
immunohistochemistry with BRAF Gene Sequence in
Solid Tumors Carrying Diverse BRAF Mutations (1797)
Zoran Gatalica, Semir Vranic, Inga Rose, Peggy Teresi,
Rebecca Feldman, Ryan P Bender
Caris Life Sciences, Phoenix, AZ; Clinical Center,
University of Sarajevo, Sarajevo, Bosnia and
Herzegowina
Role of SOX4 in PTEN-Mediated Prostate
Tumorigenesis (1811)
Carlos Moreno, Birdal Bilir, Walter Wiles, Soma
Sannigrahi, Veronique Lefebvre, Pierre Chambon,
Demetri Spyropoulos, David Martin, Adeboye O
Osunkoya
Emory University School of Medicine, Atlanta, GA;
Cleveland Clinic, Cleveland, OH; Medical University of
South Carolina, Charleston, SC; Institut de Genetique
et de Biologie Moleculaire et Cellulaire, Strasbourg,
France
The Ataxia-Telangiectasia Mutated and RAD3-Related
Protein Kinase Regulates Intracellular Hydrogen Sulfide
Concentrations (1819)
Rodney Shackelford, Jei Chen, Rabie Shanti, Junaid
Ansari, Moiz Vora
LSU Health Sciences Shreveport, Shreveport, LA; LSU
Health Sciences Center, Shreveport, LA; Feist Weiller
Cancer Center, Shreveport, LA
PEDIATRIC PATHOLOGY
294
Botryoid Wilms Tumor: A Non-Existent Entity

Causing Diagnostic and Staging Difficulties (1841)
Marco Schiavo Lena, Gordan Vujanic
San Raffaele Scientific Institute, Milano, Italy;
University Hospital of Wales, Cardiff, United Kingdom
295
Placental Pathology in Small-for-Gestational Age

Placentas from Pregnancies with Type 1 Pregestational
Diabetes (1835)
Mai He, Phinnara Has, Suzanne DeLaMonte, Roman S
Starikov
Women Infants Hospital of Rhode Island/Alpert
Medical School of Brown University, Providence, RI;
Women Infants Hospital of Rhode Island, Providence,
RI; Rhode Island Hospital / Alpert Medical School of
Brown University, Providence, RI; Phoenix Perinatal
Associates, Phonnix, AZ
296
BRAF Reactivity and BRAF Mutations in Pediatric

Langerhans Cell Histiocytosis (1840)
Essia Saiji, Christelle Cerato Biderbost, Margaret
Berczy, Anne-Laure Rougemont
Geneva University Hospitals, Geneva, Switzerland
297
Absence of Distinct Immunohistochemical Distribution

of Annexin A5, C3b, C4d and IgG in Placentas from
Patients with Antiphospholipid Antibodies Compared
to Preeclampsia and SLE (1838)
Cathleen Matrai, Jacob H Rand, Rebecca Baergen
NYPH-Weill Cornell, NYC, NY
298
Collagen XVIII and Procollagen-lysine, 2 oxoglutarate

5-dioxygenase 2 (PLOD2) Expression in Human
Pediatric and Mouse Rhabdomyosarcomas: Exploring
Potential Biomarkers of Therapeutic Relevance (1830)
Jesse Bond, Sakir H Gultekin, Christopher Hartley,
Teagan Settelmeyer, Charles Keller, Atiya Mansoor
Oregon Health and Sciences University, Portland, OR;
Childrens Cancer Therapy Development Institute, Fort
Collins, CO; Medical College of Wisconsin, Milwaukee,
WI
POSTER
POSTERSESSION
SESSIONIV
Monday,
Tuesday,March
March23,
15,2015
2016| |9:30
1:00AM
PM- 12:00
- 4:30 PM
CC Exhibit Hall C/D

4ABC
Board
Number
Board
Number
299
Prenatal Jarcho-Levin Syndrome (1837)

Ana Larque, Mar Bennasar, Paola Castillo, Alfons Nadal
Hospital Clinic, Barcelona, Spain; Barcelona Center for
Maternal-Fetal Medicine and Neonatology, Hospital
Clnic, Barcelona, Spain
303
Clinicopathological Study of Hepatoblastoma with

Pulmonary Metastases (1845)
Mio Tanaka, Misa Yoshida, Rieko Ijiri, Norihiko
Kitagawa, Masato Shinkai, Hiroaki Goto, Yukichi Tanaka
Kanagawa Childrens Medical Center, Yokohama, Japan
300
SOX10 Distinguishes Pilocytic and Pilomyxoid

Astrocytomas from Ependymomas but Shows No
Differences in Expression Level in Ependymomas from
Infant Versus Older Children or between Molecular
Subgroups (1839)
Abby M Richmond, Andrew M Donson, Nicholas K
Foreman, Bette K Kleinschmidt-DeMasters
University of Colorado, Aurora, CO; Childrens Hospital
Colorado, Aurora, CO
304
Tight Junction Dysregulation Is Involved in the

Rotavirus Infection Related Diarrhea (1848)
Richard L Wu, Artur Rangel, Monica Garcia, Janet M
Poulik
Jackson Memorial Hospital/University of Miami,
Miami, FL; Detroit Medical Center/Wayne State
University, Detroit, MI
305
Juvenile Laryngeal Papillomatosis: Relation between

p16 and p63 Expression, Human Papilloma Virus
Infection and Clinical Evolution (1834)
Louise Galmiche, Sebastien Pierrot, Helene Pere,
Vincent Couloigner, Cecile Badoual
Necker Hospital, Paris, France; Georges Pompidou
European Hospital, Paris, France
306
Reevaluation of Histological Features for Intra/Extra

Pulmonary Sequestration (1846)
Mio Tanaka, Rieko Ijiri, Kumiko Nozawa, Noriko Aida,
Masato Shinkai, Yukichi Tanaka
Kanagawa Childrens Medical Center, Yokohama, Japan
301
302
Molecular Characterization of Gliomas in Adolescents

and Young Adults (1844)
Mariona Sunol, Josep Riera Monroig, Carmen de
Torres, Iban Aldecoa, Carlota Rovira, Cristina Jou, Eva
Rodriguez, Ofelia Cruz, Teresa Ribalta
Hospital Sant Joan de Deu, Barcelona, Spain; Hospital
Clinic, Barcelona, Spain
Will the Quest for a Novel Positive Marker for a
Diagnosis of Hirschsprung Disease on Formalin
Fixed Rectal Mucosal Biopsies End with a Glucose
Transporter? A Detailed Dual IHC Panel Study of
GLUT1 and Calretinin (1831)
Maria F Bukelo, Usha Kini, Suravi Mohanty, Kanishka
Das
St. Johns Medical College and Hospital, Bangalore,
Karnataka, India
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
BREAST PATHOLOGY
Expression of Splicing Variants of Androgen Receptor

in Primary and Metastatic Breast Cancer (185)
Yehonatan Kane, Fang-Ming Deng, Yang Zhan, Yanfeng
Qi, Jane D Hon, Xichun Liu, Haitao Zhang, Jinhua
Wang, Rachel Brody, Rosemary Wieczorek, Yan Dong,
Peng Lee, Baljit Singhb
York, NY; Tulane University, New Orleans, MI
Androgen Receptor Expression in Triple Negative

Breast Cancers: A Single Institution Experience (234)
Palawinnage Vidarshi U Muthukumarana, Sheila E
Segura, Theresa L Profeta, Ramapriya Vidhun
Danbury Hospital, Danbury, CT
Integration of Androgen Receptor (AR) Expression to

Predict Survival for Triple-Negative Breast Carcinoma
(TNBC) (109)
Kristine Astvatsaturyan, Yong Yue, Shikha Bose
Luminal Androgen Receptor (LAR) Subtype Breast

Cancers Are Not Histologically Defined by Apocrine
Morphology (229)
Ann M Moyer, Xuemei Wu, Daniel W Visscher, Krishna
R Kalari, Kevin J Thompson, Xiaojia Tang, Vera J
Suman, Travis J Dockter, Sarah A McLaughlin, Alvaro
Moreno-Aspitia, Donald W Northfelt, Richard J Gray,
Katie N Jones, Amy L Conners, Eric D Wieben, Liewei
Wang, Richard M Weinshilboum, Matthew Goetz, Judy
C Boughey
FL; Mayo Clinic, Scottsdale, AZ
Molecular and Histopathologic Correlation of BRCA1and BRCA2-Associated Invasive Breast Carcinoma

(280)
Tiffany Shao, Jordan Lerner-Ellis, Martin C Chang
Mt Sinai Hospital, Toronto, ON, Canada; University of
215
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
13
Triple Negative Breast Cancers vs. Quadruple

Negative Breast Cancers: The Androgen Receptor
Factor (301)
Elena Vrotsos, Carmen Gomez-Fernandez, Mahsa
Khanlari, Mehrdad Nadji
14
Subset Populations of Patients with Triple Negative

Breast Cancer Exist Possessing Biomarkers for
Targeted Therapeutics (225)
Wilfrido Mojica, Paul Mojica, Elizabeth Marchetti
University at Buffalo, Buffalo, NY; UCLA, Los Angeles,
CA
15
Loss of PTEN in High Grade Advanced Stage Triple

Negative Breast Ductal Cancers in African American
Women (187)
Farhan Khan, Tammey Naab, Luisel J Ricks-Santi,
Yasmine Kanaan, Girmay Asgedom
Howard University Hospital, Washington, DC; Hampton
University, Hampton, VA
16
Increased BCL2 Expression Predicts Poor Survival in

Triple Negative Breast Cancer Patients (177)
Jabed Iqbal, Aye Aye Thike, Takashi Yamasaki, Joe
Yeong, Puay Hoon Tan
Singapore General Hospital, Singapore, Singapore;
Kobe University School of Medicine, Kobe, Japan
17
Strong ROR1 Expression Is an Independent Adverse

Prognostic Factor in Triple Negative Invasive Breast
Carcinoma (173)
Chuen Hsueh, Hui-Ping Chien, Shin-Cheh Chen, Yu-Sun
Chang, Shir-Hwa Ueng, Yung-Chang Lin, Yun-Feng Lo,
Hsien-Kun Chang, Wen-Yu Chuang
Chang Gung Memorial Hospital, Linkou, Taoyuan,
Taiwan; Chang Gung Memorial Hospital, Keelung,
Keelung, Taiwan; Chang Gung University College of
Medicine, Taoyuan, Taiwan
18
c-Myc Oncogene Highly Expressed, but Not Amplified

in High Grade Triple Negative Breast Ductal Cancers in
African American Women (235)
Tammey Naab, Luisel J Ricks-Santi, Farhan Khan,
Ashwini K Esnakula, Girmay Asgedom, Jeffrey
Robinson
Howard University Hospital, Washington, DC; Hampton
University, Hampton, VA; University of Florida,
Gainsville, FL
19
A Novel Risk-Predictive Metric Stratifies Triple-Negative

Breast Cancers Based on Cell Cycling Kinetics (195)
Sergey Klimov, Andrew Green, Mohammed A
Aleskandarany, Emad Rakha, Ian O Ellis, Guilherme
Cantuaria, Ayodeji O Agboola, Michelle Reid, Xiaoxian
Li, Padmashree CG Rida, Ritu Aneja
Georgia State University, Atlanta, GA; University
of Nottingham, Nottingham, United Kingdom;
Northside Hospital Cancer Institute, Atlanta, GA;
Olabisi Onabanjo University, Sagamu, Nigeria; Emory
BRCA1 and BRCA2-Associated Breast Cancers

Demonstrate Distinct Histopathologic Features,
Biomarker Expression Patterns and Molecular
Subtypes (147)
Constance Albarracin, Sagar Dhamne, Banu Arun,
Kristin Ward, Yun Wu, Daniel G Rosen, Xiaoyan Cui,
Erika Resetkova, Xiuzhen Duan, Hui Chen, Isabelle
Bedrosian, Angelica Gutierrez Barrera
MD Anderson, Houston, TX; Loyola University,
Chicago, IL; Baylor College Medicine, Houston, TX;
University Texas, El Paso, TX
Hyaline Fibrous Involution: A Novel Histologic Finding
That Is More Common in BRCA+ Breast Tissue (204)
Hee Eun Lee, Muhammad Arshad, Rushin D
Brahmbhat, Tanya L Hoskin, Stacey Winham, Marlene
H Frost, Derek C Radisky, Lori Denison, Amy Degnim,
Daniel W Visscher
A Functional Assay for Homologous Recombination
(HR) DNA Repair Assessment in Breast Cancers[/
underline] (154)
Marcia Edelweiss, Nadeem Riaz, Salvatore Piscuoglio,
Charlotte KY Ng, Britta Weigelt, Robert W Mutter,
Robert Delsite, Dilip Giri, Tari King, Jorge S Reis-Filho,
Simon Powell
MSKCC, NY, NY
Overexpression of FoxO3a Is Associated with Lymph

Node Metastasis and Poor Disease-Free Survival in
Triple-Negative Breast Cancers (101)
Rehman Abdul, Yumin Chung, Hyein Ahn, Jongmin
Sim, Min Sung Chung, Kiseok Jang
Hanyang University College of Medicine, Seoul,
Republic of Korea
10
Expression of Cancer Stem Cell Markers Predicts

Worse Outcome in Early Stage Triple Negative Invasive
Breast Carcinoma (297)
Shir-Hwa Ueng, Shin-Cheh Chen, Yu-Sun Chang, YungChang Lin, Yun-Feng Lo, Hsien-Kun Chang, Wen-Yu
Chuang, Shih-Che Shen, Chuen Hsueh
Chang Gung Memorial Hospital, Linkou, Taoyuan,
Taiwan; Chang Gung University, Taoyuan, Taiwan
11
12
216
The Forkhead Box Transcription Factor FOXC1 Further

Stratifies Prognosis of Patients with Triple-Negative
Breast Cancer (309)
Yong Yue, Kristine Astvatsaturyan, Xiaojiang Cui, Xiao
Zhang, Benedick Fraass, Shikha Bose
Down-Regulation of Fructose-1,6-Bisphosphatase
(FBP1) in Triple-Negative Breast Cancer (308)
Esther Yoon, Kenneth Hennrick, Yong Mao, Konstantin
Volyanskyy, Nevenka Dimitrova, John T Fallon, Minhao
Zhong
New York Medical College, Valhalla, NY; Philips, 345
Scarborough Road, NY
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
20
The Prognostic Value of E-Cadherin and -Catenin in

Triple-Negative Breast Cancer (TNBC) (282)
Tiansheng Shen, Gene P Siegal, Shi Wei
28
21
SAE2 Expression in c-MYC Positive Triple-Negative

Breast Carcinomas (202)
Kimberly Lally, Xuemo (Sean) Fan, Serhan Alkan
Sentinel Lymph Node Status and Patterns of Invasion

in Microinvasive Breast Carcinoma (276)
Christopher Sebastiano, Saipriya Iyer, Anibal Cordero,
George Plitas, Dilip Giri
Memorial Sloan Kettering Cancer Center, NY, NY
29
22
Retinoic Acid Receptor Alpha Is a Positive Prognostic

Biomarker in Triple-Negative Breast Cancer (242)
Angela Ogden, Andrew Green, Mohammed A
Aleskandarany, Emad Rakha, Ian O Ellis, Simak Ali,
Xiaoxian Li, Uma Krishnamurti, Michelle D Reid,
Padmashree CG Rida, Ritu Aneja
Georgia State University, Atlanta, GA; The University
of Nottingham, Nottingham, United Kingdom; Emory
University Hospital, Atlanta, GA; Imperial College
London, London, United Kingdom
Megakaryocytes in Lymph Nodes of Patients with

Breast Cancer: A Clinicopathologic Correlation (256)
Jennifer Pincus, Juehua Gao, Megan Sullivan
Northwestern University Feinberg School of Medicine,
Chicago, IL
23
High HER3-EGFR Score Predicts Aggressive Disease

Course in Triple-Negative Breast Cancer (243)
Angela Ogden, Andrew Green, Mohammed A
Aleskandarany, Emad Rakha, Ian O Ellis, Xiaoxian Li,
Uma Krishnamurti, Michelle D Reid, Padmashree CG
Rida, Ritu Aneja
Georgia State University, Atlanta, GA; The University
of Nottingham, Nottingham, United Kingdom; Emory
University Hospital, Atlanta, GA
24
CD3+ and FOXP3+ Tumor-Infiltrating Lymphocytes Are

Associated with Better Prognosis in Triple Negative
Breast Cancers (176)
Jabed Iqbal, Joe Yeong, Jeffrey Chun Tatt Lim, Puay
Hoon Tan
25
Comparison of Immune Response and PDL1

Distribution in Triple Negative Invasive Breast
Carcinomas in Different Ethnic Populations (171)
Jian He, Arundhati Rao, Arun Sreekumar
Baylor, Scott & White Memorial Hospital, Temple, TX;
Baylor College of Medicine, Houston, TX
26
Tumor Infiltrating Lymphocytes (TIL) in Predicting

Neoadjuvant Therapy Response and Survival in HER2+
Breast Cancers (106)
Caitlin Andrews, Elizabeth A Mittendorf, Juhee Song,
Kelly K Hunt, Aysegul A Sahin, Yun Wu
27
The Role of a Negative Axillary Fine Needle Aspiration

in Identifying Breast Cancer Patients with No Axillary
Metastasis[/underline][/underline] (178)
Mark Jabbour, Mothana Saadeldine, Ghina Berjawi,
Faek Jamali, Jaber Abbas, Fouad Boulos
American University of Beirut Medical Center, Beirut,
Lebanon
CYTOPATHOLOGY
30
Differential Expression of Various Clones of

Estrogen Receptor in Cell Block Preparation of Lung
Laleh Hakima, Kathie Schlesinger, Jaya Sunkara,
Rouzan G Karabakhtsian
Montefiore Medical Center, Bronx, NY
31
Morphologic Assessment of Cellularity and Tumor

Fraction in Concurrently Acquired Cytology Fine
Needle Aspiration and Surgical Core Needle Biopsy for
Sinchita Roy Chowdhuri, Hui Chen, Gregg Staerkel,
John M Stewart
Houston, TX
32
Fine Needle Aspiration Biopsy Material of Liver Lesions

Yields Higher Percentage of Tumor Cells for Molecular
Studies: A Direct Comparison to Concurrent Core
Biopsy (388)
Patricia Goldhoff, Poonam Vohra, Elham Khanafshar,
Britt-Marie Ljung
CA; San Francisco General Hospital, San Francisco, CA
33
Cytologic Preparations for Next Generation

Sequencing: An Analysis of Quality Indicators (403)
David Hwang, Edmund Cibas, Lynette M Sholl
34
Molecular Adequacy of Fine-Needle Aspiration

Cytologic Smears for Next Generation Sequencing in
Lung Adenocarcinoma (347)
Jordan Arkin, Pan Zhang, Rana S Hoda, Navneet
Narula, Hanna Rennert, Michael J Kluk, Helen
Fernandes
New York Presbyterian Hospital-Weill Cornell, New
York, NY
35
Suitability of Endobronchial Ultrasound Guided

Transbronchial Needle Aspiration (EBUS-TBNA)
Samples for Diagnosis, Staging and Molecular/NGS
Testing in Metastatic Malignancies Involving the
Mediastinum (424)
Valerica Mateescu, Ritu Nayar, Nike Beaubier, Ajit
Paintal
Northwestern Memorial Hospital, Chicago, IL
217
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
36
Molecular Testing (MT) on Endobronchial Ultrasound

(EBUS) Fine Needle Aspirates (FNA): Significance of
Appropriate Specimen Triage (ST) at Start of Procedure
(460)
Simon Sung, John P Crapanzano, David DiBardino,
David Swinarski, William A Bulman, Anjali Saqi
45
Metastases from Extrapulmonary Sites to Mediastinal

Lymph Nodes: A 10-Year Retrospective Review of
Transbronchial Needle Aspiration Cytology in a Tertiary
Care Center (470)
Emily Wilding, Teklu Legesse, Dina Kokh, Melissa
Sweeney, Paul Staats
37
Cytomorphologic Features and EGFR Mutational Status

of Combined Small Cell Lung Carcinomas (481)
Yaxia Zhang, Joseph C Cicenia, Fadi W Abdul-Karim
46
38
Detection of EGFR Mutations, ALK, and ROS1

Rearrangements in Cytological Specimens: An
Rana Naous, Shengle Zhang, Kamal K Khurana
Lymphoma Diagnosis on Endoscopic Ultrasound

Guided Fine Needle Aspiration Specimens of
Abdominal Lymphadenopathy; a Retrospective Study
at an Academic Tertiary Referral Center (343)
Roula Albadine, Danh Tran-Thanh, Antonio Maietta,
Sarto C Paquin, Anand V Sahai, Gille Gariepy
Centre Hospitalier de lUniversit de Montral,
Montral, QC, Canada
47
Follicular Lymphoma Diagnosis by Fine Needle

Aspiration Biopsies in a Cancer Center (425)
Zulfia McCroskey, Joseph D Khoury, John M Stewart,
Nancy Caraway
48
Hodgkin Lymphoma Diagnosed by Fine Needle

Aspiration Cytology: A Retrospective Review of 110
Consecutive Cases with Histopathologic Correlation
(344)
Megan Alderman, Harvey M Cramer
49
Fine Needle Aspiration Cytology of Histiocytic

Sarcoma with Correlation of Histopathology and
Yin Hung, Scott B Lovitch, Xiaohua Qian
50
Molecular Profiling of Malignant Pleural Effusion in

Metastatic Non-Small Cell Lung Carcinoma (366)
Jamal H Carter, James A Miller, Zahra Maleki
Challenge of Fine Needle Aspiration Diagnosis of

Angiomyolipoma: A Study of 33 Cases (485)
Haijun (Steve) Zhou, Ming Guo, Yun Gong
51
MicroRNA Profiling of Malignant Mesothelioma:

Diagnostic Significance in Cytology Specimens (476)
Zhongbo Yang, Qingqing Ding, Magda Esebua, Lester
Layfield
Utility of Fine Needle Aspiration and Core Needle

Biopsy to Pre-Operatively Assess Renal Lesions (355)
Aaron N Berg, Sara E Monaco, Jacqueline Cuda, Rajiv
Dhir, Ronald L Hrebinko, Liron Pantanowitz
52
Cytomorphology of Clear Cell Papillary Renal Cell

Carcinoma (419)
Xiaoqi Lin, Ximing Yang
53
A Series of Clear Cell Papillary Renal Cell Carcinoma

Sampled by Aspiration Cytology (448)
Sadia Sayeed, Kathryn Lindsey, Alexander Baras,
Christopher R Jackson, Celeste N Powers, Cora UramTuculescu, Steven Smith
Virginia Commonwealth University Medical Center,
Richmond, VA; Medical University South Carolina,
Charleston, SC; Johns Hopkins University, Baltimore,
MD
39
40
41
42
43
44
218
EGFR Mutation Detection on Non Small Cell Lung

Cancer Routine Cytological Samples by Digital PCR
(465)
Giancarlo Troncone, Pasquale Pisapia, Elena Vigliar,
Claudio Bellevicine, Umberto Malapelle
University of Napies Federico II, Napoli, Italy
EGFR, KRAS, and ALK: Are Really Mutually Exclusive?
Report of Five Cases Harboring Two Different
Theoretically Exclusive Double Mutations Diagnosed
by FNA Cytology (421)
Maria D Lozano, Tania Labiano, Jose M Lopez-Picazo,
Alfonso Gurpide, Mercedes Aguirre, Maria Eugenia
Echarri, Maria Amada Maset, Nerea Gomez, Jorge A
Arabe, Rodrigo Sanchez, Jose I Echeveste, Miguel A
Idoate, Salvador Martin-Algarra
University of Navarra, Pamplona, Spain; Complejo
Hospitalario de Navarra, Pamplona, Spain
Diagnostic Accuracy and False Negative Rate of

EBUS-TBNA in Detection of Well Differentiated
Neuroendocrine Tumors of the Lung (436)
Laila Nomani, Jordan P Reynolds
Triaging Cases with Clinically Suspicious Nodules and
Negative Findings by Electromagnetic Navigational
Biopsy: Experience from One Tertiary Care Center
(477)
Alae Yaseen, Xiu Yang, Houda Alatassi, Tanya Wiese,
Mostafa M Fraig
University of Louisville, School of Medicine, Louisville,
KY
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
54
Cytomorphologic Features and Immunoprofile Useful

to Distinguish Clear Cell Papillary Renal Cell Carcinoma
from Other Renal Cell Carcinomas in Cytology
Specimen (382)
Nazneen Fatima, Ximing Yang, Xiaoqi Lin
Chicago, IL
63
55
Accuracy of Intraoperative Imprint Cytology Performed

Exclusively by Cytopathologists of Sentinel Lymph
Nodes in Breast Cancer (451)
Tanmay Shah, Catherine S Abendroth
56
57
HER2 FISH Concordance in Breast Cancer Patients

with Both Cytology and Surgical Pathology Specimens
(377)
Erika E Doxtader, Benjamin C Calhoun, Charles D
Sturgis, Christine N Booth
Comparison of GATA-3, GCDFP-15 and Mammaglobin
Expression in Breast Carcinoma in Serous Effusions: A
Cell Block Microarray Study (391)
Jennifer P Ha, Mohamed El Hag, Rosemary Farag,
Amad Awadallah, Claire W Michael
MN; Case Western Reserve University, University
Hospitals Case Medical Center, Cleveland, OH
58
Utility of GATA3 in Urothelial Cytology (348)

Stacy J Arnold, F Zahra Aly, Hao Chen, Jordan M
Eldersveld, Robert R Klein
59
Utility and Pitfalls of GATA3 Immunocytochemistry

for Diagnosis of Breast and Urothelial Carcinomas in
Cytology Specimens (414)
Bing Leng, Ming Guo, Yun Gong
Houston, TX
60
61
62
GATA3 Expression as a Marker for Neuroblastoma:

Utility in Aspiration Cytology and Limited Tissue
Samples (471)
Austin Wiles, Jorge Almenara, Celeste N Powers,
Steven Smith
VCU Health System, Richmond, VA
GATA-3 in the Work-Up of Malignant Effusions: A Cell
Block Micro-Array Study (379)
Mohamed El Hag, Rosemary Farag, Jennifer P Ha,
Amad Awadallah, Claire W Michael
MN; Case Western Reserve University, University
Hospitals Case Medical Center, Cleveland, OH
GATA3 Expression in Malignant Mesothelioma Is a
Potential Pitfall in Effusion Cytology (446)
Jennifer L Sauter, Sarah E Kerr
Performance Characteristics of Body Fluid Cytology

(BFC): Analysis of 344,380 Responses from the College
of American Pathologists (CAP) Non-Gynecologic
Cytopathology Education (NGC) Program (461)
Z Laura Tabatabai, Ritu Nayar, Rhona J Souers, Diane
D Davey
UCSF, San Francisco, CA; Northwestern University,
Chicago, IL; CAP, Northfield, IL; University of Central
Florida, Orlando, FL
64
Identification of Helicobacter pylori in Routine Gastric

Biopsies without Reflex Ancillary Stains (769)
Meredith E Pittman, Laura Wood, Elizabeth A
Montgomery, Lysandra Voltaggio
65
Utilization of H. Pylori Immunostaining in Gastric

Biopsies: A Cost-Effective Diagnostic Algorithm (704)
Nigar Khurram, Amir Momeni Boroujeni, Elham
Yousefi, Constantine Axiotis
SUNY DMC, Brooklyn, NY
66
Portal Hypertensive Gastropathy or Gastric Antral

Vascular Ectasia: Is an Accurate Diagnosis Possible on
Histology? (839)
Yi Zhou, Guilan Chen, Haiyan Chen, Vamsi Parini,
Mohammed Atieh, Stefan Pambuccian, Xianzhong
Ding
Loyola University Medical Center, Maywood, IL; SSM
Health St. Joseph Hospital - St. Charles, Saint Charles,
MO
67
Gastrointestinal Tract Vasculopathy: A Single

Institution Experience (730)
Christine Y Louie, Gerald J Berry, Teri A Longacre
Stanford Hospital & Clinics, Stanford, CA
68
Comparison of the Extra-Ileal Manifestations of Crohns

Disease and Non-Specific Ileitis (741)
Gregory Miller, Ian Brown
Envoi Specialist Pathologists, Brisbane, Queensland,
Australia
69
Clinical and Pathologic Characteristics of Incidentally

Discovered Dysplasia in IBD Patients Resected for
Medically Refractory Disease (763)
Deepa Patil, Erica Savage, John R Goldblum, Robert
Odze
70
Retrospective Review of Colectomy in Patients with

Pre-Pouch Ieitis after Surgery for Ulcerative Colitis
(745)
Prasuna Muppa, Saba Yasir, Laura E Raffals, Thomas C
Smyrk
219
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
71
A Clinicopathologic Study of Collagenous Enteritis

(709)
Vanderlene Kung, Changqing Ma, Ta-Chiang Liu
Washington University School of Medicine, St.
Louis, MO; University of Pittsburgh Medical Center,
Pittsburgh, PA
80
72
Histopathologic Findings in Patients with Strongyloides

Stercoralis and HTLV-1 Infection (817)
Anna-Sophie Weidner, Wayne Tam, Rhonda K Yantiss,
Jose Jessurun
Identification of RhoA and Related Gene

Mutation in Diffuse Type Gastric Cancer: Distinct
Clinicopathological Features and Mucin Expression
(760)
Do Youn Park, So Jeong Lee, Chung Su Hwang, Young
Geum Kim, Sangjeong Ahn, Ahrong Kim, Nari Shin,
Kyung Un Choi, Chang Hun Lee, Gi Young Huh
Pusan National University Hospital, Pusan National
University Medical School, Busan, Seo-Gu, Republic of
Korea
81
Peptic Duodenitis Lacks Gastric Histologic,

Infectious, and Pharmocologic Correlates: A Review of
225 Consecutive Biopsies (744)
Mohamed Mostafa, Christopher Hartley, Catherine
Hagen

Mismatch Repair Deficient Gastric Tumors and Gastric
Tumors Positive for Epstein-Barr Virus (775)
Bing Ren, Krishna Patel, Fyza Shaikh, Benjamin Zhu,
Weijing Sun, Aatur Singhi, Changqing Ma
82
The Role of Immunohistochemistry in Subtyping

Ampullary Adenocarcinoma (658)
Danielle Costigan, Kieran Sheahan, Kevin C Conlon,
Justin Geoghegan, Emir Hoti, Donal Maguire, Oscar
Traynor, Dermot OToole, Miriam Hayes, Emer Burton,
Jean Murphy, Niall Swan
St. Vincents University Hospital, Dublin, Ireland
83
Appendiceal Goblet Cell Carcinoid: Common Errors in

Staging and Clinical Interpretation with a Proposal for
an Improved Terminology (820)
K Wen, G Hale, N Shafizadeh, A Huang, M Hosseini, S
Kakar
UCSF, San Francisco, CA; Kaiser, Woodland Hills, CA;
UCSD, San Diego, CA; Vista Pathology, Medford, OR
84
Completion Resections in LAMN with ExtraAppendiceal Mucin and Appendiceal Margin

Involvement (779)
Nemencio Ronquillo, Safia Rafeeq, Keith Fournier, Paul
Mansfield, Melissa W Taggart, Wai Chin Foo
The University of Texas, M.D. Anderson Cancer Center,
Houston, TX
85
Conventional Colonic-Type Adenocarcinoma of the

Appendix: Clinicopathologic Comparison with Cecal
Jolanta Jedrzkiewicz, Wai Chin Foo, Paul Mansfield,
Michael Overman, Safia Rafeeq, Asif Rashid, Melissa
W Taggart
Houston, TX
86
The Impact of Deeper Levels on the Diagnosis of

Hyperplastic Polyps and Sessile Serrated Adenomas
(635)
Adel Assaad
Virginia Mason Medical Center, Seattle, WA
73
74
75
Histopathological Findings in Gastrointestinal Tractus

in Patients with Common Variable Immunodeficiency
(CVID) (766)
Burcin Pehlivanoglu, Basak Doganavsargil, Omur
Ardeniz, Murat Sezak
Adiyaman University Training and Research Hospital,
Adiyaman, Turkey; Ege University Faculty of Medicine,
Izmir, Turkey
Gastrointestinal Tract Histologic Findings in Patients
with Systemic Lupus Erythematosus (681)
Arunima Ghosh, Whitney Green, Maryam Kherad
Pezhouh, Justin Poling, Meredith E Pittman, Elizabeth
A Montgomery, Lysandra Voltaggio
76
Spectrum of Pathologic Findings in Clinical Liver

Cirrhosis without Confirmed Cirrhosis on Histology
(654)
Margaret Cho, Natalie Patel, Kisha Mitchell
77
Lymphatic Invasion and Nodal Metastasis in Dysplasia

and Carcinoma of the Stomach: Examination of 183
Cases Undergoing Endoscopic Submucosal Dissection
Using D2-40 Immunostaining (738)
Toshiharu Matsumoto, Asumi Sakaguchi, Kanako
Ogura
Juntendo University Nerima Hospital, Tokyo, Japan
78
HPV is Not Involved in the Pathogenesis of Esophageal

Squamous Cell and Adenocarcinomas; Analysis Based
on a Highly Sensitive and Highly Specific RNA In-Situ
Hybridization Technique (626)
Agoston Agoston, Vikram Deshpande, Robert Odze
79
220
H. pylori Infection Induces Early Expression of CD44

during the Progression of Gastric Cancer (816)
Rachel Walker, Jaime Mejia, Heiko Enderling, Jose M
Pimiento, Mokenge P Malafa, Domenico Coppola
Moffitt Cancer Center, Tampa, FL; Instituto de Patologia
Mejia Jimenez, Cali, Colombia
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
87
Pathologic Assessment and Clinicopathologic

Correlation of Tumor Microenvironment in Colorectal
Carcinomas (707)
Joo Young Kim, Nam Hee Won, Yang-Seok Chae, Chul
Whan Kim, Jeong Hyeon Lee, Eunjung Lee, Youngseok
Lee
Korea University Anam Hospital, Korea University
College of Medicine, Seoul, Republic of Korea
94
88
HTRA3 Stromal Expression Is Correlated with Tumor

Budding in Stage II Colorectal Cancer (675)
Catherine Forse, Mahdi Rahimi, Eleftherios P
Diamandis, Naziheh Assarzadegan, Heather AE
Dawson, Andrea Grin, Erin Kennedy, Brenda OConnor,
David E Messenger, Robert H Riddell, George S
Karagiannis, Richard Kirsch
University of Toronto, TO, ON, Canada; Mount Sinai
Hospital, TO, ON, Canada; UHN, TO, ON, Canada;
Universitat Bern, Bern, Switzerland; St. Michaels
Hospital, TO, ON, Canada; University Hospitals Bristol
NHS, Bristol, United Kingdom; Albert Einstein College
of Medicine, Bronx, NY
Programmed Cell Death-Ligand 1 (PD-L1) in

Mismatch Repair Protein Deficient Colon Cancer: An
Immunohistochemical and Genomic Profiling Study
(716)
Hwajeong Lee, Katherine Geiersbach, Sanaz Ainechi,
Christine E Sheehan, David M Jones, Kajsa Affolter,
Mary P Bronner, Jeffrey S Ross
Albany Medical Center, Albany, NY; University of Utah,
Salt Lake City, UT
95
Analysis of PD-L1 Expression Pattern in Microsatellite

Instability Colon Cancer (804)
Yue Sun, Max Vaickus, Michael OBrien, Qing Zhao
Boston University Medical Center, Boston, MA
96
Characterization of the Effect of the Tumor Epigenetic

Clonality in the Evolution of Colorectal Cancer (746)
Eva Musulen, Sebastian Moran, Anna Martinez-Cardus,
Jose Luis Manzano, Stefania Landolfi, Elena Elez,
Josep Tabernero, Aurelio Ariza, Manel Esteller
Hospital Universitari Germans Trias i Pujol, Badalona,
Barcelona, Spain; Bellvitge Biomedical Research
Institute (IDIBELL), LHospitalet del Llobregat,
Barcelona, Spain; Catalan Oncology Institute (ICO)Hospital Universitari Germans Trias i Pujol, Badalona,
Barcelona, Spain; Hospitals Vall dHebron, Barcelona,
Spain; Vall dHebron Institute of Oncology, Barcelona,
Spain
97
Overexpression of POSTN in Cancer-Associated

Fibroblasts Is a Poor Prognostic Indicator of Colorectal
Cancer (753)
Hyeon Jeong Oh, Jeong Mo Bae, Xian-Yu Wen, NamYun Cho, Gyeong Hoon Kang
Seoul National University College of Medicine, Seoul,
Republic of Korea
98
Tumor Expression of C-Met and Plexin B1 May Predict

Peritoneal Carcinomatosis Recurrence in Colorectal
Cancer (677)
Javier Freire, Victor Ovejero, Pilar Garcia-Berbel,
Steliana F Racean, Emma Linares, Alicia Leon del
Castillo, Saray Pereda, Ainara Azueta, Javier GomezRoman
University Hospital Marqus de Valdecilla, Santander,
Spain; Sierrallana Hospital, Torrelavega, Spain
99
Utility of Longitudinal Slicing of Rectal Cancer

Specimen in the Evaluation of Resection Margins (739)
Rie Matsunaga, Motohiro Kojima, Mitsuru Yokota, Yuji
Nishizawa, Masaaki Ito, Atsushi Ochiai
National Cancer Center Hospital East, Kashiwa, Chiba,
Japan
100
Potential Therapeutic Targets for

Gastroenteropancreatic Poorly Differentiated
Neuroendocrine Carcinoma (818)
Vivian L Weiss, Raul S Gonzalez, Chanjuan Shi
89
90
91
92
93
Fatty Acid Binding Protein1 (FABP1) Is Preferentially

Lost in Microsatellite Instable and in Medullary
Carcinomas of the Colon (823)
Stephanie M Wood, Kenneth Friedman, Alexander
S Brodsky, Shaolei Lu, Kara A Lombardo, Dongfang
Yang, Anthony J Gill, Murray B Resnick
Rhode Island Hospital and Alpert Medical School at
Brown University, Providence, RI; Royal North Shore
Hospital, St. Leonards, Australia
Mismatch Repair Protein Deficiency Is Not Present at
a Higher Rate in HIV-Infected Patients with Colorectal
Carcinoma (784)
Marcela Santos Cavalcanti, Keith Sigel, Jinru Shia,
Tanisha Daniel, Efsevia Vakiani, Carlie Sigel
NY; Mount Sinai School of Medicine, New York, NY
High PSB7 Expression in Colorectal Cancer Predicts
Poor Overall Survival among Older Female
Patients and Female Patients Treated with Adjuvant
Chemotherapy (833)
J-Y Yoon, Prashant Bavi, Qian Yang, Leslie Oldfield,
Julia Y Wang, Michael H Roehrl
CALD1 and TAGLN Predict Poor Prognosis of Patients
with Colon Cancer (832)
Mitsuru Yokota, Motohiro Kojima, Atsushi Ochiai
Kurashiki Central Hospital, Kurashiki, Okayama, Japan;
National Cancer Center Hospital East, Kshiwanoha,
Chiba, Japan
Dominant Overexpression of Programmed DeathLigand 1 in MSI-Unstable Colorectal Adenocarcinoma
(666)
Audrey Deeken-Draisey, Haonan Li, Xiaoming You, Jie
Liao, Sambasiva Rao, Guang-Yu Yang
Northwestern Medicine, Chicago, IL
221
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
101
108
Testicular Torsion: A Single Tertiary Care Institution

Alireza Ghaffarieh, Karen Elizabeth Trevino, Thomas M
Ulbright, Muhammad T Idrees
109
Testicular Appendageal Tumors Evaluated in

Orchiectomies, a Single Institution Experience (921)
Alireza Ghaffarieh, Erin Baumgartner, Thomas M
Ulbright, Muhammad T Idrees
Indiana University School of Medicine, Indianapolis,
IN; University of Louisville, Louisville, KY
110
Paratesticular Soft Tissue Lesions Identified in

Orchiectomies Evaluated at a Single Tertiary Care
Center (1020)
David Priemer, Karen Elizabeth Trevino, Thomas M
Ulbright, Shaoxiong Chen, Muhammad T Idrees
111
TCF3: A Sensitive Marker to Differentiate

Seminomatous from Non-Seminomatous Germ Cell
Tumors (858)
Mary Barrett, Asif Shahab, Nisha Patel, Qi Yang,
Loralee McMahon, Guang-Qian Xiao, Faqian Li
112
PLZF: A Sensitive and Specific Biomarker for Yolk Sac

Tumor (1051)
Shana Straub, David E Burstein, Hani Katerji, Faqian Li,
Qi Yang, Loralee McMahon, Guang-Qian Xiao
University of Rochester, Rochester, NY; Mount Sinai
School of Medicine, New York, NY; University of
Minnesota, Minneapolis, MN
113
The Utility of HNF 1 Beta Immunohistochemical

Staining in the Diagnosis of Malignant Germ Cell
Tumors of the Testis (907)
Faysal A Fedda, Charles Quick, Emily Holthoff, Neriman
Gokden, Roni M Cox
114
Loss of Expression of INSL3 by immunohistochemistry

Predicts Leydig Cell Tumor (973)
Nelli Lakis, Zakaria Grada, Kara A Lombardo, Shamlal
Mangray, Andres Matoso
115
CDK2 Inhibitory Phosphorylation Regulates

Spermatogenesis and Stem Cell Maintenance (879)
Xueyan Chen, Hui Zhao, Bruce Clurman, James
Roberts, Keith Loeb
University of Washington, Seattle, WA; Fred
Hutchinson Cancer Research Center, Seattle, WA
116
Lymphomas of the Urinary Tract and Genital Organs:

An Institutional Study of 50 Cases (1026)
Julia A Ross, Pei Hui, Peter A Humphrey, Adebowale
Adeniran
102
103
CK17 Is a Marker of Anal Transition Zone and May Aid

in Distinguishing Reactive Anal Transition Zone from
High-Grade Squamous Intraepithelial Lesions (AIN II/III)
(685)
Hannah E Goyne, Keith Lai, Bradley J Fogel, Andrew
LJ Dunn, Matthew R Lindberg, Laura W Lamps, Charles
Quick
Paired Box 5 (PAX5) Expression in Poorly Differentiated
Neuroendocrine Carcinoma of the Gastrointestinal
and Pancreatobiliary Tract: Diagnostic and Potentially
Therapeutic Implications (717)
Hwajeong Lee, Sanaz Ainechi, Christine E Sheehan,
Jingmei Lin, Zhaohai Yang
Albany Medical Center, Albany, NY; Indiana University,
Indianapolis, IN; Penn State Hershey Medical Center,
Hershey, PA
Germ Cell Tumor Metastases to the Gastrointestinal
Tract: A Diagnostic Challenge (771)
Justin Poling, Arunima Ghosh, Whitney Green,
Maryam Kherad Pezhouh, Meredith E Pittman,
Lysandra Voltaggio, Elizabeth A Montgomery
104
The Histological Predictors of Metastasis and

Chemotherapy/Radiotherapy Response in Pure Classic
Seminoma (901)
Linnea Duke, Zari Dastani, Bader AlSaikhan, Armen
Aprikian, Fadi Brimo
105
Discrepancy Between Local and Central Pathological

Review of Radical Orchiectomy Specimens (941)
Saul E Harari, Daniel J Sassoon, John Eble, Thomas
M Ulbright, David J Grignon, Mohammed Idrees,
Costantine Albany, Timothy A Masterson, Nasser H
Hanna, Richard S Foster, Lawrence H Einhorn, Liang
Cheng
106
107
222
Orchidectomies for Testicular Neoplasms Less

Than 1cm in Diameter: Victims of Modern Imaging
Technology? (1038)
Glenda Scandura, Wendy Ansell, Jonathan Shamash,
Daniel Berney
Queen Mary University of London, London, Greater
London, United Kingdom; Barts Health NHS Trust,
London, United Kingdom
Testicular Sex CordStromal Tumors of Unclassified
Type (1031)
Omer AM Saeed, Thomas M Ulbright, Muhammad T
Idrees
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
117
Histopathological Risk Scoring System as a Tool

for Predicting Lymph Nodal Metastasis in Penile
Squamous Cell Carcinoma (995)
Santosh Menon, Aakash Sali, Gagan Prakash, Ganesh
Bakshi, Amit Joshi, Vedang Murthy, Umesh M
Mahantshetty, Sangeeta Desai
Tata Memorial Centre, Mumbai, India
122
118
High Correspondence of HPV Genotypes in Penile

Intraepithelial Neoplasia (PeIN) and Invasive Penile
Squamous Cell Carcinomas (SCC). A Laser Capture
Microdissection (LCM)-PCR Comparative Study of 26
Cases (1035)
Diego F Sanchez, Sofia Canete, Nuria Guimera, Maria
Jose Fernandez-Nestosa, Elsa F Velazquez, David
Jenkins, Wim Quint, Antonio L Cubilla
Facultad de Ciencias Mdicas -UNA, Asuncin,
Paraguay; Instituto de Patologa e Investigacin,
Asuncin, Paraguay; DDL Diagnostic Laboratory,
Rijswijk, Netherlands; Facultad Politcnica - UNA,
San Lorenzo, Paraguay; Miraca Life Sciences and Tuft
University, Boston, MA
Natural History of Human Papillomavirus Infection in

Non-Vaccinated Males: Low Clearance Probability in
High-Risk Genotypes (1003)
Gabriella Nesi, Tommaso Cai, Sandra Mazzoli, Raffaella
Santi
University of Florence, Florence, Italy; Santa
Chiara Regional Hospital, Trento, Italy; Santa Maria
Annunziata Hospital, Florence, Italy
123
Prevalence, Distribution, and Viral Loads of 15 HighRisk HPV Types in Squamous Cell Carcinoma of the
Scrotum (975)
Marcos Lepe, M Ruhul Quddus, Pradip Manna,
Jonathan I Epstein, Andres Matoso
Rhode Island Hospital and Brown University,
Providence, RI; Women and Infants Hospital and
Brown University, Providence, RI; Johns Hopkins
Hospital, Baltimore, MD; Physicians Reference
Laboratory, LLC, Overland Park, KS; Brown University,
Providence, RI
124
Poorly Differentiated Solid (Medullary) Carcinoma: A

Distinctive HPV-Related Penile Neoplasm. A Report of
12 Cases (871)
Sofia Canete, Omar OC Clavero, Diego F Sanchez,
Arturo Silvero, Francisco Abed, Ingrid M Rodriguez,
Laia Alemany, Nubia Munoz, Silvia de Sanjose, Wim
Quint, Francesc Xavier Bosch, Antonio L Cubilla
Instituto de Patologa e Investigacin, Asuncin,
Paraguay; Institut Catal dOncologia, Barcelona,
Spain; Facultad de Ciencias Mdicas-UNA, Asuncin,
Paraguay; DDL Diagnostic Laboratory, Rijswijk,
Netherlands
125
Spectrum of PD-L1 Expression in Penile Squamous Cell

Carcinoma (SqCC) (988)
Martin J Magers, Aaron Udager, Tzu-Ying Liu, Andrew
McDaniel, Stephanie L Skala, Todd Morgan, Ganesh
Palapattu, Alon Z Weizer, Tina Fields, Ajjai Alva, Jeffrey
S Montgomery, Arul M Chinnaiyan, Scott A Tomlins,
Hui Jiang, Rohit Mehra
126
Programmed Death Ligand-1 (PD-L1) Status in North

American Cohort of Penile Squamous Cell Carcinoma
(883)
Margaret Cocks, Diana Taheri, Mark W Ball, Stephania
M Bezerra, Maria DC Rodriguez, Alan Meeker, Trinity
J Bivalacqua, Alcides Chaux, Arthur Burnett, George J
Netto
Isfahn University of Medical Sciences, Isfahan Kidney
Iran
127
PIK3CA, MET and TP53 Gene Mutations in Penile

Cancer (895)
Jasreman Dhillon, Philippe E Spiess, Elena Ryzhova,
Yin Xiong, Julio Pow-Sang, Anthony M Magliocco
119
120
121
Warty Penile Intraepithelial Neoplasia: Morphological

and Viral Characterization in 24 Cases Using Laser
Capture Microdissection (LCM)-PCR (909)
Maria Jose Fernandez Nestosa, Nuria Guimera, Diego F
Sanchez, Sofia Canete, Elsa F Velazquez, David Jenkins,
Wim Quint, Antonio L Cubilla
Universidad Nacional de Asuncin, Asuncin,
Paraguay; DDL Diagnostic Laboratory, Rijswijk,
Netherlands; Instituto de Patologa e Investigacin,
Asuncin, Paraguay; Facultad de Ciencias MdicasUNA, Asuncin, Paraguay; Miraca Life Sciences and
Tufts University, Boston, MA
Frequent Detection of High Risk HPV and Heterogeneity
in Condylomas Associated with Penile Intraepithelial
Neoplasia (PeIN). A Laser Capture Microdissection
(LCM)-PCR Study of 30 Lesions in 6 Patients (870)
Sofia Canete, Maria Jose Fernandez Nestosa, Nuria
Guimera, Diego F Sanchez, Ingrid M Rodriguez, Jose
Barreto, David Jenkins, Wim Quint, Antonio L Cubilla
Instituto de Patologa e Investigacin, Asuncin,
Paraguay; Universidad Nacional de Asuncin,
Asuncin, Paraguay; DDL Diagnostic Laboratory,
Rijswijk, Netherlands; Facultad de Ciencias MdicasUNA, Asuncin, Paraguay
Inter-Observer Variability among Urologic Pathologists
in the Grading of Penile Squamous Cell Carcinoma
(1022)
Priya Rao, Benjamin Naovarat, Charles C Guo,
Kanishka Sircar, Miao Zhang, Farah Khalil, Mike
Hernandez, Pheroze Tamboli, Curtis A Pettaway,
Philippe E Spiess, Jasreman Dhillon
MD Anderson Cancer Center, Houston, TX; Moffitt
Cancer Center, Tampa, FL
223
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
128
135
Vasitis Nodosa and Related Lesions: A Modern

Immunohistochemical Staining Profile with Special
Emphasis on Diagnostic Dilemmas (964)
Brie Kezlarian, Liang Cheng, Nilesh S Gupta, Sean R
Williamson
Henry Ford Health System, Detroit, MI; Indiana
University, Indianapolis, IN
136
Osseous Metaplasia in GU Organs: Pathogenesis

& Significance with First Case Report in Bladder
Diverticulum (1013)
Rugvedita Parakh, Funda Vakar-Lopez, Maria S
Tretiakova
137
GSTM1, GSTT1, GSTP1 Polymorphisms, Quality

of Life, Habits, Environmental Exposure and
Predisposition to Bladder Cancer (1006)
Isis Paloppi, Ruan CA Pimenta, Sabrina T Reis, Willian
C Nahas, Miguel Srougi, Jose Cury, Mitiko Saiki, Katia
RM Leite
University of Sao Paulo Medical School, Sao Paulo,
Brazil; ICESP - Instituto do Cancer de Sao Paulo, Sao
Paulo, Brazil; University of Sao Paulo, Sao Paulo, Brazil
138
Isolated 9p21 Deletion Detected by UroVysionTM

Fluorescence In-Situ Hybridization in Urine
Samples: A Study of 69 Cases with Emphasis on
Clinicopathological Features and Outcome (1058)
Wei Tian, Eric Kroman, Wendy L Flejter, Rajal Shah
Miraca Life Sciences, Irving, TX
139
Reflex FISH Testing of Subdivided Cytologically

Atypical Urine Specimens (924)
Ryan Glass, Dwayne Breining, Rubina Cocker
North Shore Long Island Jewish, New Hyde Park, NY
129
130
GATA3 Is a Sensitive Marker for Extramammary Pagets

Diseases of Male Genital Region (876)
Dengfeng Cao, Yunquan Guo, Yan Song, Lixin Zhou,
Junqiu Yue, Xun Zhang, Ming Zhao, Li Sun, Zhongwu
Li
Washington University School of Medicine, Saint
Louis, MO; Xinjiang Cancer Hospital, Urumqi, China;
Chinese Academy of Medical Sciences Cancer Hospital,
Beijing, China; Peking University Cancer Hospital,
Beijing, China; Hubei Cancer Hospital, Wuhan, China;
Zhejiang Peoples Hospital, Hangzhou, China
Uroplakin 2: A Specific Marker of Urothelial Carcinoma
(996)
Ioana Moisini, Rajiv Dhir, Aatur Singhi, Aditi Ranade,
Esther Elishaev, David Dabbs, Rohit Bhargava
Magee-Womens Hospital, Pittsburgh, PA; UPMC,
Pittsburgh, PA; UHS Wilson Medical Center, Johnson
City, NY
Whole Exome Sequencing Reveals 19q13 Amplification
and Actionable Mutations in Carcinosarcoma of the
Bladder (1056)
Peyman Tavassoli, Bishoy S Morris Faltas, Joanna
Cyrta, Juan Miguel Mosquera, Brian D Robinson, Mark
Rubin
131
Meta-Analysis of Mesenchymal Characteristic-Related

Gene Expression in Bladder Cancer (848)
Waleed Ali, Andre Kajdacsy-Balla
132
ALK Immunohitochemical Expression in Inflammatory

Myofibroblastic Tumor (IMT) Using Novel D5F3 Clone
in Comparison to ALK1 Clone Antibody (1054)
Diana Taheri, David J Zahavi, Maria DC Rodriguez,
Abdelrazak Meliti, Neda Rezaee, Shahaboddin
Dolatkhah, Yi Ning, Justin A Bishop, George J Netto,
Rajni Sharma
Isfahan University of Medical Sciences, Isfahan, Islamic
Republic of Iran
133
134
224
Clinicopathologic and Immunohistochemical

Characteristics of Urinary Bladder(UB) Inflammatory
Myofibroblastic Tumors (IMT), Including 10 Malignant
Cases (850)
Isabel Alvarado-Cabrero, Narciso Hernandez-Toriz,
Alejandra Mantilla-Morales, Blandina Hernandez-Cruz,
Raquel Valencia-Cedillo
Oncology Hospital, Mexican Institute of Social Security,
DF, Mexico
Is Mast Cell Infiltration Specific to Interstitial Cystitis?
(844)
Yoshiyuki Akiyama, Daichi Maeda
Graduate School of Medicine, the University of Tokyo,
Tokyo, Japan; Graduate School of Medicine, Akita
University, Akita, Japan
140
The Clinicopathologic and Immunohistochemical

Features of Adenomyomatous Polyps (1239)
Kyle C Strickland, Bradley J Quade, Marisa R Nucci,
Brooke E Howitt
141
Genomewide Copy Number Analysis of Mllerian

Adenosarcoma Identified Increased Chromosomal
Instability and Chromothripsis-Like Profiles in the
Aggressive Subgroup (1168)
Jen-Chieh Lee, Tzu-Pin Lu, Chun A Changou, Cher-Wei
Liang, Hsien-Neng Huang, Alexandra Lauria, HsuanYing Huang, Ben Davidson, Ming-Chieh Lin, Kuan-Ting
Kuo
National Taiwan University Hospital, National Taiwan
University College of Medicine, Taipei, Taiwan;
National Taiwan University, Taipei, Taiwan; Taipei
Medical University, Taipei, Taiwan; Brigham and
Womens Hospital and Harvard Medical School,
Boston, MA; Kaohsiung Chang Gung Memorial
Hospital and Chang Gung University College of
Medicine, Kaohsiung, Taiwan; The Norwegian Radium
Hospital, Oslo University Hospital, Oslo, Norway
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
142
149
ALK-1 Expression in Uterine Leiomyomas with

Myxoid Change and Its Utility in Distinguishing from
Inflammatory Myofibroblastic Tumor (1222)
T Danielle Samulski, Julieta E Barroeta, Carolina Reyes
Philadelphia, PA; Pennsylvania Hospital, Philadelphia,
PA
150
Genome-Wide Copy Number Analysis of Uterine

Tumors Resembling Ovarian Sex Cord Tumors
(UTROSCT) (1196)
Joyce J Ou, Umadevi Tantravahi, John R Pepperell,
Danielle B Chau, Michele M Lomme, C James Sung, W
Dwayne Lawrence
Women & Infants Hospital, Providence, RI; Alpert
Medical School of Brown University, Providence, RI
151
The Utility of Next Generation Sequencing-Based Gene

Fusion Detection Assay in the Diagnosis of Endometrial
Stromal Sarcoma (1170)
Xiaodong Li, Mona Anand, Josh Haimes, Namitha
Manoj, Brian Kudlow, Marisa R Nucci, Colin JR
Stewart, Cheng-Han Lee
University of Alberta, Edmonton, AB, Canada;
ArcherDX, Inc, Boulder, CO; Brigham and Womens
Hospital, Boston, MA; King Edward Memorial Hospital,
Perth, Australia
152
Molecular Characterization of High Grade Endometrial

Stromal Sarcoma (1165)
Nicholas Ladwig, Joseph T Rabban, Charles Zaloudek,
Nancy M Joseph, Gregor Krings, Karuna Garg
CA
153
Loss of BAF250a (ARID1A) Expression Is Associated

with Progression of Endometriosis-Related Stage I
Ovarian Clear Cell Carcinoma (1155)
Ayako Kawabata, Takako Kiyokawa, Nozomu
Yanaihara, Aikou Okamoto
Department of Obstetrics and Gynecology, Jikei
University School of Medicine, Tokyo, Japan;
Department of Pathology, Jikei University School of
Medicine, Tokyo, Japan
154
Investigation of Napsin-A in Atypical Versus Usual

Endometriosis (1198)
Cherie Paquette, M Ruhul Quddus, C James Sung,
Joyce J Ou, W Dwayne Lawrence
Women and Infants Hospital, Providence, RI; Brown
University School of Medicine, Providence, RI
155
Frequent Homozygosity in Both Mature and Immature

Ovarian Teratomas: A Shared Genetic Basis of
Tumorigenesis (1232)
Olivia L Snir, Maura DeJoseph, Natalia Buza, Pei Hui
Yale University School of Medicine, New Haven, CT;
Office of the Chief Medical Examiner, Farmington, CT
Uterine Adenosarcomas Are Mesenchymal Neoplasms

(1250)
Britta Weigelt, Salvatore Piscuoglio, Kathleen Burke,
Charlotte KY Ng, Anastasios D Papanastasiou, Felipe C
Geyer, Gabriel S Macedo, Luciano G Martelotto, Ino De
Bruijn, Maria Rosaria De Filippo, Anne M Schultheis,
Rafael Ioris, Douglas A Levine, Robert Soslow, Brian P
Rubin, Jorge S Reis-Filho
NY; Cleveland Clinic, Cleveland, OH
143
Uterine Smooth Muscle Tumor of Uncertain Malignant

Potential: Clinicopathologic Study of 45 Cases (1237)
Sucheta Srivastava, Laura Moench, Teri A Longacre
Stanford Hospital, Stanford, CA
144
Myxoid Smooth Muscle Tumors of the Uterus:

Ronald Goh, Paola Dal Cin, Sarah Chiang, Robert H
Young, Esther Oliva
Brigham and Womens Hospital, Boston, MA; Memorial
Sloan Kettering Cancer Center, New York, NY;
145
Fumarate Hydratase (FH)-Deficient Uterine Smooth

Muscle Neoplasms Can Be Identified by Characteristic
Histological Features and Confirmed by FH IHC (1086)
Abbas Agaimy, David L Wachter, Nafisa Wilkinson,
James Bolton, Matthias W Beckmann, Florian Haller,
Arndt Hartmann
University Hospital of Erlangen, Erlangen, Germany;
St Jamess Hospital Beckett Street Leeds LS9 7TF,
Leeds, United Kingdom; Central Manchester University
Hospitals NHS Foundation Trust, Manchester, United
Kingdom
146
Fumarate Hydratase Alterations Detected by S-(2Succino)-Cysteine Expression in 6 Different Types of

Uterine Smooth Muscle Tumors (1204)
Kate Poropatich, Qing Zhang, Julianne Martinez de
Ubago, Norma Frizzell, Beihua Kong, Jian-Jun Wei
Northwestern University, Chicago, IL; University of
South Carolina School of Medicine, Columbia, SC; Qilu
hospital, Jinan, Shandong, China
147
Utility of Phosphohistone H3 in Uterine Smooth Muscle

Tumors: An Outcome-Based Assessment (1147)
Philip Ip, Kin Long Chow, Ka Wing Wong, Ka Yu Tse,
Richard WC Wong, Alice NH Chan, Nancy WF Yuen,
Annie N Cheung
The University of Hong Kong, Hong Kong, SAR, Hong
Kong
148
Extra-Uterine Smooth Muscle Tumors of the Female

Genital Tract: Clinicopathologic Study of 24 Cases
(1183)
Laura Moench, Sucheta Srivastava, Teri A Longacre
Stanford Medicine, Stanford, CA
225
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
156
Primary Glial and Neuronal Tumors of the Ovary or

Peritoneum: A Clinicopathologic Study of 11 Cases
(1172)
Li Liang, Adriana Olar, Yi Jiang, Na Niu, Anna
Yemelyanova, Gregory Fuller, Jinsong Liu
Houston, TX; The First Affiliated Hospital of Nanjing
Medical University, Nanjing, China
164
Expression of GATA-3 in Testicular and Gynecological

Mesothelial Tissues, Neoplastic and Non-Neoplastic
(1216)
Arash Ronaghy, Guang-Qian Xiao, Eugene Santagada,
Adnan Hasanovic, Pamela Unger
North Shore-LIJ Lenox Hill Hospital, New York, NY;
157
Yolk Sac Tumor of the Ovary in Adult Women: Analysis

of a Case Series (1226)
John Schoolmeester, Brigitte M Ronnett, Robert J
Kurman
Mayo Clinic, Rochester, MN; The Johns Hopkins
Hospital, Baltimore, MD
165
Malignant Mesonephric Tumors of the Female Genital

Tract: A Clinicopathologic Study of 16 Cases Including
4 Cases of Biphasic Tumor with a Sarcomatous
Component (1129)
Masaharu Fukunaga
Jikei University Daisan Hospital, Tokyo, Japan
158
Yolk Sac Tumor in Extragonadal Gynecologic Sites Still

a Diagnostic Challenge (1209)
Sanjita Ravishankar, Anais Malpica, Preetha
Ramalingam, Elizabeth D Euscher
166
Twin Placenta with Complete Hydatidiform Mole and

Its Mimics in the First Trimester: Histologic Diagnosis
and Immunohistochemical Study (1128)
Masaharu Fukunaga
Jikei University Daisan Hospital, Tokyo, Japan
159
Refined Characterization of Hepatoid Differentiation in

Gynecologic Tract Neoplasms (1227)
Angela R Shih, Xiuli Liu, Annacarolina Silva, Anna
Pesci, Robert Soslow, Vikram Deshpande, Esther Oliva
Cleveland Clinic, Cleveland, OH; Memorial Sloan
Kettering Cancer Center, New York City, NY
167
160
Genomic Analysis of Ovarian PNETs by Next

Generation Sequencing Reveals Recurrent Copy
Number and TP53 Alterations (1175)
Christopher Liverman, Nancy M Joseph, Charles
Zaloudek
CA
DNA Genotyping of Non-Molar Donor Egg

Pregnancies with Abnormal Villous Morphology:
Recommendations to Prevent Misinterpretation as
Dispermic Complete Hydatidiform Mole[/underline]
(1149)
Nancy Joseph, Caryll Pineda, Nam Tran, Joseph T
Rabban
CA
168
A Reassessment of the Incidence of Hydatidiform

Molar Disease as Defined by Histopathologic and
Terence Colgan, Martin C Chang, Shabin Nanji, Elena
Kolomietz
Mount Sinai Hospital, Toronto, ON, Canada
161
ES/PNET[/underline], A Potential for Misdiagnosis:

Clinicopathologic and Molecular Cytogenetic Analysis
of 5 Cases with Literature Review[/underline] (1112)
Yufan Cheng, Rui Bi, Bin Chang, Wentao Yang, Xiaoyu
Tu, Jian Wang
China
169
The Detection of Aneuploidy in Non-Molar Abortuses

through Selective DNA Genotyping in Cases of
Suspected Hydatidiform Mole (1116)
Terence Colgan, Martin C Chang, Shabin Nanji, Elena
Kolomietz
Mount Sinai Hospital, Toronto, ON, Canada
162
PAX-8 Expression in Women with Reactive Mesothelial

Proliferations of the Peritoneal Cavity (1108)
Cody Carter, Andrew Sciallis
170
Rethinking Decidual Vasculopathy of Preeclampsia

(1137)
Jonathan H Hecht, Zsuzsanna K Zsengeller, Ananth
Karumanchi, Seymour Rosen
Beth-Israel Deaconess Medical Center, Boston, MA
163
Inactivating BAP1 Mutations Causing Loss of Nuclear

Expression Define the Majority of Malignant Peritoneal
Mesotheliomas (1233)
David A Solomon, Yunn-Yi Chen, Charles Zaloudek,
Nancy Joseph
CA
171
The Clinical and Pathological Features of Maternal

Gastric Adenocarcinoma Metastatic to the Placenta
(1249)
Ping Wei, Mulan Jin
Beijing Chao Yang Hospital, Capital Medical University,
Beijing, China
226
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
172
Cornual/Interstitial Pregnancy: Distinction from

Conventional Tubal Pregnancy, Emphasizing
Microscopic Features to Avoid a Potential Diagnostic
Pitfall When Accompanied by a Normal Fallopian Tube
Specimen (1151)
Yuna Kang, Joseph T Rabban
CA
179
CD30 Expression and Its Prognostic Significance in

De Novo Diffuse Large B Cell Lymphoma Treated with
Rituximab-EPOCH (1525)
Jie Xu, Annapurna Saksena, Parth Desai, Pei Lin,
Cheng C Yin, Guilin Tang, M James You, L J Medeiros,
Shaoying Li
173
Histopathologic Features of Post-Ablation Tubal

Sterilization Syndrome (1094)
Jamen Bartlett, Kelly J Butnor
University of Vermont Medical Center, Burlington, VT
180
PD-L1 Expression in Diffuse Large B-Cell Lymphoma

(DLBCL) with Clinical Correlation (1470)
Aseeb Rehman, Siddhartha Dalvi, Michael Presta, Tipu
Nazeer, Jeffrey S Ross
174
Heterotopic Steroid (Hilus) Cells in the Fallopian Tube

(1091)
John Aranake-Chrisinger, Horacio M Maluf
MO
181
Prognostic Significance of CD5 Expression in Diffuse

Large B-cell Lymphoma in Patients Treated with
Rituximab-EPOCH (1492)
Beenu Thakral, Parth Desai, Pei Lin, C Cameron Yin,
Guilin Tang, Shimin Hu, Joseph D Khoury, L Jeffrey
Medeiros, Shaoying Li
182
RUNX3: A New Prognostic Marker in Diffuse Large

B-Cell Lymphoma? (1358)
Virginia E Duncan, Sooryanarayana Varambally, Deniz
Peker
183
TCF3 and ID3 Expression in Diffuse Large B-cell

Lymphoma in Burkitt Lymphoma (1439)
Pawel Mroz, Rashi L Singhal, Megan S Lim, Ryan A
Wilcox, Farah Keyoumarsi, Kristina L Fields, Nathanael
G Bailey
University of Michigan, Ann Arbor, MI; University
of Pennsylvania Perelman School of Medicine,
Philadelphia, PA; University of Pittsburgh, Pittsburgh,
PA
184
MEF2B Expression in Diffuse Large B-Cell Lymphoma

Correlates with Germinal Center Phenotype (1498)
Katherine Tumminello, Houda Alatassi, Mostafa M
Fraig, John Lam, Elizabeth Chastain, Siraj El Jamal
University of Mississippi Medical Center, Jackson, MS;
185
Flow Cytometric Detection of CD10 Expression in

Diffuse Large B-Cell Lymphoma Can Reduce the
Need to Perform the Complete Hans Algorithm by
Sapna S Patel, Chad Hudson, Richard Burack
186
Pathology Review for ECOG 1412: A Comparison

of NanoString Gene Expression Profiling and
Immunohistochemistry for Cell-of-Origin Testing in DeNovo Diffuse Large B-Cell Lymphoma (1408)
Rebecca King, David W Scott, Randy D Gascoyne,
Marissa A Fitzgibbons, Grzegorz S Nowakowski,
Thomas E Witzig, William R Macon
Mayo Clinic, Rochester, MN; British Columbia Cancer
Agency, Vancouver, BC, Canada
HEMATOPATHOLOGY
175
176
177
178
ON 01910.Na Inhibits Growth of Diffuse Large

B-Cell Lymphoma by Cytoplasmic Sequestration of
Sumoylated TRAF6/C-MYB Complex (1343)
Kung-Chao Chang, Wen-Chung Chen, Wei-An Liao
National Cheng Kung University Hospital, Tainan,
Taiwan
BCR-cholesterol-BCR Feedback Loop Is Blocked by
AMPK in Diffuse Large B-cell Lymphoma(DLBCL)
(1403)
Xiangnan Jiang, Weige Wang, Ting Li, Dong Sheng,
Xiaoyan Zhou, Xiaoqiu Li
China; Shanghai Medical College, Fudan University,
Shanghai, China
Significance of Expression of SMO in Diffuse Large B
Cell Lymphoma (1495)
Youley Tjendra, Nitin K Agarwal, Kranthi Kunkalla,
Chae Hwa Kim, Alia Gupta, Jennifer Chapman, Alfredo
Torres, Juan Alderuccio, Steven X Chen, Deukwoo
Kwon, Francisco Vega
University of Miami, Miami, FL; Sylvester Cancer
Center, Miami, FL
Clinical and Biological Significance of GLI1 Expression
in Diffuse Large B-Cell Lymphoma (1370)
David C Gajzer, Youley Tjendra, Kranthi Kunkalla, Chae
Hwa Kim, Offiong F Ikpatt, Jennifer Chapman, Sandra
Sanchez, Gloria Yang, Deukwoo Kwon, Francisco Vega,
Nitin K Agarwal
University of Miami/Sylvester Comprehensive Cancer
Center, Miami, FL
227
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
187
Computerized Image Analysis of EBER-Positive Cells in

Polymorphous Diffuse Large B Cell Lymphoma (1527)
Shan-Chi Yu, Chung-Wu Lin
National Taiwan University Hospital, Taipei, Taiwan
195
188
ALK-Positive Diffuse Large B-cell Lymphoma (ALKDLBCL): A Clinicopathologic Study of 25 Cases with
Review of Additional 108 Cases in the Literature (1450)
Zenggang Pan, Shimin Hu, Min Li, Yi Zhou, Young S
Kim, Vishnu Reddy, Zifen Gao, Huan-You Wang, Ji
Yuan
UC Denver, Aurora, CO; MDACC, Houston, TX; Peking
Uni HSC, Beijing, China; UWMC, Seattle, WA; City of
Hope, Duarte, CA; UAB, Birmingham, AL; UCSD, La
Jolla, CA; UNMC, Omaha, NE
HIV-Associated Diffuse Large B-Cell Lymphoma

Has a Disproportionate Rate of MYC / BCL6 Double
Translocations (1490)
Yaohong Tan, Adrienne Moul, Alia Gupta, Kyle J White,
Yao-Shan Fan, Offiong Francis Ikpatt, Francisco Vega,
Jennifer Chapman
Department of Pathology, University of Miami Miller
School of Medicine, Jackson Memorial Hospital,
Miami, FL
196
Expression of MYC and BCL2 in AIDS-Related High

Grade B Cell Non-Hodgkin Lymphomas[/underline][/
underline] (1441)
Anna Nam, Amy Chadburn
Weill Cornell Medical College-New York Presbyterian
197
Double-Hit Diffuse Large B-Cell Lymphomas with MYC

Gene Rearrangements More Commonly Involve BCL2
Than BCL6 Gene Rearrangements as the Second Hit: A
Large Scale Single Institution Study (1431)
Lisa McGinnis, Scott Powers, Dana Bangs, Athena
Cherry, Robert Tibshirani, Yasodha Natkunam
Stanford Universtiy School of Medicine, Stanford, CA;
198
Double-Hit Lymphomas with BCL6 / MYC

Translocations Are Clinicopathologically Different
from Those with IgH-BCL2 / MYC and from Triple-Hit
Lymphomas (1437)
Adrienne Moul, Yaohong Tan, Nouf Hijazi, Sandra
Sanchez, Offiong F Ikpatt, Jennifer Chapman, Francisco
Vega
University of Miami/ Jackson Memorial Hospital,
Miami, FL
199
Clinicopathologic Features of Large B-cell Lymphomas

with Concurrent Cytogenetic Abnormalities in MYC
and BCL2: Improved Clinical Behavior with Modern
Interventions (1413)
Yi-Shan Lee, John L Frater, Friederike H Kreisel,
Marianna B Ruzinova, Anjum Hassan
Washington University School of Medicine, Saint
Louis, MO
200
Prognostic Implications of MYC and BCL2 Expression

in Primary Diffuse Large B-cell Lymphoma of the
Central Nervous System (1407)
Sehui Kim, Soo Jeong Nam, Dohee Kwon, Hannah
Kim, Tae Min Kim, Dae Seog Heo, Sung Hye Park, Chul
Woo Kim, Yoon Kyung Jeon
Korea; Seoul National University College of Medicine,
Seoul, Republic of Moldova; Seoul National University,
Seoul, Republic of Korea; Korea Cancer Center
201
Immunohistochemical and Genetic Evaluation of

Double-Hit Lymphomas (1518)
Annie Wu, Yalda B Naeini, Dennis OMalley
Aliso Viejo, CA
189
Correlation between PD-L1 Protein Expression and

9p24.1 Amplification in EBV-Positive DLBCL of the
Elderly (1339)
Alan F Brown, Mohamad E Salama, Jay L Patel,
Christian N Paxton, Xinjie Xu, Sherrie L Perkins, K
David Li
University of Utah - ARUP Laboratories, Inc., Salt Lake
City, UT
190
Aggressive B-cell Lymphoma in Extreme Age Groups;

Review of a Series of 760 Sases (1440)
Yalda B Naeini, Annie Wu, Dennis OMalley
Aliso Viejo, CA
191
SNP Arrays and Targeted Genomic Sequencing Identify

Distinctive Genomic Alterations In Testicular Diffuse
Large B-Cell Lymphoma (1382)
Deniz Gur, Connie Batlevi, Franck Rapaport, Lu Wang,
Achim Jungbluth, Janine Pichardo, Maria E Arcila,
Andrew D Zelenetz, Anas Younes, Ahmet Dogan
MSKCC, New York, NY
192
Leukemic/Bone Marrow-Based Large B Cell

Lymphoma: A Distinct Entity with Aggressive Features
(1491)
Weihua Tang, Musharraf Navaid, Shari Brown, Lauren
E Salmon, Darla Liles, Ridas Juskevicius
East Carolina University, Greenville, NC
193
Immunophenotyic Characterization and Purification

of Neoplastic Cells from Lymph Nodes Involved by
T-Cell/Histiocyte Rich Large B Cell Lymphoma by Flow
Cytometry and Flow Cytometric Cell Sorting (1367)
Jonathan R Fromm
194
Impact of Combined Antiretroviral Therapy (cART) on

AIDS-Related Lymphoma (ARL) Biology (1468)
Heidi Rahn, Natasha Lewis, John V Mitsios, Susan
Mathew, Amy Chadburn
Northwestern University - Feinberg School of
Medicine, Chicago, IL; Weill Cornell Medical College,
New York, NY
228
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
202
Correlation of MYC Rearrangement with C-MYC

Immunohistochemistry in Aggressive B-cell
Lymphomas (1517)
Annie Wu, Yalda B Naeini, Dennis OMalley
Aliso Viejo, CA
210
203
Multi-Color Flow Cytometric Analysis of c-MYC

Protein in B-Cell Lymphomas, a Correlation Study with
Immunohistochemistry and FISH (1326)
Khaled Alayed, Karen Schweitzer, Amad Awadallah,
Samir Turakhia, Howard J Meyerson
University Hospitals/ Case Medical Center, Cleveland,
OH; King Saud University, Riyadh, Saudi Arabia
Plasmablastic Lymphoma Is Characterized by MYC &

Blimp1 Protein Coexpression (1418)
Emma Linares, Tomas Z Barrese, Sonia Gonzalez
de Villambrosia, Ana Batlle, Tamara Ranchal, Laura
Cereceda, Jose B Revert, Maria Rodriguez-Pinilla,
Miguel A Piris, Santiago Montes-Moreno
Hospital Universitario Marqus de Valdecilla/IDIVAL,
Santander, Cantabria, Spain; Fundacin Jimnez Daz,
Madrid, Spain; IDIVAL, Santander, Cantabria, Spain
211
Plasmablastic Lymphoma: Characterization of

Tumor Microenvironment by CD163 and PD1
Janice Ahn, Flavia G Rosado, Aliyah R Sohani, Jeffrey
Vos
West Virginia University, Morgantown, WV;
204
205
206
207
208
209
Prognostic Importance of MYC Deletion Detected by

Fluorescence In Situ Hybridization in Paraffin Sections
in Diffuse Large B-cell Lymphoma (1419)
Wei Liu, Shaoying Li, Gary Lu, Xinyan Lu, Yuan Ji, Zi
Chen, Jeffrey Medeiros, Shimin Hu
Houston, TX; Weill Cornell Medical College, New York,
NY; University of Nebraska, Omaha, NE
Recommendations for Utilization and Reporting of
MYC Fluorescence In Situ Hybridization Testing in High
Grade B-cell Lymphomas (1334)
Amir Behdad, Sanaz Gidfar, Yanming Zhang, Adam
Petrich
Performance of Commercially Available MAL
and CD200 Antibodies in Differentiating Primary
Mediastinal Large B-Cell Lymphoma and Diffuse Large
B-Cell Lymphoma (1372)
Michael Gentry, Eric D Hsi, James R Cook
RNA In Situ Hybridization for MAL, PDL1 and PDL2 in
Primary Mediastinal Large B-cell Lymphoma versus
Diffuse Large B-cell Lymphoma, Not Otherwise
Specified (1511)
Zhen Wang, Michael Gentry, Eric D Hsi, James R Cook
PDL1 and MUM1 Expression Are Associated with
Outcome in Primary Mediastinal Large B-cell
Lymphoma (1337)
Jacob Bledsoe, Robert Redd, Lawrence Zukerberg,
Jeremy Abramson, Aliyah R Sohani
Massachusetts General Hospital, Boston, MA; Dana
Gray Zone Lymphoma with Features Intermediate
between Diffuse Large B-Cell Lymphoma and Classical
Hodgkin Lymphoma: A Clinicopathologic Study of 17
Epstein-Barr Virus-Positive Cases (1359)
Ahmed Ali Elsayed, Akira Satou, Ahmed E Eladl, Seiichi
Kato, Naoko Asano, Shigeo Nakamura
Nagoya University Hospital, Nagoya, Japan; Nagano
Prefectural Suzaka Hospital, Nagano, Japan
LIVER
212
Comparison of C4d Immunostaining Patterns on

Posttransplant Liver Biopsies Using Two Different
Antibodies (1649)
Eunice K Choi, Haodong Xu, Hanlin L Wang
University of California Los Angeles, Los Angeles, CA
213
Sinusoid Endotheliitis as an Early Histological

Parameter for Diagnosing Liver Allograft Rejection
(1681)
Yu Shi, Kun Dong, Zu-Hua Gao
McGill University, Montreal, QC, Canada; Beijing
Youan Hospital, Beijing, China
214
The Effect of Post-Liver Transplantation Therapy

with Ledipsavir/Sofosbuvir on the Risk of Acute Graft
Rejection (1682)
Susan Shyu, William S Twaddell
University of Maryland School of Medicine, Baltimore,
MD
215
Histologic and Clinical Outcomes after Transplantation

of Donor Livers with Small Versus Large Droplet
Macrovesicular Steatosis[/underline] (1651)
Won-Tak Choi, Kuang-Yu Jen, Dongliang Wang, Ryan
M Gill
University of California at San Francisco, San
Francisco, CA; SUNY Upstate Medical University,
Syracuse, NY
216
Leptin Signaling-Related Proteins in Nonalcoholic Fatty

Liver Disease (1650)
Euno Choi, Won Kim, Byeong Gwan Kim, Sun-ju
Byeon, Sunyoung Park, Mee Soo Chang
Seoul National University Boramae Hospital, Seoul
National University College of Medicine, Seoul, Korea
217
Clinical and Pathologic Features of Nutritional and

Herbal Supplements Induced Liver Injury (1629)
Gabriel Acosta-Gonzalez, Mark Ettel, Ogechukwu Eze,
Shweta Gera, Cristina H Hajdu, James S Park, Samuel
Sigal, Ruliang Xu
229
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
218
Frequency and Pathological Characteristics of DrugInduced Liver Injury in a Tertiary Medical Center (1654)
Mark Ettel, Gabriel Acosta-Gonzalez, Ogechukwu Eze,
Shweta Gera, Cristina H Hajdu, James S Park, Samuel
Sigal, Ruliang Xu
226
219
Unique Morphologic and Clinical Features of Liver

Nodular Regenerative Hyperplasia - Single Institution,
Large Cohort Study[/underline] (1636)
Adam Beattie, Haonan Li, Xiaoming You, Jie Liao,
Sambasiva Rao, Guang-Yu Yang
Distinct Clinicopathological and Genetic Features

of Two Histologic Subsets of Intrahepatic
Akimasa Hayashi, Kento Misumi, Junji Shibahara,
Junichi Arita, Yoshihiro Sakamoto, Kiyoshi Hasegawa,
Norihiro Kokudo, Masashi Fukayama
Graduate School of Medicine, University of Tokyo,
Tokyo, Japan
227
MUC6 Is a Unique Biomarker for Bile Duct Type of

Intrahepatic Cholangiocarcinoma (1652)
Todd DeJulio, Xiaoming You, Haonan Li, Jie Liao,
Sambasiva Rao, Nike Beaubier, Guang-Yu Yang
228
The Incidence of Steatosis and Steatohepatitis in

Intrahepatic Cholangiocarcinoma and Extrahepatic
George Eng, Lawrence Zukerberg, Vikram Deshpande
MGH, Boston, MA
229
Reproducibility of Evaluation of Liver Biopsies from

Patients with Congestive Heart Failure (1663)
Bela Horvath, Hao Xie, John Guirguis, Daniela Allende,
Michael Cruise, Deepa Patil, Robert OShea, John
Rivas, Reyna Yordanka, Xiuli Liu
Cleveland Clinic, Cleveland, OH; Yale University, New
Haven, CT
230
Are Eosinophilic Glassy Globules in Autoimmune

Hepatitis, a Histologic Clue to Diagnosis? (1674)
Mamta Pant, Daniel Rowan, Kiyoko Oshima
231
Histological Features of Autoimmune Hepatitis: A

Critical Appraisal (1659)
Ananta Gurung, David Assis, Tom McCarty, Kisha
Mitchell, James L Boyer, Dhanpat Jain
Royal Columbian Hospital, New Westminster, BC,
Canada
232
Extramedullary Hematopoiesis Presenting as Focal

Lesions in Liver: A Pathological and Radiological Study
(1647)
Gregory Cheeney, Matthew Yeh
233
Interpretation of Core Biopsy of Liver Mass Lesion:

A Comparison Study between Cytopathologist and
Gastrointestinal Pathologist (1690)
Zhaohai Yang
Penn State Milton S. Hershey Medical Center, Hershey,
PA
234
Interobserver Variability in Interpreting Liver Biopsies

with a Diagnosis of Alcoholic Hepatitis (1662)
Bela Horvath, Hao Xie, John Guirguis, Daniela Allende,
Jennifer Jeung, James Lapinski, Deepa Patil, Arthur
McCullough, Srinivasan Dasarathy, Xiuli Liu
Cleveland Clinic, Cleveland, OH; Yale University, New
Haven, CT
220
Combined Use of Copper Stain and CK7

Immunohistochemistry for Diagnosis of Cholestatic
Liver Disease (1634)
Dana Balitzer, Sanjay Kakar
221
Glutamine Synthethase Expression in Liver Biopsies

from Patients with Congestive Heart Failure (1664)
Bela Horvath, John Guirguis, Daniela Allende, Michael
Cruise, Deepa Patil, Robert OShea, John Rivas, Reyna
Yordanka, Nan Lan, Xiuli Liu
222
Programmed Death Ligand-1 Expression on Tumor

Cells in Cholangiocarcinoma Is More Frequent in
Poorly Differentiated and Intrahepatic Tumors and
Tumors with Brisk Tumor Infiltrating Lymphocytes
(1685)
Michael Torbenson, Taofic Mounajjed, Benjamin R
Kipp, Robert R McWilliams, Rondell Graham
223
Clinicopathologic Review and Outcome of 31 Cases

of Liver Transplant with Both Hepatocellular and
Ghassan Tranesh, David Lee, Murli Krishna, Tushar
Patel, Justin Nguyen, Denise Harnois, Raouf E Nakhleh
Mayo Clinic Florida, Jacksonville, FL
224
Role of the Histone Acetyltransferase hMOF and

H4K16 Acetylation in Vascular Invasion and Tumor
Progression in Hepatocellular Carcinoma (1676)
Nicolas Pote, Samira Laouirem, Miguel Albuquerque,
Pierre Bedossa, Slimane Ait si ali, Valerie Paradis
Department of Pathology, Beaujon Hospital, Clichy,
France; INSERM UMR 1149, Centre de Recherche
sur lInflammation, Beaujon Hospital, Clichy, France;
UMR7216, CNRS, Paris Diderot University, Sorbonne
Paris Cit, Paris, France
225
230
Prognosis of HER2 Expression in Cholangiocarcinoma

(1641)
Antonio Campos, Maria O Begnami, Viviane T
Fernandes, Milton JDBE Silva, Maria Begnami
A C Camargo Cancer Center, Sao Paulo, SP, Brazil
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
235
Neoadjuvant Treatment Response Predicts Survival in

Non-Small Cell Lung Cancer Resections (1902)
Adina Paulk, Alexander A Berrebi, Allen P Burke
University of Maryland Medical Center, Baltimore, MD
236
Combined High-Grade Neuroendocrine Lung

Carcinomas: A Clinicopathologic Study of Surgical
Resection Cases from a Single Institution (1906)
Maheshwari Ramineni, Annikka Weissferdt, Stephen G
Swisher, Cesar A Moran, Neda Kalhor
237
Clinico-Pathologic Characteristics of Primary Lung

Carcinoma with Hepatoid Differentiation (1899)
Prodipto Pal, Lucian Chirieac
238
Malignancy Risk for the Categories: Non-Diagnostic,

Benign, Atypical, Suspicious and Malignant Used in the
Categorization of Endobronchial Ultrasound GuidedFine Needle Aspirates of Pulmonary Nodules (1879)
Lester Layfield, Leslie G Dodd, Benjamin Witt
University of Missouri, Columbia, MO; University of
North Carolina, Chapel Hill, NC; University of Utah, Salt
Lake City, UT
239
240
241
242
HPV Prevalence and Genotype in Squamous Cell

Carcinoma of the Lung (1933)
Christopher Vytlacil, Christina DiCarlo, Emily J Smith,
Matthew A VanDeusen, Samantha A Martin, Lori A
Kelly, Ali Zaidi, Gene Finley, Rodney J Landreneau,
Blair A Jobe, Jan F Silverman
Allegheny General Hospital, Pittsburgh, PA; Allegheny
Health Network, Pittsburgh, PA
Usefullness of p16 Immunostain and Molecular Testing
for HPV in Determining Primary Versus Metastatic
Squamous Cell Carcinoma in the Lung (1925)
Jamie Steinmetz, Brett E Close, Larissa V Furtado, Aliya
N Husain, Nicole A Cipriani
Expression of P16 and Detection of Subtypes of HPV
RNA in Primary Non-Small Cell Lung Cancers (NSCLC)
and Their Potential Clinical Implication (1875)
Armen Khararjian, Xiao-Jun Ma, Zhen Zhang, Frederic
Askin, Edward Gabrielson, Yuling Luo, Qing Kay Li
Johns Hopkins, Baltimore, MD; Advanced Cell
Diagnostics, Hawyard, CA
Prognostic Factors and Recurrence in Primary Lung
Carcinoid Tumor Treated at a Single Institution (1873)
Neda Kalhor, Guoping Xu, Junya Fujimoto, Francesco
Stingo, Bonnie Glisson, Reza J Mehran, James C Yao,
Cesar A Moran
MD Anderson Cancer Center, Houston, TX; Dali
University, Yunnan, China
Board
Number
243
Proliferation Activity Evaluation by Ki-67 Labeling

Index in Paired Biopsy Samples and Surgical
Specimens of Pulmonary Neuroendocrine Tumors: A
Methodological Approach for Clinical Purposes (1904)
Giuseppe Pelosi, Mara Cossa, Alessandra Fabbri,
Barbara Valeri, Angelica Sonzogni, Ugo Pastorino
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan,
MI, Italy
244
Usefulness and Limitation of Endobronchial

Ultrasound Transbronchial Needle Aspiration (EBUS)
Specimen for PD-L1 Companion Diagnosis in Lung
Cancer (1915)
Rie Sakakibara, Noriko Motoi, Hironori Ninomiya,
Kentaro Inamura, Makoto Nishio, Yuichi Ishikawa
The Cancer Institute, Japanese Foundation for Cancer
Research, Koto, Tokyo, Japan; Cancer Institute
Hospital, JFCR, Koto, Tokyo, Japan
245
PD-L1, PD-1, CD4 and CD8 Expression in Neoplastic

and Non-Neoplastic Thymus (1934)
Ann E Walts, Alberto M Marchevsky
246
Patchy High Frequency of Nonspecific Abnormal

Signals (Background Noise): A Common Pitfall in
Interpretation of ALK FISH Results (1942)
Hong Yin, Shaobo Zhu, Michele K Zelonis, Dana R
Snyder, Zongming E Chen
247
Validation of a Simplified Approach to Detect ALK

Translocations in Lung Cancer Samples by FISH (1918)
Hans-Ulrich Schildhaus, Elke Binot, Jurgen Wolf,
Reinhard Buettner, Katja Schmitz
University Hospital Goettingen, Goettingen, Germany;
University Hospital Cologne, Cologne, Germany;
Center for Integrated Oncology, Cologne-Bonn,
Germany; Lung Cancer Group Cologne, Cologne,
Germany; Comprehensive Cancer Center (G-CCC) and
Lungentumorzentrum (LTZ), Goettingen, Germany
248
Comparison of Mutational Profiles in Cytology and

Corresponding Surgical Specimens from Patients with
Lung Adenocarcinoma (1944)
Hamid Zia, Alan Marcus, Brian E Geraghty, Rana
S Hoda, Navneet Narula, Hanna Rennert, Helen
Fernandes
New York Presbyterian Hospital-Weill Cornell Medical
College, New York, NY
249
Clinical Utility of Targeted Next Generation Sequencing

in Lung Cancer (1853)
Nike Beaubier, Valerica Mateescu, Julia A Elvin, Siraj M
Ali, Elizabeth Morency, Ritu Nayar
Northwestern University, Chicago, IL; Foundation
Medicine, Cambridge, MA
250
Simultaneous Detection of Gene Rearrangements

and Variants in Non-Small Cell Lung Cancer by NextGeneration Sequencing (1939)
Shuo Xu, Alexander Boag, Mihaela Mates, Lina Chen,
Harriet Feilotter
Queens University, Kingston, ON, Canada
231
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
251
Dysregulated miR-185-STIM1 Axis in Obliterative

Bronchiolitis (1943)
Chen Zhang, Guang-Sheng Lei
252
Histopathologic Findings in the Lungs of Patients

Treated with Extracorporeal Membrane Oxygenation
(1881)
Hee Eun Lee, Eunhee S Yi, Anja C Roden
Mayo Cliinc, Rochester, MN
253
Immunohistochemical Analysis of p14ARF, p15INK4B,

p16INK4A, MTAP, and Their Combinations May Predict
the Deletion Status of 9p21 in Malignant Pleural
Mesothelioma (1868)
Tomoyuki Hida, Makoto Hamasaki, Shinji Matsumoto,
Ayuko Sato, Tohru Tsujimura, Kunimitsu Kawahara,
Yoshinao Oda, Kazuki Nabeshima
Fukuoka University School of Medicine and Hospital,
Fukuoka, Japan; Graduate School of Medical Science,
Kyushu University, Fukuoka, Japan; Hyogo College
of Medicine, Nishinomiya, Hyogo, Japan; Osaka
Prefectual Medical Center for Respiratory and Allergic
Disease, Habikino-shi, Osaka, Japan
254
255
256
232
Interobserver Variability in Assessing Sarcomatoid

Components of Biphasic Malignant Mesothelioma
(BMM): Implications for Outcome Measures (1850)
Vijayalakshmi Ananthanarayanan, Wickii Vigneswaran,
Diana Kircheva, Qudsia Arif, Thomas Krausz, Aliya N
Husain
CTLA-4 Detection in Malignant Mesothelioma Tissues
and in Effusions: Relevance for Immunotherapy (1861)
Franco Fedeli, Serena Varesano, Paola Ferro, Maria
Cristiana Franceschini, Sandra Salvi, Simona Boccardo,
Jean Louis Ravetti, Anna Morabito, Alessandro
Valentino, Silvio Roncella, Maria Pia Pistillo
ASL5, La Spezia, Italy; IRCCS AOU San Martino-IST,
Genoa, Italy
Favorable Prognostic Implications of FGFR1
Amplification and MYC Amplification or
Overexpression in Resected Esophageal Squamous
Dohee Kwon, Ji Y Yun, Bhumsuk Keam, Young T Kim,
Yoon K Jeon
Seoul National University Hospital, Seoul National
University College of Medicine, Seoul, Republic of
Korea; The Tumor Immunity Medical Research Center,
Cancer Research Center, Seoul National University
College of Medicine, Seoul, Republic of Korea
Board
Number
QUALITY ASSURANCE
257
Her2/neu Testing in Breast Cancer: Comparative

Analysis of In Situ Hybridization and
Immunohistochemistry in a Dual-Testing System
(2009)
James Solomon, Oluwole Fadare, Farnaz Hasteh
UCSD, San Diego, CA
258
Impact of 2013 ASCO/CAP Guideline

Recommendations on HER2 FISH Testing in Breast
Cancer (1983)
Shivali Marketkar, Kamaljeet Singh, Cynthia Jackson,
Jesse Hart, Murray B Resnick, Yihong Wang
Rhode Island Hospital, Providence, RI; Women and
Infants Hospital, Providence, RI
259
Differences in Ki67 Percent Identified during Breast

Consult Review Do Not Impact the IHC4 Score: A
Quality Assurance Study (1949)
Gonzalo Barraza, Erinn Downs-Kelly, Rachel E Factor
University of Utah Health Sciences Center, Salt Lake
City, UT
260
Evaluation of Repeated Biomarker Testing In a Breast

Consultation Service: One Institution Experience
(2016)
Elena Vrotsos, Cesar A Llanos
261
Tumor Heterogeneity Compromises Studies on the

Effect of Prolonged Fixation on Immunohistochemistry
(IHC) Reporting of Breast Biomarkers (2013)
Tra Truong, Ken Kao, LUIS Gai, Kim Voisey
Memorial University, St Johns, Newfoundland, Canada
262
Upfront Immunohistochemistry to Evaluate Sentinel

Lymph Nodes in Malignant Melanoma: Burden or
Benefit? (1968)
William Frampton, Dani S Zander, Dipti M
Karamchandani
Hershey Medical Center, Hershey, PA
263
Quality Assurance Aspects of implementing

BRAFV600E Immunohistochemistry (IHC) Assay
in Universal Lynch Syndrome Screening (ULS)
for Colorectal Cancer (CRC): A Single Institution
Experience (1960)
Zongming E Chen, Angela Bitting, Nefize Kip, Fan Lin
Geisinger, Danville, PA
264
Cost-Benefit Analysis of C4d Immunoflourescence and

Immunohistochemistry in Evaluation of Pulmonary
Allograft Dysfunction (1945)
Monica Aldulescu, Razvan Lapadat, Robyn Essendrop,
Kamran M Mirza, Swati Mehrotra, Vijayalakshmi
Ananthanarayanan
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
265
273
Pre-Analytical Factors Involved in the Clinical Analysis

of a Comprehensive Next-Generation Sequencing
Panel (2003)
Alaa A Salim, Rajyalakshmi Luthra, Rajesh Singh,
Keyur P Patel, Mark Routbort, Bedia A Barkoh, Jawad
Manekia, Sinchita Roy Chowdhuri, Russell Broaddus,
Hui Chen
274
The Role of p16 in the Classification of Anal Squamous

Intraepithelial Lesions: Evaluation of Interobserver
Variability (1965)
Zachary J Dureau, Uma Krishnamurti, Mario Mosunjac,
Talaat S Tadros, Marina Mosunjac
Intraoperative Evaluation of Borderline Cystic Ovarian

Lesions: Are We at Least Concordant with the Final
Diagnosis? (2019)
Kyle J White, Andre Pinto
University of Miami / Jackson Memorial Hospital,
Miami, FL
275
Evaluating the Immunostaining Detection of

Cytomegalovirus in Gastrointestinal Biopsies: Clinical
Pathological Correlation (1980)
Xiaoyan Liao, Grace Y Lin
UCSD, San Diego, CA
The Impact of Subspecialty Surgical Pathology on

Generalized Intraoperative Consultations (1982)
Sophia Ma, Ketan Patel, Kumarasen Cooper
Philadelphia, PA
276
Accuracy of Intraoperative Consultation Rendered by

General Pathologists in a Scenario Where Well-Defined
Decision Algorithm Is Followed (2001)
Sherine Salama, James Richter, Tanya Pulver, Boris
Winterhoff, Mahmoud Khalifa
University of Toronto, Toronto, ON, Canada; University
of Minnesota, Minneapolis, MN
277
The Utility of Intraoperative Gross Examination of

Colorectal Resections: A Retrospective Review of 200
Sequential Cases (1976)
Armen Khararjian, Ajuni Choudhary, Alexander Baras
278
Initial Validation of Whole Slide Imaging (WSI) for Use

in Frozen Section Consultation at Stanford University
(1966)
Sebastian Fernandez-Pol, Eugene Carneal, Mathew
Rumery, Peyman Samghabadi, Brent Tan
279
An iOS App to Expedite the Evaluation of

Immunohistochemistry Stains (1986)
Wilfrido Mojica, Gregg Mojica
University at Buffalo, Buffalo, NY; Gradology, Inc, San
Francisco, CA
280
Is Digital Imaging a Viable Method of Measurement

for Breslow Thickness in Invasive Melanomas? An
Example of Evaluation of Uncertainty in a Critical Value
in Cellular Pathology (1977)
Yi Ling Khaw, Barbara Loftus
Tallaght Hospital, Dublin, Ireland
281
Validation of Digital Whole Slide Imaging System for

Intraoperative Breast Sentinel Lymph Node Touch Prep
Analysis: A Single Institution Experience (1973)
Jenny Hoffmann, Lisa McGinnis, Chrisy T Mafnas,
Jennifer Ziskin, Ann K Folkins, Kimberly Allison, Robert
B West, John P Higgins, Neeraja Kambham, Steven R
Long, Brent Tan
266
267
268
269
270
271
272
Napsin Expression in Metastatic Colorectal

Carcinoma to the Lung, a Potential Pitfall in
the Immunohistochemical Assessment of
Adenocarcinomas in the Lung, Identified In
Immunohistochemistry Validation (2007)
Manmeet Singh, Michael Clarke, Ashley S Freyre,
Shiraz S Fidai, Melody Lee, David Stephen, Elizabeth
Wiley, John V Groth
University of Illinois Hospital & Health Sciences
System, Chicago, IL
Histologic Evaluation of the Effects of Tissue

Decalcification on the Immunohistochemical Markers
in Bone Marrow Specimen (2006)
Marianna Shvartsbeyn, Mohamed E Salama, Rajan
Dewar
New York University, New York, NY; University of Utah,
Salt Lake City, UT; University of Michigan, Ann Arbor,
MI
A Proficiency Testing Scheme for IDH1 R132H IHC: The
cIQc Experience (2020)
Jennifer Won, Max Signaevski, John Garratt, Emina
Torlakovic, Blake Gilks, Stephen Yip
Canadian Immunohistochemistry Quality Control
(cIQc), Vancouver, Canada; University of British
Columbia, Vancouver, Canada; Vancouver General
Hospital, Vancouver, Canada
Quality Assurance of ATRX Immunohistochemistry in
a Multi-Centre Diagnostic Neuropathology Initiative
(2021)
Jennifer Won, John Garratt, Emina Torlakovic, Blake
Gilks, Stephen Yip
Canadian Immunohistochemistry Quality Control
(cIQc), Vancouver, Canada; University of British
Columbia, Vancouver, Canada; Vancouver General
Hospital, Vancouver, Canada
Next Generation Sequencing for Epilepsy,
Mitochondrial Disease, and Developmental Delay: One
Pediatric Hospitals Experience (1962)
Jessica L Davis, Bonnie Cole, Jessie Contra, Jane
Dickerson
Seattle Childrens Hospital, Seattle, WA
Quantifying Protein Levels in Cells by Violin Plots: A
Facile, Readily Visualized Method (1997)
Nicholas P Reder, Jonathan C Henriksen, Lawrence
True
233
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
282
Can Westgard Rules Identify Trends in Nondiagnostic

Rates for Thyroid Fine Needle Aspiration? (2014)
Janice Tyler, Jeffrey Goldsmith, Pamela Hartzband,
James V Hennessey, Michiya Nishino
290
283
Tumor Area Measurement as a Parameter for

Determination of Specimen Adequacy in the Selection
of EBUS-FNA Specimens for Mutational Analysis
by Targeted Next Generation Sequencing (NGS)[/
underline] (2004)
Sadia Sayeed, Laura M Warmke, Michael O Idowu,
Celeste N Powers, Adele O Kraft
Virginia Commonwealth University Medical Center,
Richmond, VA
High Efficiency Prostate Biopsy Evaluation after

Training Using Full-Field Optical Coherence
Tomography (2090)
Chongqing Yang, Eugenie Dalimier, Anil Parwani,
Riccardo Riccio, Nicolas Barry Delongchamps, Arnaud
Duc
LLTech SAS, Paris, France; Ohio State University,
Columbus, OH; Hptal Cochin, Paris Descartes
University, Paris, France; Beijing Hospital of Health
Ministry, Beijing, China
291
Lymph Node Pooling. A Cost-Effective and Feasible

Way of Lymph Node Molecular Staging in Colorectal
Carcinoma (2042)
Laura Herrero, Iban Aldecoa, Natalia Rakislova, Carla
Montironi, Nuria Planell, Pedro L Fernandez, Eva
Fernandez, Salvadora Delgado, Dulce Momblan,
Antonio Lacy, Antoni Castells, Miriam Cuatrecasas
Hospital Clinic, IDIBAPS, University of Barcelona,
Barcelona, Spain; CIBERehd, IDIBAPS, University of
Barcelona, Barcelona, Spain
292
Photoacoustic Mapping of Oxygen Saturation and

Blood Volume in Ex Vivo Lymph Nodes of ColorectalCancer Patients (2068)
Emi Saegusa-Beecroft, Ashwin Sampathkumar, Eugene
Yanagihara, Junji Machi, Ernest J Feleppa
University of Hawaii and Kuakini Medical Center,
Honolulu, HI; Riverside Research, New York, NY
293
Pathological Staging of Fibrosis by HighResolution Magnetic Resonance Imaging of Liver

Microarchitecture (2078)
Mark Valasek, Vera Vavinskaya, Mojgan Hosseini,
Claude Sirlin, Graeme Bydder, Nicklaus Szeverenyi
University of California San Diego, San Diego, CA
294
Rapid, Inexpensive Slide-Free Histology via MUSE:

Ultraviolet Surface Excitation Microscopy for Imaging
Unsectioned Tissue (2053)
Richard Levenson, Zachary T Harmany, Alex R Krueger,
Farzad Fereidouni
UC Davis Medical Center, Sacramento, CA; University
of California Davis, Davis, CA
295
Optimization of Tissue Section Thickness for Evaluation

of Mitotic Figures in Whole Slide Imaging (WSI) (2093)
Shabnam Zarei, Xuemei Wu, Sarah M Jenkins, William
Flotte, Taofic Mounajjed, Thomas Flotte
Mayo Clinic, Rochester, MN; Brown University,
Providence, RI
296
Cell & Tissue Display (CTD): An Alternative

Multipurpose Tool for Microscopy (2074)
Nicholas Theodosakis, Goran Micevic, Marcus W
Bosenberg, Nemanja Rodic
284
285
286
287
288
Fine Needle Aspirations of the Lung: Impact of

Interobserver Variability amongst Cytopathologists Can
Affect the Diagnosis (1964)
Zachary J Dureau, Brian Robinson, Momin T Siddiqui,
Uma Krishnamurti, Marina Mosunjac, Talaat S Tadros,
Wei Wei Shi, Vaidehi Avadhani, Alessandra Schmitt,
George Birdsong, Gabriela M Oprea-Ilies
Quick Review of Fine Needle Aspiration Accuracy with
Focus on Cytohistologic Correlation and Evaluation of
Discrepant Cases in a Limited Sample (2022)
Somaye Yekezare, Niloufar Reisian, Xiaoyan Liao,
Farnaz Hasteh
University of California San Diego Health System, San
Diego, CA; Kaiser Medical Center, San Diego, CA
Comparison of UroVysion FISH and Urine Cytology
with Performance Evaluation of Individual
Chromosome Enumeration Probes: A Five Year Single
Paari Murugan, Sandhya Dasaraju, Amrita Rao,
Badrinath R Konety, Khalid Amin
Diagnostic Utility and Concordance of Cytopathology
and Flow Cytometry of Cerebrospinal Fluid in
Lymphoblastic Leukemia/Lymphoma (1993)
Nupam Patel, Daniela Hoehn, Karthik A Ganapathi,
Govind Bhagat, Bachir Alobeid
Implemenation of a Lean Cytopathology Service Towards Routine Same-Day Reporting (1972)
Ekkehard Hewer, Anja M Schmitt
289
234
Utility of Adenosine Diphosphate (ADP) Inhibition by

Thromboelastography with Platelet Mapping (TEG-PM)
in Predicting Hemorrhagic Stroke in a Level 1 Stroke
Center: Analysis and Review of Literature (2028)
Kelly A Bowers, Richard D Hammer
POSTER
POSTER
SESSION
SESSION
V
Wednesday,
Monday, March
March
23,
16,
2015
2016| 9:30
- 12:00
PM
PMCCCC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30AMAM- 12:00
Board
Number
Board
Number
297
302
A Novel, Rapid, and Low Cost Method for Preparing

Tissues with Metallic Stents for Routine Histology
(2044)
Thom Jensen, Tyler A Jensen, Melissa Cessna, Dylan
Miller
Intermountain Biorepository, Salt Lake City, UT;
Intermountain Healthcare / University of Utah, Salt
Lake City, UT
303
Colour Deconvolution Is Superior to Hue-SaturationIntensity in Digital Analysis of Atherosclerotic Plaques

(2025)
Murad Alturkustani, J David Spence, Catherine Currie,
Myra Cocker, Cathie Crukley, Martin J Yaffe, JeanClaude Tardif, Cheemun Lum, Robert Beanlands,
Robert Hammond, Ali Khan
King Abdulaziz University, Jeddah, Saudi Arabia;
London Health Sciences Centre and Lawson Research
Institute, London, Canada; University of Western
Ontario, London, Canada; Robarts Research Institute,
London, Canada; Ottawa Heart Institute, Ottawa,
Canada; Montreal Heart Institute, Montreal, Canada;
Sunnybrook Health Sciences Centre, Toronto, Canada
304
The Glazed, Erasable Tissue Sections. Disaccharides

Protect FFPE Tissue Section Antigens from Air-DryingInduced Masking and Allow Repeated Antibody
Removal by Stripping (2066)
Susanna Ronchi, Giovanna Boi, Carla R Scalia, Rossella
Gendusa, Giorgio Cattoretti
Universit degli Studi di Milano-Bicocca, Via Cadore
48, 20900 Monza (IT), Italy; Azienda Ospedaliera San
Gerardo, Via Pergolesi 33, 20900, Monza (IT), Italy
305
Validation of Placental Preservation for Pathologic

Examination Using the TissueSAFE Formalin-Free
Vacuum-Sealing System (2092)
Richard J Zarbo, Michelle Felicella, Arthur R Gaba
Centrosome Amplification (CA) and Mitotic Frequency

Display Poor Concordance between Patient Tumors
and Cancer Cells Cultured In Vivo: An Analysis of
Breast, Pancreatic and Bladder Carcinoma (2059)
Karuna Mittal, Michelle D Reid, Angela Ogden, Da
Hoon Choi, Meenakshi Gupta, Guilherme Cantuaria,
Kristin Jonsdottir, Emiel AM Janssen, Beatrice
Knudsen, Padmashree CG Rida, Ritu Aneja
Georgia State University, Atlanta, GA; Emory
University, Atlanta, GA; West Georgia Hospital,
Lagrange, GA; Northside Hospital Cancer Institute,
Atlanta, GA, Georgia; Stavanger University Hospital,
Stavanger, Norway; Cedars Sinai Medical Center, Los
Angeles, CA
298
Novel 3-D Exploration and Analysis Tool for Surgical

Pathology Specimens (2086)
Seth Winfree, Tarek El-Achkar, Kenneth Dunn, Carrie L
Phillips
299
Locking Tissue Orientation from Grossing through

Microtomy Using Orientation Gels (2089)
Douglas T Yamanishi, Lydia E Figueroa, Cliff Hom,
Carlos Sanchez, Luis Chavez, Julie A Galindo, Erico
von Bueren
Sakura Finetek USA, Inc., Torrance, CA
300
Numbered Agar Bodies to Individualize Needle

Biopsy Specimens - A Paradigm Shift in Specimen
Identification (2082)
Ulrich Vogel
University Hospital of Tuebingen, Tuebingen, BadenWuerttemberg, Germany
301
Label-Free Identification of Amyloid Deposits in Tissue

Using Infrared Spectroscopic Imaging[/underline]
(2036)
Bennett Davidson, Maria M Picken, Michael Walsh
University of Illinois at Chicago, Chicago, IL; Loyola
University Medical Center, Maywood, IL
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
BONE & SOFT TISSUE PATHOLOGY
TLE1 mRNA Chromogenic In Situ Hybridization (CISH):

A Potentially Powerful Diagnostic Tool for Synovial
Sarcoma (66)
Vadim Khachaturov, Rana Naous, Zhen Wang, John R
Goldblum, Steven D Billings, Brian P Rubin
Cleveland Clinic, Cleveland, OH; SUNY Upstate Medical
University, Syracuse, NY
KDM2BSetting the Stage for Aberrant Silencing in

Synovial Sarcoma (50)
Amanda R Dancsok, Ana Banito, Scott Lowe, Torsten O
Nielsen
Exploring Intra-Tumor Heterogeneity in

Neurofibromatosis Type 1 Plexiform Neurofibromas:
Integration of Histological and Genomic Data Reveals
Correlation between Progressive Loss of CDKN2A and
Degree of Cellular Atypia (83)
Cleofe Romagosa, Meritxell Carrio, Ernest Terribas,
Bernat Gel, Cristina Flamerich, Teresa Moline, Inma
Rosas, Elisabeth Castellanos, Conxi Lazaro, Eduard
Serra
Hospital Universitari Vall dHebron, Barcelona, Spain;
Institut de Medicina Predictiva i Personalitzada del
Cncer (IMPPC), Barcelona, Spain; Hereditary Cancer
Program, Institut Catal dOncologia (ICO-IDIBELL),
Barcelona, Spain
235
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
Pediatric Non-Vestibular Schwannomas: A

Clinicopathologic Study of 22 Patients (42)
Cory Broehm, Karen Fritchie
11
Epithelioid Schwannoma: Clinicopathologic Analysis of

63 Cases (62)
Vickie Y Jo, Christopher Fletcher
Brigham and Womens Hospital & Harvard Medical
School, Boston, MA
The Diagnostic Utility of CAMTA1 and TFE3

Immunohistochemistry in Epithelioid Vascular Tumors
(87)
Marta Sbaraglia, Marco Gambarotti, Alberto Righi,
Angelo P Dei Tos
Treviso Regional Hospital, Treviso, Italy; Rizzoli
Institute, Bologna, Italy
12
CIC-DUX4 Fusion-Positive Round Cell Sarcomas of

Soft Tissue and Bone: Clinicopthologic and Molecular
Analysis from a Single Institution (86)
Marta Sbaraglia, Marco Gambarotti, Stefania Benini,
Gabriella Gamberi, Stefania Cocchi, Emanuela
Palmerini, Davide Donati, Piero Picci, Daniel Vanel,
Stefano Ferrari, Alberto Righi, Angelo P Dei Tos
Treviso Regional Hospital, Treviso, Italy; Rizzoli
Institute, Bologna, Italy
13
Evaluation of NKX2-2 Expression in Round Cell

Sarcomas Including Those with CIC-DUX4 and
BCOR-CCNB3 Fusions and Tumors with EWSR1
Rearrangement: Relative Specificity for Ewing Sarcoma
(59)
Yin Hung, Christopher Fletcher, Jason L Hornick
14
Establishment and Gene Expression Analysis of a

Mouse Model for CIC-DUX4 Sarcoma (98)
Toyoki Yoshimoto, Miwa Tanaka, Takuro Nakamura
The Cancer Institute, Japanese Foundation for Cancer
Research, Tokyo, Japan; Toranomon Hospital, Tokyo,
Japan
15
BCOR-CCNB3 Sarcoma of Soft Tissue with Round and

Spindle Histology: A Study of 4 Cases Highlights the
Pitfall of Mimicking Poorly Differentiated Synovial
Sarcoma (76)
I-Chuang Liao, Wan-Shan Li, Hsuan-Ying Huang
National Cheng Kung University Hospital, Tainan,
Taiwan; E-Da Hospital, Kaohsiung, Taiwan; Kaohsiung
Chang Gung Memorial Hospital, Kaohsiung, Taiwan
16
Mutations in Histone H3.3 Variants in Giant Cell Tumor

of Bone (54)
Brendan C Dickson, Leonie G Mikael, Tenzin Gayden,
Ashot Harutyunyan, Simon Papillon-Cavanagh, Jacek
Majewski, Nada Jabado, Jay S Wunder
Mount Sinai Hospital, Toronto, ON, Canada; McGill
University, Montreal, QC, Canada
17
Histone 3.3 Mutations in Giant Cell Tumor and Giant

Cell-Rich Sarcomas of Bone (56)
Alessandro Franchi, Alberto Righi, Marco Gambarotti,
Piero Picci, Angelo Paolo Dei Tos, Lisa Simi, Irene
Mancini
University of Florence, Florence, Italy; Rizzoli Institute,
Bologna, Italy; Treviso Regional Hospital, Treviso, Italy
Mass Spectrometry Highlights Proteomic and

Epigenetic Changes upon PRC2 Loss in MPNST (96)
John Wojcik, Simone Sidoli, Benjamin A Garcia,
Kumarasen Cooper
Philadelphia, PA; University of Pennsylvania,
Philadelphia, PA
HER3 (erbB3) as a Potential Therapeutic Target in

Peripheral Nerve Sheath Tumors (PNST): In Vitro and
In Vivo Models (49)
Sherley Diaz, Javier Hernandez Losa, Joan
Castellsague, Claudia Valverde, Roso Mares,
Angel Garcia, Cristina Teixido, Teresa Moline,
Juana Fernandez-Rodriguez, Eduard Serra, Alberto
Villanueva, Santiago Ramon y Cajal, Conxi Lazaro,
Cleofe Romagosa
Vall dHebron University Hospital, Barcelona, Spain;
Hereditary Cancer Program, Institut Catal de
Oncologia, Barcelona, Spain; Institut de Medicina
Predictiva i Perzonalitzada del Cancer, Barcelona, Spain
Anastomosing Hemangiomas Arising in Unusual

Locations: A Clinicopathological Study of 15 Cases
Showing a Predilection for the Paraspinal Region (63)
Ivy John, Andrew L Folpe
Non-syndromic Low-Flow Mixed Venous/Lymphatic

Malformation of Skeletal Muscle of the Extremity
(Fibro-Adipose Vascular Anomaly): A Clinicopathologic
Study of 11 Cases with Emphasis on Distinctive
Morphologic Features (90)
Michael L Schwalbe, Lara N Mrak, Paula E North, Darya
Buehler
University of Wisconsin School of Medicine, Madison,
WI; Childrens Hospital of Wisconsin, Milwaukee, WI
10
236
Immunohistochemical Profile of Littoral Cell Angioma

of the Spleen. A Report of 25 Cases Predominantly
Associated with Visceral Malignancies (81)
Kvetoslava Peckova, Michael Michal, Ladislav
Hadravsky, Saul Suster, Ivan Damjanov, Michal Michal
Charles University, Medical Faculty and Charles
University Hospital, Plzen, Czech Republic; Medical
College of Wisconsin, Milwaukee, WI; The University of
Kansas School of Medicine, Kansas City, KS
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
18
Histologic Spectrum of Giant Cell Tumor (GCT) of Bone

in Patients < 18 Years of Age: A Study of 66 Patients
(35)
Alyaa Al-Ibraheemi, Jodi M Carter, Riyam T Zreik,
Carrie Y Inwards, Karen Fritchie
Mayo Clinic, Rochester, MN; Scott & White Healthcare,
Temple, TX
26
19
Anchored Multiplexed PCR for Targeted Next

Generation Sequencing Reveals Recurrent and Novel
Gene Fusions in Aneurysmal Bone Cyst and No Fusion
in Giant Cell Tumor of the Bone (60)
Omar Jaber, Natalya Guseva, Aaron Stence, Benjamin
Miller, Munir Tanas, Deqin Ma

Evaluation of Bone and Soft Tissue Sarcoma (71)
Ravindra Kolhe, Karen Fritchie, Alka Chaubey, Lisa C
Watson, Claire Attwooll, WonSok Lee, Deepa Jagdale,
Ashis K Mondal
Georgia Regents University, Augusta, GA; Mayo
Clinic, Rochester, MN; Illumina, Inc, San Diego, CA;
Greenwood Genetic Center, Greenwood, SC
27
Finding Fusions: A Promising Commercially Available

NGS Sarcoma Panel (95)
Ashley Windham, Kimberly L Walker, Linden L Watson,
Arundhati Rao, Riyam T Zreik
Baylor Scott & White Hospital, Temple, TX
20
Chondroblastoma of Extracranofacial Bones - Analyses

of 103 Cases by Numerical Scoring on Histology (72)
Eiichi Konishi, Yasuaki Nakashima, Masayuki Mano,
Yasuhiko Tomita, Sanae Yamazaki, Akio Yanagisawa
Kyoto Prefectural University of Medicine, Kyoto,
Japan; Kyoto University, Kyoto, Japan; Osaka National
Hospital, Osaka, Japan; Osaka Medical Center of
Cancer and Cardiovascular Diseases, Osaka, Japan
21
Extraosseous, Extradural Chordomas of the Spine: A

Unique Chordoma Subset (43)
Jodi M Carter, Doris E Wenger, Carrie Y Inwards
22
Histopathology of So-Called Synovial Cysts of the

Lumbar Spine (45)
Ivan Chebib, Connie Y Chang, Darcy A Kerr, Vikram
Deshpande, G Petur Nielsen
School, Boston, MA; University of Miami Miller School
of Medicine, Miami, FL
23
Single Institutional Analysis of Prognostic Factors for

Soft Tissue Sarcoma; Debatable Value of Tumor Depth
(93)
Yoshiya Sugiura, Noriko Motoi, Keisuke Ae, Hiroaki
Kanda, Seiichi Matsumoto, Rikuo Machinami, Yuichi
Ishikawa
The Cancer Institute, Tokyo, Japan; The Cancer
Institute, Hospital, Tokyo, Japan
24
Programmed Death-Ligand 1 Expression in Sarcomas,

a Clinical a Pathologic Study (78)
Stemm Matthew, Alexander C Mackinnon
25
Detection of Sarcoma Oncogenic Fusion Transcripts

Using ArcherTM Sequencing Technology (57)
Caleb Ho, Kerry Mullaney, Catherine OReilly, George
Jour, Purvil Sukhadia, Lu Wang, Michael F Berger,
Maria E Arcila, Marc Ladanyi, Meera Hameed, Ryma
Benayed
NY; University College Cork, Cork, Ireland; MD
BREAST PATHOLOGY
28
Clinicopathologic Factors Associated with Metastatic

Breast Cancer (BC) at Presentation (284)
Tiansheng Shen, Gene P Siegal, Shi Wei
29
P-Rex1 Expression in Invasive Breast Cancer in

Relation to Receptor Status and Metastatic Site (232)
Kristen Muller, Todd Miller, Jonathan Marotti
Dartmouth Hitchcock Medical Center, Lebanon, NH
30
PD-1/PD-L1 Expression in Brain Metastases from Breast

Cancer (158)
Kara Gawelek, Nicole Williams, Vinay Varadan,
Lyndsay Harris, Hannah Gilmore
OH
31
Sensitivity and Specificity of Five

Immunohistochemical Markers in Distinguishing Breast
Primary CK7+ Lesions from Lung Primary CK7+ Lesions
(125)
Agedi Boto, Lori Charette, Marina Baine, Ugur
Ozerdem, Malini Harigopal
Yale New Haven Hospital, New Haven, CT
32
Similar Lymphocytic Infiltration Patterns in Primary

Breast Cancer and Corresponding Distant Metastases
(298)
Zsuzsanna Varga, Bettina Sobottka, Holger Moch
Institute of Surgical Pathology, Zurich, Switzerland
33
Assessment of Pathologic Response and Long-Term

Follow Up in Locally Advanced Breast Cancers after
Neoadjuvant Chemotherapy: Comparison between
Classifications[/underline] (139)
Misun Choi, Soo Youn Cho, Eun Yoon Cho
Samsung Medical Center, Seoul, Korea
34
Mitotic Index after Neoadjuvant Chemotherapy

Prognosticates Breast Cancer Recurrence or Metastasis
(170)
Nicholas Harding-Jackson, Christopher Hartley, Zainab
Basir
237
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
35
Androgen Receptor Status and Prediction of

Neoadjuvant Chemotherapy Response in TripleNegative Breast Cancer (288)
Catherine Stoos, Shannon Huggins-Puhalla, David
Dabbs, Rohit Bhargava
Magee-Womens Hospital, Pittsburgh, PA
43
36
Use of an Immunoprofile to Predict Response of

Invasive Breast Cancer to Neoadjuvant Chemotherapy
(222)
Lauren E McLemore, Joseph Albanese, Yungtai Lo,
Murali Janakiram, Susan A Fineberg
Montefiore Medical Center and the Albert Einstein
College of Medicine, Bronx, NY; Albert Einstein College
of Medicine, Bronx, NY
High Peripheral Stromal Lymphocytic Infiltration Is

Associated with Better Survival in Triple Negative
Breast Carcinoma (200)
Uma Krishnamurti, Ceyda Sonmez, Jing Yang, Limin
Peng, Xiaoxian Li, Ritu Aneja
Emory University, Atlanta, GA; Georgia State
44
Does Tumor Infiltrating Lymphocyte (TIL) Count

Influence Oncotype DxTM Recurrence Score and Magee
Equation Scores? (186)
Brie Kezlarian, Laura Favazza, Javier Arias-Stella,
Daniel Schultz, Dhananjay A Chitale
37
PD-L1 Expression and Lymphocytic Response in

Neoadjuvant-Treated Breast Cancers (275)
Nina Schatz-Siemers, Beth Harrison, Silvia C Formenti,
Sandra Demaria
NYU Langone Medical Center, New York, NY; Weill
Cornell Medical College, New York, NY
45
38
Breast Cancer Biomarkers before and after

Neoadjuvant Chemotherapy: Do Changes in Biomarker
Status Impact Therapeutic Management? (263)
Alexander K Quinones, Gary Tozbikian, Debra L Zynger
Microinvasive Carcinoma; High Grade-HER2 Pathway

Associated with High Tumor Infiltrating Lymphocytes
(227)
Michi Morita, Rin Yamaguchi, Maki Tanaka, Susumu
Eguchi, Hirohisa Yano
Kurume University Medical Center, Kurume, Japan;
Kurume University School of Medicine, Kurume,
Japan; JCHO Kurume General Hospital, Kurume,
Japan; Nagasaki University Graduate School of
Biomedical Sciences, Nagasaki, Japan
46
Two Scoring Systems of Tumor Infiltrating

Lymphocytes in Breast Cancer: Evaluating InterObserver Variability and TILs Heterogeneity [/
Thaer Khoury, Vidya Nagrale, Dan Wang, Fadi Habib
Roswell Park, Buffalo, NY
47
Loss of LINC00478 Expression Is Associated with

Development of Nodal Metastasis in ER+ Breast Cancer
(161)
Yesim Gokmen-Polar, Maria Zavodszky, Xiaowei Chen,
Xiaoping Gu, Chinnappa Kodira, Sunil Badve
Indiana University School of Medicine, Indianapolis,
IN; GE Global Research, Niskayuna, NY
48
Extracapsular Extension and Lymphovascular Invasion

in Breast Cancer Sentinel Lymph Nodes Is Associated
with Non Sentinel Lymph Node Metastases (258)
Ana S Pires-Luis, Joao Lobo, Liliana Santos, Margarida
Caldas, Carla Bartosch, Conceicao Leal
IPO-Porto, Porto, Portugal; ICBAS-UP, Porto, Portugal
49
Minimal Clinical Impact of Intraoperative Examination

of Sentinel Lymph Nodes in Patients with DCIS: An
Opportunity for Improved Resource Utilization (181)
Amy S Joehlin-Price, Debra L Zynger
50
Breast Cancer with Skin Ulceration: Should All Cases

Be Staged as pT4b?[/underline][/underline] (190)
Thaer Khoury, Souzan Sanati, Zaibo Li, Yisheng V
Fang, Mohamed M Desouki, Rouzan G Karabakhtsian,
Dan Wang, Carmelo Gaudioso, Rebecca Jacobson
Roswell Park, Buffalo, NY; Washington University,
Saint Louis, MO; Ohio State University, Columbus, OH;
University Texas Southwest, Dallas, TX; Vanderbilt,
Nashville, TN; Montefiore, Bronx, NY; University
Pittsburgh Medical Center, Pittsburgh, PA
39
40
41
42
238
Biomarkers Predicting Pathological Complete

Response to Neoadjuvant Chemotherapy in Breast
Cancer (207)
Xiaoxian (Bill) Li, Uma Krishnamurti, Shristi Bhattarai,
Sergey Klimov, Michelle Reid, Ritu Aneja
Emory University, Atlanta, GA; Georgia State
Distinctions in Breast Tumor Recurrence Patterns PostTherapy among Ethnically Distinct Populations (304)
Nikita Wright, Jun Xia, Remus Osan, Pranay Neema,
Dora IIyasova, Sergey Klimov, Mildred Jones,
Padmashree CG Rida, Guilherme Cantuaria, Ritu Aneja
Georgia State University, Atlanta, GA; Northside
Hospital Cancer Institute, Atlanta, GA; Northside
Hospital Cancer Data Center Institute, Atlanta, GA
Breast Frozen Section of Margins (FSM) Reduces
Reexcision: The First 5 Years at an Ambulatory Surgical
Center (ASC) (183)
Julie Jorns, Michael Sabel, Stephanie Daignault,
Angela Wu
Utilizing Mammography of Breast Resection Specimen
Slices for Lesion Identification Improves Sampling
Efficacy, Accurate Assessment of Tumor Pathologic
Parameters, Margin Assessment and Decrease in
Average Overall Turn-Around Time (231)
Jeffrey Mueller, Raveena Reddy
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
51
57
Increasing Detection of Non-Squamous Malignancies

in Pap Smears in a Medical Center in Taiwan (412)
Chiung-Ru Lai, Jen-Fan Hang, Chih-Yi Hsu
58
Glandular Findings in Cervical Cytopathology Liquid

Based Preparations in Cases of Endometritis: A Series
of 250 Patients (455)
Theresa Smith, Andrew Judd, Therese Bocklage
59
Stratified Mucin-Producing Intraepithelial Lesions of

the Cervix: A Diagnostic Challenge in Cytopathology
(399)
Jennifer Hipp, Syed Z Ali
University of Michigan Health Systems, Ann Arbor, MI;
60
Role of HPV Testing in Atypical Glandular Cells on Pap

Smear Diagnosis (398)
Kinda Hayek, Amy Jencks, MHD Fayez Daaboul,
Amarpreet Bhalla, Vinod B Shidham, Rouba Ali-Fehmi,
Sudeshna Bandyopadhyay
WSU, Detroit, MI; Indiana University, Indianapolis, IN
61
Endometrial Cells on Pap Testing: Impact of Revisions

to the Bethesda System for Reporting Cervical
Cytology (463)
Pamela Tauchi-Nishi, Landon Morikawa, David Shimizu
The Queens Medical Center, Honolulu, HI; University of
Hawaii, Honolulu, HI
62
Clinical Significance of Positive Peritoneal Washings

Cytology in Patients with Stage I Endometrioid-Type of
Endometrial Adenocarcinoma: A Community Hospital
Experience (356)
Boulos Beshai, Srinivas Mandavilli
63
Clinical Outcome of LSIL Cannot Exclude HSIL

Supports the Recommendation of LSIL and ASC-H in
the 2014 Bethesda System (395)
Jen-Fan Hang, Chih-Yi Hsu, Chiung-Ru Lai
64
Comparing Outcomes of hrHPV Positive Pap Tests: HPV

16/18 Genotypes Versus Non-16/18 Genotypes (346)
Gazal Alsaati, Julio Laureano, Mary K Sidawy, Jay Zeck
MedStar Georgetown University Hospital, Washignton,
DC
65
Prevalence of HPV 16/18 Genotypes and Histological

Follow-Up Results in Women with Negative Pap
Cytology/Positive Cervista HPV HR Assay (457)
Michelle Stram, Dinesh Pradhan, Chengquan Zhao
66
Cytology and High-Risk HPV DNA Co-Testing in

Cervical Cancer Screening Program: Outcome of 3-Year
Follow-Up in an Academic Institution (474)
Jack Yang, Olga S Chajewski, Jalidsa Pellicier, Patricia
M Houser
52
53
54
55
Skin Ulceration in Breast Cancer Carries No Increased

Risk of Disease Free or Overall Survival [/underline][/
underline] (189)
Thaer Khoury, Yisheng V Fang, Souzan Sanati,
Mohamed M Desouki, Zaibo Li, Rouzan G
Karabakhtsian, Dan Wang, Carmelo Gaudioso, Rebecca
Jacobson
Roswell Park, Buffalo, NY; University Texas Southwest,
Dallas, TX; Washington University, Saint Louis, MO;
Vanderbilt, Nashville, TN; Ohio State, Columbus, OH;
Montefiore, Bronx, NY; University Pittsburgh Medical
Center, Pittsburgh, PA
Inconsistency in Following the AJCC Reporting
Guidelines for T-Staging of Breast Cancer with Skin
Ulceration[/underline][/underline] (188)
Thaer Khoury, Rouzan G Karabakhtsian, Zaibo Li,
Mohamed M Desouki, Souzan Sanati, Yisheng V Fang,
Dan Wang, Carmelo Gaudioso, Rebecca Jacobson
Roswell Park, Buffalo, NY; Montefiore, Bronx, NY;
Ohio State, Columbus, OH; Vanderbilt, Nashville, TN;
Washington University, Saint Louis, MO; University
Texas Southwest, Dallas, TX; University Pittsburgh
HPV Detection by Chromogenic In Situ Hybridization
(CISH) and p16 Immunohistochemical (IHC) Staining in
Breast Cancer (165)
Hua Guo, Juan P Idrovo, Louis J Auguste, Tawfiqul
Bhuiya, Silvat Sheikh-Fayyaz
Hofstra North Shore LIJ School of Medicine, Lake
Success, NY; Hofstra North Shore LIJ School of
Medicine, New Hyde Park, NY
Epstein Barr Virus (EBV) in Triple Negative Breast
Cancer: A Tertiary Cancer Centre Experience (249)
Trupti Pai, Sangeeta Desai, Mamta Gurav, Prerna
Walecha, Sudeep Gupta
Tata Memorial Centre, Parel, Mumbai, Maharashtra,
India
Mass Spectrometry-Based Proteomics Identifies
Lactotransferrin as Co-Localizing Protein in
Amyloidosis of the Breast (163)
Karen L Grogg, Julie A Vrana, Bolette L Caron, Jason D
Theis, Paul J Kurtin
CYTOPATHOLOGY
56
Interobserver Variability of Cytotechnologists in

Papanicolaou Smears of Glandular Lesions of Cervix
(380)
Reima El Naili, Hongbo Wang, Marlo Nicolas, Diane
Avery, Kimberly Martinez, Kathleen Flannigan,
Syed Zaidi, Daniel Schantz, Thomas Prihoda, Maria
Policarpio-Nicolas
University of Texas Health Science Center at San
Antonio, San Antonio, TX
239
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
67
Informed Cytology and HPV Genotyping Preceding

Biopsy Proven HSIL/Adenocarcinoma: Analysis from
an Academic Medical Center (383)
Nazneen Fatima, Kruti Maniar, Joseph F Peevey, Julia
Samolczk, Ajit Paintal, Ritu Nayar
Chicago, IL
74
HPV Testing of Squamous Cell Carcinomas in

Non-Gynecological Cytology: Concordance of p16
Immunostaining and In Situ Hybridization for HPV
(464)
Brian Theisen, Liron Pantanowitz, Raja R Seethala,
Alyssa Mahaffey, Sara E Monaco
68
Do HPV Types and Infection Patterns Affect the

Cytologic Detection of High Grade Cervical Lesions on
Pap Test? (352)
Siavash Azadmanesh Samimi, Steven Goodman, Yimin
Ge, Roxanne R Mody, Eric Luna, Mary R Schwartz, Dina
R Mody, Donna Armylagos
Methodist Hospital, Houston, TX; BioReference
Laboratories, Houston, TX
75
Fine-Needle Aspiration of Neck Masses/Lymph Nodes

Yields Adequate Material for HPV Testing in Head and
Neck Squamous Cell Carcinomas (401)
Yanjun Hou, Shweta Chaudhary, Rulong Shen, Zaibo Li
Columbus, OH
76
Development of a Diagnostic Model Using Key

Cytologic Features in Washed Urine Cytology (459)
Ja Hee Suh, Heounjeong Go, Chang Ohk Sung,
Seunghee Baek, Se Un Jeong, Yong Mee Cho
University of Ulsan College of Medicine, Asan Medical
Center, Seoul, Republic of Korea
77
The Performance of the Paris System for Reporting

Urine Cytology (PSRUC) in Lower and Upper Tract
Specimens: A Comparative Study of 358 Cases (362)
Fadi Brimo, Muhannad Hassan, Ozlem Fidan-Ozbilgin,
Shraddha Solanki, Yonca Kanber, Derin Caglar, Stefan
E Pambuccian, Eva M Wojcik, Manon Auger, Guliz A
Barkan
McGill University Health Center, Montreal, QC, Canada;
78
Indefinite to Positive and Indefinite to Negative Ratios

as Potential Quality Measures for Urine Cytology (439)
Lynette Parker, Dina Kokh, Emily Wilding, Teklu
Legesse, Paul Staats
University of Maryland Medical Center, Baltimore, MD
79
Paris System for Reporting Urine Cytology, a First

Approach (387)
Elvia Goez Gutierrez, Victor Delacruz, Claudia P Rojas,
Carmen Gomez-Fernandez, Merce Jorda, Monica
Garcia-Buitrago
80
Comparative Evaluation of the Paris Reporting System

for Urine Cytology with Our Original Urine Cytology
Reporting System (478)
Somaye Yekezare, Leili Mirsadraei, Xiaoyan Liao,
Niloufar Reisian, Ahmed Shabaik, Farnaz Hasteh
Universityof California San Diego, San Diego, CA;
Kaiser Medical Center, San Diego, CA
81
The Paris System for Reporting Urine Cytology

(PSRUC) Improves the Prognostic Value of an Atypical
Urothelial Cell Diagnosis (397)
Muhannad Hassan, Derin Caglar, Yonca Kanber,
Shraddha Solanki, Manon Auger, Fadi Brimo
69
70
71
72
73
240
Comparing the Histological Follow-Up Results between

Positive HC2 HR HPV Test and Cervista HPV HR Assay
for Women with ASC-US Cytology in a large Academic
Womens Hospital Practice (483)
Chengquan Zhao, Dinesh Pradhan, Michelle Stram
The Pap Test Reporting Rates for Conventional Pap
Tests and Liquid-Based Cervical Cytology from the
Largest Academic Womens Hospital in China: Analysis
of 1248785 Papanicolaou Test Reports[/underline]
(462)
Xiang Tao, Marshall R Austin, Hao Zhang, Jianan Xiao,
Lihong Zhang, Li Wang, Xianrong Zhou, Chengquan
Zhao
Obstetrics and Gynecology Hospital of Fudan
University, Shanghai, China; Magee-Womens Hospital
of University of Pittsburgh, Medical Center, Pittsburgh,
PA
Prior Pap Test and/or HPV Testing Results in 3342
Women with Histologically Diagnosed Cervical
Intraepithelial Neoplasia 2/3: Data from Chinas Largest
CAP Certified Clinical Laboratory (472)
Tao Wu, Christopher C Griffith, BaoWen Zheng,
Xiangdong Ding, Yaoming Liang, Chengquan Zhao
KingMed Diagnostics, Guangzhou, China; Emory
University, Atlanta, GA; Magee-Womens Hospital of
High Risk HPV Testing and Report Rate: Result from the
Largest CAP Certified Independent Laboratory in China
(484)
BaoWen Zheng, Zaibo Li, Zhengyu Zeng, Congde Chen,
Jia You, Lingyun Tan, Chengquan Zhao
Guangzhou Kingmed Diagnostics, Guangzhou, China;
Ohio State University Medical Center, Columbus, OH;
Magee-Womens Hospital of UPMC, Pittsburgh, PA
Prospective Tonsillar Pap Smears with High Risk HPV
Testing of 41 Adults with Neck Mass and Unknown
Primary (420)
Megan G Lockyer, Matt Prall, Andrew Veyliotti, Terry K
Morgan
OHSU, Portland, OR
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
82
Diagnostic Utility of UroVysion for Urothelial

Carcinoma of the Upper Urinary Tract (405)
Hidehiro Iwata, Toyonori Tsuzuki, Naoto Sassa, Nagako
Maeda, Yota Murase, Shuko Seko, Ryohei Hattori,
Momokazu Gotoh
Japanese Red Cross Nagoya Daini Hospital, Nagoya,
Japan; Nagoya University Hospital, Naogya, Japan;
Japanese Red Cross Nagoya Daiichi Hospital, Nagoya,
Japan
83
High Diagnostic Accuracy of Concordant Ucyte and

Urovysion Tests (480)
Lei Zhang, Hui Y Wang, Mary Levin, Neda A
Moatamed, Jonathan Said, Douglas Bell, Jianyu Rao
University of California at Los Angeles, Los Angeles,
CA
84
Experience with UroVysion FISH in Suspicious Cases

for Urothelial Malignancy from a Large Academic
Medical Center (354)
Sheldon I Bastacky, Dinesh Pradhan, Somak Roy,
Gabriela Quiroga-Garza, Kathleen M Cieply, Alyssa M
Luvison, Rajiv Dhir, Anil Parwani
UPMC, Pittsburgh, PA; Wexner Medical Center,
Columbus, OH
85
Sex and Genetic Alterations in High Grade Urothelial

Carcinoma on Urine Cytologic Specimens (363)
Darren Buonocore, Sasinya N Scott, Nancy Bouvier,
Michael F Berger, Oscar Lin
86
CellDetect , a Novel Urine-Based Bladder Cancer Test: A

Multi-Institutional Validation Study (373)
Noa Davis
Micromedic Technologies, Tel Aviv, Israel
87
88
Label-Free Enumeration, Collection and Downstream

Cytological and Cytogenetic Analysis of Circulating
Tumor Cells (456)
Jianyu Rao, Manjima Dhar, Edward Pao, Corinne
Renier, Derek E Go, James Che, Rosita Montoya,
Rachel Conrad, Melissa Matsumoto, Kyra Heirich,
Melanie Triboulet, Stefanie S Jeffrey, Edward Garon,
Jonathan Goldman, Nagesh P Rao, Rajan Kulkarni,
Elodie Sollier, Dino Di Carlo
UCLA, Los Angeles, CA; Vortex Biosciences, Menlo
Park, CA; California NanoSystems Institute, Los
Angeles, CA; Jonsson Comprehensive Cancer Center,
Los Angeles, CA; UCLA Santa Monica Hematology
Oncology, Santa Monica, CA; UCLA Medical Center,
Los Angeles, CA; Stanford University School of
Medicine, Stanford, CA
An Emerging Role for Cytopathology in Precision
Oncology (440)
Chantal Pauli, Loredana Puca, Brian D Robinson, Juan
Miguel Mosquera, Himisha Beltran, Mark Rubin, Rema
Rao
NY
Board
Number
DERMATOPATHOLOGY
89
Breaking Bad Dogma: The Diversity of Spindle Cell

Lipomas in Women (506)
Jennifer S Ko, Brianne H Daniels, Patrick Emanuel,
Vadim Khachaturov, Jesse K McKenney, John R
Goldblum, Steven D Billings
Cleveland Clinic, Cleveland, OH; UCSF, San Francisco,
CA; Auckland Health Board, Auckland, New Zealand
90
The Pseudoangiomatous Variant of Spindle Cell

Lipoma Is Genuinely Lymphangiomatous (532)
Toyohiro Tada, Takashi Tsuchida, Satoshi Baba, Hisashi
Tateyama
Toyokawa City Hospital, Toyokawa, Japan; Hamamatsu
Medical University, Hamamatsu, Japan; Kasugai City
Hospital, Kasugai, Japan
91
Cutaneous Intravascular Epithelioid Haemangioma. A

Clinico-Pathological Analysis of 21 Lesions (512)
Bostjan Luzar, Eleni Ieremia, Eduardo Calonje
Medical Faculty University of Ljubljana, Ljubljana,
Slovenia; John Radcliffe Hospital, Oxford, United
Kingdom; St Thomass Hospital, London, United
Kingdom
92
The Rich Inflammatory Infiltrate in Kaposi Sarcoma

Contains Phenotypically Defined Tumor Associated
Macrophages with Potential Tumor Immune
Suppressor and Angiogenetic Functions (491)
Gianna Ballon, Ethel Cesarman
North Shore LIJ Health System, Lake Success, NY;
93
Multinucleate Cell Angiohistiocytoma: A Study of 5

Cases of an Enigmatic Entity with Further Insights on
Its Clinical Presentation (497)
Giovanni Falconieri, Deborah Bonazza, Maurizio
Pinamonti, Bostjan Luzar
University of Trieste, Trieste, Italy; University of
Ljubljana, Ljubljana, Slovenia
94
The Generalized Eruptive Keratoacanthoma of

Grzybowski: A Reappraisal of a Challenging Conditions
Based on 4 New Cases (498)
Giovanni Falconieri, Maurizio Pinamonti, Deborah
Bonazza, Joze Pizem, Bostjan Luzar
Trieste University, Trieste, Italy; Ljubljana University,
Ljubljana, Slovenia
95
DNA Mismatch Repair Status in Keratoacanthoma:

Immunohistochemistry-Based Study of 1353 Tumors
from 1067 Patients (496)
Renee Eigsti, Carolyn Rysgaard, Ashlynne Clark, Brian
Swick, Andrew M Bellizzi
96
Relationship between p53 Status and Clinicopathologic

Variables in Cutaneous Basal Cell Carcinoma (526)
Kevin A Pettit, John VanBuren, Brian Swick, Andrew M
Bellizzi
241
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
97
Proposal of a New Molecular Classification of

Sebaceous Carcinoma with Its Clinical Significance
(522)
Hee-Young Na, Ji Eun Kim, Ji-Young Choe, Ji Yun Yun,
Sun-ah Shin, Ho-Kyung Choung, Min Joung Lee
Seoul National University Hospital, Seoul, Republic
of Korea; Seoul Municipal Governmet-Seoul National
University Boramae Hospital, Seoul, Republic of
Korea; Seoul National University Bundang Hospital,
Seoul, Republic of Korea; Hallym University Sacred
Hospital, Anyang, Republic of Korea; Seoul Municipal
Government-Seoul National University Boramae
103
New Markers for the Recognition of Primary Cutaneous

CD8-Positive Epidermotropic Cytotoxic T-cell
Lymphoma (527)
Steliana F Racean, Emma Linares, Carmen GonzalezVela, Santiago Montes, Susana Armesto, Pablo
Gonzalvo, M Asun Gonzalez-Moran, Victor Alegre,
Sonia Alonso, Javier Freire, Manuela Mollejo, Miguel
Angel Piris
University Hospital Marqus de Valdecilla, Santander,
Spain; Hospital Cabuees, Gijn, Spain; University
Hospital Len, Len, Spain; University Hospital General
de Valencia, Valencia, Spain; University Hospital Elda,
Elda, Spain; Hospital Virgen de la Salud, Toledo, Spain
98
SOX-10 and DOG1 Expression in Primary Adnexal

Tumors and Cutaneous Metastases of Epithelial Origin
(510)
Cecilia Lezcano, Jonhan Ho, Raja R Seethala
104
99
Detection of Somatic Mutations in Secondary Tumors

Associated with Nevus Sebaceus by Targeted Next
Generation Sequencing[/underline][/underline] (504)
Jong T Kim, Kimberly J Newsom, Wonwoo Shon
Differential Expression of CD123 in Photoallergic

Dermatitis, Spongiotic and Lichenoid Dermatoses, and
Mycosis Fungoides (501)
Andy C Hsi, Xiaofan Pang, Andras Schaffer
MO
105
100
Whole Exome Sequence of Merkel Cell Carcinoma

Reveals a High Degree of Genomic Instability (514)
Henry McNett, Haley Abel, David Larson, Viveca
Bjornhagen, Hong Xie, Weng-Onn Lui, Eric J
Duncavage
Washington University, St. Louis, MO; Karolinska
Institutet, Stockholm, Sweden
Chilblain Lupus Eythematosus Versus Idiopathic

Perniosis: Comparative Analysis of Histopathologic
Features and CD123 and CD30 Immunostaining (539)
Michael Wang, May P Chan
106
The Utility of Immunohistochemical and Histological

Features to Distinguish between Erythema Multiforme
and Cutaneous Graft Versus Host Disease (525)
Stephanie Petkiewicz, April Deng, Patrick ODonnell,
Kristine M Cornejo
University of Massachusetts, Worcester, MA
101
The Composition, Density, and Location of Immune

Infiltrates Correlate with Survival in Merkel Cell
Carcinoma (535)
Michael T Tetzlaff, Laurence Feldmeyer, Genevieve R
Lyons, Jonathan L Curry, Phyu P Aung, Priyadharsini
Nagarajan, Doina Ivan, Carlos A Torres-Cabala, Roland
L Bassett, Jennifer A Wargo, Victor G Prieto
Houston, TX
107
Keratin 17 Expression and Immune Phenotype of AntiTNF- Refractory Psoriasis and Anti-TNF- Related
Psoriasiform Dermatitis (519)
Andrea Moy, Mandakolathur Murali, Daniela
Kroshinsky, Thomas Horn, Rosalynn Nazarian
108
Gastrin-Releasing Peptide (GRP) and Scleroderma: A

Potential Novel Mechanism of Tissue Fibrosis (513)
Elizabeth L McKinnon, Mohamad Ibrahim, Howard
Levinson, Mary E Sunday
Duke University Hospital, Durham, NC
109
The Expression of BMP-2, Fetuin-B, and MGP in

Biopsies of Calciphylaxis (495)
Jonathan Davick, Andrew Patterson, Benjamin
Kaffenberger, Alejandro Gru
The University of Virginia, Charlottesville, VA; The Ohio
State University, Columbus, OH
102
Intratumoral Lymphovascular Invasion Detected by

D2-40 Correlates with Metastasis in Primary Cutaneous
Merkel Cell Carcinoma (488)
Rami N Al-Rohil, Laurence Feldmeyer, Priyadharsini
Nagarajan, Genevieve R Lyons, Jonathan L Curry,
Carlos A Torres-Cabala, Doina Ivan, Victor G Prieto,
Michael T Tetzlaff, Phyu P Aung
ENDOCRINE PATHOLOGY
110
242
No Detection of Circulating BRAF Mutant DNA in

Thyroid Cancer Patients[/underline] (571)
Fulvio Basolo, Vincenzo Condello, Elisabetta Macerola,
Clara Ugolini, Luigi De Napoli
University of Pisa, Pisa, Italy
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
111
Old Versus New: Individual and Combined

Performance of CK19, HBME-1, CD117, and TROP-2 in
Distinguishing a Wide Morphologic Range of Normal,
Benign, and Malignant Thyroid Tissue Cores (572)
Peter N Bonneau, Christopher Hartley, Bryan Hunt
120
112
How Reliable Are TTF-1 and PAX8 in Confirming

Thyroidal Origin in Undifferentiated (Anaplastic)
Thyroid Carcinomas? (582)
Daniel N Johnson, Tatjana Antic, Nicole A Cipriani
Calcitonin-Producing Pancreatic Neuroendocrine

Neoplasms: Clinico-Pathologic Study of 25 Cases (585)
Stefano La Rosa, Roberta Maragliano, Annika Blank,
Silvia Uccella, Aurel Perren, Fausto Sessa
Ospedale di Circolo, Varese, Italy; University of
Insubria, Varese, Italy; University of Bern, Bern,
Switzerland
121
113
C-KIT: A Useful Adjunct Marker for the Evaluation of

Papillary Thyroid Carcinoma[/underline] (610)
Jaylou Velez Torres, Ernesto Martinez Duarte,
Oleksandr N Kryvenko, Jennifer Chapman, Darcy A
Kerr, Christina Kovacs, Carmen Gomez Fernandez
University of Miami Miller School of Medicine/ Jackson
Ki67 Indices and Status of SSTR2 and SSTR5 in the

Primary Tumors and in Their Liver Metastases of
Gastro-Enteric(GE) and Pancreatic Neuroendocrine
Neoplasms(NEN): Do They Change When They
Metastasize? (598)
Robert Y Osamura, Chie Inomoto, Hiroshi Kajiwara,
Midori Matsuda
International University of Health and Welfare Mita
Hospital, Tokyo, Japan; Tokai University School of
Medicine, Isehara, Japan
122
Neuroendocrine Neoplasms of the Pancreas and

the Lungs: Potential Differences in Morphological
Characteristics and Cell Cycle Regulation (583)
Atsuko Kasajima, Samaneh Yazdani, Tomoyoshi
Tachibana, Hirotaka Ishida, Kazuma Kobayashi, Keigo
Murakami, Hironobu Sasano
Tohoku University Hospital, Sendai, Miyagi, Japan;
Tohoku University Graduate School of Medicine,
Sendai, Miyagi, Japan
123
Pancreatic NENs <2 cm Could Represent a New Entity

Worth of Further Investigation (591)
Massimo Milione, Patrick Maisonneuve, Alessio
Pellegrinelli, Giovanni Centonze, Mauro Scotti,
Joregelina Coppa, Vincenzo Mazzaferro
Fondazione IRCCS Istituto Nazionale dei Tumori,
Milano, Italy; European Institute of Oncology, Milano,
Italy
124
T-Cell Infiltrate in GEP-NENs: Identification and

Evaluation of Its Distribution Among the WHO G1, G2
and G3 NENs (592)
Massimo Milione, Alessio Pellegrinelli, Giovanni
Centonze, Francesca Dominoni, Joregelina Coppa, Sara
Pusceddu, Roberto Buzzoni, Luca Giacomelli, Vincenzo
Mazzaferro, Filippo De Braud, Andrea Anichini
Anatomic Pathology 1 Fondazione IRCCS Istituto
Nazionale dei Tumori, Milano, Italy; University of
Genoa, Genoa, Italy
125
Progesterone Receptor Expression Is a Sensitive and

Relatively Specific Biomarker for Well-Differentiated
Pancreatic Neuroendocrine Tumors (577)
Todd DeJulio, Xiaoming You, Haonan Li, Jie Liao,
Sambasiva Rao, Xiaoqi Lin, Guang-Yu Yang
114
Immunohistochemical Detection of NRASQ61R Protein in

Follicular-Patterned Thyroid Tumors (597)
Naoki Oishi, Tetsuo Kondo, Huy Vuong, Tadao
Nakazawa, Kunio Mochizuki, Kazunari Kasai, Tomohiro
Inoue, Ippei Tahara, Mitsuyoshi Hirokawa, Akira
Miyauchi, Ryohei Katoh
University of Yamanashi, Chuo, Yamanashi, Japan;
Kuma Hospital, Kobe, Hyogo, Japan
115
Stage Specific Embryonic Antigen-1 (SSEA-1)

Expression in Thyroid Tissues (615)
Jin Xu, Heather A Hardin, Ranran Zhang, Ricardo V
Lloyd
Health, Madison, WI
116
Gene Expression Profiling by Nanostring nCounter

miRGE Assay May Identify Malignant Thyroid Nodules
(590)
Danielle Meunier, Iyare Izevbaye
University of Alberta, Edmonton, AB, Canada
117
Clusterin as Ancillary Marker of Medullary Thyroid

Carcinoma (593)
Najat Mourra, Malika Bennis, Beatrix Cochand-Priollet,
Marine Lefevre, Charles Lepine, Jerzy Klijanienko,
Fabrice Menegaux, Frederique Tissier
St-Antoine Hospital, Paris, France
118
GATA3 Expression in Pituitary Adenomas (586)

Mirna Lechpammer, Jessica G Rogers, Kristin A Olson,
Kiarash Shahlaie, Alexander Borowsky, John W Bishop
University of California Davis, Sacramento, CA
119
Mixed Gangliocytoma-Pituitary Adenoma: Insights on

the Pathogenesis of a Rare Sellar Tumos (587)
M Beatriz Lopes, Emily A Sloan, Julie G Polder
243
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
134
High Expression of the Leaky Protein Claudin-2 in

Esophageal Carcinoma and Precancerous Lesions Is
Significantly Associated with the Bile Salt Receptors
VDR and TGR5 (620)
Sohaib Abu-Farsakh, Tongtong Wu, Amy Lalonde, Jun
Sun, Zhongren Zhou
135
Carbonic Anhydrase IX (CA9) Expression in

Adenocarcinoma of the Stomach and Esophagus (781)
Faisal Saeed, Hongfeng Zhang, George Kleinman,
Minghao Zhong
Westchester Medical Center, Valhalla, NY; Central
Hospital of Wuhan, Wuhan, China
126
Genta Stain Necessity in Diagnostic Accuracy of

Detecting Helicobacter Pylori in Gastric Biopsies (656)
Lani K Clinton, Jared Osaki, Hiroko Shinoda, David
Shimizu
University of Hawaii Pathology Residency Program,
Honolulu, HI; Queens Medical Center, Honolulu, HI
127
Incidental Finding of Terminal Ileitis (IFTI): Indication

for Colonoscopy Does Not Predict Outcome (799)
Hassan Siddiki, Jonathan Leighton, Suryakanth
Gurudu, Shabana F Pasha, Dora Lam-Himlin
Mayo Clinic, Scottsdale, AZ
128
Alterations of the Genomic Landscape in Inflammatory

Bowel Disease-Associated Neoplasia (780)
Mary P Rosenblatt, Alain Borczuk, Alina Iuga
Columbia University Medical Center, New York, NY;
136
CDX2 as a Prognostic Marker in Gastric

Muhammad A Masood, Muhammed A Yusuf, Asif Loya
Shaukat Khanum Memorial Cancer Hospital and
Research Centre, Lahore, Punjab, Pakistan
129
Dysplasia in Inflammatory Bowel Disease: Correlation

of Biopsy and Resection Findings (765)
Deepa Patil, Erica Savage, John Goldblum, Robert
Odze
137
130
Clinicopathologic Characteristics of Systemic

Mastocytosis in the Intestine (797)
Angela R Shih, Vikram Deshpande, Judith A Ferry,
Lawrence Zukerberg
Prospectively Reported Histologic Tumor Viability

Score and Factors Predicting Long Term Survival in
Patients Treated with Trimodality Therapy for Primary
Esophageal Adenocarcinoma (623)
Atin Agarwal, Arlene M Correa, Huamin Wang, Dipen
Maru, Dongfeng Tan, Susan C Abraham, Melissa W
Taggart, Jeannelyn S Estrella, Wai Chin Foo, Wayne L
Hofstetter, Asif Rashid
University of Texas, MD Anderson Cancer Center,
Houston, TX
138
Association between HER2 Status in Gastric Cancer

and Clinicopathological Features: A Retrospective
Study Using Whole-Tissue Sections (711)
Renato S Laboissiere, Marcelo A Buzelin, Debora
Balabram, Marina De Brot, Cristiana B Nunes, Rafael
M Rocha, Monica M Demas Alvares Cabral, Helenice
Gobbi
Federal University of So Joo del-Rei UFSJ, So
Joo del-Rei, Minas Gerais, Brazil; Federal University
of Minas Gerais UFMG, Belo Horizonte, Minas Gerais,
Brazil
139
CD44 Expression and Its Clinical and Histologic

Associations in Gastric Cancer: A Tertiary Care Center
Experience (754)
Stephen Olsen, Ilke Nalbantoglu
Washington University in St. Louis School of Medicine,
Saint Louis, MO
131
Distinct Expression of MACC1 and MET in Esophageal

Squamous Cell Carcinoma and Esophageal
Wenqing Cao, Bing Ren, Zhongren Zhou, Jiangzhou Yu
York, NY; University of Rochester Medical Center,
Rochester, NY
132
Histopathologic Features for Prognostication of

Superficial Barretts Carcinoma: Data from a MultiCenter Study in Japan (628)
Junko Aida, Tatsuro Ishizaki, Tomio Arai, Kaiyo Takubo
Tokyo Metropolitan Institute of Gerontology, Tokyo,
Japan; Japan, Research Society for Early Esophageal
Cancer and Chromoendoscopy, Tokyo, Japan; Tokyo
Metropolitan Geriatric Hospital, Tokyo, Japan
133
244
Histologic Predictors of Endoscopic Treatment Failure

in Barretts Esophagus-Associated Dysplasia (692)
Sara Higgins, Meir Mizrahi, Marcello M DiStasio,
Douglas K Pleskow, Tyler Berzin, Robert Najarian
Beth Israel Deaconess Med Center/Harvard Medical
School, Boston, MA; Beth Israel Deaconess Medical
Center, Boston, MA
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
140
149
Prognostic Significance of Venous-Associated

Colorectal Cancer Tumor Deposits Identified by Elastic
Tissue Staining (734)
Mena Mansour, Jayalakshmi P Balakrishna, Natalie
Ciomek, Noam Harpaz
150
Diagnostic Utility of Keratin and Elastic Stains in

evaluation of Tumor Invasion of Peritoneal Membranes
(648)
Jey-Hsin Chen, Melissa Borges
CellNetix Pathology and Laboratories, Seattle, WA;
Swedish Medical Center, Seattle, WA
151
Low Frequently Mutated Genes in Colo-Rectal Cancer:

Evidences from Next-Generation Sequencing of 653
Routine Cases (808)
Giancarlo Troncone, Pasquale Pisapia, Elena Vigliar,
Claudio Bellevicine, Umberto Malapelle
University of Napies Federico II, Napoli, Italy
152
Large Size and High Grade Dysplasia Are Strong

Predictors of Mismatch Repair Deficiency in Lynch
Syndrome-Associated Colorectal Adenomas (630)
Iban Aldecoa, Natalia Rakislova, Sabela Carballal,
Carla Montironi, Laura Herrero, Ariadna Sanchez,
Teresa Ocana, Maria Pellise, Antoni Castells, Francesc
Balaguer, Miriam Cuatrecasas
Hospital Clinic, Barcelona, Spain
153
Clinicopathologic Findings in Gynecologic

Proliferations of the Appendix (762)
Sapna S Patel, Raul S Gonzalez
University of Rochester Medicine, Rochester, NY
154
Adenocarcinoma Ex-Goblet Cell Carcinoid (XGC)

Is a Morphologically Distinct Appendiceal-Type
Crypt Cell Adenocarcinoma with Highly Aggressive
Behavior and Frequent Association with Peritoneal/
Intra-Abdominal Dissemination: An Analysis of 77
Cases (773)
Michelle Reid, Olca Basturk, Walid Shaib, Serdar Balci,
Hyejeong Choi, Gizem Akkas, Brian Robinson, Bahar
Memis, Bassel El-Rayes, Charles Staley, Christopher
Staley, Joshua Winer, Maria Russell, Jessica H Knight,
Michael Goodman, Alyssa Krasinskas, Volkan Adsay
Emory University, Atlanta, GA; MSKCC, NY, NY
155
Clinical Significance of Fibroblast Growth Factor

Receptor 2 Expression on Residual Disease after
Preoperative Chemoradiotherapy for Rectal Cancer: A
Retrospective Single Institution Study (787)
An Na Seo, Sol-Min Kim, Ji-Young Park, GhilSuk Yoon
Kyungpook National University Medical Center,
Kyungpook National University School of Medicine,
Daegu, Republic of Korea
156
Detection of Mismatch Repair Protein (MMR) Loss by

Immunohistochemistry (IHC) in Colorectal Adenomas
from Young Patients: An Appraisal of Its Utility in
Lynch Syndrome Screening (650)
Zongming E Chen, Jinhong Li, Nefize Kip, Fan Lin
Size Does Matter: Tumor Diameter Predicts

Lymph Node and Distant Metastases in Gastric
Heather Dawson, Alexander Novotny, Daniel Reim,
Radu Tutuian, Rupert Langer, Fatima Carneiro, Irene
Gullo, Magali Svrcek, Jean-Francois Flejou, Inti Zlobec,
Alessandro Lugli
Switzerland; Klinikum Rechts der Isar, Technische
Universitt Munich, Munich, Bavaria, Germany;
Inselspital Bern, Bern, Switzerland; Medical Faculty
of Porto and Ipatimup, Porto, Portugal; Assistance
Publique-Hpitaux de Paris, Paris, France
141
Differences between Hereditary and Sporadic Diffuse

Type Gastric Cancer Indicating Different Carcinogenetic
Pathways (715)
Hee Eun Lee, Thomas C Smyrk, Lizhi Zhang
142
MCM2 and Chromogranin Are Markers of Serrated

Polyp Progression (676)
Danielle Fortuna, Bruce M Boman, Juan P Palazzo
Thomas Jefferson University Hospital, Philadelphia, PA
143
Digital Image Analysis of Serrated Lesions of the

Colorectum[/underline][/underline] (777)
Brian Robinson, David Martin, Alton B Farris
144
Ectopic Crypt Formation Is a Common Histologic

Feature in Large Tubular and Tubulovillous Adenomas,
Not Specific for Traditional Serrated Adenomas (838)
Yi Zhou, Haiyan Chen, Vamsi Parini, Mohammed Atieh,
Stefan E Pambuccian, Xianzhong Ding
145
Yap1 Oncogene Overexpression in Colerectal Polyps

and Association with Nuclear -catenin (770)
Carolina Polanco, Christopher Hartley, Catherine Hagen
146
Glucose Metabolic Reprogramming and Cell

Proliferation Arrest in Micropapillary Colorectal
Carcinomas (815)
Monika Vyas, Natalie Patel, Margaret Cho, Narendra
Wajapeyee, Dhanpat Jain, Xuchen Zhang
147
The Prognostic Significance of Peritumoral Chronic

Inflammation in Rectal Adenocarcinoma after
Neoadjuvant Treatment (653)
Rati Chkheidze, Amit Singal, Muhammad S Beg, Purva
Gopal
148
VE1 Immunohistochemistry in Colorectal Cancer Is

Homogeneously Expressed and Is a Predictor of BRAF
Mutational Status and Worse Survival (663)
Heather Dawson, Christian Schafroth, Jose A Galvan,
Lena Sokol, Gregor Rieger, Viktor Koelzer, Rupert
Langer, Alessandro Lugli, Inti Zlobec
Switzerland
245
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
157
158
159
Implementation of a Pathology-Driven Lynch

Syndrome Screening Program (624)
Diana Agostini-Vulaj, Kelly Q McMahon, Rebecca
Amorese, Jennifer Findeis-Hosey
The Ampulla of Vater, a Potential Cancer Hot
Spot: Higher Cancer Incidence Per Surface Area in
Comparison to Other Sites of GI Tract in the Last 4
Decades of SEER 9 Registry (776)
Elizabeth Richards, Matthew Yeh
Montefiore Medical Center, Bronx, NY; University of
Washington, Seattle, WA
Line-1 Methylation Status Predicts Aggressive Behavior
in Pancreatic Endocrine Neoplasms (782)
Wesley Samore, Krishnan K Mahadevan, Vikram
Deshpande
160
Comprehensive Proteomic Characterization of

Pancreatic Adenocarcinoma (829)
Qian Yang, Sheng-Ben Liang, Julia Y Wang, Michael H
Roehrl
161
Reduced Expression of Argininoscuccinate Synthetase

1 Has a Negative Prognostic Impact in Patients with
Pancreatic Ductal Adenocarcinoma Treated with
Neoadjuvant Therapy and Pancreaticoduodenectomy
(726)
Qingqing Liu, John M Stewart, Hua Wang, Asif Rashid,
Matthew H Katz, Jeffery E Lee, Jason B Fleming,
Anirban Maitra, Robert A Wolff, Gauri R Varadhachary,
Sunil Krishnan, Huamin Wang
162
IMP3 Is Similarly Expressed Immunohistochemically

in Intrahepatic and Extrahepatic Cholangiocarcinomas
(640)
Laura Bratton, Loralee McMahon, Richard F Dunne,
Rebecca Amorese, Jennifer Findeis-Hosey
163
SSBP2 Are Associated with Patients Survival in

Hyunsung Kim, Yumin Chung, Rehman Abdul, Seung
Sam Paik, Dong Ho Choi, Kiseok Jang
Hanyang University College of Medicine, Seoul, Korea
164
Utility of Immunolabeling with Stathmin-1 in

the Accurate Classification of Anal Squamous
Intraepithelial Lesions (1138)
Erika Hissong, Adela Cimic, Edyta C Pirog
246
165
Comparative Analysis of Neuroendocrine Phenotype in

Metastases from Advanced Prostate Cancer and Their
Corresponding Primary Tumor (959)
Rafael E Jimenez, Jad Abbas, John C Cheville, Manish
Kohli
166
Type 10 Soluble Adenyl Cyclase is Significantly

Overexpressed in Small Cell Prostatic Carcinoma
Compared to Neuroendocrine Prostatic Carcinoma and
Conventional Adenocarcinoma (1055)
Peyman Tavassoli, Francesca Khani, Jonathan H
Zippin, Brian D Robinson
167
Neuroendocrine Carcinoma: A Genomically Distinctive

Form of Prostate Cancer (842)
Sanaz Ainechi, Bryan Firestone, Julia A Elvin, Siraj M
Ali, Jo-Anne Vergilio, James Suh, Badar Mian, Hugh
Fisher, Tipu Nazeer, Vincent A Miller, Philip J Stephens,
Jeffrey S Ross
168
Integrated Molecular Classifier Determines

Transdifferentiation to Neuroendocrine Prostate Cancer
(889)
Joanna Cyrta, Himisha Beltran, Davide Prandi, Juan
Miguel Mosquera, Matteo Benelli, Scott A Tomlins,
Olivier Elemento, Andrea Sboner, Levi Garraway, Mark
Rubin, Francesca Demichelis
Weill Cornell Medicine of Cornell University, New York,
NY; University of Trento, Trento, Italy; University of
Michigan, Ann Arbor, MI; Dana Farber Cancer Institute,
Boston, MA
169
Very-Small-Nuclear Circulating Tumor Cell (vsnCTC)

as a Putative Biomarker for Visceral Metastasis (VM)
in Metastatic Castration-Resistant Prostate Cancer
(mCRPC) (878)
Jie-Fu Chen, Hao Ho, Elisabeth Hodara, Ann Go,
Alexander Ureno, Elizabeth Kaufman, Margarit Sievert,
Daniel Luthringer, Zunfu Ke, Leland WK Chung, KerChau Li, Hsian-Rong Tseng, Edwin M Posadas
Cedars-Sinai Medical Center, Los Angeles, CA;
University of California, Los Angeles, Los Angeles, CA
170
Aurora A in Metastatic Castration Resistant Prostate

Cancer (mCRPC) (1001)
Daniel Nava Rodrigues, Niven Mehra, Ines Figueiredo,
Mateus Crespo, Ruth Riisnaes, Susana AA Miranda,
Ana Ferreira, Nina Tunariu, Raquel Perez-Lopez,
Gunther Boysen, Adam Sharp, Diletta Bianchini,
Michael Kolinsky, Pasquale Rescigno, Zafeiris Zafeiriou,
Joaquin Mateo, Johann S De Bono
ICR, London, United Kingdom; Royal Marsden Hospital,
London, United Kingdom
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
171
Morphological and Molecular Pathway-Based Analysis

of Gleason Score 7 Prostate Cancer Using a 17-Gene
Expression Assay (868)
Michael J Bonham, Debbie McCullough, Ruixiao Lu,
John P Bennett, Phillip G Febbo, Athanasios C Tsiatis
Genomic Health Inc., Redwood City, CA
178
172
The Performance of a 17-Gene Genomic Prostate Score

(GPS), PTEN Fluorescence In Situ Hybridization (FISH),
and PTEN Immunohistochemistry (IHC) as Predictors
of Clinical Recurrence (cR) in Prostate Cancer (PCa)
Following Radical Prostatectomy (RP) (989)
Cristina Magi-Galluzzi, Athanasios C Tsiatis, Michael
J Bonham, Dejan Knezevic, Tara Maddala, Anne Dee,
Sara Falzarano, H Jeffrey Lawrence, Phillip G Febbo,
Eric A Klein
Cleveland Clinic, Cleveland, OH; Genomic Health, Inc.,
Redwood City, CA
Monitoring CHD1 During Prostate Cancer Progression

(1002)
Daniel Nava Rodrigues, Gunther Boysen, Joaquin
Mateo, Rossitza Christova, Ruth Riisnaes, Mateus
Crespo, Theresa Y MacDonald, Susana AA Miranda,
Ines Figueiredo, Veronica Gil, Sara Aziz, Niven Mehra,
Adam Sharp, Pasquale Rescigno, Juan Miguel
Mosquera, Christopher E Barbieri, Mark Rubin, Johann
S De Bono
ICR, London, United Kingdom; Weil Medical College of
Cornell University, New York, NY
179
Urinary Exosomes with TMAs Validation: The Mirror of

Prostate Alterations (894)
Ines De Torres, Tamara Sequeiros, Dirk Michiel Pegtel,
Eduard Sabido, Marina Rigau, Iolanda Garcia-Grau,
Jordi Temprana-Salvador, Juan Morote, Santiago
Ramon y Cajal, Mireia Olivan
Vall dHebron University Hospital, Universitat
Autnoma de Barcelona (UAB), Barcelona, Spain;
Centre de Regulaci Genmica (CRG), Barcelona,
Spain; Vall dHebron Institut de Recerca (VHIR),
Barcelona, Spain; Vall dHebron University Hospital
and Autnomous University of Barcelona (UAB),
Barcelona, Spain; VU University Medical Center,
Cancer Center Amsterdam, Amsterdan, Netherlands
180
MAGI-2 is Associated with Biochemical Recurrence in

Prostate Cancer (892)
Stephanie N David, Shanna Arnold, Rajen Goyal,
Jeffery Goldstein, Lan L Gellert, Peter E Clark, Omar
Hameed, Giovanna A Giannico
Department of Veterans Affairs, Nashville, TN
181
Diagnostic Value of Dual Reactivity of STAT6 and

ALDH1 in the Differential Diagnosis of Solitary Fibrous
Tumor vs Stromal Tumor of Unknown Malignant
Potential of the Prostate (934)
Gunes Guner, Stephania M Bezerra, Diana Taheri,
David J Zahavi, Maria Angelica Mendoza Rodriguez,
Rajni Sharma, Justin A Bishop, Jonathan I Epstein,
George J Netto
Iran
182
Racial Disparity in Prostatic Expression of Proinflammatory and Paracrine Factors (954)

Kenneth A Iczkowski, Jim R Lambert, Kathleen C
Torkko, Daniel C Eastwood, Robert S Wilson, Girish V
Shah, MS Lucia
University of Colorado, Aurora, CO; University of
Louisiana, Monroe, LA
173
A New AR-V7 Rabbit Monoclonal Antibody for

Imunohistochemical Application (976)
Aihua Li, Yuekai Zhang, Shihua Sun, Jason Law,
Hongyang Pan, Jackie Chan, Daniel NavaRodrigues,
Stephen Plymate, Johann S De Bono, Taiying Chen
Epitomics an Abcam Company, Burlingame, CA;
University of Washington, Seattle, WA; Royal Cancer
Hospital, London, United Kingdom
174
Clinical Validation of AR-V7 Detection in Circulating

Tumor Cells from Castration-Resistant Prostate Cancer
Patients (984)
Parvez M Lokhandwala, Stacy Riel, Christopher D
Gocke, Ming-Tseh Lin, Gang Zheng, Emmanuel S
Antonarakis, Jun Luo, James R Eshleman
Baltimore, MD
175
Analytic Validation of RNA In Situ Hybridization (RISH)

for AR and AR-V7 Expression in Human Prostate
Cancer (931)
Liana B Guedes, Carlos L Morais, Qizhi Zheng, John
Isaacs, Emmanuel S Antonarakis, Angelo M De Marzo,
Jun Luo, Tamara Lotan
Johns Hopkins School of Medicine, Baltimore, MD
176
ERG and Prostein Expression in Prostate Cancer

Identify Different Pathways of Progression (960)
Nuria Juanpere, Josep Lloreta, Alba Font, Marta
Lorenzo, Raquel Albero, Ivonne Vazquez, Lluis Fumado,
Lluis Cecchini, Sergio Serrano, Silvia Hernandez
177
PTEN Loss Is Less Frequent in African-American

Compared to European-American Prostate Cancers
(849)
Fawaz Almutairi, Carlos L Morais, Stephanie Glavaris,
Jessica Hicks, Deb Sundi, Angelo M De Marzo, Edward
M Schaeffer, Tamara Lotan
247
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
183
190
Maspin Deficiency Promotes Prostatic Intraepithelial

Hyperplasia (903)
Sijana H Dzinic, Ye-Shih Ho, Rodrigo ValdiviaFernandez, M Magarida Bernardo, Shijie Sheng, Wael
A Sakr
WSU, Detroit, MI
191
Value of a Genomic Risk Classifier (GPS Score) in

Relation to Histopathologic Parameters (929)
Nancy Greenland, Bradley Stohr, Jeffrey P Simko
University of California, San Francisco, CA
192
Ability to Accurately Diagnose Prostate Cancer Gleason

Grade / Score Using Automated Image Analysis Tools
with Multiplex Immunofluorescence (908)
Gerardo Fernandez, Richard Scott, Faisal Khan, Michael
J Donovan
Icahn School of Medicine at Mount Sinai Hospital, New
York, NY
193
Better Treatment of Metastases Cannot Fully Explain

Prostate Cancer Survival Improvements Associated
with PSA Screening (1068)
Mitchell S Wachtel, Thomas Nelius, Allan Haynes,
Werner T de Riese
Texas Tech University Health Sciences Center, Lubbock,
TX
194
The Prognostic Significance of Perineural Invasion in

Prostatic Core Biopsies (916)
Manal Gabril, Tianzhu Zhang, Jonathan Izawa,
Madeleine Moussa
Western University/ London Health Sciences Centre,
London, ON, Canada
195
Presence of Hormone Resistant Intraductal Carcinoma

of the Prostate after Neoadjuvant Hormone Therapy Is
a Significant Prognostic Factor for High Risk Prostate
Cancer in Radical Prostatectomy Patients (1064)
Toyonori Tsuzuki, Masashi Kato, Kyosuke Kimura, Ryo
Ishida, Naoto Sassa, Akitoshi Fukatsu, Ryohei Hattori,
Momokazu Gotoh
Japanese Red Cross Nagoya Daini Hospital, Nagoya,
Japan; Nagoya University Hospital, Nagoya, Japan;
Nagoya Medical Center, Naogya, Japan; Komaki City
Hospital, Komaki, Japan; Japanese Red Cross Nagoya
Daiichi Hospital, Naogya, Japan
196
Characterization of Anterior Periprostatic Fat in a Large

Cohort of Robotic-Assisted Radical Prostatectomy with
Emphasis on Lymph Node Yield and Tumor Metastasis
(1021)
Brian C Radlinski, Eric Rafla-Yuan, Peter E Clark,
Giovanna A Giannico, Omar Hameed, Lan L Gellert
197
A Comparison of Multiparametric Magnetic Resonance

Imaging of the Prostate and Histologic Prostatectomy
Findings A Single Institutions Experience (911)
Erin Faber, Julie Anne Bishop, Mostafa M Fraig, Albert
Seow, Houda Alatassi
Diversity of Resistance Mechanisms in Prostate Cancer

after Neoadjuvant Intense Androgen Deprivation
Therapy (1078)
Huihui Ye, Adam G Sowalsky, Rachel Schaefer, Xin
Yuan, Shao-yong Chen, Sean J Gerrin, Laleh Montaser,
Fen Ma, Olga Voznesensky, Changmeng Cai, Rosina
Lis, Zhenwei Zhang, Massimo Loda, Mary-Ellen Taplin,
Steven Balk
Dana-Farber Cancer Institute, Boston, MA
184
The Relationship among ERG, PTEN and SPINK1 in

Transition and Peripheral Zone Prostate Cancers in
Japanese Patients (1037)
Shun Sato, Hiroyuki Takahashi, Takashi Yorozu,
Takahiro Kimura, Masahiro Ikegami
Jikei University School of Medicine, Tokyo, Japan
185
Increased Proliferative Rate and PTEN Loss in Prostate

Cancer Are Correlated and Both Associated with Risk
of Recurrence in Multivariate Models (1060)
Maria S Tretiakova, Wei Wei, Carlos L Morais, Ziding
Feng, Jesse K McKenney, Jeff Simko, Dean Troyer,
Lawrence True, Funda Vakar-Lopez, Ladan Fazli, Peter
S Nelson, Daniel Lin, James D Brooks, Tamara Lotan,
Canary Prostate Investigators
University of Washington, Seattle, WA; Canary
Foundation, Palo Alto, CA; John Hopkins University,
Baltimore, MD
186
ERG/PTEN Status of Isolated PIN Occurring in

Cystoprostatectomy Specimens without Invasive
Prostatic Adenocarcinoma (930)
Liana B Guedes, Carlos L Morais, Jessica Hicks, Angelo
M De Marzo, Tamara Lotan
187
Expression of miRNAs 200c and 33a That Negatively

Control HAS2 and HAS3 in Localized Prostate Cancer
(998)
Caio M Moura, Sabrina T Reis, Jose Pontes, Nayara
Viana, Nelson Dip, Miguel Srougi, Katia RM Leite
University of Sao Paulo Medical School, Sao Paulo,
Brazil
188
PIM1 Expression in Prostate Cancer: Correlation with

ERG Rearrangement, bcl-2 and Ki67 Index (893)
Silvia de Muga, Joan Gil, Silvia Hernandez, Alba Font,
Marta Lorenzo, Nuria Juanpere, Lluis Fumado, Lluis
Cecchini, Laia Serrano, Josep Lloreta
189
248
Expression of the Glucocorticoid Receptor in Prostatic

Adenocarcinoma: An Immunohistochemical and
Nelli Lakis, Andres Matoso, Shamlal Mangray, Murray
B Resnick, Evgeny Yakirevich
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
198
205
Diagnostic Significance of Simple Nonatrophic Glands

in the Interpretation of Endometrium after Progestin
Treatment in Patients with Endometrial Intraepithelial
Neoplasia and Endometrioid Adenocarcinoma in
Young Women (1163)
Kyu-Rae Kim, Su Hyun Yoo, Stanley J Robboy
Asan Medical Center, Seoul, Korea; Duke University
Medical Center, Durham, NC
206
Concordance between Beta-Catenin

Immunohistochemistry and Next-Generation
Sequencing of the CTNNB1 Gene (1161)
Grace Kim, Charanjeet Singh, Bojana Djordjevic,
Russell Broaddus
MD Anderson Cancer Center, Houston, TX; University
207
Evaluation of Microsatellite Instability (MSI) Status

in Endometrial Adenocarcinoma by Comprehensive
Genomic Profiling (CGP) Identifies Subset That May
Benefit from Immunotherapy (1123)
Julia A Elvin, Eric M Sanford, Zachary Chalmers,
Garrett Frampton, Alessandro D Santin, Jo-Anne
Vergilio, James Suh, Laurie Gay, Michael Hall, Evgeny
Yakirevich, Alexander Brodsky, Siraj M Ali, Vincent A
Miller, Philip J Stephens, Jeffrey S Ross, James Sun
Foundation Medicine, Inc., Cambridge, MA; Yale
University School of Medicine, New Haven, CT; Albany
Medical College, Albany, NY; Fox Chase Cancer Center,
Philadelphia, PA; Brown University, Providence, RI
208
Endometrial Carcinomas with POLE Exonuclease

Domain Mutations Have a Favorable Prognosis (1131)
Blake Gilks, Melissa McConechy, Aline Talhouk, Samuel
Leung, Cheng-Han Lee, David G Huntsman, Jessica N
McAlpine
University of Alberta, Edmonton, Canada
209
Immunohistochemical Characterization of Endometrial

Carcinomas Grouped by the TCGA Molecular
Classification Scheme (1236)
Robert Soslow, Lien Hoang, Angela Cheng, Maria
Bisogna, Narciso Olvera, Jessica N McAlpine, David G
Huntsman, Douglas A Levine, Blake Gilks
NY; Genetic Pathology Evaluation Center, Vancouver,
BC, Canada; University of British Columbia, Vancouver,
BC, Canada
Clinicopathological Characteristics of Patients with

Fungal Prostatitis (1030)
Evita T Sadimin, Melanie Parikh, Daniel Luthringer,
Deepika Sirohi, Mahul B Amin, Jonathan I Epstein
Rutgers Cancer Institute of New Jersey, New
Brunswick, NJ; Cedars-Sinai Medical Center, Los
Angeles, CA; Johns Hopkins Medical Institutions,
Baltimore, MD
199
Prospective Evaluation of Lymph Node Processing at

Staging Surgery for High-Grade Endometrial Cancer
(1121)
Jessie A Ehrisman, Sara Abbott, Zach Harmon,
Angeles Alvarez Secord, Andrew Berchuck, Paula S
Lee, Fidel A Valea, Gloria Broadwater, Xuechan Li,
Laura J Havrilesky, Allison Hall
200
A Standardized Endometrial Carcinoma Lymph Node

Processing Protocol Increases Lymph Node Counts but
Does Not Increase Detection of Metastases (1106)
Joseph Carlson, Denis Nastic, Babylonia Tibert, Sahar
Salehi, Henrik Falconer
Karolinska University Hospital, Stockholm, Sweden
201
Management of Insufficient Endometrial Biopsy for

Women with Abnormal Uterine Bleeding: To Further
Investigate Or Reassure? (1085)
Wamidh Adwar, Ramya Gadde, Dhananjay A Chitale,
Ghassan Allo, Daniel Schultz, Arthur R Gaba, Ziying
Zhang
202
Clinical Outcomes in a Subset of Endometrial Surface

Epithelial Lesions with Marked Nuclear Atypia (1157)
Elizabeth Kehr, Marisa R Nucci, Christopher P Crum
203
Mucinous Proliferations of the Endometrium

Subdiagnostic of Malignancy in Curettages and
Biopsies: A Clinicopathologic Analysis of 41 Cases[/
underline] (1210)
Kojo R Rawish, Mohamed M Desouki, Oluwole Fadare
UC San Diego Medical Center, San Diego, CA;
Vanderbilt University, Nashville, TN; Vanguard
Pathology Associates, Austin, TX
204
The Impact of Androgen Receptor Expression on

Woodlyne Roquiz, Vishakha Pardeshi, Oudai Hassan,
Eman Abdulfatah, Ankit Modh, Nagla Salem, MHD
Fayez Daaboul, Daniel Schultz, Mohamed A Elshaikh,
Sudeshna Bandyopadhyay, Rouba Ali-Fehmi
Wayne State University/Detroit Medical Center, Detroit,
MI; Henry Ford Hospital, Detroit, MI
249
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
210
217
Multicystic, Elongated, Fragmented Pattern of

Myometrial Invasion Does Not Impact Outcomes of
Patients with Low-Grade Endometrial Carcinomas - A
Retrospective Study at North Shore - LIJ Health System
(1143)
Maheen Hossain, Shu Liang, Peter Farmer, Cathy Fan,
Sharon Liang
North Shore - LIJ Health System, Lake Success, NY;
DOC of Oregon, Salem, OR
218
CXCL14-CXCR4 and CXCL12-CXCR4 Axises May Play

Important Roles in Achievement of Unique Invasion
Process of MELF Pattern Myoinvasive Endometrioid
Carcinoma (1223)
Sakiko Sanada, Kaori Yasuda, Sachiko Ogasawara, Jun
Akiba, Hirohisa Yano
Kurume University School of Medicine, Kurume,
Japan; Cell Innovator Inc., Fukuoka, Japan
219
The MELF Pattern of Myometrial Invasion in

Endometrial Endometrioid Carcinoma Displays a
Mesenchymal Gene Expression Signature: A Case
Series (1135)
Beth Harrison, Athena Chen, Gemma Toledo, Kshitij
Arora, Vikram Deshpande, Esther Oliva
220
HE4 Has a Role in Treatment Planning in Endometrial

Cancer (1191)
Sharon OToole, Rizmee Shireen, Seamus McDonald,
Lucy Norris, Anthony Cooney, Feras AbuSaadeh,
Waseem Kamran, Cliona Murphy, Nadine Farah, Tom
DArcy, Noreen Gleeson, John J OLeary
Trinity College Dublin, Dublin, Ireland; St. Jamess
Hospital, Dublin, Ireland; Coombe Womens and Infants
University Hospital, Dublin, Ireland
221
SOX17 Is Highly Expressed in Endometrial

Mohamed El Hag, Tracy A Stein, Bo Ye, Prachi Raut,
Haodong Xu, Mahmoud Khalifa, Faqian Li
MN; UCLA Medical Center, Los Angeles, CA
222
PELP1 Expression in Endometrial Carcinomas Is

Associated with FIGO Grade and Histological Subtype
(1188)
Shuang Niu, Yan Peng
Dallas, TX
223
Gene Expression Profiling of Endometrial Carcinoma

Type 1 in Mexican Women (1130)
Gabriela Sofia Gomez Macias, Oralia Barboza, Raquel
Garza, Barbara Saenz
Hospital Universitario de la UANL, Monterrey, Nuevo
Leon, Mexico
211
212
213
214
215
216
250
Endometrial Biopsies Can Be Used Reliably to Predict

Final Endometrial Carcinoma Classification Using Both
Histopathologic and Molecular Based Strategies (1140)
Lien Hoang, Melissa McConechy, Quentin Nakonechny,
Joyce M Leo, Angela Cheng, Sam Leung, Aline
Talhouk, Cheng-Han Lee, Martin Kobel, David G
Huntsman, Jessica N McAlpine, Robert Soslow, Blake
Gilks
NY; BC Cancer Agency, Vancouver, BC, Canada;
Genetic Pathology Evaluation Center, Vancouver, BC,
Canada; University of Edmonton, Edmonton, AB,
Canada; University of Calgary, Calgary, AB, Canada
Clinicopathologic Comparison of Lynch SyndromeAssociated and Lynch-Like Endometrial Carcinomas
Identified on Universal Screening Using Mismatch
Repair Protein Immunohistochemistry (1181)
Anne M Mills, Emily A Sloan, Martha Thomas, Susan C
Modesitt, Mark H Stoler, Kristen A Atkins, Christopher
A Moskaluk
Endometrioid Adenocarcinoma and Adjacent Atypical
Endometrial Hyperplasia Harbor Identical Somatic
Mutations by Next Generation Sequencing (1246)
Joshua I Warrick, Jordan M Newell, Joshua P
Kesterson, Rebecca Phaeton, Nadine Hempel, Carrie
Hossler, James Broach, Kathryn E Sheldon, Mariano
Russo, Kenneth R Houser, Richard D Bruggeman,
Richard Zaino
Penn State University School of Medicine, Hershey, PA
PD-L1 Expression Is Uncommon in Advanced-Staged
Jennifer L Sauter, Rondell Graham, Jo Marie Janco,
Andrea Mariani, Sarah E Kerr
Mayo Clinic, Rochester, MN; Scripps Memorial
Hospital, La Jolla, CA
PD-L1 Expression in Malignant Mixed Mullerian
Tumors: A Potentially Actionable Biomarker (1202)
Andre Pinto, Nicholas Mackrides, Mehrdad Nadji
University of Miami / Jackson Memorial Hospital,
Miami, FL
CD8, FoxP3 and CD45Ro Positive Tumor Infiltrating
Lymphocytes in Endometrial Carcinomas: Is There a
Difference between European American and African
American Patients? (1208)
Tariq Rashid, Jennifer Young Pierce, Elizabeth GarrettMayer, Laura S Spruill
The Role of T Regulatory Cell Apoptosis in the
Progression of Endometrial Hyperplasia to Endometrial
Carcinoma (1102)
Julie Anne Bishop, Mirna B Podoll, Zhenglong Wang
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
224
High NRF2 with p62 Co-Expression in PTEN Null

Endometrial Endometrioid Carcinomas Is Associated
with Different Survival Impact in Early vs Late Stage
Disease (1173)
Diana Lim, Ying Ni, Meusia Neo, Hoe Meng Chen,
Charis Eng, Joanne Ngeow
Singapore; Singapore Polytechnic, Singapore,
Singapore; Cleveland Clinic, Cleveland, OH; National
Cancer Centre, Singapore, Singapore
232
Loss of Expression of SMARCA4 (BRG1) and

SMARCB1 (INI1) in Undifferentiated Carcinoma of the
Endometrium Is Not Always Associated with Rhabdoid
Morphology (1207)
Preetha Ramalingam, Sabrina Croce, W Glenn
McCluggage
MD Anderson Cancer Center, Houston, TX; Belfast
Health and Social Care Trust, Belfast, United Kingdom;
Centre Regional de Lutte Contre Le Cancer, Bordeaux,
France
225
Immunohistochemical Profile of Pure Endometrial

Mucinous Adenocarcinoma (1256)
Gloria Zhang, Charles V Biscotti, Tao Wu, Xiangdong
Ding, Bin Yang
Cleveland Clinic, Cleveland, OH; Kingmed Diagnostics,
Guangzhou, OH
233
Dedifferentiated Endometrial Carcinoma - A

Hongying Tan, Chisa Aoyama
Olive-View UCLA Medical Center, Sylmar, CA
226
227
Evaluating Mixed Endometrial Carcinomas with a Panel

of Immunohistochemical Markers (1179)
Cathleen Matrai, Edyta C Pirog, Lora H Ellenson
NYPH-Weill Cornell, NYC, NY
234
Immunohistochemical Profiling of Endometrial Serous

Carcinoma (1111)
Wenqian Chen, Arjumand Husain, Gregg Nelson, Peter
Rambau, Sandra Lee, Maire Duggan, Cheng-Han Lee,
Martin Kobel
University of Calgary, Calgary, AB, Canada; Tom Baker
Cancer Center, Calgary, AB, Canada; University of
Alberta, Edmonton, AB, Canada; Chinook Regional
Hospital, Lethbridge, AB, Canada
ECOG 1412: High Rejection Rate for Submitted Diffuse

Large B-cell Lymphomas (DLBCLs) upon Retrospective
Central Pathology Review (CPR) Results in Protocol
Change to Novel Real-Time CPR to Establish Patient
Eligibility (1426)
William R Macon, Rebecca King
235
GATA-3 Expression in T/NK Cell Neoplasms

Determined by Immunohistochemistry (1421)
Amanda Lo, Serhan Alkan, Qin Huang
Cedar-Sinai Medical Center, Los Angeles, CA
236
Routine Comprehensive Genomic Profiling of T-Cell

Neoplasms Improves Diagnostic Accuracy and
Identifies Actionable Therapeutic Targets (1375)
Juan Gomez-Gelvez, Daniel Royston, Maria E Arcila,
Janine Pichardo, Alison J Moskowitz, Steven M
Horwitz, Ahmet Dogan
Memorial Sloan-Kettering Cancer Center, New York,
NY; Weatherall Institute of Molecular Medicine/
University of Oxford, Oxford, United Kingdom
237
Frequency and Clinical Significance of Isolated Tube

C Positivity in T-cell Receptor Beta Testing Using
BIOMED-2 Primers (1463)
Sohail Qayyum, Grant C Bullock, Steven H Swerdlow,
Marina Nikiforova, Nidhi Aggarwal
238
Cytogenetic Analysis Is Crucial in the Early Diagnosis

of Indolent T-Cell Prolymphocytic Leukemia (1369)
Ramya Gadde, Rohit Gulati, Kedar V Inamdar, Susan
Michalowski, Madhu Menon
239
Complex Karyotypes Predict a Poorer Prognosis in

T-cell Prolymphocytic Leukemia (1395)
Zhihong Hu, L Jeffrey Medeiros, Guilin Tang, Zhenya
Tang, Shimin Hu, Pei Lin, Xinyan Lu
Houston, TX
228
The Use of Immunohistochemistry in Distinction

between Clear Cell and Squamous Differentiation in
Adenocarcinoma of the Endometrium (1238)
Michelle Stram, Dinesh Pradhan, David Dabbs, Rohit
Bhargava, Agnieszka Onisko, Mirka W Jones
University of Pittsburgh, Pittsburgh, PA
229
HNF1 Expression and Loss of ARID1A Correlate with

Histological Component in Uterine Carcinosarcomas
(1126)
Joana Ferreira, Rita Luz, Fernanda Silva, Ana Felix
IPOLFG, Lisboa, Portugal; Centro Hospitalar de Setubal,
Setubal, Portugal; CEDOC-FCMUNL, Lisboa, Portugal
230
231
HEMATOPATHOLOGY
SATB2 Expression Is Sensitive but Not Specific for

Osteosarcomatous Components of Gynecologic (GYN)
Tract Carcinosarcomas (CS): A Clinicopathologic Study
of 60 Cases (1224)
Ankur R Sangoi, Malti Kshirsagar, Andrew E Horvai,
Andres A Roma
El Camino Hospital, Mountain View, CA; UCSF, San
Francisco, CA; Cleveland Clinic, Cleveland, OH
CyclinE1 Expression in High Grade Serous Carcinomas
and Malignant Mixed Mullerian Tumors (1136)
Joseph Hatem, Carolina Reyes
Philadelphia, PA
251
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
240
Loss of a Novel Tumor Suppressor KLF9 Identifies

a Subset of Peripheral T-cell Lymphoma, NOS with
Increased NOTCH1 Expression (1453)
Sudhir Perincheri, Gerald Goh, Francine M Foss,
Richard P Lifton, Mina L Xu
University College, London, United Kingdom
248
241
Patterns of Bone Marrow Involvement by Peripheral

T-cell Lymphoma (1365)
Natalie S Freed, Greiner C Timothy, Hina N Qureishi, Ji
Yuan, Catalina Amador-Ortiz
242
Hepatosplenic T-cell Lymphoma Arising in Patients

with Immunosuppression: A Clinicopathologic,
Immunophenotypic and Cytogenetic Study of 7 Cases
and a Review of 67 Cases in the Literature (1526)
Mariko Yabe, L Jeffrey Medeiros, Yahya Daneshbod,
Masoud Davanlou, Carlos E Bueso-Ramos, Elisa J
Moran, Mark Routbort, Ken H Young, Roberto Miranda
Comprehensive Immunophenotypic Analysis of 64

Cases of Breast Implant-Associated Anaplastic Large
Cell Lymphoma Shows an Activated Cytotoxic with a
Silent T-cell Receptor Pattern (1368)
Ana Claudia Frota Lopes, L Jeffrey Medeiros, Mark
W Clemens, Ming Chai, Hui Liu, Arianna Di Napoli,
Stephen Lade, Mitual Amin, Ken H Young, Roberto
Miranda
Houston, TX; Universidade de So Paulo, So Paulo,
Brazil; Sapienza University of Rome, Rome, Italy;
PathWest Laboratory Medicine, Nedlands, Australia;
Xuzhou Medical College, Xuzhou, China; Peter
MacCallum Cancer Center, Melbourne, Australia;
William Beaumont Hospital, Royal Oak, MI
249
A Proposal for Pathologic Processing of Breast Capsule

Specimens of Patients with Breast Implant-Associated
Anaplastic Large Cell Lymphoma without a Grossly
Identifiable Mass (1457)
Sergio Pina-Oviedo, L Jeffrey Medeiros, Mark W
Clemens, Kelly K Hunt, Hui Liu, Gregg Staerkel, Mitual
Amin, Andres Quesada, Adrian Alejandro CarballoZarate, Alonso Miranda, Ignacio I Wistuba, Ming Chai,
Arianna Di Napoli, Ken H Young, Joseph D Khoury,
Roberto N Miranda
250
Dual Antibody Immunohistochemistry: A Cost-Efficient

and Sensitive New Tool for the Detection of Minimal
Residual CLL[/underline] (1507)
Laura M Wake, Inhye Ahn, Mohammed Farooqui,
Jamie Hahn, Xin Tian, Maryalice Stetler-Stevenson,
Gerald Marti, Adrian Wiestner, Irina Maric
NIH/NCI, Bethesda, MD; NIH/NHLBI, Bethesda, MD;
NIH/CC/DLM, Bethesda, MD; FDA/CDRH, Bethesda, MD
251
Flow Cytometric Evaluation of 371 Mature B-cell

Lymphomas Identifies an Association of CD13
Expression with Certain Lymphoma Subtypes (1412)
Hubert D Lau, Robert S Ohgami
252
CD164: A Novel Marker Distinguishing Hematopoietic

Stem/Progenitor Cells (HSPC) from Leukemic Stem
Cells (1478)
Daniel Royston, Qi Gao, Montreh Tavakkoli, Stephen S
Chung, Sean Devlin, Mikhail Roshal, Christopher Park
Oxford University Hospitals NHS Trust, Oxford, United
Kingdom; Memorial Sloan Kettering Cancer Centre,
NYC, NY
253
Surface CD200 Is Upregulated on CD4/CD200 Double

Positive T-Cells in Follicular Lymphoma and Hodgkin
Lymphoma (1383)
Richard D Hammer, Kruthi Murthy, Dong Chen
243
244
245
A Clinicopathologic Analysis of the Significance of

Janus Kinase 3 Activating Mutations in Extranodal
Natural Killer/T-cell Lymphomas, Nasal Type (1392)
Jenny Hoffmann, Lisa Ma, Daniel A Arber, Robert S
Ohgami
Targeted Sequencing of Mutational Load Supports
the Evolutionary Model of Angioimmunoblastic T-Cell
Lymphoma (1489)
Leonard HC Tan, Maarja-Liisa Nairismagi, Siok-Bian
Ng, Tiffany Tang, Soon-Thye Lim
National Cancer Centre, Singapore, Singapore;
Singapore
A Small Series of Bone Marrow Indolent Clonal CD4Positive T-Cell Lymphoproliferative Disorder: A New
Entity? (1338)
Aleh Bobr, Dong Chen, William G Morice, Karen L
Grogg, Min Shi
246
Bilineal Large Granular Lymphocytic Leukemia: A

Distinct Subtype of LGL? (1442)
Jadee L Neff, Dragan Jevremovic, William G Morice,
Min Shi
247
Clonality Analysis of T-Cell Receptor Gamma

Rearrangement (TCGR) by Next Generation
Sequencing (NGS) in Anaplastic Large Cell
Lymphomas (ALCL) (1386)
Rong He, Ming Mai, David S Viswanatha, Andrew L
Feldman
252
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
254
262
Significance of Clonal T-cell Receptor Gene

Rearrangements in Diagnosing Refractory Celiac
Disease (1401)
Shafinaz Hussein, Tatyana Gindin, Carolina ArguellesGrande, Bachir Alobeid, Suzanne Lewis, Mahesh
Mansukhani, Peter HR Green, Govind Bhagat
263
Histologic and Corresponding Laboratory Findings

in Bone Marrow Biopsies of Post-Transplant Patients
(1467)
Heidi Rahn, LoAnn Peterson, Amir Behdad
Northwestern Memorial Hospital, Chicago, IL
Trauma Patients with Platelet Adenosine Diphosphate

(ADP) Inhibition by Thromboelastography (TEG) Show
Increased Platelet CD62P by Flow Cytometry (1384)
Richard D Hammer, Cory Johnson, Julie Lewis, James
Clevenger, Ashley Bartels, Salman Ahmad
264
Hematolymphoid Neoplasms Are Common in Bone

Marrow Biopsies Performed for Non-Specific, Diffuse
Marrow Signal Alterations on Magnetic Resonance
Imaging (MRI) (1404)
Terrell Jones, Aaron J Wyse, Sarah E Gibson
Pittsburgh, PA
Multilineage Bone Marrow Response to Eltrombopag

in Aplastic Anemia[/underline] (1357)
Alina Dulau Florea, Danielle M Townsley, Bogdan
Dumitriu, Thomas Winkler, Janet Valdez, Charles
Bolan, Cynthia Dunbar, Neal Young, Raul C Braylan,
Katherine R Calvo
NIH, Bethesda, MD
265
Expression of Glycosylphosphatidylinositol (GPI)

Anchor Protein (AP) in Bone Marrows of Normal
Subjects and Aplastic Anemia Patients with
Paroxysmal Nocturnal Hemoglobinuria (PNH) Clones,
as Determined by Fluorescent Aerolysin (FLAER)
(1356)
Alina Dulau Florea, Neal Young, Irina Maric, Raul C
Braylan
NIH, Bethesda, MD; NHLBI, Bethesda, MD
266
Development of a Novel Flow Cytometric Washing

Technique for Needle Biopsies Suspicious for
Lymphoma (1366)
Natalie S Freed, Laura Wake, Ji Yuan, Hina N Qureishi,
Catalina Amador, Timothy C Greiner, Scott Rodig,
Samuel J Pirruccello, Kai Fu
University of Nebraska Medical Center, Omaha, NE;
255
256
PD-1/PD-L1 Are Novel Therapeutic Targets for

Mastocytosis (1371)
Mary Geeze, Ellen Hatch, Cheyenne Martin, Sherrie L
Perkins, Karin Hartmann, Peter Valent, Jason Gotlib,
Diane Lidke, Tracy I George
University of New Mexico, Albuquerque, NM;
University of Utah, Salt Lake City, UT; University of
Luebeck, Luebeck, Germany; Medical University of
Vienna, Vienna, Austria; Stanford University, Stanford,
CA
257
Langerhans Cell Histiocytosis in Patients with

Concurrent Lymphoma: A Reactive Process without
Evidence of BRAF Mutation (1456)
Sergio Pina-Oviedo, L Jeffrey Medeiros, Shaoying Li,
Khaled Alayed, C Cameron Yin
258
Langerhans Cell Histiocytosis Expresses Killer Cell

Immunoglobulin-Like Receptor 2DL4 (CD158d), a
Possible Target of Antibody Therapy (1406)
Tatsuki R Kataoka, Chiyuki Ueshima, Masahiro Hirata,
Yusuke Takei, Sanju Iwamoto, Hironori Haga
Kyoto University, Kyoto, Japan; School of Medicine,
Syowa University, Tokyo, Japan
259
Angiomyomatous Hamartoma of Lymph

Nodes: Clinical, Morphologic and
Immunohistochemical Distinction from Lymph Node
Lymphangioleiomyomatosis (1435)
Michelle Moh, Ankur R Sangoi, Joseph T Rabban
CA; El Camino Hospital, Mountain View, CA
267
Spleen Histology in Children with Sickle Cell Disease

and Hereditary Spherocytosis (1461)
Marco Pizzi, Rita Alaggio, Laura Sainati, Kathrin
Ludwig, Piergiorgio Gamba, Martina Ichino, Luisa
Santoro
University of Padova, Padova, PD, Italy
Prevalence of Glomerular Disease Recurrence in Renal

Allografts: A Single Center Study[/underline] (1593)
Brad Barrows, Vighnesh Walavalkar, Zoltan Laszik,
Kuang-Yu Jen
CA
268
PLA2R Negative De Novo Membranous Nephropathy

Associated with Antibody-Mediated Rejection; a Report
of 11 Cases with Common Light Microscopic and
Ultrastructural Features (1592)
Siripron Angchuan, Mongkon Charoenpitakchai, Jittirat
Arksarapuk, Agnes B Fogo, Paisit Paueksakon
The Queens Medical Center, Honolulu, HI
260
261
Spectrum of Bone Marrow Features in CANDLE

Syndrome (1520)
Wenbin Xiao, Gina Montealegre Sanchez, Bernadette
Marrero, Adriana Almeida de Jesus, Caterina Miniti,
Shunyou Gong, Kristian T Schafernak, Raphaela
Goldbach-Mansky, Katherine R Calvo
NIH/CC, Bethesda, MD; NIH/NIAMS, Bethesda, MD;
NHLBI, Bethesda, MD; Lurie Childrens Hospital,
Chicago, IL; Phoenix Childrens Hospital, Phoenix, AZ
KIDNEY/RENAL PATHOLOGY (INCLUDING

TRANSPLANTATION)
253
POSTER
POSTER
SESSION
SESSION
VI
Wednesday,
Monday, March
March
23,16,
2015
2016
AMPM
- 12:00
- 4:00
PM
PM CC
CC
Exhibit
Exhibit
Hall
Hall
C/D
4ABC
| 9:30
| 1:00
Board
Number
Board
Number
269
The Pathology of Pure T-cell Mediated Rejection in

the Era of C4d Staining and Testing for Donor Specific
Antibodies (1616)
Parmjeet Randhawa, Gang Huang, Simrath Randhawa,
Gang Zeng, John Lunz, Xiaomu Zhao
The Thomas E. Starzl Transplant Institute, Pittsburgh,
PA
277
270
Dendritic Cells in Renal Allografts (1603)

Meghan Kapp, Sharon Phillips, Deborah O Crowe,
Jorge Garces, Agnes B Fogo, Giovanna A Giannico
Vanderbilt University, Nashville, TN; DCI Transplant
Immunology Laboratory, Nashville, TN; Ochsner Health
System, New Orleans, LA
Validation and Utility of [/underline]Telepathology[/

underline] for Immediate [/underline][/underline]
Intraoperative[/underline][/underline] Consultation
of [/underline][/underline]Donor Kidney Biopsies[/
Saba Ali, Alaa Afify, Rajendra Ramsamooj
University of California Davis Medical Center,
Sacramento, CA; California Northstate University
College of Medicine, Elk Grove, CA
278
Renal Cell Carcinoma in Allograft Kidneys: Use of Short

Tandem Repeat Analysis to Determine Donor Origin of
Cancer (1617)
Adam Robin, Colin C Hansen, Lauren Parsons,
Christopher Hartley, Eric Cohen, Alexander C
Mackinnon
271
Glomerular Complement Factor C4d Deposits

Are Structural Markers for Basement Membrane
Duplication in Transplant Glomerulopathy and
Thrombotic Microangiopathy (1612)
Volker Nickeleit, Harsharan Singh, Adil Gasim, Jamie
S Chua
The University of North Carolina, Chapel Hill, NC;
Leiden University Medical Center, Leiden, Netherlands
272
Glomerular Capillary Wall Staining with C4d Is

Associated with Glomerular Proliferation in IgA
Nephropathy (1621)
Umer Sheikh, Cynthia Cohen, Thomas E Rogers, Alton
Farris, Hong Qu, Carla Ellis
Emory University Hospital and School of Medicine,
Atlanta, GA; St. John Hospital and Medical Center,
Detroit, MI
273
Quantitative Real-Time PCR as a Surrogate Method

to Detect BK Virus (BKV) in Renal Transplant Biopsies
with Negative SV-40 Staining (1605)
Tripti Kumar, Rebecca Sovoda, John Gibson, Sarah
Britton, Andrea J Shaw, Bobby Boyanton, Dilip
Samarapungavan, Ping L Zhang
Beaumont Health System, Royal Oak, MI
274
Characterizing the Inflammatory Infiltrate in Human

Kidney Biopsies with TIN (1598)
Hae Yoon G Choung, Liying Fu, Ekaterina Castano,
Natalie Patel, Gilbert Moeckel
275
Validation of an Automated Platform to Assess the

Total Inflammatory Load in Kidney Transplant Biopsies
Using CD45 Immunohistochemistry and ComputerAssisted Quantitative Image Analysis (1626)
Vighnesh Walavalkar, Sarah Bowman, Hale Kirimlioglu,
Laura Laszik, Brad Barrows, Jarish Cohen, Daniel E
Roberts, Zoltan Laszik
UC San Francisco, San Francisco, CA
276
Renal Allograft Biopsy CD3+ Cell Quantitation

Algorithm Development for Rejection Assessment
Utilizing Open Source Image Analysis Software (1609)
Andres Moon, Geoffrey Smith, Thomas E Rogers, Carla
L Ellis, Alton B Farris
254
POSTER SESSION
ABSTRACT
Monday, ASSIGNMENT
March 23, 2015 | 9:30
COMMITTEE
AM - 12:00 PM
CC Exhibit Hall C/D
Term Ending
Jason L. Hornick, M.D., Ph.D. Chair
Jonathan L. Hecht, M.D., Ph.D.
Xiaohua Qian, M.D., Ph.D.
Justine Barletta, M.D.
Sarah M. Dry, M.D.
Simion I. Chiosea, M.D.
Daniel J. Brat, M.D., Ph.D.
Paul VanderLaan, M.D., Ph.D.
Keith K. Lai, M.D.
Leona Doyle, M.D.
Kristin Jensen, M.D.
2017
2016
2016
2016
2016
2016
2016
2016
2016
2018
2018
Term Ending
Dylan V. Miller, M.D.
Rajiv Patel, M.D.
Raga Ramachandran, M.D., Ph.D.
Charles M. Quick, M.D.
Elizabeth Morgan, M.D.
Bobbi S. Pritt, M.D.
Shree Sharma, M.D.
Alton B. (Brad) Farris, III, M.D.
Maria Westerhoff, M.D.
POSTER SESSION2015-16
Monday,
ABSTRACT
March 23, 2015
REVIEW
BOARD
- 12:00 PM
| 9:30 AM
Hikmat Al-Ahmadie
David Bahler
Ulysses Balis
Guliz Barkan
Justine Barletta
Olca Basturk
Dan Berney
Ritu Bhalla
Justin Bishop
Jennifer Black
Alexander Borowsky
Daniel Brat
Thomas Brenn
Fadi Brimo
Anne Buckley
Natalia Buza
Ben Calhoun
Anthony Chang
Andres Chiesa-Vottero
Simon Chiosea
Brian Collins
Lynn Cornell
Gregory Davis
Robin DeGallo
Leona Doyle
Sarah Dry
Daniel Dye
A. Brad Farris
Yuri Fedoriw
Raymond Felgar
Ann Folkins
Karen Fritchie
Joaquin Garcia
Karuna Garg
James Gill
Ryan Gill
Ilyssa Gordon
Omar Habeeb
Marc Halushka
Jonathan Hecht
Brooke Howitt
David Hudnall
David Hwang
Michael Idowu
Mohammed Idrees
Joseph Jakowski
Susan Jeffus
Kristin Jensen
Nicole Johnson
Kirk Jones
Keith Lai
Melinda Lerwill
Rebecca Levy
Jingmei Lin
Michael Linden
Kelly Magliocca
Joseph Maleszewski
Anais Malpica
Adrian Marino-Enriquez
Rohit Mehra
Ozgur Mete
Dylan Miller
Mari Mino-Kenudson
Roberto Miranda
Andre Moreira
Elizabeth Morgan
Juan-Miguel Mosquera
Sanjay Mukhopadyay
Anna-Marie Mulligan
Raouf Nakhleh
Ilke Nalbantoglu
Ericka Olgaard
Horatiu Olteanu
Scott Owens
Michelle Paessler
Reetesh Pai
Nicole Panarelli
Carlos Parra-Herran
Anil Parwani
Rajiv Patel
Joanna Phillips
Jenny Pogoriler
Alexi Polydorides
Bobbi Pritt
2018
2018
2018
2018
2018
2018
2018
2018
2018
2018
CC Exhibit Hall C/D
Christopher Przybycin
Xiaohua Qian
Charles Quick
Raga Ramachandran
Vijaya Reddy
Michelle Reid
Emily Reisenbichler
Jorge Reis-Filho
Brian Robinson
Anja Roden
Michael Roehrl
Mike Roh
Stephen Rohan
Marianna Ruzinova
Sandro Santagata
Stephen Schmechel
Theresa Scognamiglio
Michael Seidman
Sara Shalin
Shree Sharma
Steven Shen
Chanjuan Shi
Konstantin Shilo
Steven Smith
Aliyah Sohani
Paul Staats
Heather Stevenson-Lerner
Khin Thway
Maria Tretiakova
Paul VanderLaan
Russell Vang
Marina Vivero
Wei-Lien Wang
Yihong Wang
Ilan Weinreb
Astrid Weins
Maria Westerhoff
Sean Williamson
Laura Wood
Wei Xin
Xuefeng Zhang
Chen Zhang
255
POSTER SESSION
Abstract
Name
DISCLOSURE
Monday, March 23,INFORMATION
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
Relevant Disclosure Information
Marie Christine Aubry
Consultant for Genentech; Honorarium.
44
Torsten O Nielsen
Consultant for NanoString Technologies; Consulting fee. Partner of Bioclassifier LLC;

Ownership.
45
Vikram Deshpande
Speaker, research support for Affymetrix; Research support.
50
Torsten O Nielsen

Ownership.
64
Ahmet Dogan
Consultant for Foundation Medicine; Stipend. Advisory board for Cancer Genetics; Stipend.
71
Ravindra Kolhe
Researcher for Affymetrix Inc.; Kits and Reagents (no direct financial benefit).
71
Alka Chaubey
Speaker for Affymetrix; Travel benefits. Speaker for Cartagenia; Travel benefits.
71
Lisa C Watson
Company Employee of Illumina, Inc; Salary and stocks.
71
Claire Attwooll
Salaried Employee of Illumina, Inc; Salary.
113
Frederick L Baehner
Employee of Genomic Health, Inc.; Salary, stock.
113
Debbie McCullough
Employee of Genomic Health Inc.; Salary, stock.
113
Carolyn Mies
Employee of Genomic Health, Inc.; Salary.
113
Helen Bailey
146
Julia A Elvin
Employee of Foundation Medicine, Inc.; Employment/equity interest.
146
Kai Wang
146
Siraj M Ali
146
Jo-Anne Vergilio
146
Vincent A Miller
146
Philip J Stephens
146
Jeffrey S Ross
Employee, research support for Foundation Medicine; Employment, equity.
146
James Suh
148
Joel Lefferts
Advisory board member for Roche Molecular Diagnostics; Consulting fee.
166
Shannon L Puhalla
Local trial PI for Incyte; Research support. Local trial PI for Pfizer; Research support. Local
trial PI for Lilly; Research support. Local trial PI for Novartis; Research support. Local trial
PI, advisory committee for Abbvie; Research support. DSMB for Med Immune; Honorarium.
DSMB for Celldex; Honorarium. Local trial PI for Covance Bayer; Research support.
210
Hiroaki Nitta
Employment of Ventana Medical Systems, Inc.; Employment.
215
Gabriel Popescu
Employee, board member for G.P. has financial interest in Phi Optics, Inc., a company
developing quantitative phase imaging technology for materials and life science
applications; Salary, stocks.
241
Kai Wang
241
Jeffrey S Ross
241
Philip J Stephens
241
Vincent A Miller
241
James Suh
241
Jo-Anne Vergilio
241
Julia A Elvin
241
Siraj M Ali
241
Depinder Khaira
254
Bruno Poulet
Speaker and Consultant for ROCHE; Consultant fee.
269
Anant Madabhushi
Scientific advisory board member, scientific Consultant for Inspirata, Inc.; Equity holder.
Scientific advisory board member, scientific Consultant for Elucid Bioimaging; Equity holder.
271
Siraj M Ali
271
Philip J Stephens
271
Vincent A Miller
271
James Suh
271
Jo-Anne Vergilio
256
POSTER SESSION
Abstract Name
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
271
Julia A Elvin
271
Adrienne Johnson
Employee of Foundation Medicine, Inc.; Employment/stock ownership.
271
Kai Wang
271
Jeffrey S Ross
281
Torsten O Nielsen

Ownership.
288
Shannon Huggins-Puhalla
DSMB for Celldex; Honorarium. DSMB for Med Immune; Honorarium. Local trial PI, advisory
committee for Abbvie; Research support. Local trial PI for Lilly; Research support. Local trial
PI for Novartis; Research support. Local trial PI for Pfizer; Research support. Local trial PI for
Incyte; Research support. Local trial PI for Covance Bayer; Research support.
293
Janis Taube
Advisory board for Bristol Myers Squibb; Honorarium. Investigator-initiated Research for
Bristol Myers Squibb; Research funding. Advisory board for Astra Zenica; Honorarium.
293
Leisha Emens
Principal investigator-initiated study for Merck; Research funding. Principal investigatorinitiated study for Genentech and Roche, Inc; Research funding. Principal investigatorinitiated study for EMD Serono; Research funding. Principal investigator-initiated study for
Astrazeneca; Research funding.
300
Jeffrey S Ross
345
Derek B Allison
Research collaboration for Sienna Cancer Diagnostics Ltd.; Research materials.
345
Minesh Lalla
Program development for R&D for Sienna Cancer Diagnostics Ltd.; Employee of company.
345
Christopher J VandenBussche Researcher for Sienna Cancer Diagnostics Ltd.; Salary support and research materials.
354
Anil Parwani
Dr. Parwani also formerly served as a consultant to Omnyx, LLC, through an agreement
with the University of Pittsburgh Department of Pathology for Omnyx, LLC; Dr. Parwani
was formerly employed by an affiliate of UPMC, which owns one half of Omnyx, LLC. He
received research funding from Omnyx, LLC through the Univ. of Pitt, and has the right to
receive proceeds from the sale of Omnyx or its products.
355
Liron Pantanowitz
Consultant for Omnyx; Consulting fee.
373
Noa Davis
Employee of Micromedic Technologies Ltd.; Salary.
390
Claire M Eklund
Co-author of Hologic; Stock holdings in excess of $5000.
403
Lynette M Sholl
Scientific advisory board for Genentech; Honorarium.
442
A John Iafrate
Preliminary patent application holder with the U.S. Patent Office for Anchored Multiplex-PCR
technology for Archer Dx; Royalties and has equity in the company.
442
Long Le
Preliminary patent application holder with the U.S. Patent Office for Anchored Multiplex-PCR
technology for Archer Dx; Royalties and has equity in the company.
456
Elodie Sollier
Chief scientific officer for Vortex Biosciences; Work for the company.
456
Dino Di Carlo
Consultant for Vortex Biosciences; Shares.
464
Liron Pantanowitz
499
David Altree-Tacha
Employee of Biocare Medical; Salary and minor stock holder.
505
Krystal Brown
Employee of Myriad Genetics, Inc.; Stock, salary.
505
Richard J Wenstrup
505
M Bryan Warf
Employee of Myriad Genetic Laboratories, Inc.; Stock, salary.
505
Kathryn A Kolquist
505
Jonathan Nelson
505
Rosalie Elenitsas
Textbook editor for Lippincott Williams Wilkins; Royalties.
505
Jon A Reed
Contracted Research for Myriad; Consulting fee. Employee/owner of CellNetix Pathology &
Labs; Salary.
505
Darl D Flake
505
Loren E Clarke
505
Hillary Kimbrell
505
Benjamin B Roa
508
Barbara R DuPont
Speaker for Abbott; Travel funds.
508
Ravindra Kolhe
257
POSTER SESSION
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
Abstract Name
508
Alka Chaubey
510
Jonhan Ho
Dr. Ho also serves as a consultant to Omnyx, LLC, through an agreement with the University
of Pittsburgh Physicians Department of Dermatology for Omnyx, LLC; Jonhan Ho, MD is
employed by an affiliate of UPMC, which owns one half of Omnyx, LLC. Dr. Ho has received
research funding from Omnyx, LLC through the University of Pittsburgh, and has the right to
528
Vincent A Miller
528
Jeffrey S Ross
528
Philip J Stephens
528
James Suh
528
Jo-Anne Vergilio
528
Julia A Elvin
528
Mark Bailey
Employee of Foundation Medicine, Inc.; Salary/stock options.
528
Siraj M Ali
529
Aaron S Mansfield
Consulting for Celgene; Honorarium. Consulting for Genentech; Honorarium.
545
Michael Bonert
Founder / owner of Libre Pathology Limited; No financial benefit. Company runs

librepathology.org - an open access creative commons licenced pathology wiki - without
commercial sponsorship or advertisements.
546
Michael Bonert
Founder / owner of Libre Pathology Limited; No financial benefit. Company runs

librepathology.org - an open access creative commons licenced pathology wiki - without
commercial sponsorship or advertisements.
589
Virginia A LiVolsi
Histopatology consultation for Veracyte; Consulting fee.
599
Erik K Alexander
Consultant for Veracyte; Consulting fee.
609
Guido Rindi
Speaker for Novartis Pharma; Honorarium. Speaker for Ipsen Pharma; Honorarium.
Consultant for Bracco Imaging; Honorarium.
611
Kyle Fedorchak
611
Jeffrey S Ross
611
Philip J Stephens
611
Vincent A Miller
611
Shakti H Ramkissoon
Part-time pathologist for Foundation Medicine; Payment for work.
611
James Suh
611
Jo-Anne Vergilio
611
Siraj M Ali
611
Julia A Elvin
613
Erik K Alexander
Consultant for Veracyte; Consulting fee.
621
Wade S Samowitz
Intellectual property licensed to Ventan for Ventana; Royalties for the BRAF V600E antibody.
626
Vikram Deshpande
Research support to institution for Affymetrix; Research support to institution.
627
Gregory Y Lauwers
Consultant for NinePoint; Consultation fee.
628
Junko Aida
Diagnostic committee for Sucampo AG, Clinical trial SCMP-8811-201; Consigned research
fund.
628
Kaiyo Takubo
Diagnostic committee for Sucampo AG, Clinical trial SCMP-8811-201; Consigned research
fund.
629
Jeffrey S Ross
633
Gregory Y Lauwers
649
David L Rimm
Investigator, Consultant for Genoptix/Novartis; Support grant, honorarium. Consultant

for ACD; Honorarium. Consultant for BMS; Honorarium. Consultant for Perkin-Elmer;
Honorarium. Consultant for Astra Zenica; Honorarium. Investigator for Cepheid; Support
grant. Consultant for Amgen; Honorarium. Investigator for Gilead Sciences; Support grant.
Consultant for Biocept; Honorarium. Consultant for Cernostics; Honorarium. Consultant
for Metamark Genetics; Honorarium. Consultant for MDAgree; Honorarium. Consultant for
OptraScan; Honorarium. Investigator for Kolltan; Support grant. Investigator for OncoplexDx;
Support grant.
258
POSTER SESSION
Abstract Name
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
653
Muhammad S Beg
Advisory board for Celgene.
667
Vikram Deshpande
667
Gregory Y Lauwers
672
Gregory Y Lauwers
672
Simon Schlachter
Employee of NinePoint Medical; Salary.
672
Jacques JGHM Bergman
PI for Olympus Endoscopy; Research support for IRB approved studies. PI for Fuji-film;
Research support for IRB approved studies. PI / Speaker for Cook Medical; Research support
for IRB approved studies. PI / speaker / developer of training program for Boston Scientific;
Research support for IRB approved studies. PI / speaker / developer of training program for
GI solutions Covidien; Research support for IRB approved studies. PI for Erbe; Research
support for IRB approved studies. PI for Ninepoint Medical; Research support for IRB
approved studies. PI for C2 Therapeutics; Research support for IRB approved studies. PI for
Cernostics; Research support for IRB approved studies. PI for Interpace; Research support for
IRB approved studies.
672
Brian Sundell
Employee of NinePoint Medical; Salary.
692
Douglas K Pleskow
Consultant for Boston Scientific; Honorarium. Consultant for Covidien; Honorarium.
701
Siraj M Ali
701
Julia A Elvin
716
Jeffrey S Ross
728
Wade S Samowitz
Intellectual property licensed to Ventan for Ventana; Royalties for the BRAF V600E antibody.
749
Anthony M Magliocco
Medical advisory committee for Diacarta; Travel support and shares.
758
James Sun
758
Siraj M Ali
758
Jeffrey S Ross
772
Bassel El-Rayes
PI of clinical trial for Synta; Research support. PI on clinical trial for Novartis; Research
support. PI on clinical trial for Lily; Research support. PI on clinical trial for Roche/
Genenetech; Research support.
773
Bassel El-Rayes
PI of clinical trial for Synta; Research support. PI on clinical trial for Novartis; Research
support. PI on clinical trial for Lily; Research support. PI on clinical trial for Roche/
Genenetech; Research support.
782
Vikram Deshpande
792
Gregory Y Lauwers
796
Vikram Deshpande
796
Gregory Y Lauwers
797
Vikram Deshpande
799
Shabana F Pasha
Consulting for Covidien; Honorarium. Speaker for Covidien; Honorarium. Research for
Capsovision; Research support.
806
Robert Anders
Research for BMS; Research funding.
806
Janis Taube
811
Jacques JGHM Bergman
PI for Olympus Endoscopy; Research support for IRB approved studies. PI for Fuji-film;
Research support for IRB approved studies. PI / Speaker for Cook Medical; Research support
for IRB approved studies. PI / speaker / developer of training program for Boston Scientific;
Research support for IRB approved studies. PI / speaker / developer of training program for
GI solutions Covidien; Research support for IRB approved studies. PI for Erbe; Research
support for IRB approved studies. PI for Ninepoint Medical; Research support for IRB
approved studies. PI for C2 Therapeutics; Research support for IRB approved studies. PI for
Cernostics; Research support for IRB approved studies. PI for Interpace; Research support for
IRB approved studies.
812
Nilofer S Azad
Investigator for Celgene; Research funding. Investigator for Kinex; Research funding.
Investigator for Astex Pharmaceuticals; Research funding. Investigator for Precision
Biologics; Research funding. Investigator for Agios; Research funding. Investigator for
Genentech; Research funding. Spoke at investigator meeting for Merck; Honoraria/ travel
accommodations. Advisory role for DAVAOncology; Honoraria.
821
David T Ting
Research for Affymetrix; Research support.
259
POSTER SESSION
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
Abstract Name
821
Vikram Deshpande
822
Alexander Miron
CSO for Covariance Biosciences,LLC; Ownership interest.
827
Kai Wang
827
Kyle Gowen
827
Siraj M Ali
827
Jeffrey S Ross
831
Vikram Deshpande
842
Jo-Anne Vergilio
842
Siraj M Ali
842
Julia A Elvin
842
James Suh
842
Vincent A Miller
842
Jeffrey S Ross
842
Philip J Stephens
847
Rohit Mehra
Patent for Gen-Probe, Inc.; Royalty.
856
Charles Drake
Educational presentations and Consulting for Bristol-Myers-Squibb; Honorarium.
856
Janis Taube
868
Michael J Bonham
868
John P Bennett
868
Phillip G Febbo
868
Athanasios C Tsiatis
868
Debbie McCullough
Employee of Genomic Health Inc.; Salary, stock.
868
Ruixiao Lu
871
Francesc Xavier Bosch
Speaker for gsk; Research grants / conference. Speaker for Merck; Research grants /
conference. Advisor for qiagen; Conference.
895
Anthony M Magliocco
905
Eric A Klein
Speaker for Genomic Health, Inc.; Speaker fee.
929
Jeffrey P Simko
onsultant for Genomic Health, Inc.; Fees paid to my employer, UCSF. Research project
collaborator for Genomic Health Inc.; Unrestricted research funds paid to my employer.
Research project collaborator for Myriad Genetics; Unrestricted research funds paid to my
employer. Consultant for GenomeDx; Fees paid to my employer, UCSF. Research project
collaborator for Genome Dx; Unrestricted research funds paid to my employer. Manuscript
writing for Maximum medical solutions; Honorarium to my employer, UCSF. Meeting
attendee for Prostate Cancer Foundation; Travel reimbursement. Meeting attendee for
Canary Foundation; Travel reimbursement. Scientific advisory board for 3D biopsy Inc;
Honorarium.
931
Emmanuel S Antonarakis
Paid consultant/advisor for Sanofi US; Paid consultant/advisor. Paid consultant/advisor

for Dendreon; Paid consultant/advisor. Paid consultant/advisor for Janssen Biotech; Paid
consultant/advisor.
949
Rajal Shah
Employee of Miraca Life Sciences; Salary.
975
Pradip Manna
Employee of Physicians Reference Lab, LLC; Salary.
976
Hongyang Pan
Employee of Epitomics, an Abcam company; Employee salary.
976
Jason Law
Employee of Abcam; Salary.
976
Jackie Chan
976
Yuekai Zhang
Employee of Epitomics, an Abcam company; Employee salary.
976
Taiying Chen
Employee of Abcam; Salary and stock options.
976
Aihua Li
977
Rajal Shah
977
Savvas Mendrinos
260
POSTER SESSION
Abstract Name
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
977
Wei Tian
978
Rajal Shah
979
Wei Tian
979
Rajal Shah
979
Savvas Mendrinos
984
Emmanuel S Antonarakis
Paid consultant/advisor for Sanofi US; Paid consultant/advisor. Paid consultant/advisor

for Dendreon; Paid consultant/advisor. Paid consultant/advisor for Janssen Biotech; Paid
consultant/advisor.
988
Todd Morgan
Advisory board for MDxHealth; Honorarium. Advisory board for Genomic Health;
Honorarium. Advisory board for Myriad Genetics; Honorarium.
988
Arul M Chinnaiyan
988
Scott A Tomlins
Consultant for Ventana Medical Systems and Abbvie; Honorarium. Licensced intellectual
property for Ventana Medical Systems; Patent royalties. Licensced intellectual property
for Gen-Probe/Hologic; Patent royalties. Sponsored research agreement for Compendia
Bioscience/Life Technologies/ThermoFisher Scientififc; Research funding.
988
Rohit Mehra
989
Dejan Knezevic
989
Michael J Bonham
989
Athanasios C Tsiatis
989
Tara Maddala
989
Anne Dee
989
H Jeffrey Lawrence
989
Phillip G Febbo
989
Eric A Klein
Speaker for Genomic Health, Inc.; Speaker fee.
1018
Anil Parwani
1019
Andrew Evans
Consultants role on clinical trial design and product improvement/development for Omnyx,
LLC; Consultant fees.
1025
Jeffrey S Ross
1025
Julia A Elvin
1025
Siraj M Ali
1025
Jo-Anne Vergilio
1025
James Suh
1025
Vincent A Miller
1025
Philip J Stephens
1032
Bruce Neri
Employee of Metabolon Inc; Salary.
1032
Bryan Wittman
Employee of Metabolon Inc; Salary.
1033
Andrew Evans
1041
James Bentley
1041
Monica Chaterjee
1041
Gloria Romerocases
1041
Wei Tian
1041
Yousef Tadros
1041
Jiyoon Yoon
1041
Savvas Mendrinos
1041
Rajal Shah
261
POSTER SESSION
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
Abstract Name
1042
Wei Tian
1042
Rajal Shah
1045
Scott A Tomlins
1048
Rohit Mehra
1049
David Tacha
Employee of Biocare Medical; Stock.
1053
Janis Taube
1053
Charles Drake
Educational presentations and Consulting for Bristol-Myers-Squibb; Honorarium.
1058
Wendy L Flejter
1058
Rajal Shah
1058
Eric Kroman
1058
Wei Tian
1065
Rohit Mehra
1065
Arul M Chinnaiyan
1066
Arul M Chinnaiyan
1066
Rohit Mehra
1082
Jeffrey S Ross
1092
Robert Makowsky
Research work for Response Genetics, Inc; Regents and instrument. Research work for HTG
Molecular Genetics, Inc; miRNA sequencing.
1092
Chris Roberts
Research work for Response Genetics, Inc; Reagents and instrument. Research work for HTG
1092
Miriana Moran
1092
Craig Stephens
1092
Stephanie H Astrow
1096
Drucilla Roberts
Author of UpToDate; Royalties.
1109
David L Rimm
Investigator, Consultant for Genoptix/Novartis; Support grant, honorarium. Consultant

for ACD; Honorarium. Consultant for BMS; Honorarium. Consultant for Perkin-Elmer;
Honorarium. Consultant for Astra Zenica; Honorarium. Investigator for Cepheid; Support
grant. Consultant for Amgen; Honorarium. Investigator for Gilead Sciences; Support grant.
Consultant for Biocept; Honorarium. Consultant for Cernostics; Honorarium. Consultant
for Metamark Genetics; Honorarium. Consultant for MDAgree; Honorarium. Consultant for
OptraScan; Honorarium. Investigator for Kolltan; Support grant. Investigator for OncoplexDx;
Support grant.
1123
Philip J Stephens
1123
Jeffrey S Ross
1123
Vincent A Miller
1123
Siraj M Ali
1123
Laurie Gay
1123
Jo-Anne Vergilio
1123
Garrett Frampton
1123
Julia A Elvin
1123
Zachary Chalmers
1123
Eric M Sanford
Employee of Foundation Medicine, Inc; Compensation and equity interest.
1123
James Sun
1123
James Suh
1135
Vikram Deshpande
262
POSTER SESSION
Abstract Name
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
1144
F Stephen Hodi
Consultant/clinical Research support to institution for Bristol-Myers Squibb; Non-Paid.

Consultant/clinical Research support to institution for Genentech; Non-Paid. Consultant for
Merck; Honorarium. Consultant for Merck; Honorarium.
1144
Margaret A Shipp
for Bristol-Myers-Squibb; Research funding.
1144
Gordon J Freeman
Patent application for the use of 9A11 antibody for diagnostic purposes for Bristol-MyersSquibb, Roche, Merck, EMD-Serrono, Boehringer-Ingelheim, Amplimmune/AstraZeneca, and
Novartis; Patent royalties on the PD-1 pathway.
1144
Scott Rodig
for Patent application for the use of the 9A11 antibody for diagnostic purposes; None. for
Bristol-Myers-Squibb; Research funding.
1158
Mark H Stoler
Consultant for Advanced Cell Diagnostics; HPV ISH reagents.
1170
Josh Haimes
Employee of ArcherDX, Inc; Salary.
1170
Namitha Manoj
1170
Brian Kudlow
1174
Julia A Elvin
1174
Joel Greenbowe
Employee of Foundation Medicine; Employee, equity.
1174
Jeffrey S Ross
1174
Siraj M Ali
1181
Mark H Stoler
1182
Mark H Stoler
1221
Jacob P Crowley
Field application scientist for Affymetrix Inc.; Salary.
1221
Anthony M Magliocco
1227
Vikram Deshpande
1234
Frank Campbell
Senior scientist for Covariance Biosciences, LLC; Salary.
1240
Anthony M Magliocco
1260
Julia A Elvin
1260
Jeffrey S Ross
1260
Philip J Stephens
1260
Vincent A Miller
1260
Jo-Anne Vergilio
1260
Kyle Gowan
1260
Kyle Fedorchak
1260
Siraj M Ali
1260
James Suh
1267
Janis Taube
1278
Scott A Tomlins
1284
Andrew G Sikora
PI for Advaxis; Funding of clinical trial.
1287
Vincent A Miller
1287
Jeffrey S Ross
1287
Philip J Stephens
1287
Jo-Anne Vergilio
1287
Julia A Elvin
1287
Siraj M Ali
1287
Kyle Fedorchak
1287
James Suh
1306
Vikram Deshpande
263
POSTER SESSION
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
Abstract Name
1331
Tracy I George
PI for Allakos, Inc.; Research funding for mast cell research. Steering committee for
clinical trial, mastocytosis for Novartis, Inc.; Consulting fees. Consultant to plan clinical
trial, mastocytosis for Blueprint Medicine; Consulting fees. AML/MDS database steering
committee for Celgene; Consulting fees.
1336
Vikram Deshpande
1340
Tracy I George
1350
Robert S Ohgami
Primary Investigator for Agilent Technologies; Research grant. Primary Investigator for
Foundation Medicine; Research support.
1360
David Tacha
1366
Scott Rodig
1371
Tracy I George
1375
Ahmet Dogan
1379
Gordon J Freeman
Patent application for the use of 9A11 antibody for diagnostic purposes for Bristol-MyersSquibb, Roche, Merck, EMD-Serrono, Boehringer-Ingelheim, Amplimmune/AstraZeneca, and
Novartis; Patent royalties on the PD-1 pathway.
1379
F Stephen Hodi
Consultant/clinical Research support to institution for Bristol-Myers Squibb; Non-Paid.

Consultant/clinical Research support to institution for Genentech; Non-Paid. Consultant for
Merck; Honorarium. Consultant for Merck; Honorarium.
1379
Margaret A Shipp
for Bristol-Myers-Squibb; Research funding.
1379
Scott Rodig
1382
Ahmet Dogan
1387
Vikram Deshpande
1387
Robert P Hasserjian
Consultant for Incyte, Inc.; Salary.
1392
Robert S Ohgami
1393
Anna Porwit
Speaker for Novartis; Honorarium. Travel to the Harmonemia Working Group meeting for
Beckman Coulter; Travel grant.
1408
David W Scott
Speaker for Celgene; Honorarium.
1408
Randy D Gascoyne
Speakers bureau for Seattle Genetics; Honorarium.
1409
Ravindra Kolhe
1409
Alka Chaubey
1409
Lisa C Watson
1409
Claire Attwooll
1412
Robert S Ohgami
1427
Robert P Hasserjian
1432
Tracy I George
1440
Dennis OMalley
Employee of Clarient Pathology Services; Salary.
1448
Ahmet Dogan
1462
Robert P Hasserjian
1462
Olga Pozdnyakova
Consultant for Incyte; Honorarium. Consultant for Promedior; Honorarium.
1470
Jeffrey S Ross
264
POSTER SESSION
Abstract Name
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
1473
Tracy I George
1473
Robert P Hasserjian
1474
Ahmet Dogan
1475
Ahmet Dogan
1475
Ross Levine
Consultant for Foundation Medicine; Stipend.
1481
Ahmet Dogan
1505
Jie He
1505
Jeffrey S Ross
1505
Vincent A Miller
1505
Rachel Erlich
1505
James Suh
1505
Julia A Elvin
1505
Justin Allen
Employee of Foundation Medicine, Inc.; Salary, stocks.
1505
Samantha Morley
Employee of Foundation Medicine, Inc.; Salary, stocks.
1505
Jo-Anne Vergilio
1505
Philip J Stephens
1506
Tracy I George
1508
Robert P Hasserjian
1508
Tracy I George
1512
Robert P Hasserjian
1514
Ross Levine
Consultant for Foundation Medicine; Stipend.
1516
Robert P Hasserjian
1517
Dennis OMalley
1518
Dennis OMalley
1542
Yuling Luo
Employee of Advanced Cell Diagnostics; Stock.
1542
Xiao-Jun Ma
Employee of Advanced Cell Diagnostics; Employee.
1543
Douglas J Hartman
1549
Michelle Call
Employee of Farsight Genome Systems; Employee compensation.
1549
Sushama Thakker
1549
Charlie Kim
1549
Glenda Anderson
1555
Jeffrey L Fine
Inventor of Omnyx; IP agreement.
1557
Jeffrey L Fine
1557
Liron Pantanowitz
1557
Curtis Stratman
Employee of Omnyx, LLC; Salary.
1557
Douglas J Hartman
1557
Joe Birsa
Employee of Omnyx; Salary.
1557
Jonhan Ho
265
POSTER SESSION
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
Abstract Name
1557
Mark Nyman
Employee of Omnyx, LLC; Salary.
1560
Liron Pantanowitz
1560
Douglas J Hartman
1561
Ajay Basavanhally
Employee of Inspirata, Inc; Equity holder, salary.
1561
Anant Madabhushi
1562
Anant Madabhushi
1563
Louis J Auguste
Was responsible for digital imaging of the glass slides using the mWSI technique I invented
(played no part in the design of this study) for CEO, Co-founder and major share holder in
AlexaPath (start-up focused on developing low cost medical diagnostic tools); No financial
gain related to this project.
1563
Dhaval H Palsana
Was responsible for digital imaging of the glass slides using the mWSI technique I invented
(played no part in the design of this study) for CTO, co-founder and major share holder in
AlexaPath (start-up focused on developing low cost medical diagnostic tools); No financial
gain related to this project.
1566
Anant Madabhushi
1575
Liron Pantanowitz
1575
Jeffrey L Fine
1575
Douglas J Hartman
1582
Murray Treloar
Work done in the study for Omnyx, LLC; Hourly for professional services rendered.
1582
Michael Montalto
Senior VP of clinical and medical affairs at Omnyx, LLC for Omnyx, LLC; Salary.
1582
Anil Parwani
1582
Katy Wack
Lead clinical scientist at Omnyx, LLC for Omnyx, LLC; Salary.
1582
Laura M Drogowski
Research Manager at Omnyx, LLC for Omnyx, LLC; Salary.
1582
Jonhan Ho
1582
Andrew Evans
1583
Anant Madabhushi
1584
Olga Pozdnyakova
Consultant for Incyte; Honorarium. Consultant for Promedior; Honorarium.
1584
Robert P Hasserjian
1630
Vikram Deshpande
1653
Vikram Deshpande
1685
Benjamin R Kipp
Principle Investigator for Abbott Molecular Inc; Grant support.
1696
Shakti H Ramkissoon
1699
Garrett Frampton
1699
Jeffrey S Ross
1699
Philip J Stephens
1699
Vincent A Miller
1699
Julia A Elvin
1699
Shakti H Ramkissoon
1699
Jo-Anne Vergilio
1699
Juliann Chmielecki
266
POSTER SESSION
Abstract Name
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
1699
Zachary Chalmers
1699
James Suh
1711
Ravindra Kolhe
1711
Alka Chaubey
1711
Barbara R DuPont
Speaker for Abbott; Travel funds.
1712
Richard Levenson
Founder of MUSE Microscopy, INc; Founder shares. Consultant for Agilent; Payment.
1724
Benjamin R Kipp
1738
Ralph H Hruban
PalB2 invention for Myriad Genetics; Royalties.
1747
David T Ting
1747
Vikram Deshpande
1754
Ralph H Hruban
1757
Mari Mino-Kenudson
Consultant for Merrimack Pharmaceuticals; Consultation fee.
1760
Yutaka Hatanaka
Scientific adviser for TAIHO Pharmaceutical Co., Ltd.; Consulting fee. Scientific adviser
for GeneticLab Co., Ltd.; Consulting fee. Principal Investigator for QIAGEN K.K. Japan;
Collaborative research expense. Principal Investigator for GeneticLab Co., Ltd.; Collaborative
research expense.
1772
Ralph H Hruban
1775
Randall E Brand
Consultant for Myriad Genetics, Inc.; Honorarium. Scientific advisory board for Asuragnen,
Inc.; Honorarium.
1775
Ralph H Hruban
1776
Siraj M Ali
1776
Joel Greenbowe
Employee of Foundation Medicine; Employee, equity.
1776
Jeffrey S Ross
1785
Jo-Anne Vergilio
1785
James Suh
1785
Siraj M Ali
1785
Jeffrey S Ross
1785
Vincent A Miller
1785
Julia A Elvin
1785
Juliann Chmielecki
1785
Lee Albacker
1785
Philip J Stephens
1792
Jason Harris
Employee of Personalis, Inc; Salary.
1792
Michael J Clark
1792
John West
1792
Richard Chen
1792
Christian Haudenschild
1792
Nan Leng
1792
Massimo Morra
1792
Shujun Luo
1792
Sean M Boyle
1792
Deanna M Church
1792
Ravi K Alla
1792
Martina Lefterova
1792
Elena Helman
1795
Siraj M Ali
1795
Jeffrey S Ross
1795
Julia A Elvin
267
POSTER SESSION
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
Abstract Name
1795
Philip J Stephens
1795
Vincent A Miller
1795
James Suh
1795
Zachary Chalmers
1795
Jo-Anne Vergilio
1795
Garrett Frampton
1795
Laurie Gay
1796
Daniel DeSloover
Employee of Color Genomics; Salary.
1796
Robert Daber
Employee of Bio-Reference Laboratories; Salary.
1797
Zoran Gatalica
Employee of Caris Life Sciences; Salary.
1797
Inga Rose
1797
Peggy Teresi
1797
Rebecca Feldman
1797
Ryan P Bender
1804
Alka Chaubey
1804
Andrew Hadd
Salaried Employee of Asuragen Inc.; Salary.
1804
Ravindra Kolhe
1805
Scott A Tomlins
1813
Wei-Li Liao
Employee of Oncoplex Diagnostics/Nantomics; Salary. Employee of Oncoplex Diagnostics/

Nantomics; Stocks.
1813
Fabiola Cecchi

Nantomics; Stocks.
1813
Adele Blackler

Nantomics; Stocks.
1813
Todd Hembrough

Nantomics; Stocks.
1818
Sydney D Finkelstein
Employee of RedPath / Interpace Diagnostics; Salary.
1821
David T Ting
1821
Vikram Deshpande
1853
Julia A Elvin
1853
Siraj M Ali
1854
Peter B Illei
Scientific advisory board for Genentech; Honorarium. Scientific advisory board for Roche;
Honorarium. Speaker webinar faculty for Roche Diagnostics; Honorarium. Speaker Workshop Faculty at WCLC 2015 for AstraZeneca; Honorarium. Scientific advisory board for
Myriad Genetics; Honorarium.
1855
Benjamin R Kipp
1860
Jeffrey S Ross
1863
Scott Boerner
Speaker for Pfizer; Honorarium.
1863
David M Hwang
Speaker for Pfizer; Honorarium.
1863
Ming-Sound Tsao
Speaker for Pfizer; Honorarium. Consultant for Pfizer; Honorarium. Principal Investigator for
Pfizer; Research grant. Consultant for Novartis; Honorarium.
1870
Gary M Hunninghake
Consulting for Medna LLC; Honorarium. Consulting for George Lehman Group; Honorarium.
Scientific advisory board for Patients Like Me; Honorarium. Scientific advisory board for
Genentech; Honorarium.
1870
Lynette M Sholl
1871
Justin F Gainor
Consultant for Boehringer Ingelheim; Consulting fee. Consultant for Novartis; Consulting
fee. Consultant for Merck; Consulting fee. Consultant for Clovis Oncology; Consulting fee.
Consultant for Jounce Therapeutics; Travel reimbursement. Consultant for Kyowa Hakko
Kirin Pharmaceuticals; Consulting fee.
268
POSTER SESSION
Abstract Name
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
1871
Mari Mino-Kenudson
1874
Ryan Hoff
Employee of Myriad Genetics, Inc., Salt Lake City, UT; Receives salary and stock options.
1874
Placede Tiemeny
1874
Susanne Wagner
1875
Xiao-Jun Ma
1875
Yuling Luo
1887
Lynette M Sholl
1893
1896
Dennis OMalley
1900
Bruce E Johnson
Consulting for KEW Group-Genomic Testing Company; Honoraria.
1900
Lynette M Sholl
1909
Lynette M Sholl
1909
Pasi A Janne
Consultant, commercial research support for AstraZeneca; Consulting fee, research support.
Consultant for Pfizer; Consulting fee. Consultant for Roche; Consulting fee. Consultant
for Acea Biosciences; Consulting fee. Consultant for Chugai Pharmaceuticals; Consulting
fee. Commercial research support for Astellas; Research support. Stock ownership for
Gatekeeper pharmaceuticals; Owns stock. On DFCI-owned intellectual property on EGFR
mutations licensed to Lab Corp for Lab Corp; Post-marketing royalties.
1911
1911
Geoffrey B Johnson
Advisory panel for Pfizer Inc.; Honorarium.
1918
Hans-Ulrich Schildhaus
Speaker for Abbott Molecular; Honorarium. Speaker for ZytoVision; Honorarium. Speaker for
Pfizer; Honorarium.
1919
Diana N Ionescu
Speaker at CME events for Pfizer; Honorarium.
1920
Mari Mino-Kenudson
1922
Lynette M Sholl
1922
Cloud Paweletz
Speaker for BioRad; Honorarium.
1922
Geoffrey R Oxnard
Consultant for Sysmex; Honorarium.
1927
Jo-Anne Vergilio
1927
Julia A Elvin
1927
Jeffrey S Ross
1927
Philip J Stephens
1927
Vincent A Miller
1927
James Suh
1927
Juliann Chmielecki
1927
Garrett Frampton
1927
Kai Wang
1927
Siraj M Ali
1927
Adrienne Johnson
1932
Lynette M Sholl
2026
Bingqing Zhang
Employee of Advanced Cell Diagnostics; Salary, stock.
2026
Xiao-Jun Ma
2026
Yuling Luo
2026
Henry G Lamparski
2026
Nan Su
2026
Melanie Miller
2026
Casey Kernag
2026
Thomas Laver
2031
Claire Attwooll
269
POSTER SESSION
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
Abstract Name
2031
Lisa C Watson
2031
Ravindra Kolhe
2031
Alka Chaubey
2039
Clifford C Hoyt
Employee of PerkinElmer; Salary.
2039
Alejandro Contreras
Speaker for PerkinElmer; Travel expenses.
2039
Chichung Wang
2048
Sangheum Hwang
Researcher for Ministry of Science, ICT and Future Planning, Government of Republic of
Korea; Research grant.
2048
Hyo-Eun Kim
2048
Sangyong Song
2048
Sooyoun Cho
2048
Soohyun Hwang
2048
Jungin Lee
2048
Hyemin Shim
2051
Yuling Luo
2051
Keith Young
2051
Xiao-Jun Ma
2051
Nan Su
2051
Kuang-Jung Chang
2051
Casey Kernag
2051
Thomas Laver
2051
Melanie Miller
2051
Henry G Lamparski
2051
Daniel Kim
2051
Bingqing Zhang
2052
Mirian Karbelashvili
2052
Richard Chen
2052
John West
2052
Deanna M Church
2052
Parin Sripakdeevong
2052
Scott Kirk
2052
Elena Helman
2052
Martina Lefterova
2052
Massimo Morra
2052
Shujun Luo
2052
Ravi K Alla
2052
Michael J Clark
2052
Sean M Boyle
2052
Michael P Snyder
Membership on advisory committee for Personalis, Inc; Stock.
2053
Richard Levenson
Founder of MUSE Microscopy, INc; Founder shares. Consultant for Agilent; Payment.
2054
Yonghua Zhang
Employee of NovoDiax, Inc.; Employee.
2054
Zhiqing Zhang
2056
James Mansfield
270
POSTER SESSION
Abstract Name
DISCLOSURE
2015 | 9:30 AM - 12:00 PM
CC Exhibit Hall C/D
2057
James Mansfield
2057
Kristin Roman
2057
Chichung Wang
2057
Clifford C Hoyt
2062
Ahmet Dogan
2067
Hartmut Koeppen
Full time Employee of Roche; Salary, options, shares.
2067
Chenery Lowe
Contractor for Roche; Salary.
2067
Sandra Rost
Full time Employee of Roche; Salary, options, shares.
2076
Sydney D Finkelstein
Employee of RedPath / Interpace Diagnostics; Salary.
2078
Claude Sirlin
Research contract for General Electric Healthcare; None. Research contract for Siemens;
None.
2082
Ulrich Vogel
Inventor of Patent application by myself. No company.; Nothing. A patent application only

costs.
2084
Yonghua Zhang
2084
Zhiqing Zhang
2085
Casey Kernag
2085
Xiao-Jun Ma
2085
Nan Su
2085
Daniel Kim
2085
Yuling Luo
2085
Bingqing Zhang
2085
Henry G Lamparski
2089
Luis Chavez
Employee of Sakura Finetek USA, Inc.; Salary.
2089
Erico von Bueren
2089
Julie A Galindo
2089
Carlos Sanchez
2089
Cliff Hom
2089
Douglas T Yamanishi
2089
Lydia E Figueroa
2090
Eugenie Dalimier
Employee of LLTech; Salary.
2090
Anil Parwani
2090
Arnaud Duc
Employee of LLTech; Salary.
2091
Jillian Tyrrell
Employee of Biocare Medical; Salary.
2091
David Tacha
271
POSTER SESSION
272
Monday, March 23,

2015
NOTES
9:30 AM - 12:00 PM
CC Exhibit Hall C/D
2016
INDEX
When Making a Donation, Think Inside the Box
1003 Campaign
Reach inside your pocket while
thinking inside the box with a gift to the
1003 Campaign.
Help USCAP raise $1 million and create
a dynamic of inspired giving that means
the world to patients.
Every gift of $100 assures that
pathologists have access to the most
relevant information for patient care
and will be used to support these
state-of-the-art centers that will refine
pathologists skills and create better
pathologists world-wide.
This unique USCAP environment
supports personalized learning
and global outreach to advance
the discipline of pathology for
one world.
Visit Us Online for Donation Opportunities
www.USCAPFoundation.org
INDEX
A
Aamelfot, Christina ................. 157
Aas, Hans................................. 110
Aas, Turid ................................ 110
Abbas, Jaber ........................... 217
Abbas, Jad............................... 246
Abbas, Ossama ....................... 208
Abbott, Sara ............................ 249
Abbuhl, Mary F ....................... 140
Abdel-Wahab, Omar ............... 196
Abdul, Rehman ....... 184, 216, 246
Abdulameer, Shahad .............. 189
Abdulfatah, Eman ........... 126, 141,
................................... 142, 179, 249
Abdul-Karim, Fadi W. ...... 68, 115,
................................................... 218
Abe, Hiroyuki........................... 174
Abe, Sousei ............................. 157
Abed, Francisco ...................... 223
Abedalthagafi, Malak.............. 191
Abel, Haley .............................. 242
Abendroth, Catherine S.......... 219
Abi-Raad, Rita ......................... 143
Aboshady, Ibrahim ................. 172
Abou-Ouf, Hatem .................... 136
Abraham, Ronald .................... 160
Abraham, Susan C ........ 165, 176,
................................................... 244
Abramson, Jeremy ................. 229
Abreu, Francine de ......... 212, 213
Abudayyeh, Ala....................... 184
Abu-Farsakh, Sohaib .............. 244
AbuSaadeh, Feras................... 250
Abusada, Ellen ........................ 140
Abuzenadah, Adel................... 203
Achim, Mary ............................ 147
Ackerma, Michael J. ......... 54, 114
Acosta-Gonzalez, Gabriel ...... 229,
................................................... 230
Adam, Benjamin ..................... 131
Adem, Patricia V ..................... 197
Adeniran, Adebowale ....... 95,143,
.................... 144,147, 167, 178, 222
Adeyi, Oyedele .................. 94, 191
Adlowitz, Diana ....................... 209
Adsay, N. Volkan .... 22, 52, 91,105,
132, 133, 144, 156, 157, 166, 167,
................... 175, 184, 193, 211, 245
Adusumilli, P ........................... 136
Adwar, Wamidh ...................... 249
Ae, Keisuke .............................. 237
Aesif, Scott W.......................... 189
Affolter, Kajsa .................. 201, 221
Afify, Alaa ................................ 254
Agaimy, Abbas .... 74, 76, 207, 225
Agaram, Narasimhan P .... 76, 114,
........................................... 168, 196
Agarwal, Atin .................. 192, 244
Agarwal, Jai P ......................... 207
Agarwal, Nitin K ...................... 227
Agboola, Ayodeji O................. 216
Aggarwal, Gitika ..................... 198
Aggarwal, Nidhi ...... 129, 155, 251
Agostini-Vulaj, Diana .............. 246
Agoston, Agoston .......... 173, 202,
........................................... 203, 220
Agrawal, Tanupriya......... 123, 169

Aguayo, Gloria ........................ 193
Aguilera-Barrantes, Irene ....... 149
Aguiluz, Angela ....................... 134
Aguirre, Mercedes .................. 218
Ahearn, Thomas ..................... 109
Ahlborn, Lise ........................... 153
Ahmad, Salman ...................... 253
Ahmadi, Parnian ..................... 196
Ahmadie, Hikmat Al................ 177
Ahmed, Isthiaque.................... 190
Ahmed, Shahida ..................... 208
Ahmed, Syed Salahuddin ...... 142
Ahn, Hyein ............................... 216
Ahn, Inhye ............................... 252
Ahn, Janice...................... 210, 229
Ahn, Sangjeong ...... 174, 202, 220
Ahn, Soomin ................... 166, 174
Ahrendt, Gretchen .................. 170
Ai, Di ........................................ 170
Aida, Junko ..................... 244, 258
Aida, Noriko ............................ 215
Ainechi, Sanaz................ 121, 221,
........................................... 222, 246
Aisner, Dara ......................... 46, 95
Aizer, Ayal A ............................ 191
Akbani, Rehan ......................... 163
Akbari, Mohammad R ............ 181
Akdas, Yasemin ....................... 114
Akgul, Mahmut ....................... 123
Akgun, Hulya ........................... 195
Akhter, Ariz .............. 129, 154, 209
Akhter, Shabnam .................... 126
Akiba, Jun................................ 250
Akiyama, Yoshiyuki................. 224
Akkas, Gizem ................... 193, 245
Akki, Ashwin............................ 177
Akram, Muzaffar ..... 117, 137, 198
Akslen, Lars A ................. 110, 157
Alaggio, Rita ............ 114, 168, 253
Alago, William......................... 190
Al-Ahmadie, Hikmat A .... 126, 147,
.......................... 163, 176, 204, 214
Al-Ahwal, Mahmoud .............. 203
Alam, Elie ................................ 208
Alatassi, Houda.... 144, 218, 227, 248
Alayed, Khaled ................ 229, 253
Albacker, Lee ................... 194, 267
Albadine, Roula....................... 218
Al-Badri, Osamah.................... 131
Albanese, Joseph ................... 238
Albany, Costantine.................. 222
Albarello, Luca ........................ 140
Albarracin, Constance ............ 216
Albero, Raquel ........ 135, 189, 247
Albert, Sebastien .................... 153
Albieri, Roberta AP ................. 135
Albrecht, Hana ........................ 184
Albuquerque, Miguel...... 169, 230
Alcaraz-Mateos, Eduardo ....... 145
Al-Dandan, Sadeq ................... 186
Aldecoa, Iban .......... 215, 234, 245
Al-Delfi, Firas ........................... 131
Alden, Ryan S.......................... 188
Alderman, Megan ................... 218
Alderuccio, Juan ..................... 227

Aldrees, Sultan........................ 187
Aldulescu, Monica .................. 232
Alegre, Victor .......................... 242
Alejo, Maria ............................. 167
Alemany, Laia.................. 167, 223
Aleskandarany, Mohammed A .....
................................... 138, 216, 217
Alex, Deepu ............................. 197
Alexander, Brian M ................. 191
Alexander, Erik K..... 172, 173, 258
Alexander, Mariam P ..... 131, 160,
................................................... 184
Alexis, Claudine ...................... 140
Alford, Sharon H ..................... 180
Al-Habib, Ali ............................ 210
Al-Haddad, Sahar.................... 125
Al-Hilli, Zahraa ........................ 109
Ali, Asma ......................... 146, 153
Ali, Saba .................................. 254
Ali, Shadan ...................... 203, 212
Ali, Simak ................................ 217
Ali, Siraj M ... 111,116,117,120,121,
127, 151, 159, 163, 166, 175, 193,
194, 198, 203, 213, 231, 246, 249,
256, 258, 259, 260, 261,262, 263,
................................... 267, 268, 269
Ali, Slimane Ait si ................... 230
Ali, Syed Z ....................... 144, 239
Ali, Waleed .............................. 224
Ali-Fehmi, Rouba ........... 117, 126,
........... 141, 142, 179, 180, 239, 249
Alikhan, Mir ............................. 128
Alizadeh, Layla ........................ 126
Aljinovic, Nika ......................... 131
Al-Kawaaz, Mustafa ................ 183
Alkan, Serhan .................. 217, 251
Alkapalan, Deema ................... 140
Alla, Ravi K ...... 162, 212, 267, 270
Allaf, Mohamad E ........... 178, 179
Allard, Felicia........................... 132
Allard, Michael F. ...................... 28
Al-Ibraheemi, Alyaa ........ 196, 237
Allen, Brian .............................. 112
Allen, John .............................. 212
Allen, Justin .................... 208, 265
Allen, Peter .............................. 132
Allende, Daniela ...................... 230
Allison, Derek B............... 118, 257
Allison, Kimberly ...... 101,164, 233
Allmer, Cristine ....................... 165
Allo, Ghassan .................. 180, 249
Almadani, Noorah .................. 126
Al-Maghrabi, Jaudah .............. 203
Almeida, Madson Q ................ 173
Almeida, Raquel...................... 150
Almenara, Gorge A ................. 140
Almenara, Jorge ..................... 219
Almutairi, Fawaz ..................... 247
Al-Niaimi, Ahmed ................... 151
Alobeid, Bachir........ 159, 234, 253
Alomari, Ahmed.............. 192, 200
Alonso, Sonia .......................... 242
Alos, Llucia .............................. 207
Alosh, Baraa ............ 126, 141, 179
Alpers, Charles ................ 138, 183
Alpert, Lindsay ................. 42, 111,

................................... 185, 201, 202
Al-Quran, Samer Z .................. 126
Al-Rohil, Rami N ............. 200, 242
Alruwaii, Fatimah.................... 179
Alsaati, Gazal........................... 239
Alsafadi, Muhammad K.......... 141,
................................... 142, 148, 179
AlSaikhan, Bader .................... 222
AlSalihi, Suhair A.................... 131
Alsomali, Mohammed ............ 121
Altree-Tacha, David......... 201, 257
Alturkustani, Murad ................ 235
Alva, Ajjai ................................ 223
Alvarado, Anthony S .............. 183
Alvarado-Cabrero, Isabel ....... 171,
........................................... 177, 224
Alvarez, Maria Martinez-Lage .......
............................................. 43, 191
Aly, F Zahra ..................... 166, 219
Amador, Catalina .... 165, 252, 253
Ambaye, Abiy B ...................... 170
Ambelil, Manju........................ 131
Ambrosone, Christine ............ 171
Ameri, Maryam D ................... 209
Amin, Ali .................. 124, 147, 149
Amin, Khalid.................... 119, 234
Amin, Mahul B ........... 25, 101, 106
.... 125, 136, 149,163, 176, 205, 249
Amin, Md Shahrier ......... 118, 131
Amin, Mitual............................ 252
Amorese, Rebecca .................. 246
Amos, Christopher I........ 188, 213
An, Soyeon .............................. 156
Anand, Mona........................... 225
Ananthanarayanan, Vijayalakshmi
........................................... 134, 232
Anastasi, John ........ 130, 146, 194
Andea, Aleodor (Doru) ...... 23, 92,
........................................... 192, 200
Andeen, Nicole........ 123, 178, 183
Anders, Robert ... 86, 165, 174, 259
Anderson, Benjamin O. ............ 66
Anderson, Blake .............. 124, 146
Anderson, Carol ...................... 145
Anderson, Courtney ............... 161
Anderson, Glenda ........... 183, 265
Anderson, James .................... 196
Anderson, Matthew L ............. 112
Anderson, Neil H..................... 211
Anderson, Virginia .................. 195
Andrada, Encarna ................... 179
Andrasova, Martina ................ 145
Andre, Fabrice ......................... 194
Andrews, Caitlin...................... 217
Andrews, David............... 123, 212
Andrulis, Irene......................... 134
Aneja, Ritu ...... 116, 138, 166, 198,
........................... 216, 217, 235, 238
Angchuan, Siripron ................ 253
Angelini, Annalisa................... 118
Angelis, Camila M de ............. 146
Angell, Trevor .................. 172, 173
Angelos, Peter ......................... 172
Angert, David .......................... 118
Angevin, Eric ........................... 194
Angot, Emilie........................... 168
273
INDEX
Anichini, Andrea ..................... 243
Anita, Kumar ........................... 209
Annan, Anand ......................... 134
Ansari, Junaid ................. 196, 214
Ansell, Wendy ......................... 222
Anthony, Douglas ................... 104
Antic, Tatjana.......... 118, 123, 172,
........................................... 178, 243
Antonarakis, Emmanuel S .... 247,
........................................... 260, 261
Antonescu, Cristina ...... 27,28, 60,
74,78, 114,115, 127, 139, 151, 168,
................................................... 196
Aoyama, Chisa ........................ 251
Aplenc, Richard ....................... 154
Aplin, Alfred C ......................... 172
Appiah, Adams K .................... 165
Appleman, Leonard J ............. 125
Aprikian, Armen ...................... 222
Aqil, Barina .............................. 209
Arabe, Jorge A ........................ 218
Arafah, Maria .......................... 141
Arai, Tomio ...................... 172, 244
Araki, Asuka ............................ 201
Arana, Inigo ............................. 191
Aranake-Chrisinger, John ...... 227
Aranda, Derick M .................... 186
Arango, Jose Mantilla ............ 116
Araujo, Karina S ...................... 146
Araya, Juan Carlos ......... 157, 193
Arber, Daniel A ....... 22, 90, 91,130,
.................... 137,153, 155, 194, 252
Arcaro, Kathleen F .................. 213
Arcila, M .................................. 159
Arcila, Maria E ................ 162, 163,
................... 196, 213, 228, 237, 251
Ardeniz, Omur ......................... 220
Areas, Ana Lucia G ................. 135
Arend, Lois .............................. 131
Argani, Pedram ........ 49, 116, 117,
................................... 125, 136, 168
Arguelles-Grande, Carolina ... 253
Argyris, Prokopios .................. 139
Arias-Stella, Javier......... 138, 148,
........................................... 205, 238
Arif, Qudsia ............................. 232
Arita, Junichi ................... 184, 230
Ariza, Aurelio........................... 221
Arkin, Jordan........................... 217
Arksarapuk, Jittirat ................. 253
Armesto, Susana .................... 242
Armitage, James..................... 209
Armylagos, Donna .......... 134, 240
Arnald, David J ....................... 152
Arnason, Thomas ................... 122
Arnold, Christina A ... 93, 121, 133,
........................................... 201, 203
Arnold, Michael............... 121, 133
Arnold, Shanna ....................... 247
Arnold, Stacy J................ 166, 219
Arnould, Laurent ..................... 164
Aronson, Judith ...................... 195
Arora, Arshi ............................. 137
Arora, Kshitij ................... 123, 250
Arps, David P........................... 200
Arriola, Aileen Grace P ........... 152
Arrossi, Andrea V............ 114, 136
274
Arshad, Muhammad............... 216

Arun, Banu .............................. 216
Asa, Sylvia L. ..................... 28, 107
Asano, Naoko .......................... 229
Asato, Marcel A....................... 146
Asatrian, Greg ......................... 197
Asch-Kendrick, Rebecca J ...... 117
Asgedom, Girmay................... 216
Ash, Ryan ................................ 184
Ashok, Dhandapani ................ 122
Asioli, Sofia ..................... 121, 140
Asirvatham, Jaya R................. 115
Askan, Gokce........................... 132
Askin, Frederic ........................ 231
Aslanian, Harry ....................... 123
Asleh-Aburaya, Karama ......... 117
Assaad, Adel ................... 139, 220
Assarzadegan, Naziheh .. 120, 221
Assis, David ............................. 230
Aster, Jon C ............................. 155
Astrow, Stephanie H ....... 180, 262
Astvatsaturyan, Kristine . 215, 216
Aswad, Bassam....................... 143
Ataya, Dana ............................. 117
Atieh, Mohammed ......... 135, 212,
........................................... 219, 245
Atkins, Kristen A ........ 29, 116, 250
Attwooll, Claire ...... 154, 161, 237,
................................... 256, 264, 269
Aubry, Marie Christine .... 22, 105,
... 134, 159, 189, 190, 191, 256, 269
Augello, Claudia...................... 187
Augello, Michael ..................... 213
Auger, Manon ......................... 240
Auger, Nathalie ....................... 194
Auguste, Louis J ..... 131, 239, 266
Augustin, Jeremy ................... 153
Aull, Meredith J ...................... 138
Auman, Heidi .......................... 109
Aung, Phyu P.......... 120, 192, 200,
........................................... 201, 242
Austin, Marshall R ........... 111,240
Austin, Melissa........................ 145
Avadhani, Vaidehi .......... 118, 120,
................... 144, 167, 175, 211, 234
Avery, Diane ............................ 239
Aviki, Emeline M ..................... 149
Avila-Casado, Carmen ............ 191
Avril, Stefanie .......................... 116
Avula, Rajeswari ..................... 114
Awad, Mark ............................. 136
Awadallah, Amad.... 121, 219, 229
Axiotis, Constantine ............... 219
Aya, Francisco ......................... 158
Ayala, Alberto G ...................... 178
Ayata, Gamze .......................... 132
Aye, Le ..................................... 180
Aykutlu, Umut ......................... 185
Ayob, George H ...................... 162
Ayre, Gareth ............................ 152
Azad, Nilofer S ................ 202, 259
Azaro, Analia ........................... 213
Aziz, Mohamed S .................... 143
Aziz, Sara ................................. 247
Aziz, Sura M ............................ 110
Aziz, Tariq ................................ 118
Azueta, Ainara ......................... 221

Azzato, Elizabeth M................. 133
B
Baba, Satoshi .......................... 241
Babayeva, Sabina ... 136, 158, 188
Babushok, Daria ...................... 130
Bacchi, Carlos E ...... 142, 151, 152
Badoual, Cecile ............... 153, 215
Badve, Sunil ............. 103, 198, 238
Bae, Young K ........................... 211
Bae, Jeong Mo ........................ 221
Baehner, Frederick L ....... 142, 256
Baek, Seunghee ...................... 240
Baere, Thierry De .................... 194
Baergen, Rebecca ................... 214
Baetz, Tara ............................... 129
Bagci, Pelin .............. 157, 166, 193
Bagg, Adam......... 29, 95, 130, 137
Baggerly, Keith ........................ 124
Bagnasco, Serena ................... 131
Bagrodia, Aditya ............. 163, 204
Bahar, Burak .................... 119, 123
Bahary, Nathan ....................... 193
Bahrami, Armita...................... 168
Bai, Chunxue ........................... 114
Bai, Yalai .................................. 179
Bail, Brigitte Le ........................ 169
Bailey, Helen.................... 142, 256
Bailey, Mark ..................... 120, 258
Bailey, Nathanael G ........ 193, 227
Baine, Marina .......................... 237
Bains, S .................................... 136
Baiocchi, Robert ...................... 128
Bajaj, Renu .............................. 162
Bajorin, Dean F................ 163, 204
Baker, Gabrielle M .......... 116, 199
Baker, Suzanne J..................... 191
Bakhiet, Salih .......................... 150
Bakshi, Ganesh ....................... 223
Bal, Munita ...................... 166, 207
Balabaud, Charles ................... 169
Balabram, Debora ................... 244
Balague, Olga .......................... 164
Balaguer, Francesc.................. 245
Balakrishna, Jayalakshmi P ... 245
Balakrishnan, Dhanalakshmi .. 160
Balassanian, Ronald ........ 78, 111,
........................................... 138, 170
Balasubramanian, Ishwaria ... 111
Balatti, Veronica ...................... 122
Balci, Serdar ............ 166, 175, 245
Baldassarri, Rebecca ............. 143,
........................................... 144, 167
Baldridge, Lee Ann ................. 177
Balis, Ulysses .................... 44, 190
Balitzer, Dana .......................... 230
Balk, Steven............................. 248
Ball, Mark W .................... 178, 223
Ballard, Morgan ...................... 164
Ballo, Michael S ...................... 143
Ballon, Gianna................. 143, 241
Baloch, Zubair .............. 46, 48, 68,
..................................... 74, 121, 145
Balogh, Zsofia ......................... 194

Baltatzis, George ..................... 165
Baltay, Michele ........................ 155
Baltazar, Fatima....................... 173
Balzer, Bonnie L ...................... 176
Bander, Neil H ......................... 152
Bandy, Andrew................ 184, 211
Bandyopadhyay, Sudeshna .. 117,
126, 141, 142, 157, 179, 180, 193,..
........................................... 239, 249
Bangs, Dana ............................ 228
Banito, Ana .............................. 235
Bannan, Michael ..................... 173
Baqai, Saad ............................. 207
Baras, Alexander.... 120, 145, 179,
........................... 205, 206, 218, 233
Barber, Jason K ....................... 186
Barberis, Massimo .................. 187
Barbieri, Andrea L ........... 144, 160
Barbieri, Christopher E ........... 247
Barboza, Oralia........................ 250
Bareja, Rohan .................. 194, 204
Barkan, Gliz A....... 102, 114, 119,
........................... 123, 143, 204, 240
Barkoh, Bedia A ............. 160, 161,
........................................... 167, 233
Barletta, Justine A .............. 24, 45,
............................ 167, 172,173, 206
Barnhill, Raymond .................. 200
Baro, Teresa............................. 135
Barod, Ravi .............. 135, 136, 176
Barraza, Gonzalo ............. 115, 232
Barrera, Angelica Gutierrez.... 216
Barrese, Tomas Z .................... 229
Barreto, Jose ........................... 223
Barrett, Amanda...................... 145
Barrett, Mary ................... 204, 222
Barrett, Megan R ..................... 180
Barroca, Helena....................... 146
Barroeta, Julieta E .................. 225
Barrows, Brad ................. 253, 254
Barry, Beatrix........................... 153
Barry-Holson, Keegan ............ 180
Barry-OCrowley, Jacqueline ........
............ .......................139, 150, 181
Bartels, Ashley ....................... 253
Bartlett, Jamen........................ 227
Bartley, Angela N. ..................... 51
Bartosch, Carla ................ 112, 238
Barua, Animesh ...................... 180
Basavanhally, Ajay.......... 181, 266
Basbug, Mustafa ..................... 195
Baselga, Jose .................. 137, 164
Basir, Zainab............................ 237
Baskin, Leland B...................... 171
Baskovich, Brett ...................... 145
Basnet, Kristen M.................... 126
Basolo, Fulvio.................. 140, 242
Bassano, Cristina ............... 54, 164
Bassat, Quique ........................ 114
Bassett, Roland L ... 112, 119, 138,
................................... 164, 180, 242
Bassiouny, Dina .............. 179, 181
Basso, Cristina ................ 118, 172
Bast, Martin ............................. 209
Bastacky, Sheldon I.. 125, 205, 241
Bastard, Christian ................... 168
INDEX
Bastos, Cesar S ....................... 135
Bastos, Lucas QA .................... 146
Basturk, Olca ............ 79, 132, 166,
........................................... 193, 245
Basu, Sankha S ....................... 128
Batalis, Nicholas ..................... 146
Batdorf, Bjorn .......................... 128
Bateman, Justin .............. 147, 205
Bates, Mark.............................. 181
Batlevi, Connie ................ 213, 228
Batlle, Ana ............................... 229
Batra, Surinder K .................... 207
Battaglia-Hsu, Shyue-Fang .... 186
Baudhuin, Linnea M ............... 114
Baumgartner, Erin................... 222
Bavi, Prashant ........ 172, 190, 191,
................................... 203, 212, 221
Baxter, Aaron J ....................... 129
Baydar, Dilek ................... 163, 204
Bayerl, Michael G............... 27, 129
Baylin, Stephen ....................... 202
Bayrak, Busra Yaprak .............. 150
Beach, Jordan R ...................... 214
Beanlands, Robert .................. 235
Beattie, Adam.......................... 230
Beaubier, Nike ........ 111, 133, 211,
................................... 217, 230, 231
Beca, Francisco ............... 110, 141
Beck, Andrew H.......... 44, 110, 141
Becker, Kent............................. 140
Beckmann, Matthias W .......... 225
Bedolla, Gabriela .... 156, 166, 193
Bedossa, Pierre ............... 169, 230
Bedrosian, Isabelle ................. 216
Bedrossian, Kristi .................... 160
Beg, Muhammad S ......... 245, 259
Beggan, Caitlin ........................ 207
Begnami, Maria....................... 230
Behdad, Amir .................. 229, 253
Behm, Frederick ...................... 123
Behrens, Carmen .................... 189
Bejarano, Pablo A ................... 174
Belanger, Eric C ....... 109, 147, 205
Belchis, Deborah ..................... 188
Bell, Debra A ........................... 127
Bell, Diana ....... 127, 151, 187, 192
Bell, Douglas ........................... 241
Bell, Sarah ............................... 179
Bellara, Aarti............................ 146
Bellevicine, Claudio ........ 218, 245
Bellizzi, Andrew M ....... 27, 46,123,
.... 133,139, 140, 173, 209, 211, 241
Bellmunt, Joaquim ................. 163
Bellocq, Jean-Pierre........ 164, 198
Bellolio, Enrique R .......... 157, 193
Bellur, Shuba S ....................... 183
Beltran, Himisha ............ 162, 194,
................... 195, 204, 213, 241, 246
Beltran, Luis ............................ 109
Benammar, Assia Hafidi ......... 152
Benayed, Ryma ....................... 237
Bender, Ryan P ................ 214, 268
Benelli, Matteo ........................ 246
Benini, Stefania ....................... 236
Bennasar, Mar ......................... 215
Bennett, Ana E ........................ 122
Bennett, Jennifer A ................. 180

Bennett, John P............... 247, 260
Bennett, Michael W ....... 141, 182,
........................................... 199, 202
Bennis, Malika ......................... 243
Bentley, James ................ 148, 261
Bentley-Lewis, Rhonda........... 126
Berchuck, Andrew................... 249
Berczy, Margaret ..................... 214
Berezowska, Sabina................ 174
Berg, Aaron N ......................... 218
Berger, Michael F ............ 112, 204
126, 137,159, 163, 164, 167, 191,
................... 204, 212, 213, 237, 241
Bergholtz, Sarah ..................... 197
Bergman, Jacques JGHM ..... 174,
........................................... 191, 259
Bergsland, Emily K ................. 212
Berho, Mariana ....................... 174
Berjawi, Ghina......................... 217
Berkowitz, Aaron L.................. 186
Bernard, Philip ................ 117, 199
Bernardo, M Magarida ........... 248
Berney, Daniel ... 35, 105, 109, 136,
........................................... 163, 222
Bernie, Aaron .......................... 160
Bernstein, Jane ......................... 42
Beroukhim, Rameen ............... 191
Berrebi, Alexander A .............. 231
Berretta, Remus ...................... 118
Berry, Gerald J. ............... 107, 219
Berry, Ryan .............................. 196
Bertaglia, Emanuele ............... 118
Berthelet, Eric .......................... 152
Bertsch, Elizabeth ........... 124, 147
Bertuch, Alison A .................... 129
Berzin, Tyler............................. 244
Beshai, Boulos ........................ 239
Betz, Bryan ...................... 139, 144
Beydoun, Rafic ................ 126, 212
Beyene, Joseph....................... 118
Bezerra, Stephania M ...... 146,163,
............................ 178, 204,223, 247
Bhagat, Govind .............. 130, 159,
................................... 192, 234, 253
Bhalla, Amarpreet ... 131, 203, 239
Bhalla, Ritu .............................. 147
Bhargava, Rohit ............. 117, 160,
................... 171, 198, 224, 238, 251
Bhattacharyya, Siddharth ...... 172
Bhattarai, Shristi ............. 116, 238
Bhatti, Rahat ............................ 128
Bhinder, Bhavneet .................. 194
Bhuiya, Tawfiqul ..... 131, 140, 239
Bi, Rui............................... 179, 226
Bi, Wenya L ............................. 191
Bialik, Ann ............................... 177
Bianchini, Diletta ..................... 246
Bibars, Wafi ............................. 184
Bibbey, Scott ........................... 118
Bibeau, Frederic ...................... 202
Biderbost, Christelle Cerato ... 214
Biemer, John ........................... 210
Biernacka, Anna .............. 144, 213
Biernat, Wojciech .................... 188
Bigio, Marc Del........................ 191
Bijol, Vanesa ...................... 72, 105
Bilir, Birdal ............................... 214

Bilkey, Jade ............................. 132
Billah, Shahreen...................... 209
Billings, Steven D......... 23, 25, 27,
....... 29, 91, 192, 196, 200, 235, 241
Billis, Athanase ....................... 146
Bilodeau, Elizabeth ................. 139
Binder, Scott ............................ 152
Binot, Elke................................ 231
Binotti, Will .............................. 187
Bioulac-Sage, Paulette ........... 169
Birdsong, George.................... 234
Birney, Laura ........................... 160
Birsa, Joe ......................... 182, 265
Bisagni, Alessandra ................ 164
Biscotti, Charles V ................... 251
Bishop, John W............... 170, 243
Bishop, Julie Anne.......... 248, 250
Bishop, Justin A ..... 103, 127, 152,
................................... 153, 224, 247
Bismar, Tarek ........................... 136
Bisogna, Maria ........................ 249
Biswas, Asok ..................... 69, 192
Bittar, Humberto Trejo .... 114, 188
Bitterman, Pincas .................... 180
Bitting, Angela ........................ 232
Bivalacqua, Trinity J ....... 205, 223
Bixby, Dale............................... 154
Bizzarro, Tommaso ................. 168
Bjornhagen, Viveca................. 242
Black, Candice C.............. 145, 213
Black, Jennifer........................... 61
Black, Jonathan....................... 179
Blackler, Adele................. 213, 268
Blanchard, France ........... 166, 168
Blanco, Luis Z .......................... 116
Blando, Jorge .......................... 202
Blanes, Alfredo................ 178, 214
Blank, Annika .......................... 243
Bledsoe, Jacob ................ 128, 229
Bleiweiss, Ira J ... 66, 110, 164, 170
Blessing, Melissa M ........ 160, 191
Blevins, Lewis S ...................... 186
Blosser, Christopher ............... 183
Boag, Alexander ..................... 231
Bobr, Aleh ................................ 252
Boccardo, Simona .................. 232
Bochner, Bernard H .. 163,167, 204
Bockelmann, Robin................. 157
Bocklage, Therese... 145, 196, 239
Bodalo, Marta.......................... 207
Boddicker, Rebecca L.............. 165
Bodo, Juraj ...................... 156, 209
Boehm, Steffen ....................... 181
Boer, Bastiaan de ...................... 79
Boerner, Scott ................. 158, 268
Boffa, Daniel ............................ 123
Bogach, Jessica ...................... 118
Boger, Ravit ............................. 185
Boguniewicz, Ann B....... 116, 117,
........................................... 138, 198
Bohers, Elodie ......................... 194
Boi, Giovanna.......................... 235
Boilesen, Eugene .................... 209
Bois, Melanie C ............... 109, 172
Boisselier, Blandine ................ 191

Bolan, Charles ................. 193, 253
Boland, Jennifer M ........ 134, 158,
................................................... 168
Boldt, Brandon ........................ 173
Bolster, Margot ....................... 195
Bolton, James ......................... 225
Bolton, Warren K .................... 183
Boman, Bruce M ..................... 245
Bomeisl, Philip ........................ 141
Bonanni, Luigi ......................... 212
Bonazza, Deborah ................... 241
Bond, Jesse ............................. 214
Bondaruk, Jolanta........... 124, 163
Bondurant, Charles P.............. 186
Bonert, Michael .. 97, 145, 146, 258
Bongiovanni, Massimo .......... 168
Bonham, Michael J .. 247, 260, 261
Bonneau, Peter N ........... 149, 173,
........................................... 179, 243
Bono, Johann S De ......... 246, 247
Bonsib, Stephen M ................. 124
Bonzheim, Irina ....................... 164
Bookhout, Christine ................ 115
Boonipat, Thanapoom............ 144
Boorjian, Stephen A ............... 205
Booth, Christine N .......... 117, 219
Borbolla, Mauricio .................. 145
Borczuk, Alain ......................... 244
Bordignon, Patrizia ................. 152
Bordoni, Rodolfo..................... 151
Borges, Melissa....................... 245
Boriack, Richard ...................... 128
Boroujeni, Amir Momeni ...... 183,
........................................... 195, 219
Borowitz, Michael J ................ 129
Borowsky, Alexander..... 138, 170,
................................................... 243
Borsu, Laetitia ......................... 152
Borys, Adrianna ...................... 131
Borys, Dariusz ......................... 131
Borys, Ewa............................... 131
Bosari, Silvano ........................ 187
Bosch, Francesc Xavier ......... 167,
........................................... 223, 260
Bose, Shikha............ 143, 171,173,
........................................... 215, 216
Bosenberg, Marcus W ............ 234
Bosisio, Francesca .................. 200
Bossuyt, Veeryle ..................... 103
Boto, Agedi...................... 199, 237
Boughey, Judy C ..... 164, 198, 215
Bougrini, Mouna ..................... 202
Boulianne, Patrice ................... 189
Boulos, Fouad ................. 109, 217
Bouvier, Nancy ........ 167, 213, 241
Bovee, Judith .......................... 168
Bowers, Kelly A ....................... 234
Bowman, Sarah .............. 189, 254
Bowser, Zenica L ............. 116, 117
Boxerman, Jerrold L ............... 132
Boyanton, Bobby .................... 254
Boyd, Theonia K...................... 106
Boyer, Hilary ............................ 109
Boyer, James L........................ 230
Boyer, Michael ................ 127, 151
275
INDEX
Boyle, Sean M .. 162, 212, 267, 270
Boynton, Kathleen .................. 201
Boysen, Gunther ............. 246, 247
Bozkurtlar, Emine .................... 113
Bracamonte, Erika.............. 72, 160
Bradley, Laura ......................... 121
Braga, Ana C ................... 150, 161
Brahmbhat, Rushin D ............. 216
Brand, Randall E ............. 192, 267
Brandler, Tamar C ................... 143
Brandwein, Margaret.............. 207
Branson, Julie ................. 113, 118
Brat, Daniel J. ...................... 24, 49
Bratton, Laura ......................... 246
Braud, Filippo De .................... 243
Braxton, David R ..................... 131
Braylan, Raul C........................ 253
Braziel, Rita.............................. 129
Brcic, Luka ................................. 71
Bream, Matthew ..................... 123
Breau, Rodney H ............. 109, 147
Breese, Virginia ....................... 124
Breining, Dwayne ................... 224
Brenca, Monica ....................... 196
Brenin, Christiana M ............... 116
Brenn, Thomas.................. 94, 103
Brennan, Sandra ..................... 117
Breton, Quentin....................... 191
Brett, Mary Anne..................... 118
Brewer, Molly .......................... 181
Brewster, Ryan ........................ 191
Bridge, Julia A.................... 28, 89,
......................................Honors Tab
Briggs, Debra .......................... 208
Brimo, Fadi ............. 125, 163, 205,
........................................... 222, 240
Brinkerhoff, Brian T ........ 121, 191
Bristow, Rob G ................ 109, 148
Britton, Heidi ........................... 127
Britton, Sarah .......................... 254
Broach, James ........................ 250
Broaddus, Emily...... 166, 175, 213
Broaddus, Russell ..... 64,107, 111,
112, 160, 166, 175, 187, 192, 213,
........................................... 233, 249
Broadwater, Gloria.................. 249
Brochin, Lydia ......................... 186
Brodsky, Alexander........ 117, 176,
.................................... 203,221, 249
Brodsky, Sergey ......... 53, 138, 183
Brody, Judith ........................... 128
Brody, Rachel .......................... 215
Broehm, Cory .......................... 236
Brogi, Edi .................. 23, 116, 117,
........................... 137, 138, 164, 194
Bronner, Mary P .............. 122, 221
Brooks, James D ............. 109, 248
Brosnan-Cashman, Jacqueline .....
................................................... 156
Brot, Marina De ....................... 244
Brown, Alan F.......................... 228
Brown, David........................... 187
Brown, Ian ............... 166, 174, 219
Brown, Krystal................. 200, 257
Brown, Larry............................ 132
Brown, Noah ................... 139, 206
276
Brown, Robert ................. 131, 211

Brown, Ronald ........................ 155
Brown, Ryanne........................ 145
Brown, Shari ........................... 228
Browne, Tara Jane ......... 141, 182,
................................................... 199
Bruegl, Amanda ...................... 112
Brufsky, Adam ................. 170, 198
Brugarolas, James .................. 178
Bruggeman, Richard D ........... 250
Bruijn, Ino De .................. 137, 225
Brundler, Marie-Anne ............... 72
Brunelli, Matteo .............. 177, 178
Bryan, Andrew .......................... 50
Brynes, Russell K .................... 181
Bryson, Gareth W ................... 190
Bshara, Wiam .......................... 171
Bu, Fang................................... 148
Buchwald, Christian von ........ 153
Buckingham, Lela ................... 120
Buckland, Michael................... 186
Budd, G T......................... 116, 164
Buehler, Darya................. 121, 236
Buelow, Benjamin ........... 124, 159
Bueno, Raphael ....................... 202
Bueren, Erico von ........... 235, 271
Bueso-Ramos, Carlos E ......... 104,
.............. 105,130,137,154, 155, 252
Buettner, Reinhard .................. 231
Buhmeida, Abdelbaset ........... 203
Buhrer, Elias ............................ 130
Buhtoiarova, Tatiana............... 167
Bui, Marilyn ............................. 128
Buiga, Rares ............................ 171
Buja, L Maximilian .................. 172
Bukelo, Maria F ....................... 215
Bulimbasic, Stela .................... 177
Bull, Shelley ............................ 134
Bullock, Grant C .............. 129, 251
Bullock, Nyasha .............. 198, 201
Bulman, William A .................. 218
Bulusu, Gautam ...................... 170
Buonocore, Darren ......... 159, 241
Burack, Richard ............... 209, 227
Burdette, Elliott ............... 135, 144
Burger, Peter ..................... 43, 185
Burke, Allen P .................. 195, 231
Burke, Kathleen ....... 110, 137, 194,
................................................... 225
Burke, Louise........................... 195
Burmeister, Lynn ..................... 119
Burnes, Catherine L ................ 155
Burnett, Alexander.................. 113
Burnett, Arthur ........................ 223
Burnier, Miguel N.................... 187
Burns, Kathleen H ................... 129
Burstein, David E .................... 222
Burt, Michael M....................... 144
Burton, Emer ........................... 220
Busam, Klaus .......................... 200
Busby-Venner, Helene ............ 186
Busca, Aurelia ......................... 126
Busico, Adele .......................... 113
Bussolati, Gianni ..................... 146
Bustamante, Carlos D ............. 133
Bustamante, Daniel ................ 128

Butany, Jagdish ...... 172, 190, 191
Butko, Emerald........................ 161
Butnor, Kelly J ......................... 227
Buttner, Reinhard .................... 103
Butz, Henriett........................... 178
Buyukbabani, Nesimi ............. 206
Buza, Natalia ........................... 225
Buzelin, Marcelo A .................. 244
Buzzoni, Roberto ..................... 243
Bydder, Graeme ...................... 234
Byeon, Sun-ju.......................... 229
Byers, Richard ......................... 190
Byrnes, Kathleen ............. 120, 132
Byrum, Stephanie ................... 149
C
Caan, Bette J ........................... 199
Caballero, Fuensanta .............. 145
Cabanillas, Maria .................... 173
Cabecadas, Jose M ................. 164
Cabral, Monica M Demas Alvares
................................................... 244
Cacheux, Valere ...................... 152
Cadeddu, Jeffrey..................... 178
Caglar, Derin............................ 240
Cagle, Philip T. .......................... 51
Cahill, Dolores J ...................... 180
Cai, Changmeng ..................... 248
Cai, Donghong ........................ 208
Cai, Guoping ................... 144, 167
Cai, Shirong............................. 165
Cai, Tommaso ......................... 223
Cai, Xu ..................................... 179
Cain, James ............................. 183
Cajal, Santiago Ramon y ....... 162,
........................................... 236, 247
Caldas, Margarida................... 238
Calderone, Tiffany L................ 113
Caldwell, Trevor ...................... 146
Calhoun, Benjamin C ......... 42, 80,
........................... 116, 117,164, 219
Calio, Anna .............. 124, 177, 178
Calkins, Sarah ......................... 167
Call, Michelle ................... 183, 265
Calonje, Jaime Eduardo .. 103, 241
Calvo, Katherine R .......... 193, 253
Camacho, Jessica ................... 162
Camacho, Jowaly ................... 195
Cambor, Carolyn ..................... 145
Cameron, Stuart...................... 142
Camilleri, Michael ................... 123
Campbell, Frank .............. 181, 263
Campbell, Natalie S ................ 139
Campiotti, Leonardo ............... 209
Campo, Elias ........................... 164
Campos, Antonio .................... 230
Campuzano-Zuluaga, German......
........................................... 165, 182
Canales, Jaime Rodriguez..... 135,
........................................... 157, 202
Canepa, Mariana ..................... 143
Canete, Sofia ........................... 223
Cani, Andi K..................... 207, 214
Cannatella, John ..................... 159
Cantley, Richard ...................... 143

Cantuaria, Guilherme ............ 216,
........................................... 235, 238
Cao, Dengfeng ........................ 224
Cao, Kai.................................... 199
Cao, Pinjiang ........................... 132
Cao, Weibiao ........................... 214
Cao, Wenqing .................. 185, 244
Cao, Xuhong ................... 109, 177
Capella, Carlo R....................... 140
Capua, Daniele M di ............... 212
Caraway, Nancy ...................... 218
Carballal, Sabela ..................... 245
Carballo-Zarate, Adrian Alejandro
.......................................... 193, 252
Cardenas, Ana Maria .............. 130
Cardiff, Robert ......................... 170
Cardona, Diana M ........... 175, 201
Cardoso, Manuel..................... 150
Carey, Kyle............................... 200
Carey, Thomas E ..................... 206
Carlo, Dino Di .................. 241, 257
Carlson, Erin E......................... 198
Carlson, Joseph ...................... 249
Carneal, Eugene ...................... 233
Carneiro, Fatima ..................... 245
Carneiro, Maria Fatima............. 59
Caron, Alissa A........................ 191
Caron, Bolette L ...................... 239
Caron, Justin ................... 134, 198
Carpenter, Philip M ................. 170
Carrilho, Carla ......................... 114
Carrillo, Luis F ......... 149, 174, 179
Carrio, Meritxell ...................... 235
Carroll, Martin ......................... 154
Carroll, Peter R ........................ 109
Carslon, J Andrew .................. 120
Carstens, Billie J ..................... 208
Carter, Cody..................... 115, 226
Carter, Gloria ................... 160, 170
Carter, H Ballentine ................. 109
Carter, Jamal H ............... 185, 218
Carter, Jodi M.......... 109, 141, 237
Carter, John B ......................... 190
Carter-Monroe, Naima............ 131
Carturan, Elisa ......................... 118
Caruso, Anabela C .................. 135
Carvajal-Hausdorf, Daniel ..... 175,
................................................... 179
Carvalho, Elizabete ................. 150
Carvalho, Filipe LF .................. 202
Carvalho, Kelson R ................. 146
Casanova, Jacklyn .................. 196
Casas, Luis De Las .................. 143
Cascio, Michael J .................... 114
Cascione, Luciano ........... 122, 176
Casler, John............................. 108
Cason, Marco .......................... 118
Casse, Jean-Matthieu ............. 186
Cassivi, Stephen D .................. 159
Castain, Claire ......................... 169
Castano, Ekaterina .................. 254
Castellano, Joan J .................. 158
Castellanos, Elisabeth ............ 235
Castells, Antoni ............... 234, 245
INDEX
Castellsague, Joan.................. 236
Castillo, Alicia Leon del .......... 221
Castillo, Paola......... 114, 150, 182,
................................................... 215
Castillo-Martin, Mireia .... 183, 204
Castonguay, Mathieu...... 122, 134
Castro, Diana ........................... 208
Cataldi, Palmina ...................... 151
Catchpoole, Daniel.................. 154
Cates, Justin M ...... 121, 163, 168,
................................................... 175
Cathro, Helen .......................... 183
Cattoretti, Giorgio ................... 235
Cauchy, Francois ..................... 169
Cavalcanti, Marcela Santos... 122,
........................................... 203, 221
Cavallo, Allison B .................... 172
Cecchi, Fabiola ................ 213, 268
Cecchini, Lluis ................. 247, 248
Celeghin, Rudy ........................ 118
Celli, Romulo ................... 122, 123
Cenaj, Odise ............................ 203
Centeno, Barbara A ........ 202, 211
Centonze, Giovanni ................ 243
Cerda, Sandra ................. 143, 206
Cereceda, Laura ...................... 229
Cerhan, James R ..................... 165
Cerna, Iva................................. 145
Cerutti, Roberta ....................... 209
Cesari, Matthew ........ 71, 179, 181
Cesarman, Ethel ...................... 241
Cessna, Melissa ...................... 235
Cha, Eugene K ......... 126, 163, 204
Cha, Eun Jung ......................... 206
Chabot-Richards, Devon ........ 130
Chadburn, Amy ........... 23, 25, 228
Chadwick, Dianne ................... 161
Chae, Seoung Wan ................. 198
Chae, Yang Seok ............. 206, 221
Chai, Ming ............................... 252
Chajewski, Olga S ................... 239
Chakera, Aron ......................... 183
Chalabreysse, Philippe ........... 200
Challies, Tracy ......................... 132
Chalmers, Zachary ......... 186, 213,
........................... 249, 262, 267, 268
Chalouni, Cecile M .................. 190
Chambers, Setsuko K ............. 166
Chambon, Pierre ..................... 214
Chan, Alice NH ........................ 225
Chan, Anthony ........................ 105
Chan, Jackie .................... 247, 260
Chan, Joanna .......................... 180
Chan, John K-C. ...................... 100
Chan, May P ............ 192, 200, 242
Chan, Yiong-Huak ................... 201
Chandan, Vishal ...................... 185
Chandarlapaty, Sarat .............. 164
Chandramohan, Raghu ......... 180,
................................................... 197
Chang, Angela Y ..................... 172
Chang, Ann Margaret...Honors Tab
Chang, Anthony ......... 53, 72, 131,
................................................... 191
Chang, Bin ............................... 226
Chang, Chung-Che.................. 161
Chang, Connie Y ..................... 237

Chang, Hsien-Kun ................... 216
Chang, Hsim-Yee..................... 177
Chang, Kenneth .............. 113, 197
Chang, Kuang-Jung ........ 161, 270
Chang, Kung-Chao.................. 227
Chang, Martin C .............. 215, 226
Chang, Matthew T .................. 204
Chang, Mee Soo ..................... 229
Chang, Michael D.................... 121
Chang, Tylis Y ......................... 140
Chang, Yen-Chieh ................... 175
Chang, Yu-Sun ........................ 216
Changou, Chun A.................... 224
Channir, Hani I......................... 153
Chapman, Jennifer ........ 152, 165,
................................... 227, 228, 243
Chapuy, Bjoern................ 149, 165
Charabi, Birgitte W ................. 153
Charest, Karry ......................... 208
Charette, Lori................... 199, 237
Charlesworth, Cristine ............ 120
Charoenpitakchai, Mongkon .. 253
Charon-Barra, Celine .............. 168
Chastain, Elizabeth ................. 227
Chaterjee, Monica ........... 148, 261
Chau, Danielle B.............. 149, 225
Chaubey, Alka ......... 154, 161,185,
200, 212, 237, 256, 258, 264, 267,
........................................... 268, 270
Chaudhary, Shweta ........ 208, 240
Chaudhry, Rahman ................. 142
Chaudoir, Catherine ................ 210
Chaux, Alcides ........................ 223
Chavez, Luis .................... 235, 271
Che, James .............................. 241
Chebib, Ivan ............................ 237
Cheema, Zulfiqar .................... 195
Cheeney, Gregory ........... 169, 230
Chehab, Farid .......................... 156
Chen, Athena........................... 250
Chen, Beiyun ........................... 139
Chen, Benjamin J............ 155, 210
Chen, Carlitos .......................... 167
Chen, Chun-Liang ........... 139, 196
Chen, Congde.......................... 240
Chen, Derrick J ........................ 210
Chen, Dong.............................. 252
Chen, Eleanor .......................... 197
Chen, Guilan............................ 219
Chen, Guoli.............................. 125
Chen, Haiyan ........... 212, 219, 245
Chen, Hao ........................ 166, 219
Chen, Hoe Meng ..................... 251
Chen, Hsiang-Chun ................. 163
Chen, Hui ................ 111, 160, 216,
........................................... 217, 233
Chen, Jei .................................. 214
Chen, Jey-Hsin ........................ 245
Chen, Jie .................................. 211
Chen, Jie-Fu ............................ 246
Chen, Jun-song ....................... 179
Chen, Justin H ......................... 138
Chen, Ken ................................ 135
Chen, Lei .................................. 129
Chen, Lina................................ 231
Chen, Li-Rong.......................... 182

Chen, Min ................................ 134
Chen, Ning Neil ....................... 183
Chen, Peter .............................. 175
Chen, Pu .................. 128, 155, 208
Chen, Richard ......... 162, 212, 267,
................................................... 270
Chen, Shaoxiong .... 176, 197, 222
Chen, Shao-yong .................... 248
Chen, Shin-Cheh ..................... 216
Chen, Sonja ..................... 115, 213
Chen, Steven X ....................... 227
Chen, Taiying................... 247, 260
Chen, Weina .... 128, 129, 155, 208
Chen, Weiyi ............................. 208
Chen, Wen-Chung ................... 227
Chen, Wenqian ........................ 251
Chen, Wilson ........................... 125
Chen, Xiaowei ......................... 238
Chen, Xueyan .................. 154, 222
Chen, Yao-Tseng ..................... 158
Chen, Y-B ................................. 147
Chen, Yen-Ying ........................ 170
Chen, Yigu ....................... 140, 160
Chen, Yi-Hua ............................. 77
Chen, Ying ....................... 110, 211
Chen, Ying-Bei ....... 126, 136, 163,
................................... 176, 177, 204
Chen, Yongxin ......................... 122
Chen, Yuan Y ........................... 209
Chen, Yuan Yuan..................... 209
Chen, Yunn-Yi ........ 107, 116, 138,
................................... 142, 170, 226
Chen, Zhengming ........... 192, 201
Chen, Zi............ 130, 155, 209, 229
Chen, Zongming E ......... 185, 231,
........................................... 232, 245
Chenard, Marie-Pierre ... 164, 198,
................................................... 202
Cheng, Angela......... 149, 249, 250
Cheng, Donavan ..................... 180
Cheng, Esther .......... 141, 142, 152
Cheng, Jason .......................... 130
Cheng, Jinjun .......................... 133
Cheng, Ke ................................ 190
Cheng, Liang .......... 124, 136, 147,
... 175, 176, 177, 178, 197, 222, 224
Cheng, Lin ............................... 124
Cheng, Mingyu........................ 131
Cheng, Yufan ................... 179, 226
Cheng, Yu-Wei ........................ 120
Chennuri, Rohini ..................... 110
Cher, Michael L ....................... 148
Cheris, Sachica........................ 171
Cherniack, Andrew ................. 163
Chernock, Rebecca ........ 103, 120,
........................................... 153, 206
Cherry, Athena ........................ 228
Cherukuri, Durga P ................. 137
Chesser, Jason ........................ 169
Chetritt, Jerome .............. 164, 200
Chetty, Runjan ................... 74, 166
Cheung, Annie N..................... 225
Cheung, Grace ........................ 213
Cheung, Hoiwan H .................. 136
Chevez-Barrios, Patricia .... 56, 73,
................................................... 130
Cheville, John C ...... 134, 205, 246

Chevreau, Christine ................ 168
Chhieng, David C .................... 110
Chi, John H .............................. 186
Chi, Zhikai ................................ 176
Chia, Noel ................................ 127
Chia, Stephen KL ...................... 11
Chiang, Sarah........................ 2257
Chida, Koji ............................... 172
Chien, Hui-Ping ....................... 216
Chinea, Felix M ....................... 148
Chinnaiyan, Arul M ........ 109, 177,
................................... 223, 261, 262
Chiosea, Simion I ............... 24, 77,
............................ 127, 139,173, 207
Chioureas, Dimitrios ............... 165
Chirieac, Lucian........... 71, 94, 231
Chitale, Dhananjay A ...... 135,138,
........... 160, 164, 177, 180, 238, 249
Chiu, April................................ 155
Chiu, Charles ........................... 124
Chiu, Hak Fai ........................... 179
Chivukula, Mamatha............... 170
Chkheidze, Rati........................ 245
Chmielecki, Juliann ....... 159, 186,
........................... 194, 266, 267, 269
Cho, Eun Yoon......................... 237
Cho, Hyun Yee ......................... 206
Cho, Margaret ......... 122, 220, 245
Cho, Min-Sun .......................... 206
Cho, Nam-Yun ......................... 221
Cho, Yong Mee ................ 206, 240
Cho, Soo Youn ........ 113, 270, 237
Choe, Jin.................................. 208
Choe, Ji-Young ........................ 242
Choi, Chan ............................... 188
Choi, Da Hoon ......................... 235
Choi, David B........................... 132
Choi, Dong Ho ................. 184, 246
Choi, Eunice K ......................... 229
Choi, Euno ............................... 229
Choi, Gheeyoung .................... 206
Choi, Hyejeong............... 133, 193,
........................................... 211, 245
Choi, John ................................. 63
Choi, Joon H............................ 211
Choi, Kyung Un ............... 202, 220
Choi, Misun ..................... 211, 237
Choi, Seoung Ho ..................... 211
Choi, Sung-eun ............... 120, 135
Choi, Won-Tak ......................... 229
Choi, Woonyoung ........... 124, 163
Choi, Yeong Jin ....................... 206
Choi, Yoon-La .................. 114, 174
Choi, Yu-Deok.......................... 188
Choi-Kim, Lydia ....................... 117
Choo, Shoa-Nian..................... 201
Chopra, Pradeep ..................... 132
Chopra, Shefali ....................... 173
Chorzalska, Anna .................... 128
Choudhary, Ajuni .................... 233
Choung, Hae Yoon G .............. 254
Choung, Ho-Kyung ................. 242
Cho-Vega, Jeong Hee ............. 200
Chow, Chi-Wan ....................... 135
Chow, Christine ............... 117, 193
277
INDEX
Chow, Kin Long ....................... 225
Chowdhuri, Sinchita Roy ...... 119,
........................... 160, 167, 217, 233
Choy, Bonnie ................... 124, 146
Christensen, Brock C .............. 213
Christensen, Paul .................... 130
Christie, Alana ......................... 178
Christova, Rossitza ................. 247
Chrysostomou, Chrysostomos .....
................................................... 147
Chu, Andrew ........... 128, 155, 208
Chua, Jamie S ......................... 254
Chuang, I-Chieh ...................... 196
Chuang, Wen-Yu ..................... 216
Chung, Catherine ............ 168, 196
Chung, Doo Hyun ................... 158
Chung, Hyun Cheol................. 197
Chung, Jin-Haeng ................... 113
Chung, Leland WK .................. 246
Chung, Min Sung .................... 216
Chung, Stephen S ................... 252
Chung, Yumin ......... 184, 216, 246
Church, Deanna M ........ 162, 212,
........................................... 267, 270
Churchill, Hywyn..................... 129
Churg, Andrew .......................... 71
Chute, Deborah J .............. 27, 120
Cibas, Edmund ............... 167, 172,
........................................... 173, 217
Cicenia, Joseph C ................... 218
Cieply, Kathleen M .......... 129, 241
Cimic, Adela ............................ 246
Cimini, Beth ............................. 113
Cimino-Mathews, Ashley ........ 58,
........................... 116, 117, 140, 142
Cin, Paola Dal .. 136, 137, 202, 225
Ciomek, Natalie ....................... 245
Cipriani, Nicole A ........... 139, 172,
................................... 207, 231, 243
Clark, Ashlynne ....................... 241
Clark, Blaise ............................... 64
Clark, Jennifer L ...................... 150
Clark, Jonathan R............ 127, 151
Clark, Michael J....... 162, 212,267,
................................................... 270
Clark, Peter E ........... 124, 247, 248
Clarke, Loren E ................ 200, 257
Clarke, Michael........................ 233
Clarke, Richard R..................... 162
Clavero, Omar OC ........... 167, 223
Claxton, David ......................... 129
Clay, Michael ........................... 115
Clayman, Gary L ..................... 140
Clayton, Erica F ....................... 174
Clayton, Frederic ..................... 192
Clayton, Helen ......................... 111
Clemens, Mark W.................... 252
Clement-Kruzel, Stacia ........... 213
Cleven, Arjen HG .................... 155
Clevenger, James ................... 253
Click, Sarah.............................. 114
Cline-Kabba, Edith .................. 155
Clinton, Lani K ................. 150, 244
Cloe, Adam .............................. 118
Cloetingh, Daniel .................... 155
Close, Brett E ........................... 231
278
Clouston, Andrew ..................... 76

Clurman, Bruce ....................... 222
Cocchi, Stefania ...................... 236
Cochand-Priollet, Beatrix ....... 243
Cocker, Myra ........................... 235
Cocker, Rubina ........................ 224
Cockerell, Clay J...................... 200
Cocks, Margaret ...................... 223
Coffey, Amy ............................. 184
Coffey, Donna.................. 134, 135
Coffin, Cheryl M ...................... 160
Coffman, Brittany.................... 128
Cohen, Cynthia............... 117, 118,
... 119, 120, 127, 135, 143, 144, 254
Cohen, David ........................... 126
Cohen, Debbie L...................... 120
Cohen, Donald ........................ 152
Cohen, Eric .............................. 254
Cohen, Jarish .......... 189, 202, 254
Cohen, Mark L ......................... 132
Cohen, Michael B .................... 134
Cohen, Stephanie M ............... 171
Cohn, David E.......................... 126
Cohn, Ian S .............................. 192
Coindre, Jean-Michel ....... 60, 168
Coker, Ahmet........................... 185
Colasse, lodie ........................ 168
Colby, Thomas V. ......... 39, 47, 98,
..................... Special Lectures Tab,
......................................Honors Tab
Cole, Bonnie ............................ 233
Coleman, Jonathan A ............. 204
Coleman, Joshua .................... 213
Colgan, Terence ...................... 226
Collingwood, Robin ................ 205
Collins, Brian T ................ 118, 119
Collins, Jennifer A ......... 111, 118,
................................................... 144
Collins, Judy............................ 121
Collins, Katrina ........................ 115
Collins, Laura C. ..... 23, 25, 26, 27,
........................................ 39, 42,105
Collins, Robert......................... 128
Collinsworth, Amy .................. 121
Colvin, Robert B ...................... 131
Comanescu, Maria .................. 171
Comperat, Eva................. 136, 177
Compton, Frances........... 138, 199
Compton, Margaret ........ 115, 195
Conces, Miriam ....................... 133
Condello, Vincenzo ................. 242
Condom-Mundo, Enric ........... 177
Conlon, Kevin C ...................... 220
Conner, James ........................ 166
Conners, Amy L .............. 198, 215
Conrad, Rachel ........................ 241
Contos, Melissa J.................... 195
Contra, Jessie.......................... 233
Contreras, Alejandro ...... 189, 270
Conwell, Darwin L................... 113
Coogan, Alice .......................... 144
Cook, James R ... 70, 77, 116, 156,
................................... 164, 209, 229
Cooke, Robin ....................... 35, 62
Cooney, Anthony ............ 162, 250
Cooper, Kumarasen ......... 74, 112,
........................... 127, 149, 233, 236
Cooper, Lauren........................ 180

Cooperberg, Matthew R ......... 109
Cope, Leslie ............................. 170
Copeland, William C ............... 161
Coppa, Joregelina................... 243
Coppola, Domenico ....... 202, 211,
................................................... 220
Corben, Adriana D .................. 117
Corbman, Melanie .................. 115
Cordeiro, Ana .......................... 158
Cordero, Anibal ....................... 217
Cordon-Cardo, Carlos ..... 183, 204
Corless, Christopher ................. 59
Cornejo, Kristine M ........ 176, 199,
........................................... 204, 242
Cornell, Lynn D ......... 72, 131, 184
Corney, David .......................... 213
Cornic, Marie ........................... 168
Cornish, Toby C ............... 165, 191
Corpus, George ....................... 161
Corrado, Andrea ..................... 172
Correa, Arlene M..................... 244
Correa, Hernan ........................ 163
Correa, Nathalie QPC.............. 135
Corrigan, Mark ................ 141, 199
Cortes, Andrea ................ 113, 199
Cortes, Jorge ........................... 130
Corvera, Carlos U.................... 212
Cosar, Ediz F .... 176, 199, 204, 210
Cosimi, A Benedict ................. 131
Cosio, Fernando G .................. 131
Coss, Dylan.............................. 132
Cossa, Mara............................. 231
Costa, Helio A.................. 133, 211
Costa, Larissa BE .................... 146
Costes, Valerie......................... 152
Costigan, Danielle ... 139, 181, 220
Costinean, Stefan........... 122, 165,
........................................... 176, 208
Cote, Gilbert ............................ 140
Cote, Michele L ....................... 141
Cotelingam, James ................. 210
Cotiis, Daniel De...................... 180
Cottrell, Catherine E....... 113, 140,
........................................... 183, 185
Couce, Marta ........................... 132
Coughlin, Geoff ....................... 147
Couloigner, Vincent ................ 215
Couture, Christian ................... 118
Covinsky, Michael ........... 138, 199
Cowan, Morgan .............. 163, 204
Cox, Jesse L ............................ 124
Cox, Roni M ..................... 124, 222
Cracchiolo, Jennifer................ 128
Craig, Ryan .............................. 128
Cramer, Harvey M ..... 22, 162, 218
Crane, Genevieve M ....... 129, 209
Crapanzano, John P................ 218
Crawford, James M ................ 140
Crawford, Susan E .................. 122
Creighton, Chad .............. 135, 163
Crespo, Mateus ............... 246, 247
Cristobal, Eva .......................... 179
Croce, Carlo ............. 122, 176, 208
Croce, Sabrina......................... 251
Crook, Shannon .............. 116, 117
Crowe, Deborah O .................. 254

Crowley, Jacob P ............ 180, 263
Cruise, Michael ....... 112, 169, 230
Crukley, Cathie ........................ 235
Crum, Christopher P ...... 149, 166,
........................................... 181, 249
Crumley, Suzanne M .............. 119
Cruz, Ofelia .............................. 215
Cuatrecasas, Miriam ....... 234, 245
Cubilla, Antonio L ................... 223
Cuda, Jacqueline .................... 218
Cui, Fulan................................. 184
Cui, Isabelle ..................... 192, 201
Cui, Min ................................... 121
Cui, Wei ................................... 190
Cui, Xiaojiang .......................... 216
Cui, Xiaoyan ............................ 216
Cunha, Isabela W .... 136, 163, 204
Cunningham, Mark T .............. 190
Cunningham, Scott A ............. 210
Cupo, Marco ............................ 171
Curless, Kendra ............... 177, 197
Curran, Emily .......................... 130
Currie, Catherine ..................... 235
Curry, Jonathan L ......... 120, 192,
................................... 200, 201, 242
Curtis, Mark T .......................... 130
Cury, Jose ................................ 224
Cuzick, Jack ............................. 109
Cyrta, Joanna ................. 162, 195,
................................... 204, 224, 246
Czader, Magdalena ................. 193
Czapiewski, Piotr ..................... 188
Czerniak, Bogdan A ............... 124,
........................................... 163, 204
Czuchlewski, David ........ 102, 130,
........................................... 137, 164
D
Daaboul, MHD Fayez ..... 117, 126,
................................... 148, 239, 249
Daaboul, Mohammed F.......... 179
Dabbs, David .................. 117, 160,
................... 171, 198, 224, 238, 251
Daber, Robert .................. 133, 268
Dacey, Elizabeth ...................... 144
Dacic, Sanja .................. 22, 46, 71,
........................................... 121, 188
Dadhania, Vipulkumar .... 124, 163
Dahia, Patricia ......................... 173
Dai, Hongyan........................... 116
Daignault, Stephanie .............. 238
Dalbagni, Guido .............. 163, 204
DAlfonso, Timothy .......... 91, 141,
................................................... 142
Dalimier, Eugenie............ 234, 271
Dalland, Joanna .............. 116, 117
Dallimore, Nick........................ 111
Dallol, Ashraf........................... 203
Dalton, Leslie........................... 171
Dalvi, Siddhartha ........... 116, 138,
........................................... 188, 227
Damjanov, Ivan ............... 177, 236
Damjanov, Naveena ............... 131
Dancsok, Amanda R ............... 235
Daneshbod, Yahya .................. 252
INDEX
Dangott, Bryan J ..................... 145
Danialan, Richard...................... 79
Daniel, Tanisha ................ 122, 221
Daniels, Brianne H .......... 115, 241
Daniels, Gilbert ....................... 144
Daniels, Lauren ....... 167, 175, 211
Daniels, Molly ......................... 112
Dantey, Kossivi E .................... 196
DArcy, Tom ..................... 150, 250
Darkow, Grant Van Dyke ........ 186
Das, Kanishka .......................... 215
Das, Kasturi ............................. 147
Das, Ronnie ............................. 189
Dasaraju, Sandhya.................. 234
Dasarathy, Srinivasan............. 230
Dasari, Surendra ............ 131, 138,
........................................... 165, 172
Dastani, Zari ............................ 222
Datnow, Brian.......................... 170
Daum, Ondrej .......................... 177
Davanlou, Masoud.................. 252
Dave, Sandeep ........................ 193
Davenport, Robertson ............ 144
Davey, Diane D ........................ 219
Davicioni, Elai.......................... 146
Davick, Jonathan ............ 149, 242
David, Marjorie ....................... 114
David, Stephanie N ................. 247
Davidson, Ben ......................... 224
Davidson, Benedicte ............... 110
Davidson, Bennett .................. 235
Davies, David L ....................... 146
Davies, Michael A ................... 113
Davis, Drew G. .......................... 42
Davis, James ........................... 160
Davis, Jessica L .................. 42, 233
Davis, John W ......................... 147
Davis, Noa ....................... 241, 257
Dawidek, Theresa ................... 116
Dawson, Andrea ....................... 92
Dawson, Heather .... 111, 221, 245
Daya, Dean .............................. 151
Dazza, Marie ............................ 166
DCosta, Zenobia..................... 157
DCruz, Anil.............................. 207
De Peralta-Venturina, Mariza ........
........................................... 125, 176
De Sanjose, Silvia ........... 167, 223
De Ubago, Julianne Martinez .......
................................... 116, 112, 225
Deavers, Michael .................... 135
Decker, Paul A ......................... 191
Decouvelaere, Anne-Valerie... 168
Dee, Anne ........................ 247, 261
Deeken-Draisey, Audrey ......... 221
Deerlin, Vivianna M Van ......... 152
Deftereos, Georgios................ 143
Degnim, Amy .......... 109, 141, 216
DeGraff, David J...................... 125
Deininger, Michael .................. 128
DeJoseph, Maura.................... 225
DeJulio, Todd .................. 230, 243
Del Pino, Marta ....................... 150
Del Pozo, Maeva ..................... 193
Delacruz, Victor ............... 143, 240
Delahunt, Brett ....... 124, 136, 147,

................................................... 177
DeLaMonte, Suzanne ............. 214
Del-Castillo, Carlos Fernandez ......
................................................... 157
DeLellis, Ronald A..................... 29
DeLelys, Michelle E................. 159
Deley, Marie-Cecile Le ............ 194
Delgado, Salvadora ................ 234
DellAquila, Marie ................... 187
Dellen, Melissa Van ................ 195
Delongchamps, Nicolas Barry .. 234
Delsite, Robert......................... 216
Dema, Alis ............................... 171
Demaria, Sandra ..................... 238
Demetrick, Doug ..................... 168
Demicco, Elizabeth G..... 152, 196,
................................................... 197
Demichelis, Francesca .... 194, 246
Deng, April .............. 192, 199, 242
Deng, Fang-Ming ........... 147, 148,
................................... 173, 177, 215
Deng, Xiaobing ....................... 115
Denison, Lori ........................... 216
Deniz, Kemal ........................... 115
Dennis, Jake .................... 128, 155
Dennis, Katie ........................... 142
Deplechain, Claude ................. 200
Desai, Neil ....................... 163, 204
Desai, Parth ............................. 227
Desai, Sangeeta .............. 223, 239
Deshpande, Anita ................... 143
Deshpande, Vikram ....... 123, 127,
128, 155, 157, 166, 169, 174, 210,
212, 220, 226, 230, 237, 244, 246,
250, 256, 258, 259, 260, 262, 263,
........................... 264, 266, 267, 268
DeSloover, Daniel ........... 133, 268
Desouki, Mohamed M ... 150, 238,
........................................... 239, 249
Dettloff, Jennifer L .......... 152, 211
Detweiler, Claire J ................... 201
DeVilla, Vanessa ...................... 111
Devins, Kyle............................. 161
Devlin, Sean .................... 193, 252
Dewar, Rajan ................... 182, 233
Dey-Rao, Rama ....................... 113
Dhall, Deepti ............................ 185
Dhamne, Sagar ....................... 216
Dhanasekaran, Saravana M .... 177
Dhand, Abhay ......................... 183
Dhani, Neesha ................. 132, 166
Dhar, Manjima......................... 241
Dhillon, Jasreman........... 163, 223
Dhingra, Sadhna ..................... 131
Dhir, Rajiv .. 125, 205, 218, 224, 241
Diaconescu, Elena D ............... 121
Diamandis, Eleftherios P .. 178, 221
Diamond, Eli ............................ 129
Dias, Leonardo ........................ 187
Diaz, Lorena............................. 135
Diaz, Maria............................... 213
Diaz, Sherley ................... 162, 236
Diaz-Cano, Salvador.. 173, 178, 214
Diaz-Insua, Mireya .. 109, 147, 148
DiBardino, David ..................... 218
DiCarlo, Christina .................... 231
Dickerson, Jane....................... 233

Dickler, Maura ......................... 116
Dickson, Brendan C ................ 236
Diebold, Jacques .................... 209
Diez-Valle, Ricardo .................. 191
Diffalha, Sameer Al................. 202
Dighe, Manjiri K ...................... 143
DiGiuseppe, Joseph A ............ 130
Dillon, Deborah A ............. 80, 171
Dillon, Jessica L ...................... 198
DiMaio, Michael A .................. 144
DiMarco, Michelle ................... 124
Dimitrova, Nevenka ....... 130, 183,
................................................... 216
Din, Nasir Ud ................... 139, 168
Dina, Roberto .......................... 146
Ding, Qiang ..................... 125, 178
Ding, Qingqing ........ 116, 164, 218
Ding, Xiangdong ..... 110, 240, 251
Ding, Xianzhong ............ 134, 135,
................................... 212, 219, 245
Dinney, Colin ................... 124, 163
Dintzis, Suzanne.......... 57, 98, 141
Diolaiti, Morgan ...................... 113
Diolombi, Mairo L ..... 109, 147, 80
Dip, Nelson .............................. 248
Disho, Megan K......................... 72
Dislich, Bastian........................ 174
Dispenzieri, Angela ................. 172
DiStasio, Marcello M .............. 244
Dittman, David ........................ 211
Ditzel, Helena M .............. 166, 181
Divatia, Mukul ......................... 149
Djordjevic, Bojana.... 71, 107, 126,
................... 151, 179, 180, 205, 249
Do, Minh .................................. 199
Do, Sung-Im ............................ 198
Do, Trevor ................................ 132
Doberer, Daniel ....................... 114
Dobson, Richard ............. 178, 214
Dockter, Travis J ...... 164, 198, 215
Dodd, Leslie G ......................... 231
Dogan, Ahmet ... 95, 129,156, 162,
.. 165, 196, 209, 228, 251, 256, 264,
........................................... 265, 271
Dogan, Snjezana ............. 113, 152
Doganavsargil, Basak ............. 220
Doglioni, Claudio .................... 140
Dolan, Michelle M ................... 139
Dolatkhah, Shahaboddin........ 224
Dominoni, Francesca .............. 243
Donahue, John E .................... 132
Donaldson, Alana R ........ 116, 164
Donati, Davide......................... 236
Done, Susan J ......................... 213
Dong, Fei ................. 149, 188, 203
Dong, Jianli ............................. 184
Dong, Joanna .......................... 152
Dong, Kun................................ 229
Dong, Yan ................................ 215
Donovan, Michael J ................ 248
Donson, Andrew M................. 215
Dor, David Ben ........................ 142
Dorfman, David M .......... 197, 208
Dorreen, Alastair P.................. 122
Doss, Denaha J ....................... 155
Doucet, Laurent....................... 202

Douglas, Greg ......................... 151
Downes, Michelle ........... 109, 204
Downing, James ..................... 133
Downs-Kelly, Erinn ........ 116, 122,
................... 164, 197, 198, 201, 232
Doxtader, Erika E............. 111, 219
Doyle, Alexandra .................... 211
Doyle, Leona . 24, 26,107, 157, 197
Doyle, Maria M........................ 132
Doyle, Scott ............................. 207
Drage, Michael Gerald.............. 23
Dragnev, Konstantin H ........... 188
Drake, Charles .. 178, 205, 260, 262
Drakos, Elias ............................ 165
Dresser, Karen ................. 155, 210
Drogowski, Laura M ....... 182, 266
Druffel, Elizabeth M ................ 210
Dry, Sarah M ............. 24, 76, 115,
........................................... 197, 210
Du, Xiang ......... 165, 175, 179, 202
Du, Yunzhi ............................... 197
Duan, Xiuzhen ................. 212, 216
Duan, Xuejing ......................... 172
Duarte, Ernesto Martinez ....... 243
Dube, Valerie ................... 179, 181
Dubeau, Louis ......................... 180
Dubielecka, Patrycja M ........... 128
Dubovy, Sander .................. 56, 73
Duboy, Jon .............................. 190
Duc, Arnaud .................... 234, 271
Ducar, Matthew ....................... 173
Ducatman, Barbara ........... 73, 127
Dudley, Beth ............................ 192
Dudley, Jonathan .................... 119
Duffield, Amy S ....... 129, 204, 209
Duggan, Maire ........................ 251
Duke, Linnea............................ 222
Dumitriu, Bogdan ........... 193, 253
Dumur, Catherine I... 140, 186, 195
Dunatov, Ana........................... 177
Dunbar, Cynthia ...................... 253
Duncan, Sheila ........................ 113
Duncan, Virginia E .................. 227
Duncavage, Eric J .... 70, 104, 113,
................... 121, 140, 185, 209, 242
Dundas, Nicola ........................ 135
Dunlap, Jennifer ............. 114, 129
Dunn, Andrew LJ .................... 222
Dunn, Ian F .............................. 191
Dunn, Kenneth ........................ 235
Dunne, Richard F .................... 246
Dunseth, Craig ........ 115, 133, 211
Dunya, Gabriel ........................ 139
Duose, Dzifa Y ......................... 161
DuPont, Barbara R ......... 185, 200,
........................................... 257, 267
Durbin, Eric.............................. 134
Dureau, Zachary J.......... 117, 124,
........................................... 233, 234
Durham, Benjamin H ............. 129,
......................................Honors Tab
Durkin, Lisa M ......................... 156
Dursun, Nevra ......................... 157
Dussaq, Alex ........................... 190
Dutta, Anupurva...................... 186
279
INDEX
Dyatlov, Artem ........................
Dyhdalo, Kathryn S.................
Dyke, Alison L Van ..................
Dykoski, Richard .....................
Dzinic, Sijana H .......................
158
141
193
195
248
E
Eastwood, Daniel C......... 147, 247
Eberhart, Charles G ................ 185
Eble, John N ............... 22, 26, 124,
............................ 136, 177,178, 222
Echarri, Maria Eugenia ........... 218
Echeveste, Jose I ............ 191, 218
Eckel-Passow, Jeanette .......... 191
Ecobichon-Morris, Anne ........ 118
Edelweiss, Marcia .......... 110, 137,
................................... 138, 198, 216
Edgar, Mark A.......................... 115
Edmund, Liz............................. 109
Edwards, Joshua .................... 152
Edwards, Nancy ...................... 187
Edwards, William D ................ 118
Egele, Caroline ........................ 198
Egelhoff, Thomas T ................ 214
Egevad, Lars ...................... 48, 147
Eggener, Scott ......................... 146
Eguchi, Susumu ...................... 238
Eguchi, T .................................. 136
Ehrisman, Jessie A ................. 249
Eickhoff, Jens .......................... 129
Eigsti, Renee............................ 241
Einhorn, Lawrence H .............. 222
Eklund, Claire M .............. 119, 257
Ekmejian, Rafael ............. 127, 151
El-Achkar, Tarek....................... 235
Eladl, Ahmed E........................ 229
Eldersveld, Jordan M ............. 219
Elemento, Olivier ........... 162, 194,
........................... 195, 204, 213, 246
Elenitoba-Johnson, Kojo ........ 139
Elenitsas, Rosalie ............ 200, 257
Elez, Elena ............................... 221
El-Halaby, Amber A ................ 110
Elishaev, Esther ....................... 224
Elkin, Eric ................................. 112
Ellenburg, James L ................. 205
Ellenson, Lora H ...................... 251
Elliott, Robin M ....................... 125
Ellis, Carla ................................ 254
Ellis, Ian O..... 66,80, 109, 110, 138,
........................................... 216, 217
Ellison, David ............................ 78
El-Mofty, Samir K ............ 153, 206
Elmore, Joann ......................... 141
El-Rayes, Bassel ...... 166, 245, 259
Elsayed, Ahmed Ali ................ 229
Elshaikh, Mohamed A ............ 249
Elsheikh, Tarik M ....... 46, 108, 111
Elson, Paul ............................... 214
Eltoum, Isam ........................... 110
Elvin, Julia A ... 111, 116, 117,120,
121, 127, 151, 159, 163, 166, 186,
194, 198, 208, 213, 231, 246, 249,
256, 257, 258, 259, 260, 261, 262,
........... 263, 265, 266, 267, 268, 269
280
Ely, Scott .................................. 210

Elyamany, Ghaleb ................... 209
Emanuel, Patrick ............... 93, 241
Emens, Leisha ................. 117, 257
Emerling, Brooke .................... 213
Enderling, Heiko...................... 220
Endo, Itaru ............................... 193
Eng, Charis .............................. 251
Eng, George ............................ 230
Eng, Ken .................................. 194
Engelberg, Jesse A ................. 170
England, Jonathan.................. 174
Ennis, Darren........................... 179
Epari, Sridhar .......................... 186
Epstein, Jonathan I ........ 109, 125,
136, 140, 146, 147, 148, 163, 176,
........... 179, 180, 205, 223, 247, 249
Ercoli, Giulia ............................ 187
Erickson, Lori A ........ 77, 175, 176,
................................... 192, 201, 206
Erlich, Rachel................... 208, 265
Esebua, Magda ....................... 218
Eshleman, James R ........ 188, 247
Esmaeli, Bita.................... 187, 192
Esnakula, Ashwini K ....... 169, 216
Espinal, Paula .......................... 181
Esposito, Michael J................. 131
Essendrop, Robyn................... 232
Esserman, Laura J .................. 138
Esteller, Manel......................... 221
Esteve, Roser........................... 150
Estrada, Monica V ................... 198
Estrella, Jeannelyn S .............. 244
Eszlinger, Markus .................... 167
Etman, Ali ........................ 181, 182
Ettel, Mark ....................... 229, 230
Euscher, Elizabeth D .......... 71,112,
............................ 149,166, 180, 226
Evans, Andrew ............... 125, 148,
................................... 182, 261, 266
Everett, Rhonda ...................... 144
Eviston, Timothy J .......... 127, 151
Ewalt, Mark D .......................... 130
Ewanowich, Carol ................... 112
Ewaz, Abdulwahab ................. 145
Eze, Ogechukwu.............. 229, 230
Ezzat, Shereen ......................... 107
F
Fabbri, Alessandra .......... 113, 231
Faber, Erin ............................... 248
Factor, Rachel E.............. 115, 197,
................................... 198, 199, 232
Fadare, Oluwole ............. 142, 160,
........................................... 232, 249
Fajardo, Laura P ...................... 135
Falconer, Henrik ...................... 249
Falconieri, Giovanni....... 142, 151,
................................................... 241
Fallon, John T ................ 130, 136,
........... 158, 180, 183, 188, 197, 216
Faltas, Bishoy ......... 194, 195, 204,
................................................... 224
Falzarano, Sara ............... 124, 247
Fan, Cathy........................ 181, 250
Fan, Fang ......... 116, 117, 142, 144
Fan, Guang .............................. 129

Fan, Xuemo (Sean) ................. 217
Fan, Yao-Shan ................. 212, 228
Fanburg-Smith, JC.................. 201
Fang, Erica ............................... 129
Fang, Min................................. 178
Fang, Yisheng V .............. 238, 239
Fanucchi, Michael ........... 158, 188
Faquin, William C......... 27, 51, 68,
............. 111, 135,143,144, 152, 168
Farag, Rosemary ..................... 219
Farah, Nadine .................. 150, 250
Farahani, Navid ....................... 190
Faraj, Sheila............................. 146
Farchoukh, Lama .................... 111
Farell, James J ........................ 123
Faria, Andre M ........................ 173
Farmer, Peter ................... 181, 250
Farooq, Fahad ......................... 154
Farooq, Taliya .......................... 130
Farooqi, Midhat S ................... 133
Farooqui, Mohammed............ 252
Farris, Alton B ........... 24, 245, 254
Farshid, Gelareh................ 66, 164
Faruqi, Asma Z ........................ 181
Farver, Carol ............ 23, 83, 84, 91,
................................... 103, 114, 136
Fasani, Roberta ....................... 213
Fassina, Ambrogio.................. 146
Fata, Cynthia ........................... 121
Fatheree, Lisa A ...................... 153
Fathi, Amir T............................ 155
Fatima, Huma .......................... 138
Fatima, Nazneen ..... 110, 219, 240
Faulkner-Jones, Beverly E ..... 138,
........................................... 146, 183
Faust, Phyllis L ........................ 161
Favazza, Laura .. 135, 138, 177, 238
Faye-Petersen, Ona M. ........... 103
Fazeli, Roghayeh ..................... 134
Fazli, Ladan...................... 109, 248
Fazlollahi, Ladan ..................... 184
Feany, Mel ............................... 186
Feasel, Patrick C .............. 120, 192
Febbo, Phillip G....... 247, 260, 261
Fedda, Faysal A ....................... 222
Fedeli, Franco .......................... 232
Federman, Noah ..................... 197
Fedor, Helen .................... 109, 146
Fedorchak, Kyle....... 121, 127,151,
........................................... 258, 263
Fedoriw, Yuri ........................... 165
Feeley, Linda .... 141, 199, 200, 207
Feeney, Nora ........................... 188
Feilotter, Harriet ...................... 231
Feldman, Andrew L ... 77, 165, 252
Feldman, Michael ..................... 44
Feldman, Rebecca........... 214, 268
Feldmeyer, Laurence .............. 242
Feleppa, Ernest J .................... 234
Felgar, Ray E............................ 146
Felicella, Michelle ................... 235
Felisiak-Golabek, Anna ........... 188
Felix, Ana ................................. 251
Feller, John K .......................... 200
Fellman, Bryan ........................ 112
Fend, Falko .............................. 164

Feng, Felix Y ............................ 109
Feng, Tian ................................ 132
Feng, Zheng ............................ 179
Feng, Ziding .................... 109, 248
Fennelly, David........................ 111
Feratovic, Rusmir ............ 182, 190
Fereidouni, Farzad .......... 187, 234
Fernandes, Helen .... 121, 133,158,
........................................... 217, 231
Fernandes, Viviane T .............. 230
Fernandez, Carmen Gomez.... 243
Fernandez, Eva ........................ 234
Fernandez, Gerardo ................ 248
Fernandez, Hugo F .................. 154
Fernandez, Pedro L ............ 62, 234
Fernandez, Susan ............ 144, 167
Fernandez-Nestosa, Maria Jose ...
................................................... 223
Fernandez-Pol, Sebastian...... 137,
................................................... 233
Fernandez-Rodriguez, Juana .. 236
Ferrari, Stefano ............... 168, 236
Ferreira, Ana............................ 246
Ferreira, Joana ........................ 251
Ferreira, Marco................ 150, 161
Ferrell, Linda D. .................. 26, 28,
......................................Honors Tab
Ferrero, Stefano ...................... 187
Ferro, Paola ............................. 232
Ferrone, Cristina R .................. 157
Ferry, Judith A......... 128, 210, 244
Ferte, Charles .......................... 194
Fetique, Dominique ................ 198
Feuchtinger, Anette ................ 116
Ffrench, Brendan .................... 162
Fidai, Shiraz S ......................... 233
Fidan-Ozbilgin, Ozlem .... 119, 240
Fidler, Mary E .......................... 184
Fiel, M Isabel ..................... 52, 132
Fielden, Rachel ........................ 195
Fields, Kristina L...................... 227
Fields, Tina ...................... 179, 223
Figueiredo, Ines .............. 246, 247
Figueroa, Lydia E ............ 235, 271
Figueroa, Maria ....................... 154
Filipenko, Douglas .................. 182
Filippo, Maria Rosaria De ...... 110,
........................................... 151, 225
Filleron, Thomas ..................... 168
Finberg, Karin E ...................... 133
Findeis-Hosey, Jennifer .......... 246
Fine, Jeffrey L......... 182, 190, 265,
................................................... 266
Fine, Samson ............... 30,126,147
............................. 163,176,177, 204
Fineberg, Susan A .......... 116, 238
Fink, David ............................... 208
Finkelstein, Sydney D .... 162, 213,
........................................... 268, 271
Finley, Gene............................. 231
Fiocca, Roberto ....................... 140
Firan, Mihail ............................ 128
Firchau, Dennis J .................... 115
Firestone, Bryan ...... 121, 126, 246
Fiset, Pierre.............................. 158
INDEX
Fishbein, Gregory A................ 118
Fishbein, Lauren ..................... 120
Fisher, Cyril................................ 55
Fisher, Gabrielle ...................... 109
Fisher, Hugh ............................ 246
Fisher, Kevin E......................... 129
Fisher, Kurt ........................ 42, 131
Fisher, Pete .............................. 186
Fitzgibbons, Marissa A ........... 227
Fitzpatrick, Carrie A................. 194
Fives, Cassie .................... 141, 207
Flake, Darl D .................... 200, 257
Flamerich, Cristina .................. 235
Flanagan, Margaret ................ 195
Flannigan, Kathleen ................ 239
Flavin, Richard ........................ 162
Fleischmann, Achim ............... 206
Flejou, Jean-Francois ............. 245
Flejter, Wendy L .............. 224, 262
Fleming, Jason B ............ 202, 246
Fleming, Stewart............. 135, 136
Fletcher, Christopher ........ 22, 168,
.................... 178,196, 197, 207, 236
Fligner, Corinne......................... 50
Flood, Trevor A ....... 109, 147, 205
Florea, Alina Dulau ................. 253
Flotte, Thomas ........ 192, 201, 234
Flotte, William ......................... 234
Fogel, Bradley J ...................... 222
Fogo, Agnes B ................ 138, 183,
........................................... 253, 254
Foix, Maria Pane ..................... 177
Fokas, Emmanouil .................. 157
Folkerth, Rebecca D ................ 191
Folkins, Ann K ................. 180, 233
Folpe, Andrew L ............... 92, 101,
............................ 168, 189,196, 236
Font, Alba ................ 189, 247, 248
Fontaine, Daniel G .................. 171
Fontanilles, Maxime ............... 194
Font-Tello, Alba ............... 109, 206
Foo, Wai Chin .......... 176, 220, 244
Forcucci, Jessica ..................... 146
Ford, Sterling E ....................... 118
Foreman, Nicholas K .............. 215
Forest, Stefanie ....................... 159
Forgo, Erna .............................. 169
Formenti, Silvia C ................... 238
Fornander, Tommy ................. 138
Forsberg, Peter........................ 210
Forse, Catherine .............. 134, 221
Fortuna, Danielle............. 130, 245
Fortune, Kristin La ... 121, 1143, 62
Foss, Francine M ..................... 252
Foster, Richard S ..................... 222
Foucar, Kathryn ............... 130, 137
Foulkes, Will .............................. 64
Fournier, Keith......................... 220
Fowler, Larry J ........................ 152
Fox, Rosemary ........................ 111
Fox, Sharon E .......................... 183
Fraass, Benedick ..................... 216
Fraga, Emmanuele Conde
Da Silva..................................... 202
Fragoso, Maria CV .................. 173
Fraig, Mostafa M ............ 144, 218,

........................................... 227, 248
Frampton, Garrett .......... 159, 186,
........... 213, 249, 262, 266, 268, 269
Frampton, William .......... 167, 232
Frances, Albert ................ 189, 206
Franceschini, Maria Cristiana 232
Franchi, Alessandro ................ 236
Francoeur, Courtney A ........... 122
Frank, Igor ............................... 205
Frank, Ryan D .......................... 141
Frankel, Arthur E ..................... 128
Frankel, Wendy L ..... 22, 25, 28, 29
.............. 79, 113, 121, 122,176, 203
Franklin, Lindsey ..................... 180
Fraser, Michael ........................ 109
Frater, John L .................. 209, 228
Freed, Natalie S............... 252, 253
Freedman, Alexa ..... 144, 167, 211
Freedman, Paul ....................... 139
Freeman, Gordon J........ 149, 165,
........................................... 263, 264
Freire, Javier ................... 221, 242
Freitas, Leandro LL ................. 146
French, Christopher A ............ 167
Freud, Aharon ......................... 128
Freyre, Ashley S ...................... 233
Fridman, Rafael ....................... 126
Friedman, Kenneth ........ 176, 184,
........................................... 200, 221
Friedman, Paul ........................ 178
Fritcher, Emily G Barr ............. 186
Fritchie, Karen ..... 76, 91, 168, 192,
...................... 196, 197, 236, 237 91
Frizzell, Kimberly..................... 130
Frizzell, Norma ................ 112, 225
Fromm, Jonathan R ........ 154, 228
Frost, Marlene H ..... 109, 141, 216
Frydenlund, Noah ........... 192, 200
Fu, Kai ...................... 165, 208, 253
Fu, Li ........................................ 117
Fu, Liying ......................... 147, 254
Fuda, Franklin................. 128, 129,
........................................... 155, 208
Fuhrer, Kimberly A.................. 205
Fujikura, Kohei ................ 157, 184
Fujimoto, Junya ............. 157, 158,
........................................... 190, 231
Fujimoto, Masakazu................ 158
Fukatsu, Akitoshi..................... 248
Fukayama, Masashi ............... 174,
........................................... 184, 230
Fukunaga, Masaharu .............. 226
Fukuoka, Junya ....................... 133
Fulle, Gregory N........................ 26
Fullen, Douglas R .... 192, 200, 214
Fuller, Christine E. ..................... 42
Fuller, Gregory N. .. 26, 28, 43, 226
Fulton, Regan .......... 134, 198, 201
Fulzele, Sadanand................... 161
Fumado, Lluis................. 109, 189,
........................................... 247, 248
Fumagalli, Caterina................. 187
Furlan, Daniela ........................ 209
Furman, Richard R .................. 165
Furtado, Larissa V ........... 122, 231
Furth, Emma E ............... 122, 123,
........................................... 131, 132
Fusco, Nicola ........................... 187
Futreal, Andrew ........................ 19
G
Gaba, Arthur R ................ 235, 249
Gabrielson, Edward ................ 231
Gabril, Manal........... 177, 184, 248
Gadde, Ramya................ 136, 148,
................................... 176, 249, 251
Gage, Heather M ..................... 144
Gai, Luis ................................... 232
Gaillot, Alain............................ 200
Gainor, Justin F ............... 136, 268
Gajzer, David C ........................ 227
Gal, Anthony A.......................... 65
Gal, Tamas ............................... 134
Galateau-Salle, Francoise ...... 137
Gale, James............................. 128
Gales, Jordan M...................... 186
Galindo, Julie A .............. 235, 271
Gallagher, Michael F ....... 162, 181
Gallagher, Thomas ................... 57
Gallan, Alexander J ................ 131
Gallegos, Marlene................... 123
Galletta, Henry ........................ 190
Gallinger, Steven .................... 132
Gallo, Marco ............................ 140
Gallo, Mathieu......................... 152
Galmiche, Louise .................... 215
Galon, Jerome .......................... 86
Galsky, Matthew ..................... 204
Galvan, Jose A ................ 174, 245
Gamba, Piergiorgio ................ 253
Gambacorta, Francesca.......... 113
Gambarotti, Marco ......... 168, 236
Gamberi, Gabriella ................. 236
Gambier, Nicolas .................... 186
Gambin, Anna ......................... 163
Gamez, Roberto .............. 123, 131
Gan, Qiong .............................. 120
Ganapathi, Karthik A .....................
........................... 159, 193, 209, 234
Gandhi, Manoj ........................ 153
Gandhi, Nilay .......................... 205
Gandour-Edwards, Regina ..... 175
Ganesan, Raji .......................... 181
Ganly, Ian......................... 140, 152
Gao, Dongxia .......................... 117
Gao, Jing ................................. 174
Gao, Juehua ............................ 217
Gao, Kan .......................... 127, 151
Gao, Ling ................................. 120
Gao, Qi ..................................... 252
Gao, Sizhi P ............................. 163
Gao, Yan .................................. 117
Gao, Yuan ................................ 145
Gao, Zhibin .............................. 159
Gao, Zifen ................................ 228
Gao, Zu-Hua ............................ 229
Garapati, Manjula ................... 203
Garces, Jorge .......................... 254
Garces, Yolanda I .................... 159
Garcia, Angel................... 179, 236
Garcia, Benjamin A ......... 112, 236
Garcia, Elizabeth ..................... 136
Garcia, Fernando .................... 115
Garcia, Joaquin J .................... 151

Garcia, Julieta ......................... 158
Garcia, Monica ........................ 215
Garcia, Rochelle L ................... 141
Garcia-Berbel, Pilar ................. 221
Garcia-Buitrago, Monica ....... 143,
................................... 167, 201, 240
Garcia-Burillo, Amparo .......... 162
Garcia-Fernandez, Eugenia .... 127
Garcia-Grau, Iolanda .............. 247
Garcia-Moliner, Maria............. 149
Gardini, Giorgio ...................... 164
Gardner, Jerad ............ 30, 97, 114
Gardner, Timothy B................. 144
Garg, Karuna ............. 64, 166, 225
Gariepy, Gille........................... 218
Garon, Edward ........................ 241
Garrard, John ................ 24, 26, 30
Garratt, John ........................... 233
Garraway, Levi ........................ 246
Garrett-Mayer, Elizabeth ........ 250
Garza, Raquel .......................... 250
Gascoyne, Randy D ........ 227, 264
Gasim, Adil .............................. 254
Gasparinho, Gabriela ............. 150
Gasparini, Elisa ....................... 164
Gasparotto, Daniela ................ 196
Gatalica, Zoran ................ 214, 268
Gattuso, Paolo......... 116, 120, 180
Gauchotte, Guillaume ............ 186
Gaudioso, Carmelo ......... 238, 239
Gaut, Joseph ................... 131, 183
Gawelek, Kara ......................... 237
Gay, Laurie ...... 213, 249, 262, 268
Gayden, Tenzin........................ 236
Gayetsky, Vera......................... 167
Ge, Yimin ......................... 134, 240
Gedik, Reyhan ......................... 143
Geeze, Mary ............................ 253
Geiersbach, Katherine .... 197, 221
Gel, Bernat............................... 235
Geller, Rachel .................. 117, 124
Geller, Stephen A. ..................... 65
Gellert, Lan L .................. 124, 140,
................................... 163, 247, 248
Gendusa, Rossella .................. 235
Genega, Elizabeth ... 148, 160, 174
Genitsch, Vera ......................... 206
Gennaro, Lucas ....................... 117
Gentry, Michael ....................... 229
Geoghegan, Justin ................. 220
George, C. Tracy ..................... 102
George, Eva Vertes ................... 23
George, Michael...................... 141
George, Tracy I ......... 77, 128, 130,
................... 137, 153, 253, 264, 265
Georgescu, Rares.................... 171
Gera, Shweta................... 229, 230
Geradts, Joseph ...................... 171
Geraghty, Brian E .................... 231
Geraghty, Robert..................... 111
Gerds, Thomas A .................... 153
Germer, Jeffrey ....................... 169
Gerrin, Sean J ......................... 248
Gershenwald, Jeffery E ... 113, 200
281
INDEX
Gerszten, Enrique ..................... 62
Gertych, Arkadiusz.................. 125
Gessi, Marco ........................... 186
Getz, Gad ................................. 163
Geyer, Felipe C ............... 109, 110,
................... 137, 138, 171, 194, 225
Geyer, Julia T ... 130, 137, 165, 208
Ghaffarieh, Alireza .................. 222
Ghai, Ritu ................................. 116
Ghemrawi, Rose ..................... 186
Gheorghe, Gabriela ................ 128
Ghofrani, Mohiedean ............. 143
Ghosh, Arunima...... 204, 220, 222
Ghosh, Kankana .............. 153, 154
Ghossein, Ronald............. 45, 128,
........................................... 140, 153
Giacomelli, Luca ..................... 243
Gianduzzo, Troy ...................... 147
Giannico, Giovanna A ... 124, 163,
................................... 247, 248, 254
Giannini, Caterina ... 101, 186, 191
Gibson, Blake .......................... 160
Gibson, Briana R ..................... 205
Gibson, Joanna A ................... 203
Gibson, John ........................... 254
Gibson, Sarah E .............. 129, 253
Gidfar, Sanaz ........................... 229
Gil, Joan .................................. 248
Gil, Veronica ............................ 247
Gilani, Syed ..................... 189, 204
Gilberte, Agnes ....................... 145
Gilks, Blake .................. 28, 64, 102
112, 117, 126, 127, 129, 161, 181,
................................... 233, 249, 250
Gill, Anthony J ........ 175, 176, 221
Gill, Ginjeet GK ....................... 195
Gill, Ryan M ............. 132, 169, 229
Gillies, Elizabeth...................... 134
Gilmore, Hannah............ 141, 181,
........................................... 199, 237
Gilroy, Richard ........................ 184
Gimotty, Phyllis A ................... 154
Gindin, Tatyana ....................... 253
Ginter, Paula .................... 141, 158
Giordano, Mirella .................... 140
Giordano, Thomas .... 45, 105, 179
Giri, Dilip.......................... 216, 217
Givertz, Michael M .................. 118
Gjini, Evisa....................... 149, 165
Glass, Benjamin ...................... 110
Glass, Ryan.............................. 224
Glass, William F ...................... 184
Glasser, Daniel ................ 114, 141
Glassy, Eric F. ........................... 98,
...................... Special Lectures Tab
Glavaris, Stephanie ....... 109, 146,
................................................... 247
Glawe, John ............................ 210
Gleave, Martin E ..................... 109
Gleeson, Noreen ..... 162, 181, 250
Gleich, Gerald ......................... 192
Glisson, Bonnie ............... 188, 231
Glomski, Krzysztof .................. 140
Gnepp, Douglas R ................... 152
Go, Ann.................................... 246
Go, Derek E.............................. 241
Go, Heounjeong .............. 158, 240
282
Gobbi, Helenice....................... 244

Gocke, Christopher D ............ 129,
........................................... 188, 247
Godwin, Andrew K ................. 116
Goetz, Matthew ....... 164, 198, 215
Goez-Gutierrez, Elvia .............. 143
Goh, Gerald ............................. 252
Goh, Ronald ............................ 225
Gokden, Murat .......................... 43
Gokden, Neriman........... 123, 124,
........................................... 136, 222
Gokmen-Polar, Yesim ..... 198, 238
Golardi, Natalia ............... 129, 209
Gold, Kathryn A ...................... 188
Goldbach-Mansky, Raphaela ... 253
Goldberg, Allison .................... 180
Goldblum, John R........ 22, 25, 26,
27, 28, 29, 122, 123,196, 202,
........................... 219, 235, 241, 244
Goldhoff, Patricia ............... 26, 217
Goldman, Jonathan ................ 241
Goldsmith, Jeffrey ........... 72, 132,
........................................... 140, 234
Goldstein, David ..................... 187
Goldstein, Jeffery ........... 124, 247
Goldstein, Jennifer B .............. 202
Gologan, Olga ........................... 93
Gomez, Adam J ...................... 119
Gomez, Maria C ...................... 179
Gomez, Nerea ......................... 218
Gomez-Fernandez, Carmen .. 143,
................... 152, 167, 181, 216, 240
Gomez-Gelvez, Juan............... 251
Gomez-Roman, Javier ............ 221
Gomolcakova, Barbora........... 150
Goncalves, Lucilia ................... 150
Gondim, Dikson Dibe ............. 206
Gonen, Mithat ......................... 112
Gong, Jerald............................ 162
Gong, Shunyou ....... 164, 209, 253
Gong, Yun................ 168, 218, 219
Gonzalez, Anne K Koehne de ... 184
Gonzalez, Blanca ..................... 164
Gonzalez, Dimitri..................... 161
Gonzalez, Ivan R...................... 158
Gonzalez, Oscar ...................... 162
Gonzalez, Raul S ....... 30, 121, 174,
................................... 175, 221, 245
Gonzalez-Moran, M Asun....... 242
Gonzalez-Vela, Carmen .......... 242
Gonzalvo, Pablo ...................... 242
Gooding, William E................. 139
Goodlad, John R ............. 107, 164
Goodman, Abigail L............... 118,
.................................... 120, 124,135
Goodman, Michael ........ 144, 167,
................................... 175, 211, 245
Goodman, Steven ........... 134, 240
Gopal, Purva.... 169, 185, 202, 245
Gopal, Satish ........................... 165
Gopalan, Anuradha ....... 126, 147,
........................... 163, 176, 177, 204
Gordenin, Dmitry A ................ 163
Gordetsky, Jennifer B ............ 148,
........................................... 163, 205
Gordon, Stuart R ..................... 144
Gorin, Michael A ..................... 179
Gorman, Blythe ....................... 134
Goswami, Rashmi................... 137

Gotlib, Jason ........................... 253
Goto, Hiroaki ........................... 215
Goto, Keisuke .......................... 201
Gotoh, Momokazu ... 205, 241, 248
Gottlieb, Chelsea E ................. 116
Gounder, Mrinal M ................. 196
Gowan, Kyle .................... 151, 263
Gowen, Kyle .................... 175, 260
Gown, Allen M ........... 25, 66, 134,
........................................... 189, 198
Goyal, Bella ............................. 121
Goyal, Lipika............................ 169
Goyal, Rajen ............ 124, 177, 247
Goyne, Hannah E .................... 222
Goytain, Angela .............. 113, 197
Grada, Zakaria ........ 119, 124, 128,
........................................... 210, 222
Graf, Erin H .............................. 130
Graf, Nicole ............................. 168
Graham, Alexander ................ 162
Graham, Rondell ............ 121, 132,
........... 169, 184, 185, 201, 230, 250
Gramatges, Maria M............... 129
Granja, Sara ............................ 173
Granter, Scott ............................ 61
Gratzinger, Dita ....................... 102
Gravel, Denis ........................... 127
Gray, Arielle..................... 161, 200
Gray, Richard J........ 164, 198, 215
Green, Andrew ........ 138, 216, 217
Green, Anthony....................... 205
Green, Peter HR .............. 192, 253
Green, Whitney ............... 220, 222
Green-Church, Kari ................. 208
Greenbowe, Joel............................
........................... 166, 193, 263, 267
Greenfield, Jeffrey .................. 195
Greenland, Nancy ........... 113, 248
Greenwood, Michael .............. 133
Greer, Wenda .......................... 134
Greiner, Timothy C .......... 165, 253
Greipp, Patricia ....................... 169
Griewank, Klaus ...................... 186
Griffin, Gabriel K ..................... 165
Griffin, Marie R........................ 150
Griffith, Christopher C ... 110, 207,
................................................... 240
Griffiths, Annie ................... 39, 98,
...................... Special Lectures Tab
Grignon, David J ... 22, 25, 124, 136,
................................... 177, 178, 222
Grillo, Federica ........................ 140
Grimes, Margaret M. ................ 29
Grin, Andrea ............................ 221
Grizzle, William E .................... 205
Grody, Wayne W. ...................... 88
Grogan, Martha....................... 172
Grogan, Raymon..................... 172
Grogg, Karen L ........ 165, 239, 252
Grondin, Katherine ................. 112
Groppi, Diane .......................... 140
Grossman, Stuart.................... 185
Groth, John V .......................... 233
Gru, Alejandro................. 128, 242
Grubbs, Elizabeth G ................ 173
Gruber, Tanja ........................... 133

Gruenberg, Jessica ................. 142
Grushchak, Solomiya ..... 161, 200
Gu, Mi J ................................... 211
Gu, Xiaoping ........................... 238
Gu, Yan .................................... 211
Guajardo, Andrew .......... 115, 118
Guancial, Elizabeth ................. 206
Guarch, Rosa ........................... 179
Guardiola, Philippe ................. 191
Guarner, Jeannette ................... 50
Gubbins, Luke ......................... 181
Guda, Kishore ......................... 111
Gueant, Jean-Louis................. 186
Guedes, Liana B .............. 247, 248
Guellec, Sophie Le .................. 168
Guerini-Rocco, Elena ..... 109, 171,
................................................... 187
Guerra, Paula .......................... 150
Guerzon, Godfrey M ............... 135
Gui, Dorina ...................... 174, 175
Guileyardo, Joseph M ............ 115
Guillen, Francisco ................... 191
Guilmette, Julie....................... 135
Guimera, Nuria ....................... 223
Guinan, Mairead ..................... 160
Guindi, Maha............. 76, 132, 185
Guinee, Donald ......................... 47
Guirguis, John ........................ 230
Gulati, Rohit ............................ 251
Gulavita, Previn............... 136, 178
Gulbahce, H Evin .... 197, 198, 199
Guleria, Indira ......................... 186
Gulino, Sam P. ........................... 54
Gullo, Irene .............................. 245
Gultekin, Sakir H ..................... 214
Guner, Gunes ................. 109, 163,
................................... 185, 204, 247
Gunning, William T................. 131
Guo, Charles C ............... 124, 163,
........................................... 204, 223
Guo, Guangwu ........................ 163
Guo, Hua.......................... 128, 239
Guo, Huazhang ....................... 182
Guo, Ming................ 119, 218, 219
Guo, Ruifeng ........................... 192
Guo, Tao .................................. 170
Guo, Yunquan ......................... 224
Guo, Zhenying ........................ 121
Gupta, Rajib............................. 157
Gupta, Alia............... 120, 227, 228
Gupta, Gopal ........................... 178
Gupta, Mamta ......................... 166
Gupta, Meenakshi ................... 235
Gupta, Nilesh S .............. 109, 135,
... 136, 147, 148, 176, 177, 205, 224
Gupta, Raavi ............................ 183
Gupta, Rajib............................. 131
Gupta, Ruta ..................... 127, 151
Gupta, Sarika........................... 209
Gupta, Sounak ............... 176, 205,
........................................... 206, 214
Gupta, Sudeep ........................ 239
Gupta, Tejpal ........................... 186
Gur, Deniz ................................ 228
Guragain, Deepti Adhikari...... 149
INDEX
Gurav, Mamta ......................... 239
Gurbuxani, Sandeep............... 130
Gurda, Grzegorz T................... 198
Gurman, Jonathan.................. 182
Gurpide, Alfonso..................... 218
Gurudu, Suryakanth ............... 244
Gurung, Ananta ...................... 230
Guseva, Natalya ...................... 237
Gutierrez, Elvia Goez .............. 240
Gutierrez-Pecharroman, Ana ... 179
Gutmann, Edward........... 144, 213
Guy, Cynthia ....................... 76, 175
Guzman, Grace ............... 113, 123
Gyure, Kym ............................... 73
H
Ha, Sang Yun........................... 174
Ha, Jennifer P.......................... 219
Habermann, Thomas .............. 165
Habib, Fadi .............................. 238
Habib, Robert .......................... 139
Habr, Fadlallah ........................ 214
Habra, Mouhammed A ... 120, 124
Hacihasanoglu, Ezgi ...... 144, 156,
................... 157, 166, 167, 175, 211
Hadd, Andrew ....................... 153
Hadravsky, Ladislav................ 236
Haemmig, Stefan.................... 157
Hafez, Khaled.......................... 177
Hafezi-Bakhtiari, Sara............. 166
Hag, Mohamed El...........158, 173,
........................................... 219, 250
Haga, Hironori................. 158, 253
Hagen, Catherine.... 174, 220, 245
Hagiya, Ashley S..................... 181
Hahn, Jamie.................... 156, 252
Hahn, Noah M......................... 205
Haider, Irfanullah.................... 117
Haimes, Josh................... 225, 263
Haines, G K.............................. 152
Hajdu, Cristina H............. 229, 230
Hajifathalian, Kaveh................ 123
Hakam, Ardeshir..................... 166
Hakima, Laleh.......................... 217
Hakimi, A Ari........................... 177
Hakin, Sofia............................. 179
Hale, G..................................... 220
Hale, Gillian L.......................... 210
Hale, Tracy K........................... 124
Haley, Lisa............................... 188
Halimi, Caroline...................... 153
Hall, Allison............................. 249
Hall, Dimity.............................. 111
Hall, Michael............................ 249
Haller, Jasmine.........................114
Haller, Florian.......................... 225
Haller, Michaela J................... 207
Halling, Kevin C......................... 90
Halpenny, Darragh F............... 137
Halperin, Daniel M.................. 202
Halushka, Marc K.................... 118
Hamad, Eman.......................... 172
Hamamatsu, Akihiko.............. 172
Hamasaki, Makoto.......... 157, 232
Hameed, Meera....... 23, 162,197,

................................................... 237
Hameed, Omar. ........... 27, 57, 109,
... 124, 140, 160, 163, 170, 247, 248
Hamilton, Ronald.................... 191
Hamilton, Stanley R............ 51, 59
Hammer, Richard D. 234, 252, 253
Hammer, Suntrea............ 122, 174
Hammer, Suntrea TG................ 26
Hammerman, Peter........ 114, 136
Hammond, M. Elizabeth........... 51
Hammond, Robert.................. 235
Hampel, Heather............. 176, 203
Han, Guangming............................
.......................... 179, 181, 189, 198
Han, Misop.............................. 146
Han, Yiping W ......................... 192
Hang, Jen-Fan......... 186, 206, 239
Haninger, Diana M.................. 182
Hanley, Krisztina Z.. 144, 167, 211
Hanna, Nasser H..................... 222
Hanna, Wedad................. 189, 198
Hansel, Donna .............Honors Tab
Hanson, Joshua A................... 145
Hanson, Paul J ........................ 172
Hao, Suyang .................... 193, 210
Hao, Xueli ........................ 176, 204
Hara, Masatake ....................... 133
Harada, Shuko......... 142, 190, 198
Haraldsdottir, Sigurdis ........... 203
Harari, Saul E .................. 178, 222
Harbert, Tracey ........................ 110
Harbhajanka, Aparna .............. 116
Hardin, Heather A ........... 121, 243
Harding-Jackson, Nicholas ...........
........................................... 147, 237
Hardisson, David............. 127, 179
Hardwick, David F. .................... 29
Hardy, Robert W. ....................... 22
Harigopal, Malini ... 144, 167, 171,
........................................... 199, 237
Hariri, Lida P ....................... 47, 113
Harmany, Zachary T ....... 187, 234
Harmon, Michael A ................. 161
Harmon, Zach.......................... 249
Harms, Kelly L ......................... 214
Harms, Paul W ........ 192, 207, 214
Harnois, Denise ....................... 230
Harpaz, Noam ......... 101, 191, 245
Harrington, Alexandra .... 128, 210
Harrington, Kyle ...................... 138
Harris, Cynthia ........................ 211
Harris, Hobart W ..................... 212
Harris, Jason ................... 212, 267
Harris, Lyndsay ....................... 237
Harrison, Beth ................. 238, 250
Harrison, Grant ....................... 175
Harrison, Jenna....................... 154
Harruff, Richard C ................... 195
Harshyne, Larry....................... 130
Hart, Jesse ....................... 149, 232
Hart, John A. ................ 23, 25, 27,
.................... 52, 59, 79, 93,111, 185
Hart, Phil A .............................. 121
Hartley, Christopher....... 173, 174,

........... 214, 220, 237, 243, 245, 254
Hartman, Aaron ...................... 178
Hartman, Anne-Renee ............ 112
Hartman, Douglas J ....... 182, 190,
................................... 210, 265, 266
Hartmann, Arndt ..................... 225
Hartmann, Karin...................... 253
Hartzband, Pamela ... 103, 119, 234
Harutyunyan, Ashot................ 236
Harwalkar, Jyoti ...................... 214
Has, Phinnara .......................... 214
Hasanovic, Adnan ................... 226
Hasegawa, Kiyoshi ......... 184, 230
Hasegawa, Mizue .................... 159
Hashisako, Mikiko ................... 133
Haspel, Richard ......................... 81
Hassan, Anjum ........ 118, 209, 228
Hassan, Muhannad ................. 240
Hassan, Oudai ................. 148, 249
Hasserjian, Robert P . 24, 137, 155,
........................... 182, 264, 265, 266
Hasteh, Farnaz... 170, 232, 234, 240
Hatakeyama, Kinta .................. 142
Hatanaka, Yutaka ............ 211, 267
Hatch, Ellen ............................. 253
Hatem, Joseph ........................ 251
Hattori, Ryohei ........ 205, 241, 248
Hau, Andrew M ....................... 214
Haudenschild, Christian ... 212, 267
Hausen, Axel zur ..................... 155
Have, Cherry L......................... 204
Haverkos, Bradley ................... 128
Havrilesky, Laura J.................. 249
Hawkins, Doug ........................ 196
Hawley, Sarah J ...................... 109
Hayashi, Akimasa ........... 184, 230
Haydu, Lauren E...................... 113
Hayek, Kinda ........................... 239
Hayes, Malcolm M .................. 117
Hayes, Miriam ......................... 220
Haynes, Allan .......................... 248
He, Jian .................................... 217
He, Jianguo ............................. 172
He, Jie .............................. 208, 265
He, Jing.................................... 163
He, Hong-Lin ........................... 175
He, Mai..................................... 214
He, Rong .................................. 252
He, Xin ..................................... 165
Heagley, Dawn ........................ 110
Healey, John............................ 197
Heaphy, Christopher M .......... 156
Heayn, Michelle .............. 132, 190
Hecht, Jonathan H .......... 166, 226
Hecht, Jonathan L. .................... 24
Hechtman, Jaclyn .......... 112, 122,
........................................... 203, 212
Hedley, David .......................... 132
Heffron, Cynthia .............. 200, 207
Heher, Yael K ...... 97, 139, 140, 160
Heide, Richard S Vander ........ 183
Heider, Amer ........................... 144
Heimann, Alan ........................ 160
Heintzelman, Rebecca ............ 115
Heirich, Kyra ............................ 241
Helba, Brian ............................. 146

Helbig, Petra ............................ 212
Helenowski, Irene B ................ 116
Helgeland, Lars ....................... 157
Helle, Deborah ........................ 186
Heller, Debra S. ....................... 103
Helm, Klaus F .......................... 200
Helm, Samantha ..................... 162
Helman, Elena .. 162, 212, 267, 270
Hellmann, Matthew D............. 137
Hemamali, Samaratunga ....... 147
Hembrough , Todd .......... 213, 268
Hemmerich, Amanda ............. 175
Hemminger, Jessica ............... 138
Hempel, Nadine ...................... 250
Henderson, Ying C .......... 140, 173
Hendrickson, Shelby............... 170
Hennessey, James V....... 119, 234
Hennrick, Kenneth .................. 216
Henriksen, Jonathan C .......... 114,
........................................... 141, 233
Henriksen, Kammi J ....... 131, 191
Henzler, Christine .................... 142
Heo, Dae Seog ........................ 228
Herculiani, Amanda P ............. 146
Herman, James G ................... 202
Hernandez, Loren P Herrera... 205
Hernandez, Marier .................. 192
Hernandez, Mike ..................... 223
Hernandez, Monica ................. 182
Hernandez, Silvia ........... 109, 189,
................................... 206, 247, 248
Hernandez, Valeria .................. 145
Hernandez-Cruz, Blandina...... 224
Hernandez-Losa, Javier .......... 162
Hernandez-Prera, Juan C ....... 145,
........................................... 151, 152
Hernandez-Toriz, Narciso ....... 224
Herrera, Guillermo A ........ 55, 131,
........................................... 135, 138
Herrera, Hannah B .................. 173
Herrero, Laura ................. 234, 245
Hes, Ondej ................................. 74
Hes, Ondrej.............. 135, 136, 177
Heuer, Monica ......................... 145
Hewer, Ekkehard ..................... 234
Hexner, Elizabeth .................... 130
Hickey, Tyler ............................ 195
Hickman, Richard .................... 148
Hicks, David G... 110, 170, 171, 199
Hicks, Jessica .......... 185, 247, 248
Hicks, John ........................ 55, 189
Hida, Tomoyuki ............... 157, 232
Higgins, John P ....................... 233
Higgins, Sara ........................... 244
Hijazi, Nouf .............................. 228
Hill, Charles E .......................... 120
Hill, Dana A........................ 115,125
Hillen, Lisa ............................... 155
Hillen, Uwe .............................. 186
Hillier, Sharon ......................... 111
Hinoue, Toshinori.................... 163
Hinterbrandner, Magdalena ... 130
Hinton, Alice ............................ 183
Hipp, Jennifer.................. 110, 239
Hirabayashi, Kenichi ............... 193
283
INDEX
Hirano, Michio......................... 161
Hirano, Satoshi ....................... 211
Hirata, Masahiro ..................... 253
Hirokawa, Mitsuyoshi ............. 243
Hirose, Ryutaro ....................... 212
Hirose, Takanori ...................... 184
Hiroshima, Kenzo.................... 159
Hirsch, Michelle ........ 23, 101, 106,
........................... 136, 166, 178, 206
Hirschowitz, Lynn.................... 181
Hissong, Erika ................. 121, 246
Hlady, Ryan A .......................... 121
Ho, Alex ................................... 173
Ho, Caleb ................................. 237
Ho, Cheng-Ying ....................... 115
Ho, Cheryl ................................ 134
Ho, Donald M-T ....................... 186
Ho, Hao .................................... 246
Ho, Jonhan................ 182, 242,258,
........................................... 265, 266
Ho, Ye-Shih .............................. 248
Hoadley, Katherine A .............. 163
Hoang, Lien ............. 112, 126, 249
Hoang, Mai P ..................... 69, 192
Hobday, Timothy J.................. 166
Hoch, Benjamin....... 168, 185, 197
Hod, Syed A. ........................... 108
Hoda, Rana S...... 27, 94, 108, 168,
........................................... 217, 231
Hoda, Syed ...................... 141, 160
Hodara, Elisabeth.................... 246
Hodgin, Jeffrey ......................... 53
Hodgkinson, Kendra ....... 179, 180
Hodgson, Shirley .................... 176
Hodi, F Stephen ............. 149, 165,
........................................... 263, 264
Hodi, Zsolt ............................... 109
Hodjat, Parsa ................... 153, 154
Hodul, Pamela J ...................... 211
Hoehn, Daniela................ 159, 234
Hoepner, Sabine ..................... 130
Hoff, Kirsten E ......................... 161
Hoff, Ryan ........................ 158, 269
Hoffman, Ronald ..................... 182
Hoffmann, Jenny ............ 233, 252
Hofstetter, Wayne L ................ 244
Hogan, Kevin ................... 109, 144
Hogeboom, Adriana ............... 191
Hohenwalter, Mark ................. 182
Hojilla, Carlo ............................ 128
Holdhoff, Matthias .................. 185
Holland, Eric C......................... 186
Holland, Steven M .................. 193
Hollebecque, Antoine ............. 194
Holleran, Evan ......................... 173
Hollowell, Monica ................... 167
Holman, Carol ......................... 209
Holmes, Margaret P ................ 187
Holthoff, Emily ........ 124, 149, 222
Homayoun, Farrah .................. 178
Hom, Cliff......................... 235, 271
Hon, Jane D ............................. 215
Hong, Christine ....................... 159
Hong, Hong ............................. 133
Hong, Seung-Mo..................... 156
284
Hong, Soon Won............. 120, 135

Hoon, Puay Tan ......................... 66
Hooper, DCraig........................ 130
Hooper, Jody E ...102, 115, 121, 195
Hopkins, Benjamin.................. 213
Hoque, Mohamed ................... 205
Hora, Milan .............................. 177
Horbinski, Craig ................ 43, 191
Horn, Paul ................................ 187
Horn, Susanne ........................ 186
Horn, Thomas ......................... 242
Hornick, Jason L ...................... 23,
24, 49, 60, 76, 107, 114, 139, 165,
168, 170, 176, 173, 192, 196,
................................... 197, 211, 236
Horning, Lisa ........................... 140
Horowitz, Neil.......................... 149
Horst, Basil A........................... 203
Horst, David............................. 203
Horvai, Andrew E .... 115, 202, 251
Horvath, Bela........................... 230
Horwitz, Steven M .................. 251
Hoshi, Masato ......................... 131
Hoskin, Tanya L ............... 109, 216
Hosking, Paul .................. 128, 210
Hossain, Maheen .................... 250
Hosseini, M.............................. 220
Hosseini, Mojgan .................... 234
Hossler, Carrie ......................... 250
Hotchandani, Nihar................. 168
Hoti, Emir................................. 220
Hou, Yanjun ............. 164, 170, 240
Hou, Yingyong ........................ 114
Houghton, Donald C ............... 191
Hourseau, Muriel .................... 153
Houser, Kenneth R .................. 250
Houser, Patricia M................... 239
Houser, Steven R .................... 118
Hovelson, Daniel H ......... 207, 214
Howe, James R ....................... 140
Howe, Philip H......................... 214
Howell, Lydia P. ......................... 26
Howitt, Brooke E .... 112, 149, 151,
................... 166, 173, 181, 206, 224
Howlett, Christopher .............. 177
Hoyle, Aoisha .......................... 179
Hoyle, Eric ............................... 154
Hoyt, Clifford C....... 189, 190, 270,
................................................... 271
Hrebinko, Ronald L ................. 218
Hristov, Alexandra .................. 192
Hruban, Ralph H................ 59, 156,
................................... 192, 193, 267
Hsi, Andy C .............................. 242
Hsi, Eric D .................. 63, 104, 105,
................... 130, 137, 156, 209, 229
Hsiao, Susan J ........................ 203
Hsieh, Eugene ......................... 179
Hsu, Amy P .............................. 193
Hsu, Chih-Yi ............. 170, 186, 239
Hsu, Peihong ........................... 128
Hsueh, Chuen .......................... 216
Hu, Buqu .................................. 122
Hu, Shaomin ........................... 141
Hu, Shimin...... 130, 137, 155, 165,
........... 209, 210, 227, 228, 229, 251
Hu, Wenhuo ............................ 193
Hu, Yan .................................... 207

Hu, Zhihong..................... 209, 251
Huang, A .................................. 220
Huang, Dan...................... 165, 202
Huang, Gang ........................... 254
Huang, He ................................ 124
Huang, Hsien-Neng ................ 224
Huang, Hsuan-Ying ........ 185, 196,
............................................ 224,236
Huang, Liang ........................... 212
Huang, Qin .............................. 251
Huang, Shian........................... 172
Huang, Shih-Chiang 114, 127, 168
Huang, Weei-Yuan .................. 123
Huang, Weei-Yuarn ......... 122, 134
Huang, Wei .............................. 121
Huang, Weihua ...... 130, 136, 180,
........................................... 183, 197
Huang, Xin............................... 165
Huck, Amelia ........................... 159
Hudis, Clifford ......................... 116
Hudson, Chad.................. 209, 227
Huebner, Thomas ................... 201
Huggins-Puhalla, Shannon ..........
........................................... 238, 257
Hughes, Ian ............................. 178
Huguenin, Anne-Laure ........... 130
Huh, Gi Young ................. 202, 220
Huh, Jooryung ........................ 206
Huh, Yang O ............................ 165
Huho, Albert ............................ 129
Hui, Ling .................................. 197
Hui, Pei............................. 222, 225
Hui, Yiang ............... 121, 125, 126,
................................... 149, 210, 213
Humayun, Irshad .................... 141
Hummelen, Paul Van .............. 191
Humphrey, Peter A ....... 48, 49, 95,
................................... 147, 178, 222
Humphreys, Elizabeth ............ 146
Hung, Yin ................. 187, 218, 236
Hunninghake, Gary M .... 187, 268
Hunt, Bryan ..................... 173, 243
Hunt, Jennifer ............. 46, 97, 100
Hunt, Kelly K.... 138, 164, 217, 252
Hunter, Robert L ...... 117, 129, 211
Huntsman, David G ....... 112, 126,
........................................... 249, 250
Huo, Lei............................ 116, 171
Hurtado-Coll, Antonio ............ 109
Husain, Aliya N ........ 47, 159, 171,
........................................... 231, 232
Husain, Arjumand ................... 251
Husain, Sanam ........................ 134
Huse, Jason ............................... 78
Hussaini, Mohammad O....137, 154
Hussein, Shafinaz ................... 253
Hussey, George S ................... 214
Hussong, Jerry W ........... 159, 210
Huston, Hunter ........................ 138
Hutchens, Kelli A............. 161, 200
Hutchinson, Lloyd .......... 176, 199,
........................................... 204, 210
Huynh, Tiffany G ............. 136, 157
Hwang, Chung Su ........... 202, 220
Hwang, David .......... 158, 268, 217
Hwang, Michael ...................... 147
Hwang, Samuel....................... 195

Hwang, Sangheum ......... 113, 270
Hwang, Shen-An ..................... 211
Hwang, Soohyun ............ 113, 270
Hyer, J M ................................. 146
Hyjek, Elizabeth ....................... 128
Hyland, John ........................... 111
Hyrcza, Martin ................. 139, 152
I
Iacobuzio-Donahue, Christine... 212
Iafrate, Anthony .. 89, 118, 119, 257
Ibarra, Javier ........................... 179
Ibrahim, Ashley ....................... 143
Ibrahim, Gena ................. 177, 184
Ibrahim, Mohamad ................. 242
Ibrahimpasic, Tihana .............. 140
Ichihara, Shu ........................... 142
Ichino, Martina ........................ 253
Iczkowski, Kenneth A ..... 147, 163,
................................... 182, 206, 247
Ide, Hiroki ................................ 206
Idoate, Miguel A.............. 191, 218
Idowu, Michael O ............ 140, 234
Idrees, Mohammed ...105, 178, 222
Idrovo, Juan P ......................... 239
Ieremia, Eleni .......................... 241
Iezzoni, Julia C. ................... 22, 28
Iglesias, Alejandra .......... 161, 213
Iglesias, Carmela..................... 162
IIyasova, Dora ........................ 238
Ijiri, Rieko ................................. 215
Ikegami, Masahiro .................. 248
Ikpatt, Offiong F .............. 227, 228
Illei, Peter B ..................... 188, 268
Imber, Michael J ..................... 120
Inagaki, Akiko .......................... 137
Inamdar, Kedar V .................... 251
Inamura, Kentaro .................... 231
Incharoen, Pimpin................... 188
Inderbitzin, Daniel ................... 111
Ingram, Davis .................. 196, 197
Inomoto, Chie.......................... 243
Inoue, Satoshi ......................... 206
Inoue, Tomohiro...................... 243
Inwards, Carrie Y ..... 160, 206, 237
Inzani, Frediano....................... 140
Ionescu, Diana N ............. 134, 269
Iorgulescu, Bryan .................... 186
Ioris, Rafael.............................. 225
Iossifov, Ivan ........................... 194
Ip, Philip ................................... 225
Iqbal, Jabed ............. 142, 216, 217
Irving, Julie A .......................... 126
Isaacs, John............................. 247
Isacson, Christina...................... 26
Isaila, Bogdan.......................... 134
Ishida, Hirotaka ....................... 243
Ishida, Ryo ............................... 248
Ishikawa, Nahoko.................... 201
Ishikawa, Noriyoshi ................ 201
Ishikawa, Yuichi ...... 158, 231, 237
Ishizaki, Tatsuro....................... 244
INDEX
Islam, Humayun ...................... 136
Islam, Shahidul ....................... 151
Ismail, Mamudo R................... 114
Ismail, Wesam ......................... 138
Ismiil, Nadia .................... 179, 181
Itami, Hiroe .............................. 142
Itani, Doha ............................... 168
Itani, Malak .............................. 143
Itano, Osamu ........................... 184
Ito, Masaaki ............................. 221
Ito, Noriko ................................ 142
Itoh, Tomoo ..................... 157, 184
Itzkowitz, Steven ..................... 101
Iuga, Alina ....................... 201, 244
Ivan, Doina .............. 192, 200, 242
Ivelja, Sinisa ............................ 203
Iwamoto, Sanju ....................... 253
Iwasaki, Akinori ....................... 157
Iwata, Hidehiro ........................ 241
Iyer, Gopa ................ 126, 163, 204
Iyer, Saipriya ........................... 217
Izawa, Jonathan ...................... 248
Izevbaye, Iyare ........................ 243
J
Jabado, Nada .......................... 236
Jabbour, Mark ......................... 217
Jaber, Omar............................. 237
Jackson, Christopher R .......... 218
Jackson, Cynthia ............. 124, 232
Jackson, Nicholas Harding .... 163
Jackson-Cook, Colleen ........... 195
Jacob, Reuben P ..................... 127
Jacobs, Timothy W. ................ 107
Jacobsohn, Kenneth ............... 182
Jacobson, Rebecca ......... 238, 239
Jacquemont, Celine ................ 134
Jaffe, Elaine S ............ 26, 164, 209
Jaffee, Elizabeth M ................. 174
Jaffer, Shabnam...... 110, 164, 170
Jagdale, Deepa .............. 154, 161,
................................... 200, 212, 237
Jain, Dhanpat ... 122, 123, 230, 245
Jain, Nitin ................................ 208
Jain, Richa ............................... 116
Jain, Sanjay ..................... 131, 183
Jain, Sarika .............................. 129
Jain, Shilpa.............................. 112
Jajoo, Kunal ............................ 175
Jakate, Kiran............................ 121
Jakubowski, Maureen A ......... 120
Jalali, Rakesh .......................... 186
Jamal, Mohsin ................ 109, 147
Jamal, Siraj El ......................... 227
Jamali, Faek ............................ 217
James, Aaron .......................... 197
Janaki, Nafiseh........................ 123
Janakiram, Murali ................... 238
Janco, Jo Marie ...................... 250
Jang, Erika L ............................ 172
Jang, Jin-Young ...................... 193
Jang, Kee-Taek ........ 157, 193, 211
Jang, Kiseok ............ 184, 216, 246
Jang, Mi ................................... 175

Jankowitz, Rachel ................... 198
Janne, Pasi A................... 188, 269
Janowczyk, Andrew........ 181, 199
Janssen, Emiel AM ................. 235
Jarboe, Elke ............................. 115
Jardin, Fabrice ................ 168, 194
Jaso, Jesse M.................. 129, 209
Javadi, Mehrbod S ................. 179
Javidiparsijani, Sara ............... 120
Javier, Breanna M ................... 212
Jawale, Rahul M ..................... 213
Jazaeri, Amir A........................ 180
Jean-Gilles, Jerome................ 204
Jedrzkiewicz, Jolanta...... 196, 220
Jeffrey, Stefanie S................... 241
Jeffreys, Matt .......................... 124
Jehi, Lara ................................. 186
Jelloul, Fatima-Zahra...... 128, 131
Jen, Kuang-Yu ................. 229, 253
Jencks, Amy ............................ 239
Jeney, Csaba ........................... 150
Jenkins, David ......................... 223
Jenkins, Robert B .................... 191
Jenkins, Sarah M ... 118, 127, 134,
........................... 159, 189, 191, 234
Jenkins, Stephen .................... 138
Jenkins, Taylor M .................... 122
Jennette, Charles J. .................. 72
Jennings, Timothy A .............. 151
Jensen, Kristin C ....... 24, 101, 109,
........................................... 164, 170
Jensen, Thom ......................... 235
Jensen, Tyler A ....... 118, 170, 235
Jentoft, Mark E ........................ 186
Jeon, Yoon Kyung... 158, 232, 228
Jeong, Se Un........................... 240
Jessup, Morgan ...................... 182
Jessurun, Jose ........ 158, 192, 220
Jesus, Adriana Almeida de .... 253
Jesus-Acosta, Ana De............. 202
Jeung, Jennifer ....................... 230
Jevremovic, Dragan ............... 252
Jewett, Michael ....................... 178
Jhala, Nirag ............. 168, 171, 172
Jhavar, Sameer ....................... 208
Ji, Yuan ............................ 155, 229
Jia, Liwei.......................... 125, 132
Jiang, Hui ................................ 223
Jiang, Xiangnan ...................... 227
Jiang, Xiaoyin Sara .............. 30
Jiang, Yi ........................... 179, 226
Jiang, Yuying .......................... 119
Jiang, Zhong ........................... 176
Jimenez, Jose ......................... 213
Jimenez, Rafael E.... 134, 205, 246
Jin, Gang ................................. 211
Jin, Ming.......................... 123, 167
Jin, Mulan................................ 226
Jin, Yasuto ............................... 158
Jing, Jian ................................. 152
Jing, Xin .......................... 119, 144
Jo, Vickie Y .. 77,143, 167, 207, 236
Jobe, Blair A ............................ 231
Jochumsen, Kirsten M ........... 166
Joehlin-Price, Amy S ...... 126, 238

Johannsen, Shulammite ........ 147
Johkoh, Takeshi ...................... 133
John, Ivy .................................. 236
Johncilla, Melanie................... 173
Johns, Cameila ....................... 184
Johnson, Adrienne ........ 159, 198,
........................................... 257, 269
Johnson, Arthur ...................... 142
Johnson, Bruce E ............ 114, 269
Johnson, Charnell................... 160
Johnson, Cory ......................... 253
Johnson, Daniel N .......... 172, 243
Johnson, Geoffrey B....... 159, 269
Johnson, Howard ................... 160
Johnson, Kevin C .................... 213
Johnson, Michael H ................ 146
Johnson, Rebecca L................ 146
Johnson, Timothy M .............. 214
Johnston, Abbey..................... 151
Jolly, Grant .............................. 132
Jones, Andrea ................. 184, 185
Jones, D ................................... 159
Jones, Dan................... 89, 95, 208
Jones, Daniel........................... 213
Jones, David M ....... 120, 121, 221
Jones, Katie N ................. 198, 215
Jones, Kirk ............................... 167
Jones, Martin .......................... 119
Jones, Mildred ........................ 238
Jones, Mirka W ....................... 251
Jones, Ryan ............................. 111
Jones, Tara .............................. 210
Jones, Terrell ........................... 253
Jonsdottir, Kristin ................... 235
Jorda, Merce .................. 120, 143,
................... 147, 148, 163, 167, 240
Jordan, Emmet J ............ 126, 163
Jordan, Sheryl......................... 115
Jordan, Suzanne ..................... 149
Jordao, Dercio......................... 114
Jorgensen, Jeffrey L ............... 208
Jorns, Julie .............. 115, 163, 238
Joseph, Nancy ............... 115, 116,
........... 124, 142, 166, 167, 225, 226
Joshi, Amit .............................. 223
Joshua, Anthony..... 172, 190, 191
Josselin, Nicolas ..................... 200
Jou, Cristina ............................ 215
Joubert, Philippe..................... 118
Jour, George ........... 196, 197, 237
Jour, Kimberly S Point du ...... 117
Ju, Jennifer ............................. 132
Juanpere, Nuria ............. 109, 135,
........................... 189, 206, 247, 248
Judd, Andrew.......................... 239
Julian, Jeffrey ......................... 132
Jun, Dae Won .......................... 184
Jun, Ding ................................. 176
Jun, Sun-Young ...................... 156
Jung, Soo Jin .......................... 206
Jungbluth, Achim ........... 156, 228
Juric-Sekhar, Gordana............ 186
Juskevicius, Ridas................... 228
Juskewitch, Justin .................. 190
K
Kaag, Matthew G .................... 125
Kaczmarowski, Amy ............... 182
Kada, Akiko.............................. 142
Kadi, Wendy ............................ 134
Kadokura, Alexander .............. 192
Kadota, K ................................. 136
Kadri, Sabah ............................ 122
Kaffenberger, Benjamin ......... 242
Kahl, Brad ................................ 129
Kajdacsy-Balla, Andre ........... 123,
........................................... 199, 224
Kajiwara, Hiroshi..................... 243
Kakar, S ............................ 203, 220
Kakar, Sanjay.............. 49, 52, 102,
........................... 111, 169, 202, 230
Kakar, Sham S ......................... 207
Kalari, Krishna R ..... 164, 198, 215
Kalariya, Jigna ........................ 176
Kalhor, Neda................... 137, 157,
................................... 158, 188, 231
Kalife, Elizabeth............... 110, 126
Kalimuthu, Sangeetha N ........ 166
Kalir, Tamara L ........................ 110
Kallakury, Bhaskar VS..... 126, 138
Kallen, Michael E .................... 193
Kalloger, Steve ................ 123, 193
Kalusova, Kristyna .................. 177
Kamal, Mohammed ................ 126
Kamat, Ashish ......................... 163
Kambham, Neeraja ................. 233
Kamel-Reid, Suzanne ............. 128
Kaminski, Mark ....................... 159
Kaminsky, David B. ...... 22, 23, 24,
....................... 25, 26, 27, 28, 29, 34
Kaminsky, Ethan ....................... 30
Kamiza, Steve.......................... 165
Kampani, Coxcilly ................... 165
Kamran, Waseem ................... 250
Kanaan, Yasmine .................... 216
Kanagal-Shamana, Rashmi...........
...................................... .....153, 154
Kanagasabapathy, D Anand Rajan
................................................... 206
Kanber, Yonca ......................... 240
Kanda, Hiroaki ......................... 237
Kandukuri, Shivani ......... 119, 167
Kane, Shubhada...................... 207
Kane, Yehonatan ..................... 215
Kang, Gyeong Hoon ............... 221
Kang, Ningling ........................ 122
Kang, So Young ...................... 185
Kang, Yuna .............................. 227
Kannangai, Rajesh .................. 201
Kanno, Atsushi ........................ 156
Kansal, Rina............................. 129
Kantarjian, Hagop ................... 130
Kantekure, Kanchan................ 123
Kantoff, Philip W ..................... 109
Kao, Ken .................................. 232
Kao, Yu-Chien.......................... 168
Kaplan, Edwin L ...................... 172
Kapp, Meghan ......................... 254
Kapur, Payal ............................ 178
Kapus, Andras ......................... 178
285
INDEX
Kapusta, Linda R ..................... 161
Karabakhtsian, Rouzan G ....... 217,
........................................... 238, 239
Karagiannis, George S ........... 221
Karam, Jose A ......................... 135
Karamchandani, Dipti M ........ 232
Karamitopoulou, Eva .............. 157
Karandikar, Nitin ..................... 209
Karasinska, Joanna................. 193
Karbelashvili, Mirian....... 162, 270
Karia, Sushil ............................ 176
Karlon, William ....................... 111
Karnes, R Jeffrey..................... 205
Karnezis, Anthony........... 126, 149
Karumanchi, Ananth............... 226
Kasai, Kazunari........................ 243
Kasajima, Atsuko .................... 243
Kashgarian, Michael ............... 131
Kashikar, Nilesh D ................... 201
Kashiwagi, Eiji ......................... 206
Kaspirkova, Jana..................... 150
Kassouf, Wassim..................... 205
Katabi, Nora ............ 128, 152, 153
Kataoka, Tatsuki R ................... 253
Kate, Fiebo J ten ..................... 191
Katerji, Hani ..................... 209, 222
Kates, Max ............................... 205
Kato, Masashi.................. 205, 248
Kato, Seiichi ............................ 229
Katoh, Ryohei .......................... 243
Katz, Matthew H .............. 202, 246
Katzenberg, Jennifer .............. 125
Kauffman, Lauren R ................ 208
Kaufman, Elizabeth ................. 246
Kaul, Karen ................................ 88
Kaushal, Rajiv.......................... 207
Kawa, Shigeyuki ..................... 156
Kawabata, Ayako .................... 225
Kawahara, Kunimitsu ............. 232
Kawahara, Takashi .................. 206
Kawahara, William.................. 145
Kawai, Tatsuo .......................... 131
Kawasaki, Tomonori ............... 142
Kazakov, Dmitry ........................ 61
Kazemimood, Rossana ........... 203
Ke, Zunfu ................................. 246
Keam, Bhumsuk ...................... 232
Keaney, Debra ......................... 189
Kearney, Padraig ..................... 150
Keefe, Daniel T ................ 109, 147
Keegan, Helen ................. 139, 150
Keeney, Gary L ........ 139, 150, 160
Keeney, Michael ...................... 150
Kehr, Elizabeth ........................ 249
Keibler, Mark A........................ 128
Keller, Charles ......................... 214
Kelley, Alyssa .......................... 165
Kelley, Todd W ................ 130, 137
Kellough, David....................... 208
Kelly, Alyssa ............................ 149
Kelly, Brian ...................... 141, 182
Kelly, Karen ............................... 74
Kelly, Kevin .............................. 162
Kelly, Lori A ............................. 231
Kelly, Lynne ............................. 150
286
Kelly, Melissa .......................... 146

Kelly, Paul ........................ 166, 211
Kelly, Ronan ............................ 165
Kelly, Thomas J....................... 149
Kelting, Sarah M ..................... 180
Kendall, Monica L ................... 160
Kennedy, Erin .......................... 221
Kennedy, Susan .............. 139, 187
Kennelly, Rory ......................... 111
Kensler, Kevin ......................... 110
Keohane, Catherine ................ 195
Kernag, Casey .. 161, 269, 270, 271
Kerr, Darcy A ................... 237, 243
Kerr, Keith M. ............................ 47
Kerr, Sarah E ... 127, 160, 219, 250
Kesterson, Joshua P ....... 167, 250
Ketcham, Catherine .................. 22
Ketwaroo, Gyanprakash ......... 191
Kevil, Chris .............................. 210
Keyashian, Kian ...................... 121
Keyoumarsi, Farah.................. 227
Kezlarian, Brie ......... 138, 224, 238
Khachaturov, Vadim 196, 235, 241
Khaira, Depinder ............. 117, 256
Khalifa, Mahmoud ......... 158, 179,
................................... 181, 233, 250
Khalifeh, Ibrahim ............ 139, 208
Khalighi, Mazdak..................... 138
Khalil, Farah ............................ 223
Khalil, Kamal ........................... 172
Khalili, Hamed ......................... 201
Khan, Adnan............................ 201
Khan, Ali .................................. 235
Khan, Faisal ............................. 248
Khan, Farhan ........................... 216
Khanafshar, Elham... 140, 173, 217
Khang, Shin K. .......................... 35
Khani, Francesca ........... 147, 160,
........................... 161, 180, 204, 246
Khanlari, Mahsa ...................... 216
Khanna, Abha.......................... 119
Khararjian, Armen .......... 231, 233
Khatri, Sameer ........................ 200
Khattar, Pallavi ........ 130, 180, 197
Khaw, Yi Ling .................. 111, 233
Khella, Heba WZ ..................... 125
Khoor, Andras ........................... 71
Khoury, Joseph D .......... 130, 154,
................................... 218, 227, 252
Khoury, Thaer... 164, 171, 238, 239
Khurana, Kamal K ... 110, 119, 218
Khurram, Nigar ....................... 219
Kiehl, Rasmus ......................... 191
Kiernan, Colleen M ................. 144
Kilari, Deepak .......................... 206
Kilgore, Mark R ....................... 141
Kilic, Fusun .............................. 126
Killian, Jonathan ..................... 213
Kilpatrick, Scott E. ................... 103
Kim, Ahrong .................... 202, 220
Kim, Byeong Gwan ................. 229
Kim, Chae Hwa........................ 227
Kim, Charlie ..................... 183, 265
Kim, Christopher J .................. 182
Kim, Chul Whan .............. 206, 221
Kim, Chul Woo ........................ 228

Kim, Daniel .............. 161, 270, 271
Kim, Dong-Hoon ..................... 198
Kim, Eric S ............................... 206
Kim, Eun Kyung ...................... 175
Kim, Grace E........... 156, 166, 193,
........................................... 212, 249
Kim, Haeryoung ...................... 156
Kim, Hannah............................ 228
Kim, Hoguen ........................... 175
Kim, Hyo-Eun .................. 113, 270
Kim, Hyun-Jung ...................... 206
Kim, Hyunseok ........................ 170
Kim, Hyunsung ....................... 246
Kim, Joo Young....................... 156
Kim, Jaegil............................... 163
Kim, Jeri .................................. 147
Kim, Jhingook ......................... 114
Kim, Ji Eun .............................. 242
Kim, Jinah ............................... 200
Kim, Ji-seop ............................ 120
Kim, Ji Yeon ............................ 206
Kim, Jong T ..................... 162, 242
Kim, Joo Young............... 156, 221
Kim, Jung ................................ 125
Kim, Kyoung............................ 166
Kim, Kyoung-Mee ........... 174, 175
Kim, Kyu-Rae................... 150, 249
Kim, Min J ............................... 211
Kim, Moon-Young ................... 158
Kim, Robert ............................. 195
Kim, Sang Kyum ..................... 206
Kim, Sehui ....................... 158, 228
Kim, Seokhwi .......................... 113
Kim, Seong-Ik .......................... 185
Kim, Seungwon ...................... 207
Kim, Sol-Min ........................... 245
Kim, Sungeun ......... 127, 188, 198
Kim, Sunhee S ........................ 212
Kim, Tae-Beom ........................ 135
Kim, Tae Min ........................... 228
Kim, William Y ........................ 163
Kim, Won ................................. 229
Kim, Young Geum........... 202, 220
Kim, Young S................... 209, 228
Kim, Young T ........................... 232
Kim, Yujin ................................ 185
Kimbrell, Hillary .............. 200, 257
Kimura, Kyosuke ..................... 248
Kimura, Takahiro ..................... 248
King, Caleb .............................. 140
King, Rebecca.................. 227, 251
King, Tari.................................. 216
Kini, Ameet .............................. 155
Kini, Usha ................................ 215
Kinlaw, Kathy .......................... 120
Kinloch, Mary A ...................... 112
Kinoshita, Yoshikazu ............... 201
Kinsey, Richard S .................... 122
Kinzler, Kenneth ...... 163, 178, 204
Kip, Nefize ....................... 232, 245
Kipp, Benjamin R ... 158, 186, 230,
................................... 266, 267, 268
Kirby, Sean M. ........................... 42
Kircheva, Diana ....................... 232
Kirimlioglu, Hale ..................... 254

Kirk, Scott ........................ 162, 270
Kirkwood, Kimberly S............. 212
Kirsch, Richard ................ 211, 221
Kiss, Katalin ............................. 153
Kitagawa, Norihiko ................. 215
Kitagawa, Yuko ....................... 184
Kiyokawa, Takako.................... 225
Klapman, Jason ...................... 211
Klco, Jeffery M. ......................... 70
Kleer, Celina G........................... 28
Klein, Eric A ..... 124, 247, 260, 261
Klein, Melissa .......................... 143
Klein, Michael............................ 92
Klein, Molly ............................. 142
Klein, Robert R ........ 160, 166, 219
Klein, Roger D ......... 116, 120, 164
Kleinman, George ................... 244
Kleinschmidt-DeMasters, Bette K .
........................................... 105, 215
Klersy, Catherine ..................... 140
Kliethermes, Stephanie .. 161, 200
Klijanienko, Jerzy .................... 243
Klimek, Szczepan ............ 147, 148
Klimov, Sergey ........ 138, 216, 238
Klimstra, David....... 112, 121, 122,
........... 132, 182, 192, 193, 196, 203
Klinge, Petra M........................ 132
Klingen, Tor Audun ................. 110
Klion, Amy ............................... 156
Kluge, Michelle L .................... 114
Kluk, Michael J ........ 133, 194, 217
Knapp, Michael ....................... 195
Knechtges, Paul M .................. 182
Knezevic, Dejan ............... 247, 261
Knicely, Daphne ...................... 183
Knight, Jessica H .................... 245
Knudsen, Beatrice ........... 125, 235
Knutsvik, Goril......................... 110
Ko, Andrew H .......................... 212
Ko, Huaibin Mabel .................. 191
Ko, Jennifer S... 192, 196, 200, 241
Kobashigawa, Jon .................... 74
Kobayashi, Kazuma ................ 243
Kbel, M. ................................. 102
Kobel, Martin... 112, 126, 250, 251
Kodira, Chinnappa .................. 238
Koduru, Prasad ...... 128, 129, 155,
................................................... 208
Koelzer, Viktor ................. 111, 245
Koeppen, Hartmut .......... 190, 271
Koepsell, Scott A............. 124, 133
Koh, Jaemoon ......................... 158
Koh, Valerie ..................... 170, 199
Kohashi, Kenichi ............. 196, 197
Kohler, Ted............................... 172
Kohli, Manish .......................... 246
Kohlmann, Wendy K ............... 122
Kojima, Motohiro .................... 221
Kojima, Yumi ................... 138, 199
Kokh, Dina ............... 144, 218, 240
Kokudo, Norihiro ............ 184, 230
Kolar, Grant ............................. 122
Kolhe, Ravindra................. 97, 154,
161, 185, 200, 212, 237, 256, 257,
........................... 264, 267, 268, 270
INDEX
Kolinsky, Michael .................... 246
Kollmeyer, Tom ....................... 191
Kolomietz, Elena ..................... 226
Kolowitz, Brian J ..................... 190
Kolquist, Kathryn A......... 200, 257
Komatsu-Fujii, Takayoshi ....... 201
Komorkji, Rami S ............ 129, 153
Kondo, Jordan K ..................... 150
Kondo, Tetsuo ......................... 243
Kondoh, Yasuhiro ................... 133
Konety, Badrinath R ................ 234
Kong, Beihua ................... 112, 225
Kong, Christina S .... 119, 144, 145
Kong, Hui ................................. 114
Kong, Max ....................... 148, 177
Konishi, Eiichi.......................... 237
Konno, Fumiko ................ 164, 198
Konopleva, Marina ................. 208
Konopleva, Sergej Naumovich .....
........................................... 210, 208
Koo, Jamie .............................. 185
Kooby, David ... 156, 157, 166, 193
Kopach, Pavel.................. 148, 174
Kopetz, Scott ........... 166, 175, 213
Kos, Zuzana ..................... 117, 151
Koshiol, Jill .............................. 193
Kothari, Tarush ........................ 140
Kotliar, Justin A....................... 173
Kott, Marylee M ...................... 129
Kotzer, Katrina E...................... 114
Kouba, Erik .............................. 178
Koutlas, Ioannis ...................... 139
Koutzaki, Sirma ....................... 189
Kovacs, Christina ............ 152, 243
Kowalski, Diane............... 144, 167
Kowalsky-Moskaliuk, Daniel .. 118
Kozakewich, Harry .................. 196
Kraft, Adele O .......................... 234
Kraft, Ruth ....................... 109, 141
Kragel, Peter .................... 145, 173
Kramer, Paula M ..................... 131
Krane, Jeffrey F ...... 111, 143, 144,
................................... 167, 172, 173
Krasinska, Alyssa M..... 23, 25, 79,
105, 156, 157,193, 211, 245, 133
........... 144, 166, 167, 175, 193, 211
Krausz, Thomas .............. 128, 232
Krawitz, Sherry........................ 191
Krcedinac, Jelena.................... 145
Kreisel, Friederike H........ 209, 228
Kresak, Jesse L........................ 121
Krinchai, Teppituk ................... 190
Krings, Gregor................. 116, 138
................................... 142, 170, 225
Krishna, Murli.......................... 230
Krishna, Somashekar G.......... 113
Krishnamurthy, Savitri .......... 113,
........................................... 167, 199
Krishnamurti, Uma ........ 116, 144,
... 167, 171, 211, 217, 233, 234, 238
Krishnan, Kumar ..................... 119
Krishnan, Sunil........................ 246
Krizova, Adriana...................... 125
Kroft, Steven ................... 128, 210
Kroman, Eric.................... 224, 262
Krone, James T ....................... 149
Kroneman, Trynda N .............. 166

Kroshinsky, Daniela ................ 242
Krueger, Alex R ............... 187, 234
Krueger, JoEllen...................... 129
Krysiak, Robert ........................ 165
Krystel-Whittemore, Melissa . 116
Kryvenko, Oleksandr N... 147,148,
........................... 152, 163, 176, 243
Kshirsagar, Malti ..................... 251
Kuan, Shih-Fan................ 111, 175
Kuang, Fei Li............................ 156
Kuba, Maria G ......................... 198
Kubal, Chandrashekhar .......... 132
Kubo, Hajime........................... 118
Kucherlapati, Raju................... 163
Kudlow, Brian .................. 225, 263
Kudose, Satoru ....................... 131
Kuhn, Elisabetta ...................... 164
Kuk, Deborah........................... 112
Kulac, Ibrahim ......................... 109
Kulkarni, Rajan ........................ 241
Kulkarni, Shashikant ............... 113
Kulkarni, Tanvee...................... 207
Kumar, Kirthi ........................... 155
Kumar, Rajiv ............................ 207
Kumar, Tripti ............................ 254
Kumchala, Prasanthi....... 122, 176
Kummerlin, Intan .................... 125
Kunchala, Sudhir .................... 125
Kunder, Komal ........................ 207
Kundisova, Alexandra ............ 145
Kung, Vanderlene ................... 220
Kunju, L Priya ..................... 75, 136
Kunju, Lakshmi P ............ 176, 179
Kunkalla, Kranthi..................... 227
Kunz, Pamela L........................ 212
Kuo, Frank ............... 149, 155, 203
Kuo, Kuan-Ting ....................... 224
Kurani, Hetakshi ...................... 186
Kurek, Kyle ................................ 72
Kurman, Robert J.................... 226
Kurnit, Katherine ..................... 112
Kurrer, Anja Schmitt ................. 45
Kurtin, Paul J ... 131, 138, 172, 239
Kurtycz, Daniel FI .................... 143
Kutys, Robert........................... 114
Kvasnicka, Hans Michael........ 137
Kwak, Heewon ........................ 122
Kwast, Theodorus H Van der ........
........................... 109, 125, 148, 204
Kweldam, Charlotte ............... 125,
......................................Honors Tab
Kwiatkowski, David J...... 114, 163
Kwon, Deukwoo ...................... 227
Kwon, Dohee ................... 228, 232
Kwon, Ghee Young ................. 206
Kwon, Ji Eun ........................... 206
Kwong, Stanley ....................... 119
L
Labiano, Tania ......................... 218
Laboissiere, Renato S ............. 244
Lachance, Dan ......................... 191
LaChaud, Gregory................... 197

Lacombe, Jeff.......................... 145
Lacroix, Ludovic ...................... 194
Lacroix-Triki, Magali ............... 164
Lacy, Antonio .......................... 234
Ladanyi, Marc..... 22, 28, 113, 137,
................... 194, 196, 212, 213, 237
Lade, Stephen ......................... 252
Ladich, Elena ................... 114, 172
Ladwig, Nicholas .................... 225
Lafaro, Rocco .................. 158, 188
Laga, Alvaro C ......................... 114
Lagana, Stephen M ...161, 184, 192
Lagoo, Anand .......................... 155
Laheru, Daniel ......................... 202
Lai, Chi K.................. 127, 139, 203
Lai, Chiung-Ru......................... 239
Lai, Jinping .............................. 122
Lai, Keith ............................ 24, 222
Lai, Stephen Y ......................... 173
Lai, Win S ................................ 148
Lai, Win Shun .......................... 205
Lai, Yumei ................................ 174
Laib, Annie .............................. 115
Laird, Peter .............................. 163
Lajer, Christel B ....................... 153
Lakis, Nelli ....................... 222, 248
Lalla, Minesh ................... 118, 257
Lally, Kimberly ........................ 217
Lalonde, Amy .......................... 244
Lam, John................................ 227
Lam-Himlin, Dora....... 93, 96, 121,
........................... 132, 169, 201, 244
Lambert, Jim R........................ 247
Lamon, Stefano....................... 196
Lamovec, Janez ...................... 142
Lamparski, Henry G ....... 161, 269,
........................................... 270, 271
Lampreia, Leontino................. 161
Lamps, Laura W. .... 23, 24, 25, 27,
............................. 79, 101, 104, 222
Lamzabi, Ihab .......................... 116
Lan, Nan .......................... 174, 230
Lance, Raymond ..................... 109
Lancet, Jeffrey......................... 130
Lanciault, Christian ................. 195
Landis, Charles........................ 169
Landolfi, Stefania .................... 221
Landreneau, Rodney J ........... 231
Lane, Carolyn ............................ 26
Lane, Jason ............................. 153
Langer, Rupert................. 174, 245
Langford, Erin E ...................... 135
Lanigan, Christopher P ... 116, 164
Lantuejoul, Sylvie ................... 137
Laouirem, Samira ........... 169, 230
Lapadat, Razvan ...... 134, 135, 232
Lapinski, James ...................... 230
Laquerriere, Annie .................. 194
Larque, Ana ..................... 207, 215
Larsen, Chris ............................. 53
Larsen, Christian G ................. 153
Larsen, Christopher ................ 138
Larson, Alexandra................... 116
Larson, Benjamin .................... 121
Larson, Brent ................... 132, 185
Larson, David .......................... 242

Laskar, Derek ........................... 195
Laskar, Sarbani........................ 207
Lasota, Jerzy ........................... 188
Lastra, Ricardo R ..................... 151
Laszik, Laura .................... 189, 254
Laszik, Zoltan........... 189, 253, 254
Latario, Luke ............................ 199
Lau, Hubert D .......... 119, 144, 252
Lau, Sean K ............................. 173
Laudadio, Jennifer .................... 51
Laughlin, Todd S ..................... 110
Laureano, Julio ....................... 239
Lauria, Alexandra.................... 224
Lauriola, Libero ....................... 186
Laury, Anna ............................. 151
Lauwers, Gregory Y ........ 102,165,
........... 166, 174, 201, 202, 258, 259
Laver, Nora V. .......................... 107
Laver, Thomas......... 161, 269, 270
LaViolette, Peter S .................. 182
Law, Charles ............ 138, 146, 183
Law, Jason....................... 247, 260
Lawlor, Elizabeth R ................. 197
Lawrence, H Jeffrey ........ 247, 261
Lawrence, W Dwayne ..... 126, 225
Lawson, Barrett C ................... 112
Lawson, Diane......................... 135
Lawton, Thomas ..................... 115
Layfield, Lester ........ 160, 218, 231
Lazar, Alexander .......... 22, 89,103,
............................................ 113,196
Lazaro, Conxi................... 235, 236
Lazenby, Audrey J ....... 22, 28, 133
Lazova, Rossitza ........................ 69
Lazzarini, Elisabetta ................ 118
Le, Long ........................... 119, 257
Leal, Conceicao ....................... 238
Leandro, Gioacchino .............. 148
Lebda, Paulette ....................... 117
LeBrun, David P ...................... 129
Lebwohl, Benjamin ................. 192
Lech, Mazur ............................. 203
Lechpammer, Mirna ....... 187, 243
Ledezma, Rodrigo A ............... 177
Leduc, C ................................... 159
Leduc, Charles.. 113, 114, 118, 172
Lee, Byron H .................... 126, 163
Lee, Chang Hun............... 202, 220
Lee, Cheng-Han..... 112, 126, 225,
................................... 249, 250, 251
Lee, David ................................ 230
Lee, Eimear...................... 150, 181
Lee, EunJee ............................. 183
Lee, Eunjung ........................... 221
Lee, George ............................. 190
Lee, Hee Eun .................. 175, 185,
................................... 216, 232, 245
Lee, Hwajeong ........ 185, 221, 222
Lee, Hwa Jeong ...................... 121
Lee, Hyoun Wook .................... 188
Lee, Jae Hoon ......................... 156
Lee, Jae-Hyuk .......................... 188
Lee, James .............................. 188
Lee, Jeffery E................... 202, 246
Lee, Jen-Chieh ........................ 224
287
INDEX
Lee, Jeong Hyeon ................... 221
Lee, J Jack ............... 166, 175, 213
Lee, Ji Shin .............................. 188
Lee, John ................................. 155
Lee, Jong Im............................ 206
Lee, Julieann ........................... 186
Lee, Jungin ...................... 113, 270
Lee, Kenneth R ........................ 166
Lee, KyoungBun...................... 193
Lee, Kyung-Hwa ...................... 188
Lee, Larissa.............................. 149
Lee, Lik Hang ........... 122, 168, 203
Lee, Melody ............................. 233
Lee, Min Joung ....................... 242
Lee, Minju ........................ 174, 185
Lee, Mi-Sook ........................... 114
Lee, Nathan ............... 30, 114, 130
Lee, Paula S ............................. 249
Lee, Peng .. 128, 147, 148, 177, 215
Lee, Sandra ............................. 251
Lee, Seung Eun ....................... 206
Lee, Seungjae.......................... 168
Lee, So Jeong ................. 202, 220
Lee, Sun Mi ............................. 111
Lee, Wonae .............................. 206
Lee, WonSok .......... 154, 161, 185,
................................... 200, 212, 237
Lee, Yi-Shan ............................ 228
Lee, Ying-En ............................ 175
Lee, Youngseok ....................... 221
Lee, Zach ................................. 170
Leen, Sarah L .......................... 181
Leeman-Neill, Rebecca J 129, 155
Leenders, Geert van ............... 125
Lefebvre, Veronique ............... 214
Lefevre, Marine ....................... 243
Lefferts, Joel.................... 198, 256
Lefterova, Martina ......... 162, 212,
........................................... 267, 270
LeGallo, Robin......................... 195
Legesse, Teklu ................. 218, 240
Lehman, John R ...................... 191
Lehrke, Heidi D ........................ 132
Lei, Guang-Sheng ................... 232
Lei, Li........................................ 183
Leiferman, Kristin ................... 192
Leighton, Jonathan................. 244
Leise, Michael ......................... 169
Leite, Katia RM ................ 224, 248
Lembo, Anthony ..................... 191
Lena, Marco Schiavo .............. 214
Leng, Bing ....................... 170, 219
Leng, Nan ........................ 212, 267
Lenik, Joanna .......................... 145
Lennerz, Jochen K .................. 157
Leo, Joyce M ........................... 250
Leo, Patrick .............................. 190
Leon, Marino E ........................ 152
Leonard, Debra ................... 81, 95
Leonar, John P. .......................... 63
Leone, Dominick ............. 192, 200
Lepe, Marcos ................... 143, 223
Lepine, Charles ....................... 243
Lepor, Herber .................. 147, 148
Lerario, Antonop M ................ 173
288
Lerner, Seth ............................. 163

Lerner-Ellis, Jordan ................ 215
Lerwill, Melinda F. ................... 101
Leszczynska, Iga ...................... 145
Leung, Sam ............. 149, 249, 250
Levenson, Richard ......... 187, 234,
........................................... 267, 270
Leventaki, Vasiliki.................... 165
Levi, Angelique W........... 144, 167
Levin, Mary.............................. 241
Levine, Douglas A ... 112, 225, 249
Levine, Ross ............ 154, 156, 265
Levinson, Howard ................... 242
Levy, David .............................. 119
Lew, Madelyn .................. 119, 144
Lewandowski, Raymond ........ 195
Lewin, David............................ 146
Lewin, Paul M............................ 28
Lewis, James.................... 99, 103,
................................... 139, 153, 206
Lewis, Jean.............................. 206
Lewis, Jenna ........................... 167
Lewis, Julie.............................. 253
Lewis, Natasha ................ 150, 228
Lewis, Susan ........................... 111
Lewis, Suzanne ....................... 253
Lezcano, Cecilia....................... 242
Li, Aihua........................... 247, 260
Li, Anqi..................................... 142
Li, Betty ............................ 155, 208
Li, Bill ....................................... 135
Li, Chien-Feng ......... 175, 196, 207
Li, Dan ...................................... 214
Li, Haonan .............. 184, 211, 221,
........................................... 230, 243
Li, Jianbo ......................... 147, 148
Li, Jianhong............. 147, 148, 177
Li, Jianyi .................................. 213
Li, Jie........................................ 116
Li, Jieliang ....................... 171, 172
Li, Jinhong............................... 245
Li, K David ....................... 159, 228
Li, Ker-Chau ............................. 246
Li, Faqian ......... 158, 173, 222, 250
Li, Li.......................... 111, 166, 172
Li, Long .................................... 174
Li, Ma ....................................... 203
Li, Min .............................. 117, 228
Li, Ming .................................... 142
Li, Na ........................................ 210
Li, Nim ..................................... 179
Li, Qing Kay ............................. 231
Li, Shaoying ................... 165, 209,
................................... 227, 229, 253
Li, Ting ..................................... 227
Li, Wan-Shan ........................... 236
Li, Weihong ............................. 143
Li, Xiaodong ............................ 225
Li, Xiaoqiu ............................... 227
Li, Xiaoxian....... 80, 116, 142, 216,
................................... 171, 217, 238
Li, Xinran ................................. 183
Li, Xinyan................................. 183
Li, Xuechan.............................. 249
Li, Yan .............................. 137, 165
Li, Yi ......................................... 129
Li, Yu-I ...................................... 175

LI, Yunjie .................................. 125
Li, Zaibo .......... 110, 164, 170, 203,
................................... 238, 239, 240
Li, Zhongwu .................... 174, 224
Liang, Cher-Wei....................... 224
Liang, Li ........................... 179, 226
Liang, Peir-In ........................... 207
Liang, Sharon .................. 181, 250
Liang, Sheng-Ben ........... 203, 246
Liang, Shu ............................... 250
Liang, Xiayuan ........................ 208
Liang, Yaoming ....................... 240
Liao, I-Chuang ......................... 236
Liao, Jie ... 184, 211, 221, 230, 243
Liao, Wei-An ............................ 227
Liao, Wei-Li ...................... 213, 268
Liao, Xiaoyan .......... 233, 234, 240
Li-Chang, Hector ..................... 105
Lichner, Zsuzsanna ................. 178
Lidke, Diane ............................. 253
Lieberman, David B ................ 133
Liegsalz, Veronika ................... 116
Lifton, Richard P...................... 252
Ligon, Azra H ........... 149, 165, 191
Ligon, Keith L .................. 186, 191
Liles, Darla ............................... 228
Lim, Diana ............................... 251
Lim, Jeffrey Chun Tatt .... 142, 217
Lim, Jeong............................... 121
Lim, Megan S ................ 23, 25, 93,
........................................... 139, 227
Lim, Raymond ......................... 137
Lim, Soon-Thye....................... 252
Lin, Caroline M ........................ 167
Lin, Chieh-Yu ........................... 170
Lin, Chung-Wu ........................ 228
Lin, Daniel........................ 109, 248
Lin, Doug I ............................... 166
Lin, Douglas ............................ 166
Lin, Fan .... 167, 185, 189, 232, 245
Lin, Fritz ................................... 170
Lin, Grace Y ............................. 233
Lin, Henry ........................ 130, 183
Lin, Jingmei............ 122, 131, 176,
........................................... 185, 222
Lin, Jonathan H ....................... 187
Lin, Ming-Chieh....................... 224
Lin, Ming-Tseh ................ 188, 247
Lin, Oscar........ 153, 159, 162, 167,
........................... 182, 190, 213, 241
Lin, Pei ..... 193, 208, 210, 227, 251
Lin, Peter T ............... 101, 118, 191
Lin, Steven............................... 190
Lin, Xiaoqi ....... 184, 218, 219, 243
Lin, Yi ....................................... 165
Lin, Yung-Chang ..................... 216
Linares, Emma ........ 221, 229, 242
Lincoln, Mark........................... 145
Lindberg, Matthew R .............. 222
Lindeman, Neal .......... 58, 85, 111,
................... 132, 149, 157, 173, 175
Lindholm, Kaleigh E ............... 119
Lindsey, Kathryn ............... 98, 218
Lindstrom, Linda S ......... 138, 170
Lingen, Mark ........................... 207
Link, Brian................................ 165

Liomba, N George .................. 165
Lipkin, Steven.......................... 194
Lira, Maruja E .......................... 197
Lis, Rosina ............................... 248
Lisovsky, Mikhail ..................... 201
Listewnik, Marc ....................... 191
Litzow, Mark R ......................... 154
Liu, Chao.................................. 172
Liu, Chen.................................. 121
Liu, Chengbao ......................... 160
Liu, Cheng Z ............................ 173
Liu, Chia-Jen ................... 207, 214
Liu, Haiyan............... 167, 185, 189
Liu, Hui............................. 199, 252
Liu, Huifei ................................ 209
Liu, Jen-Jane ........................... 205
Liu, Jingxuan........................... 160
Liu, Jinsong ..................... 179, 226
Liu, Li ....................................... 202
Liu, Liping ................................ 134
Liu, Qingqing................... 176, 246
Liu, Rangjiao ........................... 183
Liu, Shiguang .......................... 172
Liu, Shu-hong.................. 171, 210
Liu, Su-Yang ............ 111, 116, 142
Liu, Ta-Chiang ......................... 220
Liu, Ting Ting ........................... 185
Liu, Tzu-Ying ........................... 223
Liu, Wei ............................ 143, 229
Liu, Xiaoying ... 144, 201, 212, 213
Liu, Xichun .............................. 215
Liu, Xiuli... 111, 166, 174, 226, 230
Liu, Xulei.......................... 171, 172
Liu, Yajuan ............................... 197
Liu, Yen-Chun .......... 137, 165, 208
Liu, Yifang ............................... 142
Liu, Yuan .................................. 117
Liu, Yuhua................................ 197
Liu, Yuxin ................................. 150
Liu, Zach .......................... 147, 148
Liverman, Christopher............ 226
LiVolsi, Virginia ....... 120, 121, 206,
................................................... 258
Ljung, Britt-Marie ........... 111, 167,
........................................... 173, 217
Llanos, Cesar A ............... 182, 232
Lloret, Adria............................. 135
Lloreta, Josep......... 135, 189, 206,
........................................... 247, 248
Lloveras, Belen........................ 167
Lloyd, Isaac...................... 122, 138
Lloyd, Ricardo V ...... 121, 140, 243
Lo, Amanda ............................. 251
Lo, Amy A ........................ 133, 211
Lo, Darrick ............................... 187
Lo, Ying-Chun ......................... 120
Lo, Yun-Feng ........................... 216
Lo, Yungtai ...................... 141, 238
Loarer, Francois Le ................... 60
Lobo, Joao............................... 238
Lockhart, Valerie ..................... 135
Lockwood, Christina ................. 70
Lockyer, Megan G ................... 240
Loda, Massimo................ 109, 248
INDEX
Loeb, Keith .............................. 222
Loftus, Barbara........................ 233
Logan, Patrick.......................... 187
Loghavi, Sanam .............. 154, 155
Logothetis, Christopher J....... 147
Lohse, Christine M .................. 166
Lokhandwala, Parvez M ......... 247
Lomazzi, Sandra...................... 186
Lombard, David ...................... 197
Lombardo, Kara A.......... 125, 128,
... 152, 175, 176, 187, 213, 221, 222
Lomme, Michele M ................. 225
Long, Bradley .......................... 122
Long, Steven R ................ 119, 233
Long, Susan ............................ 213
Long, Tiffany I ......................... 180
Longacre, Teri A ...... 101, 119, 122,
........... 144, 151, 180, 212, 219, 225
Longatto, Adhemar................. 173
Longerich, Thomas ................. 169
Lopategui, Jean .............. 133, 134
Lopes, Ana............................... 161
Lopes, Ana Claudia Frota ....... 252
Lopes, Beatriz ............................ 78
Lopes, Jose M ......................... 112
Lopes, M Beatriz ............. 195, 243
Lopez, Ariana .......................... 198
Lopez, Giselle .......................... 186
Lopez, Jose I.................... 136, 177
Lopez, Mae .............................. 160
Lopez, Mirtha .................. 113, 199
Lopez-Beltran, Antonio........... 149
Lopez-Guerrero, Jose Antonio ....
................................................... 179
Lopez-Janeiro, Alvaro ............ 191
Lopez-Picazo, Jose M ............. 218
Lopez-Terrada, Dolores .......... 129
Lorduy, Ana Collazo........ 183, 204
Loren, Alison W ...................... 154
Lorente, Jose A ....................... 189
Lorenzo, Marta ...... 109, 189, 206,
........................................... 247, 248
Lorenzoni, Cesaltina ............... 114
Lorsbach, Robert B. ................ 108
Losa, Javier Hernandez .......... 236
Losada, Daniele M .................. 146
Losada, Hector ........................ 157
Lotan, Tamara ......... 109, 247, 248
Lotan, Yair ............................... 205
Louie, Christine Y............ 122, 219
Louis, David N. .......................... 27
Loundas, Craig ........................ 145
Lovane, Lucilia ........................ 114
Love, Cassandra...................... 193
Lovisolo, Silvana M ................ 173
Lovitch, Scott B ....... 128, 165, 218
Low, Lawrence ........................ 209
Lowe, Alarice........................... 167
Lowe, Chenery ................ 190, 271
Lowe, Lori ................................ 192
Lowe, Scott.............................. 235
Loya, Asif ................................. 244
Lozano, Maria D ...................... 218
Lu, Dan..................................... 197
Lu, David Y ...................... 141, 163
Lu, Fang-I ......... 179, 181, 189, 198
Lu, Gary ................................... 229

Lu, Ruixiao....................... 247, 260
Lu, Shaohua .................... 114, 136
Lu, Shaolei..... 121, 123, 125, 133,
........................... 176, 203, 210, 221
Lu, Tzu-Pin ............................... 224
Lu, Zhichun.............................. 148
Lu, Xinyan 208, 209, 210, 229, 251
Lubin, Daniel ................... 122, 137
Luchini, Claudio ...................... 178
Lucia, MS ................................. 247
Ludwig, Kathrin....................... 253
Luebker, Stephen .................... 133
Luger, Selina M ....................... 154
Lugli, Alessandro ............ 111, 245
Lui, Weng-Onn ........................ 242
Luinetti, Ombretta................... 140
Luk, Adriana ............................ 118
Luk, Peter P...................... 127, 151
Luke, Patrick ............................ 184
Lum, Amy ................................ 197
Lum, Cheemun........................ 235
Lum, Trina ....................... 127, 151
Luna, Eric ......................... 134, 240
Lunz, John ............................... 254
Luo, Bing ................................. 110
Luo, Jun ................................... 247
Luo, Shujun ..... 162, 212, 267, 270
Luo, Yuling ............. 161, 210, 231,
........................... 265, 269, 270, 271
Lusco, Mark ............................. 183
Luskin, Marlise ........................ 154
Luthra, Raja ..................... 160, 187
Luthra, Rajyalakshmi ..... 111, 153,
................... 154, 161, 167, 192, 233
Luthringer, Daniel .......... 118, 125,
................................... 205, 246, 249
Lutterbaugh, James................ 111
Luu, Hung S............................. 128
Luvison, Alyssa M... 121, 139, 241
Luz, Rita ................................... 251
Luzar, Bostjan .......................... 241
Lyapichev, Kirill ....................... 148
Lydon, Christine ...................... 188
Lyons, Genevieve R ....... 112, 119,
................................... 138, 164, 242
Lytwyn, Alice ............................. 11
M
Ma, Changqing........................ 220
Ma, Deqin ................................ 237
Ma, Fen .................................... 248
Ma, Juan .................................. 129
Ma, Lisa ................... 137, 194, 252
Ma, Shuhua ............................. 145
Ma, Sophia .............................. 233
Ma, Xiao-Jun .................. 161, 210,
................... 231, 265, 269, 270, 271
Ma, Yihong .............................. 212
Ma, Zheng ............................... 173
MacDonald, Theresa Y ........... 247
Macedo, Fabiane C ................. 135
Macedo, Gabriel S ... 110, 137, 225
Macedo, Mariana Petaccia de 113
Macerola, Elisabetta ............... 242
MacEwen, Clare ...................... 183

MacGrogan, Gaetan ............... 164
Macha, Muzafar A ................... 207
Machi, Junji ............................. 234
Machinami, Rikuo ................... 237
Maciak, Charlene .................... 115
Macias, Gabriela Sofia Gomez .....
................................................... 250
Macias, Virgilia................ 123, 199
Mackinnon, Alexander C ....... 149,
................................... 179, 237, 254
Mackrides, Nicholas ....... 165, 250
MacLennan, Gregory ............. 123,
........................................... 125, 177
MacLennan, Kenneth.............. 209
Macon, William R............ 227, 251
Madabhushi, Anant ....... 181, 190,
................................... 199, 256, 266
Madan, Rashna ....................... 144
Madan, Shashi ........................ 117
Maddala, Tara.................. 247, 261
Madore, Jason ........................ 127
Madory, Jim ............................ 146
Madrigal, Emilio...................... 145
Maeda, Daichi ................. 151, 224
Maeda, Nagako ....................... 241
Maedler, Chelsea .................... 122
Maestro, Roberta .................... 196
Mafnas, Chrisy T ..................... 233
Mafolasire, Abiodun ............... 178
Magaki, Shino ......................... 187
Magers, Martin J....... 42, 119, 176,
................................................... 223
Maggioni, Marco..................... 187
Magid, Margret S .................... 191
Magi-Galluzzi, Cristina.. 26, 75, 95,
........................... 103, 124, 147, 247
Maglantay, Remegio............... 183
Maglio, Giovanna De .............. 142
Magliocco, Anthony M .......... 166,
........... 180, 202, 223, 259, 260, 263
Magno, Crystal ........................ 132
Magnoli, Francesca................. 209
Magro, Cynthia ....................... 199
Maguire, Donal ....................... 220
Mahadevan, Krishnan K ........ 157,
........................................... 174, 246
Mahadevan, Navin.................. 136
Mahaffey, Alyssa............. 127, 240
Mahajan, Aparna .................... 151
Mahalingam, Meera .. 69, 192, 200
Mahan, Sarah .......................... 150
Mahantshetty, Umesh M ........ 223
Mahe, Etienne ......................... 209
Maheshwari, Priyanka ............ 201
Mahlow, Jonathon .................. 120
Mahmoud, Amr....................... 202
Mahon, Sarah.......................... 181
Mai, Kien T ...... 109, 144, 147, 205
Mai, Ming ................................ 252
Maier, Cheryl ........................... 120
Maietta, Antonio ..................... 218
Main, Nelson ........................... 160
Mainar, Margarita ................... 182
Maisel, Julia R ......................... 120
Maisonneuve, Patrick ............. 243
Maithel, Shishir .............. 156, 157,

........................................... 166, 193
Maitra, Anirban ............... 202, 246
Majeed, Hassaan..................... 199
Majewski, Jacek ...................... 236
Majewski, Tadeusz .......... 124, 163
Makowsky, Robert .......... 180, 262
Malafa, Mokenge P .. 202, 211, 220
Malapelle, Umberto ........ 218, 245
Malcolm, Joan ........................ 162
Maldonado, Leonel ................. 145
Maldonado-Duran, Mayra ...... 110
Maleki, Zahra... 134, 188, 202, 218
Malenie, Renuka ..................... 145
Maleszewski, Joseph J ........... 101,
........... 114, 118, 158, 172, 190, 191
Maletta, Francesca .......... 121, 140
Malhotra, Saurabh .................. 201
Maliakkal, Benedict ................. 185
Mallon, Abbie .......................... 160
Maloney, Kuda ........................ 146
Malpica, Anais.. 71, 107, 112, 149,
................................... 180, 192, 226
Maluf, Horacio M .................... 227
Mamut, Adiel........................... 184
Manca, Rachele ....................... 140
Mancini, Irene ......................... 236
Mandal, Rakesh....................... 121
Mandavilli, Srinivas ................ 239
Manekia, Jawad ...... 161, 167, 233
Mangray, Shamlal........... 123, 175,
................... 187, 203, 213, 222, 248
Mangus, Richard S ................. 176
Maniar, Kruti............ 110, 150, 240
Manivel, Juan Carlos .............. 195
Manna, Pradip ......... 126, 223, 260
Mannan, Abul Ala Syed Rifat.. 151
Manning, Suzanne .................. 198
Manning, Tim .................. 141, 182
Mano, Masayuki...................... 237
Manoj, Namitha .............. 225, 263
Mansfield, Aaron S ......... 201, 258
Mansfield, James.... 190, 270, 271
Mansfield, Paul ....................... 220
Mansoor, Adnan ............. 129, 209
Mansoor, Atiya ........................ 214
Mansoor, Mohammad O ........ 154
Mansoor, Was ......................... 188
Mansour, Mena ............... 152, 245
Mansukhani, Mahesh ............ 161,
........................................... 203, 253
Mantilla-Morales, Alejandra .. 224
Manzano, Jose Luis ................ 221
Mao, Mao ................................ 197
Mao, Yong ............................... 216
Maque-Acosta, Yvan............... 165
Marafioti, Theresa................... 164
Maragliano, Roberta ....... 140, 243
Marcano, Eugenio................... 110
Marchand, Vinciane ................ 168
Marchetti, Elizabeth ................ 216
Marchevsky, Alberto M ......... 134,
........................................... 159, 231
Marchio, Caterina .......... 109, 137,
........................................... 146, 171
Marco, Marta ........................... 126
289
INDEX
Marcus, Alan ................... 167, 231
Mares, Roso ............................ 236
Marginean, Esmeralda C. ......... 26
Margolskee, Elizabeth .... 137, 155
Marguet, Florent ..................... 194
Margulis, Vitaly ....................... 178
Mariani, Andrea ...................... 250
Maric, Irina .............. 156, 252, 253
Marimon, Lorena .................... 150
Marino-Enriquez, Adrian 194, 197
Mark, Eugene J ....................... 158
Mark, Tomer ............................ 210
Marketkar, Shivali ........... 116, 232
Markowitz, Sanford ................ 111
Marks, Randolph S ................. 159
Marotti, Jonathan ... 144, 198, 237
Marques, Sara ......................... 161
Marrades, Ramon ................... 158
Marrero, Bernadette ............... 253
Marsh, William L ..................... 203
Marshall, Carrie B ................... 143
Marshall, Hyejong S ............... 115
Martelotto, Luciano G............ 110,
........................................... 137, 225
Marti, Carles ............................ 207
Marti, Gerald ........................... 252
Martignoni, Guido ... 136, 177, 178
Martin-Algarra, Salvador ....... 218
Martin, Brock A ....................... 144
Martin, Cara............ 111, 139, 150,
.................................. 162, 181, 214
Martin, Cheyenne ................... 253
Martin, Cristina ....................... 145
Martin, David........... 211, 214, 245
Martin, Jennifer ...................... 160
Martin, Samantha A ............... 231
Martin, Sean T......................... 111
Martinek, Petr .......................... 177
Martinez, Anthony .......... 115, 196
Martinez, Kimberly ................. 239
Martinez, Laura ....................... 145
Martinez, Miguel J .................. 114
Martinez, Paola ....................... 213
Martinez-Cardus, Anna........... 221
Martinez-Duarte, Ernesto ....... 181
Martino, Julie Di ..................... 169
Martino, Michele ..................... 140
Maru, Dipen..................... 192, 244
Marukawa, Katsuji .................. 211
Maruyama, Riruke .................. 201
Marzo, Angelo M De ...... 109, 185,
........................................... 247, 248
Masand, Ramya P ................... 112
Maset, Maria Amada .............. 218
Masia, Ricard........................... 169
Mason, Emily .......................... 165
Masood, Muhammad A ......... 244
Massard, Christopher ............. 194
Massi, Daniela ......................... 105
Master, Stephen R .................. 154
Master, Viraj A ......................... 124
Masterson, Timothy A ............ 222
Masugi, Yohei.......................... 184
Mata, Douglas A ..................... 206
Mateescu, Valerica .......... 217, 231
290
Mateo, Joaquin ............... 246, 247

Mates, Mihaela........................ 231
Mather, Cheryl................. 185, 212
Mathew, Susan .............. 133, 137,
........................................... 165, 228
Mathur, Priya ........................... 123
Matias, Gilberto ...................... 150
Matias, Pamela R .................... 158
Matias-Guiu, Xavier .......... 64, 112
Matos, Ana .............................. 150
Matos, Rute ............................. 161
Matoso, Andres.............. 109, 123,
... 124, 147, 163, 213, 222, 223, 248
Matrai, Cathleen.............. 214, 251
Matsubara, Osamu ................. 158
Matsuda, Midori...................... 243
Matsuda, Yoko......................... 172
Matsukuma, Karen.......... 174, 175
Matsumoto, Melissa ............... 241
Matsumoto, Seiichi................. 237
Matsumoto, Shinji .................. 232
Matsumoto, Toshiharu ........... 220
Matsunaga, Rie ....................... 221
Matsuno, Yoshihiro................. 211
Matthew, Stemm .................... 237
Mattia, Antony ........................ 174
Maurer, Matthew .................... 165
Mauzo, Shakuntala ................. 129
Maxfield, Erin .......................... 187
Maxwell, Jessica E.................. 140
Mayigowda, Pramod ...... 130, 183
Mazzaferro, Vincenzo ............. 243
Mazzoli, Sandra....................... 223
Mboko, Wadzanai ................... 210
McAlpine, Jessica N ...... 112, 149,
........................................... 249, 250
McCall, Brant ........................... 143
McCall, Chad M ............... 155, 209
McCall, Shannon J.................. 175
McCann, Amanda ................... 181
McCann, Brooke...................... 184
McCarthy, Aoife .............. 187, 199
McCarthy, Julie ....................... 160
McCarty, Tom .......................... 230
McCash, Samuel I ................... 159
McCleskey, Brandi C ............... 163
McCluggage, Glenn .. 64, 112, 180,
........................................... 181, 251
McConechy, Melissa ....... 112, 249
McConkey, David ............ 124, 163
McCormack, Gina ................... 160
McCormick-Baw, Clare ........... 160
McCoy, Lucie ........................... 191
McCroskey, Zulfia ........... 119, 218
McCuiston, Austin M .............. 129
McCullough, Arthur ................ 230
McCullough, Debbie ...... 142, 247,
........................................... 256, 260
McDaniel, Andrew .................. 223
McDermott, Ray ...................... 111
McDonald, Anna G ................. 127
McDonald, Robert ........... 116, 117
McDonald, Seamus ................ 250
McDonald, William ................. 186
McEnery-Stonelake, Melissa.. 199
McFadden, Julie...................... 181
McGinnis, Lisa......... 194, 228, 233

McGovern, Brianan................. 212
McGrath, Patrick C .......... 116, 117
McGraw, Kathy........................ 129
McGregor, Stephanie ............ 116,
........................................... 159, 199
McHugh, Jeffrey ..................... 182
McHugh, Jonathan ........ 139, 176,
........................................... 206, 207
McHugh, Kelsey .............. 126, 136
McIntosh, Rebekah ................. 205
McKee, Thomas ...................... 152
McKee, Trevor ......................... 132
McKenna, W Gillies ................ 157
McKenney, Jesse K ....... 28, 29, 48,
.... 109, 124,136, 149, 177, 241, 248
McKeon, Frank D..................... 181
McKinnon, Elizabeth L ............ 242
McKissic, Devin ....................... 173
McLaughlin, Sarah A ...... 164, 198,
................................................... 215
McLemore, Lauren E .............. 238
McMahon, Kelly Q .................. 246
McMahon, Loralee ... 204, 222, 246
McManus, Bruce M................. 172
McMasters, Richard L. ............ 106
McNally, Scott ......................... 118
McNeal, SaRah McNeal......... 180
McNeer, Jennifer .................... 130
McNeish, Iain .......................... 179
McNett, Henry ......................... 242
McNiff, Jennifer M .......... 169, 200
McWilliams, Robert R ............ 132,
........................................... 184, 230
Medeiros, L Jeffrey ........... 63, 130,
137, 154, 155,, 161, 165, 167,
193, 208, 209, 210, 227, 229, 251,
........................................... 252, 253
Medieros, Bruno C .................. 155
Medlin, Erin E .......................... 151
Medline, Paul .......................... 211
Meeker, Alan ... 117, 156, 205, 223
Mehr, Chelsea ......................... 145
Mehra, Niven................... 246, 247
Mehra, Rohit... 109, 163, 176, 177,
........................... 223, 260, 261, 262
Mehrad, Mitra ................. 114, 188
Mehran, Reza J ....... 158, 188, 231
Mehrotra, Meenakshi ............. 161
Mehrotra, Swati ...68, 134, 135, 232
Mehta, Vikas ............................ 204
Meijer, Sybren L ...................... 191
Meinke, Kyle ............................ 123
Meireles, Catarina ................... 112
Mejia, Jaime ............................ 220
Melamed, Jonathan ..147, 148, 177
Meliti, Abdelrazak ........... 147, 224
Melnick, Ari M ......................... 154
Meltzer, Paul ............................ 213
Memis, Bahar .. 132, 133, 144, 156,
................... 157, 166, 175, 193, 245
Mendrinos, Savvas ......... 147,148,
........................................... 260, 261
Menegaux, Fabrice ................. 243
Menei, Philippe ....................... 191
Menndez, Clara ..................... 114
Meng, Bin ................................ 165
Meng, Xiuling.......... 199, 204, 210
Mengel, Michael ..................... 131

Menon, Madhu........................ 251
Menon, Mani ........... 109, 147, 148
Menon, Santosh...................... 223
Meo, Ashley Di ........................ 178
Merchant, Nipun B.................. 144
Merino, Maria J................. 58, 187
Merli, Michele ......................... 209
Merrill, Parker.......................... 191
Merzianu, Mihai ...... 159, 171, 207
Mesa, Hector ........................... 195
Meschter, Steven ............ 106, 119
Meserve, Emily ............... 166, 171
Messenger, David E ................ 221
Messing, Edward M ................ 206
Mete, Ozgur ..................... 107, 191
Meunier, Danielle .................... 243
Meunier, Rashna ....................... 30
Meyer, Rose............................. 140
Meyers, Carolyn A .................. 197
Meyerson, Howard J ...... 155, 229
Mezhir, James J .............. 133, 211
Mian, Badar ............................. 246
Micevic, Goran ........................ 234
Michael, Claire W ....... 94, 119, 219
Michael, Helen E ..................... 178
Michal, Michael ....... 150, 177, 236
Michalak, Sophie .................... 191
Michalowski, Susan ................ 251
Middha, Sumit ........ 112, 162, 197
Middleton, Lavinia .................. 110
Mierau, Gary ........................... 189
Mies, Carolyn .......... 101, 142, 256
Miettinen, Markku ............. 60, 188
Migliacci, Jocelyn C ................ 128
Migliore, Federico ................... 118
Mihalov, Mike .......................... 203
Mihm, Martin C ............... 105, 120
Mikael, Leonie G ..................... 236
Miki, Yasuhiro ......................... 195
Miles, LiLi ................................ 187
Miles, Michael ......................... 187
Miley, Timothy G..................... 153
Milikowski, Clara ............. 115, 201
Milione, Massimo ................... 243
Millan, David ........................... 179
Millan, Rosana ........................ 182
Miller, Benjamin ...................... 237
Miller, Caitlyn .......................... 139
Miller, Dianne M...................... 149
Miller, Dylan ..................... 23, 107,
........................... 118, 138, 170, 235
Miller, Gregory ................ 174, 219
Miller, James A ....................... 218
Miller, Melanie ........ 161, 269, 270
Miller, Michael................. 122, 186
Miller, Naomi A ....................... 213
Miller, Ross A .......................... 119
Miller, Sue ............................... 154
Miller, Todd.............................. 237
Miller, Vincent A ..... 116, 117, 120,
121, 127, 151, 159, 163, 186, 194,
198, 208, 213, 246, 249, 256, 258,
260, 261, 262, 263, 265, 266, 267,
........................................... 268, 269
INDEX
Mills, Anne M ................. 116, 127,
................................... 132, 150, 250
Mills, Gordon ................. 112, 113,
................................... 135, 163, 199
Mills, Stacey E ......................... 121
Milman, Tatyana ......... 56, 73, 206
Milne, Katy ...................... 123, 134
Milner, Dan A. .............. 23, 25, 58,
........................................... 108, 171
Milton, Denai R ....... 120, 200, 201
Min, Kyueng-Whan ................. 198
Minami, Yuko .......................... 113
Minca, Eugen C ....................... 200
Minden, Mark .......................... 128
Miniti, Caterina........................ 253
Minkovsky, Alissa ................... 208
Mino, Barbara ......... 157, 188, 189
Mino-Kenudson, Mari.... 113, 136,
................................... 157, 267, 269
Mir, Saad ................................. 186
Miranda, Alonso ..................... 252
Miranda, Roberto ............ 209, 252
Miranda, Susana AA....... 246, 247
Mirkovic, Jelena .............. 143, 166
Miron, Alexander .... 111, 181, 260
Mirsadraei, Leili ...................... 240
Mirza, Kamran M .... 114, 194, 232
Mirza, M Kamran .................... 128
Misumi, Kento ................. 184, 230
Mitchell, Brendon ................... 200
Mitchell, James Michael .......... 29
Mitchell, Kisha................. 220, 230
Mitchell, Mary J ...................... 182
Mitchell, Richard N ................. 118
Mito, Jeffrey ............................ 202
Mitsios, John V ....................... 228
Mitsuhashi, Tomoko ............... 211
Mittal, Karuna.......................... 235
Mittal, Khushbakhat................ 167
Mittal, Pardeep ................ 156, 193
Mittendorf, Elizabeth A.......... 138,
........................................... 164, 217
Miura, Tomisato ...................... 181
Miyamoto, Hiroshi .................. 206
Miyaoka, Youichi ..................... 201
Miyauchi, Akira ....................... 243
Mizrahi, Meir ........................... 244
Mneimneh, Wadad ................. 134
Mo, Angela Y........................... 172
Moatamed, Neda A.. 149, 179, 241
Moch, Holger............. 48, 136, 237
Mochizuki, Kunio .................... 243
Mockus, Susan ................ 183, 212
Mod, Dina .................................. 68
Modesitt, Susan C................... 250
Modh, Ankit ............................. 249
Modiano, Nir ........................... 121
Mody, Dina R ..... 78, 119, 134, 240
Mody, Roxanne R............ 134, 240
Moeckel, Gilbert .............. 131, 254
Moeller, Inga ........................... 186
Moench, Laura ........................ 225
Moffitt, Andrea ........................ 193
Moh, Michelle ......................... 253
Mohamed, Nehad ................... 213
Mohammad, Amin.......... 146, 160
Mohan, Helen .......................... 111

Mohanty, Suravi...................... 215
Moises, Jorge.......................... 158
Moisini, Ioana.......................... 224
Moiyadi, Aliasgar .................... 186
Mojica, Gregg.......................... 233
Mojica, Paul ..................... 113, 216
Mojica, Wilfrido....... 113, 216, 233
Moldovan, Cosmin ................. 171
Moldovan, Krisztina ................ 132
Molinaro, Annette ................... 191
Moline, Teresa ................. 235, 236
Molins, Laureano .................... 158
Mollejo, Manuela .................... 242
Moller, Henrik .......................... 109
Moller, Michael B .................... 130
Molnar, Stacy L ....................... 143
Molofsky, Ari ........................... 156
Molony, Peter .......................... 195
Momblan, Dulce...................... 234
Momtahen, Shabnam............. 199
Monaco, Sara E .. 78, 190, 218, 240
Monaghan, Sara A .......... 146, 155
Moncea, Denisa ...................... 171
Mondal, Ashis K ..... 154, 161, 185,
................................... 200, 212, 237
Monges, Genevieve ................ 202
Monroig, Josep Riera ............. 215
Montahen, Shabnam .............. 199
Montalto, Michael ........... 182, 266
Montaser, Laleh ...................... 248
Montecalvo, Joseph ............... 159
Montemayor-Garcia, Celina ... 121
Montes, Santiago............ 179, 242
Montes-Moreno, Santiago ..... 229
Montgomery, Elizabeth A...... 174,
........................... 204, 219, 220, 222
Montgomery, Jeffrey S .......... 223
Montgomery, Liz ....................... 96
Montgomery, Nathan ............. 165
Montgomery-Goecker, Crystal .. 155
Montilla, Silvia ........................ 158
Montironi, Carla .............. 234, 245
Montironi, Rodolfo ......... 163, 177
Montone, Kathleen ........... 91,120,
........................................... 127, 145
Montoya, Rosita ...................... 241
Monzo, Mariano ...................... 158
Moon, Andres ................. 143, 254
Moon, Kyung Chul .................. 206
Moon, Kyung-Sub................... 188
Mooney, Kelly ......................... 141
Moore, Erika M........................ 129
Moorhead, Jane .............. 178, 214
Morabito, Anna ....................... 232
Morais, Carlos L .............. 247, 248
Moran, Cesar A .............. 137, 157,
................................... 158, 188, 231
Moran, Elisa J ......................... 252
Moran, Miriana ............... 180, 262
Moran, Sebastian.................... 221
Morandi, Luca ......................... 140
Morash, Chris .................. 109, 147
Moreira, A................................ 159
Moreira, Andre .. 113, 136, 137, 162
Moreira, Roger ................ 184, 185
Morellas, Vassilios .................. 183

Morency, Elizabeth ......... 110, 231
Moreno, Carlos ....................... 214
Moreno, Debora ...................... 213
Moreno, Vanessa .................... 187
Moreno-Aspitia, Alvaro ......... 164,
........................................... 198, 215
Morey, Gabriel E ..................... 178
Morgan, Elizabeth A .. 24, 193, 208
Morgan, Margaret B ............... 163
Morgan, Terry K ...... 121, 144, 240
Morgan, Todd .................. 223, 261
Morgen, Eric ............................ 182
Mori, Yukiko ............................ 205
Morice, William G ................... 252
Morikawa, Landon .................. 239
Morikawa, Teppei.................... 174
Morita, Kouhei ........................ 142
Morita, Michi ........................... 238
Moritani, Suzuko ..................... 142
Morley, Samantha .......... 208, 265
Morlote, Diana ........................ 198
Morooka, Asami...................... 211
Morote, Juan ........................... 247
Morotti, Raffaella .................... 133
Morra, Massimo............. 162, 212,
........................................... 267, 270
Morris, Catherine S................. 122
Morris, Elizabeth ..................... 117
Morris, Robert T ...................... 126
Morrison, Carl ........................... 95
Morrissette, Jennifer JD........ 131,
........................................... 133, 137
Moscinski, Lynn C ... 129, 137, 154
Moser, Justin........................... 201
Moskaluk, Christopher A 127, 250
Moskowitz, Alison J................ 251
Mosquera, Juan Miguel ........ 162,
... 194, 195, 204, 213, 224, 241, 247
Mosse, Claudio A .................... 195
Mostafa, Mohamed ................ 220
Mosunjac, Marina ........... 233, 234
Mosunjac, Mario ..................... 233
Motoi, Noriko .................. 231, 237
Mott, Sarah L........................... 211
Moukarbel, Roger ........... 139, 208
Moul, Adrienne ............... 165, 228
Mounajjed, Taofic ............ 76, 175,
........................... 184, 185, 230, 234
Moura, Caio M ........................ 248
Mourra, Najat .......................... 243
Moussa, Madeleine ........ 184, 248
Moy, Andrea ............................ 242
Moyer, Ann M ......... 164, 198, 215
Mozos, Anna ........................... 164
Mpunga, Tharcisse ................. 171
Mrak, Lara N ............................ 236
Mroz, Pawel ..................... 154, 227
Mucci, Lorelei A ...................... 109
Mucientes, Francisco .............. 193
Mudaliar, Kumaran ......... 161, 200
Mudalige, Tudor ...................... 134
Muehlenbachs, Atis ............ 50, 75
Mueller, Jeffrey ....................... 238
Muezzinoglu, Bahar ................ 150
Muga, Silvia de ............... 109, 248
Muhlbauer, Aaron ................... 199

Muir, Jennifer .......................... 211
Mukherjee, Somnath .............. 157
Mukhopadhyay, Sanjay ......... 103,
........................................... 114, 136
Mullaney, Kerry ....................... 237
Mullen, Dorinda .............. 150, 181
Muller, Kristen ......................... 237
Muller, Sarina .......................... 207
Muller-Hermelink, H Konrad .. 209
Mulligan, Anna Marie ....... 80, 134
Mulligha, Charles ...................... 63
Mullighan, Charles G .............. 133
Munday, William ..................... 120
Mungall, Andy......................... 163
Munkarah, Adnan R ........ 179, 180
Munne, Jessica ....................... 135
Munoz, Nubia .......................... 223
Muppa, Prasuna .............. 205, 219
Murakami, Keigo..................... 243
Muraki, Takashi...156, 157, 166, 193
Murali, Mandakolathur ........... 242
Murali, Rajmohan ... 151, 180, 186
Muralidhar, Akshay................. 134
Murase, Yota ........................... 241
Murgic, Jure ............................ 109
Murillo, Lena ........................... 154
Murphy, Claire E ..................... 122
Murphy, Cliona................ 150, 250
Murphy, Jean .................. 212, 220
Murphy, Joanne ...................... 122
Murphy, Noel .................. 141, 182
Murphy, Rose .......................... 141
Murphy, Sandra ...................... 200
Murphy, Tom ........................... 202
Murray, Arlene ........................ 118
Murray, David.......................... 161
Murray, Melissa ............. 117, 137,
........................................... 138, 194
Murro, Diana ........................... 120
Murthy, Jayasimha N ............ 121,
........................................... 149, 210
Murthy, Kruthi ......................... 252
Murthy, Stacey L ..................... 213
Murthy, Vedang....................... 223
Murugan, Paari ....... 173, 204, 234
Murugesan, Karthikeyan ........ 183
Muscarella, Peter .................... 113
Muschel, Ruth ......................... 157
Music, Jodi S........................... 171
Musulen, Eva........................... 221
Muthukumarana, Palawinnage
Vidarshi U ................................. 215
Mutter, George L ..................... 166
Mutter, Robert W .................... 216
Muvugabigwi, Gaspard .......... 171
Muzikansky, Alona .................. 113
Muzzafar, Tariq ................ 153, 154
Myers, Charles ................ 135, 144
Myerson, David ......................... 50
Mylander, W Charles .............. 170
Myles, Jonathan ..................... 124
Myles, Nickolas ............... 117, 182
291
INDEX
N
N, Ashwini ............................... 207
Na, Hee-Young ........................ 242
Naab, Tammey ........................ 216
Nabais, Henrique .................... 150
Nabeshima, Kazuki ......... 157, 232
Naccache, Samia .................... 124
Nadal, Alfons................... 207, 215
Nadasdy, Gyongyi .................. 138
Nadasdy, Tibor ... 72, 107, 138, 183
Naderi, Samah El .................... 153
Nadji, Mehrdad ............... 216, 250
Naeim, Magda................. 179, 181
Naeini, Yalda B ........ 187, 228, 229
Nafa, Doudja ........................... 162
Nafa, Khedoudja ..................... 197
Nafisi, Houman ............... 189, 198
Nagarajan, Priyadharsini....... 120,
........................... 192, 200, 201, 242
Nagel, Barbara ........................ 122
Nagrale, Vidya................. 164, 238
Nagy, Peter L ........................... 161
Nagymanyoki, Zoltan ............. 111
Nahar, Niru .............................. 140
Nahas, Willian C...................... 224
Naidoo, Jarushka .................... 137
Naili, Reima El ......................... 239
Naini, Ali B............................... 161
Naini, Bita V............. 121, 132, 201
Nair, Ranju ............................... 213
Nairismagi, Maarja-Liisa ........ 252
Naizhen, Xu ............................. 187
Najafian, Behzad ..................... 183
Najarian, Robert ................. 26, 51,
................................... 132, 191, 244
Najfeld, Vesna ......................... 152
Nakai, Tokiko ........................... 142
Nakakura, Eric K ...................... 212
Nakamura, Shigeo .................. 229
Nakamura, Takuro................... 236
Nakamura, Toru ...................... 211
Nakamura, Yasuhiro ............... 195
Nakashima, Megan O. .... 104, 105
Nakashima, Yasuaki ................ 237
Nakazawa, Tadao .................... 243
Nakazawa, Takahiro ................ 156
Nakhleh, Raouf E ........... 101, 139,
........................................... 153, 230
Nakitandwe, Joy ..................... 133
Nalbantoglu, Ilke ............. 132, 244
Nam, Anna .............................. 228
Nam, Soo Jeong ..................... 228
Namiki, Thomas ...................... 145
Nandula, Subhadra................. 208
Nanji, Shabin........................... 226
Nanus, David M ...................... 204
Naous, Rana .... 110, 119, 218, 235
Naovarat, Benjamin ........ 163, 223
Napoli, Arianna Di .................. 252
Napoli, Luigi De ...................... 242
Nardi, Valentina ...................... 136
Narra, Krishna ......................... 118
Nart, Deniz ............................... 185
292
Narula, Navneet ............. 133, 158,

........................................... 217, 231
Nasir, Aqsa ...................... 142, 195
Nasr, Samih ............... 53, 138, 184
Nasser, Imad ........................... 132
Nassiri, Mehdi ................. 182, 193
Nastic, Denis ........................... 249
Nathanson, Katherine L.......... 120
Nathwani, Bharat N ................ 209
Natkunam, Yaso ........................ 63
Natkunam, Yasodha........ 165, 228
Natu, Ashwini.......................... 207
Naugler, Christopher ...... 171, 182
Navaid, Musharraf .................. 228
NavaRodrigues, Daniel........... 247
Navarro, Alfons ....................... 158
Nawaf, Cayce .......................... 178
Nayak, Anupma ...... 110, 164, 170
Nayar, Ritu ........ 29, 110, 111, 217,
................................... 219, 231, 240
Nayor, Jennifer ....................... 175
Nazarian, Rosalynn ................. 242
Nazeer, Tipu ..... 126, 163, 227, 246
Nedved, Drew ......................... 190
Neelkantan, Nikhil................... 143
Neely, Cameron ...... 116, 135, 144
Neema, Pranay........................ 238
Neff, Jadee L ........................... 252
Neill, Kevin .............................. 202
Neill, Stewart........................... 120
Nejati, Reza.............................. 202
Nelius, Thomas ....................... 248
Nelso, Ann Marie ...................... 28
Nelson, Andrew .............. 119, 142
Nelson, Brad H ................ 123, 134
Nelson, Emily R....................... 116
Nelson, Gregg ......................... 251
Nelson, Jonathan............ 200, 257
Nelson, Karen.......................... 114
Nelson, Peter S ............... 109, 248
Neo, Meusia ............................ 251
Neppalli, Vishala ..................... 194
Neri, Bruce....................... 205, 261
Nes, Johannes van de ............ 186
Nesbitt, Shannon .................... 154
Nesi, Gabriella................. 136, 223
Ness, Michael Van .................. 130
Nestosa, Maria Jose Fernandez ...
................................................... 223
Netto, George J.......... 88, 90, 107,
125,146,163, 178, 204, 205, 206,
.................................... 223,224, 247
Neuberg, Donna...................... 149
Neupane, Binod ...................... 118
Newcomb, Lisa ....................... 109
Newell, Jordan M ........... 167, 250
Newman, Scott ....................... 183
Newman, Travis ........................ 25
Newsom, Kent J...................... 126
Newsom, Kimberly J ...... 121, 242
Ng, Charlotte KY ............ 109, 110,
........... 137, 138, 171, 194, 216, 225
Ng, Dianna....................... 173, 210
Ng, H.K....................................... 35
Ng, Siok-Bian .................. 201, 252
Ng, Tony .......................... 113, 197
Ngeow, Joanne ....................... 251

Nguyen, Doreen .............. 163, 204
Nguyen, Giang H .................... 199
Nguyen, Johnny ............. 129, 130
Nguyen, Justin ........................ 230
Nguyen, Khanh ....................... 193
Nguyen, Nghia D .................... 129
Nguyen, Peter ......................... 171
Nguyen, Tan ............................ 199
Nguyen, Tu Dung T ................. 118
Nguyen, Vi ............................... 197
Ni, Shujuan...................... 165, 202
Ni, Ying .................................... 251
Nickeleit, Volker ...................... 254
Nickols, Hilary Highfield ......... 195
Nicolas, Marlo ................. 173, 239
Nicole, Thomas E .................... 153
Nicosia, Roberto ..................... 172
Nictolis, Michele De ................ 127
Nieboer, Daan ......................... 125
Niederberge, Nicholas............ 167
Niederberger, Philipp ............. 206
Nielsen, G Petur ....... 103, 135, 237
Nielsen, Torsten O ......... 117, 197,
................................... 235, 256, 257
Niesvizky, Ruben ..................... 210
Nikiforov, Yuri E ........... 45, 49, 90
............................ 121, 125,173, 191
Nikiforova, Marina ......... 121, 125,
... 155, 173, 188, 191, 192, 193, 251
Nine, Jeffrey ............................ 195
Ning, Gang .............................. 181
Ning, Jing ................................ 192
Ning, Yi ............................ 142, 224
Ninomiya, Hironori ................. 231
Nishikimi, Toshinori ................ 205
Nishimura, Michael I ...... 161, 200
Nishino, Michiya ..... 103, 119, 234
Nishio, Makoto ........................ 231
Nishizawa, Yuji ........................ 221
Nitta, Hiroaki ................... 164, 256
Nitta, Takeo.............................. 211
Niu, Na ............................. 179, 226
Niu, Shuang ............................ 250
Nobre, Rui ............................... 150
Nodit, Laurentia ...................... 144
Nofech-Mozes, Roy................. 178
Nofech-Mozes, Sharon .. 179, 181,
........................................... 189, 198
Nohr, Erik ................................. 168
Nolan, Amber .................... 42, 166
Nomani, Laila .......... 117, 156, 218
Nonaka, Daisuke ..................... 188
Nonaka, Keisuke ..................... 172
Nonell, Lara ..................... 206, 207
Nordenskjold, Bo .................... 138
Norkowski, Emma................... 169
Norris, Lucy ............................. 250
North, Bernard ........................ 109
North, Paula E ......................... 236
Northfelt, Donald W 164, 198, 215
Norton, Larry ................... 117, 137
Nose, Vania .......... 49, 61, 127, 135
Notohara, Kenji ....................... 156
Nour, Sherif G ......................... 124
Novo, Manuela........................ 161
Novotny, Alexander ................ 245

Nowak, Jonathan ............ 175, 203
Nowakowski, Grzegorz S ....... 227
Noy, Shawna ........................... 191
Nozad, Sahar ................... 117, 121
Nozaka, Hiroyuki ..................... 181
Nozawa, Kumiko ..................... 215
Nshimiyimana, Irenee ............ 171
Ntiamoah, Peter ...................... 162
Nucci, Marisa R ... 23, 25, 149, 151,
........................... 166, 224, 225, 249
Nuciforo, Paolo ....................... 213
Nunes, Cristiana B .................. 244
Nuttall, David .......................... 111
Nwadei, Ifeoma ....................... 120
Nybakken, Grant ..................... 194
Nyman, Mark................... 182, 266
O
Oak, Jean ................................. 137
Oakes, Scott A ......................... 212
Oakley, Fredrick D ................... 150
Ober, Elisa ............................... 142
OBrien, John K ....................... 180
OBrien, Michael ..................... 221
OBrien, Odharnaith................ 200
OBrien, Shannon ................... 127
Obstfeld, Amrom .................... 145
Ocal, Idris T ............................. 143
Ocana, Teresa .......................... 245
Ochiai, Atsushi ........................ 221
Ochsenbein, Adrian ................ 130
OConnell, Fionnuala ............. 141,
........................................... 182, 199
OConnell, Ronan .................... 111
OConnor, Brenda ................... 221
OConnor, Kathleen L ............. 134
OConnor, William .................. 134
Oda, Yoshinao ......... 196, 197, 232
ODonnell, Kathryn ................. 189
ODonnell, Patrick ................... 242
ODonoghue, Diarmuid .......... 111
ODorisio, Thomas .................. 140
Odze, Robert............ 102, 173, 174,
................... 202, 203, 219, 220, 244
Offerhaus, G Johan A ............. 191
Ogasawara, Sachiko ............... 250
Ogawa, Kumiko....................... 201
Ogden, Angela ........ 198, 217, 235
Ogino, Shuji ............................ 203
Oguejiofor, Kenneth ............... 190
Ogura, Kanako ........................ 220
Ogurtsova, Aleksandra ........... 117
Oh, Danielle ............................. 129
Oh, Hyeon Jeong .................... 221
Oh, Young-Ha .......................... 156
Ohbayashi, Chiho ................... 142
Ohe, Chisato .................... 125, 176
Ohgami, Robert S ... 155, 252, 264
Ohike, Nobu .................... 166, 193
Ohkawa, Shinichiro ................ 172
Oishi, Naoki ............................. 243
Ojima, Hidenori ....................... 184
Okal, Ryan ............................... 210
INDEX
Okamoto, Aikou ...................... 225
OKane, Sara ........................... 180
OKeane, John Conor ............. 160
Okoye, Ekene........................... 135
Okten, Turhan .......................... 195
Olar, Adriana ........................... 226
Oldfield, Leslie ................ 172, 221
OLeary, Gerard ....................... 207
OLeary, John ................. 111, 139,
........... 150, 162, 180, 181, 214, 250
OLeary, Matthew.................... 182
Oliva, Esther ....... 26, 64, 108, 112,
... 127, 151, 166, 180, 225, 226, 250
Oliva, Jorge De la ................... 207
Olivan, Mireia .......................... 247
Oliveira, Andre ........................ 196
Oliveira, Gabriel LP ................. 146
Oliveira, Rita SS .............. 150, 161
Oliver, Dwight ......................... 128
Olsen, Stephen........................ 244
Olson, Kristin A ....... 174, 175, 243
Olson, Matthew T. ................... 102
Olson, Michelle ....................... 114
Olson, Nicholas ....................... 201
Olteanu, Horatiu.............. 128, 210
Olvera, Narciso ....................... 249
OMalley, Dennis .... 187, 228, 229,
................................... 264, 265, 269
Omman, Reeba ....................... 135
Ondic, Ondrej .......................... 150
ONeil, Maura .......................... 184
ONeill, Eric.............................. 157
Ong, Clara........................ 170, 199
Ong, Menchu........................... 210
Onisko, Agnieszka........... 111, 251
Onozato, Maristela L............... 118
Onuma, Hideyuki .................... 201
Oord, Joost van den ............... 200
Oprea-Ilies, Gabriela M ... 117, 234
Opyrchal, Mateusz .................. 164
Orazi, Attilio............ 130, 137, 155,
........................................... 165, 208
Ordi, Jaume..... 114, 150, 167, 182
Ordulu, Zehra .......................... 127
ORegan, Esther M .................. 139
O'Reilly, Catherine .................. 237
ORiain, Ciaran ................ 162, 181
Orien, Jason ............................ 125
Orloff, Mark ............................. 185
Orlowski, Robert ............. 193, 210
Orta, Lurmag ........................... 110
Osaki, Jared............................. 244
Osamura, Robert Y ................. 243
Osan, Remus ........................... 238
OShea, Robert ........................ 230
Oshilaja, Olaronke O............... 117
Oshima, Kiyoko ............... 157, 230
Osman, Hany............................. 98
Osmond, Allison ..................... 122
Ostrovnaya, Irina .................... 163
Osunkoya, Adeboye O. 23, 27, 92
103, 124, 125,136, 144, 147, 167,
................................... 177, 211, 214
Otani, Kyoko ............................ 184
Otis, Christopher N ................. 213
OToole, Dermot ...................... 220
OToole, Sandra A ........... 127, 151

OToole, Sharon ............. 150, 162,
........................... 180, 181, 214, 250
Otsuka, Fumiyumi................... 172
Otto, Joie ................................. 195
Ou, Joyce J...................... 126, 225
Ouansafi, Ihsane ..................... 210
Ouseph, Madhu ...... 117, 128, 203
Oussalah, Abderrahim ........... 186
Ovcin, Emanuela ..................... 146
Ovejero, Victor ........................ 221
Overman, Michael .................. 220
Owens, Scott R........................ 159
Oxnard, Geoffrey R ......... 188, 269
Ozaki, Daisuke ......................... 159
Ozawa, Tatsuya ....................... 186
Ozerdem, Ugur........ 169, 171, 237
Ozkaya, Neval.......................... 129
Ozluk, Yasemin ........................ 206
Ozturk, Figen ........................... 195
P
Pac, Lincoln ..................... 122, 169
Pace, Lydia .............................. 171
Paddock, Christopher ............. 210
Padera, Robert F ................ 74, 118
Padmanabhan, Vijayalakshmi ......
................................... 143, 144, 213
Pagan, Carlos .......................... 212
Page, Sylvain........................... 118
Pai, Prathamesh ...................... 207
Pai, Reetesh K .. 111, 175, 176, 210
Pai, Rima.................................. 184
Pai, Rish K..................... 24, 76, 105
................................... 111, 169, 184
Pai, Trupti ................................ 239
Paietta, Elisabeth M ................ 154
Paik, Paul K .............................. 137
Paik, Seung Sam ............. 184, 246
Paintal, Ajit ...................... 217, 240
Pairon, Jean-Claude ............... 137
Pak, Christine .................. 149, 165
Pal, Prodipto ............ 114, 188, 231
Palacios, Jose.......................... 179
Palanisamy, Nallasivam .. 135, 177
Palapattu, Ganesh........... 177, 223
Palazzo, Juan P ....................... 245
Paliga, Aleksandra .................. 129
Palisoul, Scott M ..................... 212
Pallavi, Ranjita......................... 158
Palme, Carsten E ..................... 127
Palmerini, Emanuela .............. 236
Paloppi, Isis ............................. 224
Palsana, Dhaval H ........... 131, 266
Paluru, Swetha ........ 163, 176, 205
Pambuccian, Stefan E.... 119, 123,
134, 135,139, 167, 219, 212,
........................................... 240, 245
Pan, Chin-Chen ............... 148, 206
Pan, Hongyang................ 247, 260
Pan, Jincheng.......................... 177
Pan, Wei ................................... 206
Pan, Zenggang ................ 165, 228
Panarelli, Nicole .............. 192, 201
Panaretakis, Theocharis ......... 165

Pandya, Chintan ...................... 206
Paner, Gladell P ...... 124, 146, 149,
................................... 177, 185, 204
Pang, Judy C ................... 119, 144
Pang, Xiaofan .......................... 242
Pannu, Neesh .......................... 131
Pant, Mamta ............................ 230
Pantanowitz, Liron ............. 24, 44,
... 182, 190, 218, 240, 257, 265, 266
Pao, Andy ........................ 133, 134
Pao, Edward ............................ 241
Paolini, Michael............... 186, 190
Papadopoulos, Nickolas .. 163, 204
Papanastasiou, Anastasios D........
................................... 110, 137, 225
Papanikolopoulos, Nikolaos .. 183
Papaxoinis, George ................ 188
Papillon-Cavanagh, Simon .... 236
Paquette, Cherie...... 119, 180, 225
Paquin, Sarto C ....................... 218
Paradis, Valerie ............... 169, 230
Parajuli, Shobha...................... 127
Parakh, Rugvedita ................... 224
Pardeshi, Vishakha ........ 117, 126,
........................... 141, 142, 179, 249
Pareja, Fresia ........................... 117
Paresy, Marianne .................... 166
Parham, David......................... 133
Parikh, Jignesh G ............ 184, 201
Parikh, Melanie ....................... 249
Parikh, Rahul ........................... 125
Parini, Vamsi ... 125, 131, 219, 245
Parisi, Joseph E....................... 186
Park, Christopher .... 129, 193, 252
Park, Donghyun ...................... 211
Park, Do Youn .......... 156, 202, 220
Park, Emily....................... 161, 210
Park, Eun Su ............................ 206
Park, James S.................. 229, 230
Park, Jeongsoon ..................... 197
Park, Ji Young ................. 150, 245
Park, Kay J ............................... 151
Park, Kwang-Min..................... 156
Park, Kyung ............................. 158
Park, Minhee ........................... 175
Park, Sanghui .......................... 206
Park, Seung L .......................... 190
Park, Sung Hye................ 185, 228
Park, Sunyoung....................... 229
Park, Won Young .................... 206
Park, Woongyang.................... 211
Park, Yong Wook ..................... 206
Parkash, Vinita .. 112, 145, 146, 160
Parker, Elizabeth U .................. 114
Parker, Lynette................. 144, 240
Parker, Joel .............................. 165
Parks, Eric R............................. 153
Parra, Edwin .................... 188, 189
Parra-Herran, Carlos ...... 126, 151,
........................................... 179, 180
Parsons, Lauren ...................... 254
Partin, Alan .............................. 146
Parwani, Anil .. 182, 205, 234, 241,
........................... 257, 261, 266, 271
Paschke, Ralf ........................... 167
Pasha, Shabana F ........... 244, 259

Pashankar, Farzana D ............. 133
Pasic, Maria D ......................... 178
Pastor, Francisco ..................... 179
Pastorino, Ugo ................ 113, 231
Patel, Chiraag ............................ 24
Patel, Jay L ...................... 159, 228
Patel, Ketan ............................. 233
Patel, Keyur P ... 153, 154, 208, 233
Patel, Krishna .......................... 220
Patel, Natalie .................. 122, 123,
................................... 220, 245, 254
Patel, Nimesh R....................... 129
Patel, Nisha ..................... 204, 222
Patel, Nupam................... 159, 234
Patel, Rajiv ................... 24, 26, 192
Patel, Robin ............................. 210
Patel, Roshan S ....................... 123
Patel, Sanjay............................ 129
Patel, Sapna S ......... 209, 227, 245
Patel, Shraddha....................... 189
Patel, Snehal ........... 128, 133, 134
Patel, Tushar ............................ 230
Patel, Vatsal ............................. 152
Patel, Viren ...................... 168, 172
Patil, Asawari .......................... 207
Patil, Dattatraya....................... 124
Patil, Deepa .... 122, 123, 169, 191,
........................... 202, 219, 230, 244
Patterson, Andrew .................. 242
Patterson, Kara................ 208, 213
Patterson, Sara E ............ 183, 212
Pattillo, Chris ........................... 210
Patton, Kurt T .......................... 168
Paueksakon, Paisit .......... 190, 253
Pauli, Chantal ... 162, 195, 213, 241
Paulk, Adina ............................ 231
Paulson, Vera .......................... 173
Pavan, Nicola .......................... 163
Pavlisko, Elizabeth ............ 74, 136
Pawel, Bruce R ........................ 125
Paweletz, Cloud............... 188, 269
Paxton, Christian N ................. 228
Peabody, James .............. 109, 147
Pearlman, Rachel .................... 203
Pease, Garrison ....................... 160
Peckova, Kvetoslava ....... 177, 236
Pederson, Elizabeth ................ 197
Peevey, Joseph F .................... 240
Pegtel, Dirk Michiel ................. 247
Pehlivanoglu, Burcin .............. 220
Peiper, Stephen C ................... 162
Peixoto, Renata ....................... 193
Pejchal, Martina ...................... 210
Peker, Deniz ............................. 227
Pekmezci, Melike............. 186, 191
Pellegrinelli, Alessio ....... 113, 243
Pelletier, Daniel ....................... 172
Pellicier, Jalidsa ...................... 239
Pellise, Maria ........................... 245
Pelosi, Giuseppe ............. 113, 231
Pemmaraju, Manideepthi....... 150
Penault-Llorca, Frederique ............
........................................... 164, 202
Peng, Bo .................................. 135
293
INDEX
Peng, Limin ............. 116, 171, 238
Peng, Sui ................................. 165
Peng, Xuan .............................. 164
Peng, Yan ................................. 250
Peng, Yu-Ching ....................... 148
Pennington, Stephen R .......... 180
Penson, Alexander V .............. 204
Pentecost, Brian T ................... 213
Pepperell, John R.................... 225
Pere, Helene .................... 153, 215
Pereda, Saray .......................... 221
Perencevich, Molly ................. 175
Perez, Adeline ......................... 194
Perez-Atayde, Antonio............ 196
Perez-Lopez, Raquel ............... 246
Perez-Ordonez, Bayardo......... 139
Periakaruppan, Ramayee ....... 113
Perincheri, Sudhir ................... 252
Perizzolo, Marco...................... 168
Perkins, Sherrie L .............. 77, 159,
........................................... 228, 253
Perot, Gaelle ............................ 168
Perren, Aurel ........... 157, 206, 243
Perrino, Carmen M ......... 125, 173
Perrone, Federica .................... 113
Perrone, Marie ........................ 191
Perry, Anamarija ..................... 209
Perry, Arie ............... 26, 58, 78, 90,
................................... 101, 186, 191
Persad, Paul............................. 183
Pesci, Anna ...................... 151, 226
Pessetto, Ziyan ........................ 116
Peterson, Jason D ................... 213
Peterson, Kathryn ................... 192
Peterson, LoAnn ............. 137, 253
Petersson, Fredrik ................... 152
Petimar, Joshua ...................... 109
Petkiewicz, Stephanie ............. 242
Petrich, Adam.......................... 229
Petrova-Drus, Kseniya ............ 155
Pettaway, Curtis A........... 163, 223
Pettersson, Jonas ................... 180
Pettit, Kevin A.......................... 241
Pezhouh, Maryam Kherad..... 174,
........................................... 220, 222
Pfeifer, John D.... 98, 104, 113, 183
Phaeton, Rebecca ........... 167, 250
Pharaon, Majed ....................... 127
Phelan, Sine ............................ 160
Philip, Philip ............................ 203
Phillips, Carrie L ...................... 235
Phillips, Nancy J ..................... 122
Phillips, Sharon ....................... 254
Phung, Thuy .............................. 79
Piao, Jin ................................... 192
Piao, Jinhua............................. 122
Piao, Wenhua .......................... 129
Picard, Annabelle .................... 153
Picarsic, Jennifer..................... 170
Picci, Piero ....................... 168, 236
Piccoli, Anthony L ................... 182
Pichardo, Janine ..... 209, 228, 251
Picken, Maria M ............. 123, 125,
................................... 131, 178, 235
Picquenot, Jean-Michel .......... 194
Pierce, Jennifer Young ........... 250
294
Pierrot, Sebastien ................... 215

Pierson, Tiffany ....................... 116
Pietanza, Maria........................ 137
Pietsch, Torsten ....................... 186
Pijuan, Lara.............................. 135
Pike, John M............................ 142
Pilichou, Kalliopi ..................... 118
Pilkington, Loretto .................. 150
Pillai, Raju ................................ 209
Pillappa, Raghavendra ........... 184
Pimenta, Ruan CA ................... 224
Pimiento, Jose M .................... 220
Pinamonti, Maurizio ............... 241
Pina-Oviedo, Sergio........ 252, 253
Pincus, Jennifer .............. 116, 217
Pineda, Caryll .......................... 226
Pineda, Itzel ............................. 187
Ping, Zheng ..................... 129, 142
Pinheiro, Celine ....................... 173
Pinheiro, Katherine ................. 116
Pinnaduwage, Dushanthi ....... 134
Pintilie, Melania ...................... 109
Pinto, Andre ............ 181, 233, 250
Pinto, Carla .............................. 112
Pinto, Luis V ............................ 150
Pipas, J Marc ........................... 144
Pires, Andrea RC ..................... 135
Pires-Luis, Ana S ............. 112, 238
Piris, Miguel A ......... 130, 229, 242
Pirog, Edyta C.................. 246, 251
Pirruccello, Elaina ................... 129
Pirruccello, Samuel J...... 209, 253
Pisapia, David.................. 195, 213
Pisapia, Pasquale ............ 218, 245
Pischler, Carina ....................... 186
Piscuoglio, Salvatore ..... 109, 110,
........... 137, 138, 171, 194, 216, 225
Pisharodi, Latha R ................... 143
Pisters, Louis L ........................ 147
Pistillo, Maria Pia .................... 232
Pitman, Martha .................. 28, 119
Pittaluga, Stefania........... 164, 209
Pittman, Meredith E ................ 204,
................................... 219, 220, 222
Pivovarcikova, Kristyna .......... 177
Pizem, Joze.............................. 241
Pizzi, Marco ............................. 253
Pizzo, Donald P........................ 167
Pizzolitto, Stefano ................... 142
Planell, Nuria ........................... 234
Plant, Pamela .......................... 125
Plesec, Thomas ....................... 169
Pleskow, Douglas K ........ 244, 259
Plitas, George .......................... 217
Plotkin, Anna ........................... 161
Plouhinec, Helene ................... 191
Plymate, Stephen.................... 247
Podduturi, Varsha ................... 115
Podoll, Mirna B ....................... 250
Poirier, John T ......................... 137
Polanco, Carolina .................... 245
Polano, Maurizio ..................... 196
Polder, Julie G ......................... 243
Policarpio-Nicolas, Maria ....... 239
Poling, Justin .......... 142, 220, 222
Polito, Humbert ............... 156, 157

Pollack, Alan ............................ 148
Polydorides, Alexandros ....... 101,
........................................... 175, 191
Pontes, Jose ............................ 248
Ponzoni, Maurilio .................... 130
Pool, Kara-Lee ......................... 141
Popescu, Gabriel ............. 199, 256
Poppiti, Robert ........................ 198
Porcu, Pierluigi ........................ 128
Poropatich, Kate.............. 112, 225
Porter, Teresa C ....................... 150
Portier, Bryce P................ 116, 164
Portnoy, David......................... 183
Porwit, Anna.................... 128, 264
Posadas, Edwin M .................. 246
Post, Kristin ..................... 177, 197
Post, Robert ............................. 190
Post, Steven ............................ 149
Pote, Nicolas ................... 169, 230
Poterucha, John ...................... 169
Poulet, Bruno .................. 164, 256
Poulik, Janet M ....................... 215
Pouw, Roos E .......................... 191
Poveda, Andres ....................... 179
Poveda, Julio........................... 181
Powell, Isaac............................ 148
Powell, Simon ......................... 216
Powell, Suzanne Z ...... 22, 29, 130
Power, Derek ................... 200, 202
Powers, Celeste N ......... 22, 26, 28
......140, 218, 219, 234, Honors Tab
Powers, Scott .......................... 228
Pow-Sang, Julio ...................... 223
Pozdnyakova, Olga ........ 137, 155,
........................... 182, 208, 264, 266
Prabhash, Kumar .................... 207
Pradhan, Anuja ....................... 207
Pradhan, Dinesh............. 125, 205,
........................... 239, 240, 241, 251
Prajapati, Shyam..................... 145
Prakash, Gagan ....................... 223
Prakash, Nachiketh S .............. 148
Prakash, Sonam ...................... 156
Prall, Matt ................................ 240
Prandi, Davide ......................... 246
Prasad, Vinod K....................... 201
Prat, Jaime .............................. 127
Prayson, Richard ........ 93, 105,186
Prazeres, Hugo ........................ 150
Preffer, Frederic I..................... 159
Prendeville, Susan .................. 148
Press, Richard ......................... 129
Presta, Michael........................ 227
Prichard, Jeffrey............. 23, 24,97,
........................................... 106, 119
Priemer, David......................... 222
Prieto, Victor G .......... 79, 113, 120,
........................... 192, 200, 201, 242
Prihoda, Thomas..................... 239
Pritchard, Colin ................. 95, 194
Pritt, Bobbi............ 24, 50, 75, 101,
........................................... 114, 210
Priyanka, Priyanka .......... 153, 154
Procop, Gary ............. 75, 103, 159
Profeta, Theresa L ................... 215
Prokhorova, Ina ....................... 147

Provenzano, Elena .................. 103
Prudkin, Ludmila ..................... 213
Przybyci, Christopher G... 75, 101,
................................................... 124
Ptashkin, Ryan................. 212, 213
Puca, Loredana ............... 213, 241
Puccio, Carmelo ...................... 158
Puhalla, Shannon L......... 198, 256
Puiggros, Anna ....................... 189
Pulitzer, Melissa .............. 103, 107
Pulliam, Lynn .......................... 159
Pulver, Tanya ........................... 233
Punia, Jyotinder N .................. 129
Punnen, Sanoj ......................... 148
Punsoni, Michael ............ 132, 187
Purgina, Bibianna .......... 127, 139,
........................................... 160, 207
Pusceddu, Sara ....................... 243
Pusztaszeri, Marc .... 144, 152, 168
Putman, Rachel K.................... 187
Putorak, Renn .......................... 145
Putra, Juan ...................... 201, 212
Pyo, Ju Yeon.................... 120, 135
Pytel, Peter ...................... 104, 122
Q
Qarmali, Morad ....................... 142
Qayyum, Sohail ...................... 251
Qi, Jenny ................................. 212
Qi, Yanfeng .............................. 215
Qian, Xiaohua ........... 24, 167, 218
Qiu, Jihui J .............................. 171
Qu, Hong ................................. 254
Qu, Xiaoyu............................... 178
Quade, Bradley J ....... 23, 25, 166,
................................................... 224
Quann, Kevin........................... 130
Quddus, M Ruhul ........... 110, 119,
........... 121, 126, 149, 210, 223, 225
Quddus, Sana.......................... 134
Querishi, Raheela.................... 140
Quesada, Andres .... 154, 209, 252
Quick, Charles ....... 24, 97, 93, 113,
............................ 146,149, 151, 222
Quigley, Brian......... 133, 156, 157,
........................................... 166, 193
Quinones, Alexander K .......... 238
Quinones, Frances L Rosario ........
........................................... 156, 165
Quint, Wim .............................. 223
Quintana, Liza ......................... 131
Quintana, Teresa ..................... 145
Quintanilla-Fend, Leticia ........ 164
Quiroga-Garza, Gabriela ........ 241
Qureishi, Hina N...... 165, 252, 253
Qutub, Mohammed ................ 187
R
Raad, Rita Abi.................. 144, 199
Rabban, Joseph ................ 94, 166
........................... 225, 226, 227, 253
Raca, Gordana................. 130, 194
Racanelli, Dominga................. 196
INDEX
Racean, Steliana F .......... 221, 242
Racila, Emilian......................... 187
Raciti, Patricia.......................... 193
Radio, Stanley J ...................... 172
Radisky, Derek C ..... 109, 141, 216
Radlinski, Brian C .................... 248
Radpour, Ramin ...................... 130
Radtke, Ina ............................... 133
Rafeeq, Safia ........................... 220
Raffals, Laura E ....................... 219
Raffeld, Mark ................... 156, 209
Rafla-Yuan, Eric ....................... 248
Ragazzi, Moira ......................... 164
Ragheb, Josette ........................ 26
Raghunathan, Aditya .............. 186
Rahemtulla, Amir .................... 152
Rahimi, Mahdi ......................... 221
Rahman, Rozana Abdul .......... 212
Rahmani, Mahboubeh ............ 160
Rahn, Heidi ...................... 228, 253
Rahrig, Samantha ................... 214
Rai, Harpreet ........................... 172
Rai, Manoj ............................... 204
Rai, Samarpit........................... 163
Rais-Bahrami, Soroush .. 148, 205
Rajab, Amr............................... 128
Rajoria, Gaurav ............... 147, 148
Rakha, Emad .................. 109, 110,
................................... 138, 216, 217
Rakheja, Dinesh .............. 128, 178
Rakislova, Natalia .......... 150, 167,
................................... 182, 234, 245
Rakshit, Sagar ......................... 181
Ram, Prahlad ........................... 192
Ramachandran, Raga ............... 23
Ramalingam, Preetha ............ 180,
........................................... 226, 251
Raman, Jay D .......................... 125
Ramandeep, Rattan ................ 179
Ramaswamy, Bhuvaneswari... 213
Rambau, Peter......................... 251
Ramey, Jennifer K................... 194
Ramineni, Maheshwari ......... 137,
........................................... 157, 231
Ramirez, Angela M Sanguino .......
........................................... 162, 213
Ramirez, Jose .................. 158, 182
Ramirez, Ricardo ..................... 163
Ramkissoon, Shakti H.... 121, 186,
................................... 191, 258, 266
Ramnefjell, Maria.................... 157
Ramos, Benjamin.................... 145
Ramos, Irma ............................ 162
Rampal, Raajit K...................... 156
Ramsamooj, Rajendra ............ 254
Ramsay, Jennifer .................... 118
Rand, Jacob H ......................... 214
Ranade, Aditi ........................... 224
Ranchal, Tamara ..................... 229
Randev, Jabina........................ 154
Randhawa, Parmjeet .............. 254
Randhawa, Simrath ................ 254
Randolph, Melissa L ............... 162
Rane, Swapnil ......................... 207
Ranganathan, Sarangarajan .... 72
Rangel, Artur ................... 123, 215
Rangel-Filho, Artur ......... 182, 212

Rao, Amrita ............................. 234
Rao, Arundhati ....... 146, 160, 170,
................................... 208, 217, 237
Rao, Deepthi ............................ 117
Rao, Jianyu...................... 182, 241
Rao, Nagesh P ......................... 241
Rao, Priya ................ 124, 163, 223
Rao, Rema ....................... 213, 241
Rao, Sam ......................... 133, 211
Rao, Sambasiva ............. 184, 211,
................................... 221, 230, 243
Rao, Uma ................................. 196
Raoux, Delphine...................... 200
Rapaport, Franck ..................... 228
Raparia, Kirtee........................... 47
Raphael, Kalani ....................... 138
Ras, Aleksandra ...................... 162
Rashid, Asif ............ 176, 202, 220,
........................................... 244, 246
Rashid, Tariq............................ 250
Rassidakis, George ................. 165
Rasty, Golnar ........................... 151
Ratnam, Manohar ................... 180
Raugnath, Mike ....................... 140
Raut, Prachi ..................... 158, 250
Rautou, Pierre-Emmanuel ...... 169
Ravetti, Jean Louis ................. 232
Ravi, Vinod .............................. 196
Ravindranathan, Ajay ............. 113
Ravishankar, Sanjita ....... 200, 226
Rawi, Sumaya Al..................... 142
Rawish, Kojo R ........................ 249
Ray-Chaudhury, Abhik............ 187
Razavi, Pedram ....................... 164
Razmaria, Aria A ..................... 146
Rea, Bryan ............................... 137
Redd, Lucas ............................. 155
Redd, Robert ........................... 229
Reddy, Opal L .................. 149, 179
Reddy, Raveena ...................... 238
Reddy, Vijaya B ....................... 116
Reddy, Vishnu ................. 129, 228
Reder, Nicholas P .... 114, 141, 233
Redig, Amanda J .................... 188
Redline, Raymond W .............. 133
Redman, Bruce........................ 179
Redmond, David ..................... 194
Reed, Jon A ..................... 200, 257
Rehman, Aseeb ....... 120, 198, 227
Reichard, R Ross ..................... 190
Reid, Michelle......... 133, 138, 144,
156, 157, 166, 167, 175, 193, 198,
........... 211, 216, 217, 238, 235, 245
Reindl, Bailey A ....... 110, 164, 170
Reis, Katia ................................ 161
Reis, Sabrina T ................ 224, 248
Reisenbichler, Emily S ............ 115
Reis-Filho, Jorge S......... 109, 110,
........... 137, 138, 171, 194, 216, 225
Reisian, Niloufar ............. 234, 240
Reith, John D.............. 22, 24, 103,
........................................... 162, 192
Rekhtman, N............................ 159
Rekhtman, Natasha ........ 113, 137
Remotti, Helen ........ 184, 201, 203
Ren, Bing ......... 175, 203, 220, 244

Ren, Fei .................................... 175
Ren, Qinghu ............................ 126
Rendi, Mara H ................. 114, 141
Renier, Corinne ....................... 241
Rennert, Hanna ............... 217, 231
Renouf, Daniel................. 123, 193
Renwick, Neil........................... 158
Rescigno, Pasquale......... 246, 247
Resetkova, Erika .............. 171, 216
Resnick, Murray B ..... 25, 117, 121,
123, 125, 133, 175, 176, 203, 213,
.................................... 221,232, 248
Retallack, Hanna EG ............... 170
Rets, Anton V .................. 156, 210
Reuter, Victor E .. 27, 48, 126, 136,
.................... 163,176, 177, 182, 204
Revelo, Monica P .................... 138
Revert, Jose B ......................... 229
Rexer, Brent ............................. 198
Reyes, Carolina ...... 149, 151, 225,
................................................... 251
Reyes-Mugica, Miguel ............ 115
Reynolds, Alexandra .............. 208
Reynolds, Jordan P........ 101, 120,
........................................... 124, 218
Reynolds, Sam ........................ 145
Rezaee, Neda........................... 224
Reznik, Ed ................................ 177
Rezvani, Katy ........................... 184
Rhijn, Bas WG van .................. 204
Riad, Sara ................................ 178
Riaz, Nadeem .......................... 216
Riazy, Maziar ........................... 193
Ribalta, Teresa ......................... 215
Ricci, Andrew .................. 115, 117
Riccio, Riccardo....................... 234
Ricciotti, Robert............... 185, 197
Rice, Terri ................................. 191
Richard, Hope T ...................... 186
Richards, Elizabeth ................. 246
Richards, Kristy ....................... 165
Richardson, Mary S. ..... 25, 27, 28
Richmond, Abby M ................. 215
Richter, James................. 142, 233
Rickman, David ....................... 213
Ricks-Santi, Luisel J ................ 216
Rida, Padmashree CG.... 138, 198,
........................... 216, 217, 235, 238
Riddell, Robert H ............. 211, 221
Riddle, Nicole D. ................. 29, 30
Riedel, Elyn.............................. 198
Rieger, Gregor ................. 111, 245
Riel, Stacy ................................ 247
Riese, Werner T de ................. 248
Riether, Carsten....................... 130
Rigau, Marina .......................... 247
Righi, Alberto ... 121, 140, 168, 236
Riisnaes, Ruth ................. 246, 247
Riley, Elizabeth C..................... 170
Riley, Jacquelyn ...................... 159
Riley, Meghan P ...................... 129
Rimm, David L........... 87, 175, 179,
........................................... 258, 262
Rimsza, Lisa.......................... 63, 95
Rinaldo, Charles R .................. 211
Rinder, Henry .......................... 146

Rindi, Guido .................... 140, 258
Ring, Kari ................................. 112
Ritterhouse, Lauren L ....... 42, 149
Rivas, John .............................. 230
Rivera, Christine...... 116, 123, 164
Rizzo, Stefania ................. 118, 172
Ro, Jae Y.......................... 178, 206
Roa, Benjamin B ............. 200, 257
Roa, Juan Carlos ............. 157, 193
Robadi, Ibrahim A ................... 127
Robboy, Stanley J ................... 249
Robert, Marie ....................... 28, 94
Roberts, Chris.................. 180, 262
Roberts, Daniel E ........... 115, 169,
........................................... 189, 254
Roberts, Dianna ...................... 151
Roberts, Drucilla ..... 106, 126, 262
Roberts, Ian SD ....................... 183
Roberts, James ....................... 222
Roberts, Jordan ...................... 135
Robertson, Gordon ................. 163
Robertson, Keith D.................. 121
Robertson, Scott A.................. 145
Robertson, Susan J ... 109, 141, 147
Robin, Adam ................... 206, 254
Robin, Yves-Marie .................. 168
Robinson, Brian D .... 94, 152, 160,
162, 163, 195, 204, 213, 224,
........................... 234, 241, 245, 246
Robinson, Jeffrey.................... 216
Robinson, Robert ............ 100, 152
Rocha, Alejandro Best ............ 138
Rocha, Rafael M ...................... 244
Rocha, Ruana M ...................... 146
Rock, Jonathan ....................... 203
Roden, Anja C .................. 105,134,
................................... 159, 189, 232
Rodic, Nemanja............... 120, 234
Rodig, Scott ........ 77, 87, 149, 165,
................................... 253, 263, 264
Rodon, Jordi............................ 213
Rodrigues, Daniel Nava.. 246, 247
Rodriguez, Abelardo ................. 73
Rodriguez, Eva ........................ 215
Rodriguez, Fausto ... 101, 185, 187
Rodriguez, Ingrid M ................ 223
Rodriguez, Maria Angelica
Mendoza ............163, 178, 204, 247
Rodriguez, Maria DC...... 163, 204,
........................................... 223, 224
Rodriguez-Pinilla, Maria ......... 229
Rodriguez-Canales, Jaime .... 188,
........................................... 189, 199
Roehrl, Michael H .. 161, 172, 190,
................... 191, 203, 212, 221, 246
Roemer, Margaretha GM 149, 165
Roessler, Stephanie ................ 169
Rogers, Craig G .............. 109, 135,
................................... 136, 147, 176
Rogers, Heesun J ............ 130, 137
Rogers, Jessica G ................... 243
Rogers, Thomas E................... 254
Roggli, Victor L.................. 55, 102
Roh, Mee Sook ........................ 188
Roh, Michael H ................ 119, 144
Rojanapremsuk, Theera ......... 171
295
INDEX
Rojas, Claudia P ............. 143, 167,
........................................... 201, 240
Rojiani, Amyn.......................... 185
Rokutan, Mariyo...................... 158
Roland, Joseph T .................... 124
Roland, Robert ........................ 145
Roldan, Belen .......................... 145
Roma, Andres A ............... 93, 124,
........................................... 151, 251
Romagosa, Cleofe........... 235, 236
Roman, Kristin ................ 190, 271
Romanel, Alessandro ............. 194
Romaschin, Alexander ........... 178
Romero, Eduardo.................... 199
Romero, Ignacio...................... 179
Romero, Maria ........................ 172
Romerocases, Gloria ...... 148, 261
Romo-Bucheli, David .............. 199
Ronaghy, Arash....................... 226
Roncella, Silvio ....................... 232
Ronchi, Susanna ..................... 235
Rong, Yuan .............................. 186
Ronnett, Brigitte M ......... 151, 226
Ronquillo, Nemencio .............. 220
Roobol, Monique .................... 125
Rooney, Sydney ...................... 152
Rooper, Lisa M ........ 127, 140, 153
Roque, Ruben R ...................... 150
Roquiz, Woodlyne ........... 141, 249
Rosa, Marilin ........................... 198
Rosa, Stefano La ..... 140, 209, 243
Rosado, Flavia G ............. 210, 229
Rosales, Ivy A. ........................... 72
Rosas, Inma ............................. 235
Rosca, Adriana ........................ 116
Rose, Inga ........................ 214, 268
Rosen, Daniel G ...................... 216
Rosen, Devin ........................... 138
Rosen, Seymour ..... 131, 138, 226
Rosenbaum, Jason N ..... 113, 140
Rosenbaum, Matthew W........ 119
Rosenberg, Andrew E............. 152
Rosenberg, Jonathan E .. 163, 204
Rosenblatt, Mary P ................. 244
Rosenblum, Frida.................... 110
Rosenblum, Marc.................... 129
Rosenblum, Norman .............. 180
Rosenthal, Dorothy L. ............. 102
Roshal, Mikhail 155, 159, 165, 252
Rosman, Martin ...................... 170
Ross, Ashley ............................ 146
Ross, Dara S ............ 137, 164, 194
Ross, Jeffrey S ........... 85,116, 117,
120, 121, 126, 127, 138, 151, 159,
163, 166, 175, 186, 188, 193,194,
198, 203, 208, 213, 221, 227, 246,
249, 256, 257, 258,259, 260, 261,
262,263, 264, 265, 266, 267,
........................................... 268, 269
Ross, Julia A............................ 222
Rosser, Julie A ................ 119, 130
Rossi, Esther............................ 168
Rossi, Sabrina ......................... 196
Rost, Sandra .................... 190, 271
Rosty, Christopher .................... 59
Roth, David B .......................... 145
Roth, Rachel .................... 167, 203
296
Rothberg, Paul G..................... 110

Rotondo, Fabio........................ 178
Rotterova, Pavla ...................... 177
Rougemont, Anne-Laure ........ 214
Rousseau, Audrey................... 191
Roussel, Helene ...................... 153
Routbort, Mark ............... 153, 154,
................................... 161, 233, 252
Rovin, Brad .............................. 183
Rovira, Carlota ........................ 215
Rowan, Daniel ......... 157, 174, 230
Rowe, Jordi ............................... 92
Rowe, Neal .............................. 184
Rowe, Steve P ......................... 179
Roy, Angshumoy .................... 129
Roy, Somak ..... 125, 191, 205, 241
Roychoudhury, Sudarshana .. 181
Royer, Robert .......................... 181
Royston, Daniel ............... 251, 252
Ruano, Ana .............................. 209
Rubin, Brian P ..... 25, 27, 110, 194,
................................... 196, 225, 235
Rubin, Charles ......................... 194
Rubin, Mark .................... 162, 194,
... 195, 204, 213, 224, 241, 246, 247
Rubinstein, Mara R ................. 192
Rudin, C ................................... 159
Rudin, Charles M .................... 137
Rudomina, Dorota .......... 182, 190
Rudzinski, Erin R ..................... 196
Rueter, Jens............................. 212
Ruiz-Cordero, Roberto ............ 120
Rumery, Mathew..................... 233
Ruminy, Philippe ..................... 168
Runza, Letterio ........................ 187
Ruo, Leyo................................. 118
Rusch, V ................................... 159
Ruschoff, Josef ....................... 103
Rush, Natalia ........................... 132
Russ, Pierre A. ........................... 72
Russell, Maria.......................... 245
Russo, Mariano ....................... 250
Rustin, Jeannette G ................ 172
Ruterbusch, Julie J ................. 141
Rutgers, Joanne KL ........ 122, 151
Rutter, Sara.............................. 199
Ruttle, Carmel ......................... 162
Ruzinova, Marianna B .... 209, 228
Ryan, Elizabeth J..................... 111
Ryan, Philip ............................. 160
Rysgaard, Carolyn .......... 140, 241
Ryzhova, Elena ........................ 223
S
Saab, Jad ................................. 133
Saade, Rami E ......................... 151
Saadeldine, Mothana ............. 217
Sabel, Michael......................... 238
Sabido, Eduard ....................... 247
Sabir, Sharjeel ................. 113, 199
Sabourin, Jean-Christophe ...........
................................... 166, 168, 194
Sacher, Adrian......................... 188
Sacks, Wendy .......................... 143
Saco, Adela ............. 150, 158, 182

Saddiqui, Saaduddin .............. 172
Sadimin, Evita T ...... 136, 147, 249
Sadot, Eran .............................. 203
Sadow, Peter M ........ 61, 135, 140,
........................................... 144, 167
Sadowska, Justyna ................. 162
Saeed, Faisal ........................... 244
Saeed, Omer AM .................... 222
Saeed-Vafa, Daryoush ............ 198
Saegusa-Beecroft, Emi ........... 234
Saenz, Barbara ........................ 250
Sae-Ow, Wichit........................ 209
Saffitz, Jeffrey E. ................. 27, 54
Safran, Howard ....................... 175
Sagasta, Amaia ....................... 150
Saglam, Ozlen ................. 166, 180
Sahai, Anand V ....................... 218
Sahin, Aysegul A .............. 66,138,
........................................... 164, 217
Sahnane, Nora ........................ 209
Sahoo, Sunati.......................... 171
Sahu, Divya ............................. 205
Said, Ian ................................... 181
Said, Jonathan ........................ 241
Said, Samar ............................. 184
Saiji, Essia ............................... 214
Saiki, Mitiko ............................. 224
Sainati, Laura .......................... 253
Saito, Ruri ................................ 174
Sajed, Dipti ...................... 127, 212
Saka, Burcu ............. 156, 157, 166
Sakaguchi, Asumi ................... 220
Sakakibara, Rie........................ 231
Sakamoto, Michiie .................. 184
Sakamoto, Reid ....................... 145
Sakamoto, Yoshihiro ...... 184, 230
Sakr, Sharif ...................... 126, 179
Sakr, Wael A .................... 148, 248
Saksena, Annapurna .............. 227
Salahuddin, Sadia................... 165
Salama, Mohamed E ..... 128, 129,
........... 156, 181, 182, 210, 228, 233
Salama, Rasha ........................ 185
Salama, Sherine...................... 233
Salaria, Safia N ....................... 140
Salaverria, Itziar ...................... 164
Salazar, Paulo A ...................... 162
Saleeb, Rola .................... 125, 178
Salehi, Sahar ........................... 249
Salem, Fadi.............................. 110
Salem, Nagla ........... 117, 126, 249
Sali, Aakash ............................. 223
Salido, Marta ........................... 189
Salim, Alaa A........................... 233
Salimian, Kevan ...................... 134
Salipante, Stephen J .............. 154
Salipante, Steve ........................ 75
Salmon, Lauren E ................... 228
Salomao, Diva ............. 56, 73, 160
Salomao, Marcela ..................... 52
Saltel, Frederic ........................ 169
Saltzman, John R .................... 175
Saluja, Karan ........................... 173
Salvatore, Steven.... 138, 183, 195
Salvi, Sandra ........................... 232

Samarapungavan, Dilip.......... 254
Samayoa, Luis................. 116, 117
Samedi, Von G ........................ 145
Samghabadi, Peyman ............ 233
Samimi, Setareh ..................... 193
Samimi, Siavash Azadmanesh .....
................................................... 240
Samolczk, Julia ....................... 240
Samore, Wesley ...................... 246
Samowitz, Wade S .. 111,122, 201,
........................................... 258, 259
Sampathkumar, Ashwin ......... 234
Sampson, Barbara .................... 54
Samuelson, Megan I............... 149
Samulski, T Danielle ...... 122, 145,
................................................... 225
Sanada, Sakiko........................ 250
Sanati, Souzan ........ 142, 238, 239
Sanchez, Ariadna .................... 245
Sanchez, Carlos............... 235, 271
Sanchez, Diego F .................... 223
Sanchez, Gina Montealegre ... 253
Sanchez, Ignacio ..................... 135
Sanchez, Rodrigo .................... 218
Sanchez, Sandra ............. 227, 228
Sanchez, Sergio ...................... 158
Sandell, Rosalind .................... 189
Sander, Chris ........................... 177
Sanders, Mary Ann ................. 170
Sanders, Melinda E..... 23, 25, 198
Sanders, Victoria..................... 212
Sanford, Eric M ............... 249, 262
Sangel, Nikhil ..............Honors Tab
Sanger, Warren G ................... 209
Sangoi, Ankur R ...... 166, 251, 253
Sanmann, Jennifer N ............. 209
Sannier, Aurelie ...................... 169
Sannigrahi, Soma ................... 214
SantaCruz, Karen .................... 186
Santagada, Eugene................. 226
Santagata, Sandro .................. 191
Santi, Raffaella ........................ 223
Santin, Alessandro D ...... 179, 249
Santoro, Luisa ......................... 253
Santos, Liliana......................... 238
Sapino, Anna........... 121, 140, 171
Sapp, Heidi .............................. 122
Saqi, Anjali .............................. 218
Saqib, Naveed U ..................... 172
Sarafan-Vasseur, Nasrin ......... 166
Sargent, Rachel ............... 137, 146
Sari, Sule ................................. 206
Sarkar, Fazlul ................... 203, 212
Sarkar, Gobinda ...................... 191
Sarkaria, Inderpal S ................ 193
Sarmiento, Juan ............ 156, 157,
........................................... 166, 193
Sarungbam, Judy ... 126, 147, 177
Sasano, Hironobu ........... 195, 243
Sassa, Naoto ........... 205, 241, 248
Sassoon, Daniel J ........... 178, 222
Sastri, Jayant .......................... 186
Satgunaseelan, Laveniya ....... 127
Sato, Ayuko ............................. 232
Sato, Daisuke .......................... 211
INDEX
Sato, Shun ............................... 248
Satoskar, Anjali ............... 107, 138
Satou, Akira ............................. 229
Saullo, Jennifer L .................... 201
Sauter, Jennifer L............ 219, 250
Savage, Amanda..................... 111
Savage, Erica.................. 122, 123,
................................... 202, 219, 244
Sawabe, Motoji ....................... 172
Saxe, Debra F .......................... 131
Saxen, Romil ............... 26, 52, 132
Saxena, Rovin ......................... 143
Sayada, Chalom ...................... 161
Sayeed, Hadi ........................... 129
Sayeed, Sadia ................. 218, 234
Sazonova, Olga ....................... 118
Sbaraglia, Marta ............. 168, 236
Sboner, Andrea ...... 162, 194, 195,
................................... 204, 213, 246
Scala-Bertola, Julien............... 186
Scalia, Carla R ......................... 235
Scandura, Glenda ................... 222
Scarborough, John ................. 197
Scardino, Peter........................ 109
Schaberg, Kurt ........................ 119
Schadendorf, Dirk ................... 186
Schaefer, Inga-Marie .............. 168
Schaefer, Rachel ..................... 248
Schaeffer, David F ... 105, 123, 192,
........................................... 193, 203
Schaeffer, Edward M ...... 146, 247
Schafernak, Kristian T ............ 253
Schaffer, Andras ..................... 242
Schafroth, Christian ................ 245
Schalper, Kurt.......................... 179
Schantz, Daniel ....................... 239
Schatz-Siemers, Nina ............. 238
Scheier, Benjamin ................... 179
Scherpelz, Kathryn.................. 207
Scherpereel, Arnaud............... 137
Scherr, Douglas....................... 204
Schiano, Thomas .................... 132
Schieda, Nicola ............... 109, 147
Schiffman, Marc...................... 162
Schildhaus, Hans-Ulrich .. 231, 269
Schilling, Bastian .................... 186
Schirmacher, Peter ................. 169
Schittenhelm, Jens ......... 145, 146
Schlachter, Simon........... 174, 259
Schlegel, Peter N .................... 160
Schlesinger, Kathie ................. 217
Schmechel, Stephen C ........... 143
Schmidt, Janine ...................... 164
Schmidt, Robert L ........... 115, 134
Schmidt, Ryan ......................... 208
Schmidt, Yao ........................... 155
Schmitt, Alessandra ............... 234
Schmitt, Anja M ...................... 234
Schmitt, Sarah ........................ 116
Schmitz, Katja ......................... 231
Schneider, Frank ..................... 108
Schneider, Kelli ....................... 156
Schneider, Thomas ................. 183
Schnitt, Stuart J. ........... 27, 89, 98,
...... 105, 109, Special Lectures Tab
Schoedel, Karen ...................... 196
Schoen, Frederick ..................... 74

Schoenberg, Mark .................. 205
Schofield, Kevin .............. 143, 167
Scholz, Simone ....................... 186
Schoolmeester, John............. 150,
........................................... 151, 226
Schowinsky, Jeffrey T .... 119, 130
Schreckenberger, Paul............ 210
Schuh, Andre .......................... 128
Schultenover, Stephen J ........ 195
Schultheis, Anne M ....... 110, 171,
........................................... 204, 225
Schultz, Daniel ........ 138, 238, 249
Schultz, Fred............................ 145
Schultz, Nikolaus .................... 112
Schurch, Christian .................. 130
Schwalbe, Michael L............... 236
Schwartz, Lauren .... 145, 151, 163
Schwartz, Mary R .............. 78, 119,
........................................... 134, 240
Schwartz, Robert A ................. 139
Schweitzer, Karen ................... 229
Schwertfeger, Kathryn L......... 142
Sciallis, Andrew ...................... 226
Sciot, Raf ................................... 60
Sclafani, Francesco G ............. 111
Scognamiglio, Theresa ......... 152,
........................................... 160, 161
Scolyer, Richard A ... 105, 127, 186
Scott, David W ................ 227, 264
Scott, Richard .......................... 248
Scott, Sasinya N............. 163, 167,
................................... 204, 213, 241
Scotti, Mauro........................... 243
Sebastiano, Christopher.. 117,160,
................................................... 217
Secord, Angeles Alvarez ........ 249
See, William ............................ 182
Seethala, Raja R .......... 23, 25, 100,
.... 121, 132,139, 173, 207, 240, 242
Segal, Jeremy ......................... 122
Segal, Joshua.......................... 145
Segal, Neil ............................... 122
Segura, Ana M ........................ 172
Segura, Sheila E...................... 215
Seheult, Jansen ...................... 211
Sehn, Jennifer ......................... 104
Seibel, Eric J............................ 189
Seidman, Michael A ....... 172, 195
Seiler, Christian A ................... 174
Seiler, Roland .......................... 206
Sekar, Rishi R .......................... 124
Sekeres, Mikkael A.................. 153
Seki, Atsuko............................. 172
Sekine, Yasuo .......................... 159
Seko, Shuko ............................ 241
Seldenrijk, Cornelis A ............. 191
Selegean, Sorin....................... 122
Self, Craig W ........................... 140
Selig, Martin ............................ 135
Selinger, Christina I ........ 127, 151
Sell, Evan W ............................ 142
Selove, William ....................... 155
Sempoux, Christine ................ 169
Sen, Filiz .................................. 156
Sensi, Elisa .............................. 140
Seo, An Na .............................. 245

Seow, Albert ............................ 248
Sequeiros, Tamara .................. 247
Serdy, Kate M .......... 117, 171, 198
Serra, Eduard .................. 235, 236
Serra, Stefano ......................... 166
Serrano, Laia ................... 189, 248
Serrano, Sergio .............. 109, 135,
................................... 189, 206, 247
Seshan, Surya ................. 138, 183
Sesok-Pizzini, Deborah ........... 145
Sessa, Fausto .......... 140, 209, 243
Sethi, Aisha ............. 122, 176, 203
Sethi, Sanjeev ......................... 131
Sethi, Seema ........................... 123
Setia, Namrata ........ 111, 201, 202
Seto, Yasuyuki ......................... 174
Settanni, Giulio ....................... 113
Settelmeyer, Teagan ............... 214
Settembre, Elizabeth D ........... 182
Seven, Ipek Erbarut .......... 156, 93
Seviour, Elena G ..................... 192
Seward, David ......................... 197
Sezak, Murat............................ 220
Sfakianos, John P ................... 204
Shabaik, Ahmed.............. 205, 240
Shabani-Rad, Meer-Taher ...... 154,
................................................... 209
Shabihkhani, Maryam ............ 115
Shackelford, Rodney ...... 196, 214
Shafizadeh, N .................. 203, 220
Shah, Akeesha ................ 121, 207
Shah, Alpa ....................... 148, 205
Shah, Anish ............................. 123
Shah, Girish V ......................... 247
Shah, Kabeer ................... 192, 201
Shah, Rajal .............. 108, 147, 148,
........................... 224, 260, 261, 262
Shah, Ronak ............................ 204
Shah, Sejal S ........... 139, 185, 201
Shah, Tanmay ................. 125, 219
Shahab, Asif ............................ 222
Shahi, Maryam................ 119, 142
Shahlaie, Kiarash ............ 187, 243
Shahsafaei, Ali ................ 197, 208
Shaib, Walid ............................ 245
Shaikh, Fyza ............................ 220
Shailendra, Giri ....................... 179
Shakil, Fouzia .......................... 158
Shalin, Sara ............... 25, 114, 120
Shamash, Jonathan................ 222
Shanes, Elisheva ..................... 160
Shankaran, Veena ................... 122
Shannon, Kristen M ................ 112
Shanti, Rabie ................... 196, 214
Shao, Haipeng................. 137, 154
Shao, Hiapeng......................... 128
Shao, Lina................................ 154
Shao, Tiffany ........................... 215
Shareef, Hasanain................... 206
Sharif, Asma............................ 123
Sharifzad, Hamidreza ............ 172,
........................................... 190, 191
Sharma, Gaurav .............. 107, 190
Sharma, Meenal...................... 185
Sharma, Rajni... 117, 142, 224, 247
Sharma, Sachein..................... 156

Sharma, Sameer ..................... 180
Sharma, Shree .................. 24, 124
Sharp, Adam ................... 246, 247
Sharp, Linda ............................ 150
Shaw, Andrea J ....................... 254
Shaw, Gene ............................. 129
Shaw, Kenna .......... 113, 135, 166,
................................... 175, 199, 213
Shazly, Sherif .......................... 142
Sheahan, Kieran............. 111, 160,
........................................... 212, 220
Sheahan, Patrick ..................... 207
Sheehan, Christine E ..... 121, 126,
................... 138, 188, 198, 221, 222
Sheffield, Brandon S ..... 117, 123,
........................................... 134, 193
Sheikh, Umer .................. 119, 254
Sheikh-Fayyaz, Silvat...... 128, 239
Sheils, Orla ...................... 162, 214
Sheldon, Kathryn E ................. 250
Shelton, Jeremy...................... 139
Shen, Bo .................................. 174
Shen, Dejun ............. 129, 142, 198
Shen, Jia .................................. 197
Shen, Lin.................................. 174
Shen, Ronglai .......................... 137
Shen, Rulong........................... 240
Shen, Shih-Che ....................... 216
Shen, Steven ..................... 48, 178
Shen, Tiansheng ..... 170, 217, 237
Shen, Wei ................................ 130
Shen, Xiaohan......................... 175
Shen, Xuxia ............................. 179
Sheng, Dong ........................... 227
Sheng, Shijie ........................... 248
Sheng, Weiqi ........... 165, 175, 202
Sherer, Carol R ........................ 129
Sherman, William ................... 159
Shetty, Prakash ....................... 186
Shetty, Shashirekha ....... 116, 123,
................................................... 164
Shi, Min ........................... 211, 252
Shi, Qiuying............................. 207
Shi, Wei Wei ............................ 234
Shi, Yu...................................... 229
Shi, Dongping ................. 126, 148
Shi, Chanjuan .......... 121, 144, 221
Shia, Jinru .............. 112, 121, 122,
........................... 192, 203, 212, 221
Shibahara, Junji .............. 184, 230
Shibahara, Yukiko ................... 195
Shidham, Vinod B ........... 203, 239
Shields, Anthony .................... 203
Shih, Angela R ............... 113, 151,
................................... 166, 226, 244
Shim, Hyemin ................. 113, 270
Shimada, Hideaki .................... 159
Shimizu, David ........ 150, 239, 244
Shimizu, Michio ...................... 193
Shimosegawa, Tooru.............. 156
Shin, Eunah ..................... 120, 135
Shin, Hyeong C ....................... 211
Shin, Nari......................... 202, 220
Shin, Sandra J......................... 142
Shin, Sun-ah............................ 242
297
INDEX
Shinkai, Masato ...................... 215
Shinoda, Hiroko ...................... 244
Shintaku, Itsushi P .......... 149, 179
Shipe, Tracy ............................. 195
Shipp, Margaret A ......... 149, 165,
........................................... 263, 264
Shireen, Rizmee ...................... 250
Shirsat, Hemlata ..................... 134
Shiue, Yow-Ling ...................... 175
Shivdasani, Priyanka ...... 173, 203
Shojaei, Hadi ........................... 133
Sholl, Lynette M .. 47, 49, 114, 136,
... 158, 187, 188, 217, 257, 268, 269
Shon, Wonwoo .............. 120, 162,
........................................... 192, 242
Shoskes, Aaron C.................... 214
Shpall, Elizabeth ..................... 184
Shrestha, Rupendra ................ 119
Shrestha, Swati ....................... 197
Shrock, Devin L ....................... 123
Shroff, Stuti G ......... 122, 123, 131
Shuch, Brian ............................ 178
Shulman, Lawrence N ............ 171
Shun, Chia-Tung ..................... 175
Shvartsbeyn, Marianna .......... 233
Shyu, Susan ............................ 229
Si, Qiusheng ............................ 110
Sibley, Richard K ..................... 164
Sibony, Mathilde ..................... 136
Sicotto, Hugues....................... 191
Sidawy, Mary K ....................... 239
Siddiki, Hassan........................ 244
Siddiqi, Imran N ...................... 181
Siddiqui, Iram.......................... 132
Siddiqui, Javed ....................... 177
Siddiqui, Momin T ......... 118, 119,
................... 120, 127, 135, 143, 234
Siddon, Alexa .......................... 120
Sidiropoulos, Nikoletta........... 104
Sidoli, Simone................. 112, 236
Siegal, Gene P .................... 22, 27,
................... 142, 170, 212, 217, 237
Siegelbaum, Robert ................ 190
Siegele, Bradford ............ 130, 208
Siek, Lidia E ............................. 118
Sievert, Margarit ..................... 246
Sigal, Samuel .................. 229, 230
Sigel, Carlie ............. 122, 132, 221
Sigel, Keith ...................... 122, 221
Signaevski, Max ...................... 233
Sikora, Andrew G............ 152, 263
Silva, Annacarolina......... 180, 226
Silva, Elvio ....................... 112, 151
Silva, Fernanda ....................... 251
Silva, Mike ............................... 157
Silva, Milton JDBE .................. 230
Silva, Monique F ..................... 135
Silveira, Armandina .............. 1502
Silverman, Jan F ..... 162, 213, 231
Silvero, Arturo......................... 223
Sim, Jongmin.......................... 216
Sim, Jordan ............................. 141
Simi, Lisa ................................. 236
Simko, Jeffrey P ...... 109, 248, 260
Simon, Mercedes ............ 135, 189
Simonson, Paul D ................... 189
298
Simper, Novae ........................ 178

Simpson, Jean .................... 66, 80
Sinard, John .............................. 22
Singal, Amit..................... 202, 245
Singh, Arun ............................. 197
Singh, Charanjeet ................... 249
Singh, Hardeep ....................... 160
Singh, Harsharan .................... 254
Singh, Kamaljeet............ 110, 116,
........................................... 126, 232
Singh, Manmeet ..................... 233
Singh, Manpreet ..................... 123
Singh, Nanda .......................... 112
Singh, Naveena....... 102, 149, 181
Singh, Rajendra ................ 69, 192
Singh, Rajesh ................. 111, 154,
........... 160, 161, 167, 187, 192, 233
Singhal, Rashi L ...................... 227
Singhb, Baljit ........................... 215
Singhi, Aatur .......... 132, 176, 192,
................................... 193, 220, 224
Sinha, Namita ......................... 123
Sinnwell, Jason P ................... 198
Siqueira, Deborah P................ 135
Sirintrapun, Sahussapont J .........
........................................... 176, 204
Sirintrapun, S Joseph..... 126, 147
................................... 177, 182, 190
Sirlin, Claude ................... 234, 271
Sirohi, Deepika ....... 125, 136, 149,
................................... 176, 205, 249
Siroy, Alan E ............................ 201
Sisto, Andrea........................... 168
Siziopikou, Kalliopi P .............. 116
Skacel, Marek .......................... 212
Skala, Stephanie L .......... 200, 223
Skalova, Alena .......... 77, 139, 152
Skehan, Sinead ....................... 214
Skinner, Kristin ................ 110, 171
Skinner, Mary .......................... 197
Sklar, Jeffrey L ........................ 133
Slager, Susan L ....................... 165
Slambrouck, Charles van ....... 130
Slater, Shahrzad .............. 126, 149
Sloan, Emily A................ 127, 195,
........................................... 243, 250
Sloan, Sonia ............................ 111
Slodkowska, Elzbieta ..... 179, 181,
........................................... 189, 198
Slovak, Marilyn L .................... 153
Smart, Chandra ......................... 79
Smith, Catherine ..................... 154
Smith, Emily J ......................... 231
Smith, Geoffrey.............. 135, 144,
........................................... 183, 254
Smith, Kelly ..................... 114, 134
Smith, Kenneth M ................... 160
Smith, Kerrington D................ 144
Smith, Kristen ......................... 146
Smith, Lauren B .............. 154, 159
Smith, Lynette M..................... 165
Smith, R Neal .......................... 131
Smith, Steven........... 28, 125, 176,
................................... 195, 218, 219
Smith, Theresa ........................ 239
Smola, Brian............................ 119
Smolkin, Mark E ...................... 180
Smyrk, Thomas C .......... 132, 166,

........................................... 219, 245
Smyth, Lilian ........................... 137
Snape, Katie ............................ 176
Snarskis, Connor..................... 178
Snipes, George J .................... 213
Snir, Olivia L .................... 133, 225
Snyder, Dana R ....................... 231
Snyder, Michael P ........... 162, 270
Soares, Maria Fernanda ......... 183
Sobel, Mark E. ........................... 58
Sobottka, Bettina .................... 237
Soderquist, Craig .................... 130
Sohani, Aliyah R ............. 159, 229
Sohn, Jin Hee .......................... 198
Soike, Thomas ........................ 146
Sojitra, Payal ................... 134, 155
Sokol, Lena ...................... 111, 245
Solanki, Shraddha .................. 240
Solcia, Enrico .......................... 140
Solit, David B... 126, 137, 163, 204
Sollier, Elodie .................. 241, 257
Solomon, David .............. 202, 226
Solomon, Isaac H .................... 114
Solomon, James ..... 187, 205, 232
Soloway, Roger ....................... 184
Somoza, Rosa ......................... 162
Song, Jinming................. 137, 154
Song, Joo Y ............................. 209
Song, Juhee ............................ 217
Song, Sangyong ............. 113, 270
Song, Yan ................................ 224
Soni, Abha ............................... 190
Sonmez, Ceyda ....................... 238
Sonzogni, Angelica ......... 113, 231
Soo, Chia ................................. 197
Soonawalla, Zahir ................... 157
Soong, Thing Rinda 108, 175, 181
Soria, Jean-Charles ................ 194
Sosa, Luis D Mejias ................ 191
Soslow, Robert ..... 23, 71, 92, 101,
112, 126, 180, 194, 225, 226,
........................................... 249, 250
Soubrane, Olivier .................... 169
Souers, Rhona J...... 143, 153, 219
Soukiazian, Nyrie ............ 170, 199
Soundar, Esther ...................... 112
Soundararajan, Suganthi ....... 189
Sovoda, Rebecca .................... 254
Sowalsky, Adam G.................. 248
Spalding, M John ................... 190
Spaulding, Reed.............. 116, 117
Spears, Grant .......................... 189
Specht, Charles S.................... 107
Spence, J David ...................... 235
Spence, Janice M.................... 209
Sperga, Maris .......................... 177
Spiess, Philippe E ........... 163, 223
Spillane, Cathy D .... 162, 181, 214
Sporn, Thomas A. ................... 102
Spotlow, Vanessa.................... 162
Springer, Simeon ............ 163, 204
Spruill, Laura S ....................... 250
Spyropoulos, Demetri ............ 214
Sreedhar, Hari ......................... 113
Sreekumar, Arun ..................... 217
Srigley, John R ........................ 136

Sripakdeevong, Parin ..... 162, 270
Srivastava, Amitabh ...... 102, 157,
................................... 175, 202, 203
Srivastava, Sucheta ........ 164, 225
Srougi, Miguel ................ 224, 248
Staats, Paul.............. 144, 218, 240
Stacey, Xavier ......................... 114
Stachler, Matthew D ............... 175
Stadler, Nadine ....................... 186
Stadler, Zsofia ................. 112, 203
Staerkel, Gregg .............. 119, 167,
........................................... 217, 252
Stal, Olle .................................. 138
Staley, Charles ........................ 245
Staley, Christopher ................. 245
Stallworth, Christina ............... 124
Stamelos, Evangelos .............. 182
Stanek, Jerzy ........................... 115
Stang, Nolwenn Le ................. 137
Starikov, Roman S .................. 214
Stark, Alejandro ...................... 202
Starosta, Tim ........................... 118
Starostik, Petr .......................... 121
Stas, Marguerite ..................... 200
Stashek, Kristen ...... 122, 123, 131
Statz, Cara ....................... 183, 212
Steele, Lucinda........................ 110
Stefansson, Ingunn................. 110
Stein, Alexandra ..................... 174
Stein, Tracy A .......... 158, 173, 250
Steinhoff, Margaret ........ 116, 119
Steinmetz, Jamie .................... 231
Stemmer, Melissa ................... 119
Stemmer-Rachamimo, Anat ... 107
................................................... 191
Stence, Aaron.......................... 237
Stephanopoulos, Gregory...... 128
Stephen, David........................ 233
Stephens, Craig............... 180, 262
Stephens, Julie A .................... 126
Stephens, Philip J .......... 116, 117,
120,121, 127, 151, 159, 163, 186,
194, 198, 208, 213, 246, 249, 256,
258, 260, 261, 262, 263, 265, 266,
................................... 267, 268, 269
Stetler-Stevenson, Maryalice ........
........................................... 156, 252
Stevens, Keith ......................... 125
Stevens, Todd M ..................... 205
Steward, David........................ 143
Stewart, Colin JR .................... 225
Stewart, Douglas Allan... 129, 209
Stewart, John M ............ 167, 217,
........................................... 218, 246
Stewart, Rachel ....................... 134
Steyerberg, Ewout .................. 125
Stickland, Kyle......................... 166
Stieglitz, Elliot ......................... 156
Stiller, Mathias ........................ 186
Stingo, Francesco ................... 231
Stocchi, Luca ........................... 122
Stock, Wendy .......................... 130
Stockdale, Colleen .................. 149
Stoff, Benjamin K .................... 120
Stohr, Bradley ................. 113, 248
Stoler, Mark H . 150, 180, 250, 263
INDEX
Stoller, James K. ....................... 83
Stolnicu, Simona .................... 171
Stone, James R. ........................ 54
Stone, John H ......................... 128
Stoos, Catherine ............. 160, 238
Stopa, Edward G ............. 132, 187
Stopinskijs, Aleksijs ................ 145
Storer, Chad ............................ 140
Stout, Clarke ............................ 195
Stram, Michelle .............. 195, 211,
................................... 239, 240, 251
Stranahan, Alec....................... 193
Stratman, Curtis .............. 182, 265
Straub, Shana ................. 174, 222
Street, Leslie............................ 209
Streutker, Catherine J ............. 121
Stricker, Hans .......... 109, 147, 148
Strickland, Kyle C .... 167, 172, 224
Strickland, Sarah..................... 180
Strohecker, Ingrid ................... 162
Strosberg, Carolina................. 166
Stuart, Joshua M .................... 163
Stueck, Ashley E ..................... 132
Sturgis, Charles D ..... 78, 110, 117,
........................................... 143, 219
Su, Albert................................. 152
Su, Fengyun ............................ 177
Su, Nan ............ 161, 269, 270, 271
Su, Xiaoping............................ 163
Suarez, Adrian A ............. 126, 203
Suarez, Maria J ....................... 187
Suarez, Yvelisse .............. 123, 174
Subramaniyam, Shivakumar .. 158
Suciu, Christopher .................. 211
Sucker, Antje ........................... 186
Sugawara, Yumi...................... 195
Sugiura, Yoshiya ..................... 237
Suh, Ja Hee ............................. 240
Suh, James.. 116,117,120,121,127,
151,159,163,186,194, 198, 208,
213, 246,249,256,258,260,261,262,
.................................... 263,265, 267
Suh, Yeon-Lim ......................... 185
Sukhadia, Purvil ...................... 237
Sukhai, Mahadeo .................... 128
Sukhanova, Madina ................ 130
Sukov, William R ..... 172, 186, 192
Sule, Norbert ........................... 207
Suleiman, Sarah ..................... 138
Sullivan, Brian ......................... 162
Sullivan, Megan ...................... 217
Sullivan, Peggy ....................... 141
Suman, Vera J ......... 164, 198, 215
Sumiyoshi, Shinji.................... 158
Sun, Heather ........................... 149
Sun, Hongxia........... 117, 138, 199
Sun, Hongzhe .......................... 210
Sun, James...... 203, 249, 259, 262
Sun, Jun .................................. 244
Sun, Li .............................. 174, 224
Sun, Shihua ............................. 247
Sun, Tianlin ............................. 168
Sun, Weijing ............................ 220
Sun, Xiangjie ........................... 202
Sun, Yu .................................... 166
Sun, Yue .......................... 206, 221
Sun, Zhuoxin ........................... 154

Sunday, Mary E ....................... 242
Sundell, Brian.................. 174, 259
Sundi, Deb ............................... 247
Sundling, Kaitlin ..................... 121
Sundram, Uma........................ 145
Sung, Anthony D .................... 201
Sung, C James ....... 110, 119, 121,
........................... 126, 149, 210, 225
Sung, Chang Ohk .................... 240
Sung, Ji Youn .......................... 206
Sung, Simon ........................... 218
Sung, Sun Hee ........................ 206
Sung, Yun-Shao ............. 114, 115,
................................... 139, 168, 196
Sunkara, Jaya.......................... 217
Sunol, Mariona ....................... 215
Suresh, Raagini ....................... 203
Suriawinata, Arief A ....... 201, 212
Surti, Urvashi .......................... 129
Suryavanshi, Moushumi ........ 125
Suster, Saul ..................... 177, 236
Sutherland, Russel.......... 178, 214
Svajdler, Marian ...................... 177
Svrcek, Magali......................... 245
Swager, Anne-Fre ................... 174
Swan, Niall .............. 160, 212, 220
Swanson, Benjamin J............. 113
Swanson, Paul E. ...................... 29
Sweeney, Brenda J ................. 111
Sweeney, Carol ....................... 199
Sweeney, Melissa ................... 218
Sweeney, Robert T.................. 170
Swenson, Maria Evasovich .... 119
Swerdlow, Steven H .. 95,129, 146,
........................................... 155, 251
Swick, Brian............................. 241
Swinarski, David ..................... 218
Swisher, Shannon................... 138
Swisher, Stephen G ................ 231
Swisshelm, Karen ................... 208
Sy, Keiyan ................................ 161
Sybenga, Amelia..................... 146
Sykes, Don............................... 113
Sykulski, Maciej ...................... 163
Symbol, Brittany ..................... 117
Symmans, W. Fraser .............. 103
Syngal, Sapna ......................... 192
Szablewski, Vanessa ............... 152
Szankasi, Philippe ................... 130
Szentgyorgyi, Eva ................... 166
Szeverenyi, Nicklaus............... 234
Szporn, Arnold H .................... 110
Szymanski, James .................. 141
T
Tabatabai, Z Laura .................. 219
Tabernero, Josep .................... 221
Taccioli, Cristian ...................... 208
Tacha, David ................... 189, 205,
........................... 210, 262, 264, 271
Tachibana, Tomoyoshi............ 243
Tackett, Alan ............................ 149
Tada, Toyohiro......................... 241
Tada, Yuji ................................. 159

Tadros, Talaat S ............... 233, 234
Tadros, Yousef ................. 148, 261
Tafe, Laura J ................... 136, 187,
................................... 188, 198, 213
Tagawa, Masatoshi ................. 159
Tagawa, Scott T....................... 204
Tager, Andrew M....................... 47
Taggart, Melissa W .. 176, 220, 244
Tahara, Ippei ............................ 243
Taheri, Diana .......... 163, 178, 204,
................................... 223, 224, 247
Tajiri, Takuma .......................... 166
Takahashi, Hiroyuki................. 248
Takahashi, Satoru ................... 205
Takano, Masato ....................... 142
Takeda, Maiko ......................... 142
Takei, Yusuke ........................... 253
Takubo, Kaiyo .................. 244, 258
Talhouk, Aline.......... 112, 249, 250
Taljaard, Monica...................... 151
Tallini, Giovanni ........................ 45
Tallman, Martin S.................... 154
Talmon, Geoffrey A................. 124
Tam, Wayne ....... 27, 137, 208, 220
Tamagnini, Ione ...................... 164
Tamboli, Pheroze .... 135, 163, 223
Tamborini, Elena ..................... 113
Tamimi, Rulla M ...................... 110
Tan, Benjamin Yongcheng .... 170,
................................................... 199
Tan, Brent ................................ 233
Tan, Carmela ............................. 74
Tan, Char-Loo .......................... 201
Tan, Cong......................... 165, 202
Tan, Dongfeng ......................... 244
Tan, Hongying ......................... 251
Tan, Kay See ............................ 113
Tan, KS ..................................... 136
Tan, Leonard HC...................... 252
Tan, Lingyun ............................ 240
Tan, Puay Hoon .............. 137, 142,
............................ 170,199, 216, 217
Tan, Wei ................................... 207
Tan, Yaohong .................. 152, 228
Tanaka, Kuniaki ....................... 205
Tanaka, Maki............................ 238
Tanaka, Mio ............................. 215
Tanaka, Miwa .......................... 236
Tanaka, Yukichi........................ 215
Tanas, Munir............................ 237
Taneja, Krishan........................ 171
Tang, Guilin ............ 130, 137, 165,
........................... 208, 209, 227, 251
Tang, Ping ................ 170, 171, 199
Tang, Shangguo ...................... 118
Tang, Tiffany ............................ 252
Tang, Weihua .......................... 228
Tang, Xiaojia............................ 215
Tang, Yan ................................. 213
Tang, Zhaoyi ............................ 187
Tang, Zhenya ................... 208, 251
Tangella, Krishnarao ............... 199
Tanguay, Jeffrey...................... 158
Taniguchi, Hiroyuki ................. 133
Tantravahi, Umadevi .............. 225
Tao, Xiang........................ 110, 240

Tapia, Coya .............................. 138
Tapia, Elsa Li Ning .................. 147
Taplin, Mary-Ellen ................... 248
Taraboanta, Catalin ................. 127
Tarakanova, Vera..................... 210
Tardif, Jean-Claude ................. 235
Tarrell, Robert F....................... 205
Tashi, Tsewang ........................ 156
Tashkandi, Hammad ............... 123
Tasian, Sarah ........................... 154
Taskin, Orhun C ....................... 206
Tateyama, Hisashi ................... 241
Taube, Janis ....... 86, 90, 117, 152,
165, 178, 205, 257, 259, 260,
........................................... 262, 263
Tauchi-Nishi, Pamela ..... 145, 150,
........................................... 201, 239
Taute, Lindsay ......................... 195
Tavakkoli, Montreh ................. 252
Tavassoli, Fattaneh A...... 169, 171
Tavassoli, Peyman ......... 160, 204,
........................................... 224, 246
Tawedrous, Eriny ............ 125, 178
Tawfik, Ossama ....... 116, 117, 142
Tay, Jessica.............................. 127
Taylor, Barry S ................. 163, 204
Taylor, Martin .......................... 212
Taylor, Norman ................. 24, 173
Tazelaar, Henry .......................... 25
Tebit, Emaculate V .................. 116
Teixeira, Manuel R .................. 112
Teixido, Cristina ...................... 236
Tejaswi, Sooraj ........................ 174
Tempero, Margaret A ............. 212
Tempier, Ariane ....................... 152
Temprana-Salvador, Jordi..... 162,
................................................... 247
Teng, Jiamin ............................ 138
Teo, Iris .................................... 160
Teot, Lisa A .............................. 167
Terada, Keith ........................... 150
Teresi, Peggy ................... 214, 268
Terracciano, Luigi M ............... 169
Terribas, Ernest ....................... 235
Terrier, Philippe ....................... 168
Terris, Benoit ................... 193, 202
Tesdahl, Brennan .................... 152
Tessier-Cloutier, Basile ........... 126
Tetzlaff, Michael T ..... 79, 113, 120,
................... 187, 192, 200, 201, 242
Tewari, Anupama .................... 193
Tewari, Prerna ................. 139, 150
Thai, Anne ............................... 174
Thakker, Sushama .......... 183, 265
Thakral, Beenu ........ 153, 154, 227
Thalmann, George N .............. 206
Thangamani, Muthukumar .... 138
Thapa, Prabin .......................... 205
Theis, Jason D......... 131, 172, 239
Theisen, Brian ......................... 240
Theodosakis, Nicholas ........... 234
Thiele, Jurgen ......................... 137
Thiene, Gaetano.............. 118, 172
Thike, Aye Aye ............... 142, 170,
........................................... 199, 216
299
INDEX
Thomas, Cody ......................... 213
Thomas, Dafydd...................... 179
Thomas, Mariam..................... 128
Thomas, Martha...................... 250
Thompson, Carlie K ........ 138, 170
Thompson, Elizabeth ...... 117, 165
Thompson, Erika J .................. 155
Thompson, Ian ........................ 109
Thompson, Kevin J................. 215
Thompson, Lester D.R. .... 99, 100,
................................... 139, 173, 207
Thompson, R Houston ........... 205
Thomsen, Matthew B ............. 159
Thomson, Thomas.................. 152
Thor, Ann ................................... 73
Thorson, John A ............. 125, 187
Thota, Prashanthi N ................ 123
Thrall, Michael J ..................... 130
Thung, Irene ............................ 205
Tian, Shaozhou ....... 113, 137, 162
Tian, Wei .. 147, 148, 224, 261, 262
Tian, Xin................................... 252
Tian, Xuejun .................... 197, 208
Tibert, Babylonia ..................... 249
Tibshirani, Robert ................... 228
Tickoo, Satish K.............. 126, 163,
................................... 176, 177, 204
Tickoo, SK ................................ 147
Tiemeny, Placede ............ 158, 269
Tihan, Tarik .... 26, 43, 78, 186, 191
Tijssen, Jan G .......................... 191
Timon, Conrad ........................ 139
Timothy, Greiner C.................. 252
Ting, David T .................. 123, 157,
........................... 212, 259, 267, 268
Ting, Kang ............................... 197
Tirode, Franck.......................... 168
Tissier, Frederique .................. 243
Tjendra, Youley ....................... 227
Tjionas, George A ................... 147
Toetsch, Martin ....................... 146
Toganel, Cornelia .................... 171
Toledo, Gemma....................... 250
Tolle, Brian............................... 159
Tomassetti, Sara ....................... 47
Tomaszewicz, Keith........ 176, 199,
........................................... 204, 210
Tomaszewski, John................. 207
Tomita, Yasuhiko ..................... 237
Tomlins, Scott A .... 125, 176, 207,
... 214, 223, 246, 261, 262, 263, 268
Tomoka, Tamiwe ..................... 165
Tondon, Rashmi ............. 122, 123,
........................................... 127, 131
Toner, Mary ............................. 139
Torbenson, Michael .. 76, 102, 169,
........................... 184, 185, 201, 230
Torkko, Kathleen C .......... 119, 247
Torlakovic, Emina.................... 233
Tormey, Chris .......................... 120
Torne, Aureli ............................ 150
Tornos, Carmen....................... 108
Torre, Matthew ........................ 186
Torregrossa, Liborio ............... 140
Torrence, Dianne ..................... 192
Torres, Alfredo ........................ 227
300
Torres, Carmen de .................. 215

Torres, Ines De ........................ 247
Torres, Javiera......................... 193
Torres, Jaylou Velez ................ 243
Torres, Keila............................. 196
Torres, Maria L ................ 162, 213
Torres-Cabala, Carlos A .. 120, 192,
................................... 200, 201, 242
Torrez, Mary ............................ 123
Tos, Angelo Paolo Dei .... 196, 236
Tos, Paolo Dei.......................... 168
Tosi, Davide ............................. 187
Tosoian, Jeffrey....................... 146
Toth, Laura N ................... 187, 188
Toukatly, Mirna........................ 183
Toure, Emmanuel.................... 166
Toussaint, M Andrew.............. 124
Townsley, Danielle M...... 193, 253
Toydemir, Reha M ................... 210
Tozbikian, Gary........ 141, 170, 238
Tracht, Jessica ......................... 148
Traer, Elie ................................. 129
Trahan, Sylvain ....................... 118
Train, Laura J .......................... 114
Tran, Henry .............................. 133
Tran, Nam ................................ 226
Tran, Truc ................................. 125
Tranchida, Paul ....................... 126
Tranesh, Ghassan ................... 230
Tran-Thanh, Danh ................... 218
Travis, W ............ 113,136, 137,159
Traynor, Oscar ......................... 220
Treaba, Diana O ...................... 128
Treacy, Ann .............................. 160
Treloar, Murray................ 182, 266
Tretiakova, Maria S ........ 109, 123,
........................... 124, 178, 224, 248
Treurniet, Kilian M .................. 204
Trevino, Karen Elizabeth......... 222
Trevisan, Giorgia ..................... 181
Triboulet, Melanie ................... 241
Tripp, Sheryl R ................ 128, 156
Trochesset, Denise .................. 139
Trock, Bruce ............................. 146
Troester, Melissa ..................... 171
Troncone, Giancarlo ....... 218, 245
Troncoso, Patricia ................... 147
Trotter, Marin J........................ 182
Troxell, Megan ............... 114, 138,
........................................... 170, 191
Troyer, Dean .................... 109, 248
Trpkov, Kiril ....... 23, 108, 136, 145
True, Lawrence ........ 109, 233, 248
Truong, Luan D ....................... 178
Truong, Tra .............................. 232
Truskinovsky, Alexander M .... 183
Tsai, Albert .............................. 137
Tsai, Jen-Wei ........................... 197
Tsao, Ming S. ............................ 47
Tsao, Ming-Sound........... 158, 268
Tschen, Jaime ......................... 200
Tse, Darren .............................. 160
Tse, Julie Y .............................. 210
Tse, Ka Yu ................................ 225
Tseng, Hsian-Rong .................. 246
Tseng, Li-Hui ........................... 188

Tseng, Ling-Min ...................... 170
Tseng, Yun-An ......................... 123
Tsesmetzis, Nikolaos .............. 165
Tsiatis, Athanasios C...... 247, 260,
................................................... 261
Tsongalis, Gregory J ...... 162, 182
................................... 188, 212, 213
Tsongalis, Peter D ................... 213
Tsuchida, Takashi .................... 241
Tsuijikawa, Hanako ................. 184
Tsuji, Ichiro .............................. 195
Tsujimura, Tohru ..................... 232
Tsuzuki, Toyonori ........... 148, 149,
................................... 205, 241, 248
Tu, Xiaoyu ............................... 226
Tubbs, Raymond ............. 116, 164
Tucker, Tracy ............................ 197
Tull, Jamie ............................... 115
Tuluc, Madalina ....................... 139
Tumminello, Katherine ........... 227
Tunariu, Nina ........................... 246
Tung, Rebecca ......................... 161
Tung, Spencer ......................... 187
Turakhia, Samir ............... 155, 229
Turbat-Herrera, Elba A ............. 55,
........................................... 131, 138
Turmel-Roy, Justine ................ 118
Turner, Bradley ........ 170, 171, 199
Turner, Jerrold R ..................... 123
Turpin, Sara B ......................... 150
Tuschl, Thomas ....................... 158
Tuthill, J. Mark .......................... 44
Tuthill, Mark ............................ 160
Tuttle, R Michael ..................... 140
Tutuian, Radu .......................... 245
Twaddell, William S ........ 184, 229
Tworek, Joseph A ................... 153
Tykodi, Scott............................ 178
Tylee, Tracy S .......................... 143
Tyler, Janice .................... 119, 234
Tyner, Angela .......................... 123
Tyrrell, Jillian................... 189, 271
Tyryshkin, Kathrin ........... 129, 158
Tzalis, Vasilis ........................... 116
Tzankov, Alexander ................ 130
U
Uccella, Silvia .................. 209, 243
Uchiyama, Tomoko ................. 142
Udager, Aaron ................ 109, 139,
........................... 177, 179, 206, 223
Uehara, Tsuyoshi .................... 156
Ueki, Toshiharu ....................... 156
Ueng, Shir-Hwa ....................... 216
Ueno, Naoto T ......................... 116
Ueshima, Chiyuki .................... 253
Ugolini, Clara .......................... 242
Uguz, Alper.............................. 185
Ulamec, Monika ...................... 177
Ulbright, Thomas M .......... 48, 91,
................................... 125, 163, 222
Umbricht, Chris B ................... 170
Umetsu, S ................................ 203
Unger, Pamela................. 204, 226
Upadhyay, Swikrity................. 147

Uppal, Guldeep ....................... 162
Upton, Melissa P ................ 73, 189
Uraizee, Imran ......................... 171
Uram-Tuculescu, Cora ............ 218
Urbauer, Diana ........................ 112
Ureno, Alexander.................... 246
Uruga, Hironori ....................... 113
Ussene, Esperanca ................. 114
V
Vachharajani, Neeta................ 132
Vacirca, Davide........................ 187
Vafaii, Pardis.................... 129, 130
Vaickus, Max ................... 206, 221
Vainer, Ben .............................. 153
Vairamuthu, Hemamalini ....... 212
Vajpeyi, Rajkumar ................... 166
Vakar-Lopez, Funda........ 109, 123,
........................................... 224, 248
Vakiani, Efsevia .............. 111, 112,
........................... 122, 203, 212, 221
Valasek, Mark .......................... 234
Valdez, Janet ........................... 253
Valdivia-Fernandez, Rodrigo .. 248
Valea, Fidel A........................... 249
Valencia-Cedillo, Raquel......... 224
Valent, Peter ............................ 253
Valente, Alfredo .............. 115, 119
Valente, Marialuisa ......... 118, 172
Valentino, Alessandro .... 152, 232
Valenzuela, Gerardo ............... 145
Valeri, Barbara................. 113, 231
Vallangeon, Bethany............... 155
Valle, Maria.............................. 209
Valluru, Neelima ..................... 212
Valo, Isabelle ........................... 168
Valori, Laura ............................ 196
Valverde, Claudia .................... 236
VanBeek, Christine .................. 190
VanBuren, John ...................... 241
VandenBussche, Christopher J.....
102,111, 115, 118, 144,163,
........................................... 204, 257
Vanderboom, Patrick .............. 120
Vanderhyden, Barbara.... 179, 180
VanderLaan, Paul ...................... 24
VanDeusen, Matthew A .......... 231
Vanel, Daniel ........................... 236
Vanoli, Alessandro .................. 140
Varadan, Vinay ........................ 237
Varadhachary, Gauri R.... 202, 246
Varambally, Sooryanarayana. 227
Vardiman, James W ............... 194
Vardouniotis, Alexandra......... 120
Varesano, Serena .................... 232
Varga, Zsuzsanna ............ 110, 237
Varier, Indu .............................. 152
Varma, Hemant ....................... 161
Varma, Sushama............. 169, 170
Varma, Vishal .......................... 113
Varney, Ruan ........................... 160
Varshney, Neha ....................... 131
Vasef, Mohammad.................. 128
INDEX
Vasiliadis, Theodore ....... 171, 172
Vassella, Erik ........................... 157
Vats, Pankaj ............................. 177
Vaucher, Jonathan .................. 118
Vavinskaya, Vera ..................... 234
Vaz, Rui .................................... 161
Vazquez, Ivonne ...... 135, 189, 247
Veer, Laura J vant .................. 138
Vega, Francisco ....... 165, 227, 228
Vega, Lorena Lazo de la .. 207, 214
Veigl, Martina .......................... 111
Veillon, Diana .......................... 210
Veinot, John .............. 28, 107, 160
Vela, Deborah .......................... 172
Velasco, Valerie ....................... 168
Velazquez, Elsa F ............... 75, 223
Velcheti, Vamsidhar ................ 181
Vella, Jo ................................... 181
Velosa, Claudia........................ 207
Veltri, Robert W ....................... 120
Venkataraman, Girish ............. 128
Venkatraman, Lakshmi ........... 211
Vennam, Sujay ........................ 170
Vera, Francisco ........................ 179
Veraldi, Kristen L. .................... 108
Verardino, Gustavo C ............. 135
Vergilio, Jo-Anne ... 116, 117, 120,
121, 127, 151, 159, 163, 186, 194,
198, 208, 213, 246, 249, 256, 258,
260, 261, 262, 263, 265, 266, 267,
........................................... 268, 269
Verhoef, Esther........................ 125
Verstovsek, Srdan ................... 137
Veyliotti, Andrew .................... 240
Viale, Agnes .................... 162, 163
Viana, Nayara .......................... 248
Vidhun, Ramapriya ................. 215
Vieites, Begona ....................... 179
Vielh, Philippe ......................... 194
Vierkant, Robert A................... 141
Vierkoetter, Koah R ................. 150
Vieth, Michael ........................... 96
Vigliar, Elena ................... 218, 245
Vignaud, Jean-Michel............. 186
Vigneswaran, Wickii ............... 232
Vigouroux, Charlene............... 186
Vila, Jordi ................................ 114
Vila, Natalia ............................. 187
Vilaro, Marta............................ 213
Villa, Celina.............................. 130
Villalobos, Pamela .......... 188, 189
Villambrosia, Sonia Gonzalez de .
................................................... 229
Villanueva, Alberto ................. 236
Villanueva-Siles, Esperanza ... 116
Villaseca, Miguel A ......... 157, 193
Vincent-Salomon, Anne ......... 194
Vinolas, Nuria.......................... 158
Vinters, Harry .................... 65, 187
Virani, Nilam ........................... 144
Virmani, Renu ................. 114, 172
Vishal, Sagar J ........................ 133
Visscher, Daniel W ......... 109, 139,
................... 141, 164, 198, 215, 216
Visser, Mike ............................. 191
Viswanatha, David S............... 252
Viswanathan, Akila ................. 149

Viudez, Antonio....................... 202
Vivancos, Ana ......................... 213
Vivero, Marina. 158, 167, 187, 188
Vlad, George ........................... 159
Vogel, Ulrich .................... 235, 271
Vogelstein, Bert ....... 163, 178, 204
Vohra, Manjiv .......................... 170
Vohra, Poonam .............. 116, 142,
........................................... 170, 217
Voidazan, Septimiu ................. 171
Voisey, Kim .............................. 232
Volders, Nathalie..................... 200
Volel, Vladimir H ..................... 140
Volinia, Stefano ....................... 208
Voltaggio, Lysandra ............... 219,
........................................... 220, 222
Volyanskyy, Konstantin .......... 216
Volz, Marcus ............................ 208
Vora, Moiz........................ 196, 214
Voronel, Olga .......... 121, 126, 138
Vos, Jeffrey...................... 210, 229
Voznesensky, Olga .................. 248
Vrana, Julie...... 131, 138, 172, 239
Vrancken, Michael Van ........... 174
Vranic, Semir ........................... 214
Vrotsos, Elena ......... 181, 216, 232
Vujanic, Gordan ...................... 214
Vuong, Huy .............................. 243
Vural, Cigdem.......................... 150
Vyas, Monika ... 122, 123, 203, 245
Vytlacil, Christopher ............... 231
W
Wachtel, Mitchell S ................. 248
Wachter, David L ..................... 225
Wack, Katy ....................... 182, 266
Wagner, Jay............................. 146
Wagner, Susanne ............ 158, 269
Waha, Andreas ........................ 186
Wajapeyee, Narendra ............. 245
Wake, Laura ..................... 252, 253
Wakely, Paul .... 23, 25, 68, 91, 167
Wala, Samantha J ........... 125, 178
Walavalkar, Vighnesh ............ 189,
........................................... 253, 254
Walch, Axel ............................. 174
Wald, Abigail I ......................... 191
Walecha, Prerna ...................... 239
Wales, Cameron ...................... 161
Waljee, Akbar .......................... 202
Walker, Kimberly L .. 170, 208, 237
Walker, Rachel ......................... 220
Wallace, Michael ............. 113, 199
Wallace, Zachary S ................. 128
Walsh, Joanna C ..................... 122
Walsh, Kyle M ......................... 191
Walsh, Michael 113, 123, 171, 235
Walsh, Paul ...................... 141, 182
Walter, Otto ............................. 192
Walther, Zenta ......................... 133
Walts, Ann E ................... 134, 143,
........................... 159, 171, 173, 231
Wampfler, Jason A ................. 158
Wands, Jack ............................ 214

Waner, Emily E ........................ 143
Wang, Charlotte I .................... 157
Wang, Chi ................................ 134
Wang, Chichung............. 189, 190,
........................................... 270, 271
Wang, Dan ............... 164, 238, 239
Wang, Dehua ........................... 106
Wang, Dongliang .................... 229
Wang, Endi .............................. 155
Wang, Grace ............................ 200
Wang, Guiqing ................ 130, 183
Wang, Guofeng ....................... 182
Wang, Hai ........................ 125, 210
Wang, Hanlin L ........ 169, 185, 229
Wang, He ......... 113, 168, 171, 172
Wang, Helen ............. 103, 119, 132
Wang, Hongbo ........................ 239
Wang, Hongyue ...................... 172
Wang, Hua ....................... 202, 246
Wang, Huamin ........ 202, 244, 246
Wang, Huan-You ..................... 228
Wang, Hui Jun ........................ 205
Wang, Hui Y ............................ 241
Wang, James .......................... 199
Wang, Jian .............................. 226
Wang, Jianmin ........................ 171
Wang, Jindong ........................ 172
Wang, Jing .............................. 190
Wang, Jinhua .......................... 215
Wang, Julia Y .......... 212, 221, 246
Wang, Kai ....... 116, 117, 159, 175,
................... 198, 256, 257, 260, 269
Wang, Lai Mun ........................ 157
Wang, Laura ............................ 140
Wang, Li ................................... 240
Wang, Li-chong ....................... 161
Wang, Liewei ................... 198, 215
Wang, Lijuan ................... 125, 133
Wang, Li Juan ......... 121, 189, 210
Wang, Lisa ............................... 161
Wang, Lisha ............. 175, 177, 178
Wang, Lu ........ 123, 152, 177, 178,
................................... 197, 228, 237
Wang, Michael ........................ 242
Wang, Min ....................... 192, 200
Wang, Mindy ........................... 210
Wang, Mingsheng........... 177, 178
Wang, Rui ................................ 177
Wang, Sa ......... 130, 137, 165, 208
Wang, Wei ............... 130, 155, 209
Wang, Weige ........................... 227
Wang, Wei-lien ................ 196, 197
Wang, Wei-Lien (Billy) .............. 76
Wang, Weixin .......................... 193
Wang, Xi .................................. 110
Wang, Xiangxue ..................... 181
Wang, Xiaohong I ........... 138, 199
Wang, Xiuhong ....................... 138
Wang, Xiuqing ........................ 117
Wang, Xiu Qing ............... 113, 197
Wang, Xu ......................... 171, 172
Wang, Xuemei ........................ 163
Wang, Yan ....................... 116, 127
Wang, Yanhua ......................... 141
Wang, Yihong... 117, 152, 189, 232

Wang, Yinong.......................... 171
Wang, Yiqin ............................. 179
Wang, Yuxuan ................. 163, 204
Wang, Zengfeng...................... 188
Wang, Zhen ............ 120, 209, 212,
........................................... 229, 235
Wang, Zhenghe ....................... 111
Wang, Zhenglong ................... 250
Wang, Zixing ........................... 135
Wang, Zi-Xuan ........................ 162
Wani, Khalida .......................... 113
Ward, John F ........................... 147
Ward, Kristin ........................... 216
Ward, Michael B ...................... 118
Ward, Pamela M ..................... 180
Ward, Stephen C ..................... 191
Warf, M Bryan ................. 200, 257
Wargo, Jennifer A ................... 242
Warmke, Laura ................. 195, 234
Warrick, Joshua I .... 125, 167, 250
Wartchow, Eric P ..................... 189
Wartenberg, Martin ................ 157
Wasag, Bartosz ....................... 188
Wasco, Matthew ....................... 30
Washington, Kay ....................... 52
Washington, Mary K ............... 175
Wasserman, Jason K ..... 127, 141,
........................... 144, 160, 205, 207
Watanabe, Mamoru ................ 156
Waters, Kevin .......................... 118
Waters, Rebecca ..................... 184
Watkin, Emmanuel.................. 200
Watkin, William ....................... 160
Watkins, Jaclyn C .................... 149
Watkins, Simon ....................... 182
Watson, Kristalee .................... 131
Watson, Linden L .................... 237
Watson, Lisa C ....... 154, 161, 237,
................................... 256, 264, 270
Watson, Sarah ......................... 168
Watt, Christopher D ................ 145
Watts, Katherine ..................... 124
Weaver, Donald L .................... 141
Webber, Douglas..................... 195
Weber, Randal S...................... 151
Weening, Berber ..................... 204
Wei, Alice ................................. 166
Wei, Jian-Jun .................. 112, 225
Wei, Ping ................................. 226
Wei, Shi .................. 170, 197, 198,
................................... 212, 217, 237
Wei, Wei................... 109, 116, 248
Weidner, Anna-Sophie .......... 161,
........................................... 192, 220
Weigelt, Britta ........ 109, 110, 137,
... 138, 151, 171, 194, 204, 216, 225
Weinberg, Olga K .................... 155
Weinbreck, Nicolas ................. 200
Weinreb, Ilan ......... 28, 49, 77, 139
Weinshilboum, Richard M....... 98,
................................................... 215
Weinstein, John ...................... 163
Weinstein, Ronald S ............... 160
Weisenburger, Dennis D......... 209
Weiser, Martin ................. 112, 203
301
INDEX
Weisman, Paul S ..................... 151
Weiss, Heidi ............................. 134
Weiss, Sharon W .................... 196
Weiss, Vivian L ................ 144, 221
Weissferdt, Annikka 137, 157, 231
Weixiang, Chen ....................... 176
Weizer, Alon Z ................. 177, 223
Wel, Myrtle J van der ............. 191
Welch, William R ..................... 166
Welker, Kirk M ......................... 206
Wells, Jason M ........................ 115
Wen, Hannah Y ....... 116, 117, 164
Wen, Huei Chi ......................... 110
Wen, K ..................................... 220
Wen, Kwun Wah ............. 132, 156
Wen, Xian-Yu .......................... 221
Wen, Yong Hannah ................. 194
Wendroth, Scott M.................. 116
Weng, Weiwei ......... 165, 179, 202
Wenger, Doris E ...................... 237
Wenham, Robert M......... 166, 180
Wenig, Bruce M ............. 100, 105,
................................... 140, 151, 152
Wenstrup, Richard J ....... 200, 257
Wenzel, Sally ........................... 114
Werlang-Perurena, Ada .. 160, 170
Wernerson, Annika ................... 53
Wertheim, Gerald ................... 154
West, Dava .............................. 134
West, John ...... 162, 212, 267, 270
West, Robert B ............... 164, 169,
........................................... 170, 233
Westerhoff, Maria ............ 24, 122,
........................................... 169, 185
Weston, Darlene A. ................... 62
Weston, Jared D ..................... 151
Westra, William H ... 127, 152, 153
Wetzel, Stephanie ................... 139
Wexler, Deborah ..................... 126
Wheeler, Darren T. .................... 24
Wheeler, Ferrin........................ 198
Wheeler, Michael .................... 175
White, Christine .............. 139, 150
White, Kristie ..................... 26, 156
White, Kyle J ................... 228, 233
Whitman, Jeffrey D................. 132
Whittington, Elizabeth .... 147, 163
Wic, Mark R. .............................. 61
Wieben, Eric D................. 198, 215
Wieczorek, Rosemary ............. 215
Wieczorek, Tad ........................ 167
Wiemels, Joseph .................... 191
Wiencke, John......................... 191
Wiese, Tanya ........................... 218
Wiestner, Adrian ..................... 252
Wik, Elisabeth.......................... 110
Wilcox, Rebecca ...................... 146
Wilcox, Ryan A ........................ 227
Wilczak, Cynthia A. ................... 62
Wilding, Emily ................. 218, 240
Wilding, Gregory .................... 207
Wiles, Austin ................... 195, 219
Wiles, Walter ........................... 214
Wiley, Elizabeth ....................... 233
Wilkinson, David S.................... 29
302
Wilkinson, Edward J ............... 126

Wilkinson, Nafisa .................... 225
Willey, Christopher D.............. 190
Williams, Erik .................. 123, 212
Williams, Kristin E................... 213
Williams, Lindsay.................... 139
Williams, Michelle D ....... 140, 173
Williams, Nicole ...................... 237
Williams, Pamela Holtzclaw ... 114
Williams, Phillip ...................... 213
Williams, Tamara ...................... 81
Williamson, Alex K. ................ 102
Williamson, Sean R ............ 24, 30,
109, 135, 136, 147, 148, 176, 177,
................................... 178, 205, 224
Willingham, Field .................... 156
Willis, Joseph .......................... 111
Wilson, Parker ......................... 131
Wilson, Robert S ..................... 247
Wimmer, Daniel ...................... 120
Winblad, Onalisa..................... 117
Windham, Ashley ................... 237
Winer, Ira ................................. 180
Winer, Joshua ......................... 245
Winfree, Seth .......................... 235
Winham, Stacey .............. 141, 216
Winkler, Nicole ........................ 115
Winkler, Thomas ..................... 253
Winter, Des .............................. 111
Winterhoff, Boris..................... 233
Wismayer, David Schembri ... 160
Wistuba, Ignacio I .......... 157, 158,
................... 161, 188, 190, 202, 252
Witt, Benjamin ........................ 231
Wittman, Bryan ............... 205, 261
Witzig, Thomas E .................... 227
Wludarski, Sheila .................... 142
Wobker, Sara E ........................ 176
Woda, Bruce A ................ 176, 210
Wojcik, Eva M ............ 67, 68, 102
................................... 119, 123, 240
Wojcik, John .................... 112, 236
Wolber, Robert ........................ 117
Wolf, J Stuart .................. 177, 179
Wolf, Jurgen ............................ 231
Wolfe, Gregory ........................ 195
Wolff, Antonio C...................... 170
Wolff, Robert A................ 202, 246
Wolfgang, Christopher L ........ 202
Won, Helen .............................. 137
Won, Jennifer .................. 117, 233
Won, Nam Hee ........................ 221
Wong, Jerry T ......................... 209
Wong, Ka Wing ....................... 225
Wong, Kristine S ..................... 172
Wong, Richard ................ 128, 225
Wong, Serena ......................... 203
Wong, Waihay ......................... 137
Wood, Adam J ........................ 160
Wood, Brent L ................... 63, 154
Wood, Laura .................... 192, 219
Wood, Stephanie M ........ 176, 221
Woodroof, Janet ..................... 190
Woods, Robbie ........................ 139
Woods, Tina............................. 152
Woolthuis, Carolien ................ 193
Worral, Amber ........................ 171

Wou, Karen .............................. 161
Wouters, Jasper ...................... 200
Wozniak, Jason ....................... 160
Wozniak, Laura ........................ 132
Wrensch, Margaret ................. 191
Wright, Jesse P ....................... 144
Wright, Nikita .......................... 238
Wronowska, Weronika ........... 163
Wu, Angela .............. 115, 176, 238
Wu, Annie ........ 169, 187, 228, 229
Wu, Cecilia............................... 118
Wu, Chin-Lee ........................... 127
Wu, David .......................... 70, 154
Wu, Di ...................................... 159
Wu, Frances............................. 187
Wu, Gang................................. 133
Wu, Howard ............................ 143
Wu, JIn..................................... 196
Wu, Jonn ................................. 152
Wu, Richard L .......... 123, 212, 215
Wu, Roseann I. .......................... 30
Wu, Tao ............................ 240, 251
Wu, Tongtong.......................... 244
Wu, Tsung-Teh ................ 175, 185
Wu, Xuemei............. 198, 215, 234
Wu, Xun ................................... 199
Wu, Yongping.......................... 199
Wu, Yu ..................................... 197
Wu, Yun ........... 138, 164, 216, 217
Wunder, Jay S ......................... 236
Wykes, James ......................... 127
Wyse, Aaron J ........................... 25
X
Xi, Liqiang ............................... 209
Xia, Daniel ............................... 132
Xia, Guanjun ........................... 189
Xia, Jun............................ 166, 238
Xia, Michelle............................ 176
Xian, Wa .................................. 181
Xiao, Guang-Qian .......... 158, 204,
........................................... 222, 226
Xiao, Jianan ............................ 240
Xiao, Shu-Yuan ....................... 111
Xiao, Wenbin ................... 156, 253
Xiao, Yaoxing .......................... 142
Xie, Hao ................................... 230
Xie, Hong ................................. 242
Xie, Wei ................................... 155
Xie, Xian-Jin ............................ 178
Xie, Yan ............................ 130, 184
Xie, Yi ....................................... 155
Xin, Wei ........................... 121, 123
Xing, Wei ................................. 210
Xinyan, Lu ............................... 193
Xiong, Changming.................. 172
Xiong, Jianghong ................... 197
Xiong, Jinjun ........................... 117
Xiong, Yin ................................ 223
Xiong, Yiqin ............................. 210
Xu, Bin ............. 128, 140, 152, 153
Xu, Guiyan............................... 213
Xu, Guoping .................... 158, 231

Xu, Haiying .............................. 117
Xu, Haodong ........... 158, 229, 250
Xu, Huihong ............................ 143
Xu, Jessica .............................. 207
Xu, Jie .............................. 197, 227
Xu, Jin...................................... 243
Xu, Jing ................................... 132
Xu, Midie ................. 165, 179, 202
Xu, Mina L ............................... 252
Xu, Qing................................... 197
Xu, Ruliang ...................... 229, 230
Xu, Shuo .................................. 231
Xu, Xinjie ................................. 228
Xu, Xiongfei ............................ 211
Xu, Yan .................................... 142
Xu, Zhaolin .............................. 134
Xue, Yue .................. 133, 166, 193
Xu-Monett, Zijun Y ................. 130
Y
Yabe, Mariko ........................... 252
Yachnis, Anthony ................. 23, 92
Yaffe, Martin J ......................... 235
Yagi, Yukako .............................. 44
Yahagi, Kazuyuki ..................... 114
Yakirevich, Evgeny ......... 123, 125,
133, 139, 152, 175, 187, 203,
........................................... 248, 249
Yamada, Shin .......................... 205
Yamada, Yuichi ....................... 197
Yamaguchi, Rin ....................... 238
Yamamoto, Hidetaka ...... 196, 197
Yamamoto, Tomohiko ............ 201
Yamamoto, Yusuke ................. 181
Yamanaka, Kazuteru ............... 158
Yamanishi, Douglas T ..... 235, 271
Yamano, Yasuhiko .................. 133
Yamasaki, Takashi ........... 184, 216
Yamashita, Hiroharu ............... 174
Yamauchi, Shuta ..................... 158
Yamazaki, Sanae ..................... 237
Yan, Xiting ............................... 122
Yan, Zhantao ........................... 199
Yanagawa, Naoki .................... 157
Yanagihara, Eugene ................ 234
Yanagisawa, Akio .................... 237
Yanaihara, Nozomu ................ 225
Yang, Biao ............................... 211
Yang, Bin ................................. 251
Yang, Chen .............................. 142
Yang, Ching-Fen ...................... 170
Yang, Chongqing .................... 234
Yang, David T .......................... 129
Yang, Dongfang .... 117, 121, 125,
................................... 176, 210, 221
Yang, Eric ......................... 149, 166
Yang, Fei .................................. 138
Yang, Gloria ............................. 227
Yang, Guang-Yu ..... 133, 184, 211,
................................... 221, 230, 243
Yang, Haichun ......................... 138
Yang, Huaitao .......................... 143
INDEX
Yang, Hui-Min ......................... 203
Yang, Jack ............................... 239
Yang, James C. ......................... 58
Yang, Jing ........................ 116, 238
Yang, Jung Wook .................... 174
Yang, Miso ............................... 113
Yang, Ping ............................... 158
Yang, Qi ........................... 204, 222
Yang, Qian .............. 172, 203, 212,
........................................... 221, 246
Yang, Shi ......................... 192, 200
Yang, Wan Rou........................ 129
Yang, Wentao .......... 142, 179, 226
Yang, Xiaojing ......................... 158
Yang, Ximing .......... 123, 125, 177,
................................... 197, 218, 219
Yang, Xiu ................. 144, 207, 218
Yang, Youling .......................... 149
Yang, Zhaohai ......... 111, 222, 230
Yang, Zhongbo ........................ 218
Yano, Hirohisa ................. 238, 250
Yantiss, Rhonda K ......... 23, 25, 92,
...... 96, 104,121, 192, 201, 203, 220
Yao, Hui ................................... 167
Yao, James C ........................... 231
Yao, Joseph ............................. 169
Yao, Song ................................ 164
Yap, Kai Lee ............................. 130
Yaqub, Abid ............................. 143
Yardi, Ruta ............................... 186
Yared, Marwan A. .............. 42, 108
Yaseen, Alae ............................ 218
Yasir, Saba ............................... 219
Yaskiv, Oksana ................ 140, 147
Yasuda, Kaori .......................... 250
Yau, Christina .................. 138, 170
Yau, Jonathan ......................... 161
Yaxley, John ............................ 147
Yazdani, Samaneh .................. 243
Yaziji, Hadi ............................... 198
Ye, Bo ............................... 158, 250
Ye, Fei....................................... 120
Ye, Huihui ........................ 206, 248
Ye, Xiaobu ............................... 185
Yee, Eric ................................... 132
Yeh, Matthew .................... 76, 105,
........................... 169, 185, 230, 246
Yekezare, Somaye ........... 234, 240
Yemelyanova, Anna ........ 180, 226
Yenamandra, Ashwini ............ 198
Yeong, Joe ....................... 216, 217
Yergiyev, Oleksandr ................ 196
Yerian, Lisa .............................. 185
Yi, Chunhui .............................. 120
Yi, Eunhee S .... 158, 159, 189, 232
Yi, Kijong ................................. 184
Yilmaz, Funda .......................... 185
Yilmaz, Ismail .......................... 206
Yilmaz, Omer ........................... 123
Yilmaz, Osman ................ 123, 169
Yin, C Cameron ............... 153, 154,
........................................... 227, 253
Yin, Cheng C ............................ 227
Yin, Fufen ................................ 110
Yin, Hong ................................. 231
Ying, Zhitao ............................. 209
Yip, Stephen .............. 85, 197, 233

Yoder, Sean ............................. 180
Yokota, Mitsuru ....................... 221
Yonescu, Raluca ...................... 142
Yoo, Su Hyun................... 150, 249
Yoon, Esther ............................ 216
Yoon, GhilSuk.......................... 245
Yoon, Jiyoon ................... 148, 261
Yoon, J-Y ......................... 203, 221
Yordanka, Reyna ..................... 230
York, Eric B .............................. 212
Yorozu, Takashi ....................... 248
Yoshida, Akihiko...................... 196
Yoshida, Misa .......................... 215
Yoshimoto, Toyoki .................. 236
Yoshimura, Masayo ................ 157
Yoshino, Yasushi ..................... 205
Yoshizawa, Akihiko ......... 113, 158
You, Jia .................................... 240
You, M James.......................... 227
You, Xiaoming................ 184, 211,
................................... 221, 230, 243
Younes, Anas........... 209, 213, 228
Young, Keith .................... 161, 270
Young, Ken H................... 130, 252
Young, Neal ..................... 193, 253
Young, Robert H ...................... 225
Youngson, Bruce J .................. 213
Yousaf, Hira ............................. 195
Yousef, George M ... 107, 125, 178
Yousefi, Elham ........ 183, 195, 219
Yousefi, Kasra.......................... 146
Yousem, Samuel A ......... 114, 182
Yoxtheimer, Lorene................. 143
Yu, Bing ................................... 151
Yu, Danghui ............................. 211
Yu, Elliot................................... 207
Yu, Eunsil ................................. 156
Yu, Eunsil ................................. 156
Yu, Guixia ................................ 124
Yu, Hui ..................................... 148
Yu, Jiangzhou.......................... 244
Yu, Jindan................................ 125
Yu, Jing .................................... 111
Yu, Shan-Chi............................ 228
Yuan, Ji .......... 132, 165, 208, 228,
........................................... 252, 253
Yuan, Lisi ................................. 174
Yuan, Wei ................................ 189
Yuan, Xin ................................. 248
Yucesoy, Izzet .......................... 150
Yue, Junqiu ............................. 224
Yue, Pan ................................... 181
Yue, Yong......................... 215, 216
Yuen, Nancy WF...................... 225
Yun, Ji Y................................... 232
Yun, Ji Yun .............................. 242
Yusa, Toshikazu ....................... 159
Yusifli, Zerife ................... 144, 175
Yusuf, Muhammed A.............. 244
Yusuf, Yasmin ........................... 18
Z
Zabor, Emily C ......................... 163
Zaccarini, Daniel ..................... 115
Zafar, Nadeem......................... 122
Zafeiriou, Zafeiris .................... 246
Zafon, Carles ........................... 162
Zahavi, David J ............... 224, 247
Zahrani, Ali Matar Al .............. 209
Zahurak, Marianna.................. 202
Zai, Ertao ................................. 165
Zaidi, Ali................................... 231
Zaidi, Syed............................... 239
Zaino, Richard ................. 151, 250
Zaki, Sherif ........................ 75, 210
Zaloudek, Charles ... 166, 225, 226
Zamboni, Giuseppe ................ 193
Zanatta, Lucia .......................... 196
Zanconati, Fabrizio ................. 142
Zander, Dani ...................... 83, 232
Zante, Annemieke van............ 111
Zarbo, Richard J...... 107, 160, 235
Zarei, Shabnam............... 127, 234
Zarrabi, Nikou ......................... 156
Zavodszky, Maria .................... 238
Zeck, Jay .................................. 239
Zedek, Daniel C. ........................ 29
Zeh, Herbert J ................. 192, 193
Zehir, Ahmet............ 164, 196, 212
Zehnder, Jim ................... 133, 211
Zeitouni, Joseph ..................... 182
Zelenetz, Andrew D ........ 209, 228
Zelonis, Michele K .................. 231
Zemek, Allison J ............. 119, 212
Zen, Yoh ........................... 157, 184
Zenali, Maryam ....................... 161
Zeng, Chun .............................. 138
Zeng, Gang .............................. 254
Zeng, Jennifer ................. 167, 173
Zeng, Yu................................... 165
Zeng, Zhengyu ........................ 240
Zera, Richard ........................... 142
Zerbini, Maria .......................... 173
Zere, E. Handan......................... 71
Zhai, Qihui Jim.............. 94, 108
Zhan, Yang .............................. 215
Zhang, Bingqing ............ 161, 269,
........................................... 270, 271
Zhang, Cathy ........................... 173
Zhang, Chen ............................ 232
Zhang, Da ................................ 190
Zhang, David ........... 110, 120, 152
Zhang, Gloria .................. 117, 251
Zhang, Guojuan ...................... 208
Zhang, Hailing ................. 137, 154
Zhang, Haitao .......................... 215
Zhang, Hao .............................. 240
Zhang, Hongfeng ............ 188, 244
Zhang, Jiexin........... 166, 175, 213
Zhang, Jing ............................. 211
Zhang, Jinghui ........................ 133
Zhang, Jun ...................... 176, 206
Zhang, Lei ............... 115, 139, 168,
........................................... 196, 241
Zhang, Li .......................... 124, 163
Zhang, Lihong ......................... 240

Zhang, Ling ..................... 129, 130
Zhang, Lingxin ................ 142, 153
Zhang, Linsheng ..................... 183
Zhang, Lizhi ............. 132, 166, 245
Zhang, Miao ............ 124, 184, 223
Zhang, Ming ............................ 213
Zhang, Mingjuan L.................. 187
Zhang, Pan ...................... 121, 217
Zhang, Ping L .......................... 254
Zhang, Pingchuan ................... 168
Zhang, Qing..................... 112, 225
Zhang, Qiongyan .... 165, 179, 202
Zhang, Ranran......... 121, 151, 243
Zhang, Rongzhen .................... 129
Zhang, Rui ............................... 210
Zhang, Shanxiang................... 182
Zhang, Shaobo................ 177, 178
Zhang, Shengle ....... 115, 119, 218
Zhang, Shizhen ....................... 124
Zhang, Songlin........ 117, 138, 199
Zhang, Tianzhu........................ 248
Zhang, Tuo .............................. 194
Zhang, Weiwei ........................ 179
Zhang, Xiao ............................. 216
Zhang, Xiaofei ................. 175, 191
Zhang, Xiaohui................ 154, 202
Zhang, Xinmin ........................ 128
Zhang, Xuchen ............... 122, 144,
........................................... 203, 245
Zhang, Xuefeng ...................... 175
Zhang, Xun .............................. 224
Zhang, Yang .................... 184, 195
Zhang, Yanhong ...................... 170
Zhang, Yanmin ........................ 123
Zhang, Yanming ...................... 229
Zhang, Yaxia ............................ 218
Zhang, Yonghua ...... 189, 270, 271
Zhang, Yuekai.................. 247, 260
Zhang, Zesong ........................ 110
Zhang, Zhen ............................ 231
Zhang, Zhenwei ...................... 248
Zhang, Zhiqing ........ 189, 270, 271
Zhang, Ziying .......................... 249
Zhao, Chaohui L .............. 133, 152
Zhao, Chengquan ... 110, 239, 240
Zhao, Chenyan ........................ 211
Zhao, Chong ............................ 155
Zhao, Hui ................................. 222
Zhao, Jing-min ........................ 210
Zhao, Joe Z.............................. 134
Zhao, Kevin Y .......................... 213
Zhao, Lei .......................... 122, 185
Zhao, Liena .............................. 143
Zhao, Ming .............................. 224
Zhao, Qing ............................... 221
Zhao, Song Q .......................... 189
Zhao, Tianhao ......................... 182
Zhao, Weiqiang ....... 125, 208, 213
Zhao, Xiaomu.......................... 254
Zhelnin, Kristen E.................... 133
Zheng, BaoWen .............. 110, 240
Zheng, Gang.................... 134, 247
Zheng, Guangjuan .................. 197
Zheng, Mei ...................... 165, 209
303
INDEX
Zheng, Qizhi ............................ 247
Zheng, Wenxin ........................ 166
Zheng, Xiaoyong .................... 126
Zheng, Yifan ............................ 202
Zheng, Zhongxi ....................... 181
Zhong, Minghao ............ 136, 158,
........................... 180, 188, 197, 244
Zhong, Minhao........................ 216
Zhou, Delu ............................... 182
Zhou, Haijun (Steve) ....... 119, 218
Zhou, Jiehao ................... 182, 185
Zhou, Lan................................. 121
Zhou, Li .................................... 154
Zhou, Lixin............................... 224
Zhou, Ming ....... 75, 101, 108, 123,
................... 124, 136, 147, 148, 177
Zhou, Shuling.......................... 142
Zhou, Wendi .................... 132, 185
Zhou, Xianrong ....... 110, 179, 240
Zhou, Xiaoyan ................. 175, 227
Zhou, Yaolin .............. 25, 120, 159
Zhou, Yi ... 131, 134, 135,154, 155,
................... 165, 212, 219, 228, 245
Zhou, Yu .................................. 181
Zhou, Zhongren ...................... 244
Zhu, Andrew............................ 169
Zhu, Benjamin ......................... 220
Zhu, Bin ................................... 193
Zhu, Guo .................................. 191
Zhu, Hongfa............................. 191
Zhu, Hongguang ..................... 114
Zhu, Jun................................... 183
Zhu, Menglei ........................... 123
Zhu, Minghua .......................... 211
Zhu, Shaobo ............................ 231
Zhu, Shirley X ......................... 170
Zhu, Ya-Zhen ........................... 197
Zhuge, Jian.............................. 130
Zia, Hamid ....... 128, 133, 208, 231
Ziemnik, Suzanne M ............... 153
Zimmer, Lisa............................ 186
Zimmermann, Michael ........... 165
Ziober, Amy ............................. 127
Zippin, Jonathan H ................. 246
Zirpoli, Gary ............................ 171
Ziskin, Jennifer........................ 233
Zlobec, Inti ....... 111, 130, 174, 245
Zoino, Roberto ................ 147, 148
Zoppo, Franco ......................... 172
Zorn, Kristin............................. 113
Zoroquiain, Pablo ................... 187
Zreik, Riyam T ......... 146, 160, 237
Zsengeller, Zsuzsanna K......... 226
Zukerberg, Lawrence ..... 123, 155,
........... 166, 174, 210, 229, 230, 244
Zuna, Rosemary ...................... 134
Zuo, Chunlai ............................ 126
Zuo, Zhuang .... 116, 153, 154, 155
Zuppan, Craig.......................... 183
Zweidler-McKay, Patrick A ..... 208
Zynger, Debra L........ 97, 125, 141,
................................... 170, 173, 238
304

2016 ProgramBook PDF

Transféré par

Informations du document

Description originale:

Titre original

Copyright

Formats disponibles

Partager ce document

Partager ou intégrer le document

Options de partage

Avez-vous trouvé ce document utile ?

Ce contenu est-il inapproprié ?

Droits d'auteur :

Formats disponibles

2016 ProgramBook PDF

Transféré par

Droits d'auteur :

Formats disponibles

2016

SCHEDULE & GENERAL INFO

s two new FDA-approved PD-L1 pharmDx kits.

ng is a promising new tool for pathologists, oncologists and

th two FDA-approved PD-L1 tests for patients with NSCLC.

QR codes to the right for more information on either

Version 1.1 25 October 2013

IntelliSite is a new innovative platform to

Visit us at USCAP 2016 at booth #1002 or

Stand Out with Biocare

TRIDENT FISH probes are generated using the most

CK HMW + p63 + AMACR (RM)

Order Online 24/7! www.biocare.net 800 949 9799 facebook.com/biocaremedical

Inspirata and Philips are delivering on

To learn more about the role

digital pathology. Together, our goal is

VISIT BOOTH #1007

The sponsor of this ad veries that they had no input

Need PD-L1 answers

PD-L1 IHC 22C3 pharmDx

PD-L1 IHC 28-8 pharmDx

Scan the QR codes to the right for more information on either

Learn more at www.dako.com.

The sponsor of this ad verifies that they had no input

50242 2015NOV06 USCAP16 Program Advert_halfpage_horizontal.indd 1

Official Silver Sponsor of USCAP 16 Booth #1018

Comprehensive Diagnostic and Predictive

PD-L1 by IHC for Non-Small Cell Lung Cancer

Expanded RAS and RAF Predictive Testing for Colorectal Cancer

IntelliGEN Next Generation Sequencing Therapeutic Panel

Prosigna Breast Cancer Prognostic Gene Signature Assay

Reveal SNP Array for Hematologic Malignancies

Because Knowledge is a Powerful Tool.

Prosigna is a registered trademark of NanoString Technologies, Inc.

Lab for all your

Discover how our exploration of

Visit us at Booth #433 and

Creating a Better Pathologist

WHAT IS THE SINGLE BIGGEST CAUSE OF DEATH FOR WOMEN,

HUT LUNG: A POIGNANT PORTRAIT

THOMAS V. COLBY, M.D.

AMI VITALE | RIPPLE EFFECT IMAGES

TAB 5 SPECIAL COURSES

Certificate of CME/SAM Credit or Participation ........................... p. 3

Saturday Residents Workshop: Genomic Medicine for

TAB 3 COMPANION SOCIETY MEETINGS

TAB 4 SPECIALTY CONFERENCES

TAB 6 LONG COURSE

TAB 7 SHORT COURSES

TAB 8 SPECIAL LECTURES

NEXTGENERATION LEARNING 2016

2016 NEXTGENERATION LEARNING

CERTIFICATE OF CME/SAM CREDIT OR PARTICIPATION

8.75 TOTAL CREDITS

JOINT ACCREDITATION STATEMENT

NEXTGENERATION LEARNING 2016

JOINT ACCREDITATION STATEMENT (CONTINUED)

COMPANION SOCIETY MEETINGS EXCEPT*

Endocrine Pathology Society

3.0 CREDITS EACH

History of Pathology Society*

MARCH 13 ..................................................... 3:00 PM